Citrus Sinensis ID: 045652
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 621 | 2.2.26 [Sep-21-2011] | |||||||
| Q3E991 | 659 | Probable inactive leucine | no | no | 0.933 | 0.880 | 0.446 | 1e-145 | |
| C0LGR9 | 676 | Probable LRR receptor-lik | no | no | 0.916 | 0.841 | 0.378 | 1e-112 | |
| C0LGU0 | 662 | Probable LRR receptor-lik | no | no | 0.925 | 0.868 | 0.375 | 1e-109 | |
| Q9LPT1 | 686 | Probably inactive leucine | no | no | 0.937 | 0.848 | 0.359 | 6e-97 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.916 | 0.864 | 0.346 | 3e-88 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.906 | 0.840 | 0.339 | 5e-83 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.924 | 0.876 | 0.329 | 1e-79 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.916 | 0.907 | 0.334 | 3e-78 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.919 | 0.873 | 0.336 | 7e-78 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.909 | 0.873 | 0.332 | 1e-75 |
| >sp|Q3E991|Y5269_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At5g20690 OS=Arabidopsis thaliana GN=At5g20690 PE=2 SV=4 | Back alignment and function desciption |
|---|
Score = 517 bits (1331), Expect = e-145, Method: Compositional matrix adjust.
Identities = 285/638 (44%), Positives = 396/638 (62%), Gaps = 58/638 (9%)
Query: 1 MSESEALLKLKSSFTNAKA-LDSWMPSTAPCRGGEEEWSGVVCLKGI-VTGLYINSMGLS 58
+SESE L++ K+S K L+SW T PC G +W G+ C KG+ V+G+++ +GLS
Sbjct: 28 VSESEPLVRFKNSVKITKGDLNSWREGTDPCSG---KWFGIYCQKGLTVSGIHVTRLGLS 84
Query: 59 GKIDVDALTELTGL--------------------RGLRAIYLDKNQFSGEIPPGYFDEMG 98
G I VD L +L L RGL+++ L N FSGEI +F +M
Sbjct: 85 GTITVDDLKDLPNLKTIRLDNNLLSGPLPHFFKLRGLKSLMLSNNSFSGEIRDDFFKDMS 144
Query: 99 ALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIP-SF-DQPTLVRLNLSSNKL 156
L++L+ +NKF G +P S+ +LP L ELH++SN G IP F L L+LS+N L
Sbjct: 145 KLKRLFLDHNKFEGSIPSSITQLPQLEELHMQSNNLTGEIPPEFGSMKNLKVLDLSTNSL 204
Query: 157 EGEIPASLL--RFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDD 214
+G +P S+ + A + + N LCG + V C N + + + P P E +
Sbjct: 205 DGIVPQSIADKKNLAVNLTENEYLCGPVVDVGCENIELNDPQEGQPPSKPSSSVPE-TSN 263
Query: 215 SKKVIAAGVALSVMLVSIAIVVIIRIRRKRK--AFKVL-EKESVQAVEVRVSVPNKSRDV 271
+ A V++S++L+ IV +I+ R K+K F++L VEVR+S +S
Sbjct: 264 KAAINAIMVSISLLLLFFIIVGVIKRRNKKKNPDFRMLANNRENDVVEVRIS---ESSST 320
Query: 272 DVSRKASSSRRGSSHHGKNS---GVG-------------------ELVLVNGQKGVFGLP 309
R SSR+ H S GV ++++VN KG FGLP
Sbjct: 321 TAKRSTDSSRKRGGHSDDGSTKKGVSNIGKGGNGGGGGALGGGMGDIIMVNTDKGSFGLP 380
Query: 310 DLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV 369
DLMKAAAEVLGNG LGS+YKA+M G++VVVKR+++ + +AR+ FD E+RR G+LRH N+
Sbjct: 381 DLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLAREPFDVEMRRFGKLRHPNI 440
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L PLAYHYR +EKL+V EY+P SLLY+LHGDRG H ELTW RLKI+QG+A G+ +LH
Sbjct: 441 LTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWATRLKIIQGVAHGMKFLH 500
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKV 489
E A DLPHGNLKSSN+ +S EPLIS++ F ++ +N +QALFA+K PE Q+ +V
Sbjct: 501 EEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNASQALFAFKTPEFAQTQQV 560
Query: 490 TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549
+ K DVYCLGIIILEILTGKFPSQYL NG GG D+V+WV S+ +E + +L+DPEI ++T
Sbjct: 561 SHKSDVYCLGIIILEILTGKFPSQYLNNGKGGTDIVQWVQSSVAEQKEEELIDPEIVNNT 620
Query: 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587
S +M +LL +G AC S+P++RL+MREAVRRI +++
Sbjct: 621 ESMRQMVELLRVGAACIASNPDERLDMREAVRRIEQVK 658
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGR9|Y4312_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g31250 OS=Arabidopsis thaliana GN=At4g31250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1044), Expect = e-112, Method: Compositional matrix adjust.
Identities = 241/637 (37%), Positives = 343/637 (53%), Gaps = 68/637 (10%)
Query: 3 ESEALLKLKSSFTNAKALDSWMPSTAPC---RGGEEEWSGVVCLKGIVTGLYINSMGLSG 59
+++ALLK KSS NA +L W PC +G + +W GV+C G V L + +M LSG
Sbjct: 29 DADALLKFKSSLVNASSLGGWDSGEPPCSGDKGSDSKWKGVMCSNGSVFALRLENMSLSG 88
Query: 60 KIDVDALTELTGLRG---------------------LRAIYLDKNQFSGEIPPGYFDEMG 98
++DV AL + GL+ L +YL NQF+GEI F M
Sbjct: 89 ELDVQALGSIRGLKSISFMRNHFEGKIPRGIDGLVSLAHLYLAHNQFTGEIDGDLFSGMK 148
Query: 99 ALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
AL K+ N+F G +P SL KLP LTEL+LE N F G IP+F Q LV +N+++N+LEG
Sbjct: 149 ALLKVHLEGNRFSGEIPESLGKLPKLTELNLEDNMFTGKIPAFKQKNLVTVNVANNQLEG 208
Query: 159 EIPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKV 218
IP +L N + FSGN GLCG L + CR + PP +
Sbjct: 209 RIPLTLGLMNITFFSGNKGLCGAPL-LPCRYTR-----------PPFFTVF--------L 248
Query: 219 IAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQAVEVRV--------SVPNKSRD 270
+A + V+L+++ + V I RR+ K ++ V +V S+D
Sbjct: 249 LALTILAVVVLITVFLSVCILSRRQGKGQDQIQNHGVGHFHGQVYGQPEQQQHSEKSSQD 308
Query: 271 VDVSRKASSS--RRGSSHHGKNSGVG-------------ELVLVNGQKGVFGLPDLMKAA 315
V RK ++ +R S+ VG +L V + F L D+++A+
Sbjct: 309 SKVYRKLANETVQRDSTATSGAISVGGLSPDEDKRGDQRKLHFVRNDQERFTLQDMLRAS 368
Query: 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
AEVLG+GG GSSYKA ++ G VVVKR + S + R+ F ++++GRL H N+L +A+
Sbjct: 369 AEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGREEFYDHMKKIGRLSHPNLLPLIAF 428
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+YR +EKLLV YI GSL LLH +R P L WP RLKIV+G+ RG+ YL+ L
Sbjct: 429 YYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLDWPIRLKIVRGVTRGLAYLYRVFPDL 488
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDV 495
+LPHG+LKSSN+ + P EPL++++ ++N Q + AYKAPE Q + + + DV
Sbjct: 489 NLPHGHLKSSNVLLDPNFEPLLTDYALVPVVNRDQSQQFMVAYKAPEFTQQDRTSRRSDV 548
Query: 496 YCLGIIILEILTGKFPSQYLTNGNGGID-VVEWVASAFSEGRVTDLLDPEIASSTNSPGE 554
+ LGI+ILEILTGKFP+ YL G G D + WV S D+ D E+ + +
Sbjct: 549 WSLGILILEILTGKFPANYLRQGKGADDELAAWVESVARTEWTADVFDKEMKAGKEHEAQ 608
Query: 555 MEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591
M +LL+IG C D E+R+E+ EAV RI E+ + G
Sbjct: 609 MLKLLKIGLRCCDWDIEKRIELHEAVDRIEEVDRDAG 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU0|RLK_ARATH Probable LRR receptor-like serine/threonine-protein kinase RLK OS=Arabidopsis thaliana GN=RLK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 234/624 (37%), Positives = 351/624 (56%), Gaps = 49/624 (7%)
Query: 1 MSESEALLKLKSSFT--NAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLS 58
+S+SEA+LK K S AL SW + PC WSGV+C G V L + ++ LS
Sbjct: 32 LSDSEAILKFKESLVVGQENALASWNAKSPPC-----TWSGVLCNGGSVWRLQMENLELS 86
Query: 59 GKIDVDALTELTGLR--------------------GLRAIYLDKNQFSGEIPPGYFDEMG 98
G ID++AL+ LT LR L+++YL NQF G+IP F+ MG
Sbjct: 87 GSIDIEALSGLTSLRTLSFMNNKFEGPFPDFKKLAALKSLYLSNNQFGGDIPGDAFEGMG 146
Query: 99 ALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
L+K+ + NKF G++P S+ KLP L EL L+ NQF G IP F+ L LNLS+N L G
Sbjct: 147 WLKKVHLAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEFEH-QLHLLNLSNNALTG 205
Query: 159 EIPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKV 218
IP SL + F GN GL GK L EC + I PP ++ V
Sbjct: 206 PIPESLSMTDPKVFEGNKGLYGKPLETECDSPY-------IEHPPQSEARPKSSSRGPLV 258
Query: 219 IAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSR--- 275
I A VA +L+ + ++ ++ K K ++ + +++ + + R+ D SR
Sbjct: 259 ITAIVAALTILIILGVIFLLNRSYKNKKPRLAVETGPSSLQKKTGI----READQSRRDR 314
Query: 276 KASSSRRGS---SHHGKNSGV--GELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKA 330
K + R+GS G +GV +L + + F L DL+KA+AE+LG+G G+SYKA
Sbjct: 315 KKADHRKGSGTTKRMGAAAGVENTKLSFLREDREKFDLQDLLKASAEILGSGCFGASYKA 374
Query: 331 MMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390
+++ G +VVKR K+ + RD F ++RLGRL H N+L+ +AY+YR +EKLLV ++
Sbjct: 375 VLSSGQMMVVKRFKQMNNAGRDEFQEHMKRLGRLMHHNLLSIVAYYYRKEEKLLVCDFAE 434
Query: 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS 450
GSL LH ++ L WP RLKIV+G+A+G+ YLH +L L PHG+LKSSN+ ++
Sbjct: 435 RGSLAINLHSNQSLGKPSLDWPTRLKIVKGVAKGLFYLHQDLPSLMAPHGHLKSSNVLLT 494
Query: 451 PENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKF 510
EPL++++G +IN + AY++PE +Q ++T K DV+ LGI+ILEILTGKF
Sbjct: 495 KTFEPLLTDYGLIPLINQEKAQMHMAAYRSPEYLQHRRITKKTDVWGLGILILEILTGKF 554
Query: 511 PSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDP 570
P+ + + D+ WV S F L D + +++ G++ +LL IG C + D
Sbjct: 555 PANFSQSSEE--DLASWVNSGFHGVWAPSLFDKGMGKTSHCEGQILKLLTIGLNCCEPDV 612
Query: 571 EQRLEMREAVRRIVEIQQSDGNMD 594
E+RL++ +AV +I E+++ +G+ D
Sbjct: 613 EKRLDIGQAVEKIEELKEREGDDD 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPT1|Y1061_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At1g50610 OS=Arabidopsis thaliana GN=At1g50610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (911), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 230/639 (35%), Positives = 337/639 (52%), Gaps = 57/639 (8%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKI 61
S+++ LL+ K + N SW P ++PC+G W GV+C V GL + MGL+GK+
Sbjct: 46 SDADCLLRFKDTLANGSEFRSWDPLSSPCQGNTANWFGVLC-SNYVWGLQLEGMGLTGKL 104
Query: 62 DVDALTELTGLR--------------------GLRAIYLDKNQFSGEIPPGYFDEMGALR 101
++D L + LR L+++YL N+FSGEIP F M L+
Sbjct: 105 NLDPLVPMKNLRTISFMNNNFNGPMPQVKRFTSLKSLYLSNNRFSGEIPADAFLGMPLLK 164
Query: 102 KLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
K+ +NN FRG +P SL LP L EL L NQF G IPSF Q L + +N L+G IP
Sbjct: 165 KILLANNAFRGTIPSSLASLPMLLELRLNGNQFQGQIPSFQQKDLKLASFENNDLDGPIP 224
Query: 162 ASLLRFNASSFSGNAGLCG-------KNLGVECRNAKASAANKNIHPPPPPHPAAENVDD 214
SL + SF+GN GLC + + K+ PP
Sbjct: 225 ESLRNMDPGSFAGNKGLCDAPLSPCSSSSPGVPVVPVSPVDPKSTSPPTGKKAG------ 278
Query: 215 SKKVIAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPNKSRDVDVS 274
S +A + + +++ I +V ++ +R+ F L A + R+ N + + +
Sbjct: 279 SFYTLAIILIVIGIILVIIALVFCFVQSRRRNF--LSAYPSSAGKERIESYNYHQSTNKN 336
Query: 275 RKASSS----RRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKA 330
K + S RRGS + G G L+ V F L DL++A+AEVLG+G G+SYKA
Sbjct: 337 NKPAESVNHTRRGSM---PDPG-GRLLFVRDDIQRFDLQDLLRASAEVLGSGTFGASYKA 392
Query: 331 MMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390
++ G T+VVKR K + + RD F +RRLGRL H N+L +AY+YR +EKLLV E++P
Sbjct: 393 AISSGQTLVVKRYKHMNNVGRDEFHEHMRRLGRLNHPNILPLVAYYYRREEKLLVTEFMP 452
Query: 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS 450
SL LH + D W RLKI++G+A+G+ YL EL L +PHG++KSSNI +
Sbjct: 453 NSSLASHLHANNSAGLD---WITRLKIIKGVAKGLSYLFDELPTLTIPHGHMKSSNIVLD 509
Query: 451 PENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGK--VTPKCDVYCLGIIILEILTG 508
EPL++++ M++S + + AYK+PE S +T K DV+C G++ILE+LTG
Sbjct: 510 DSFEPLLTDYALRPMMSSEHAHNFMTAYKSPEYRPSKGQIITKKTDVWCFGVLILEVLTG 569
Query: 509 KFPSQYLTNG-NGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQ 567
+FP YLT G + + +V WV E + D+ D E+ N EM LL+IG C +
Sbjct: 570 RFPENYLTQGYDSNMSLVTWVNDMVKEKKTGDVFDKEMKGKKNCKAEMINLLKIGLRCCE 629
Query: 568 SDPEQR------LEMREAVRRIVEIQQSDGNMDARTSQN 600
+ E+R +EM E +R E + G+MD R + N
Sbjct: 630 EEEERRMDMREVVEMVEMLRE-GESEDDFGSMDHRGTHN 667
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 217/627 (34%), Positives = 331/627 (52%), Gaps = 58/627 (9%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCL--KGIVTGLYINSMGLSG 59
+E +ALL + L W S + C W GV C + + L + GL G
Sbjct: 27 AEKQALLTFLQQIPHENRLQ-WNESDSAC-----NWVGVECNSNQSSIHSLRLPGTGLVG 80
Query: 60 KIDVDALTELTGLR---------------------GLRAIYLDKNQFSGEIPPGYFDEMG 98
+I +L LT LR LR++YL N+FSGE P F ++
Sbjct: 81 QIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTS-FTQLN 139
Query: 99 ALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
L +L S+N F G +P S+ L HLT L L +N F+G +PS LV N+S+N L G
Sbjct: 140 NLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GLVDFNVSNNNLNG 198
Query: 159 EIPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKV 218
IP+SL RF+A SF+GN LCG L C++ S P P P+ N +
Sbjct: 199 SIPSSLSRFSAESFTGNVDLCGGPLK-PCKSFFVS---------PSPSPSLINPSNRLSS 248
Query: 219 IAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPN----KSRDVDVS 274
+ ++ + ++ I ++ + + ++ + E R P +R+VD+
Sbjct: 249 KKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLP 308
Query: 275 RKASSSRRGSSHHGKNSGVG------ELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSY 328
ASSS+ + G +SG+G +LV G F L DL++A+AEVLG G +G+SY
Sbjct: 309 PGASSSKEEVT--GTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSY 366
Query: 329 KAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388
KA++ +G TVVVKR+K+ A ++ F+T++ +G+++H NV+ AY+Y DEKLLV+++
Sbjct: 367 KAVLEEGTTVVVKRLKDVMA-SKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDF 425
Query: 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448
+P GSL LLHG RG L W R++I ARG+ +LH L HGN+K+SNI
Sbjct: 426 MPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVS---AKLVHGNIKASNIL 482
Query: 449 ISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTG 508
+ P + +S++G + ++++ L Y APE +++ KVT K DVY G+++LE+LTG
Sbjct: 483 LHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTG 542
Query: 509 KFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQS 568
K P+Q + G GID+ WV S E ++ D E+ N EM QLL+I AC +
Sbjct: 543 KSPNQA-SLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVST 601
Query: 569 DPEQRLEMREAVRRIVEIQQSDGNMDA 595
P+QR M+E +R I ++ +S+ D
Sbjct: 602 VPDQRPVMQEVLRMIEDVNRSETTDDG 628
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 214/631 (33%), Positives = 329/631 (52%), Gaps = 68/631 (10%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKI 61
++SE LL K + + L+SW +T PC +W+GV C + VT L + + L+G I
Sbjct: 30 TDSETLLNFKLTADSTGKLNSWNTTTNPC-----QWTGVSCNRNRVTRLVLEDINLTGSI 84
Query: 62 DVDA------------------LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKL 103
+ L+ L L+ ++L NQFSG P + L +L
Sbjct: 85 SSLTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTS-ITSLTRLYRL 143
Query: 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPAS 163
S N F G++PP L L HL L LESN+F+G IP+ + L N+S N G+IP S
Sbjct: 144 DLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNS 203
Query: 164 LLRFNASSFSGNAGLCGKNLGVECRN-------------AKASAANKNIHPPPPP---HP 207
L +F S F+ N LCG L ++C AKAS NK P P H
Sbjct: 204 LSQFPESVFTQNPSLCGAPL-LKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHG 262
Query: 208 AAENVDDSK----KVIAAGVALSVMLVSIAIVVIIRIRR-----KRKAFKVLEKESVQAV 258
++ + S+ +IA + ++L +++++ R K+K K+LE E +
Sbjct: 263 GDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKI--- 319
Query: 259 EVRVSVPNKSRDVDVSRKASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEV 318
V S P +S++ ++ + + G++V G + F L DL++A+AE+
Sbjct: 320 -VYSSNP----------YPTSTQNNNNQNQQVGDKGKMVFFEGTR-RFELEDLLRASAEM 367
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNVLAPLAYHY 377
LG GG G++YKA++ DG V VKR+K++ +A + F+ ++ LGRLRH+N+++ AY++
Sbjct: 368 LGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYF 427
Query: 378 RTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDL 437
+EKLLVY+Y+P GSL +LLHG+RGP L W RLKI G ARG+ ++H L L
Sbjct: 428 AREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKL 487
Query: 438 PHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYC 497
HG++KS+N+ + +S+FG S +A++ Y+APE I K T K DVY
Sbjct: 488 THGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKS-NGYRAPELIDGRKHTQKSDVYS 546
Query: 498 LGIIILEILTGKFPSQYLTNGNGG-IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEME 556
G+++LEILTGK P+ T +GG +D+ WV S E ++ D E+ + EM
Sbjct: 547 FGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMV 606
Query: 557 QLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587
LL+I ACT + R +M V+ I +I+
Sbjct: 607 GLLQIAMACTAVAADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (762), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 208/631 (32%), Positives = 320/631 (50%), Gaps = 57/631 (9%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKI 61
++ ALL L+S+ + + T+PC W+GV C VT L + + LSG I
Sbjct: 35 ADRTALLSLRSA-VGGRTFRWNIKQTSPC-----NWAGVKCESNRVTALRLPGVALSGDI 88
Query: 62 DVDALTELTGLR---------------------GLRAIYLDKNQFSGEIPPGYFDEMGAL 100
LT LR LR +YL N+FSGEIP F + L
Sbjct: 89 PEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLF-SLSHL 147
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+L ++N F G + L L L LE+NQ +G+IP D P LV+ N+S+N L G I
Sbjct: 148 VRLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP-LVQFNVSNNSLNGSI 206
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKA--SAANKNIHPPPPPHPAAENVDDSKKV 218
P +L RF + SF LCGK L + C + + S + PP +E K+
Sbjct: 207 PKNLQRFESDSFL-QTSLCGKPLKL-CPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKL 264
Query: 219 IAAGVALSVM--LVSIAIVVIIRI----RRKRKAFKVLEKESVQAVEVRVSVPNKSRDVD 272
+A V+ +V A++V+I + ++ K + ++ +++ E + P VD
Sbjct: 265 SGGAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEI--PGDKEAVD 322
Query: 273 VSRKASSSR--------RGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGL 324
S S G + G +LV VF L DL++A+AEVLG G
Sbjct: 323 NGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTF 382
Query: 325 GSSYKAMMADGVTVV-VKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKL 383
G++YKA++ D VTVV VKR+K+ MA F ++ +G + H N++ AY++ DEKL
Sbjct: 383 GTAYKAVL-DAVTVVAVKRLKDV-MMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKL 440
Query: 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLK 443
LVY+++P GSL LLHG+RG L W R +I G ARG+ YLH++ HGN+K
Sbjct: 441 LVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQ--GTSTSHGNIK 498
Query: 444 SSNIFISPENEPLISEFGFYTMI-NSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIII 502
SSNI ++ ++ +S+FG ++ +SA Y+APE +V+ K DVY G+++
Sbjct: 499 SSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVL 558
Query: 503 LEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS-STNSPGEMEQLLEI 561
LE++TGK PS + N G+D+ WV S + ++ D E+ S +T+ M +++++
Sbjct: 559 LELITGKAPSNSVMN-EEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQL 617
Query: 562 GRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592
G CT P+QR EM E VR++ ++ G+
Sbjct: 618 GLECTSQHPDQRPEMSEVVRKMENLRPYSGS 648
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 206/616 (33%), Positives = 312/616 (50%), Gaps = 47/616 (7%)
Query: 2 SESEALLKLKSSFTNAKALDSW-MPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
S+ ALL +++S L W M +++PC W GV C G VT L + GL G
Sbjct: 28 SDRRALLAVRNSVRGRPLL--WNMSASSPC-----NWHGVHCDAGRVTALRLPGSGLFGS 80
Query: 61 IDVDALTELTGLRGL---------------------RAIYLDKNQFSGEIPPGYFDEMGA 99
+ + + LT L+ L R +YL N FSGEIP F + +
Sbjct: 81 LPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIPSLLF-TLPS 139
Query: 100 LRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGE 159
+ ++ NKF GR+P ++ L L+LE NQ +G IP P L + N+SSN+L G
Sbjct: 140 IIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITLP-LQQFNVSSNQLNGS 198
Query: 160 IPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKV- 218
IP+SL + ++F GN LCGK L C + + PP ++ + V
Sbjct: 199 IPSSLSSWPRTAFEGNT-LCGKPLDT-CEAESPNGGDAGGPNTPPEKKDSDKLSAGAIVG 256
Query: 219 IAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKES-VQAVEVRVSVPNKSRDVDVSRKA 277
I G + ++L+ + + + R R+K + E+ V A ++P ++ V KA
Sbjct: 257 IVIGCVVGLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKA 316
Query: 278 SSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVT 337
+ S G+ + +L G F L L+KA+AEVLG G +GSSYKA G+
Sbjct: 317 TGSESGAVNK-------DLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLV 369
Query: 338 VVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYL 397
V VKR+++ ++ F + LG + H+N++ +AY++ DEKLLV+EY+ GSL +
Sbjct: 370 VAVKRLRDVVVPEKE-FRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAI 428
Query: 398 LHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457
LHG++G L W R I G AR I YLH+ HGN+KSSNI +S E +
Sbjct: 429 LHGNKGNGRTPLNWETRAGIALGAARAISYLHSRDGTTS--HGNIKSSNILLSDSYEAKV 486
Query: 458 SEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517
S++G +I+S + + Y+APE + K++ K DVY G++ILE+LTGK P+ N
Sbjct: 487 SDYGLAPIISSTSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLN 546
Query: 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGE-MEQLLEIGRACTQSDPEQRLEM 576
G+D+ WV S + +D+LDPE+ E + +LL+IG +CT P+ R M
Sbjct: 547 -EEGVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSM 605
Query: 577 REAVRRIVEIQQSDGN 592
E R I E+ S G+
Sbjct: 606 AEVTRLIEEVSHSSGS 621
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 210/625 (33%), Positives = 314/625 (50%), Gaps = 54/625 (8%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKG--IVTGLYINSMGLSG 59
S+ +ALL +S + + L+ W + C+ W GV C V L + +GL G
Sbjct: 47 SDRQALLAFAASVPHLRRLN-WNSTNHICKS----WVGVTCTSDGTSVHALRLPGIGLLG 101
Query: 60 KIDVDALTELTGLR---------------------GLRAIYLDKNQFSGEIPPGYFDEMG 98
I + L +L LR L IYL N FSGE+P ++
Sbjct: 102 PIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSRQLN 161
Query: 99 ALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
L S N F G++P + L LT L L++N+ +G +P+ D +L RLNLS+N L G
Sbjct: 162 ILD---LSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLNLSNNHLNG 218
Query: 159 EIPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPP-PPHPAAENVDDSKK 217
IP++L F +SSFSGN LCG L ++ + +I PP PP P E SK+
Sbjct: 219 SIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHKEG---SKR 275
Query: 218 VIAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKA 277
+ + + A++++I + K +K V+V+ ++ KA
Sbjct: 276 KLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT----------LTEKA 325
Query: 278 SSSR-RGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGV 336
G KN +LV NG F L DL++A+AEVLG G G++YKA++ +
Sbjct: 326 KQEFGSGVQEPEKN----KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEEST 381
Query: 337 TVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395
TVVVKR+KE +A R+ F+ ++ + R+ H +V+ AY+Y DEKL+V +Y P G+L
Sbjct: 382 TVVVKRLKEVAAGKRE-FEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLS 440
Query: 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEP 455
LLHG+RG L W +R+KI A+GI +LH HGN+KSSN+ + E++
Sbjct: 441 SLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAA-GGPKFSHGNIKSSNVIMKQESDA 499
Query: 456 LISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYL 515
IS+FG ++ Y+APE +++ K T K DVY G++ILE+LTGK P Q
Sbjct: 500 CISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSP 559
Query: 516 TNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE 575
+ + +D+ WV S E +++ D E+ N EM Q+L+I AC PE R
Sbjct: 560 SR-DDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPT 618
Query: 576 MREAVRRIVEIQQSDGNMDARTSQN 600
M + VR I EI+ SD +S +
Sbjct: 619 MDDVVRMIEEIRVSDSETTRPSSDD 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (727), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 210/632 (33%), Positives = 322/632 (50%), Gaps = 67/632 (10%)
Query: 2 SESEALLKLKSSFTNAKALDSW-MPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
++ ALL +S+ L W + T+PC W+GV+C G VT L + LSG
Sbjct: 33 ADKSALLSFRSAVGGRTLL--WDVKQTSPC-----NWTGVLCDGGRVTALRLPGETLSGH 85
Query: 61 IDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK 120
I LT LR L L N +G +P LR+L+ N+F G +P LF
Sbjct: 86 IPEGIFGNLTQLRTLS---LRLNGLTGSLPLD-LGSCSDLRRLYLQGNRFSGEIPEVLFS 141
Query: 121 LPHLTELHLESNQFNGTIPS-FDQPTLVR----------------------LNLSSNKLE 157
L +L L+L N+F+G I S F T ++ N+S+N L
Sbjct: 142 LSNLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQFNVSNNLLN 201
Query: 158 GEIPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKK 217
G IP SL +F++ SF G + LCGK L V + ++ P +E KK
Sbjct: 202 GSIPKSLQKFDSDSFVGTS-LCGKPLVVCSNEGTVPSQPISVGNIPGTVEGSEEKKKRKK 260
Query: 218 VIAAGVALSVM--LVSIAIVVIIRIRRKRKAFKVLEKESVQAVEV------RVSVPNKSR 269
+ +A V+ +V ++++V+I + RK E +A+++ V +P +
Sbjct: 261 LSGGAIAGIVIGCVVGLSLIVMILMVLFRKK----GNERTRAIDLATIKHHEVEIPGEKA 316
Query: 270 DVDVSRKASSSRRGSSHHGK-----NSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGL 324
V+ S S K +SG+ +LV VF L DL++A+AEVLG G
Sbjct: 317 AVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTF 376
Query: 325 GSSYKAMMADGVTVV-VKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKL 383
G++YKA++ D VT+V VKR+K+ + MA F ++ +G + H N++ AY+Y DEKL
Sbjct: 377 GTAYKAVL-DAVTLVAVKRLKDVT-MADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKL 434
Query: 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE--LAHLDLPHGN 441
LVY+++P GSL LLHG++G L W R I G ARG+ YLH++ L+ HGN
Sbjct: 435 LVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSS----HGN 490
Query: 442 LKSSNIFISPENEPLISEFGFYTMIN-SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGI 500
+KSSNI ++ ++ +S+FG +++ S+ Y+APE +V+ K DVY G+
Sbjct: 491 VKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGV 550
Query: 501 IILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE---IASSTNSPGEMEQ 557
++LE+LTGK PS + N G+D+ WV S E ++ D E I + + EM +
Sbjct: 551 VLLELLTGKAPSNSVMN-EEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAE 609
Query: 558 LLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+L++G CT+ P++R M E VRRI E++QS
Sbjct: 610 MLQLGIDCTEQHPDKRPVMVEVVRRIQELRQS 641
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 621 | ||||||
| 255583966 | 702 | Serine/threonine-protein kinase PBS1, pu | 0.974 | 0.861 | 0.549 | 0.0 | |
| 224070780 | 659 | predicted protein [Populus trichocarpa] | 0.961 | 0.905 | 0.552 | 0.0 | |
| 224119608 | 604 | predicted protein [Populus trichocarpa] | 0.909 | 0.935 | 0.569 | 0.0 | |
| 147853855 | 686 | hypothetical protein VITISV_015737 [Viti | 0.954 | 0.864 | 0.543 | 0.0 | |
| 356560175 | 672 | PREDICTED: probable inactive leucine-ric | 0.933 | 0.863 | 0.539 | 0.0 | |
| 297742976 | 686 | unnamed protein product [Vitis vinifera] | 0.954 | 0.864 | 0.538 | 0.0 | |
| 359482466 | 664 | PREDICTED: probable inactive leucine-ric | 0.954 | 0.893 | 0.538 | 0.0 | |
| 225444669 | 626 | PREDICTED: probable inactive leucine-ric | 0.924 | 0.916 | 0.531 | 0.0 | |
| 356522414 | 681 | PREDICTED: probable inactive leucine-ric | 0.971 | 0.885 | 0.524 | 0.0 | |
| 449488217 | 645 | PREDICTED: probable inactive leucine-ric | 0.924 | 0.889 | 0.515 | 1e-175 |
| >gi|255583966|ref|XP_002532730.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223527538|gb|EEF29661.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/635 (54%), Positives = 458/635 (72%), Gaps = 30/635 (4%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKI 61
SESEAL+KLKSSFT+A AL SW+ + PC G+ +W+G++C G V GL + MGLSGKI
Sbjct: 27 SESEALIKLKSSFTDASALSSWVNGSTPC-AGDTQWNGLLCSNGTVVGLRLEKMGLSGKI 85
Query: 62 DVDALTELTGLRG--------------------LRAIYLDKNQFSGEIPPGYFDEMGALR 101
DVDAL +++GLR L++I+L NQFSGEIP +F +M +L+
Sbjct: 86 DVDALIDISGLRTVSFARNSFSGSIPELSRLGYLKSIFLTGNQFSGEIPSDFFLKMVSLK 145
Query: 102 KLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
K+W S+NKF G +P SL L +L EL LE+N+F+G IPS +Q TL N+S+NKL G+IP
Sbjct: 146 KVWLSDNKFSGEIPSSLIHLSNLLELRLENNEFSGNIPSIEQSTLTTFNVSNNKLRGQIP 205
Query: 162 ASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVIAA 221
A L +FN++SF GN+ LCG+ +G ECR +AA + + + S K+ A
Sbjct: 206 AGLEKFNSTSFEGNSELCGEMIGKECRTVSLAAAA--LISSVSKNAIYDKDSKSLKMTNA 263
Query: 222 GV-ALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQA---VEVRVSVPNKSRDVDVSRKA 277
G+ L+ ML+S+ VVI ++ RK K F+V K+ A VEV+V++P +S++++ ++K
Sbjct: 264 GIITLAAMLLSVVGVVIFKLSRKDKDFQVGGKDGSDADESVEVQVTMPVRSKEMEATKKL 323
Query: 278 SSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVT 337
S+R+GS+ + K GV ELV+VN +KGVFGLPDLMKAAAEVLGNGGLGSSYKA+M DG
Sbjct: 324 GSTRKGSNQN-KGGGVAELVMVNNEKGVFGLPDLMKAAAEVLGNGGLGSSYKALMTDGEA 382
Query: 338 VVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYL 397
+VVKR++E +A+ RD FD EVR LG+LRH N+L PLA+HYR DEKLL+YEY+P GSLLYL
Sbjct: 383 MVVKRLREMNALGRDGFDAEVRHLGKLRHPNILGPLAFHYRKDEKLLIYEYMPTGSLLYL 442
Query: 398 LHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457
LHGDRGPS EL WP RLK+V GIARG+GYLH EL+ DLPHGNLKSSNIF++ +NEP+I
Sbjct: 443 LHGDRGPSRTELNWPTRLKVVVGIARGLGYLHAELSSFDLPHGNLKSSNIFLNYDNEPMI 502
Query: 458 SEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517
SEFGF + + QAL AYKAPEA Q G V+PKCDVYCLG++ILEILTGK PSQYL
Sbjct: 503 SEFGFNQLTKPSVGRQALLAYKAPEAAQFG-VSPKCDVYCLGLVILEILTGKVPSQYLNY 561
Query: 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMR 577
GNG ID+V+WV ++ +EGR ++L DP+IASST+S GE+ LL IG C +S+P QRL++R
Sbjct: 562 GNGEIDLVQWVQNSITEGRESELFDPDIASSTDSVGEIRALLHIGARCAESNPAQRLDLR 621
Query: 578 EAVRRIVEIQQSDGNMDARTSQNILPTLDHGCAEN 612
EA+ RI EI+ G D RT Q +LP+L G A++
Sbjct: 622 EAIERIEEIKLGIGYSDNRTMQ-LLPSLRDGYADS 655
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224070780|ref|XP_002303233.1| predicted protein [Populus trichocarpa] gi|222840665|gb|EEE78212.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/646 (55%), Positives = 455/646 (70%), Gaps = 49/646 (7%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
+SESE+L++LK SFTNA A+ SW+P + PC + W GVVC GIVT L + +MGLSG
Sbjct: 27 VSESESLIRLKKSFTNAGAISSWLPGSVPCNK-QTHWRGVVCFNGIVTVLQLENMGLSGT 85
Query: 61 IDVDALTELTGLRGL--------------------RAIYLDKNQFSGEIPPGYFDEMGAL 100
IDVDAL + GLR L +AIYL NQFSGEIP +F +M +L
Sbjct: 86 IDVDALANMQGLRSLSFAYNYFTGTIPALNRLGYLKAIYLRGNQFSGEIPSDFFLKMKSL 145
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+K+W S+N F G +P SL +L L+ELHLE+NQF+GTIPS DQPTL+ N+S+NKL+GEI
Sbjct: 146 KKVWISDNNFSGGIPSSLAELSRLSELHLENNQFSGTIPSIDQPTLMSFNVSNNKLDGEI 205
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAA-----ENVDDS 215
P L RFN+SSF GN GLCG+ +G C +S PP A E D+
Sbjct: 206 PPKLARFNSSSFRGNDGLCGQKIGKGCELQGSS------EPPTDVGVDANMMVSEGSDNK 259
Query: 216 K----KVIAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKES---VQAVEVRVSVPNKS 268
+ K +A V L+V+LVSI VVI R+ R+ K F +E S A+EV+VS+ N+
Sbjct: 260 RNSVTKTVAGLVTLAVLLVSIIAVVIFRMWRRGKDFDAIESRSSGNAAALEVQVSLSNRP 319
Query: 269 RDVDVSRKASSSRRGSSHHGKNSG---VGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLG 325
++++V++K GS H G N+G VGELV+VN +K VFGLPDLMKA+AEVLGNG LG
Sbjct: 320 KEMEVAKKM-----GSGHKGSNNGRGVVGELVIVNNEKSVFGLPDLMKASAEVLGNGVLG 374
Query: 326 SSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385
SSYK MA+GV VVVKRM+E + +++ F+ E+R+LGRL H N+L PLA+HYR DEKLL+
Sbjct: 375 SSYKTQMANGVVVVVKRMREMNTLSKSQFNAEIRKLGRLHHPNILTPLAFHYRPDEKLLI 434
Query: 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSS 445
Y+++P GSLLYLLHGDRGPSH EL+W RLKIVQGIA+G+GYLHTELA +LPHGNLKSS
Sbjct: 435 YDFVPKGSLLYLLHGDRGPSHAELSWSVRLKIVQGIAKGLGYLHTELAPSNLPHGNLKSS 494
Query: 446 NIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEI 505
N+F+S +NEPL+SEFG +I+ LAQALF Y+APEA + G V+PKCDVYCLGIIILEI
Sbjct: 495 NVFLSNDNEPLLSEFGLSPLISPPMLAQALFGYEAPEAAEFG-VSPKCDVYCLGIIILEI 553
Query: 506 LTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRAC 565
L+GK PSQYL N GG DVV WV SA S+GR TD LDPEIASS NS +M+QL IG AC
Sbjct: 554 LSGKIPSQYLNNARGGTDVVHWVESAISDGRETDFLDPEIASSKNSLCQMKQLQGIGAAC 613
Query: 566 TQSDPEQRLEMREAVRRIVEIQQSDGNMDARTSQNILPTLDHGCAE 611
+ +PEQRL++ +A++ I EI+ DG+ T+Q +LP+L G A+
Sbjct: 614 VKRNPEQRLDITQAIQLIQEIKLEDGDYAGGTTQ-VLPSLRDGYAD 658
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119608|ref|XP_002331202.1| predicted protein [Populus trichocarpa] gi|222873323|gb|EEF10454.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/611 (56%), Positives = 438/611 (71%), Gaps = 46/611 (7%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
+S+SEALL+LK SFTNA AL SW+ + PC + W+G++C GIVTGL + +MGLSG
Sbjct: 15 VSDSEALLRLKKSFTNAGALSSWISGSVPCNR-QTHWNGLLCFNGIVTGLQLENMGLSGT 73
Query: 61 IDVDALTELTGLR--------------------GLRAIYLDKNQFSGEIPPGYFDEMGAL 100
IDVDAL + GLR L+AIYL NQFSGEIP +F +M +L
Sbjct: 74 IDVDALATIQGLRSLSFARNSFTGAIPELNRLGNLKAIYLRGNQFSGEIPSDFFSKMKSL 133
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+K+W S+NKF G +PPSL +LP L+ELHLE+NQF+GTIPS DQPTL+ N+S+N LEGEI
Sbjct: 134 KKVWLSDNKFTGGIPPSLAELPRLSELHLENNQFSGTIPSIDQPTLMSFNVSNNMLEGEI 193
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVIA 220
P +L FN SSF GN LCG G C N +++ + +A
Sbjct: 194 PPNLAIFNYSSFDGNDHLCGDRFGRGCENTMQTSS-----------------ESPTGTVA 236
Query: 221 AGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKES-----VQAVEVRVSVPNKSRDVDVSR 275
V L+V+L+SI ++I R+RR+ K F V+E S A+EV+VS+ N+ + VD ++
Sbjct: 237 GAVTLAVLLLSITALIIFRMRRRDKDFDVIENSSNGNAAAAALEVQVSLSNRPKGVDATK 296
Query: 276 KASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADG 335
K SSR+GS ++G+ GVGELV+VN +KGVFGLPDLMKA+AEVLGNGG+GS YKA MA+G
Sbjct: 297 KMGSSRKGS-NNGR-GGVGELVIVNNEKGVFGLPDLMKASAEVLGNGGMGSLYKAQMANG 354
Query: 336 VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395
VVVKR +E + +++D FD E+R+LGRL H+N+L PLA+ YR DEKLLVYEY+P GSLL
Sbjct: 355 AMVVVKRTREMNTLSKDQFDAEIRKLGRLHHTNILTPLAFLYRPDEKLLVYEYMPKGSLL 414
Query: 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEP 455
YLLHGDRG SH EL W RLKIVQGIA+G+GYLHT+LA LPHGNLKSSN+F+S +NEP
Sbjct: 415 YLLHGDRGTSHAELNWFVRLKIVQGIAKGLGYLHTKLASSPLPHGNLKSSNVFLSNDNEP 474
Query: 456 LISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYL 515
L+SEFG +I+ LAQALF YKAPEA Q G V+P CDVYCLGII+LEILTGKFPSQYL
Sbjct: 475 LLSEFGLSPLISPPMLAQALFGYKAPEAAQYG-VSPMCDVYCLGIIVLEILTGKFPSQYL 533
Query: 516 TNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE 575
GG DVV+WV SA S+GR TDLLDPEIASSTNS G+M QLL IG AC + +P+QRL+
Sbjct: 534 NKAKGGTDVVQWVESAVSDGRETDLLDPEIASSTNSLGQMRQLLGIGAACVKRNPQQRLD 593
Query: 576 MREAVRRIVEI 586
+ +A++ I I
Sbjct: 594 ITDAIQMIQGI 604
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853855|emb|CAN83804.1| hypothetical protein VITISV_015737 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/639 (54%), Positives = 453/639 (70%), Gaps = 46/639 (7%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
MS+SEALLKLK SFTN ALDSW P + PC G ++EW G+VC GIVTGL++ MGLSGK
Sbjct: 23 MSDSEALLKLKQSFTNTNALDSWEPGSGPCTG-DKEWGGLVCFNGIVTGLHLVGMGLSGK 81
Query: 61 IDVDALTELTGLR--------------------GLRAIYLDKNQFSGEIPPGYFDEMGAL 100
IDV+AL +TGLR L+AI++ NQFSGEIPP YF M +L
Sbjct: 82 IDVEALIAITGLRTISIVNNSFSGSIPEFNRSGALKAIFISGNQFSGEIPPDYFVRMASL 141
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+KLW S+NKF G +P S+ L HL ELHLE+NQF GTIP F+ PTL LNLS+NKL+G I
Sbjct: 142 KKLWLSDNKFTGAIPLSIQLLSHLIELHLENNQFTGTIPDFNLPTLKSLNLSNNKLKGAI 201
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVIA 220
P SL +F S+F+GNAGLCG+ LG C + H D S+K IA
Sbjct: 202 PDSLSKFGGSAFAGNAGLCGEELGNGCND----------------HGIDLGTDRSRKAIA 245
Query: 221 AGVALSVMLVSIAIVVIIRIRR-KRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKA-S 278
++++V+++S+ I+V+ +RR K + F VLE ++VEVR+S ++ SR+A
Sbjct: 246 VIISVAVVIISLLIIVVFLMRRRKEEEFDVLENVD-ESVEVRISGSSRKEGSSTSRRAIG 304
Query: 279 SSRRGS--SHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGV 336
SS+RGS S K+S ++V+VN +KG+FG+ DLMKAAAEVLG G LGS+YKA+MA G+
Sbjct: 305 SSQRGSNRSSQVKSSMKEDMVVVNEEKGIFGMSDLMKAAAEVLGTGSLGSAYKAVMATGI 364
Query: 337 TVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396
VVVKRMKE + ++++ FD E+RRLG L+H NVL PL YH+R +EKL++YEYIP GSLL+
Sbjct: 365 AVVVKRMKEMNRVSKEGFDLELRRLGSLQHPNVLNPLGYHFRKEEKLIIYEYIPKGSLLF 424
Query: 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456
+LHGDRGPSH EL WPARLKIVQGIARG+GYLHTELA LDLPHGNLKSSNI ++ +++PL
Sbjct: 425 VLHGDRGPSHAELNWPARLKIVQGIARGLGYLHTELASLDLPHGNLKSSNILLTFDHDPL 484
Query: 457 ISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLT 516
+S++G+ +I+ + ++QALFAY+APEA++ +++PKCDVYCLGI+ILEIL GKFP+QYL
Sbjct: 485 LSDYGYSPLISVSFVSQALFAYRAPEAVRDNQISPKCDVYCLGIVILEILIGKFPTQYLN 544
Query: 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEM 576
N GG DVVEW SA ++GR ++ DPEIASS NS EM +LL IG AC +S+ EQR ++
Sbjct: 545 NSKGGTDVVEWAVSAIADGREAEVFDPEIASSINSMEEMVKLLHIGVACAESNLEQRPDI 604
Query: 577 REAVRRIVEIQQSDGNMDARTSQN----ILPTLDHGCAE 611
+EA+RRI EI G S + +LP+L G E
Sbjct: 605 KEAIRRIEEIHVDGGGSGGGASHDRTIQVLPSLRDGYGE 643
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560175|ref|XP_003548370.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/626 (53%), Positives = 446/626 (71%), Gaps = 46/626 (7%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
M+E+EAL+ LKSSF+N + LD+W+P +APC E++W GV C G+VTGL + +GL+G+
Sbjct: 25 MTEAEALVSLKSSFSNPELLDTWVPGSAPC-SEEDQWEGVACNNGVVTGLRLGGIGLAGE 83
Query: 61 IDVDALTELTGLRG--------------------LRAIYLDKNQFSGEIPPGYFDEMGAL 100
I VD L EL GLR L+A+YL N+FSG+IP YF M +L
Sbjct: 84 IHVDPLLELKGLRTISLNNNAFSGSMPEFHRIGFLKALYLQGNKFSGDIPMDYFQRMRSL 143
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+KLW ++N+F G++P SL ++P L ELHLE+NQF G IP P+LV+ N+S+NKLEG I
Sbjct: 144 KKLWLADNQFTGKIPSSLVEIPQLMELHLENNQFVGNIPDLSNPSLVKFNVSNNKLEGGI 203
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDD----SK 216
PA LLRFN SSFSGN+GLC + LG C K + PP P ++V S
Sbjct: 204 PAGLLRFNVSSFSGNSGLCDEKLGKSCE--------KTMEPPSPSPIVGDDVPSVPHRSS 255
Query: 217 KVIAAGVAL-SVMLVSIAIVVIIRIRRKRKA-FKVLEKESVQ-AVEVRVSVPNKSRDVDV 273
AG+ L SV LVS+ + +I+R RRK++ F + +E+ + +VEV+V+ P K RD+D
Sbjct: 256 SFEVAGIILASVFLVSLVVFLIVRSRRKKEENFGTVGQEANEGSVEVQVTAPVK-RDLDT 314
Query: 274 SR------KASSSRRGS-SHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGS 326
+ K SSSRRG S KN+G ELV+VN +KGVFG+PDLM+AAAEVLGNG GS
Sbjct: 315 ASTSSTPVKKSSSRRGCISSQSKNAG--ELVMVNNEKGVFGMPDLMRAAAEVLGNGSFGS 372
Query: 327 SYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386
SYKA++A+GV VVVKR +E + + +D FD E+R+L L+H N+L PLAYH+R DEKL++
Sbjct: 373 SYKAVLANGVAVVVKRTREMNVLEKDDFDAEMRKLTMLKHWNILTPLAYHFRKDEKLVIS 432
Query: 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSN 446
EY+P GSLL+ LHGDRG SH EL WPARLKIV+GIA+G+ YL+T L DLPHGNLKSSN
Sbjct: 433 EYVPRGSLLFSLHGDRGASHVELDWPARLKIVRGIAQGMHYLYTVLGSSDLPHGNLKSSN 492
Query: 447 IFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEIL 506
+ + P+NEP++ ++GF M+N + +AQ LFAYKAPEA Q G+V+ CDVYCLG++I+EIL
Sbjct: 493 VLLGPDNEPMLVDYGFSHMVNPSTIAQTLFAYKAPEAAQQGQVSRSCDVYCLGVVIIEIL 552
Query: 507 TGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACT 566
TG+FPSQYL+NG GG DVV+WV +A SEGR +++LDPEIA S N GEMEQLL IG ACT
Sbjct: 553 TGRFPSQYLSNGKGGADVVQWVETAISEGRESEVLDPEIAGSRNWLGEMEQLLHIGAACT 612
Query: 567 QSDPEQRLEMREAVRRIVEIQQSDGN 592
+S+P+ RL+M EAVRRI+EI+ G+
Sbjct: 613 ESNPQWRLDMAEAVRRIMEIKFEGGH 638
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742976|emb|CBI35843.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/639 (53%), Positives = 449/639 (70%), Gaps = 46/639 (7%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
MS+SEALLKLK SFTN ALDSW P + PC G++EW G+VC GIVTGL++ MGLSGK
Sbjct: 23 MSDSEALLKLKQSFTNTNALDSWEPGSGPC-SGDKEWGGLVCFNGIVTGLHLVGMGLSGK 81
Query: 61 IDVDALTELTGLR--------------------GLRAIYLDKNQFSGEIPPGYFDEMGAL 100
IDV+AL +TGLR L+AI++ NQFSGEIPP YF M +L
Sbjct: 82 IDVEALIAITGLRTISIVNNSFSGSIPEFNRLGALKAIFISGNQFSGEIPPDYFVRMASL 141
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+KLW S+NKF G +P S+ L HL ELHLE+NQF GTIP F+ PTL LNLS+NKL+G I
Sbjct: 142 KKLWLSDNKFTGAIPLSIQLLSHLIELHLENNQFTGTIPDFNLPTLKSLNLSNNKLKGAI 201
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVIA 220
P SL +F S+F+GNAGLCG+ LG C + H D S+K IA
Sbjct: 202 PDSLSKFGGSAFAGNAGLCGEELGNGCND----------------HGIDLGTDRSRKAIA 245
Query: 221 AGVALSVMLVSIAIVVIIRIRR-KRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKA-- 277
++++V+++S+ I+V+ +RR K + F VLE ++VEVR+S ++ SR+A
Sbjct: 246 VIISVAVVIISLLIIVVFLMRRRKEEEFDVLENVD-ESVEVRISGSSRKEGSSTSRRAIG 304
Query: 278 -SSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGV 336
S S K+S ++V+VN +KG+FG+ DLMKAAAEVLG G LGS+YKA+MA G+
Sbjct: 305 SSRRGSNRSSQVKSSMKEDMVVVNEEKGIFGMSDLMKAAAEVLGTGSLGSAYKAVMATGI 364
Query: 337 TVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396
VVVKRMKE + ++++ FD E+RRLG L+H NVL PL YH+R +EKL++YEYIP GSLL+
Sbjct: 365 AVVVKRMKEMNRVSKEGFDLELRRLGSLQHPNVLNPLGYHFRKEEKLIIYEYIPKGSLLF 424
Query: 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456
+LHGDRGPSH EL WPARLKIVQGIARG+GYLHTELA LDLPHGNLKSSNI ++ +++PL
Sbjct: 425 VLHGDRGPSHAELNWPARLKIVQGIARGLGYLHTELASLDLPHGNLKSSNILLTFDHDPL 484
Query: 457 ISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLT 516
+S++G+ +I+ + ++QALFAY+APEA++ +++PKCDVYCLGI+ILEIL GKFP+QYL
Sbjct: 485 LSDYGYSPLISVSFVSQALFAYRAPEAVRDNQISPKCDVYCLGIVILEILIGKFPTQYLN 544
Query: 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEM 576
N GG DVVEW SA ++GR ++ DPEIASS NS EM +LL IG AC +S+PEQR ++
Sbjct: 545 NSKGGTDVVEWAVSAIADGREAEVFDPEIASSINSMEEMVKLLHIGVACAESNPEQRPDI 604
Query: 577 REAVRRIVEIQQSDGNMDARTSQN----ILPTLDHGCAE 611
+EA+RRI EI G S + +LP+L G E
Sbjct: 605 KEAIRRIEEIHVEGGGSGGGASHDRTIQVLPSLRDGYGE 643
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482466|ref|XP_003632778.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/639 (53%), Positives = 449/639 (70%), Gaps = 46/639 (7%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
MS+SEALLKLK SFTN ALDSW P + PC G++EW G+VC GIVTGL++ MGLSGK
Sbjct: 1 MSDSEALLKLKQSFTNTNALDSWEPGSGPC-SGDKEWGGLVCFNGIVTGLHLVGMGLSGK 59
Query: 61 IDVDALTELTGLR--------------------GLRAIYLDKNQFSGEIPPGYFDEMGAL 100
IDV+AL +TGLR L+AI++ NQFSGEIPP YF M +L
Sbjct: 60 IDVEALIAITGLRTISIVNNSFSGSIPEFNRLGALKAIFISGNQFSGEIPPDYFVRMASL 119
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+KLW S+NKF G +P S+ L HL ELHLE+NQF GTIP F+ PTL LNLS+NKL+G I
Sbjct: 120 KKLWLSDNKFTGAIPLSIQLLSHLIELHLENNQFTGTIPDFNLPTLKSLNLSNNKLKGAI 179
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVIA 220
P SL +F S+F+GNAGLCG+ LG C + H D S+K IA
Sbjct: 180 PDSLSKFGGSAFAGNAGLCGEELGNGCND----------------HGIDLGTDRSRKAIA 223
Query: 221 AGVALSVMLVSIAIVVIIRIRR-KRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKA-- 277
++++V+++S+ I+V+ +RR K + F VLE ++VEVR+S ++ SR+A
Sbjct: 224 VIISVAVVIISLLIIVVFLMRRRKEEEFDVLENVD-ESVEVRISGSSRKEGSSTSRRAIG 282
Query: 278 -SSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGV 336
S S K+S ++V+VN +KG+FG+ DLMKAAAEVLG G LGS+YKA+MA G+
Sbjct: 283 SSRRGSNRSSQVKSSMKEDMVVVNEEKGIFGMSDLMKAAAEVLGTGSLGSAYKAVMATGI 342
Query: 337 TVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396
VVVKRMKE + ++++ FD E+RRLG L+H NVL PL YH+R +EKL++YEYIP GSLL+
Sbjct: 343 AVVVKRMKEMNRVSKEGFDLELRRLGSLQHPNVLNPLGYHFRKEEKLIIYEYIPKGSLLF 402
Query: 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456
+LHGDRGPSH EL WPARLKIVQGIARG+GYLHTELA LDLPHGNLKSSNI ++ +++PL
Sbjct: 403 VLHGDRGPSHAELNWPARLKIVQGIARGLGYLHTELASLDLPHGNLKSSNILLTFDHDPL 462
Query: 457 ISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLT 516
+S++G+ +I+ + ++QALFAY+APEA++ +++PKCDVYCLGI+ILEIL GKFP+QYL
Sbjct: 463 LSDYGYSPLISVSFVSQALFAYRAPEAVRDNQISPKCDVYCLGIVILEILIGKFPTQYLN 522
Query: 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEM 576
N GG DVVEW SA ++GR ++ DPEIASS NS EM +LL IG AC +S+PEQR ++
Sbjct: 523 NSKGGTDVVEWAVSAIADGREAEVFDPEIASSINSMEEMVKLLHIGVACAESNPEQRPDI 582
Query: 577 REAVRRIVEIQQSDGNMDARTSQN----ILPTLDHGCAE 611
+EA+RRI EI G S + +LP+L G E
Sbjct: 583 KEAIRRIEEIHVEGGGSGGGASHDRTIQVLPSLRDGYGE 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225444669|ref|XP_002277642.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/606 (53%), Positives = 429/606 (70%), Gaps = 32/606 (5%)
Query: 3 ESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKID 62
E+EALLKLK S + ALDSW+PS+ PC+G W G++CL GIVTGL + SM LSG ID
Sbjct: 31 ENEALLKLKKSLVHTGALDSWVPSSNPCQG---PWDGLICLNGIVTGLRLGSMDLSGNID 87
Query: 63 VDALTELTGLR--------------------GLRAIYLDKNQFSGEIPPGYFDEMGALRK 102
VDAL ++ GLR L+ +YL +NQFSGEIP YF + +L+K
Sbjct: 88 VDALIDIRGLRTISLTNNSFSGPLPAFNRLGSLKGLYLTRNQFSGEIPSDYFSTLTSLKK 147
Query: 103 LWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPA 162
LW S NKF G++P S+ +L HL ELHL+ NQF+G IPS +L L LS+NKLEGEIP
Sbjct: 148 LWLSKNKFTGQIPKSVMQLTHLMELHLDDNQFSGPIPSTLPLSLKSLGLSNNKLEGEIPE 207
Query: 163 SLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVIAAG 222
+L +F+A +F GN GLCGK LG +C A + + PPP P ++ SK + AG
Sbjct: 208 TLAKFDAKAFEGNEGLCGKQLGKQCEQANKALSPSPPPPPPSPEIEKSKINISKVMTMAG 267
Query: 223 VALSVMLVSIAIVVIIRIRRKRKAFKVLEKESV-QAVEVRVSVPNKSRDVDVSRKASSSR 281
+A +M+ + ++ R+++ F +L KE++ + VE++VS + + D +KA+ S
Sbjct: 268 IAF-LMIALLVFTSLVSSSRRKEEFNILGKENLDEVVEIQVSGSTR-KGADSLKKANGSS 325
Query: 282 RGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVK 341
R S HG+ S V +LV++N +KG FGLPDLMKAAAEVLGNGGLGS+YKA+MA+G+ VVVK
Sbjct: 326 RRGSQHGRAS-VSDLVMINDEKGSFGLPDLMKAAAEVLGNGGLGSAYKAVMANGLAVVVK 384
Query: 342 RMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGD 401
RM+E + + RD+FD ++R++GRLRH N+L PLAYHYR +EKLL+ EY+P GSLLY++HGD
Sbjct: 385 RMREINRLGRDSFDAQIRKIGRLRHENILTPLAYHYRKEEKLLISEYVPKGSLLYVMHGD 444
Query: 402 RGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461
RG SH EL WP RLKI+QGIA G+ +LH+E A LDLPHGNLKSSNI + PL++++
Sbjct: 445 RGISHSELNWPTRLKIIQGIASGMNFLHSEFASLDLPHGNLKSSNILLDEHYVPLLTDYA 504
Query: 462 FYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG 521
FY ++N+ +QA+FAY+A Q V+PKCDVYCLGI+ILEI+TGKFPSQYL+NG GG
Sbjct: 505 FYPLVNATQASQAMFAYRA----QDQHVSPKCDVYCLGIVILEIITGKFPSQYLSNGKGG 560
Query: 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
DVV+WV SA E R T+L+DPEIAS S EM++LL+I CT+S+PE RL+M+EA+R
Sbjct: 561 TDVVQWVKSAIEENRETELIDPEIASEA-SEREMQRLLQIAAECTESNPENRLDMKEAIR 619
Query: 582 RIVEIQ 587
RI EI+
Sbjct: 620 RIQEIK 625
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522414|ref|XP_003529841.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/662 (52%), Positives = 455/662 (68%), Gaps = 59/662 (8%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
M+E+EAL+ KSSF+NA+ LDSW+P +APC E++W GV C G+VTGL + MGL G+
Sbjct: 25 MTEAEALVSFKSSFSNAELLDSWVPGSAPC-SEEDQWEGVTCNNGVVTGLRLGGMGLVGE 83
Query: 61 IDVDALTELTGLRG--------------------LRAIYLDKNQFSGEIPPGYFDEMGAL 100
I VD L EL GLR L+A+YL N+FSG+IP YF +M +L
Sbjct: 84 IHVDPLLELKGLRQISLNDNSFSGPMPEFNRIGFLKALYLQGNKFSGDIPTEYFQKMRSL 143
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+K+W S+N F G++P SL +P L ELHLE+NQF+G IP P+L ++S+NKLEG I
Sbjct: 144 KKVWLSDNLFTGKIPSSLADIPQLMELHLENNQFSGNIPDLSNPSLAIFDVSNNKLEGGI 203
Query: 161 PASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAEN--VDDSKKV 218
PA LLRFN SSFSGN+GLC + L C + P P P A++ V D
Sbjct: 204 PAGLLRFNDSSFSGNSGLCDEKLRKSCEKTMET-------PSPGPIDDAQDKVVGDHVPS 256
Query: 219 ---------IAAGVALSVMLVSIAIVVIIRIRRKRKA--FKVLEKESVQ---AVEVRVSV 264
+A + SV LVS+ +++I+R RRK++ F + + V AVEV+V+
Sbjct: 257 VPHSSSSFEVAGIIVASVFLVSLVVLLIVRSRRKKEEENFDHIVGQQVNEGGAVEVQVTA 316
Query: 265 PNKSRDVDVSR------KASSSRRGS-SHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAE 317
P K R +D + K +SSRRGS S KN VGELV VN +KGVFG+ DLM+AAAE
Sbjct: 317 PVK-RVLDAASTSSTPMKKTSSRRGSISSQSKN--VGELVTVNDEKGVFGMSDLMRAAAE 373
Query: 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHY 377
VLGNG GSSYKA+MA+GV VVVKR +E + + +D FD E+R+L +L+H N+L PLAYH+
Sbjct: 374 VLGNGSFGSSYKAVMANGVAVVVKRTREMNVLEKDDFDAEMRKLTKLKHWNILTPLAYHF 433
Query: 378 RTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDL 437
R DEKL++ EY+P GSLL+ LHGDR PSH EL WPAR+KIV+GIA G+ YL+TEL+ LDL
Sbjct: 434 RKDEKLVISEYVPRGSLLFSLHGDRRPSHAELDWPARMKIVRGIAEGMHYLYTELSSLDL 493
Query: 438 PHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYC 497
PHGNLKSSN+ + P+NEP++ ++GF M+N ++ A LFAYKAPEA Q G+V+ CDVYC
Sbjct: 494 PHGNLKSSNVLLGPDNEPMLVDYGFSHMVNPSSAANTLFAYKAPEAAQHGQVSRSCDVYC 553
Query: 498 LGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQ 557
LG++I+EILTGK+PSQYL+NG GG DVV+WV +A SEGR T++LDPEIASS N GEMEQ
Sbjct: 554 LGVVIIEILTGKYPSQYLSNGKGGADVVQWVETAISEGRETEVLDPEIASSRNWLGEMEQ 613
Query: 558 LLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDARTSQNILPTLDHGCAENQESGK 617
LL IG ACTQS+P++RL+M EAVRRI EI ++G ++RT I T + G +Q+S +
Sbjct: 614 LLHIGAACTQSNPQRRLDMGEAVRRIKEI-NTEGGQESRT---IEETWNQGY-HDQQSQR 668
Query: 618 SH 619
H
Sbjct: 669 RH 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449488217|ref|XP_004157971.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At5g20690-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1598), Expect = e-175, Method: Compositional matrix adjust.
Identities = 313/607 (51%), Positives = 420/607 (69%), Gaps = 33/607 (5%)
Query: 1 MSESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK 60
+SE+EALLKLK SFT++++L+SW P + PC W G++C +G++TGL+++ + LSGK
Sbjct: 51 LSENEALLKLKESFTHSESLNSWNPDSVPCSA---RWIGIICNRGVITGLHLSGLQLSGK 107
Query: 61 IDVDALTELTGLRG--------------------LRAIYLDKNQFSGEIPPGYFDEMGAL 100
IDV+AL +L GLR L+++ L N FSG IP +F + +L
Sbjct: 108 IDVEALLQLRGLRTISFVDNQFSGPIPEFNKIGVLKSLLLTGNHFSGAIPSDFFSSLTSL 167
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLV-RLNLSSNKLEGE 159
+K+W S+N F G +P SL +L HL ELHLESNQF+G IP +++ LN+S+NKLEG+
Sbjct: 168 KKVWLSSNNFSGNIPHSLAQLSHLIELHLESNQFSGPIPHLKHASIITSLNVSNNKLEGQ 227
Query: 160 IPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVI 219
IP L +F+A +F+GN GLCG L C A+ S K PP P + SK V+
Sbjct: 228 IPDILSKFDAKAFAGNEGLCGNPLPKSC-GAQISEDQK----PPSSPPGESQGNISKLVV 282
Query: 220 AAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKASS 279
A+ +A++V L + + + +R+ F VL +E ++ V V V VP+ D SR+
Sbjct: 283 ASLIAVTVFL--MVFIFLSASKRREDEFSVLGREQMEEV-VEVHVPSSGHDKQSSRRGGG 339
Query: 280 SRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVV 339
+ S GK +G+ +LV+VN KG+FGL DLMKAAAEVLGNGGLGS+YKA+M++G++VV
Sbjct: 340 DSKRGSQQGK-AGMSDLVVVNEDKGIFGLADLMKAAAEVLGNGGLGSAYKAVMSNGLSVV 398
Query: 340 VKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLH 399
VKRM+E + + +D FD E+RRLGRLRH N+L PLAYHYR +EKLLV EYIP GSLLY+LH
Sbjct: 399 VKRMREMNKLGKDGFDAEMRRLGRLRHHNILTPLAYHYRREEKLLVSEYIPKGSLLYVLH 458
Query: 400 GDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459
GDRG H +L W RL+IVQGIARG+G+LH+E A DLPHGNLKSSN+ + EPL+S+
Sbjct: 459 GDRGACHADLNWATRLRIVQGIARGLGFLHSEFATYDLPHGNLKSSNVLLCDNYEPLLSD 518
Query: 460 FGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGN 519
+ F+ +IN N QA+FAY++PE Q +V+PK DVYCLGIIILEI+T KFPSQYLTNG
Sbjct: 519 YAFHPLINPNNATQAMFAYRSPEYAQYQEVSPKSDVYCLGIIILEIMTSKFPSQYLTNGK 578
Query: 520 GGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
GG DVV+WV+SA SE R +L+DPEIA+ T++ M LL IG CT ++P+QR EMREA
Sbjct: 579 GGTDVVQWVSSAVSEKREAELIDPEIANDTDALDRMVHLLTIGADCTHNNPQQRPEMREA 638
Query: 580 VRRIVEI 586
+RRI EI
Sbjct: 639 IRRIEEI 645
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 621 | ||||||
| TAIR|locus:2180409 | 659 | PRK6 "pollen receptor like kin | 0.475 | 0.447 | 0.596 | 3.5e-122 | |
| TAIR|locus:2078546 | 633 | PRK3 "AT3G42880" [Arabidopsis | 0.809 | 0.794 | 0.459 | 3.7e-119 | |
| TAIR|locus:2193942 | 644 | AT1G72460 [Arabidopsis thalian | 0.856 | 0.826 | 0.443 | 3.3e-111 | |
| TAIR|locus:2087595 | 679 | PRK4 "pollen receptor like kin | 0.476 | 0.435 | 0.432 | 9.9e-95 | |
| TAIR|locus:2128156 | 676 | AT4G31250 [Arabidopsis thalian | 0.478 | 0.439 | 0.439 | 2.4e-91 | |
| TAIR|locus:2008061 | 686 | PRK5 "pollen receptor like kin | 0.489 | 0.443 | 0.415 | 1e-86 | |
| TAIR|locus:2063621 | 647 | PRK2A "AT2G07040" [Arabidopsis | 0.483 | 0.463 | 0.396 | 9.2e-86 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.856 | 0.808 | 0.357 | 1.4e-80 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.515 | 0.477 | 0.384 | 1.1e-78 | |
| TAIR|locus:2044913 | 672 | AT2G36570 [Arabidopsis thalian | 0.475 | 0.438 | 0.394 | 4.1e-73 |
| TAIR|locus:2180409 PRK6 "pollen receptor like kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 3.5e-122, Sum P(2) = 3.5e-122
Identities = 176/295 (59%), Positives = 233/295 (78%)
Query: 293 VGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARD 352
+G++++VN KG FGLPDLMKAAAEVLGNG LGS+YKA+M G++VVVKR+++ + +AR+
Sbjct: 364 MGDIIMVNTDKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLARE 423
Query: 353 AFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWP 412
FD E+RR G+LRH N+L PLAYHYR +EKL+V EY+P SLLY+LHGDRG H ELTW
Sbjct: 424 PFDVEMRRFGKLRHPNILTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWA 483
Query: 413 ARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472
RLKI+QG+A G+ +LH E A DLPHGNLKSSN+ +S EPLIS++ F ++ +N +
Sbjct: 484 TRLKIIQGVAHGMKFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNAS 543
Query: 473 QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAF 532
QALFA+K PE Q+ +V+ K DVYCLGIIILEILTGKFPSQYL NG GG D+V+WV S+
Sbjct: 544 QALFAFKTPEFAQTQQVSHKSDVYCLGIIILEILTGKFPSQYLNNGKGGTDIVQWVQSSV 603
Query: 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587
+E + +L+DPEI ++T S +M +LL +G AC S+P++RL+MREAVRRI +++
Sbjct: 604 AEQKEEELIDPEIVNNTESMRQMVELLRVGAACIASNPDERLDMREAVRRIEQVK 658
|
|
| TAIR|locus:2078546 PRK3 "AT3G42880" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1173 (418.0 bits), Expect = 3.7e-119, P = 3.7e-119
Identities = 244/531 (45%), Positives = 336/531 (63%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLES 131
L GL+++ L N FSGEI +F E L++++ NN+ G++P SL +L L ELH++
Sbjct: 113 LPGLKSLLLSNNSFSGEIADDFFKETPQLKRVFLDNNRLSGKIPASLMQLAGLEELHMQG 172
Query: 132 NQFNGTIPSFDQ--PTLVRLNLSSNKLEGEIPASLL-RFNAS-SFSGNAGLCGKNLGVEC 187
NQF G IP L L+LS+N LEGEIP ++ R N F GN LCG L +EC
Sbjct: 173 NQFTGEIPPLTDGNKVLKSLDLSNNDLEGEIPITISDRKNLEMKFEGNQRLCGSPLNIEC 232
Query: 188 RNAKASAANKNIXXXXXXXXAAENVDDSKKVIAAGVALSVMLVSXXXXXXXXXXXXXXXF 247
+S + N E + +K + + L + L F
Sbjct: 233 DEKPSSTGSGN-----------EKNNTAKAIFMVILFLLIFLF-VVAIITRWKKKRQPEF 280
Query: 248 KVLEKESVQAVE-VRVSVPNK-SRDVDVXXXXXXXXXXXXXXXXX----------XXVGE 295
++L K+ + E V V VP+ + +D +G+
Sbjct: 281 RMLGKDHLSDQESVEVRVPDSIKKPIDSSKKRSNAEGSSKKGSSHNGKGAGGGPGSGMGD 340
Query: 296 LVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFD 355
+++VN +KG FGLPDLMKAAAEVLGNG LGS+YKA+MA+G++VVVKR+++ + +AR+AFD
Sbjct: 341 IIMVNSEKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMANGLSVVVKRIRDMNKLAREAFD 400
Query: 356 TEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARL 415
TE++R G+LRH NVL PLAYHYR +EKL+V EY+P SLLY+LHGDRG H ELTW RL
Sbjct: 401 TEMQRFGKLRHPNVLTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGVYHSELTWATRL 460
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL 475
KI+QG+ARG+ +LH E A DLPHGNLKSSN+ +S EPLIS++ F ++ N +QAL
Sbjct: 461 KIIQGVARGMDFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPNNASQAL 520
Query: 476 FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535
FA+K+PE +Q+ +V+PK DVYCLGII+LE++TGKFPSQYL G GG D+VEWV S+ ++
Sbjct: 521 FAFKSPEFVQNQQVSPKSDVYCLGIIVLEVMTGKFPSQYLNTGKGGTDIVEWVQSSIAQH 580
Query: 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
+ +L+DPEIAS+T+S +M +LL IG AC S+P +R M+E VRRI +
Sbjct: 581 KEEELIDPEIASNTDSIKQMVELLRIGAACIASNPNERQNMKEIVRRIERV 631
|
|
| TAIR|locus:2193942 AT1G72460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
Identities = 257/579 (44%), Positives = 346/579 (59%)
Query: 40 VVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGA 99
V LK + + I+ M S D+ LT L+ L Y+ N+FSG IP YF+ M +
Sbjct: 83 VAPLKDLPSLRTISIMNNSFSGDIPEFNRLTALKSL---YISGNRFSGNIPSDYFETMVS 139
Query: 100 LRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
L+K W SNN F G +P SL LP+L EL LE+NQF G+IP+F Q TL ++LS+N+L G
Sbjct: 140 LKKAWLSNNHFSGLIPISLATTLPNLIELRLENNQFIGSIPNFTQTTLAIVDLSNNQLTG 199
Query: 159 EIPASLLRFNASSFSGNAGLCGKNLGVECRNAKASAANKNIXXXXXXXXAAENVDDSKKV 218
EIP LL+F+A +F+GN+GLCG L C K S A+ I ++ + SK
Sbjct: 200 EIPPGLLKFDAKTFAGNSGLCGAKLSTPCPQPKNSTASITIEGTM------KDANKSKYF 253
Query: 219 IA---AGVALSVMLVSXXXXXXXXXXXXXXXFKVLEKESV--QAVEVRVSVPNKSRDVDV 273
+A GV L V+LVS + E+++ Q ++V V N SR
Sbjct: 254 LAFSTLGVLLIVVLVSLAFRKKKKKRRRKKARRTSEQDNSDDQQIQVTVEGSNSSRQ--- 310
Query: 274 XXXXXXXXXXXXXXXXXXXVGELVLVNGQKGVFGLPDLMKAAAEVLGN-----------G 322
+LV+VN +KGVF L DLMKAAA VLGN G
Sbjct: 311 ----SRSSRSGELNKGVAGTSDLVMVNKEKGVFRLSDLMKAAAHVLGNPGGGSNRPRSSG 366
Query: 323 GLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK 382
G+GS+YKA++++GVTVVVKR+ + ++ D FD E+R+LG L+H NVL PLAYH+R DEK
Sbjct: 367 GVGSAYKAVLSNGVTVVVKRVTVMNQVSVDVFDKEIRKLGSLQHKNVLTPLAYHFRQDEK 426
Query: 383 LLVYEYIPGGSLLYLLHGDRGPSHDE--LTWPARLKIVQGIARGIGYLHTELAHLDLPHG 440
LLV+E++P +LL+ LHGD H+E L WP+RLKI+QGIARG+ YLH EL L+LPHG
Sbjct: 427 LLVFEFVPNLNLLHRLHGD----HEEFQLDWPSRLKIIQGIARGMWYLHRELGFLNLPHG 482
Query: 441 NLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGI 500
NLKSSNIF++ + EPLISEFG +IN +Q+L A+K+PEA + G V+ K DV+ G+
Sbjct: 483 NLKSSNIFLAEDGEPLISEFGLQKLINPDAQSQSLVAFKSPEADRDGTVSAKSDVFSFGV 542
Query: 501 IILEILTGKFPSQYL-TNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPG----EM 555
++LEILTGKFPSQY N GG ++VEW+ SA +G DLL P + ++ E+
Sbjct: 543 VVLEILTGKFPSQYAGLNRAGGANLVEWLGSALEQGGWMDLLHPMVVTAAAEDKIMEEEI 602
Query: 556 EQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMD 594
E +L IG CT+ DP+QR M E V E+ D N D
Sbjct: 603 ENVLRIGVRCTREDPDQRPNMTEVVD---ELTIEDSNDD 638
|
|
| TAIR|locus:2087595 PRK4 "pollen receptor like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 9.9e-95, Sum P(2) = 9.9e-95
Identities = 129/298 (43%), Positives = 193/298 (64%)
Query: 306 FGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR 365
F L DL++A+AEVLG+G GSSYK + G +VVKR K + + RD F +RRLGRL+
Sbjct: 365 FDLQDLLRASAEVLGSGSFGSSYKTGINSGQMLVVKRYKHMNNVGRDEFHEHMRRLGRLK 424
Query: 366 HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
H N+L +AY+YR +EKLL+ E++P SL LH + L WP RLKI+QG+A+G+
Sbjct: 425 HPNLLPIVAYYYRREEKLLIAEFMPNRSLASHLHANHSVDQPGLDWPTRLKIIQGVAKGL 484
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQ 485
GYL EL L +PHG+LKSSN+ + EPL++++ ++NS + +YK+PE
Sbjct: 485 GYLFNELTTLTIPHGHLKSSNVVLDESFEPLLTDYALRPVMNSEQSHNLMISYKSPEYSL 544
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNG-NGGIDVVEWVASAFSEGRVTDLLDPE 544
G +T K DV+CLG++ILE+LTG+FP YL+ G + + +V WV++ E + D+ D E
Sbjct: 545 KGHLTKKTDVWCLGVLILELLTGRFPENYLSQGYDANMSLVTWVSNMVKEKKTGDVFDKE 604
Query: 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMD-ARTSQNI 601
+ N EM LL+IG +C + D E+R+EMR+AV +I +++ + + D A T+ N+
Sbjct: 605 MTGKKNCKAEMLNLLKIGLSCCEEDEERRMEMRDAVEKIERLKEGEFDNDFASTTHNV 662
|
|
| TAIR|locus:2128156 AT4G31250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 649 (233.5 bits), Expect = 2.4e-91, Sum P(2) = 2.4e-91
Identities = 131/298 (43%), Positives = 186/298 (62%)
Query: 295 ELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAF 354
+L V + F L D+++A+AEVLG+GG GSSYKA ++ G VVVKR + S + R+ F
Sbjct: 348 KLHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGREEF 407
Query: 355 DTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPAR 414
++++GRL H N+L +A++YR +EKLLV YI GSL LLH +R P L WP R
Sbjct: 408 YDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLDWPIR 467
Query: 415 LKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA 474
LKIV+G+ RG+ YL+ L+LPHG+LKSSN+ + P EPL++++ ++N Q
Sbjct: 468 LKIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVLLDPNFEPLLTDYALVPVVNRDQSQQF 527
Query: 475 LFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID-VVEWVASAFS 533
+ AYKAPE Q + + + DV+ LGI+ILEILTGKFP+ YL G G D + WV S
Sbjct: 528 MVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQGKGADDELAAWVESVAR 587
Query: 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591
D+ D E+ + +M +LL+IG C D E+R+E+ EAV RI E+ + G
Sbjct: 588 TEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAVDRIEEVDRDAG 645
|
|
| TAIR|locus:2008061 PRK5 "pollen receptor like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 631 (227.2 bits), Expect = 1.0e-86, Sum P(2) = 1.0e-86
Identities = 131/315 (41%), Positives = 194/315 (61%)
Query: 294 GELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDA 353
G L+ V F L DL++A+AEVLG+G G+SYKA ++ G T+VVKR K + + RD
Sbjct: 356 GRLLFVRDDIQRFDLQDLLRASAEVLGSGTFGASYKAAISSGQTLVVKRYKHMNNVGRDE 415
Query: 354 FDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPA 413
F +RRLGRL H N+L +AY+YR +EKLLV E++P SL LH + D W
Sbjct: 416 FHEHMRRLGRLNHPNILPLVAYYYRREEKLLVTEFMPNSSLASHLHANNSAGLD---WIT 472
Query: 414 RLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ 473
RLKI++G+A+G+ YL EL L +PHG++KSSNI + EPL++++ M++S +
Sbjct: 473 RLKIIKGVAKGLSYLFDELPTLTIPHGHMKSSNIVLDDSFEPLLTDYALRPMMSSEHAHN 532
Query: 474 ALFAYKAPEAIQS-GKV-TPKCDVYCLGIIILEILTGKFPSQYLTNG-NGGIDVVEWVAS 530
+ AYK+PE S G++ T K DV+C G++ILE+LTG+FP YLT G + + +V WV
Sbjct: 533 FMTAYKSPEYRPSKGQIITKKTDVWCFGVLILEVLTGRFPENYLTQGYDSNMSLVTWVND 592
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
E + D+ D E+ N EM LL+IG C + + E+R++MRE V + +++ +
Sbjct: 593 MVKEKKTGDVFDKEMKGKKNCKAEMINLLKIGLRCCEEEEERRMDMREVVEMVEMLREGE 652
Query: 591 -----GNMDARTSQN 600
G+MD R + N
Sbjct: 653 SEDDFGSMDHRGTHN 667
|
|
| TAIR|locus:2063621 PRK2A "AT2G07040" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 612 (220.5 bits), Expect = 9.2e-86, Sum P(2) = 9.2e-86
Identities = 120/303 (39%), Positives = 187/303 (61%)
Query: 295 ELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAF 354
+L + KG F L DL+KA+AE+LG+G G+SYK ++++G +VVKR K ++ D F
Sbjct: 320 KLSFLRDDKGKFELQDLLKASAEILGSGCFGASYKTLLSNGSVMVVKRFKHMNSAGIDEF 379
Query: 355 DTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPAR 414
++RLGRL H N+L +AY+Y+ +EKL V +++ GSL LHG + L WP R
Sbjct: 380 QEHMKRLGRLNHENLLPIVAYYYKKEEKLFVSDFVANGSLAAHLHGHKSLGQPSLDWPTR 439
Query: 415 LKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA 474
IV+G+ RG+ YLH L L PHG+LKSSN+ +S + EPL+ ++G MIN + +
Sbjct: 440 FNIVKGVGRGLLYLHKNLPSLMAPHGHLKSSNVLLSEKFEPLLMDYGLIPMINEESAQEL 499
Query: 475 LFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYL-TNGNGGIDVVEWVASAFS 533
+ AYK+PE ++ +VT K DV+ LG++ILEILTGK + + D+ WV S+F
Sbjct: 500 MVAYKSPEYVKQSRVTKKTDVWGLGVLILEILTGKLLESFSQVDKESEEDLASWVRSSFK 559
Query: 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI--QQSDG 591
+L D E+ ++N + L+ IG +C + D E+RL++REAV ++ ++ ++ G
Sbjct: 560 GEWTQELFDQEMGKTSNCEAHILNLMRIGLSCCEVDVEKRLDIREAVEKMEDLMKEREQG 619
Query: 592 NMD 594
+ D
Sbjct: 620 DDD 622
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 1.4e-80, P = 1.4e-80
Identities = 195/545 (35%), Positives = 289/545 (53%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + S LSG+I D + L LR++YL N+FSGE P F ++ L +L S+N
Sbjct: 96 LSLRSNRLSGQIPSD----FSNLTHLRSLYLQHNEFSGEFPTS-FTQLNNLIRLDISSNN 150
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNA 169
F G +P S+ L HLT L L +N F+G +PS LV N+S+N L G IP+SL RF+A
Sbjct: 151 FTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNNLNGSIPSSLSRFSA 209
Query: 170 SSFSGNAGLCGKNLGVECRNAKASAANKNIXXXXXXXXAAENVDDSKKVIAAGVALSVML 229
SF+GN LCG L C++ S + +++ SK I A + S L
Sbjct: 210 ESFTGNVDLCGGPLK-PCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVASA-L 267
Query: 230 VSXXXXXXXXXXXXXXXFKVLEKESVQAVEVRVSVPNKSRDVDVXXXXXXXXXXXXXXXX 289
V+ E + Q V+ N
Sbjct: 268 VALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGG 327
Query: 290 XXXVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM 349
+LV G F L DL++A+AEVLG G +G+SYKA++ +G TVVVKR+K+ A
Sbjct: 328 ETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMAS 387
Query: 350 ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDEL 409
++ F+T++ +G+++H NV+ AY+Y DEKLLV++++P GSL LLHG RG L
Sbjct: 388 KKE-FETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPL 446
Query: 410 TWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469
W R++I ARG+ +LH L HGN+K+SNI + P + +S++G + +++
Sbjct: 447 DWDNRMRIAITAARGLAHLHVSAK---LVHGNIKASNILLHPNQDTCVSDYGLNQLFSNS 503
Query: 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVA 529
+ L Y APE +++ KVT K DVY G+++LE+LTGK P+Q + G GID+ WV
Sbjct: 504 SPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQ-ASLGEEGIDLPRWVL 562
Query: 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
S E ++ D E+ N EM QLL+I AC + P+QR M+E +R I ++ +S
Sbjct: 563 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRS 622
Query: 590 DGNMD 594
+ D
Sbjct: 623 ETTDD 627
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 589 (212.4 bits), Expect = 1.1e-78, Sum P(2) = 1.1e-78
Identities = 125/325 (38%), Positives = 190/325 (58%)
Query: 294 GELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMA-RD 352
G++V G + F L DL++A+AE+LG GG G++YKA++ DG V VKR+K++ +A +
Sbjct: 344 GKMVFFEGTRR-FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKK 402
Query: 353 AFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWP 412
F+ ++ LGRLRH+N+++ AY++ +EKLLVY+Y+P GSL +LLHG+RGP L W
Sbjct: 403 EFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWT 462
Query: 413 ARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472
RLKI G ARG+ ++H L L HG++KS+N+ + +S+FG S +A
Sbjct: 463 TRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVA 522
Query: 473 QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG-IDVVEWVASA 531
++ Y+APE I K T K DVY G+++LEILTGK P+ T +GG +D+ WV S
Sbjct: 523 KSN-GYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSV 581
Query: 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591
E ++ D E+ + EM LL+I ACT + R +M V+ I +I+ G
Sbjct: 582 VREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIR-GGG 640
Query: 592 NMDARTSQNILPTLDHGCAENQESG 616
+ + + I +D C G
Sbjct: 641 SEASPCNDGINSAVDSPCLSEDTCG 665
|
|
| TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
Identities = 123/312 (39%), Positives = 180/312 (57%)
Query: 306 FGLPDLMKAAAEVLGNGGLGSSYKAMMADG-VTVVVKRMKESSAMARDAFDTEVRRLGRL 364
F L DL+KA+AE+LG G LG+ YKA++ DG TV VKR+K+++ R F+ + +GRL
Sbjct: 350 FELDDLLKASAEMLGKGSLGTVYKAVLDDGSTTVAVKRLKDANPCPRKEFEQYMEIIGRL 409
Query: 365 RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARG 424
+H NV+ AY+Y +EKLLVYEY+P GSL LLHG+RGP L W R+ ++ G ARG
Sbjct: 410 KHQNVVKLRAYYYAKEEKLLVYEYLPNGSLHSLLHGNRGPGRIPLDWTTRISLMLGAARG 469
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAI 484
+ +H E + +PHGN+KSSN+ + LI++FG ++N + L Y+APE
Sbjct: 470 LAKIHDEYSISKIPHGNIKSSNVLLDRNGVALIADFGLSLLLNPVHAIARLGGYRAPEQS 529
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGN--------------GGIDVVEWVAS 530
+ +++ K DVY G+++LE+LTGK PS + + +D+ +WV S
Sbjct: 530 EIKRLSQKADVYSFGVLLLEVLTGKAPSIFPSPSRPRSAASVAVEEEEEAVVDLPKWVRS 589
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI--QQ 588
E ++ DPE+ N EM +L IG AC PE+R M E V+ + EI +Q
Sbjct: 590 VVKEEWTAEVFDPELLRYKNIEEEMVAMLHIGLACVVPQPEKRPTMAEVVKMVEEIRVEQ 649
Query: 589 SDGNMDARTSQN 600
S D S+N
Sbjct: 650 SPVGEDFDESRN 661
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 621 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-30 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.001 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.001 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.001 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.003 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.003 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.003 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.003 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.004 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.004 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.004 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.004 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-39
Identities = 136/527 (25%), Positives = 231/527 (43%), Gaps = 103/527 (19%)
Query: 65 ALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW---FSNNKFRGRLPPSLFKL 121
+L+EL L+ L +N+ SGEIP DE+ + +KL S+N+ G++P S ++
Sbjct: 497 SLSELMQLK------LSENKLSGEIP----DELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 122 PHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPAS--LLRFNASSFSGNAG 177
P L++L L NQ +G IP + +LV++N+S N L G +P++ L NAS+ +GN
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606
Query: 178 LCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKK----VIAAGVALSVMLVSIA 233
LCG + S P + V + + A V+ +
Sbjct: 607 LCGGD--------TTSGL-----------PPCKRVRKTPSWWFYITCTLGAFLVLALVAF 647
Query: 234 IVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKASSSRRGSSHHGKNSGV 293
V IR R LE + V+ G
Sbjct: 648 GFVFIRGRN------NLELKRVE--------------------------------NEDGT 669
Query: 294 GELVLVNGQ-KGVFGLPDLMKAAAE--VLGNGGLGSSYKA-MMADGVTVVVKRMKESSAM 349
EL + + + D++ + E V+ G G+SYK + +G+ VVK + + +++
Sbjct: 670 WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI 729
Query: 350 ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDEL 409
+E+ +G+L+H N++ + L++EYI G +L +L L
Sbjct: 730 P----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------L 777
Query: 410 TWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEP--LISEFGFYTMIN 467
+W R KI GIA+ + +LH + + GNL I I ++EP +S G
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVV-GNLSPEKIIIDGKDEPHLRLSLPGLLCTDT 836
Query: 468 SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEW 527
++ A Y APE ++ +T K D+Y G+I++E+LTGK P+ +G I VEW
Sbjct: 837 KCFISSA---YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI--VEW 891
Query: 528 VASAFSEGRVTDLLDPEIASSTNS-PGEMEQLLEIGRACTQSDPEQR 573
+S+ + +DP I + E+ +++ + CT +DP R
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTAR 938
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 16/195 (8%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
LG GG G+ Y A G V +K + KE S+ + E+ L +L H N++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ LV EY GGSL LL + G L+ L+I+ I G+ YLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLH----SNG 112
Query: 437 LPHGNLKSSNIFI-SPENEPLISEFGFYTMINSANLAQALF----AYKAPEAIQS-GKVT 490
+ H +LK NI + S + +++FG ++ S AY APE + G +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 491 PKCDVYCLGIIILEI 505
K D++ LG+I+ E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 78/273 (28%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM--ARDAFDTEVRRLGRLRHSNVLAPL 373
LG+G G+ YKA G V VK +K+ S E+R L RL H N++ +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-L 432
D LV EY GG L L L+ KI I RG+ YLH+ +
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-LAQALFA---YKAPEAIQSGK 488
H D LK NI + I++FG + ++ Y APE + G
Sbjct: 120 IHRD-----LKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 489 -VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547
PK DV+ LG+I+ E+LTGK P G +D ++ L E
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFS----GENILDQLQ----LIRRILGPPLEFDEPKW 226
Query: 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAV 580
S+ S E + L++ C DP +R E +
Sbjct: 227 SSGSE-EAKDLIK---KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E LG G G Y A G V +K + K+ R+ E++ L +L+H N++ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR-LY 63
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-L 432
+ ++KL LV EY GG L LL S DE AR ++ I + YLH++ +
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE----AR-FYLRQILSALEYLHSKGI 118
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF---AYKAPEAIQSGKV 489
H DL K NI + + +++FG ++ Y APE +
Sbjct: 119 VHRDL-----KPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 490 TPKCDVYCLGIIILEILTGKFP 511
D++ LG+I+ E+LTGK P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 79/289 (27%), Positives = 121/289 (41%), Gaps = 57/289 (19%)
Query: 317 EVLGNGGLGSSYKAM-----MADGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVL 370
+ LG G G YK V V VK +KE ++ + F E R + +L H N++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L + ++V EY+PGG LL YL R EL+ L IARG+ YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYL----RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK---------- 479
+ H +L + N + IS+FG L++ L+
Sbjct: 121 ----SKNFIHRDLAARNCLVGENLVVKISDFG---------LSRDLYDDDYYKVKGGKLP 167
Query: 480 ----APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534
APE+++ GK T K DV+ G+++ EI T G+ P ++N +V+E++ +
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN----AEVLEYLKKGYR- 222
Query: 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
L P N P E+ +L+ C DPE R E V +
Sbjct: 223 -----LPKPP-----NCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 76/284 (26%), Positives = 116/284 (40%), Gaps = 48/284 (16%)
Query: 317 EVLGNGGLGSSYKAM-----MADGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVL 370
+ LG G G YK V V VK +KE ++ + F E R + +L H NV+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L + +V EY+ GG LL L + +L+ L IARG+ YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK----NRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYK--A 480
+ H +L + N + IS+FG Y L + A
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP-----IRWMA 171
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539
PE+++ GK T K DV+ G+++ EI T G+ P ++N +V+E++ + +
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN----EEVLEYLKNGYR------ 221
Query: 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
L P N P E+ L+ C DPE R E V +
Sbjct: 222 LPQPP-----NCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 81/288 (28%), Positives = 118/288 (40%), Gaps = 48/288 (16%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLA 371
+ LG G G YK + V VK +KE S R F E R + +L H NV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLL-YLL---HGDRGPSHDELTWPARLKIVQGIARGIGY 427
L + LV EY+ GG LL YL P L+ L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK-------- 479
L H +L + N + + IS+FG S ++ + K
Sbjct: 121 LA----SKKFVHRDLAARNCLVGEDLVVKISDFGL-----SRDVYDDDYYRKKTGGKLPI 171
Query: 480 ---APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535
APE+++ G T K DV+ G+++ EI T G P L+N +V+E++ +G
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYL----RKG 223
Query: 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
L PE E+ +L+ +C Q DPE R E V R+
Sbjct: 224 YR--LPKPEYCPD-----ELYELM---LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 32/296 (10%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMK---ESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
LG G G Y A D V +K + ES + + F E++ L L H + L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
++ + L LV EY+ GGSL LL + L+ L I+ I + YLH+
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEYLHS-- 119
Query: 433 AHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTMINSANLAQALF----------AYKAP 481
+ H ++K NI + + + +FG ++ ++ Y AP
Sbjct: 120 --KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 482 EAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538
E + + D++ LGI + E+LTG P + N + ++ + +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---- 233
Query: 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMD 594
S +N + ++ + DP+ RL + + D
Sbjct: 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
|
Length = 384 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 49/285 (17%)
Query: 317 EVLGNGGLGSSYKA-----MMADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
+ LG G G YK V VK +KE +S R+ F E + +L H N++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L + + +V EY+PGG LL L LT L++ IA+G+ YL +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK----LTLKDLLQMALQIAKGMEYLES 120
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFG---------FYTMINSANLAQALFAYK-- 479
+ H +L + N ++ IS+FG +Y K
Sbjct: 121 ----KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGG-----KLPIKWM 171
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538
APE+++ GK T K DV+ G+++ EI T G+ P ++N +V+E + +G
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN----EEVLELLE----DGYR- 222
Query: 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
L PE N P E+ +L+ C DPE R E V +
Sbjct: 223 -LPRPE-----NCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 54/277 (19%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMAR--DAFDTEVRRLGRLRHSNVLAPL 373
E+LG G GS Y A+ D G + VK ++ S +A + E+R L L+H N++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 374 AYHYRTDEKLLVY---EYIPGGSLLYLLHGDRGPSHDELTWPARL---KIVQGIARGIGY 427
R +EK + EY+ GGSL LL + E R +I++G+A Y
Sbjct: 66 -GSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPV--IRKYTRQILEGLA----Y 116
Query: 428 LHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL------FAYKA 480
LH+ + H D+ K +NI + + +++FG + + + A
Sbjct: 117 LHSNGIVHRDI-----KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540
PE I+ + D++ LG ++E+ TGK P W + + L
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP---------------W---SELGNPMAAL 213
Query: 541 LDPEIASSTNSP----GEMEQLLEIGRACTQSDPEQR 573
I SS P E+ + R C + DP++R
Sbjct: 214 YK--IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKR 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G GG G YKA G V +K +K S ++ E++ L + +H N++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAH 434
+ + DE +V E+ GGSL LL + E + A + + + +G+ YLH+ + H
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTE-SQIA--YVCKELLKGLEYLHSNGIIH 121
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF---AYKAPEAIQSGKVTP 491
D +K++NI ++ + E + +FG ++ + + APE I
Sbjct: 122 RD-----IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 492 KCDVYCLGIIILEILTGKFP 511
K D++ LGI +E+ GK P
Sbjct: 177 KADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 74/261 (28%), Positives = 115/261 (44%), Gaps = 32/261 (12%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG G G + V VK +K + M+ +AF E + + +LRH ++ A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLP 438
+ +V EY+ GSLL L G +L P + + IA G+ YL + +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESR----NYI 125
Query: 439 HGNLKSSNIFISPENEPLISEFGFYTMI--NSANLAQ-ALFAYK--APEAIQSGKVTPKC 493
H +L + NI + I++FG +I + + A F K APEA G+ T K
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 494 DVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSP 552
DV+ GI++ EI+T G+ P +TN +V+E V + R N P
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVERGYRMPRP-----------PNCP 230
Query: 553 GEMEQLLEIGRACTQSDPEQR 573
E+L ++ C DPE+R
Sbjct: 231 ---EELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMK----ESSAMARDAFDTEVRRLGRLRHSNVLA 371
+++G G G YK + + G V +K++ + A+ E+ L L+H N++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS--IMQEIDLLKNLKHPNIVK 63
Query: 372 PLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ T + L ++ EY GSL ++ GP + L + + Q + +G+ YLH
Sbjct: 64 YIG-SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESL---VAVYVYQ-VLQGLAYLHE 117
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQS 486
+ + H ++K++NI + + +++FG T +N + A + APE I+
Sbjct: 118 Q----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLT 516
+ D++ LG ++E+LTG P L
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLN 203
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 32/261 (12%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG G G + + V VK +K + M+ AF E + L+H ++ A +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLP 438
+ ++ EY+ GSLL L D G ++ P + IA G+ Y+ + +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERK----NYI 125
Query: 439 HGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAIQSGKVTPKC 493
H +L+++N+ +S I++FG +I A+ + APEAI G T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 494 DVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSP 552
DV+ GI++ EI+T GK P ++N + V SA G + N P
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGY-------RMPRMENCP 230
Query: 553 GEMEQLLEIGRACTQSDPEQR 573
++L +I + C + E+R
Sbjct: 231 ---DELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARD---AFDTEVRRLGRLRHSNVLAP 372
+G G G +K + AD +K++ S R+ A D E R L +L S ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSSYIIR- 63
Query: 373 LAYHYRT---DEKL-LVYEYIPGGSLLYLLHGDRG-PSHDELTWPARLKIVQGIARGIGY 427
+Y + KL +V EY G L LL RG P ++ W + I G+ +
Sbjct: 64 ---YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN-SANLAQALFA---YKAPEA 483
LH++ + H ++KS N+F+ + I + G +++ + N A + Y +PE
Sbjct: 117 LHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ K DV+ LG+++ E TGK P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 76/293 (25%), Positives = 117/293 (39%), Gaps = 51/293 (17%)
Query: 317 EVLGNGGLGSSYKAMMA------DGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNV 369
LG G G + D V VK +KE +S AR F+ E L +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLL--HG-------DRGPSHDELTWPARLKIVQG 420
+ D ++V+EY+ G L L HG ELT L+I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG---------FYTMINSANL 471
IA G+ Y LA H +L + N + + I +FG +Y + L
Sbjct: 131 IASGMVY----LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
+ PE+I K T + DV+ G+++ EI T GK P L+N +V+E +
Sbjct: 187 P---IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIECITQ 239
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
GR+ L P S + +I C + DP+QR+ +++ R+
Sbjct: 240 ----GRL--LQRPRTCPSE--------VYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G G G YK ++ V VK + + + F E L + H N++ +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+ +V E +PGGSLL L R + LT L++ A G+ YL ++
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL---RKKK-NRLTVKKLLQMSLDAAAGMEYLESK---- 112
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYKAPEAIQSG 487
+ H +L + N + N IS+FG YT+ S L Q + APEA+ G
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV--SDGLKQIPIKWTAPEALNYG 170
Query: 488 KVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517
+ T + DV+ GI++ E + G P ++N
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSN 201
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 59/260 (22%), Positives = 116/260 (44%), Gaps = 30/260 (11%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG+G G ++ + + V V +K +K + + F EV+ L RLRH ++++ A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLP 438
+ ++ E + GSLL L R P L + + + +A G+ YL + +
Sbjct: 74 GEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLEEQ----NSI 126
Query: 439 HGNLKSSNIFISPENEPLISEFGFYTMIN----SANLAQALFAYKAPEAIQSGKVTPKCD 494
H +L + NI + + +++FG +I ++ + + + APEA G + K D
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 495 VYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPG 553
V+ GI++ E+ T G+ P + N +V + + + + + P
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNH----EVYDQITAGY-----------RMPCPAKCPQ 231
Query: 554 EMEQLLEIGRACTQSDPEQR 573
E+ +++ C ++PE R
Sbjct: 232 EIYKIM---LECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-16
Identities = 83/305 (27%), Positives = 118/305 (38%), Gaps = 73/305 (23%)
Query: 3 ESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCL------KGIVTGLYINSMG 56
E AL LKSS W + PC + WSG C K + GL +++ G
Sbjct: 373 EVSALQTLKSSLGLPLRF-GW--NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQG 429
Query: 57 LSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP 116
L G I D ++ LR L++I L S N RG +PP
Sbjct: 430 LRGFIPND----ISKLRHLQSINL-------------------------SGNSIRGNIPP 460
Query: 117 SLFKLPHLTELHLESNQFNGTIP-SFDQPTLVR-LNLSSNKLEGEIPASL----LRFNAS 170
SL + L L L N FNG+IP S Q T +R LNL+ N L G +PA+L L +
Sbjct: 461 SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520
Query: 171 SFSGNAGLCGKNLGVECRNAKASAANKNIHPPPPPHPAAENVDDSKKVIAAGVALSVMLV 230
+F+ NAGLCG + P + G+A V +
Sbjct: 521 NFTDNAGLCGI---------------PGLRACGPHLSVGAKI---------GIAFGVSVA 556
Query: 231 SIAIVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKASSSRRGSSHHGKN 290
+ +V+ KR+ +L + + A E + K+R SR +R +HG
Sbjct: 557 FLFLVICAMCWWKRRQ-NILRAQRIAAREAPYA---KAR-THFSRDVQMTRHHRQNHGSA 611
Query: 291 SGVGE 295
E
Sbjct: 612 RTAAE 616
|
Length = 623 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
+V+G G G + + + V +K +K SS R F TE +G+ H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
++ +++ EY+ GSL L + G + T + +++GIA G+ YL +E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYL-SE 124
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK------APEAIQ 485
+ ++ H +L + NI ++ +S+FG + + K APEAI
Sbjct: 125 MNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 486 SGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517
K T DV+ GI++ E+++ G+ P ++N
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 35/264 (13%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ LG G G + V +K +K+ S M+ +AF E + +L+H ++ Y
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVR--LYA 68
Query: 377 YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
T E + ++ EY+ GSL+ L G +LT + + IA G+ ++ +
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK---- 121
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMI-NSANLAQ--ALFAYK--APEAIQSGKVT 490
+ H +L+++NI +S I++FG +I ++ A+ A F K APEAI G T
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 491 PKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549
K DV+ GI++ EI+T G+ P +TN +V++ + + R P+
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNLERGYRMPR------PD----- 226
Query: 550 NSPGEMEQLLEIGRACTQSDPEQR 573
N P E L E+ R C + PE+R
Sbjct: 227 NCPEE---LYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 32/261 (12%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG G G ++ + + V VK +K + M F E + + +LRH ++ A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLP 438
+ +V E + GSLL L G G + L P + + +A G+ YL + +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYLEAQ----NYI 125
Query: 439 HGNLKSSNIFISPENEPLISEFGFYTMI-----NSANLAQALFAYKAPEAIQSGKVTPKC 493
H +L + N+ + N +++FG +I + A+ + APEA + + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 494 DVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSP 552
DV+ GI++ EI+T G+ P +TN +V++ V + + P
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQVDQGY-----------RMPCPPGCP 230
Query: 553 GEMEQLLEIGRACTQSDPEQR 573
++L +I C + DP+ R
Sbjct: 231 ---KELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 9e-15
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLA 374
LG G G D G +K +K+ + R + TE L R+ H + L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPF-IVKLH 59
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
Y ++T+EKL LV EY PGG L L + E AR + I + YLH+
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFSEER--ARFYAAE-IVLALEYLHS--- 111
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKV 489
L + + +LK NI + + +++FG ++S F Y APE +
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 490 TPKCDVYCLGIIILEILTGKFP 511
D + LG+++ E+LTGK P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 312 MKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMAR---------DAFDTEVRRL 361
+K A ++G+G GS Y M A G + VK+++ S A DA E+ L
Sbjct: 3 IKGA--LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 362 GRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGI 421
L+H N++ L D + EY+PGGS+ LL+ ++ V+ I
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQI 115
Query: 422 ARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI--NSANLA------- 472
+G+ YLH + H ++K +NI + + IS+FG + NS +
Sbjct: 116 LKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 473 -QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Q + APE ++ T K D++ LG +++E+LTGK P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 45/288 (15%)
Query: 319 LGNGGLGSSYKAMMA------DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
LG G G + A D + V VK +KE+S AR F E L L+H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 373 LAYHYRTDEKLLVYEYIPGGSL----------LYLLHGDRGPSHDELTWPARLKIVQGIA 422
L+V+EY+ G L +L G + +LT L I IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 423 RGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA------LF 476
G+ YL A L H +L + N + I +FG I S + +
Sbjct: 133 SGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 477 AYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535
+ PE+I K T + D++ G+++ EI T GK P L+N I+ + ++G
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIECI-------TQG 240
Query: 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
R E+ P E+ ++ + C Q +P+QR+ +++ R+
Sbjct: 241 R-------ELERPRTCPPEVYAIM---QGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 79/282 (28%), Positives = 120/282 (42%), Gaps = 47/282 (16%)
Query: 319 LGNGGLGSSYKAMM------ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
LG G G + A D + V VK +K++S AR F E L L+H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLL--HGD------RGPSHDELTWPARLKIVQGIARG 424
D ++V+EY+ G L L HG G ELT L I Q IA G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 425 IGYLHTE-LAHLDLPHGN-LKSSNIFISPENEPLISEFGFYTMINSANLAQA------LF 476
+ YL ++ H DL N L N+ + I +FG + S + +
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVK------IGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 477 AYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535
+ PE+I K T + DV+ LG+++ EI T GK P L+N +V+E + ++G
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECI----TQG 238
Query: 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMR 577
RV + P E+ L+ C Q +P RL ++
Sbjct: 239 RV-------LQRPRTCPKEVYDLM---LGCWQREPHMRLNIK 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E+LG G G +K + D V VK KE + F +E R L + H N++ +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+ +V E +PGG L L + DEL +K A G+ YL ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLESK---- 112
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYT-----MINSANLAQALFAYKAPEAIQSGKVT 490
+ H +L + N + N IS+FG + +S+ L Q + APEA+ G+ +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 491 PKCDVYCLGIIILEILT-GKFPSQYLTN 517
+ DV+ GI++ E + G P +TN
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTN 200
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 47/282 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT------EVRRLGRLRHSNV 369
+ LG G S Y+A + G + VK++ + + + E+R + RL H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ L L E++ GGS+ +LL G + + + + + RG+ YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVI----INYTEQLLRGLSYLH 120
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPL-ISEFG----FYTMINSANLAQALF----AYKA 480
+ H ++K +N+ I + L I++FG A Q A+ A
Sbjct: 121 EN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540
PE ++ + CDV+ +G +I+E+ T K P W A S
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---------------WNAEKHSNHLA--- 218
Query: 541 LDPEIASSTNSPGEMEQL----LEIGRACTQSDPEQRLEMRE 578
L +IAS+T +P E L ++ C + PE R RE
Sbjct: 219 LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 49/280 (17%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRM--------KESSAMAR--DAFDTEVRRLGRLR 365
E++G G G Y A+ G + VK++ + S A +E+ L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 366 HSNVLAPLAYHYRTDEKLLVY-EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARG 424
H N++ L + T+E L ++ EY+PGGS+ L G ++L ++++G+A
Sbjct: 67 HLNIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLR-TYGRFEEQLVRFFTEQVLEGLA-- 122
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF-------YTMINSANLAQALFA 477
YLH++ + H +LK+ N+ + + IS+FG Y + ++ ++F
Sbjct: 123 --YLHSK----GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF- 175
Query: 478 YKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535
+ APE I S + K D++ LG ++LE+ G+ P E +A+ F G
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----------EAIAAMFKLG 225
Query: 536 --RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
R + P+++ + + L+ AC +P+ R
Sbjct: 226 NKRSAPPIPPDVSMNLSPVA-----LDFLNACFTINPDNR 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 35/262 (13%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LGNG G + V VK +K + M+ ++F E + + +LRH ++ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQ--LYAVV 70
Query: 379 TDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDL 437
++E + +V EY+ GSLL L G + L P + + +A G+ Y+ ++
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRA---LKLPNLVDMAAQVAAGMAYIE----RMNY 123
Query: 438 PHGNLKSSNIFISPENEPLISEFGFYTMI--NSANLAQ-ALFAYK--APEAIQSGKVTPK 492
H +L+S+NI + I++FG +I N Q A F K APEA G+ T K
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 493 CDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
DV+ GI++ E++T G+ P + N +V+E V + + +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQVERGY-----------RMPCPQDC 228
Query: 552 PGEMEQLLEIGRACTQSDPEQR 573
P + +L+ C + DPE+R
Sbjct: 229 PISLHELM---LQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 317 EVLGNGGLGSSYK------AMMADGVTVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNV 369
E LG G G YK +V +K +KE++ + F E + L+H N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLL-YLL----HGDRGPSHDE------LTWPARLKIV 418
+ L + +++EY+ G L +L+ H D G + L L I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 419 QGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN----LAQA 474
IA G+ YL + H +L + N + IS+FG I SA+ +++
Sbjct: 131 IQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 475 LFAYK--APEAIQSGKVTPKCDVYCLGIIILEI 505
L + PEAI GK T + D++ G+++ EI
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 50/286 (17%)
Query: 319 LGNGGLGSSYKAM------MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
LG G G + A D + V VK +K+ + AR F E L L+H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 373 LAYHYRTDEKLLVYEYIPGGSL-----------LYLLHGDRGPSHDELTWPARLKIVQGI 421
D ++V+EY+ G L + L+ G + EL L I I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 422 ARGIGYLHTE-LAHLDLPHGN-LKSSNIFISPENEPLISEFGFYTMINSANLAQA----- 474
A G+ YL ++ H DL N L +N+ + I +FG + S + +
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVK------IGDFGMSRDVYSTDYYRVGGHTM 186
Query: 475 -LFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAF 532
+ PE+I K T + DV+ G+I+ EI T GK P L+N +V+E +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIECI---- 238
Query: 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMRE 578
++GRV L P + +++ +I C Q +P+QRL ++E
Sbjct: 239 TQGRV--LERPRVCP--------KEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+G G G G V VK +K+ S A AF E + LRH N++ L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ + +V EY+ GSL+ L RG + +T +L + G+ YL + +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLR-SRGRAV--ITLAQQLGFALDVCEGMEYLEEK----N 122
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK--APEAIQSGKVTPKCD 494
H +L + N+ +S + +S+FG S K APEA++ K + K D
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGL-AKEASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 495 VYCLGIIILEILT-GKFP 511
V+ GI++ EI + G+ P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 38/278 (13%)
Query: 319 LGNGGLGSSY----KAMMADG---VTVVVKRMKESSAMARDA-FDTEVRRLGRLRHSNVL 370
LG+G G Y ++ G + V VK +++ + F E + H N++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE--LTWPARLKIVQGIARGIGYL 428
L + + ++ E + GG LL L R LT L I +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 429 H-TELAHLDLPHGN-LKSSNIFISPENEPLISEFGFYTMINSANL----AQALFAYK--A 480
H DL N L S + + I +FG I ++ + L + A
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVK-IGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539
PE++ GK T + DV+ G+++ EILT G+ P L N +V++ V + GR
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVT---AGGR--- 231
Query: 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMR 577
L PE N P ++ QL+ C DP +R
Sbjct: 232 LQKPE-----NCPDKIYQLMTN---CWAQDPSERPTFD 261
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 3e-13
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT--EVRRLGRLRHSNVLAPL 373
+ +G G G Y +DG V+K + S+ ++ D EV+ L +L H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 374 AYH--YRTDEKLL-VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKI-VQGIARGIGYLH 429
Y+ + KL V EY GG L + + L VQ + + YLH
Sbjct: 64 -YYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQ-LCLALKYLH 120
Query: 430 TE-LAHLDLPHGNLKSSNIFISPENEPLISEFGF-YTMINSANLAQALF---AYKAPEAI 484
+ + H D+ K NIF++ + +FG + ++ +LA+ + Y +PE
Sbjct: 121 SRKILHRDI-----KPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
Q+ K D++ LG ++ E+ T K P
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 70/268 (26%), Positives = 108/268 (40%), Gaps = 40/268 (14%)
Query: 318 VLGNGGLGSSYKAM-MADGVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAY 375
VLG G G YK G +K++ R E++ L V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
Y+ E +V EY+ GGSL LL ++ P I + I +G+ YLHT+
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDYLHTKR--- 119
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF---------AYKAPEAIQS 486
+ H ++K SN+ I+ + E I++FG S L L Y +PE IQ
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGI-----SKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG-IDVVEWVASAFSEGRVTDLLDPEI 545
+ D++ LG+ +LE GKFP +L G ++++ + L E
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDGPPP-----SLPAEE 227
Query: 546 ASSTNSPGEMEQLLEIGRACTQSDPEQR 573
S E + AC Q DP++R
Sbjct: 228 FSP-----EFRDFIS---ACLQKDPKKR 247
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 37/263 (14%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG G G + V +K +K + M +AF E + + +LRH L PL Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDK-LVPL-YAVV 70
Query: 379 TDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
++E + +V E++ GSLL +L GD L P + + IA G+ Y+ ++
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIE----RMN 122
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAIQSGKVTP 491
H +L+++NI + I++FG +I A+ + APEA G+ T
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 492 KCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
K DV+ GI++ E++T G+ P + N +V+E V + +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVERGY-----------RMPCPQG 227
Query: 551 SPGEMEQLLEIGRACTQSDPEQR 573
P E L E+ + C + DP++R
Sbjct: 228 CP---ESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G G G YKA A G V +K+M+ ++ E+ + +H N++ Y
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVD---Y 80
Query: 376 H--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
+ Y ++L +V EY+ GGSL ++ + + P + + + +G+ YLH++
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIIT----QNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF----AYKAPEAIQSG 487
+ H D+ KS NI +S + +++FGF + + + APE I+
Sbjct: 137 VIHRDI-----KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
PK D++ LGI+ +E+ G+ P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG G G + A V VK MK S M+ +AF E + L+H ++ A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLP 438
+ ++ E++ GSLL L D G + P + IA G+ ++ +
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYI 124
Query: 439 HGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAIQSGKVTPKC 493
H +L+++NI +S I++FG +I A+ + APEAI G T K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 494 DVYCLGIIILEILT-GKFPSQYLTN 517
DV+ GI+++EI+T G+ P ++N
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 59/190 (31%), Positives = 78/190 (41%), Gaps = 39/190 (20%)
Query: 3 ESEALLKLKSSFTNA-KALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKI 61
E E LL KSS + K L +W S C W G+ C + S+ LSGK
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWNSSADVCL-----WQGITC----NNSSRVVSIDLSGKN 80
Query: 62 DVDALTELT-GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK 120
++ L ++ I L NQ SG IP F +LR L SNN F G +P
Sbjct: 81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--S 138
Query: 121 LPHLTELHLESNQFNGTIP----SFDQ----------------------PTLVRLNLSSN 154
+P+L L L +N +G IP SF +L L L+SN
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198
Query: 155 KLEGEIPASL 164
+L G+IP L
Sbjct: 199 QLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG G G + V +K +K + M+ +AF E + + +LRH ++ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQ--LYAVV 70
Query: 379 TDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDL 437
++E + +V EY+ GSLL L G+ G L P + + IA G+ Y+ ++
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE----RMNY 123
Query: 438 PHGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAIQSGKVTPK 492
H +L+++NI + +++FG +I A+ + APEA G+ T K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 493 CDVYCLGIIILEILT-GKFPSQYLTN 517
DV+ GI++ E+ T G+ P + N
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 42/275 (15%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK--ESSAMARDA---FDTEVRRLGRLRHSNVL 370
E+LG+G GS Y+ + + DG VK + + ++A + E+ L +L+H N++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 371 APLAYHYRTDEKLLVY-EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L R ++ L ++ E +PGGSL LL G + + RL Q I G+ YLH
Sbjct: 66 QYLGTE-REEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVI---RLYTRQ-ILLGLEYLH 119
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA---YKAPEAI-Q 485
+ H ++K +NI + +++FG + + A++ + APE I Q
Sbjct: 120 DR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP-SQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544
G D++ LG +LE+ TGK P SQ E VA+ F GR +L P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQL-----------EGVAAVFKIGRSKEL--PP 222
Query: 545 IASSTNSPGEME-QLLEIGRACTQSDPEQRLEMRE 578
I P + + + C Q DP R E
Sbjct: 223 I------PDHLSDEAKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 14/202 (6%)
Query: 318 VLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
VLG G G Y A ++ V + +K + E + E+ L+H N++ L
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ E +PGGSL LL GP D + + I G+ YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDN--EQTIIFYTKQILEGLKYLH----DNQ 128
Query: 437 LPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFA----YKAPEAIQSGK--V 489
+ H ++K N+ ++ + + IS+FG + N F Y APE I G
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 490 TPKCDVYCLGIIILEILTGKFP 511
D++ LG I+E+ TGK P
Sbjct: 189 GAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 11/198 (5%)
Query: 318 VLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNVLAPLAY 375
LG G G K + G + VK ++ A + E+ L + ++
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
Y + + EY+ GGSL +L +G + + KI + +G+ YLH + +
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG----KIAVAVLKGLTYLHEKHKII 123
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYT-MINSANLAQA-LFAYKAPEAIQSGKVTPKC 493
H ++K SNI ++ + + +FG ++NS +Y APE IQ + K
Sbjct: 124 ---HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 494 DVYCLGIIILEILTGKFP 511
D++ LG+ ++E+ TG+FP
Sbjct: 181 DIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 39/274 (14%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG+G G + + V +K ++E AM+ D F E + + +L H N++ +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLP 438
+V EY+ G LL L +G E L + + + YL +
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWL----LDMCSDVCEAMEYLESN----GFI 122
Query: 439 HGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYKAPEAIQSGKVT 490
H +L + N + +N +S+FG YT S+ + + PE + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT---SSQGTKFPVKWAPPEVFDYSRFS 179
Query: 491 PKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549
K DV+ G+++ E+ + GK P + +N +VVE V++ + L P++A
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVESVSAGYR------LYRPKLAP-- 227
Query: 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
++ I +C PE R ++ + ++
Sbjct: 228 ------TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 44/278 (15%)
Query: 318 VLGNGGLGSS--YKAMMADGVTVVVKR--MKESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
VLG G G + Y+ D VV K + S R E+ L L+H N++A
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 374 AYHYRTDEKLLV-YEYIPGGSLLYLLHGDRGPSHDE--LTWPARLKIVQGIARGIGYLHT 430
H+ D LL+ EY GG+L + +G +E + W + I + Y+H
Sbjct: 66 N-HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHK 119
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NLAQALFA---YKAPEAIQS 486
+ H ++K+ NIF++ + +FG ++ S ++A+ + Y +PE Q
Sbjct: 120 A----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175
Query: 487 GKVTPKCDVYCLGIIILEILTGK--FPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544
K K D++ LG ++ E+LT K F + N I + T ++
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY----------TPVVSVY 225
Query: 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582
+ E+ L+ + Q DPE+R E + +
Sbjct: 226 SS-------ELISLV---HSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 26/241 (10%)
Query: 278 SSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVT 337
S+SR GS K+ + EL + +F DL + +G+G G+ Y A
Sbjct: 2 STSRAGSL---KDPEIAELFFKEDPEKLFT--DLRE-----IGHGSFGAVYFARDVRTNE 51
Query: 338 VV-VKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393
VV +K+M S + + + EV+ L R++H N + + R LV EY G S
Sbjct: 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-S 110
Query: 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453
LL + P E+ A I G +G+ YLH+ ++ H ++K+ NI ++
Sbjct: 111 ASDLLEVHKKPLQ-EVEIAA---ITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPG 162
Query: 454 EPLISEFGFYTMINSANLAQALFAYKAPE---AIQSGKVTPKCDVYCLGIIILEILTGKF 510
+ +++FG ++ + AN + APE A+ G+ K DV+ LGI +E+ K
Sbjct: 163 QVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222
Query: 511 P 511
P
Sbjct: 223 P 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 58/271 (21%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 309 PDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN 368
P + E +G+G G + + V +K ++E AM+ + F E + + +L H
Sbjct: 3 PSELTLVQE-IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPK 60
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
++ LV+E++ G L L RG + + L + + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYL 116
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI-----NSANLAQALFAYKAPEA 483
+ ++ H +L + N + +S+FG + S+ + + +PE
Sbjct: 117 ESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 484 IQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542
K + K DV+ G+++ E+ + GK P + +N +VVE + + F L
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVETINAGFR------LYK 222
Query: 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
P +AS + + E+ + C + PE R
Sbjct: 223 PRLAS--------QSVYELMQHCWKERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 30/269 (11%)
Query: 307 GLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR 365
G P E +G G G+ Y A+ +A G V +K+M ++ E+ + +
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74
Query: 366 HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
H N++ L + DE +V EY+ GGSL ++ DE A + + + +
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA---VCRECLQAL 128
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAP 481
+LH+ + H ++KS NI + + +++FGF I ++ + AP
Sbjct: 129 EFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFP--------SQYL--TNGNGGIDVVEWVASA 531
E + PK D++ LGI+ +E++ G+ P + YL TNG + E +++
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244
Query: 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLE 560
F D L+ + G ++LL+
Sbjct: 245 FR-----DFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK--ESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
V+G G G K A G V +K+ K E + EV+ L +LRH N++ L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN-L 65
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+R +L LV+EY+ L L G D + R I Q + + I Y H+
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAV----RSYIWQ-LLQAIAYCHS-- 118
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA------YKAPEA-IQ 485
++ H ++K NI +S + +FGF + A A L Y+APE +
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARAL-RARPASPLTDYVATRWYRAPELLVG 175
Query: 486 SGKVTPKCDVYCLGIIILEILTGK--FP 511
DV+ +G I+ E+L G+ FP
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 66/267 (24%), Positives = 113/267 (42%), Gaps = 33/267 (12%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHY 377
LG G G Y+ + +TV VK +KE M + F E + ++H N++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 378 RTDEKLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
R ++ E++ G+LL YL +R E+ L + I+ + YL + +
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK----N 124
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANL---AQALFAYK--APEAIQSGKVTP 491
H +L + N + + +++FG ++ A A F K APE++ K +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
K DV+ G+++ EI T Y + GID+ + V +LL+
Sbjct: 185 KSDVWAFGVLLWEIAT------YGMSPYPGIDLSQ----------VYELLEKGYRME-RP 227
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMRE 578
G ++ E+ RAC Q +P R E
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAE 254
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 47/145 (32%), Positives = 61/145 (42%), Gaps = 31/145 (21%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
+Y+ LSG+I + + LT L L +Y N +G IP + L+ L+ NK
Sbjct: 217 IYLGYNNLSGEIPYE-IGGLTSLNHLDLVY---NNLTGPIPSS-LGNLKNLQYLFLYQNK 271
Query: 110 FRGRLPPSLFKLPHLTEL------------------------HLESNQFNGTIPS--FDQ 143
G +PPS+F L L L HL SN F G IP
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 144 PTLVRLNLSSNKLEGEIPASLLRFN 168
P L L L SNK GEIP +L + N
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHN 356
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 317 EVLGNGGLGSSYKAMMAD--GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+ +G G G M+ D G V VK +K + A A+ AF E + +LRHSN++ L
Sbjct: 12 QTIGKGEFGD---VMLGDYRGNKVAVKCIK-NDATAQ-AFLAEASVMTQLRHSNLVQLLG 66
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
L +V EY+ GSL+ L RG S L LK + + YL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRS--VLGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPK 492
+ H +L + N+ +S +N +S+FG +S + + + APEA++ K + K
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 493 CDVYCLGIIILEILT-GKFP 511
DV+ GI++ EI + G+ P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 35/266 (13%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E +G G G + + AD V VK +E+ + F E R L + H N++ +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ +V E + GG L L + GP L +++V+ A G+ YL ++
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTE-GP---RLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFY------TMINSANLAQALFAYKAPEAIQSGK 488
H +L + N ++ +N IS+FG ++ + Q + APEA+ G+
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 489 VTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547
+ + DV+ GI++ E + G P L+N + A +G L PE
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQG--VRLPCPE--- 219
Query: 548 STNSPGEMEQLLEIGRACTQSDPEQR 573
P + +L+E C + DP QR
Sbjct: 220 --LCPDAVYRLME---RCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 35/272 (12%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378
LG+G G + + V +K + E AM+ + F E + + +L H ++ +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 379 TDEKLLVYEYIPGGSLLYLLHGDRGP-SHDELTWPARLKIVQGIARGIGYLHTELAHLDL 437
+V E++ G LL L +G S D L L + Q + G+ YL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN----SF 121
Query: 438 PHGNLKSSNIFISPENEPLISEFGFYTMI-----NSANLAQALFAYKAPEAIQSGKVTPK 492
H +L + N +S +S+FG + S++ A+ + PE K + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 493 CDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
DV+ G+++ E+ T GK P + +N +VVE ++ F L P++AS T
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISRGFR------LYRPKLASMT-- 229
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
+ E+ +C PE R E +R I
Sbjct: 230 ------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 48/209 (22%)
Query: 339 VVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLY 396
++K K E L RL H ++ L Y ++ +E L V EY P G LL
Sbjct: 39 LIKEKKVKYVK------IEKEVLTRLNGHPGIIK-LYYTFQDEENLYFVLEYAPNGELLQ 91
Query: 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEP 455
+ + S DE R + I + YLH++ + H DL K NI + +
Sbjct: 92 YIR--KYGSLDEKC--TRFYAAE-ILLALEYLHSKGIIHRDL-----KPENILLDKDMHI 141
Query: 456 LISEFGFYTMINSANLAQALFA------------------------YKAPEAIQSGKVTP 491
I++FG +++ + ++ Y +PE +
Sbjct: 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201
Query: 492 KCDVYCLGIIILEILTGKFP----SQYLT 516
D++ LG II ++LTGK P ++YLT
Sbjct: 202 SSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 309 PDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD---TEVRRLGRL 364
P+ + + +G+G G+ Y A + + V +K+M S + + + EVR L +L
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 365 RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARG 424
RH N + + R LV EY G S LL + P E+ A + G +G
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQ-EVEIAA---VTHGALQG 127
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPE-- 482
+ YLH+ ++ H ++K+ NI +S + +FG +++ AN + APE
Sbjct: 128 LAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVI 183
Query: 483 -AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
A+ G+ K DV+ LGI +E+ K P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 318 VLGNGGLGSSYKAM-MADG----VTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLA 371
VLG+G G+ YK + + +G + V +K ++E ++ A E + + H +V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV- 72
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L + + L+ + +P G LL + H D S L W VQ IA+G+ YL
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC-----VQ-IAKGMSYL- 125
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS------ANLAQALFAYKAPEA 483
E L H +L + N+ + I++FG +++ A + + A E+
Sbjct: 126 -EEKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 484 IQSGKVTPKCDVYCLGIIILEILT-GKFP 511
I T K DV+ G+ + E++T G P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY-TMINS-ANLAQ 473
KI + G+ YL+ + H ++K SNI ++ + + +FG +INS A+
Sbjct: 107 KIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163
Query: 474 ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y +PE IQ GK T K DV+ LGI I+E+ GKFP
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 317 EVLGNGGLGSSYKA-MMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+ +G+G G YKA +A G V +K +K + E+ L RH N++A
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGP-SHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ R D+ +V EY GGSL + RGP S ++ + R + +G+ YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLH----E 119
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQ---SG 487
H ++K +NI ++ + + +++FG + + + F + APE G
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
KCD++ LGI +E+ + P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 41/247 (16%)
Query: 338 VVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396
V + ++ S R F E LG+ HSN++ R + ++V EY+ G+L
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456
L G +L + ++ G+A G+ YL +E+ ++ H L + + ++ +
Sbjct: 96 FLRKHEG----QLVAGQLMGMLPGLASGMKYL-SEMGYV---HKGLAAHKVLVNSDLVCK 147
Query: 457 ISEFG---------FYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
IS F YT ++ + + APEAIQ + DV+ GI++ E+++
Sbjct: 148 ISGFRRLQEDKSEAIYTTMSGKSPV----LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
Query: 508 -GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACT 566
G+ P + G DV++ V F + + N P + QL+ C
Sbjct: 204 YGERPYWDM----SGQDVIKAVEDGF-----------RLPAPRNCPNLLHQLM---LDCW 245
Query: 567 QSDPEQR 573
Q + +R
Sbjct: 246 QKERGER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 61/259 (23%), Positives = 116/259 (44%), Gaps = 30/259 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G G G+ Y A+ +A G V +K+M ++ E+ + ++ N++ L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+ DE +V EY+ GGSL ++ DE A + + + + +LH+
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA---VCRECLQALDFLHSN---- 134
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVTP 491
+ H ++KS NI + + +++FGF I ++ + APE + P
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 492 KCDVYCLGIIILEILTGKFP--------SQYL--TNGNGGIDVVEWVASAFSEGRVTDLL 541
K D++ LGI+ +E++ G+ P + YL TNG + E +++ F D L
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR-----DFL 249
Query: 542 DPEIASSTNSPGEMEQLLE 560
+ + + G ++LL+
Sbjct: 250 NRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 309 PDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKR---MKESSAMARDAFDTEVRRLGRLR 365
P+ + E +G G G +K + VV + ++E+ D E+ L +
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCD 60
Query: 366 HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
V + + + ++ EY+ GGS L LL GP DE LK I +G+
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GP-FDEFQIATMLK---EILKGL 114
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAP 481
YLH+E H ++K++N+ +S + + +++FG + + + F + AP
Sbjct: 115 DYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFPS 512
E IQ K D++ LGI +E+ G+ P+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKR--MKESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
+ +G G G Y A +D V+K + + ++A EV L +++H N++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE---LTWPARLKIVQGIARGIGYLHT 430
A +V EY GG L+ ++ RG E L+W VQ I+ G+ ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW-----FVQ-ISLGLKHIHD 119
Query: 431 ELAHLDLPHGNLKSSNIFISPENE-PLISEFGFYTMIN-SANLAQALFA---YKAPEAIQ 485
+ H ++KS NIF+S + +FG +N S LA Y +PE Q
Sbjct: 120 R----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP 511
+ K D++ LG ++ E+ T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK--RMKESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
E LG G GS YKA+ G V +K ++E E+ L + ++
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL----QEIIKEISILKQCDSPYIVK-- 62
Query: 374 AYH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
Y+ Y + L +V EY GS+ ++ + E A I+ +G+ YLH+
Sbjct: 63 -YYGSYFKNTDLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAA---ILYQTLKGLEYLHS 117
Query: 431 -ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQ 485
+ H D+ K+ NI ++ E + +++FG + + + APE IQ
Sbjct: 118 NKKIHRDI-----KAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP 511
K D++ LGI +E+ GK P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVK--RMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+G G G Y A+ + G + VK R++++ E++ L L+H N++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
++ + EY GG+L LL G DE R+ +Q + G+ YLH+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH--GRILDEHV--IRVYTLQ-LLEGLAYLHSH---- 118
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA-----QALF---AYKAPEAIQSG 487
+ H ++K +NIF+ + +FG + + Q+L AY APE I G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 488 KVTPK---CDVYCLGIIILEILTGKFP 511
K D++ LG ++LE+ TGK P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT-----EVRRLGRLRHSNVL 370
E++G G G+ Y+ + G V +K + + D EV L +LR S
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPP 62
Query: 371 APLAYH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
Y+ Y +L ++ EY GGS+ L+ GP + I++ + + Y
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GP----IAEKYISVIIREVLVALKY 116
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEA 483
+H + + H ++K++NI ++ + +FG ++N + ++ F + APE
Sbjct: 117 IH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172
Query: 484 IQSGKV-TPKCDVYCLGIIILEILTGKFP 511
I GK K D++ LGI I E+ TG P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G G G+ Y AM +A G V +++M ++ E+ + ++ N++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+ DE +V EY+ GGSL ++ DE A + + + + +LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA---VCRECLQALEFLHSN---- 135
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVTP 491
+ H ++KS NI + + +++FGF I ++ + APE + P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 492 KCDVYCLGIIILEILTGKFP 511
K D++ LGI+ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT--EVRRLGRLRHSNVLAPLAY 375
LG G GS YK ++D +K + S ++ D E+R L + H N+++ Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIIS---Y 64
Query: 376 H--YRTDEKL-LVYEYIPGGSLLYLL---HGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ KL +V EY P G L + R ++ W +I + RG+ LH
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALH 120
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA---YKAPEAIQS 486
+ H +LKS+NI + + I + G ++ N+A+ Y APE +
Sbjct: 121 E----QKILHRDLKSANILLVANDLVKIGDLGISKVLKK-NMAKTQIGTPHYMAPEVWKG 175
Query: 487 GKVTPKCDVYCLGIIILEILTGKFP 511
+ K D++ LG ++ E+ T P
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 50/214 (23%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLA 371
+V+G G G ++ ++ V V +K +K + R F +E +G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
+ +++ EY+ G+L L G E + + +++GIA G+ YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL--- 123
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN-------SANLAQALFAYKAPEAI 484
+ ++ H +L + NI ++ E +S+FG ++ + + + + APEAI
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 485 QSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517
K T DV+ GI++ E+++ G+ P ++N
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 39/256 (15%)
Query: 338 VVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK--LLVYEYIPGGSLL 395
V +K +KE S M+ D F E + + +L H ++ Y T ++ +V EY+ G LL
Sbjct: 31 VAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQ--LYGVCTKQRPIYIVTEYMSNGCLL 87
Query: 396 -YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE 454
YL + +L L++ + + G+ YL ++ H +L + N + +
Sbjct: 88 NYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGC 138
Query: 455 PLISEFGFYTMI-----NSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-G 508
+S+FG + S+ ++ + PE + K + K DV+ G+++ E+ + G
Sbjct: 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 509 KFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQS 568
K P + N + VE V+ L P +AS E++ I +C
Sbjct: 199 KMPYERFNNS----ETVEKVSQGLR------LYRPHLAS--------EKVYAIMYSCWHE 240
Query: 569 DPEQRLEMREAVRRIV 584
E+R ++ + I
Sbjct: 241 KAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G G G+ + A+ +A G V +K++ ++ E+ + L++ N++ L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
DE +V EY+ GGSL ++ DE A + + + + +LH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAA---VCRECLQALEFLHAN---- 134
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVTP 491
+ H ++KS N+ + + +++FGF I ++ + APE + P
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 492 KCDVYCLGIIILEILTGKFP 511
K D++ LGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 317 EVLGNGGLGSSYKAMM---ADG---VTVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNV 369
E LG G YK + A G V +K +K+ + R+ F E RL+H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLL-----HGDRGPSHDELTWPARLK------IV 418
+ L + +++ Y L L H D G + D+ T + L+ IV
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 419 QGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--- 475
IA G+ +L + + H +L + N+ + + IS+ G + + +A+ + +
Sbjct: 131 TQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 476 ---FAYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ +PEAI GK + D++ G+++ E+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLA 374
+G+G G+ Y A + V +K+M S + + + EVR L +LRH N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSH-DELTWPARLKIVQGIARGIGYLHTELA 433
+ R LV EY GS +L + P E+ I G +G+ YLH+
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-----AICHGALQGLAYLHS--- 133
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPE---AIQSGKVT 490
+ H ++K+ NI ++ +++FG ++++ AN + APE A+ G+
Sbjct: 134 -HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 491 PKCDVYCLGIIILEILTGKFP 511
K DV+ LGI +E+ K P
Sbjct: 193 GKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 309 PDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN 368
P+ + E +G G G +K + VV ++ + A D + + + L +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCD 60
Query: 369 VLAPLAYH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
Y+ Y D KL ++ EY+ GGS L LL + GP L I++ I +G+
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGP----LDETQIATILREILKGL 114
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAP 481
YLH+E H ++K++N+ +S E +++FG + + + F + AP
Sbjct: 115 DYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYL 515
E I+ K D++ LGI +E+ G+ P L
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 309 PDLMKAAAEVLGNGGLGSSYKAM---MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR 365
P+ + E +G G G YK + + V + + ++E+ D E+ L +
Sbjct: 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCD 60
Query: 366 HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
+ + + + ++ EY+ GGS L LL P E T+ A I++ I +G+
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK----PGPLEETYIA--TILREILKGL 114
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAP 481
YLH+E H ++K++N+ +S + + +++FG + + + F + AP
Sbjct: 115 DYLHSERK----IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYL 515
E I+ K D++ LGI +E+ G+ P+ L
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 60/270 (22%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
E++G G G+ + G V VK +K + AF E + +L H N L L
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKN-LVRLLGV 67
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ +V E + G+L+ L R ++ L+ +A G+ YL ++
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK----K 120
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK--APEAIQSGKVTPKCD 494
L H +L + NI +S + +S+FG + S + + K APEA++ K + K D
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGL-ARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179
Query: 495 VYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPG 553
V+ G+++ E+ + G+ P ++ ++ V +G + PE P
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMS--------LKEVKECVEKGYRME--PPE-----GCPA 224
Query: 554 EMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
++ L+ +C +++P++R + ++
Sbjct: 225 DVYVLM---TSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 63/286 (22%), Positives = 111/286 (38%), Gaps = 38/286 (13%)
Query: 319 LGNGGLGSSYKA---MMADGVT--VVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNV--L 370
LG G G + D V VK + S R F+ E+ L L H N+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ L+ EY+P GSL L R D++ L I +G+ YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS 127
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN-------SANLAQALFAYKAPEA 483
+ H +L + NI + E+ IS+FG ++ ++ + APE
Sbjct: 128 Q----RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFPSQY-LTNGNGGIDVVEWVASAFSEGRVTDLLD 542
+++ K + DV+ G+ + E+ T PSQ + + A + VT LL+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE------FLRMIGIAQGQMIVTRLLE 237
Query: 543 -----PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
+ + P E+ L+ + C +++P+ R + + +
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLM---KLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 28/215 (13%)
Query: 317 EVLGNGGLGSSYKAM-----MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
E LG G YK M V +K +K+ ++ F E + L H N++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLL-----HGDRGPSHDE-------LTWPARLKIV 418
L + +++EY+ G L L H D G S DE L L I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 419 QGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--- 475
IA G+ YL + H +L + NI I + IS+ G I SA+ +
Sbjct: 131 IQIAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 476 ---FAYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ PEAI GK + D++ G+++ EI +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 49/129 (37%), Positives = 65/129 (50%), Gaps = 17/129 (13%)
Query: 57 LSGKIDVDALTELT-GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLP 115
LSG+I EL L+ L ++L N F+G+IP + L+ L +NKF G +P
Sbjct: 296 LSGEI-----PELVIQLQNLEILHLFSNNFTGKIPVA-LTSLPRLQVLQLWSNKFSGEIP 349
Query: 116 PSLFKLPHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKLEGEIPASL--------L 165
+L K +LT L L +N G IP L +L L SN LEGEIP SL +
Sbjct: 350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV 409
Query: 166 RFNASSFSG 174
R +SFSG
Sbjct: 410 RLQDNSFSG 418
|
Length = 968 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 319 LGNGGLGSSYKAMMADGVTVV-VKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLA 374
+G+G G+ Y A + VV VK+M S + + EV+ L +L+H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ + LV EY G S LL + P E+ A I G +G+ YLH+
Sbjct: 89 CYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQ-EVEIAA---ITHGALQGLAYLHSH--- 140
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPE---AIQSGKVTP 491
++ H ++K+ NI ++ + +++FG + + AN + APE A+ G+
Sbjct: 141 -NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDG 199
Query: 492 KCDVYCLGIIILEILTGKFP 511
K DV+ LGI +E+ K P
Sbjct: 200 KVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMA---RDAFDTEVRRLGRLRHSNVLAP 372
E +G G G+ K +DG +V K + + M + +EV L L+H N++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHPNIVR- 63
Query: 373 LAYHYR----TDEKL-LVYEYIPGGSLLYLL---HGDRGPSHDELTWPARLKIVQGIARG 424
Y+ R +++ L +V EY GG L L+ +R +E W +I+ +
Sbjct: 64 --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLA 117
Query: 425 IGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK 479
+ H + H +LK +NIF+ N + +FG ++ + + Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+PE + K D++ LG +I E+ P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 317 EVLGNGGLGSSYKAMMA-----DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNV 369
E LG G GS Y +M G V +K+ ES M + E+R L +LRH N+
Sbjct: 4 ENLGLVGEGS-YGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ + R LV+E++ L L G DE R + Q I RGI + H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESR--VRKYLFQ-ILRGIEFCH 117
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ----ALFAYKAPE-AI 484
+ ++ H ++K NI +S + +FGF + + A Y+APE +
Sbjct: 118 SH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173
Query: 485 QSGKVTPKCDVYCLGIIILEILTGK--FPS 512
K D++ +G ++ E+LTG+ FP
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 335 GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394
G V VK+M R+ EV + H NV+ + DE +V E++ GG+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE 454
++ +H + + + R + YLH + + H ++KS +I ++ +
Sbjct: 107 TDIV------THTRMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGR 156
Query: 455 PLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKF 510
+S+FGF ++ + + APE I + D++ LGI+++E++ G+
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 511 P 511
P
Sbjct: 217 P 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 10/100 (10%)
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY-TMINSANLAQA 474
KI + + +G+ YLH+ + H ++K SNI ++ + + + +FG ++NS LA
Sbjct: 109 KIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGT 162
Query: 475 LFA---YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y APE IQ + DV+ LG+ +LE+ +FP
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E +G G G YKA+ V +K + E + + E++ L + R +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK--- 63
Query: 375 YH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
Y+ + KL ++ EY GGS L LL G + I++ + G+ YLH E
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYI----AFILREVLLGLEYLHEE 117
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQS 486
H D+ K++NI +S E + +++FG + S + F + APE I+
Sbjct: 118 GKIHRDI-----KAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 487 GKVTPKCDVYCLGIIILEILTGKFP 511
K D++ LGI +E+ G+ P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 38/291 (13%)
Query: 317 EVLGNGGLG--SSYKAMMAD---GVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVL 370
VLG G G S Y A+ G V VK +K E + E+ L L H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 371 APLAYHYRTDEK--LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
K L+ EY+P GSL L P H L L Q I G+ YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHK-LNLAQLLLFAQQICEGMAYL 123
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL--------AQALFAYKA 480
H++ H +L + N+ + + I +FG + + +F Y A
Sbjct: 124 HSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-A 178
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540
E ++ K + DV+ G+ + E+LT Q + +++ + R+ +L
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQ--SPPKKFEEMIGPKQGQMTVVRLIEL 236
Query: 541 LD--PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
L+ + N P E+ L++ C +++ + R R ++ I +
Sbjct: 237 LERGMRLPCPKNCPQEVYILMK---NCWETEAKF----RPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 318 VLGNGGLGS-SYKAMMADGVTVVVKRM--KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
V+G G G S DG V+K++ + +S R A + E + L +L+H N++A
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRG---PSHDELTWPARLKIVQGIARGIGYLHT 430
D L +V + GG L + L +G P + + W VQ IA + YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW-----FVQ-IAMALQYLHE 120
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI-NSANLAQALFA---YKAPEAIQS 486
+ + H +LK+ N+F++ N + + G ++ N ++A L Y +PE +
Sbjct: 121 K----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 487 GKVTPKCDVYCLGIIILEILTGK 509
K DV+ LG + E+ T K
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 317 EVLGNGGLGS----SYKAMMADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLA 371
+ LG+G G + + V VK +K + + D F E + L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
L T ++V E P GSLL L H IA G+ YL ++
Sbjct: 61 -LYGVVLTHPLMMVTELAPLGSLLDRLR-KDALGH--FLISTLCDYAVQIANGMRYLESK 116
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPLISEFG----------FYTMINSANLAQALFAYKA 480
H DL + NI ++ +++ I +FG Y M +L + FA+ A
Sbjct: 117 RFIHRDL-----AARNILLASDDKVKIGDFGLMRALPQNEDHYVM--EEHL-KVPFAWCA 168
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILT 507
PE++++ + DV+ G+ + E+ T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 31/209 (14%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLA 374
+ G G + A + G +K +K++ + ++ D TE L + + V+ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LY 59
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLH--GDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
Y ++ + L LV EY+PGG L LL G S DE AR+ I + I + YLH+
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVG----SLDEDV--ARIYIAE-IVLALEYLHS- 111
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGF--YTMINSANLAQALFA----------YK 479
+ H +LK NI I +++FG ++ Y
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILTG 508
APE I + D + LG I+ E L G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 42/193 (21%), Positives = 87/193 (45%), Gaps = 18/193 (9%)
Query: 334 DGVTVVVKRMKESSAMAR---DAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKL----LVY 386
+ V+++ K+ + D + E++ L R+ +N+L + + L L+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSN 446
EY G L +L ++ +L++ +L + +G+ L+ + + P+ NL S +
Sbjct: 102 EYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVS 153
Query: 447 IFISPENEPLISEFGFYTMINSANLAQALF-AYKAPEAIQS--GKVTPKCDVYCLGIIIL 503
++ + I G +++S F Y + + + + T K D+Y LG+++
Sbjct: 154 FLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213
Query: 504 EILTGKFPSQYLT 516
EI TGK P + LT
Sbjct: 214 EIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRM------KESSAMARDAFDTEVRRLGRLRHSNVL 370
EVLG G G+ Y + G + VK++ ++ + EV L L+H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L + + E++PGGS+ +L+ GP L P K + I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGP----LPEPVFCKYTKQILDGVAYLHN 120
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI-------NSANLAQALFA---YKA 480
+ H ++K +N+ + P + +FG + +N+ +++ + A
Sbjct: 121 N----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
PE I K D++ +G + E+ TGK P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 61/202 (30%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLR------HSNVLA 371
+G GG G + A D G V +KRMK+S + EVR + R S L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN----EVRHVLTERDILTTTKSEWLV 64
Query: 372 PLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L Y ++ DE L L EY+PGG LL+ S D AR + + + LH
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----ARFYMAEMFE-AVDALH- 118
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT-MINSANLAQALFAYKAPEAIQSGKV 489
EL ++ H +LK N I +++FG ++ AN Y APE ++
Sbjct: 119 ELGYI---HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 490 TPKCDVYCLGIIILEILTGKFP 511
D + LG ++ E L G FP
Sbjct: 176 DFTVDYWSLGCMLYEFLCG-FP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 33/232 (14%)
Query: 317 EVLGNGGLGSSYKAMMA--DGVT--VVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVL 370
++LG G GS + ++ DG V VK MK + F +E + H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 371 APLAYHYRTDEK------LLVYEYIPGGSL-LYLLHGDRGPSHDELTWPARLKIVQGIAR 423
+ + +++ ++ G L +LL+ G ++L LK + IA
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 424 GIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAP-- 481
G+ YL + H +L + N + + +++FG I S + + K P
Sbjct: 125 GMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 482 ----EAIQSGKVTPKCDVYCLGIIILEILT-GKFP---------SQYLTNGN 519
E++ T K DV+ G+ + EI T G+ P YL +GN
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 45/195 (23%), Positives = 86/195 (44%), Gaps = 17/195 (8%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHY 377
+G+G G YKA + G +K +K E+ + +HSN++A +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 378 RTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDL 437
R D+ + E+ GGSL + H S ++ + +R + +G+ YLH++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK----GK 127
Query: 438 PHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI---QSGKVT 490
H ++K +NI ++ +++FG I + + F + APE + G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 491 PKCDVYCLGIIILEI 505
CD++ +GI +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 41/183 (22%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 333 ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392
+ G V VK+M R+ EV + +H NV+ + DE +V E++ GG
Sbjct: 43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102
Query: 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452
+L ++ +H + + + + + LH + + H ++KS +I ++ +
Sbjct: 103 ALTDIV------THTRMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHD 152
Query: 453 NEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVTPKCDVYCLGIIILEILTG 508
+S+FGF ++ + + APE I P+ D++ LGI+++E++ G
Sbjct: 153 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
Query: 509 KFP 511
+ P
Sbjct: 213 EPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 29/203 (14%)
Query: 323 GLGSSYKAMMA----DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
G GS KA++ DG V+K + S S R+ EV L ++H N++ Y
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---YQ 65
Query: 377 YRTDEK---LLVYEYIPGGSLLYLLHGDRG---PSHDELTWPARLKIVQGIARGIGYLHT 430
+E +V +Y GG L ++ RG P L W VQ I + ++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW-----FVQ-ICLALKHVHD 119
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NLAQALFA---YKAPEAIQS 486
+ H ++KS NIF++ + + +FG ++NS LA+ Y +PE ++
Sbjct: 120 R----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 487 GKVTPKCDVYCLGIIILEILTGK 509
K D++ LG ++ E+ T K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNV 369
++LG G G K ++ A G +K +K+ +A+D TE R L RH
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-F 56
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L L Y ++T ++L V EY+ GG L + L +R S D + I + YL
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYG-----AEIVSALDYL 111
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT--MINSANLAQ--ALFAYKAPEAI 484
H+ + + +LK N+ + + I++FG + ++A + Y APE +
Sbjct: 112 HSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
+ D + LG+++ E++ G+ P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 75/287 (26%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 318 VLGNGGLGSSYKA----MMADGV--TVVVKRMKESSAMARDA-FDTEVRRLGRLRHSNVL 370
LG+G G Y+ D V V VK + ES + ++ F E + + H N++
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRG----PSHDELTWPARLKIVQGIARGIG 426
+ + + ++ E + GG L L +R PS LT L + +A+G
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS--SLTMKDLLFCARDVAKGCK 130
Query: 427 YLHTELAHLDLPHGNLKSSNIFIS---PENEPLISEFGFYTMINSANL----AQALFAYK 479
YL E H H ++ + N ++ P I++FG I A+ +A+ K
Sbjct: 131 YL--EENHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 480 --APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGR 536
PEA G T K DV+ G+++ EI + G P TN +V+E+V GR
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEFVTGG---GR 239
Query: 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
LDP PG + +++ C Q PE R + RI
Sbjct: 240 ----LDP----PKGCPGPVYRIM---TDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 15/153 (9%)
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L L + ++T +KL V +YI GG L Y L +R L AR + IA +GYL
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC----FLEPRARFYAAE-IASALGYL 112
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI 484
H+ L++ + +LK NI + + ++++FG N + F Y APE +
Sbjct: 113 HS----LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517
D +CLG ++ E+L G P Y N
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSRN 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 22/186 (11%)
Query: 340 VKRMKESSAMARD--AFDTEVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLY 396
+K MK+S +A++ +F E R + + +S + L Y ++ + L LV EY PGG LL
Sbjct: 31 MKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS 90
Query: 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456
LL+ +++ A+ + + + I +H + H ++K N+ I
Sbjct: 91 LLNRYEDQFDEDM---AQFYLAE-LVLAIHSVHQ----MGYVHRDIKPENVLIDRTGHIK 142
Query: 457 ISEFGFYTMINSANLAQALFA-----YKAPEAIQS----GKVT--PKCDVYCLGIIILEI 505
+++FG + + + + Y APE + + GK T +CD + LG+I E+
Sbjct: 143 LADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 506 LTGKFP 511
+ G+ P
Sbjct: 203 IYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH---SNV 369
+V+G G G K ++A DG VK +++ + R E + + R+ NV
Sbjct: 1 KVIGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNR----KEQKHIMAERNVLLKNV 53
Query: 370 LAP----LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWP---ARLKIVQGI 421
P L Y ++T EKL V +++ GG L + L +R ++P AR + I
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-------SFPEPRARFYAAE-I 105
Query: 422 ARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA---- 477
A +GYLH+ +++ + +LK NI + + ++++FG + + F
Sbjct: 106 ASALGYLHS----INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161
Query: 478 YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y APE I+ D +CLG ++ E+L G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 317 EVLGNGGLG----------SSYKAMMADGVTVVVKRMKESSAMA-RDAFDTEVRRLGRLR 365
+V+G G G S+ A+ ++K+ +++ MA R+ L L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL------LKNLK 54
Query: 366 HSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARG 424
H L L Y ++T EKL V +Y+ GG L + L +R AR + +A
Sbjct: 55 HP-FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR----ARFYAAE-VASA 108
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKA 480
IGYLH+ L++ + +LK NI + + ++++FG + F Y A
Sbjct: 109 IGYLHS----LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLA 164
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
PE ++ D +CLG ++ E+L G P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 41/181 (22%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 335 GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394
G V VK M R+ EV + +H NV+ + +E ++ E++ GG+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE 454
++ S L + + + + + YLH++ + H ++KS +I ++ +
Sbjct: 106 TDIV------SQTRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGR 155
Query: 455 PLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKF 510
+S+FGF I+ + + APE I + D++ LGI+++E++ G+
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 511 P 511
P
Sbjct: 216 P 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 41/182 (22%), Positives = 86/182 (47%), Gaps = 16/182 (8%)
Query: 335 GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394
G V VK+M R+ EV + +H N++ + + DE +V E++ GG+L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE 454
++ +H + + + + + +LH + + H ++KS +I ++ +
Sbjct: 104 TDIV------THTRMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGR 153
Query: 455 PLISEFGFYTMINSANLAQ--ALFA---YKAPEAIQSGKVTPKCDVYCLGIIILEILTGK 509
+S+FGF + S + + +L + APE I + D++ LGI+++E++ G+
Sbjct: 154 VKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
Query: 510 FP 511
P
Sbjct: 213 PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 53/224 (23%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK--------ESSAMARDAFDTEVRRLGRLRHS 367
E LG G G YKA G V +K+++ S+A+ R E+ L L+H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-R-----EISLLKELKHP 58
Query: 368 NVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLK-IVQGIARGI 425
N++ L + T+ KL LV+EY L L GP P +K I+ + RG+
Sbjct: 59 NIVKLLDVIH-TERKLYLVFEYCDM-DLKKYLDKRPGPLS-----PNLIKSIMYQLLRGL 111
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-------- 477
Y H +H L H +LK NI I+ + +++FG LA+A
Sbjct: 112 AYCH---SHRIL-HRDLKPQNILINRDGVLKLADFG---------LARAFGIPLRTYTHE 158
Query: 478 -----YKAPEAIQSGKV-TPKCDVYCLGIIILEILTGK--FPSQ 513
Y+APE + K + D++ +G I E++TGK FP
Sbjct: 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 23/190 (12%)
Query: 334 DGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392
V V VK ++E ++ AR+ F E++ + RL+ N++ LA +D ++ EY+ G
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 393 SLLYLL--HGDRGPSHDE----LTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSN 446
L L H + + +++ + + IA G+ YL + L+ H +L + N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS----LNFVHRDLATRN 160
Query: 447 IFISPENEPLISEFG---------FYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYC 497
+ I++FG +Y + A L ++ E+I GK T DV+
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW---ESILLGKFTTASDVWA 217
Query: 498 LGIIILEILT 507
G+ + EILT
Sbjct: 218 FGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRMK---ESSAMARD--AFDTEVRRLGRLRHSNV 369
++LG G G Y AD G + VK+++ ES +++ A + E++ L L H +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 370 LAPLAYHYRTDEKLL--VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
+ E+ L E++PGGS+ D+ S+ LT K + I G+ Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSI-----KDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-------YKA 480
LH+ + + H ++K +NI + +FG + + L+ + +
Sbjct: 122 LHSNM----IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
PE I K D++ +G ++E+LT K P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNV 369
++LG G G K ++ A G +K +K+ +A+D TE R L RH
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-F 56
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L L Y ++T ++L V EY GG L + L +R S D AR + I + YL
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----ARFYGAE-IVSALDYL 111
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI 484
H+E ++ + +LK N+ + + I++FG F Y APE +
Sbjct: 112 HSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 168
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
+ D + LG+++ E++ G+ P
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 59/256 (23%), Positives = 107/256 (41%), Gaps = 39/256 (15%)
Query: 336 VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394
+ V +K +K + R F +E +G+ H N++ ++ ++V EY+ GSL
Sbjct: 33 IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 92
Query: 395 LYLLHGDRGPSHDELTWPARLKIVQ--GIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452
L HD + ++Q G+ RGI L+ + H +L + NI ++
Sbjct: 93 DAFLR-----KHD-----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN 142
Query: 453 NEPLISEFGFYTMINSANLA-------QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEI 505
+S+FG ++ A + + APEAI K T DV+ GI++ E+
Sbjct: 143 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
Query: 506 LT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRA 564
++ G+ P ++N + V A EG + + + P + QL+
Sbjct: 203 MSYGERPYWEMSNQD--------VIKAIEEGY-------RLPAPMDCPAALHQLM---LD 244
Query: 565 CTQSDPEQRLEMREAV 580
C Q D +R + + V
Sbjct: 245 CWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 70/268 (26%), Positives = 101/268 (37%), Gaps = 52/268 (19%)
Query: 335 GVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLL-VYEYIP 390
G V +K ++ + R F E RL H N++A L L V+EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIA----RGIGYLHTELAHLDLPHGNLKSSN 446
G +L +L D G T L+++ +A +GI H +LK N
Sbjct: 63 GRTLREVLAAD-GALPAGETGRLMLQVLDALACAHNQGI------------VHRDLKPQN 109
Query: 447 IFISP---ENEPLISEFGFYTMINSANLAQALF-----------AYKAPEAIQSGKVTPK 492
I +S + +FG T++ A Y APE ++ VTP
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 493 CDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSP 552
D+Y G+I LE LTG+ Q G V E + S V+ L P IA
Sbjct: 170 SDLYAWGLIFLECLTGQRVVQ-------GASVAEILYQQLSPVDVS--LPPWIAG----- 215
Query: 553 GEMEQLLEIGRACTQSDPEQRLEMREAV 580
L ++ R DP QR A+
Sbjct: 216 ---HPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNV 369
++LG G G K ++ A G +K +++ +A+D TE R L RH
Sbjct: 1 KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-F 56
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L L Y ++T ++L V EY GG L + L +R + + AR + I + YL
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAE-IVSALEYL 111
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI 484
H+ D+ + ++K N+ + + I++FG S F Y APE +
Sbjct: 112 HSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
+ D + LG+++ E++ G+ P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMK---ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+G G G YKA G V +K++K ES + + A E++ L L H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL-REIKLLKELNHPNIIKLLD 65
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ LV+E++ + RG + + + +G+ + H +H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS-----YLYQLLQGLAFCH---SH 117
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ----ALFAYKAPEAI-QSGKV 489
L H +LK N+ I+ E +++FG S Y+APE +
Sbjct: 118 GIL-HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 490 TPKCDVYCLGIIILEILTGK--FP 511
+ D++ +G I E+L+ + FP
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 43/287 (14%)
Query: 319 LGNGGLGSSYKAMMADGVT-------VVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVL 370
LG G G Y+ + A GV V +K + E+++M R F E + +V+
Sbjct: 14 LGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE--LTWPARLKIVQ---GIARGI 425
L + L++ E + G L L R + P+ K++Q IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQALFAYK-- 479
YL+ H +L + N ++ + I +FG I + + L +
Sbjct: 133 AYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538
+PE+++ G T DV+ G+++ EI T + P Q ++N E V EG +
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLRFVMEGGLL 240
Query: 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585
D D N P + L E+ R C Q +P+ R E + I E
Sbjct: 241 DKPD-------NCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRMK---ESSAMARD--AFDTEVRRLGRLRHSNV 369
++LG G G Y D G + K+++ ES +++ A + E++ L L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 370 LAPLAYHYRTDEKLLV--YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
+ EK L EY+PGGS+ D+ ++ LT K + I G+ Y
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSV-----KDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFG----FYTMINSANLAQALFA---YKA 480
LH+ + + H ++K +NI + +FG T+ S +++ + +
Sbjct: 122 LHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
PE I K DV+ LG ++E+LT K P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
EV+G G Y A+ + + V +KR+ E + D EV+ + + H NV+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---- 62
Query: 375 YHYRT-----DEKLLVYEYIPGGSLLYLL-HGDRGPSHDELTWPARLKIVQGIARGIGYL 428
Y T DE LV Y+ GGSLL ++ DE LK + +G+ YL
Sbjct: 63 -KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---EVLKGLEYL 118
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFG----FYTMINSANLAQALFA----YKA 480
H+ + H ++K+ NI + + I++FG + + F + A
Sbjct: 119 HSN-GQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 481 PEAIQSGK-VTPKCDVYCLGIIILEILTGKFP 511
PE ++ K D++ GI +E+ TG P
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 49/161 (30%), Positives = 68/161 (42%), Gaps = 26/161 (16%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARL 415
E R L +RH L L ++ D L LV EY+PGG L L AR
Sbjct: 51 EKRILQSIRHPF-LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV----ARF 105
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMIN 467
Q + + YLH LD+ + +LK N+ + + I++FGF YT+
Sbjct: 106 YAAQ-VVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160
Query: 468 SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTG 508
+ Y APE I S D + LGI+I E+L G
Sbjct: 161 TPE-------YLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 21/217 (9%)
Query: 318 VLGNGGLGSSYKAMM-----ADGVTVV-VKRMKESS-AMARDAFDTEVRRLGRLRHSNVL 370
LG G G + A G T+V VK ++++ + F E+ +L H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLL----HGDRGPSHDELTWPARLKIVQGIARGIG 426
L + ++ EY G L L D L+ ++ + IA G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---LAQALFAYK--AP 481
+L H +L + N +S + E +S + ++ L AL + AP
Sbjct: 132 HLSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517
EA+Q + K DV+ G+++ E+ T G+ P L++
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 75/313 (23%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 319 LGNGGLGSSYKAMMADGV-----------TVVVKRMKESSAMARDAFD--TEVRRLGRL- 364
LG G G + +MA+ + TV VK +K+ A +D D +E+ + +
Sbjct: 20 LGEGCFG---QVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIG 75
Query: 365 RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHD-----------ELTWPA 413
+H N++ L + ++ EY G+L L R P D +LT+
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 414 RLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG---------FYT 464
+ +ARG+ YL ++ H +L + N+ ++ +N I++FG +Y
Sbjct: 136 LVSCAYQVARGMEYLASQ----KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 465 MINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV 524
+ L + APEA+ T + DV+ G+++ EI T S Y GI V
Sbjct: 192 KTTNGRLP---VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-GSPY-----PGIPV 242
Query: 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR--- 581
E + EG D + A+ T+ +L I R C + P QR ++ V
Sbjct: 243 EE-LFKLLKEGHRMD----KPANCTH------ELYMIMRECWHAVPSQRPTFKQLVEDLD 291
Query: 582 RIVEIQQSDGNMD 594
R++ + +D +D
Sbjct: 292 RVLTVTSTDEYLD 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRM-----KESSAMARDAFDTEVRRLGRLRHSNV 369
++LG G G Y AD G + VK++ + ++ +A + E++ L LRH +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 370 LAPLA-YHYRTDEKLLVY-EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
+ ++KL ++ EY+PGGS+ D+ ++ LT + + I +G+ Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSI-----KDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-------YKA 480
LH+ + + H ++K +NI + +FG I + ++ + +
Sbjct: 122 LHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
PE I K DV+ + ++E+LT K P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 319 LGNGGLGS----SYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA-- 371
LG G GS Y + + G V VK+++ S+A F+ E+ L L+H N++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
+ Y LV EY+P GSL L R + L L I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEY---- 123
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGF---------YTMINSANLAQALFAYKAPE 482
L H +L + NI + EN I +FG Y + +F Y APE
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG-ESPIFWY-APE 181
Query: 483 AIQSGKVTPKCDVYCLGIIILEILT 507
++ K + DV+ G+++ E+ T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 65/270 (24%), Positives = 105/270 (38%), Gaps = 43/270 (15%)
Query: 331 MMADGVT-VVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388
AD V VK ++ ++ AR+ F EV+ L RL N+ L ++ EY
Sbjct: 41 DNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEY 100
Query: 389 IPGGSLLYLLH----GDRGPSHDELTWPAR--LKIVQGIARGIGYLHTELAHLDLPHGNL 442
+ G L L G + + + L + IA G+ Y L L+ H +L
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY----LESLNFVHRDL 156
Query: 443 KSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK------------APEAIQSGKVT 490
+ N + I++FG S NL + + Y+ A E++ GK T
Sbjct: 157 ATRNCLVGKNYTIKIADFGM-----SRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFT 210
Query: 491 PKCDVYCLGIIILEILT--GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548
K DV+ G+ + EILT + P ++LT+ + V D +
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQPYEHLTD--------QQVIENAGHFFRDDGRQIYLPRP 262
Query: 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMRE 578
N P ++ +L+ C + D E R RE
Sbjct: 263 PNCPKDIYELM---LECWRRDEEDRPTFRE 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLA 371
EV+G G G + + + V +K +K + R F +E +G+ H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
++ +++ E++ G+L L + G + T + +++GIA G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYL--- 122
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN---------SANLAQALFAYKAPE 482
+ ++ H +L + NI ++ +S+FG + S+ + + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 483 AIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517
AI K T DV+ GI++ E+++ G+ P ++N
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 52/288 (18%)
Query: 336 VTVVVKRMKESSAMARDAFD--TEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGG 392
VTV VK +K++ A +D D +E+ + + +H N++ L + ++ EY G
Sbjct: 45 VTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKG 103
Query: 393 SLLYLLHGDRGPSHD-----------ELTWPARLKIVQGIARGIGYLHTELAHLDLPHGN 441
+L L R P D +L++ + +ARG+ YL + H +
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRD 159
Query: 442 LKSSNIFISPENEPLISEFG---------FYTMINSANLAQALFAYKAPEAIQSGKVTPK 492
L + N+ ++ +N I++FG +Y ++ L + APEA+ T +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP---VKWMAPEALFDRVYTHQ 216
Query: 493 CDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
DV+ GI++ EI T G P GI V E + EG D +N
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYP-------GIPVEE-LFKLLREGHRMD-------KPSNC 261
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVR--RIVEIQQSDGNMDART 597
E+ L+ R C + P QR ++ V V S+ +D
Sbjct: 262 THELYMLM---RECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSM 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 31/224 (13%)
Query: 303 KGVFGLPDLMKAA--AEVLGNGGLGSSYKAMMADGVTVVVKRMK-ESSAMARDAFDTEVR 359
+G FG L +A AE LG G + ++ V VK ++ + + AR+ F E++
Sbjct: 15 EGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIK 69
Query: 360 RLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLL----------HGDRGPSHDEL 409
+ RL++ N++ L D ++ EY+ G L L H + PS +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS---V 126
Query: 410 TWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469
+ L + IA G+ Y LA L+ H +L + N + I++FG + S
Sbjct: 127 SIANLLYMAVQIASGMKY----LASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 470 NL------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ A + A E+I GK T DV+ G+ + E+ T
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARL 415
E R L + H ++ + ++ EY+PGG L YL + R + L + +
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE- 109
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMIN 467
I + YLH+ ++ + +LK NI + E +++FGF +T+
Sbjct: 110 -----IVCALEYLHS----KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG 160
Query: 468 SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ Y APE IQS D + LGI+I E+L G P
Sbjct: 161 TPE-------YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHY 377
LG+G G YKA + G K ++ S + + E+ L H ++ L Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 378 RTDEKLLVYEYIPGGSL-LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ ++ E+ PGG++ +L DRG LT P I + + + YLH+ +
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVICRQMLEALQYLHS----MK 130
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ-----ALFAYKAPEAI--QSGKV 489
+ H +LK+ N+ ++ + + +++FG + N L + + APE + ++ K
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGV-SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 490 TP---KCDVYCLGIIILEI 505
TP K D++ LGI ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 40/227 (17%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKE---SSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+G GG+G Y A V +K+++E + + + F E + L H ++ P+
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV-PV- 67
Query: 375 YHYRTDEKLLVYE--YIPGGSLLYLLHGDR------GPSHDELTWPARLKIVQGIARGIG 426
Y +D + Y YI G +L LL ++ + A L I I I
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN---------SANLAQALFA 477
Y+H++ + H +LK NI + E +I ++G + ++
Sbjct: 128 YVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 478 -------------YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y APE + + D+Y LG+I+ ++LT FP
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 39/211 (18%)
Query: 318 VLGNGGLGSSYKAMMA-DG----VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
VLG+G G+ YK + DG + V +K ++E+++ + E+ L + V+A
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS---PKANKEI-----LDEAYVMAG 65
Query: 373 LAYHY--------RTDEKLLVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIA 422
+ Y T LV + +P G LL + + DR S D L W VQ IA
Sbjct: 66 VGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW-----CVQ-IA 119
Query: 423 RGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN------SANLAQALF 476
+G+ YL + L H +L + N+ + N I++FG +++ A+ +
Sbjct: 120 KGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 477 AYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ A E+I + T + DV+ G+ + E++T
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 318 VLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRR--------LGRLRHSN 368
V+G G G A ADG VK +++ + + + E + L ++H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK----EQKHIMAERNVLLKNVKHP- 56
Query: 369 VLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
L L Y ++T +KL V +Y+ GG L + L +R AR + IA +GY
Sbjct: 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGY 111
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEA 483
LH+ L++ + +LK NI + + ++++FG + + F Y APE
Sbjct: 112 LHS----LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFP 511
++ D +CLG ++ E+L G P
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLA 374
+G G G +K + G V +K+ ES + + A E+R L +L+H N L L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-REIRMLKQLKHPN-LVNLI 66
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSH-DELTWPARLKIVQGIARGIGYLHTEL 432
+R KL LV+EY ++L L ++ P E KI+ + + + H
Sbjct: 67 EVFRRKRKLHLVFEYC-DHTVLNEL--EKNPRGVPEHL---IKKIIWQTLQAVNFCH--- 117
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ----ALFAYKAPEAI---- 484
H + H ++K NI I+ + + + +FGF ++ A Y+APE +
Sbjct: 118 KH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 485 QSGKVTPKCDVYCLGIIILEILTG 508
Q G P DV+ +G + E+LTG
Sbjct: 177 QYG---PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRM---KESSAMARD--AFDTEVRRLGRLRHSNVLAP 372
LG G G Y D G + VK++ +S ++ A + E++ L L+H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 373 LAYHYRTDEKLLVY-EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
R DE L ++ EY+PGGS+ D+ ++ LT K + I G+ YLH+
Sbjct: 70 YGCL-RDDETLSIFMEYMPGGSV-----KDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-------YKAPEAI 484
+ + H ++K +NI + +FG + + + + +PE I
Sbjct: 124 M----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
K DV+ +G ++E+LT K P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 41/132 (31%), Positives = 59/132 (44%), Gaps = 15/132 (11%)
Query: 54 SMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR 113
S SG+I + L L + L N +GEIP G G L KL +N G
Sbjct: 341 SNKFSGEIPKN----LGKHNNLTVLDLSTNNLTGEIPEGLCSS-GNLFKLILFSNSLEGE 395
Query: 114 LPPSLFKLPHLTELHLESNQFNGTIPS-FDQPTLVR-LNLSSNKLEGEIPA--------S 163
+P SL L + L+ N F+G +PS F + LV L++S+N L+G I +
Sbjct: 396 IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455
Query: 164 LLRFNASSFSGN 175
+L + F G
Sbjct: 456 MLSLARNKFFGG 467
|
Length = 968 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 21/206 (10%)
Query: 319 LGNGGLGSSYKAMMADGVT---VVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLA 374
+GNG G G++ VVVK ++ S+ + F EV+ L H NVL L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ LLV E+ P G L L +RG ++ +A G+ +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----Q 118
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGF------YTMINSANLAQALFAYKAPEAIQS-- 486
D H +L N ++ + I ++G + + + APE ++
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 487 -----GKVTPKCDVYCLGIIILEILT 507
T K +++ LG+ + E+ T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 48/222 (21%), Positives = 83/222 (37%), Gaps = 30/222 (13%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARL 415
E R L L H L L Y ++ +E + LV + + GG L Y H + E +
Sbjct: 50 ERRILQELNH-PFLVNLWYSFQDEENMYLVVDLLLGGDLRY--HLSQKVKFSEEQ--VKF 104
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL 475
I + I + YLH++ + H ++K NI + + I++F T + L +
Sbjct: 105 WICE-IVLALEYLHSKG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159
Query: 476 ---FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAF 532
Y APE + + D + LG+ E L GK P + + + + + +
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR-----TIRDQIRAKQ 214
Query: 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL 574
V E + + DP++RL
Sbjct: 215 ETADVL--------YPATWSTEAIDAI---NKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNV 369
VLG G G K M+A G VK +K+ + D + TE R L R+
Sbjct: 1 RVLGKGSFG---KVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 370 LAPLAYHYRTDEKLL-VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG-IARGIGY 427
L L ++T ++L V E++ GG L++ H + DE AR + I + +
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMF--HIQKSRRFDE----ARARFYAAEITSALMF 111
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEA 483
LH + + + +LK N+ + E +++FG + F Y APE
Sbjct: 112 LHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFP 511
+Q P D + +G+++ E+L G P
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARD---AFDTEVRRLGRLRHSNVLAPLA 374
V+G G G + +V+ + M +D A E + L L H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
++V EY PGG+L + DE T L I + ++HT+L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI---LHFFVQILLALHHVHTKL-- 121
Query: 435 LDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFA---YKAPEAIQSGKVT 490
+ H +LK+ NI + + I +FG +++S + A + Y +PE +
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 491 PKCDVYCLGIIILEILTGK 509
K D++ LG ++ E+ + K
Sbjct: 180 QKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 387 EYIPGGSL-LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSS 445
E++ GGSL +Y + P H +I + +G+ YL + L + H ++K S
Sbjct: 79 EFMDGGSLDVY----RKIPEH------VLGRIAVAVVKGLTYLWS----LKILHRDVKPS 124
Query: 446 NIFISPENEPLISEFGFYT-MINS-ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIIL 503
N+ ++ + + +FG T ++NS A AY APE I + DV+ LGI +
Sbjct: 125 NMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 504 EILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEM-EQLLEIG 562
E+ G+FP + G + ++ + E DP + G+ E+ +
Sbjct: 185 ELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPPVLPV----GQFSEKFVHFI 233
Query: 563 RACTQSDPEQRLEMREAVRRIVEIQQSDGNMDA 595
C + P++R + +Q +DGN +
Sbjct: 234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 16/106 (15%)
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY-TMINSANLAQA 474
KI I + + YLH++L+ + H ++K SN+ I+ + + +FG +++S +A+
Sbjct: 107 KIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKT 161
Query: 475 LFA----YKAPEAI-----QSGKVTPKCDVYCLGIIILEILTGKFP 511
+ A Y APE I Q G K DV+ LGI ++E+ TG+FP
Sbjct: 162 IDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 317 EVLGNGGLGSSYKAMMAD--GVTVV--VKRMKESSAMARDAFD---TEVRRLGRLRHSNV 369
+VLG G G K M+A+ G V +K +K+ + D D TE R L
Sbjct: 1 KVLGKGSFG---KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 370 LAPLAYHYRTDEKLL-VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG-IARGIGY 427
L L ++T ++L V EY+ GG L++ + R DE R + + + +
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDE----PRSRFYAAEVTLALMF 111
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM-INSANLAQALFA---YKAPEA 483
LH + + +LK NI + E +++FG I + Y APE
Sbjct: 112 LHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI 167
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFP 511
+Q + P D + LG+++ E++ G+ P
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHY 377
+G+G G YKA + G VK +K E+ + +H N++A Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG-SY 75
Query: 378 RTDEKLLV-YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ EKL + EY GGSL + H S ++ + R + +G+ YLH++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI---QSGKV 489
H ++K +NI ++ + +++FG I + + F + APE ++G
Sbjct: 129 --HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 490 TPKCDVYCLGIIILEI 505
CD++ +GI +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 30/226 (13%)
Query: 295 ELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAF 354
EL+ V G G +G L++ +G G Y + T+V K
Sbjct: 3 ELLRVLG-TGAYGKVFLVRK----VGGHDAGKLYAMKVLKKATIVQKAKTAEHTR----- 52
Query: 355 DTEVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPA 413
TE + L +R L L Y ++TD KL L+ +Y+ GG L L E +
Sbjct: 53 -TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHL------YQREHFTES 105
Query: 414 RLKIVQG-IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472
+++ I + +LH L + + ++K NI + E ++++FG +
Sbjct: 106 EVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 473 QA-----LFAYKAPEAIQSGKV--TPKCDVYCLGIIILEILTGKFP 511
+A Y APE I+ G D + LG++ E+LTG P
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 64/274 (23%), Positives = 115/274 (41%), Gaps = 44/274 (16%)
Query: 334 DGVTVVVKRMKESSAMARDAFD--TEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIP 390
+ VTV VK +K+ A +D D +E+ + + +H N++ L + ++ EY
Sbjct: 46 EAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 104
Query: 391 GGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPH 439
G+L L R P +++T+ + +ARG+ YL ++ H
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIH 160
Query: 440 GNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL------FAYKAPEAIQSGKVTPKC 493
+L + N+ ++ N I++FG +N+ + + + APEA+ T +
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220
Query: 494 DVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSP 552
DV+ G+++ EI T G P GI V E + EG D + A+ TN
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYP-------GIPVEE-LFKLLKEGHRMD----KPANCTN-- 266
Query: 553 GEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
+L + R C + P R ++ V + I
Sbjct: 267 ----ELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 31/193 (16%)
Query: 338 VVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL-- 394
V VK ++ +++ AR+ F EV+ L RL+ N++ L D ++ EY+ G L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 395 ---LYLLHGDRGPSHDE---------LTWPARLKIVQGIARGIGYLHTELAHLDLPHGNL 442
+ L +D +++ + L + IA G+ YL + L+ H +L
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS----LNFVHRDL 164
Query: 443 KSSNIFISPENEPLISEFG---------FYTMINSANLAQALFAYKAPEAIQSGKVTPKC 493
+ N + I++FG +Y + A L A+ E I GK T
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW---ECILMGKFTTAS 221
Query: 494 DVYCLGIIILEIL 506
DV+ G+ + EIL
Sbjct: 222 DVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 45/286 (15%)
Query: 319 LGNGGLGSSYKAMMADGV-------TVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNVL 370
LG G G Y+ + A GV V +K + E+++M R F E + +V+
Sbjct: 14 LGQGSFGMVYEGL-AKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE---LTWPARLKIVQ---GIARG 424
L L+V E + G L L R P + L P K +Q IA G
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRR-PEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQALFAYK- 479
+ YL H +L + N ++ + I +FG I + + L +
Sbjct: 132 MAYLAA----KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 480 -APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
APE+++ G T K DV+ G+++ E+ T + P Q L+N E V +G
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKFVIDGGH 239
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
DL PE N P ++LLE+ R C Q +P+ R E V +
Sbjct: 240 LDL--PE-----NCP---DKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 32/214 (14%)
Query: 317 EVLGNGGLGSSY---KAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGR-----LRHSN 368
+VLG G G + K D + ++ + +A+ + A E R R +R S
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 369 VLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG-IARGIG 426
L L Y ++T+ KL L+ +Y+ GG + L+ S DE+ + G I +
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV------RFYSGEIILALE 119
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-----FAYKAP 481
+LH L + + ++K NI + E ++++FG S + Y AP
Sbjct: 120 HLHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 482 EAIQS----GKVTPKCDVYCLGIIILEILTGKFP 511
E I+ GK D + LGI+I E+LTG P
Sbjct: 176 EIIRGKGGHGKAV---DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 26/213 (12%)
Query: 317 EVLGNGGLGSSYK-AMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLA 374
E +G G G YK DG VK + S + + + E L L H NV+
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE-IEAEYNILQSLPNHPNVVKFYG 86
Query: 375 YHYRTDEKL-----LVYEYIPGGSLLYLLHG--DRGPSHDELTWPARLKIVQGIARGIGY 427
Y+ D+ + LV E GGS+ L+ G G DE I+ G G+ +
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE---AMISYILYGALLGLQH 143
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEA 483
LH + H ++K +NI ++ E + +FG + S L + + APE
Sbjct: 144 LHNN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 484 IQSGK-----VTPKCDVYCLGIIILEILTGKFP 511
I + +CDV+ LGI +E+ G P
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 66/268 (24%), Positives = 107/268 (39%), Gaps = 29/268 (10%)
Query: 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMAR--DAFDTEVRRLGRLRHSNVLAPLA 374
VLG GG G + A G KR+++ R ++ +++ +S + LA
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
Y Y T + L LV + GG L + ++ P +E L I G+ LH E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHRE-- 121
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA---LFAYKAPEAIQSGKVT 490
+ + +LK NI + IS+ G I + Y APE + + + T
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
D + LG +I E++ G+ P + E V + RV + E+ S+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRK---------EKVKREEVDRRVLE--TEEVYSAKF 228
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMRE 578
S E+ I + DP+QRL +E
Sbjct: 229 S----EEAKSICKMLLTKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 317 EVLGNGGLGSSYKAMMADG--------VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN 368
+VLG G G + G + V+ K A + TE + L +R S
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 369 VLAPLAYHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQG-IARGI 425
L L Y ++TD KL L+ +YI GG L +L +R + ++I G I +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE-------VQIYSGEIVLAL 118
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-----FAYKA 480
+LH L + + ++K NI + ++++FG + + +A Y A
Sbjct: 119 EHLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 481 PEAIQSGKV--TPKCDVYCLGIIILEILTGKFP 511
P+ ++ G D + +G+++ E+LTG P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 319 LGNGGLGSSYKA--MMADG--VTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
LG+G GS K +M G V V VK +K E A + F E + +L H ++ +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRG-PSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ + +LV E P G LL L R P D +A G+ YL E
Sbjct: 63 GV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL--ES 113
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-LAQALFAYK------APEAIQ 485
H H +L + N+ + ++ IS+FG + + + +A A + APE I
Sbjct: 114 KHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 486 SGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
GK + K DV+ G+ + E + G P + G +V+ + S
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAMLES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVT----VVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVL 370
+VLG+G G+ YK + + +G T V +K + E++ A F E + + H +++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L + LV + +P G LL + H D S L W + IA+G+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN------SANLAQALFAYKAPE 482
L H +L + N+ + N I++FG ++ +A+ + + A E
Sbjct: 126 EER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 483 AIQSGKVTPKCDVYCLGIIILEILT 507
I K T + DV+ G+ I E++T
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 60/275 (21%), Positives = 99/275 (36%), Gaps = 45/275 (16%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVK-------RMKESSAMARDAFDTEVRRLGRLRHSNVL 370
LG GG G + G K + ++ MA + +++ S +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNE-----KKILEKVSSRFI 55
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLL--HGDRG-PSHDELTWPARLKIVQGIARGIG 426
LAY + T + L LV + GG L Y + G+ G P + + A+ I G+
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ------IICGLE 109
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA---LFAYKAPEA 483
+LH + + +LK N+ + IS+ G + + Y APE
Sbjct: 110 HLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV 165
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543
+Q D + LG + E++ G+ P + E V + R L
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFR---------QRKEKVEKEELKRRT--LEMA 214
Query: 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMRE 578
SP + ++ A Q DPE+RL R
Sbjct: 215 VEYPDKFSP----EAKDLCEALLQKDPEKRLGCRG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNV 369
++LG G G K ++ A G +K +K+ +A+D TE R L RH
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP-F 56
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L L Y ++T ++L V EY GG L + L +R S D AR + I +GYL
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----ARFYGAE-IVSALGYL 111
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI 484
H+ D+ + +LK N+ + + I++FG S F Y APE +
Sbjct: 112 HSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
+ D + LG+++ E++ G+ P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 66/291 (22%), Positives = 115/291 (39%), Gaps = 45/291 (15%)
Query: 319 LGNGGLGSSYKAMMADGVT------VVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLA 371
LG G G Y+ D + V VK + ES+++ R F E + +V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPA-----RLKIVQGIARGIG 426
L + L+V E + G L L R + + P +++ IA G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQALFAYK--A 480
YL+ + H +L + N ++ + I +FG I + + L + A
Sbjct: 134 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539
PE+++ G T D++ G+++ EI + + P Q L+N E V +G D
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGGYLD 241
Query: 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
P+ N P + L+ + C Q +P +MR IV + + D
Sbjct: 242 --QPD-----NCPERVTDLMRM---CWQFNP----KMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 318 VLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
++GNG G Y+A+ D V +K++ + + E+ + L H N++ Y+
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK----NRELLIMKNLNHINIIFLKDYY 128
Query: 377 Y----RTDEKLL----VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
Y + +EK + V E+IP Y+ H R +H + +L Q + R + Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN-NHALPLFLVKLYSYQ-LCRALAYI 186
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFA---YKAPE-A 483
H++ + H +LK N+ I P L + +FG + + + + Y+APE
Sbjct: 187 HSKF----ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID 523
+ + T D++ LG II E++ G +P + +G +D
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILG-YP---IFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADG----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
+VLG+G G+ YK + + +G + V +K ++E +S A E + + + +V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L T L+ + +P G LL + H D S L W VQ IA+G+ YL
Sbjct: 73 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW-----CVQ-IAKGMNYL 125
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS------ANLAQALFAYKAPE 482
L H +L + N+ + I++FG ++ + A + + A E
Sbjct: 126 EER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 483 AIQSGKVTPKCDVYCLGIIILEILT 507
+I T + DV+ G+ + E++T
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 19/198 (9%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMK---ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+G G YKA+ + DG V +K+++ A AR E+ L +L H NV+ LA
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLH--GDRGPSHDELT-WPARLKIVQGIARGIGYLHTE 431
+E +V E G L ++ + E T W VQ + + ++H++
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY---FVQ-LCSALEHMHSK 125
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-AQALFA---YKAPEAIQSG 487
+ H ++K +N+FI+ + + G +S A +L Y +PE I
Sbjct: 126 ----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 488 KVTPKCDVYCLGIIILEI 505
K D++ LG ++ E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 318 VLGNGGLGSSYKAM------MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
LG G G KA A TV VK +KE +S+ +E L ++ H +V+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLH-------------GDRGPSHDE------LTW 411
+ LL+ EY GSL L G+R S+ + LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 412 PARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF----YTMIN 467
+ I+RG+ YL A + L H +L + N+ ++ + IS+FG Y +
Sbjct: 127 GDLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 468 SANLAQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT 507
++ K A E++ T + DV+ G+++ EI+T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDA-FDTEVRRLGRLRHSNVLAPLAYHY 377
LG G GS YK + T V MKE ++ F+ + L L + + ++
Sbjct: 9 LGKGNYGSVYKVLHRP--TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 378 RTDEKLLVY---EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ VY EY+ GSL L G G + + + +I + +G+ +L E
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAG--GVATEGIPEDVLRRITYAVVKGLKFLKEEH-- 122
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-------AYKAPEAIQSG 487
++ H ++K +N+ ++ + + +FG S NL +L +Y APE I+SG
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 488 KV------TPKCDVYCLGIIILEILTGKFP 511
T + DV+ LG+ ILE+ G++P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 70/269 (26%), Positives = 103/269 (38%), Gaps = 31/269 (11%)
Query: 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMAR--DAFDTEVRRLGRLRHSNVLAPLA 374
VLG GG G + A G K++++ R +A +++ +S + LA
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG-IARGIGYLHTEL 432
Y Y T + L LV + GG L + ++ P DE R I G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE----ERAVFYAAEITCGLEDLHRE- 121
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA---LFAYKAPEAIQSGKV 489
+ + +LK NI + IS+ G I + Y APE +++ +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 490 TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549
T D + LG +I E++ GK P + E V E RV + D E S
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRK---------EKVKREEVERRVKE--DQEEYSEK 227
Query: 550 NSPGEMEQLLEIGRACTQSDPEQRLEMRE 578
S E I R DP RL R
Sbjct: 228 FS----EAARSICRQLLTKDPGFRLGCRG 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 12/128 (9%)
Query: 387 EYIPGGSL-LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSS 445
E++ GGSL L R P KI + RG+ YL + + H ++K S
Sbjct: 79 EHMDGGSLDQVLKKAGRIPE------NILGKISIAVLRGLTYLREKHKIM---HRDVKPS 129
Query: 446 NIFISPENEPLISEFGFYTM-INS-ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIIL 503
NI ++ E + +FG I+S AN +Y +PE +Q T + D++ LG+ ++
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 504 EILTGKFP 511
E+ G++P
Sbjct: 190 EMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E LG G + YK G V +K + ++ E+ + L+H N++ L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVR-LH 64
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYL-LHGDRGPSHDELTWPARLK-IVQGIARGIGYLHTE 431
T+ KL LV+EY+ Y+ HG RG P +K + +GI + H
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD-----PNTVKSFTYQLLKGIAFCHEN 119
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFG----FYTMINSANLAQALFAYKAPEAIQSG 487
+ H +LK N+ I+ E +++FG F +N+ + Y+AP+ +
Sbjct: 120 ----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 488 KV-TPKCDVYCLGIIILEILTGK 509
+ + D++ +G I+ E++TG+
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 70/279 (25%), Positives = 115/279 (41%), Gaps = 45/279 (16%)
Query: 304 GVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS-AMARDAFDTEVRRLG 362
G FG +++A A GL S M V VK +K ++ + R+A +E++ +
Sbjct: 46 GAFG--KVVEATAY-----GLSKSDAVM-----KVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 363 RL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGI 421
L H N++ L L++ EY G LL L R LT L +
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQV 150
Query: 422 ARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI-NSANL-----AQAL 475
A+G+ +L A + H +L + N+ ++ I +FG I N +N A+
Sbjct: 151 AKGMAFL----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 476 FAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534
+ APE+I + T + DV+ GI++ EI + G P G+ V E
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP-------GMPVDSKFYKLIKE 259
Query: 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
G + PE A ++ +I + C +DP +R
Sbjct: 260 G--YRMAQPEHAP--------AEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRR-----LGRLRHSNVLAP 372
V+G G G +A++ V K + + + + E R L +++H N++A
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA- 62
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRG---PSHDELTWPARLKIVQGIARGIGYL 428
+ D L +V EY GG L+ + RG P L W VQ + G+ ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW-----FVQ-MCLGVQHI 116
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI 484
H + + H ++KS NIF++ + + +FG ++ S + Y PE
Sbjct: 117 HEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQ 513
++ K D++ LG I+ E+ T K P Q
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 303 KGVFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMK---ESSAMARDAFDTEV 358
K ++ +PD + +V G+G G+ A+ G V +K++ +S A+ A+ E+
Sbjct: 8 KTIWEVPDRYRDLKQV-GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-REL 65
Query: 359 RRLGRLRHSNVLAPLAYHYRTDEKL-------LVYEYIPGGSLLYLLHGDRGPSHDELTW 411
R L ++H NV+ L + D L LV ++ G L L+ H++L+
Sbjct: 66 RLLKHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFM-GTDLGKLM------KHEKLSE 117
Query: 412 PARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL 471
+V + +G+ Y+H + H +LK N+ ++ + E I +FG +S
Sbjct: 118 DRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 472 AQALFA-YKAPEAIQSG-KVTPKCDVYCLGIIILEILTGK 509
+ Y+APE I + T D++ +G I+ E+LTGK
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 50/195 (25%), Positives = 78/195 (40%), Gaps = 14/195 (7%)
Query: 322 GGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLAYHY 377
G GS Y A + G +K +K+S +A++ E + S +A L Y +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 378 RTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
++ + L LV EY+ GG L+ G D W A+ I + + G+ LH
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPED---W-AKQYIAE-VVLGVEDLHQR----G 117
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVY 496
+ H ++K N+ I +++FG Y APE I D +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 497 CLGIIILEILTGKFP 511
LG +I E L G P
Sbjct: 178 SLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 70/293 (23%), Positives = 117/293 (39%), Gaps = 57/293 (19%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKESSAMAR-DAFDTEVRRLGRLRHSNVLA 371
V+G G G Y + D + VK + + + + F E + H NVL+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGD-----RGPSHDELTWPARLKIVQG----IA 422
L ++ LV L Y+ HGD R +H+ P +K + G +A
Sbjct: 61 LLGICLPSEGSPLVV-------LPYMKHGDLRNFIRSETHN----PT-VKDLIGFGLQVA 108
Query: 423 RGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG---------FYTMINSANLAQ 473
+G+ YL A H +L + N + +++FG +Y++ N A+
Sbjct: 109 KGMEYL----ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG-AK 163
Query: 474 ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533
+ A E++Q+ K T K DV+ G+++ E++T P + D+ ++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLL---- 216
Query: 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
+GR LL PE L E+ +C PE R E V RI +I
Sbjct: 217 QGR--RLLQPEYCPDP--------LYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 56/212 (26%), Positives = 84/212 (39%), Gaps = 40/212 (18%)
Query: 319 LGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDA---FDTEVRRLGRLRHSNVLAPLA 374
LG GG G + T +K +K+ + +E L H ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVK--- 57
Query: 375 YHYRT--DEKLLVY---EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
YRT D+K +Y EY GG L +L DRG DE T AR I + YLH
Sbjct: 58 -LYRTFKDKKY-IYMLMEYCLGGELWTILR-DRG-LFDEYT--ARFYIAC-VVLAFEYLH 110
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGF----------YTMINSANLAQALFAYK 479
+ + + +LK N+ + + +FGF +T + Y
Sbjct: 111 ----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE-------YV 159
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
APE I + D + LGI++ E+LTG+ P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 20/204 (9%)
Query: 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMAR--DAFDTEVRRLGRLRHSNVLAPLA 374
VLG GG G + A G K++++ R +A +R+ +S + LA
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDE---LTWPARLKIVQGIARGIGYLHT 430
Y Y T + L LV + GG L + ++ P DE + + A L G+ L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL------CCGLEDLQR 120
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA---LFAYKAPEAIQSG 487
E + + +LK NI + IS+ G I + Y APE I +
Sbjct: 121 E----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
K T D + LG +I E++ G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 317 EVLGNGGLGSSYKA------MMADGVTVVVKRMKESSAMARDAFD--TEVRRLGRL-RHS 367
+ LG G G KA + TV VK +K+ A +D D +E+ + + +H
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHK 76
Query: 368 NVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE-----------LTWPARLK 416
N++ L + +V EY G+L L R P LT +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 417 IVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----A 472
+ARG+ +L A H +L + N+ ++ ++ I++FG I+ +
Sbjct: 137 FAYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 473 QALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVA 529
K APEA+ T + DV+ G+++ EI T G S Y GI V E
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG--GSPY-----PGIPVEELFK 245
Query: 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAV 580
R ++ N E+ L+ R C P QR ++ V
Sbjct: 246 LLKEGYR----MEK----PQNCTQELYHLM---RDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-05
Identities = 18/44 (40%), Positives = 22/44 (50%), Gaps = 8/44 (18%)
Query: 2 SESEALLKLKSSFTNA--KALDSWMPS-TAPCRGGEEEWSGVVC 42
+ +ALL KSS AL SW PS + PC W+GV C
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCS-----WTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 317 EVLGNGGLGSSY---KAMMAD-GVTVVVKRMKESSAMARDAFDTEVRR--LGRLRHSNVL 370
+VLG G G + K D G +K +K+++ RD T++ R L + H ++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELT-WPARLKIVQGIARGIGYL 428
L Y ++T+ KL L+ +++ GG L L + + +++ + A L A + +L
Sbjct: 62 K-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL------ALALDHL 114
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT-MINSANLAQAL---FAYKAPEAI 484
H+ L + + +LK NI + E +++FG I+ A + Y APE +
Sbjct: 115 HS----LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQ 513
T D + G+++ E+LTG P Q
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 36/137 (26%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
Y E + E++ GGSL +L + + L K+ + RG+ YL + H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK--H-Q 124
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFY-TMINS-ANLAQALFAYKAPEAIQSGKVTPKCD 494
+ H ++K SNI ++ E + +FG +I+S AN +Y +PE +Q + + D
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 495 VYCLGIIILEILTGKFP 511
++ +G+ ++E+ G++P
Sbjct: 185 IWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 23/155 (14%)
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHG--DRGPSHDELTWPARLKIVQGIARGIG 426
+ L Y ++ + L LV +Y GG LL LL DR P AR I + + I
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYIAE-MVLAIH 116
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-----YKAP 481
+H L H ++K N+ + +++FG +N Q+ A Y +P
Sbjct: 117 SIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 482 EAIQS-----GKVTPKCDVYCLGIIILEILTGKFP 511
E +Q+ GK P+CD + LG+ + E+L G+ P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHG--DRGPSHDELTWPARLKIVQGIARGIG 426
+ L Y ++ + L LV +Y GG LL LL DR P + A + I +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-----YKAP 481
Y+H ++ K NI + +++FG + Q+ A Y +P
Sbjct: 123 YVHRDI----------KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 482 EAIQS-----GKVTPKCDVYCLGIIILEILTGKFP 511
E +Q+ GK P+CD + LG+ + E+L G+ P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 17/105 (16%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLK 416
E R L + R + V P+ Y D L+V EYI G L + AR
Sbjct: 49 EARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELL------------KDALEEARPD 96
Query: 417 IVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461
+++ + R +G LH + HG+L +SNI +S I +FG
Sbjct: 97 LLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGRIYFI-DFG 136
|
Length = 204 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-05
Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESN 132
L+++ L N+ + IP G F + L+ L S N + P F LP L L L N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58
Query: 133 QF 134
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 23/152 (15%)
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLH--GDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L Y ++ + L LV +Y GG LL LL DR P +++ AR + + + I +H
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP--EDM---ARFYLAE-MVLAIDSVH 119
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-----YKAPEAI 484
L H ++K N+ + +++FG + + Q+ A Y +PE +
Sbjct: 120 ----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 485 QS-----GKVTPKCDVYCLGIIILEILTGKFP 511
Q+ G+ P+CD + LG+ + E+L G+ P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 319 LGNGGLGSSYKAMMADGVT-------VVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
+G G G ++A A G+ V VK +KE +SA + F E + H N++
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGP------SHD------------ELTWP 412
L L++EY+ G L L R P SH L+
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLR-HRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 413 ARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472
+L I + +A G+ YL + H +L + N + I++FG I SA+
Sbjct: 131 EQLCIAKQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 473 QA------LFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVV 525
+A + PE+I + T + DV+ G+++ EI + G P + +
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-------- 238
Query: 526 EWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
E V +G V L P+ N P E+ L+ R C P R
Sbjct: 239 EEVIYYVRDGNV--LSCPD-----NCPLELYNLM---RLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 5e-05
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 58/221 (26%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT----EVRRLGRLRHSNVLAPL 373
+G G G YKA G V +K+++ ++ F E++ L +LRH N++ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIV-RL 63
Query: 374 AYHYRTDEK---LLVYEYIPGGSLLYLLHGDRGPSHD----------ELTWPARLK-IVQ 419
+ K +V+EY+ HD + T +++K ++
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD---------------HDLTGLLDSPEVKFT-ESQIKCYMK 107
Query: 420 GIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFG---FYTMINSA---NLA 472
+ G+ YLH+ + H D+ K SNI I+ + +++FG YT NSA N
Sbjct: 108 QLLEGLQYLHSNGILHRDI-----KGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 473 QALFAYKAPE----AIQSGKVTPKCDVYCLGIIILEILTGK 509
L+ Y+ PE A + G P+ D++ +G I+ E+ GK
Sbjct: 163 ITLW-YRPPELLLGATRYG---PEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 30/85 (35%), Positives = 47/85 (55%), Gaps = 10/85 (11%)
Query: 439 HGNLKSSNIFISPENEPLISEFGF---YTMINSANLAQALFA---YKAPEAIQSGKVTPK 492
H +LKS+NIF+ P + +FGF Y+ S ++A + Y APE + + + K
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 493 CDVYCLGIIILEILT----GKFPSQ 513
D++ LG+I+ E+LT K PSQ
Sbjct: 252 ADMWSLGVILYELLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLK 416
E+ L + H NV+ E ++ E++ GGSL G L AR +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADVAR-Q 176
Query: 417 IVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----NLA 472
I+ GIA YLH + H ++K SN+ I+ I++FG ++ N +
Sbjct: 177 ILSGIA----YLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228
Query: 473 QALFAYKAPEAIQS----GKVTPKC-DVYCLGIIILEILTGKFP 511
AY +PE I + G D++ LG+ ILE G+FP
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 312 MKA----AAEVLGNGGLGSSYKAMMADGVTVVVKRMK-----ESSAMARDAFDTEVRRLG 362
MKA +V+G G G ++ T V MK E + AF E R +
Sbjct: 40 MKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 363 RLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGI 421
+S + L Y ++ D L +V EY+PGG L+ L+ P + A + +
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 157
Query: 422 ARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA---- 477
+G++H + +K N+ + +++FG +N + + A
Sbjct: 158 IHSMGFIHRD----------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 478 -YKAPEAIQS----GKVTPKCDVYCLGIIILEILTGKFP 511
Y +PE ++S G +CD + +G+ + E+L G P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 319 LGNGGLGSSYKA--MMADGVTVVVKRMKESSAMARDAFDT--EV---RRLGRLRHSNV-- 369
+G G G +KA + G V +KR++ + T EV R L H NV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 370 LAPLAYHYRTDEKL---LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIG 426
L + RTD + LV+E++ YL D+ P T + + Q + RG+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYL---DKVPEPGVPTETIKDMMFQ-LLRGLD 124
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF---YTMINSANLAQALFAYKAPEA 483
+LH+ + H +LK NI ++ + +++FG Y+ + Y+APE
Sbjct: 125 FLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 484 -IQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID 523
+QS TP D++ +G I E+ F + L G+ +D
Sbjct: 181 LLQSSYATP-VDLWSVGCIFAEM----FRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN------VLA 371
LG G G + A+ +D V VK++ + + E++ + RL H N VL
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 372 PLAYHYRTDEKLL--------VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIAR 423
P D L V EY+ L G H ARL + Q + R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH------ARLFMYQ-LLR 125
Query: 424 GIGYLHTELAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMIN-----SANLAQALFA 477
G+ Y+H+ ++ H +LK +N+FI+ E+ L I +FG +++ L++ L
Sbjct: 126 GLKYIHSA----NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 478 --YKAPE-AIQSGKVTPKCDVYCLGIIILEILTGK 509
Y++P + T D++ G I E+LTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 9e-05
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 43/217 (19%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD-TEVRRLGRL-RHSNVLAPL 373
+ LG+G GS Y A G V +K+MK+ + + EV+ L +L H N++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
DE V+EY+ G LY L DR + I+ I +G+ ++H
Sbjct: 65 EVFRENDELYFVFEYMEGN--LYQLMKDRKGKP--FSESVIRSIIYQILQGLAHIHK--- 117
Query: 434 HLDLPHG----NLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA------------ 477
HG +LK N+ +S I++FG LA+ + +
Sbjct: 118 -----HGFFHRDLKPENLLVSGPEVVKIADFG---------LAREIRSRPPYTDYVSTRW 163
Query: 478 YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE + +S + D++ LG I+ E+ T + FP
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 22/61 (36%), Positives = 30/61 (49%), Gaps = 6/61 (9%)
Query: 100 LRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQFNGTIP--SFDQPTLVR-LNLSSNK 155
L+ L SNN+ +P FK LP+L L L N +I +F +R L+LS N
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 156 L 156
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 36/208 (17%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESS-------AMARDAFDTEV---RRLGRLRHS 367
+G G G+ YKA + G V +K+++ + R E+ ++L H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-----EIALLKQLESFEHP 61
Query: 368 NV--LAPLAYHYRTDEKL---LVYEYIPGGSLLYLLH-GDRGPSHDELTWPARLKIVQGI 421
N+ L + + RTD +L LV+E++ YL G + + +++ +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD-----LMRQL 116
Query: 422 ARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF---YTMINSANLAQALFAY 478
RG+ +LH+ + H +LK NI ++ + + I++FG Y+ + Y
Sbjct: 117 LRGVDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWY 172
Query: 479 KAPEA-IQSGKVTPKCDVYCLGIIILEI 505
+APE +QS TP D++ +G I E+
Sbjct: 173 RAPEVLLQSSYATP-VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRM-------KESSAMARDAFDTEVRRLGRLRHSNVL 370
+G G G +KA G TV +K++ + R E++ L +H V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-----EIKALQACQHPYVV 62
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L +LV EY+P L +L + P L ++ + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP----LPEAQVKSYMRMLLKGVAYMHA 117
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ-----ALFAYKAPEAI- 484
+ H +LK +N+ IS + I++FG + + A Y+APE +
Sbjct: 118 N----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 485 QSGKVTPKCDVYCLGIIILEILTGK--FPS 512
+ K P D++ +G I E+L G FP
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 19/204 (9%)
Query: 319 LGNGGLGS-SYKAMMADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLA 374
LG GG G S M A G K++ + R ++ E R L ++ HS + LA
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHG--DRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
Y ++T L LV + GG L Y ++ + P E P I G+ +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE---PRACFYTAQIISGLEHLHQR 116
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSG 487
+ + +LK N+ + + IS+ G + +A + APE +Q
Sbjct: 117 ----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
+ D + LG+ + E++ + P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
E++GNG G YK + ++ + + + E+ L + H +A
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 377 Y-------RTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ D+ LV E+ GS+ L+ +G + E W A I + I RG+ +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIAY--ICREILRGLSHLH 128
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQ 485
+ H ++K N+ ++ E + +FG ++ + F + APE I
Sbjct: 129 QH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 486 SGKVTP------KCDVYCLGIIILEILTGKFP 511
+ P K D++ LGI +E+ G P
Sbjct: 185 CDE-NPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 318 VLGNGGLGSSYKAMMADGV----TVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAP- 372
VLG GG G ++ G +K +K+++ + R+ DT + R V P
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKAT-IVRNQKDTAHTKAERNILEAVKHPF 61
Query: 373 ---LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L Y ++T KL L+ EY+ GG L +H +R E T A + + I+ + +L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDT--ACFYLSE-ISLALEHL 116
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI 484
H + + +LK NI + + +++FG F Y APE +
Sbjct: 117 H----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
D + LG ++ ++LTG P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 18/205 (8%)
Query: 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMAR--DAFDTEVRRLGRLRHSNVLAPLA 374
VLG GG G + A G K++++ R ++ +++ +S + LA
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLH--GDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
Y Y T + L LV + GG L + ++ G+ G + A I G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYA-----AEICCGLEDLHQE 121
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA---LFAYKAPEAIQSGK 488
+ + +LK NI + IS+ G + + Y APE +++ +
Sbjct: 122 ----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 489 VTPKCDVYCLGIIILEILTGKFPSQ 513
T D + LG ++ E++ G+ P Q
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 303 KGVFGLPDLMKAAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMK---ESSAMARDAFDTEV 358
K ++ +P+ + + V G+G GS A G+ V VK++ +S A+ + E+
Sbjct: 10 KTIWEVPERYQNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-REL 67
Query: 359 RRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL-----LYLLHGDRGPSHDELTWPA 413
R L ++H NV+ L+ + P SL +YL+ G + +
Sbjct: 68 RLLKHMKHENVIG------------LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 115
Query: 414 RLK------IVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467
+L ++ I RG+ Y+H+ D+ H +LK SN+ ++ + E I +FG +
Sbjct: 116 KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171
Query: 468 SANLAQ-ALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGK--FP 511
A Y+APE + + D++ +G I+ E+LTG+ FP
Sbjct: 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 43/222 (19%)
Query: 319 LGNGGLGSSYKAMMADG----------VTVVVKRMKESSAMARDAFD--TEVRRLGRL-R 365
LG G G + +MA+ VT V +M +S A +D D +E+ + + +
Sbjct: 26 LGEGCFG---QVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 366 HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQ------ 419
H N++ L + ++ EY G+L L R P + P ++ Q
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 420 -----GIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG---------FYTM 465
+ARG+ YL A H +L + N+ ++ +N I++FG +Y
Sbjct: 143 VSCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 466 INSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ L + APEA+ T + DV+ G+++ EI T
Sbjct: 199 TTNGRLP---VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESS-AMARD--AFDT--EVRRLGRLRHSNVLAP 372
LG G YKA G V +K++K A+D F E++ L L+H N++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLK-IVQGIARGIGYLHT 430
L + + LV+E++ L + D+ LT PA +K + RG+ YLH
Sbjct: 68 LDV-FGHKSNINLVFEFMETD--LEKVIKDKSIV---LT-PADIKSYMLMTLRGLEYLH- 119
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAI- 484
++ L H +LK +N+ I+ + +++FG S N + Y+APE +
Sbjct: 120 --SNWIL-HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-YRAPELLF 175
Query: 485 QSGKVTPKCDVYCLGIIILEILTGK--FPSQ 513
+ D++ +G I E+L P
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADG----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
++LG+G G+ +K + + +G + V +K +++ S + +G L H+ ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE--LTWPARLKIVQGIARGIGYL 428
L +L V + P GSLL + R + L W VQ IA+G+ YL
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW-----CVQ-IAKGMYYL 125
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA------NLAQALFAYKAPE 482
+ H NL + NI + ++ I++FG ++ + + + A E
Sbjct: 126 EEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 483 AIQSGKVTPKCDVYCLGIIILEILT 507
+I G+ T + DV+ G+ + E+++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPL--A 374
EV+GNG G YK + ++ + + + E+ L + H +A A
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 375 YHYRT-----DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ ++ D+ LV E+ GS+ L+ +G + E W A I + I RG+ +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAY--ICREILRGLAHLH 138
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQ 485
AH + H ++K N+ ++ E + +FG ++ + F + APE I
Sbjct: 139 ---AH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 486 SGKVTP------KCDVYCLGIIILEILTGKFP 511
+ P + D++ LGI +E+ G P
Sbjct: 195 CDE-NPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 13/104 (12%)
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY-TMINSANLAQA 474
KI + + YL EL + H ++K SNI + + +FG +++S +A+
Sbjct: 111 KIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKT 165
Query: 475 LFA----YKAPEAIQSGKVTP---KCDVYCLGIIILEILTGKFP 511
A Y APE I + DV+ LGI + E+ TGKFP
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 33/109 (30%)
Query: 423 RGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----- 477
R + Y+HT ++ H +LK NI + + + I +FG LA+ F
Sbjct: 114 RALKYIHTA----NVFHRDLKPKNILANADCKLKICDFG---------LARVAFNDTPTA 160
Query: 478 -----------YKAPEAIQS--GKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE S K TP D++ +G I E+LTGK FP
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 30/189 (15%)
Query: 335 GVTVVVKRMKESSAMARDA-FDTEVRRLGRLRHSNVLAPLAYHYR---TDEK----LLVY 386
G V VK +K S A E+ L L H N++ Y+ T++ L+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV-----KYKGICTEDGGNGIKLIM 87
Query: 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSN 446
E++P GSL L R + L +LK I +G+ YL + H +L + N
Sbjct: 88 EFLPSGSLKEYL--PRNKNKINLK--QQLKYAVQICKGMDYLGSR----QYVHRDLAARN 139
Query: 447 IFISPENEPLISEFGFYTMINSA--------NLAQALFAYKAPEAIQSGKVTPKCDVYCL 498
+ + E++ I +FG I + +L +F Y APE + K DV+
Sbjct: 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSF 198
Query: 499 GIIILEILT 507
G+ + E+LT
Sbjct: 199 GVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 318 VLGNGGLGSSYKAMMAD----GVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
VLG G G K ++A+ VK +K+ + D + TE R L L
Sbjct: 2 VLGKGSFG---KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG-IARGIGYL 428
L ++T ++L V EY+ GG L++ + DE R + I G+ +L
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDE----PRARFYAAEIVLGLQFL 112
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT--MINSANLAQALFA----YKAPE 482
H + + +LK N+ + E I++FG ++ + F Y APE
Sbjct: 113 HER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE 166
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ P D + LG+++ E+L G+ P
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 319 LGNGGLGSSYKAMMADGVTV-VVKRMKESSAMARDAFDTEVRRLGRLRHSN--VLAPLAY 375
+G G G + D + +K ++++ ++R + L N + PL +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+++ EKL LV +I GG L + H R D AR + + + LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFH--HLQREGRFDL--SRARFYTAE-LLCALENLHK---- 111
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVT 490
++ + +LK NI + + + +FG + + F Y APE + T
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGN 519
D + LG+++ E+LTG P Y N N
Sbjct: 172 KAVDWWTLGVLLYEMLTG-LPPFYDENVN 199
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 24/206 (11%)
Query: 318 VLGNGGLGSSYKAMMAD----GVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
VLG G G K M+A+ +K +K+ + D + E R L L
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L ++T ++L V EY+ GG L+Y H + E P + I+ G+ +LH
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMY--HIQQVGKFKE---PQAVFYAAEISVGLFFLH 118
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQ 485
+ + +LK N+ + E I++FG + F Y APE I
Sbjct: 119 RR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP 511
D + G+++ E+L G+ P
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 61/258 (23%), Positives = 104/258 (40%), Gaps = 37/258 (14%)
Query: 336 VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395
+ V++K + S AF + ++ H +++ R E ++V E++ G L
Sbjct: 33 IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE--- 452
+H D LT P + K+ + +A + YL + DL HGN+ + NI ++ E
Sbjct: 93 LFMH----RKSDVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGID 144
Query: 453 NE--PLI--SEFGFYTMINSANLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEI-L 506
E P I S+ G + S + APE ++ K + D + G + EI
Sbjct: 145 GECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY 204
Query: 507 TGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACT 566
G+ P + T + E F EG+ L+ P ++L ++ C
Sbjct: 205 NGEIPLKDKT-------LAE--KERFYEGQCM-LVTPSC----------KELADLMTHCM 244
Query: 567 QSDPEQRLEMREAVRRIV 584
DP QR R +R I
Sbjct: 245 NYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 60/240 (25%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 319 LGNGGLGSSYKAMMADGVTVVVKRMKE---SSAMARDAFDTEVRRLGRLRHSNV------ 369
+G GL S + + G V +K++ + + +A+ + E++ L LRH N+
Sbjct: 20 MGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDI 77
Query: 370 -LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQ----GIARG 424
++PL Y E L G L LL + P + +Q I RG
Sbjct: 78 FISPLEDIYFVTELL-------GTDLHRLLT----------SRPLEKQFIQYFLYQILRG 120
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA--YKAPE 482
+ Y+H+ + H +LK SNI I+ + I +FG I + + Y+APE
Sbjct: 121 LKYVHSA----GVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTRYYRAPE 175
Query: 483 AIQS-GKVTPKCDVYCLGIIILEILTGK--FPSQYLTN---------GNGGIDVVEWVAS 530
+ + K + D++ G I E+L GK FP + N G DV+ + S
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 18/204 (8%)
Query: 317 EVLGNGGLGSSYKA-MMADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAP 372
++LG G G + A + +K +K+ + D + E R L L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 373 LAYHYRTDEKLL-VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
L ++T E L V EY+ GG L++ + S + P I G+ +LH++
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGF--YTMINSANLAQ--ALFAYKAPEAIQSG 487
+ + +LK NI + + I++FG M+ A Y APE +
Sbjct: 116 ----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
K D + G+++ E+L G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPL-AYH 376
LG+G G YKA + G+ K ++ S + F E+ L +H N++ AY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 377 YRTDEKLLVY-EYIPGGSLLYL-LHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
Y + KL + E+ GG+L + L +RG LT P + + + + +LH+
Sbjct: 73 Y--ENKLWILIEFCDGGALDSIMLELERG-----LTEPQIRYVCRQMLEALNFLHSHK-- 123
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI--QSGK 488
+ H +LK+ NI ++ + + +++FG S + F + APE + ++ K
Sbjct: 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 489 VTP---KCDVYCLGIIILEILTGKFP 511
P K D++ LGI ++E+ + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 317 EVLGNGGLGSSYKAMMA-DG--VTVVVKRMKE--SSAMARDAFDTEVRRLGRL-RHSNVL 370
+V+G G G +AM+ DG + +K +KE S RD F E+ L +L H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHPNII 66
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHD-----------ELTWPARLKIVQ 419
L + EY P G+LL L R D LT L+
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 420 GIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY---TMINSANLAQALF 476
+A G+ YL + H +L + N+ + I++FG + + +
Sbjct: 127 DVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182
Query: 477 AYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ A E++ T K DV+ G+++ EI++
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 26/213 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLA 374
E +G G G +K + +G VK + + + + E L L H NV+
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE-IEAEYNILKALSDHPNVVKFYG 82
Query: 375 YHYRTDEK-----LLVYEYIPGGSLLYLLHG--DRGPSHDELTWPARLKIVQGIARGIGY 427
+Y+ D K LV E GGS+ L+ G RG + + P I+ G+ +
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG---ERMEEPIIAYILHEALMGLQH 139
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEA 483
LH H ++K +NI ++ E + +FG + S L + + APE
Sbjct: 140 LHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 484 IQ-----SGKVTPKCDVYCLGIIILEILTGKFP 511
I +CDV+ LGI +E+ G P
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 36/213 (16%)
Query: 317 EVLGNGGLGSSYKAMMAD----GVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNV 369
+VLG G G K ++A+ G VK +K+ + D + E R L +
Sbjct: 1 KVLGKGSFG---KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 370 LAPLAYHYRTDEKLL-VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG------IA 422
L L ++T E L V E++ GG L++ + D+G R + + I
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ-DKG----------RFDLYRATFYAAEIV 106
Query: 423 RGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF-YTMINSANLAQALFA---Y 478
G+ +LH++ + + +LK N+ + + I++FG + N A Y
Sbjct: 107 CGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDY 162
Query: 479 KAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
APE +Q K T D + G+++ E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 54/234 (23%), Positives = 85/234 (36%), Gaps = 56/234 (23%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDA-------------FDT--EVRRLG 362
LG G G KA G V +K++K ++ D F T E++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 363 RLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE---LTWPARLKIVQ 419
++H N++ + + D LV + + D D LT I+
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKCILL 126
Query: 420 GIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGF-----YTMINSANLAQ 473
I G+ LH H DL +NIFI+ + I++FG Y +
Sbjct: 127 QILNGLNVLHKWYFMHRDL-----SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 474 ALFA-------------YKAPEAIQ-SGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE + + K D++ +G I E+LTGK FP
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235
|
Length = 335 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 38/209 (18%)
Query: 319 LGNGGLGSSYKA---MMADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
LG+G G K M + V +K +K E+ RD E + +L + ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ +LV E GG L L G + DE+T ++++ ++ G+ YL +
Sbjct: 63 V-CEAEALMLVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGK--- 114
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKA---------- 480
+ H +L + N+ + ++ IS+FG L++AL A YKA
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFG---------LSKALGADDSYYKARSAGKWPLKW 164
Query: 481 --PEAIQSGKVTPKCDVYCLGIIILEILT 507
PE I K + + DV+ GI + E +
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 26/98 (26%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY-TMINS-ANLAQ 473
K+ + +G+ YL + H + H ++K SNI ++ E + +FG +I+S AN
Sbjct: 107 KVSIAVIKGLTYLREK--H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163
Query: 474 ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+Y +PE +Q + + D++ +G+ ++E+ G++P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 42/194 (21%), Positives = 76/194 (39%), Gaps = 26/194 (13%)
Query: 339 VVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA------PLAYHYRTDEKLLVYEYIPGG 392
+ KR+K S A + E+ LGRL H N+L A Y +K Y++
Sbjct: 196 IAKRVKAGSRAA-IQLENEILALGRLNHENILKIEEILRSEANTYMITQK---YDF---D 248
Query: 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452
++ L R I++ + + Y+H + L H ++K NIF++ +
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK----LIHRDIKLENIFLNCD 303
Query: 453 NEPLISEFGFYTMINSANLAQ-----ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ ++ +FG A A +PE + D++ G+I+L++L+
Sbjct: 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
Query: 508 GKFPSQYLTNGNGG 521
F GG
Sbjct: 364 HDFCP---IGDGGG 374
|
Length = 501 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK--RMKESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
E LG G + YK +G V +K R++E A E L L+H+N++
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLH 69
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
+ + LV+EY+ Y+ G + + +L + Q + RG+ Y+H
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENV----KLFLFQ-LLRGLSYIHQRY- 123
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTM--INSANLAQALFA--YKAPEAIQSGKV 489
+ H +LK N+ IS E +++FG + S + + Y+ P+ +
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 490 TPKC-DVYCLGIIILEILTG--KFP 511
C D++ +G I +E++ G FP
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 45/204 (22%), Positives = 83/204 (40%), Gaps = 19/204 (9%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAPLA 374
+G G Y+A + DGV V +K+++ M AR E+ L +L H NV+ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSH---DELTWPARLKIVQGIARGIGYLHTE 431
+E +V E G L ++ + ++ W K + + ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLCSALEHMHSR 125
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSG 487
+ H ++K +N+FI+ + + G +S A Y +PE I
Sbjct: 126 ----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
K D++ LG ++ E+ + P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVL---- 370
EV+G G G YKA G V +K M + + E L + H N+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 371 -----APLAYHYRTDEKLLVYEYIPGGSLLYLLHG--DRGPSHDELTWPARLKIVQGIAR 423
P D+ LV E GGS+ L+ G +G E W A I++ R
Sbjct: 71 AFIKKNPPGND---DQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EWIAY--ILRETLR 124
Query: 424 GIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF----AYK 479
G+ YLH + + H ++K NI ++ E + +FG ++S + F +
Sbjct: 125 GLAYLH---ENKVI-HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 480 APEAI---QSGKVT--PKCDVYCLGIIILEILTGKFP 511
APE I + + + DV+ LGI +E+ GK P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 9/100 (9%)
Query: 415 LKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG---FYTMINSANL 471
L I + + R I YLH + H ++K+ NIFI+ + + +FG F IN+
Sbjct: 185 LAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 472 A--QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK 509
A APE + P D++ GI++ E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 24/111 (21%), Positives = 46/111 (41%), Gaps = 23/111 (20%)
Query: 417 IVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT---MINSANLAQ 473
I++ + + Y+H H ++K+S+I +S + + ++S G MI +
Sbjct: 106 ILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQR 159
Query: 474 ALFAYK----------APEAIQ---SGKVTPKCDVYCLGIIILEILTGKFP 511
+ + +PE +Q G K D+Y +GI E+ G P
Sbjct: 160 VVHDFPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 415 LKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF--YTMINSANLA 472
L I + I G+ YLH + + H ++K+ NIFI+ ++ I + G + ++ A L
Sbjct: 160 LIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215
Query: 473 QA-LFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPS 512
A APE + K K D++ GI++ E+L +PS
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPS 254
|
Length = 357 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 34/180 (18%)
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF---------YTMINSANL 471
+A+G+ +L A H +L + NI +S N I +FG Y A L
Sbjct: 188 VAKGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
+ APE I T + DV+ G+++ EI + G P G+ + E
Sbjct: 244 P---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCR 293
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
EG T + P+ + EM Q + C +P QR E V + + Q++
Sbjct: 294 RLKEG--TRMRAPDYTTP-----EMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMK---ESSAMARDAFDTEVRRLGRLRHSNVLAP 372
+G+G G A G V +K++ +S+ A+ + E+R L + H NV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGL 79
Query: 373 L-AYHYRTDEKL-------LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARG 424
L + L LV + G+ L + + S D + + +V I RG
Sbjct: 80 LDVFT--PASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQF-----LVYQILRG 130
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ--ALFAYKAPE 482
+ Y+H+ + H +LK SNI ++ + E I +FG + A Y+APE
Sbjct: 131 LKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTGYVATRWYRAPE 185
Query: 483 AIQS-GKVTPKCDVYCLGIIILEILTGK--FP 511
+ + D++ +G I+ E+LTGK FP
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 24/206 (11%)
Query: 318 VLGNGGLGSSYKAMMAD--GVT--VVVKRMKESSAMARDAFDT---EVRRLGRLRHSNVL 370
VLG G G K M+A+ G +K +K+ + D + E R L L
Sbjct: 2 VLGKGSFG---KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 371 APLAYHYRTDEKLL-VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L ++T E L V EY+ GG L++ H DE AR + I G+ +LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMF--HIQSSGRFDEAR--ARFYAAE-IICGLQFLH 113
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGF-YTMINSANLAQALFA---YKAPEAIQ 485
+ + + +LK N+ + + I++FG +N A Y APE ++
Sbjct: 114 KK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP 511
K D + G+++ E+L G+ P
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 24/141 (17%)
Query: 439 HGNLKSSNIFISPENEPLISEFGF---YTMINSANLAQALFA---YKAPEAIQSGKVTPK 492
H ++KS+NI + + +FGF Y S ++ + Y APE + + K
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225
Query: 493 CDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSP 552
D++ LG+++ E+LT K P G ++ E + + GR D L P I SP
Sbjct: 226 ADMFSLGVLLYELLTLKRPFD-------GENMEEVMHKTLA-GRY-DPLPPSI-----SP 271
Query: 553 GEMEQLLEIGRACTQSDPEQR 573
EM+ EI A SDP++R
Sbjct: 272 -EMQ---EIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESS-------AMARDAFDTEVRRLGRLRHSNV- 369
+G G G+ YKA G V +K ++ + + R+ ++RL H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV--ALLKRLEAFDHPNIV 65
Query: 370 -LAPLAYHYRTDEKL---LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
L + RTD + LV+E++ YL D+ P L +++ RG+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQDLRTYL---DKVPPPG-LPAETIKDLMRQFLRGL 121
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ----ALFAYKAP 481
+LH + H +LK NI ++ + +++FG I S +A Y+AP
Sbjct: 122 DFLHANC----IVHRDLKPENILVTSGGQVKLADFGL-ARIYSCQMALTPVVVTLWYRAP 176
Query: 482 EA-IQSGKVTPKCDVYCLGIIILEILTGK 509
E +QS TP D++ +G I E+ K
Sbjct: 177 EVLLQSTYATP-VDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 34/163 (20%)
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF---------YTMINSANL 471
+ARG+ +L A H +L + NI +S N I +FG Y SA L
Sbjct: 183 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
+ APE+I T + DV+ G+++ EI + G P G+ + E
Sbjct: 239 P---LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-------GVQINEEFCQ 288
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
+G T + PE A+ ++ I AC Q DP++R
Sbjct: 289 RLKDG--TRMRAPENATP--------EIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 27/217 (12%)
Query: 312 MKA----AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMAR---DAFDTEVRRLGRL 364
MKA +V+G G G V ++ M + AF E R +
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 365 RHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIAR 423
+S + L ++ D+ L +V EY+PGG L+ L+ P W A+ + +
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE----KW-AKFYTAE-VVL 153
Query: 424 GIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-----Y 478
+ +H+ + L H ++K N+ + +++FG ++ + + A Y
Sbjct: 154 ALDAIHS----MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209
Query: 479 KAPEAIQS----GKVTPKCDVYCLGIIILEILTGKFP 511
+PE ++S G +CD + +G+ + E+L G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 19/204 (9%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAPLA 374
+G G Y+A + D V +K+++ M AR E+ L +L H NV+ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSH---DELTWPARLKIVQGIARGIGYLHTE 431
+E +V E G L ++ + + W K + + ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW----KYFVQLCSAVEHMHSR 125
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-ANLAQALFA---YKAPEAIQSG 487
+ H ++K +N+FI+ + + G +S A +L Y +PE I
Sbjct: 126 ----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
K D++ LG ++ E+ + P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 317 EVLGNGGLGSSYKAMMA-DGVTV--VVKRMKE--SSAMARDAFDTEVRRLGRL-RHSNVL 370
+V+G G G KA + DG+ + +KRMKE S RD F E+ L +L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 59
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHD-----------ELTWPARLKIVQ 419
L L EY P G+LL L R D L+ L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 420 GIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY---TMINSANLAQALF 476
+ARG+ YL + H +L + NI + I++FG + + +
Sbjct: 120 DVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 175
Query: 477 AYKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
+ A E++ T DV+ G+++ EI++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 63/280 (22%), Positives = 104/280 (37%), Gaps = 50/280 (17%)
Query: 318 VLGNGGLGSSYKAMM----ADGVTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNV-- 369
+LG G GS +A + V VK +K + D F E + H NV
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDR---------GPSHDELTWPARLKIVQG 420
L ++ R +L IP L ++ HGD G L ++ +
Sbjct: 66 LIGVSLRSRAKGRLP----IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKA 480
IA G+ YL ++ + H +L + N ++ +++FG I S + + A K
Sbjct: 122 IASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 481 P------EAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFS 533
P E++ T DV+ G+ + EI+T G+ P G++ E
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-------AGVENSEIYNYLIK 230
Query: 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
R L P P +E + E+ C +P+ R
Sbjct: 231 GNR---LKQP--------PDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 46/219 (21%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK---ESSAMARDAFDTEVRRLGRLRHSNVLAP 372
E +G G G YKA G V +K+++ E + A E+ L L H N++
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-REISLLKELNHPNIVRL 63
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLK--IVQGIARGIGYLH 429
L + ++ KL LV+E++ L + D P L P +K + Q + +GI Y H
Sbjct: 64 LDVVH-SENKLYLVFEFL---DLDLKKYMDSSP-LTGLD-PPLIKSYLYQ-LLQGIAYCH 116
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-------------F 476
+ H L H +LK N+ I E +++FG LA+A
Sbjct: 117 S---HRVL-HRDLKPQNLLIDREGALKLADFG---------LARAFGVPVRTYTHEVVTL 163
Query: 477 AYKAPEAIQSGKV--TPKCDVYCLGIIILEILTGK--FP 511
Y+APE + + TP D++ +G I E++ + FP
Sbjct: 164 WYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 45/180 (25%), Positives = 72/180 (40%), Gaps = 34/180 (18%)
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF---------YTMINSANL 471
+ARG+ +L A H +L + NI +S N I +FG Y A L
Sbjct: 182 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
+ APE+I T + DV+ G+++ EI + G P G+ + E
Sbjct: 238 P---LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-------GVQIDEEFCR 287
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
EG T + PE A+ ++ I C ++PE R E V + ++ Q +
Sbjct: 288 RLKEG--TRMRAPEYAT--------PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 621 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.0 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.77 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.77 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.75 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.73 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.56 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.54 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.5 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.47 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.4 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.39 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.22 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.17 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.14 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.0 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.97 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 97.96 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.91 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.85 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-58 Score=540.61 Aligned_cols=468 Identities=26% Similarity=0.473 Sum_probs=338.6
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.+..|+|++|+++|.+|. .+..|++|+.|+|++|+++|.+|.+ ++.+++|++|+|++|+++|.+|..+.++++|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 550 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPR----KLGSLSELMQLKLSENKLSGEIPDE-LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550 (968)
T ss_pred cceEEECcCCccCCccCh----hhhhhhccCEEECcCCcceeeCChH-HcCccCCCEEECCCCcccccCChhHhCcccCC
Confidence 466777777777776663 4566788999999999999989887 88899999999999999999999999999999
Q ss_pred eeeccCccccccCCCC--CCCCccEEEcccCccccccCcc--ccccccCCCCCCCCCCCCCCC---CCccccccccccCC
Q 045652 126 ELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPAS--LLRFNASSFSGNAGLCGKNLG---VECRNAKASAANKN 198 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~~c~~~~~---~~c~~~~~~~~~~~ 198 (621)
.|+|++|+++|.+|.. ..++|+.|++++|+++|.+|.. +..+....+.||+++||.+.. ..|..
T Consensus 551 ~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~--------- 621 (968)
T PLN00113 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR--------- 621 (968)
T ss_pred EEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc---------
Confidence 9999999999999974 5788999999999999999964 446667788999999985432 11210
Q ss_pred CCCCCCCCCCCCCCCCcccchhhHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhhhhccceeeecccCCCCCcccccccC
Q 045652 199 IHPPPPPHPAAENVDDSKKVIAAGVALSVMLVSIAIVVIIRIRRKRKAFKVLEKESVQAVEVRVSVPNKSRDVDVSRKAS 278 (621)
Q Consensus 199 ~~p~~~~~~~~~~~~~~~~~i~~~v~~~v~ll~l~~~~~~~~rrrr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (621)
. .....+.+++++++++++++++++++++++|+|+.. +..+. +.. ...
T Consensus 622 ----------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~------~~~------~~~-------- 669 (968)
T PLN00113 622 ----------V-RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL-ELKRV------ENE------DGT-------- 669 (968)
T ss_pred ----------c-cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcc-ccccc------ccc------ccc--------
Confidence 0 011122222222222222222222222223222211 10000 000 000
Q ss_pred CCCCCCCCCCCCCCccceEEec-CCCccCChhHHHHH--HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHH
Q 045652 279 SSRRGSSHHGKNSGVGELVLVN-GQKGVFGLPDLMKA--AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAF 354 (621)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~ 354 (621)
.+..... .....+++.++... ..+.||+|+||.||+|.. .+++.||||+++..... .
T Consensus 670 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~ 730 (968)
T PLN00113 670 ---------------WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----P 730 (968)
T ss_pred ---------------ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----c
Confidence 0000000 00112333343332 245799999999999985 57899999998754322 2
Q ss_pred HHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCC
Q 045652 355 DTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434 (621)
Q Consensus 355 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 434 (621)
..|++++++++|||||+++++|.+.+..++||||+++|+|.++++ .++|.++.+++.|+++||+|||..+ .
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~-~ 801 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRC-S 801 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCC-C
Confidence 356889999999999999999999999999999999999999995 2789999999999999999999542 2
Q ss_pred CCCccCCCCCCCEEeCCCCCcEEEeeecceeccccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 435 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
.+|+||||||+||+++.++.+++. ||............++..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 802 ~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 389999999999999999988875 6665544444444677899999999999999999999999999999999999854
Q ss_pred ccCCCCCcchHHHHHHHhhcCccccccccchhcC-CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 515 LTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS-TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.. .....+.+|.............+|+.+... .....+..++.+++.+||+.||++||+|+|+++.|+++....
T Consensus 881 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 881 EF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 22 223456677766555555555666655332 223456678899999999999999999999999999886643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=424.36 Aligned_cols=283 Identities=35% Similarity=0.651 Sum_probs=244.3
Q ss_pred CCccCChhHHHHHHH-----HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEE
Q 045652 302 QKGVFGLPDLMKAAA-----EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376 (621)
Q Consensus 302 ~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 376 (621)
....|++.++..++. +.||+|+||.||+|...+|..||||++.........+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 345789999999873 699999999999999999999999988754432144599999999999999999999999
Q ss_pred EeCC-eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCc
Q 045652 377 YRTD-EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEP 455 (621)
Q Consensus 377 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~ 455 (621)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||..+.+ .||||||||+|||+|+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCE
Confidence 9998 499999999999999999865422 789999999999999999999997544 69999999999999999999
Q ss_pred EEEeeecceeccc-ccc---c-cccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHH
Q 045652 456 LISEFGFYTMINS-ANL---A-QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVAS 530 (621)
Q Consensus 456 kl~DfG~a~~~~~-~~~---~-~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 530 (621)
||+|||+|+.... ... . .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+... ......+.+|+..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKP 295 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHH
Confidence 9999999977654 322 1 78999999999999999999999999999999999998876432 2334458999999
Q ss_pred HhhcCccccccccchhcCCCCH-HHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 531 AFSEGRVTDLLDPEIASSTNSP-GEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.+.++.+.+++||.+....... .+...+..++.+|++.+|.+||+|.||++.|+.+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999999987433333 6788899999999999999999999999999776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=376.94 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=212.9
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccC-CChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe-e
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE-K 382 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~ 382 (621)
+++.|+. ..+.||+|..|+||++.+ .+++.+|+|.+.. .+...++++.+|++++++.+||+||.+||.|..... .
T Consensus 76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 4556664 468899999999999995 4689999999953 345567889999999999999999999999999984 9
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.++||||.+|+|+.++... +.+++...-+|+.+|++||.|||+ + +||||||||+|||++..|++||+|||
T Consensus 154 sI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEecccc
Confidence 9999999999999999743 458999999999999999999996 6 89999999999999999999999999
Q ss_pred cceecccc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 462 FYTMINSA--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 462 ~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.+..+... ....||..|||||.+.+..|+.++||||||++++|+++|++||... .....+..+.+.....+..
T Consensus 225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~pp--- 299 (364)
T KOG0581|consen 225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLCAIVDEPP--- 299 (364)
T ss_pred ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCCC---
Confidence 99877543 6678999999999999999999999999999999999999998753 1222334443333333211
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
|.++.. ...+++.+++..||++||.+||+++|+++|=
T Consensus 300 ---P~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 300 ---PRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred ---CCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 122111 2557899999999999999999999999883
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=388.22 Aligned_cols=253 Identities=32% Similarity=0.497 Sum_probs=209.8
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCC-eeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD-EKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 390 (621)
.+.+.||+|+||+||+|.+.....||||++..... ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 35567999999999999996555599999975432 22568999999999999999999999999887 7899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC-CccCCCCCCCEEeCCCC-CcEEEeeecceeccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD-LPHGNLKSSNIFISPEN-EPLISEFGFYTMINS 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~ 468 (621)
+|+|.++++.. ....+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999864 246799999999999999999999998 7 99999999999999997 999999999987653
Q ss_pred ---c-ccccccccccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 469 ---A-NLAQALFAYKAPEAIQ--SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 ---~-~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
. ....||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...+......+. .
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~-----R 264 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGL-----R 264 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCC-----C
Confidence 2 3367899999999999 56899999999999999999999999985432 222222222222 1
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
|.+ +..+.+.+..++.+||..||+.||++.+++..|+.+....
T Consensus 265 p~~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 265 PPI-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCC-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 111 1225567899999999999999999999999999887643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=367.91 Aligned_cols=191 Identities=27% Similarity=0.422 Sum_probs=173.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
..+.||+|+||+||+|++ .++..||||.+... .....+.+..|+++|+.++|||||+++++++..+..|||||||.|
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 345699999999999994 45899999999765 555677889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC------CCcEEEeeeccee
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE------NEPLISEFGFYTM 465 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfG~a~~ 465 (621)
|+|.+|++.. ..+++..+..++.||+.||++||++ +||||||||+||||+.. -.+||+|||+|+.
T Consensus 94 GDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 94 GDLSDYIRRR-----GRLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999854 3689999999999999999999999 99999999999999865 4589999999999
Q ss_pred cccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 466 INSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
+... ....|++-|||||++..++|+.|+|+||+|+|+|++++|+.||..
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 8765 456788999999999999999999999999999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=382.42 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=217.7
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEE
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (621)
.+.++.-.....+.||+|-||.||.|.+.....||+|.++... ...+.|.+|+++|++|+|+|||+++++|..++..+|
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 3455555667889999999999999999777799999998653 346788999999999999999999999999889999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|||||+.|+|.++|+... ...+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||+|+
T Consensus 279 VtE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999998632 45688899999999999999999999 99999999999999999999999999999
Q ss_pred ecccccc-----ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 465 MINSANL-----AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 465 ~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
.+..... ..-...|.|||.+..+.++.|||||||||+||||+| |+.||..+++ .++++.+ ..|.
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----~ev~~~l----e~Gy-- 421 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----EEVLELL----ERGY-- 421 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----HHHHHHH----hccC--
Confidence 6654432 122356999999999999999999999999999998 8999875432 2333333 3332
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
++ +.++.++..+.++|..||+.+|++|||++.+...|+++...
T Consensus 422 -----Rl---p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 -----RL---PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -----cC---CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 11 22345667899999999999999999999999999888653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=353.48 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=209.6
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccC--CChhhHHHHHHHHHHHhcCCCCCcccceEE-EEeCCe-eEEEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKE--SSAMARDAFDTEVRRLGRLRHSNVLAPLAY-HYRTDE-KLLVY 386 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~ 386 (621)
.|.+.++||+|+||+||++. ..+|..||.|.++- .+...++.+..|+.+|++|+|||||++++. +.++.. .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45688999999999999998 67899999999873 245567889999999999999999999984 444444 78999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
|||..|+|.++++..+. ..+.+++..+++++.|++.||..+|+..+..-|+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999975442 35679999999999999999999999654445899999999999999999999999999998
Q ss_pred ccc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 467 NSA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 467 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
... ....||+.||+||.+.+.+|+.|+||||+||++|||+.-+.||.+. .+. .+...+.++....+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~-~L~~KI~qgd~~~~-- 248 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLL-SLCKKIEQGDYPPL-- 248 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHH-HHHHHHHcCCCCCC--
Confidence 765 4567999999999999999999999999999999999999999742 122 22333444432211
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
...-...++..|+..|+..||+.||+...++..+.
T Consensus 249 -------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 249 -------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11445678999999999999999999665555554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=384.13 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=208.1
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|...++||+|+|+.||.++. .+|+.||+|++.+. ....++...+||+|.+.|+|||||+++++|++.+..|||+|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 34567899999999999996 78999999999753 344577889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|+.++|..++++ .+.+++.+++.++.||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 100 C~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 100 CHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred cCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999973 45799999999999999999999999 999999999999999999999999999998864
Q ss_pred c----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....||+.|+|||++....++..+||||+|||||-|++|++||+.. -++.....+.... ..-
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~---Y~~-- 237 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNE---YSM-- 237 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcC---ccc--
Confidence 3 4567999999999999999999999999999999999999999741 1222222222211 111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.....+..+||.++|+.||.+|||+.+|+.+
T Consensus 238 ------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 ------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22344678999999999999999999999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=370.14 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=201.7
Q ss_pred HHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChh-------hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM-------ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
-+.+.||+|+||.|-+|. .++|+.||||++++.... .....++|+++|++|+|||||+++++|...+..|||
T Consensus 175 ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV 254 (475)
T KOG0615|consen 175 IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV 254 (475)
T ss_pred EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence 356889999999999998 667999999999743211 123357999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC---CCcEEEeeec
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE---NEPLISEFGF 462 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~ 462 (621)
|||++||+|.+++-.++ .+.+..-.-+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+
T Consensus 255 lE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999997543 466666688999999999999999 99999999999999876 6799999999
Q ss_pred ceecccc---ccccccccccCcccccCCC--C-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSGK--V-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~~--~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
|+..... ....||+.|.|||++.+.. + ..++|+||+|||||-+++|.+||..... ...+.+.+ ..|+
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~sl~eQI----~~G~ 398 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DPSLKEQI----LKGR 398 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---CccHHHHH----hcCc
Confidence 9998654 5678999999999997654 3 3488999999999999999999975322 22233333 2333
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
... .+..+....++..++|.+||..||++|||+.|+++|-
T Consensus 399 y~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 399 YAF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred ccc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 211 1223456778899999999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=394.61 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=217.3
Q ss_pred HHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
..+.||+|.||+||+|+. .+...||||.+++.... .+++|++|++++..++|||||+++|+|.+++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 468899999999999983 33578999999976555 78999999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 388 YIPGGSLLYLLHGDRGPS---------HDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
||..|||.+||....... ..+++..+.+.||.|||.|++||-++ .+|||||-.+|+||.++..+||+
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhceeccceEEEec
Confidence 999999999997543211 33489999999999999999999998 89999999999999999999999
Q ss_pred eeecceecccccccc------ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHH
Q 045652 459 EFGFYTMINSANLAQ------ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 459 DfG~a~~~~~~~~~~------~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
|||+++.+-...... -..+|||||.+..++||++||||||||||||+++ |+.||....+ +.+...
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------~EVIe~ 717 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------QEVIEC 717 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------HHHHHH
Confidence 999999876554322 2357999999999999999999999999999998 9999987654 335555
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
++++++.. .+..++.++.+||..||+.+|.+||+++||-..|+.....
T Consensus 718 i~~g~lL~----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 IRAGQLLS----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHcCCccc----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 66666421 2356678899999999999999999999999999887543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=344.66 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=203.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|...-++|+|+||.||+++.+ +|+.||||++.++. +..++-..+|+++|++++|+|+|.++++|......+||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 455678999999999999954 59999999997543 445666789999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
+. ++.+-|.+. ...++...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||||||+|+.+..+
T Consensus 84 dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 84 DH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 77 544445433 34588889999999999999999999 9999999999999999999999999999998743
Q ss_pred ----ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh-----------
Q 045652 470 ----NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS----------- 533 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 533 (621)
.....|..|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+ ..+.+....+...+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG----~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG----RSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC----cchHHHHHHHHHHHcccCHHHHHHhc
Confidence 23457889999999987 7899999999999999999999977764 344444444433221
Q ss_pred cCc------cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 EGR------VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 ~~~------~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... +.+.-+++-.. ...+....-++++++.||+.||++|++.+|++.|
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe-~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLE-RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchh-hhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111 11111111111 1123445678999999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=358.51 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=207.5
Q ss_pred HHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHH-HHHHHHHHHhcCC-CCCcccceEEEEeCC-eeEEE
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARD-AFDTEVRRLGRLR-HSNVLAPLAYHYRTD-EKLLV 385 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 385 (621)
.-.|.+.++||.|+||.||+|+ ..+|..||||+++.......+ .-.+|+..|++|. |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4567889999999999999999 566999999999865433222 2358999999998 999999999999988 89999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
||||+ .+|.++++++ .+.+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.
T Consensus 89 fE~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred HHhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccc
Confidence 99996 4999999854 46799999999999999999999999 999999999999999999999999999999
Q ss_pred cccc---ccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 466 INSA---NLAQALFAYKAPEAIQ-SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
+... .....|..|+|||++. .+-|+.+.||||+|||++|+.+-++.|.+ ..+.|..-.+-..+.......+.
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG----~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG----ASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC----CcHHHHHHHHHHHhCCCccccch
Confidence 8665 3456788999999975 56799999999999999999998877764 33333333333333322111110
Q ss_pred c------------cchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 542 D------------PEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 542 d------------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
. |..... .-.+....++.+++.+|+.+||++|||+.|++++-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0 111000 00123567899999999999999999999999873
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.40 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=208.2
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChh--hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM--ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.|...+.||+|.||.||+|+ .++|+.||||+++..... ......+|++.|+.++|+||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 46678999999999999999 667999999999754322 234567999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|+. +|...++.. ...++..++..++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 83 m~t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ccc-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 975 999999754 35689999999999999999999999 999999999999999999999999999999865
Q ss_pred ccc----ccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc---
Q 045652 469 ANL----AQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL--- 540 (621)
Q Consensus 469 ~~~----~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 540 (621)
... ...|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|. ++.+.+....+.+.+......++
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHHcCCCCcccCccc
Confidence 432 3467789999998765 69999999999999999999875443 34555666666555543322111
Q ss_pred ---cc-------cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 ---LD-------PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ---~d-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
-| |........+.+..++++|+..|+..||.+|+++.|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 0000111224455678999999999999999999999976
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=347.28 Aligned_cols=241 Identities=22% Similarity=0.348 Sum_probs=198.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.++||+|+||.||.++. .+++.+|+|++++..- ...+....|..+|.+++||.||.++..|++.++.|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 568999999999999984 4589999999986432 234567899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc--
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-- 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 468 (621)
||.|..+|++ ...+++..+.-++.+|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..-.
T Consensus 109 GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 109 GGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred CccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999984 34688998999999999999999999 999999999999999999999999999985422
Q ss_pred --cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 469 --ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 469 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
.....||+.|||||++.+..|+..+|+||+|+++|||++|.+||... +..+++.... .++...
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~~~I~-~~k~~~------- 244 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMYDKIL-KGKLPL------- 244 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHHHHHh-cCcCCC-------
Confidence 24568999999999999999999999999999999999999999742 2223332222 222100
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCC----cHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRL----EMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~ 582 (621)
.+.-...+..+++.+.|..||++|. ++.++-+|
T Consensus 245 ---~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 245 ---PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ---CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 0111335689999999999999996 45555444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=352.57 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=203.6
Q ss_pred HHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC--eeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--EKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~ 390 (621)
...+.||+|+||.||++...+ |...|||.....+....+.+++|+.+|.+++|||||+++|...... .++++|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 456889999999999999654 8999999987554333677899999999999999999999855544 5889999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecceeccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFYTMINS- 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~- 468 (621)
+|+|.+++.+.++ .+++..+..+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999986542 599999999999999999999999 9999999999999999 79999999999887652
Q ss_pred ------cccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 ------ANLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.....||+.|||||++..+ ....++|||||||++.||+||+.||... .+...++.........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~---- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSL---- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCC----
Confidence 2346789999999999853 3345999999999999999999999742 2223333333222211
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
|.+ +...+.+..+++.+|+..||++||||.++++|.-....
T Consensus 242 -P~i-----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 -PEI-----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -CCC-----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 111 22345678999999999999999999999999754443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=350.50 Aligned_cols=265 Identities=20% Similarity=0.259 Sum_probs=207.2
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-- 379 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 379 (621)
........|...++||+|.||.||+|+ ..+|+.||+|+++... ........+||.||++|+||||+++.+...+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 344455566778899999999999999 6679999999987543 33445567999999999999999999998876
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
...|||+|||+. ||.-++... .-.|+..++..++.|++.||+|||++ +|+|||||.+|||||.+|.+||+|
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEecc
Confidence 679999999976 999888642 34699999999999999999999999 999999999999999999999999
Q ss_pred eecceeccccc-----cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 460 FGFYTMINSAN-----LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 460 fG~a~~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
||+|+++.... ....|..|+|||++.+. .|++++|+||.||||.||++|++.|.+ ..+.+..+.|.....
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G----~tEveQl~kIfklcG 337 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG----RTEVEQLHKIFKLCG 337 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC----ccHHHHHHHHHHHhC
Confidence 99999886543 34467789999999865 699999999999999999999988764 333444444443332
Q ss_pred cCc---cc--c-----ccccchhcCC----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 EGR---VT--D-----LLDPEIASST----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 ~~~---~~--~-----~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... +. + .+.+...... .....+...++|+..+|..||.+|.|+.++++.
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 211 11 0 1111100000 011223567899999999999999999999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=358.84 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=209.8
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.|...++||+|+.|.||.|. ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|...++.|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 34456789999999999998 66789999999987766677888999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
||+|.+.+.. ..+++.++..|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 354 ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 354 GGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999863 3489999999999999999999999 9999999999999999999999999999887654
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....||+.|||||++....|++|+||||||++++||+-|.+||.... -.+.+......+. .++
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAlyLIa~ng~-P~l------ 489 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALYLIATNGT-PKL------ 489 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHHHHHhhcCC-CCc------
Confidence 45678999999999999999999999999999999999999987411 1222222222222 222
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+.....+.+++.+||+.|+++|+++.|+|+|
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1224556789999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=354.38 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=200.8
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+|++|++|+ ..+++.||||++.+.. ....+.+.+|-.+|.+| .||.|++++..|.++...|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 57889999999999998 5669999999997532 12234566889999999 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.++|++. +.|++...+.++.||+.||+|||++ |||||||||+|||+|.|+++||+|||.|+.+...
T Consensus 157 ~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 157 PNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred CCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999854 4688888999999999999999999 9999999999999999999999999999876432
Q ss_pred -----------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHh
Q 045652 470 -----------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAF 532 (621)
Q Consensus 470 -----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 532 (621)
....||..|.+||++.+...++.+|+|+||||||.|+.|++||... .+.-+.+.+...
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----NeyliFqkI~~l- 302 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----NEYLIFQKIQAL- 302 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----cHHHHHHHHHHh-
Confidence 2356888899999999999999999999999999999999999742 222222222211
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+- ..++..++.+.+|+.+.|..||.+|+|++++.+|
T Consensus 303 ---------~y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ---------DY-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------cc-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 1122334678999999999999999999999887
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=353.09 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=207.2
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|.+.+.||+|+||.||+|+. .+.+.||+|.+.+.. ....+.+.+|++|++.++|||||.++++|+...+.++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 56789999999999999984 458899999987543 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
.| +|..++.. ...+++..+..++.|++.||.|||+. +|+|||+||+|||++..+.+|++|||+|+.+...
T Consensus 84 ~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 84 VG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 76 99999974 45699999999999999999999999 9999999999999999999999999999988665
Q ss_pred ----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....||+.|||||+..+++|+..+|+||+|||+||+++|++||.. ..+.+.+..+..+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v--------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPV--------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCC---------
Confidence 345789999999999999999999999999999999999999973 123333333332211
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+......+.+++...|.+||.+|.+..+++.|
T Consensus 218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1123556779999999999999999999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=346.86 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=210.2
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.++||+|.||.|.++....+..||||.++... ...+.+|.+|+++|.+|+|||||+++|+|..++..++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 4679999999999999998788999999999654 445689999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 472 (621)
+|.+++..+..+ .+.-...++|+.||+.|++||.+- ++|||||.+.|+|+|.++++||+|||+++.+-.....
T Consensus 621 DLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 621 DLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred cHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999876532 234455678999999999999998 9999999999999999999999999999866544332
Q ss_pred ------cccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 473 ------QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT--GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 473 ------~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.-..+|||||.+.-+++++++|||+||+++||+++ ...||..+++ .++++.....+..+.....
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~~~---- 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQVV---- 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCccee----
Confidence 22468999999999999999999999999999886 7789876543 2344444333333321111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
...+..++..+.+++.+||+.|-.+||+++++..+|.+.
T Consensus 766 ---l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ---LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111234556788999999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=352.79 Aligned_cols=239 Identities=24% Similarity=0.390 Sum_probs=200.6
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
-.+-||.|+.|.||+|++ .++.||||+++... +.+|+-|++|+||||+.|.|+|....-++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 357899999999999998 46899999886432 4688999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---cc
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---NL 471 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~ 471 (621)
...|+. ...++....+.|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-++..... -.
T Consensus 200 ~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 200 YEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred HHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh
Confidence 999984 34688888999999999999999999 9999999999999999999999999998876544 34
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
+.||..|||||++...+.+.|+||||||||||||+||..||........ ++ .+.. +... ...+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------Iw-GVGs-NsL~--------LpvP 333 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IW-GVGS-NSLH--------LPVP 333 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EE-eccC-Cccc--------ccCc
Confidence 6789999999999999999999999999999999999999985432110 00 0111 1111 1123
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
..+++.+.-|+++||+..|..||++++++.||+-..
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 455677888999999999999999999999997543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=356.24 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=207.5
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeE
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKL 383 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (621)
+.+..-...+.+.||+|+||+||+|+|.. .||||.++.. .....+.|++|+..+++-+|.||+-+.|||..... .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 33333333467899999999999999854 6999998754 34467889999999999999999999999988776 9
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
||+.+|+|-+|+.++|-. +..|.....+.|+.||++|+.|||.+ +|||||||..||++.+++++||+|||++
T Consensus 464 IiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred eeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccce
Confidence 999999999999999854 35688999999999999999999999 9999999999999999999999999998
Q ss_pred eecccc------ccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 464 TMINSA------NLAQALFAYKAPEAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 464 ~~~~~~------~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
..-... ....+...|||||+++. .+|++.+||||||+|+|||+||..||.. .. .+.+.-.+..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~-------~dqIifmVGr 607 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QN-------RDQIIFMVGR 607 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CC-------hhheEEEecc
Confidence 654322 22334567999999964 4699999999999999999999999972 21 1111111222
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
|.. .+++. .....+.+++.+|+..||.+++++||.+.+++..|+.+..+.
T Consensus 608 G~l----~pd~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 608 GYL----MPDLS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccc----Cccch--hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 211 11111 112345568899999999999999999999999999888754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.65 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=203.8
Q ss_pred ChhHHHHHHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEe
Q 045652 307 GLPDLMKAAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR 378 (621)
Q Consensus 307 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 378 (621)
.++.-.|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34444566778999999999999973 235689999997543 23456788999999999 89999999998876
Q ss_pred CC-eeEEEEeecCCCChhHHhhcCCCC-----------------------------------------------------
Q 045652 379 TD-EKLLVYEYIPGGSLLYLLHGDRGP----------------------------------------------------- 404 (621)
Q Consensus 379 ~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 404 (621)
.+ ..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578999999999999999743210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc------ccccc
Q 045652 405 ----SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA------NLAQA 474 (621)
Q Consensus 405 ----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------~~~~~ 474 (621)
....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....+
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 013478889999999999999999998 9999999999999999999999999999765322 12234
Q ss_pred cccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHH
Q 045652 475 LFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPG 553 (621)
Q Consensus 475 ~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 553 (621)
+..|+|||++.+..++.++|||||||++|||++ |..||..... .+.+...+..+.... . ...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~~~~~-----~-----~~~ 301 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------NEEFCQRLKDGTRMR-----A-----PEN 301 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHhcCCCCC-----C-----CCC
Confidence 567999999998899999999999999999997 9999864221 111112222221110 0 122
Q ss_pred HHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 554 EMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 554 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 34578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=352.83 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=206.1
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.++.||+|+.|.|-+|+ ..+|+.+|||++.+.. ......+++|+-+|+.+.|||++++|+++++..+.|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 35789999999999998 5779999999997542 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|.|.+++.. .+.+++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|......
T Consensus 96 gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 96 GGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred CchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999974 34688999999999999999999998 9999999999999999999999999999876554
Q ss_pred --ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 --NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...+|.+.|.|||++.+.+| +.++||||.|||||.|+||+.||++ + -.+.+...++.|.+.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----d----Nir~LLlKV~~G~f~-------- 230 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----D----NIRVLLLKVQRGVFE-------- 230 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----c----cHHHHHHHHHcCccc--------
Confidence 45678889999999999988 4789999999999999999999973 1 122333334444321
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.+.....++.+|+.+|+..||++|.|++||++|-.
T Consensus 231 ---MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 231 ---MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 12344567899999999999999999999999953
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.73 Aligned_cols=241 Identities=22% Similarity=0.358 Sum_probs=199.4
Q ss_pred HHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC----Ch-hhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES----SA-MARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.|+.|. ..++..||+|++... .. ...+.+.+|+.++++++ ||||+++++++......++||
T Consensus 20 ~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivm 99 (370)
T KOG0583|consen 20 ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVM 99 (370)
T ss_pred eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEE
Confidence 345789999999999997 556899999977643 11 23456778999999999 999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeeccee
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTM 465 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~ 465 (621)
||+.||+|.+++.. ...+.+.++.+++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||++..
T Consensus 100 Ey~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 100 EYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999985 24578899999999999999999999 99999999999999999 9999999999987
Q ss_pred cc----ccccccccccccCcccccCCC-CC-cchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 466 IN----SANLAQALFAYKAPEAIQSGK-VT-PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 466 ~~----~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.. ......|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||... +.... ...+..+...
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l-~~ki~~~~~~- 241 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NVPNL-YRKIRKGEFK- 241 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHH-HHHHhcCCcc-
Confidence 72 235678999999999999877 85 7899999999999999999999851 11111 1222222211
Q ss_pred ccccchhcCCCCHHH-HHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGE-MEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
-| ... ..++.+++.+||..||.+|+++.+++++
T Consensus 242 --~p--------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 242 --IP--------SYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred --CC--------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 01 111 4678999999999999999999999954
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=340.52 Aligned_cols=255 Identities=20% Similarity=0.325 Sum_probs=202.6
Q ss_pred ChhHHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChh---hHHHHHHHHHHHhcCCCCCcccceEEEEe----C
Q 045652 307 GLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAPLAYHYR----T 379 (621)
Q Consensus 307 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~ 379 (621)
+.+++.......||+|+++.||+|.. +|+.||||.++..... ..+.+.+|+.+|++++||||+++++++.+ .
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 33444333345799999999999998 7899999999754322 24678899999999999999999999877 3
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
...++||||+++|+|.+++... ..+++....+++.|++.||.|||+.. +++||||||+||+++.++.+||+|
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcc
Confidence 4678999999999999999743 35889999999999999999999731 678999999999999999999999
Q ss_pred eecceecccc-ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 460 FGFYTMINSA-NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 460 fG~a~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..++.. .....+.
T Consensus 167 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~----~~~~~~---~i~~~~~ 239 (283)
T PHA02988 167 HGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT----TKEIYD---LIINKNN 239 (283)
T ss_pred cchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC----HHHHHH---HHHhcCC
Confidence 9998865443 23456788999999976 679999999999999999999999997422 111111 1111111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
. +.. +...+..+.+++.+||+.||++|||++|+++.|+.++
T Consensus 240 -~----~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 -S----LKL-----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -C----CCC-----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0 011 1134467899999999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=334.08 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=204.9
Q ss_pred HHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 311 LMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
-.|...+.||.|..+.||+|+ ...+..||||++.-.. ....+.+++|+..|+.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 334556789999999999998 6678999999997433 23468899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|.+|++.++++..- ...+.+..+..|++++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+..
T Consensus 106 Ma~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999997543 34589999999999999999999999 999999999999999999999999998655432
Q ss_pred c--------ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 469 A--------NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 469 ~--------~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
. ....+++.|||||++.. ..|+.|+||||||++..||.+|..||..+.. .+.+...++... .
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~p-p 250 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDP-P 250 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCC-C
Confidence 2 44578899999999643 4699999999999999999999999985432 222222232221 1
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... -..............+.+++..||++||++|||+++++++
T Consensus 251 ~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred Ccc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 000 0000111122334579999999999999999999999976
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=343.02 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=197.0
Q ss_pred HHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhh---HHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMA---RDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||+|+ ..+|..+|+|+++++.... .+..+.|-.+|...++|.||+++..|.+.+..||||||+
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 367899999999999999 4559999999999775444 345678999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
+||++..+|.+ ...|++..+..++.+.+.|++.||+. |+|||||||+|+|||..|++||+|||++..+..
T Consensus 224 PGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 224 PGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred CCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999974 45789999999999999999999999 999999999999999999999999999753210
Q ss_pred ------------------------c--------------------------ccccccccccCcccccCCCCCcchhhHHH
Q 045652 469 ------------------------A--------------------------NLAQALFAYKAPEAIQSGKVTPKCDVYCL 498 (621)
Q Consensus 469 ------------------------~--------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 498 (621)
. ....||+.|||||++.+..|+..+|+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 01246778999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc---
Q 045652 499 GIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE--- 575 (621)
Q Consensus 499 Gvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps--- 575 (621)
|||+|||+.|.+||...+..+.-..++.|..... .| .......+..+||.+|+. ||++|..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------fP------~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------FP------EEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------CC------CcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 9999999999999985332221122222221110 01 012223678999999999 9999985
Q ss_pred HHHHHHH
Q 045652 576 MREAVRR 582 (621)
Q Consensus 576 ~~evl~~ 582 (621)
++||.+|
T Consensus 439 ~~EIK~H 445 (550)
T KOG0605|consen 439 AEEIKKH 445 (550)
T ss_pred HHHHhcC
Confidence 5666554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=340.24 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=202.2
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.|...+.||+|+||.||+|. ..+++.||+|++.-. .....+.+++|+.+|.+++++||.++|+.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 34445889999999999999 556899999999743 3445678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
.||++.+.++... .+.+..+.-++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+...
T Consensus 94 ~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999997433 336666777899999999999999 9999999999999999999999999999877543
Q ss_pred ----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....||+.|||||++....|+.|+||||||++.+||++|.+|+....... + .-. +.+-..|.+
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----v----lfl-----Ipk~~PP~L 231 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----V----LFL-----IPKSAPPRL 231 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----E----EEe-----ccCCCCCcc
Confidence 56789999999999998899999999999999999999999987543210 0 000 011111222
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ....+.+.+++..||++||+.||++.++++|
T Consensus 232 ~-----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 D-----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred c-----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1 2344669999999999999999999999987
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=370.37 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=211.1
Q ss_pred HHHHcCcCCcccEEEEEEcC--C----cEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMAD--G----VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
..+.||+|.||.||+|...+ | ..||||.+++. +.....+|.+|..+|++++|||||+++|+|.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35789999999999998544 3 35999999865 44567789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 388 YIPGGSLLYLLHGDRG--PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
||++|+|..+|++.+. .....++..+.+.++.|||+|+.||+++ ++|||||..+|+||+....+||+|||+|+.
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 9999999999986542 1245689999999999999999999999 999999999999999999999999999996
Q ss_pred cccccc------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 466 INSANL------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 466 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
+..... ..-...|||||.+.++.++.|+|||||||++||++| |..||....+ .++.. .....+++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----~~v~~---~~~~ggRL- 923 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----FEVLL---DVLEGGRL- 923 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----HHHHH---HHHhCCcc-
Confidence 543321 122357999999999999999999999999999998 8899875432 22222 12333332
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
. .+..++..+.++|.+||+.+|++||++..+++++..+......
T Consensus 924 -------~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 924 -------D---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred -------C---CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 1 1234556788999999999999999999999999988765443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=319.13 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=201.4
Q ss_pred HHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChh--hHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM--ARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 387 (621)
|...+.|++|+||.||+|+ .++++.||+|+++-.... ..-...+||.+|.+++|||||.+-++... -+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 3467899999999999999 456899999999743311 12235699999999999999999988764 356899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||+. +|..++.... +.+...++..++.|+++|++|||.. .|+||||||+|+|+...|.+||+|||+|+.+.
T Consensus 158 ~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9976 9999998543 5789999999999999999999999 99999999999999999999999999999987
Q ss_pred cc----ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
.+ .....|..|+|||.+.+. .|++..|+||+|||+.||+++++-|.+ ....+..+.+.+.+... .+.+.
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G----~sE~dQl~~If~llGtP--te~iw 302 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG----KSEIDQLDKIFKLLGTP--SEAIW 302 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC----CchHHHHHHHHHHhCCC--ccccC
Confidence 66 334567889999999875 599999999999999999999977753 44555555554443321 11111
Q ss_pred cchh-------------------cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIA-------------------SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
|.+. ..+......+.-.+|+..+|.+||.+|.|+.|.++|
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1100 011111133667899999999999999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=314.38 Aligned_cols=239 Identities=23% Similarity=0.329 Sum_probs=199.3
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE 381 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (621)
++++|. .+.+.||.|+||.|.+++ ..+|..+|+|++.+..- ...+...+|..+|+.+.||.++++++.+.+.+.
T Consensus 41 ~~l~df--e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDF--ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhh--hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 344443 356889999999999998 45689999999975432 234556789999999999999999999999999
Q ss_pred eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.||||||++||.|..++++. +.++++.++-++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEecc
Confidence 99999999999999999853 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 462 FYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 462 ~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
+|+.+... -...||+.|+|||++....|+.++|.|||||++|||+.|.+||.... ... +...+-++.+.
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~----~~~----iY~KI~~~~v~-- 259 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN----PIQ----IYEKILEGKVK-- 259 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC----hHH----HHHHHHhCccc--
Confidence 99988654 45679999999999999999999999999999999999999997422 122 22333333321
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL 574 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 574 (621)
. +.-...++.+|+...|+.|-.+|.
T Consensus 260 ----f-----P~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 260 ----F-----PSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred ----C-----CcccCHHHHHHHHHHHhhhhHhhh
Confidence 1 122235688999999999999993
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=338.61 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=199.3
Q ss_pred HHHHHHcCcCCcccEEEEEEcC-----------------CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD-----------------GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLA 374 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 374 (621)
|.+.+.||+|+||.||+|.+.+ +..||+|.++... ......+.+|++++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3456789999999999997532 3479999987543 334567999999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHhhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccC
Q 045652 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRG--------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHG 440 (621)
Q Consensus 375 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~ 440 (621)
++.+.+..++||||+++|+|.+++..... .....+++..+++++.||+.||.|||+. +|+||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ivH~ 162 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NFVHR 162 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----Ccccc
Confidence 99999999999999999999999864321 1123578889999999999999999998 99999
Q ss_pred CCCCCCEEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCC
Q 045652 441 NLKSSNIFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT--GKFPS 512 (621)
Q Consensus 441 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~P~ 512 (621)
||||+|||++.++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999999999999999999988654321 2233567999999988899999999999999999987 55676
Q ss_pred CcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 513 QYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.... ..+....+...+........ ....+..+..+.+++.+||+.||++|||+.|+.+.|+
T Consensus 243 ~~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 243 GELT----DEQVIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CcCC----HHHHHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5422 12223333222221110000 0011233467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.09 Aligned_cols=246 Identities=20% Similarity=0.333 Sum_probs=208.9
Q ss_pred HHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
...|.+.+.||+|.||.|-+|. ...|+.||||.+++. +..+.-.+.+||+||..|+||||+.++++|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4567788999999999999998 567999999999754 334455688999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||..+|.|++|+.+ .+.+++.+...++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..
T Consensus 132 MEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhh
Confidence 999999999999975 34699999999999999999999999 999999999999999999999999999988
Q ss_pred cccc---ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 466 INSA---NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
+... ..+.|++-|.+||++.+.+| ++.+|-|||||+||.|+.|..||++. +.-..+++ +..|...+
T Consensus 203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-------Dhk~lvrQ-Is~GaYrE-- 272 (668)
T KOG0611|consen 203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-------DHKRLVRQ-ISRGAYRE-- 272 (668)
T ss_pred hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-------hHHHHHHH-hhcccccC--
Confidence 7665 45678888999999999988 57899999999999999999999752 22222222 23333222
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
+..+....-||++||..+|++|.|+.+|..|..
T Consensus 273 ----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 ----------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 222345778999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.12 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=213.4
Q ss_pred HHHHcCcCCcccEEEEEEcC----CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.++||.|.||.||+|+++. ...||||.++... +..+.+|..|+.||.+++||||+++.|+........||.|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 45789999999999998543 4689999999653 456778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|+.||+.+. .++++-+...++++|+.|+.||-+. ++|||||..+|||++.+..+|++|||+++.+.+.
T Consensus 713 ENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 713 ENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999998654 4599999999999999999999998 9999999999999999999999999999988554
Q ss_pred c-ccc------ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 N-LAQ------ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 ~-~~~------~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
. ... ...+|.|||.+...+++.++||||||+||||.++ |..||..+.+ .++++.+ .++.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----QdVIkaI----e~gy----- 851 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVIKAI----EQGY----- 851 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----HHHHHHH----Hhcc-----
Confidence 3 111 1257999999999999999999999999999886 9999986543 2333333 3222
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
++ +.+.+++..|.+||..||++|-.+||.+.+++..|.++......
T Consensus 852 --RL---PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 852 --RL---PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred --CC---CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 11 22356778899999999999999999999999999998765433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=306.35 Aligned_cols=252 Identities=21% Similarity=0.331 Sum_probs=208.7
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD 380 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 380 (621)
.+++++. .+.+.||+|.||.||.|+ .+++-.||+|++.+.. .....++.+|++|-..|+||||+++|++|.+..
T Consensus 18 ~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 4555554 367899999999999999 5568899999987542 223567899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..||++||..+|++...|+..+ ...+++.....++.|+|.||.|+|.+ +|+||||||+|+|++..+..||+||
T Consensus 96 riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCC
Confidence 9999999999999999998544 34577888889999999999999998 9999999999999999999999999
Q ss_pred ecceeccc--cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 461 GFYTMINS--ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 461 G~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
|.+..... .....||..|.+||+..+..++..+|+|++|++.||++.|..||.... ..+..+.+ .. .
T Consensus 169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI----~k---~ 237 (281)
T KOG0580|consen 169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----HSETYKRI----RK---V 237 (281)
T ss_pred CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHH----HH---c
Confidence 99876543 255678999999999999999999999999999999999999997522 11222222 11 1
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
+..+| ......+.++|.+|+..+|.+|.+..|+++|-.
T Consensus 238 ~~~~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 238 DLKFP--------STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred cccCC--------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 12222 334467899999999999999999999998754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=325.81 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=199.4
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe-----eEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE-----KLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e~ 388 (621)
..+++|.|+||.||+|. ..+++.||||+.-.... .-.+|+++|++++|||||++..+|..... ..+||||
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 35789999999999999 45579999998864432 22479999999999999999998876432 2499999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeecceecc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTMIN 467 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~ 467 (621)
|+. +|.++++.... ....++.-.+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.|+.+.
T Consensus 104 mP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred chH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 986 99999874211 134567777888999999999999998 99999999999999976 899999999999885
Q ss_pred cc---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc-------
Q 045652 468 SA---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR------- 536 (621)
Q Consensus 468 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 536 (621)
.. ....-+..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+ +...+....+.+.+....
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG----~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG----DSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC----CCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 54 234456789999999875 699999999999999999999988764 333444444433332211
Q ss_pred ---cccccccchhcCC----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhcc
Q 045652 537 ---VTDLLDPEIASST----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQS 589 (621)
Q Consensus 537 ---~~~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~ 589 (621)
..+...|.+.... ......+++.+|+.++|+++|.+|.++.|++.| +.++++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1112222222211 233456789999999999999999999999987 5666665
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.37 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=206.7
Q ss_pred HHHcCcCCcccEEEEEEcC--C---cEEEEEEccC---CChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 316 AEVLGNGGLGSSYKAMMAD--G---VTVVVKRMKE---SSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
.++||+|+||.||+|.+.. + ..||||..+. .......+|.+|+++|++++|||||+++|++......++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 3899999999999998543 2 2389999885 345667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
+|.||+|.++|+... ..++..+++.++.+.|.||+|||++ +++||||-.+|+|++.++.+||+|||+++.-.
T Consensus 242 l~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred ecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999998543 2599999999999999999999999 99999999999999999999999999987653
Q ss_pred cc---c-cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 468 SA---N-LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 468 ~~---~-~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
.- . .......|+|||.+....|+.++|||||||++||+++ |..||..... .++..++ ...+....
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~v~~kI---~~~~~r~~--- 383 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YEVKAKI---VKNGYRMP--- 383 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HHHHHHH---HhcCccCC---
Confidence 21 1 2234568999999999999999999999999999998 8889875432 1222222 12221111
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
.+...+..+..++.+||..||++||+|.++.+.|+.+......
T Consensus 384 -------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 384 -------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1123446678888899999999999999999999999876554
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.96 Aligned_cols=245 Identities=22% Similarity=0.252 Sum_probs=197.1
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46799999999999984 579999999886432 12234578899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99998886432 23588999999999999999999998 9999999999999999999999999999876432
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.........
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~----------- 222 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE----RVKREEVDRRVKEDQE----------- 222 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc----chhHHHHHHHhhcccc-----------
Confidence 234578899999999999999999999999999999999999974321 1111112221111110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
.........+.+|+.+||+.||++||+ ++++++|
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011223457889999999999999997 7888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=325.87 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=197.2
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCCh--------------hhHHHHHHHHHHHhcCCCCCcccceEEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA--------------MARDAFDTEVRRLGRLRHSNVLAPLAYH 376 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 376 (621)
.|.+.+.||+|.||.|-+|+ ..+++.||||++.+... ...+...+||.+|++++|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 34567889999999999999 45699999999864321 1135788999999999999999999998
Q ss_pred EeC--CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC
Q 045652 377 YRT--DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE 454 (621)
Q Consensus 377 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~ 454 (621)
.+. +..|||+|||..|.+...- .....++..++++++.+++.||+|||.+ +||||||||+|+||+++|+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCCCc
Confidence 663 5689999999988875332 1223399999999999999999999999 9999999999999999999
Q ss_pred cEEEeeecceecccc---------ccccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCC
Q 045652 455 PLISEFGFYTMINSA---------NLAQALFAYKAPEAIQSGK----VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG 521 (621)
Q Consensus 455 ~kl~DfG~a~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 521 (621)
+||+|||.+...... ....||+.|+|||...++. .+.+.||||+||+||.|+.|+.||... ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----~~ 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----FE 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----hH
Confidence 999999998766221 2357899999999987632 357899999999999999999999741 11
Q ss_pred cchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.++.+ +++. ..+.. ...++..+.+.+||.++|.+||++|++..+|..|..--+.
T Consensus 325 ~~l~~---KIvn---------~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 LELFD---KIVN---------DPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHH---HHhc---------CcccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 12221 1111 11111 1123556789999999999999999999999998764443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.65 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=203.1
Q ss_pred ChhHHHHHHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEe
Q 045652 307 GLPDLMKAAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR 378 (621)
Q Consensus 307 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 378 (621)
.++.-.+.+.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34444566789999999999999963 235689999987432 33456788999999999 89999999999999
Q ss_pred CCeeEEEEeecCCCChhHHhhcCCCC------------------------------------------------------
Q 045652 379 TDEKLLVYEYIPGGSLLYLLHGDRGP------------------------------------------------------ 404 (621)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 404 (621)
.+..++||||+++|+|.++++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999999999999643210
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 405 ----------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 405 ----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
....+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 012478899999999999999999998 999999999999999999999999999987643
Q ss_pred cc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 AN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.. ...++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+ .+..+... .
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~----~~~~~~~~--~ 337 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYK----MIKEGYRM--L 337 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHH----HHHhCccC--C
Confidence 22 1223456999999999999999999999999999998 8888864321 111111 22221100 0
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.+ ...+.++.+|+.+||+.||++||++.|+++.|++.
T Consensus 338 ~~--------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SP--------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CC--------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01 11235689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=340.34 Aligned_cols=238 Identities=22% Similarity=0.287 Sum_probs=194.7
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999985 468999999987432 223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 999998742 3588999999999999999999999 9999999999999999999999999998754221
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..... ..+..+.. ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~----~~~~~~~~------~~--- 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLF----ELILMEEI------RF--- 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHH----HHHHcCCC------CC---
Confidence 23457889999999998899999999999999999999999986321 11111 11111110 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+.....++.+++.+||+.||++|| ++.++++|
T Consensus 215 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 --PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 122345688999999999999999 79999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.47 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=201.8
Q ss_pred HHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCC-cccceEEEEeCC------ee
Q 045652 313 KAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSN-VLAPLAYHYRTD------EK 382 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~~ 382 (621)
|...++||+|+||+||+|+ ..+|+.||+|+++-... .......+|+.+|++++|+| |+++++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 3456779999999999999 56799999999975433 23445679999999999999 999999998877 78
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
++||||+. -+|..++....... ..++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccch
Confidence 89999995 49999997544211 4567788999999999999999999 999999999999999999999999999
Q ss_pred ceecccc----ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 463 YTMINSA----NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 463 a~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
|+...-+ .....|..|+|||++.+. .|++..||||+|||++||++++.-|.+. .+.+....+.+.+.....
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~----se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD----SEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHHHcCCCCc
Confidence 9876532 334567789999999876 6999999999999999999998777643 223333333333322211
Q ss_pred ---ccc---cc--cchhcCCCC-------HHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHh
Q 045652 538 ---TDL---LD--PEIASSTNS-------PGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEI 586 (621)
Q Consensus 538 ---~~~---~d--~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i 586 (621)
... .+ +........ +.......+++.+||+.+|.+|.|++.++.| +..+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 000 00 000000000 1112478999999999999999999999987 5444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.20 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=204.8
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEE
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYH 376 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 376 (621)
.+.++.-.+.+.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++.+ +|+||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34455556678899999999999998731 23579999997543 33456788999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHhhcCCC-----------------------------------------------------
Q 045652 377 YRTDEKLLVYEYIPGGSLLYLLHGDRG----------------------------------------------------- 403 (621)
Q Consensus 377 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 403 (621)
...+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999864210
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 404 ------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 404 ------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
.....+++.++++++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 0113478889999999999999999998 99999999999999999999999999987654321
Q ss_pred -----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 471 -----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 471 -----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...... .. .......+. .+.
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~~----~~~~~~~~~-----~~~ 335 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---SK----FYKMVKRGY-----QMS 335 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---HH----HHHHHHccc-----Ccc
Confidence 1223457999999988899999999999999999997 99998643211 11 111111110 000
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
. ....+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 336 ~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 R-----PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0 0112357899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=309.89 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=203.2
Q ss_pred HHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccC--CChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKE--SSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
+-.|.+.+.||+|.|+.||++. ..+|+.+|+|++.. ......+.+++|++|-+.|+||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3456788999999999999997 56699999998753 23446788999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC---CCcEEEeeecc
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE---NEPLISEFGFY 463 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a 463 (621)
|+|.|++|..-|-. +..+++..+-.++.||+.+|.|+|.+ +|||||+||+|+++... --+||+|||+|
T Consensus 90 e~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred ecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceE
Confidence 99999999765542 23467778889999999999999999 99999999999999643 35899999999
Q ss_pred eecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 464 TMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 464 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
..+... ....||++|||||++...+|+..+|||+.|||||-|+.|..||... ....+.+.+. .+.. ++
T Consensus 161 i~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rlye~I~----~g~y-d~ 231 (355)
T KOG0033|consen 161 IEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYEQIK----AGAY-DY 231 (355)
T ss_pred EEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHh----cccc-CC
Confidence 988744 2356899999999999999999999999999999999999999742 2223333332 2221 11
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+ ...++...++..+|+.+||..||.+|+|+.|+++|
T Consensus 232 -~-----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 -P-----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -C-----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1 12234556789999999999999999999998865
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=322.51 Aligned_cols=253 Identities=23% Similarity=0.411 Sum_probs=208.9
Q ss_pred hHHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 309 PDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 309 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
....|.+.+.||+|+||.||+|...+++.+++|.+........+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34557788999999999999999888999999999876655677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.++++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||.+.....
T Consensus 84 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999997543 34589999999999999999999998 999999999999999999999999999876643
Q ss_pred cc----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 469 AN----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 469 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+..+.+. .+.. +
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~~~~~~~~~----~~~~-----~ 223 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----NHEVYDQIT----AGYR-----M 223 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHHHH----hCCc-----C
Confidence 31 1234557999999988889999999999999999998 899986422 112222221 1110 0
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
......+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01123346789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.89 Aligned_cols=260 Identities=19% Similarity=0.305 Sum_probs=200.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
|.+.+.||+|+||.||++... ++..||+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 345678999999999999954 5889999998754 33445679999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 87 GGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREK---HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhc---CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999743 3588899999999999999999975 15999999999999999999999999998765432
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---c--------
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---V-------- 537 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~-------- 537 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... .++...+......+. .
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhcccccccccCCccccCcccc
Confidence 334578899999999988999999999999999999999999863211 111111000000000 0
Q ss_pred -------------------ccccc---cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 538 -------------------TDLLD---PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 538 -------------------~~~~d---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.+..+ ..............++.+|+.+||+.||++|||+.|+++|-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00000 000000001123467899999999999999999999998853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.89 Aligned_cols=241 Identities=21% Similarity=0.274 Sum_probs=197.2
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 4578999999999999954 68999999986432 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 85 GGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 99999999743 3588899999999999999999999 9999999999999999999999999998876443
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .....+ .+..+.. .+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~~~~~~----~i~~~~~------~~---- 217 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----PFGIYE----KILAGKL------EF---- 217 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHH----HHHhCCc------CC----
Confidence 23457889999999998889999999999999999999999986421 111111 1111111 00
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRRI 583 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~L 583 (621)
.......+.+++.+||+.||.+||+ +.|+++|-
T Consensus 218 -~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 218 -PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1112356889999999999999995 88888773
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.51 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=202.1
Q ss_pred HHHcCcCCcccEEEEE-EcCCcEEEEEEccC--CChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-----CCeeEEEEe
Q 045652 316 AEVLGNGGLGSSYKAM-MADGVTVVVKRMKE--SSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-----TDEKLLVYE 387 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e 387 (621)
.+.||+|+||.|..+. ..+|+.||||++.. ......++-.+|+++|+.++|+||+.+++.+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 5789999999999998 45699999999873 344456777899999999999999999999865 356899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
+| +-+|.+.++. .+.++...+..+++|+++||.|+|+. +|+||||||.|++++.+..+||+|||+|+...
T Consensus 107 lM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccceeecc
Confidence 99 5599999974 33589999999999999999999999 99999999999999999999999999999885
Q ss_pred cc------ccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc----
Q 045652 468 SA------NLAQALFAYKAPEAIQ-SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---- 536 (621)
Q Consensus 468 ~~------~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 536 (621)
.. .....|..|+|||++. ...|+.+.||||.|||+.||++|+.-|.+. +..+....+...+....
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~----d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK----DYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC----chHHHHHHHHHhcCCCCHHHH
Confidence 31 3455688899999885 457999999999999999999999877642 22222222222111110
Q ss_pred -------cccccc-----cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhccCCC
Q 045652 537 -------VTDLLD-----PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQSDGN 592 (621)
Q Consensus 537 -------~~~~~d-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~~~~ 592 (621)
....+. |........+...+..++|+.+||..||.+|+|++|+++| |....+...+
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 000000 0000001123445678999999999999999999999998 5555444333
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.81 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=209.0
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEEEcCC-cEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEE-EEe---C
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAMMADG-VTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAY-HYR---T 379 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~---~ 379 (621)
|++......+.+.|.+|||+.||.|....+ ..||+|++-..++.+.+.+.+||++|++|+ |+|||.+++. ... .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 344444455678999999999999996665 999999998778888999999999999997 9999999993 222 1
Q ss_pred ---CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcE
Q 045652 380 ---DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456 (621)
Q Consensus 380 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k 456 (621)
-+.+|.||||+||.|-+++..+. ...|++.++++|+.|+++|+++||.. .+.|||||||-+||||+.+++.|
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEE
Confidence 24679999999999999997443 23499999999999999999999976 44699999999999999999999
Q ss_pred EEeeecceecccc-------------ccccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC
Q 045652 457 ISEFGFYTMINSA-------------NLAQALFAYKAPEAI---QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG 520 (621)
Q Consensus 457 l~DfG~a~~~~~~-------------~~~~~~~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 520 (621)
|||||.+...-.. -....|+.|+|||++ .+..+++|+|||||||+||-|+....||+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 9999988643211 123467889999987 467899999999999999999999999974210
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+++-.+.. +..+.....+.+||..||+.||++||++-+|+.++.++...
T Consensus 264 -----------------laIlng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 -----------------LAILNGNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----------------eeEEeccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111111111 11256778899999999999999999999999999988764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.71 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=201.8
Q ss_pred HHHHHcCcCCcccEEEEEEcC------CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD------GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|.... ...|++|.++... ......+.+|++++++++||||+++++++...+..+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 457889999999999998533 2579999987443 334567899999999999999999999999888999999
Q ss_pred eecCCCChhHHhhcCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCc
Q 045652 387 EYIPGGSLLYLLHGDRGPSH-----------DELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEP 455 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~ 455 (621)
||+++++|.+++........ ..+++..++.++.|++.||.|||+. +++||||||+||++++++.+
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCCCcE
Confidence 99999999999975432111 4588899999999999999999999 99999999999999999999
Q ss_pred EEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHH
Q 045652 456 LISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528 (621)
Q Consensus 456 kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 528 (621)
||+|||++....... ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... .++..
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----~~~~~-- 237 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----QEVIE-- 237 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH--
Confidence 999999987653321 2234567999999988899999999999999999998 9999864221 12222
Q ss_pred HHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 529 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
.+..+.... .....+.++.+|+.+||+.||++||++.|++++|+.
T Consensus 238 --~i~~~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIRSRQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222221111 112345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.80 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=207.1
Q ss_pred HHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC-----eeE
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD-----EKL 383 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 383 (621)
+-.|.+.+.||+|+|+-||+++ ..++..+|+|++.-....+.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3445667899999999999998 7789999999998777777888999999999999999999998875443 389
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
++++|...|+|.+.+..... ....+++.+++.|+.+|++||++||+.. +.++||||||.|||+.+++.++|.|||.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~--~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE--PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC--CcccccCCCcceeEecCCCceEEEeccCc
Confidence 99999999999999975542 3457899999999999999999999872 24899999999999999999999999998
Q ss_pred eecccc-------------ccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHH
Q 045652 464 TMINSA-------------NLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEW 527 (621)
Q Consensus 464 ~~~~~~-------------~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 527 (621)
....-. ....-|..|+|||.+. +...++++|||||||+||+|+.|..||+......+...
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla---- 252 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA---- 252 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE----
Confidence 764211 1223467899999985 45678999999999999999999999975332111100
Q ss_pred HHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 528 VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 528 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
.....+.+..+. .....+.+.++++.|++.||.+||++.+++.++..+.
T Consensus 253 ----------LAv~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 ----------LAVQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------EeeeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 011111121111 1235678999999999999999999999999988653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.55 Aligned_cols=248 Identities=22% Similarity=0.359 Sum_probs=199.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc----CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 345678999999999999743 36789999988543 3335678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 87 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 87 YMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred eCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999997432 3589999999999999999999998 99999999999999999999999999866542
Q ss_pred ccc-----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 468 SAN-----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 468 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
... ...++..|+|||.+.+..++.++|||||||++||+++ |+.||.... ..+..+ .+.++...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~----~~~~~~----~~~~~~~~--- 227 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS----GQDVIK----AVEDGFRL--- 227 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC----HHHHHH----HHHCCCCC---
Confidence 221 1223467999999998999999999999999999775 999986432 111222 22221110
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
..+...+..+.+++.+||+.+|++||++.++++.|.++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01123446789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.06 Aligned_cols=263 Identities=26% Similarity=0.399 Sum_probs=201.5
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCCcccceEEEEeCC----eeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGR--LRHSNVLAPLAYHYRTD----EKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~ 388 (621)
..++||+|+||.||+|.+ +++.||||++.. ..++.|+.|-+|.+. ++|+||++++++-.... +++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 467899999999999998 459999999874 346678888777765 48999999999876655 78999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL-----AHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
.+.|+|.++|.. ..++|....+|+.-+++||+|||+.. +++.|+|||||++|||+..|+++.|+|||+|
T Consensus 290 h~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 290 HPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred ccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999974 46999999999999999999999764 3457999999999999999999999999999
Q ss_pred eecccc------ccccccccccCcccccCCC-CC-----cchhhHHHHHHHHHHHhCCCCCCc--------ccCCC-CCc
Q 045652 464 TMINSA------NLAQALFAYKAPEAIQSGK-VT-----PKCDVYCLGIIILEILTGKFPSQY--------LTNGN-GGI 522 (621)
Q Consensus 464 ~~~~~~------~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwSlGvvl~elltg~~P~~~--------~~~~~-~~~ 522 (621)
..+... ....||.+|||||++.+.. +. .+.||||+|.|||||++.-.-+.. ....+ +..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 887543 2356899999999997542 22 368999999999999986433211 00000 001
Q ss_pred chHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 523 DVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
.-.+.++..+ +.+..+|.++........+..+.+.+..||..||+.|.|+.=|.+++.++.....
T Consensus 444 Pt~e~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1112222222 2223334444333334556789999999999999999999999999988876544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.22 Aligned_cols=241 Identities=20% Similarity=0.270 Sum_probs=197.3
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999954 58999999986432 223456889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 101 VGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred CCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999743 3578888999999999999999999 9999999999999999999999999999876543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... . .+ ....+..+... .+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~---~~-~~~~i~~~~~~------~p-- 235 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----P---FR-IYEKILAGRLK------FP-- 235 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----H---HH-HHHHHhcCCcC------CC--
Confidence 33457889999999998899999999999999999999999986321 1 11 11222222210 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
......+.+++.+||+.||++||+ +++++.|
T Consensus 236 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 ---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112346889999999999999997 6888876
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=324.97 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=203.3
Q ss_pred HHHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (621)
.|.+.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 3567789999999999999853 3478999998755433 46789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCc
Q 045652 385 VYEYIPGGSLLYLLHGDRG---------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEP 455 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~ 455 (621)
||||+++++|.+++..... .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCCeE
Confidence 9999999999999975431 1234588999999999999999999998 99999999999999999999
Q ss_pred EEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHH
Q 045652 456 LISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528 (621)
Q Consensus 456 kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 528 (621)
||+|||++...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..+.+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~----~~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS----NEEVIECI 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH
Confidence 99999998765322 12233567999999999999999999999999999998 999986422 11222222
Q ss_pred HHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 529 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
..+..... ....+..+.+++.+||+.||++||++.|+++.|+
T Consensus 238 ----~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ----TQGRLLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----HcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 22221110 1123457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.22 Aligned_cols=236 Identities=19% Similarity=0.233 Sum_probs=192.2
Q ss_pred cCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 319 LGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 319 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
||+|+||.||+|... +++.||+|.++.. .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999954 5889999998643 223345678899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 9999743 3588999999999999999999998 9999999999999999999999999998754221 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...++..|+|||++.+..++.++|||||||++|||++|+.||... ...+....... ... . .
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-------~~~~~~~~~~~-~~~------~-----~ 212 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-------NVNEMYRKILQ-EPL------R-----F 212 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-------CHHHHHHHHHc-CCC------C-----C
Confidence 345788999999999999999999999999999999999998642 11122222211 110 0 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCc---HHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLE---MREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 582 (621)
.......+.+++.+||+.||++||+ +.|++.|
T Consensus 213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1223456889999999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.99 Aligned_cols=238 Identities=21% Similarity=0.289 Sum_probs=193.6
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999985 468999999987432 223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 999888642 3588999999999999999999999 9999999999999999999999999998754221
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .....+ .... ... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~---~~~~-~~~------~~--- 214 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFE---LILM-EEI------RF--- 214 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC----HHHHHH---HHhc-CCC------CC---
Confidence 23457889999999998899999999999999999999999986421 111111 1111 110 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+....+.+.+++.+||+.||++|| ++.++++|
T Consensus 215 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 --PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 112345688999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=339.29 Aligned_cols=248 Identities=21% Similarity=0.216 Sum_probs=199.0
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++...+..++||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 3467999999999999965 58999999987432 2234567899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-c
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-A 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-~ 469 (621)
+|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..... .
T Consensus 85 g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~ 155 (333)
T cd05600 85 GGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA 155 (333)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence 99999999642 3588899999999999999999999 999999999999999999999999999876644 2
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+..... ....+... .
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~-----~~~~~~~~--~ 224 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST----PNETWENLKYWKE-----TLQRPVYD--D 224 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC----HHHHHHHHHhccc-----cccCCCCC--c
Confidence 34567889999999998899999999999999999999999986421 1111111111100 00001100 0
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......++.+++.+||..+|++||++.+++++
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 001334678999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.29 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=208.0
Q ss_pred HHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe-eEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE-KLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~ 388 (621)
|...+++|+|+||.++.++ ..+++.+++|.+.-. ....++...+|+.++++++|||||.+.+.+..++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 4567899999999999998 456889999988643 33345577899999999999999999999999888 8999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|+||++.+.+.+.+ ...+++..+.+|+.|++.|+.|||++ .|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus 86 ~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred cCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999998665 35689999999999999999999988 999999999999999999999999999999876
Q ss_pred c----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....||+.||.||.+.+.+|+.|+|||||||++|||++-+.+|... +....+.+.+... .
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-------~m~~Li~ki~~~~-----~--- 223 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-------NMSELILKINRGL-----Y--- 223 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-------chHHHHHHHhhcc-----C---
Confidence 5 3467899999999999999999999999999999999999998742 2223333332211 1
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+.....++..++..||+.+|+.||++.+++.+
T Consensus 224 ---~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 ---SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11134555789999999999999999999999987
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=322.95 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=202.2
Q ss_pred HHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 344568899999999999998888899999987543 3357789999999999999999999999988899999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
++|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 86 GSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999997542 34578899999999999999999998 99999999999999999999999999998764321
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
...++..|+|||++....++.++|||||||++|||+| |+.||.... .......+ ..+... +
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~----~~~~~~----~-- 224 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS----NSDVMSAL----QRGYRM----P-- 224 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC----HHHHHHHH----HcCCCC----C--
Confidence 1223457999999988889999999999999999998 999986421 11222221 111100 0
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
.....+..+.+++.+||..+|++||+++++.+.|++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 ----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.74 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=203.5
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCCcccceEEEEeCC----eeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGR--LRHSNVLAPLAYHYRTD----EKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~ 389 (621)
.+.||+|.||.||+|.+ .|+.||||++...+ ++.+.+|.+|++. |+|+||+.+++.-..+. ..|||.+|.
T Consensus 216 ~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 36899999999999998 58899999997543 4556677777765 49999999998865443 478999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL----AHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+.|||++||.+ ..++....++++..+|.||+|||... ..+.|.|||||+.|||+..++.+.|+|+|+|..
T Consensus 292 e~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 292 EHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 99999999974 46899999999999999999999643 456799999999999999999999999999977
Q ss_pred cccc--------ccccccccccCcccccCCC----C--CcchhhHHHHHHHHHHHhC----------CCCCCcccCCCCC
Q 045652 466 INSA--------NLAQALFAYKAPEAIQSGK----V--TPKCDVYCLGIIILEILTG----------KFPSQYLTNGNGG 521 (621)
Q Consensus 466 ~~~~--------~~~~~~~~y~aPE~~~~~~----~--~~~~DvwSlGvvl~elltg----------~~P~~~~~~~~~~ 521 (621)
.... +...||-+|||||++.... + -..+||||||.|+||+... +.||......+..
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 6433 4567899999999986432 1 1368999999999999862 3677665544333
Q ss_pred cchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.+. ++..+ ..+-+.|.++......+.+..+.++|+.||..+|..|.|+-.+.+.|.++.+
T Consensus 446 ~ee---MrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 FEE---MRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHH---Hhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222 11111 2233455555566667888999999999999999999999999999988875
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.05 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=191.6
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 4568999999999999985 468999999986442 33456789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.... ...+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 157 GSLEGTH---------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred Ccccccc---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9986432 245677889999999999999998 9999999999999999999999999999876432
Q ss_pred --ccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 --NLAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....++..|+|||++.. ...+.++|||||||++|||++|+.||..... .+....+..... ...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~-~~~----- 293 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDWASLMCAICM-SQP----- 293 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhc-cCC-----
Confidence 23467889999998743 2345689999999999999999999873211 111111111111 000
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+ ........++.+|+.+||+.||++||++.|+++|-
T Consensus 294 ~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 294 P-----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred C-----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 01123346789999999999999999999999873
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.96 Aligned_cols=237 Identities=20% Similarity=0.269 Sum_probs=193.9
Q ss_pred HcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 589999999999985 468999999987432 2334567889999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|..++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 82 LFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence 99888642 3588999999999999999999999 9999999999999999999999999998754221
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+... .+.... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~-~~~~~~------~~~---- 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFE-LILMED------IKF---- 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-------HHHHHH-HhccCC------ccC----
Confidence 23457889999999998899999999999999999999999986421 111111 111111 001
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+.....++.+++.+||+.||++|| ++.|+++|
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112335688999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.82 Aligned_cols=259 Identities=19% Similarity=0.296 Sum_probs=199.2
Q ss_pred HHHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 311 LMKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
-.|.+.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 34566789999999999999954 5889999988754 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 85 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999742 3478888999999999999999974 1699999999999999999999999999876533
Q ss_pred c--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc--------
Q 045652 469 A--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT-------- 538 (621)
Q Consensus 469 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 538 (621)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ..+. .+......+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA----KELE-LMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch----hHHH-HHhcCcccCCccccccCccc
Confidence 2 334577889999999988899999999999999999999999864221 0010 000000000000
Q ss_pred ---------------------cccccchh---cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 ---------------------DLLDPEIA---SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ---------------------~~~d~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.+.... ..........++.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000 000001123568999999999999999999999977
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=324.99 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=206.1
Q ss_pred HHHHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
.+.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 344567899999999999974 23567999999876666677899999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 386 YEYIPGGSLLYLLHGDRG--------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
|||+++++|.+++..... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEe
Confidence 999999999999974331 1233589999999999999999999998 9999999999999999999999
Q ss_pred Eeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHH
Q 045652 458 SEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530 (621)
Q Consensus 458 ~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 530 (621)
+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+ +..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~----~~~ 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NE----VIE 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HH----HHH
Confidence 999998765322 12223567999999998889999999999999999998 8888864221 11 112
Q ss_pred HhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.+..+..... ....+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 234 ~i~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQR----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2222221111 012235689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.71 Aligned_cols=264 Identities=21% Similarity=0.319 Sum_probs=207.3
Q ss_pred ccCChhHHHHHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCCcccceEE
Q 045652 304 GVFGLPDLMKAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLR-HSNVLAPLAY 375 (621)
Q Consensus 304 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 375 (621)
+.++++.-.+.+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 355556666678899999999999999842 13479999997533 334567899999999996 9999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHhhcCCCC---------------------------------------------------
Q 045652 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGP--------------------------------------------------- 404 (621)
Q Consensus 376 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 404 (621)
+.+.+..++|||||++|+|.++++.....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999999999998643210
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCC
Q 045652 405 ----------------------------------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKS 444 (621)
Q Consensus 405 ----------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp 444 (621)
....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp 265 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAA 265 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCh
Confidence 012478888999999999999999998 999999999
Q ss_pred CCEEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccC
Q 045652 445 SNIFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517 (621)
Q Consensus 445 ~NIll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 517 (621)
+|||++.++.+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99999999999999999988654321 1234567999999988899999999999999999997 8899864221
Q ss_pred CCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
. ..+......+.. + ......+..+.+++.+||+.||++||++.++.+.|+++..
T Consensus 346 ~-------~~~~~~~~~~~~-----~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 346 D-------STFYNKIKSGYR-----M-----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred h-------HHHHHHHhcCCC-----C-----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 111112222110 0 0112334678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.32 Aligned_cols=242 Identities=32% Similarity=0.546 Sum_probs=190.8
Q ss_pred HHcCcCCcccEEEEEEc-----CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMMA-----DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++||||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 56999999999999976 2678999999654 33457889999999999999999999999998888999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.++++... ...+++..+..|+.||++||.|||++ +++|+||+++||+++.++.+||+|||++......
T Consensus 85 ~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 85 GGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccc---cccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccc
Confidence 999999998652 35689999999999999999999998 9999999999999999999999999999877321
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
........|+|||.+.+..++.++||||||+++|||++ |+.||... ...+... .+.++....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-------~~~~~~~-~~~~~~~~~---- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-------DNEEIIE-KLKQGQRLP---- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-------CHHHHHH-HHHTTEETT----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccc-cccccccce----
Confidence 22334567999999988889999999999999999999 67887532 1122222 222222111
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.....+..+.+++.+||..||++||++.++++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0122345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.30 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=194.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 4567999999999999964 58899999987432 23356788999999999999999999999999999999999998
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
+.+..+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 85 NMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 777655432 23588999999999999999999998 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHH------------hhc
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASA------------FSE 534 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------~~~ 534 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE----IDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 123467889999999988899999999999999999999999874221 1111111110 000
Q ss_pred CccccccccchhcCC-----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRVTDLLDPEIASST-----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+...... ........+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 011234579999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.65 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=204.6
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC--------ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEE
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES--------SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (621)
..+.||+|..+.|-++. .++|..+|+|++... .....++-.+|+.||+++ .||+|+.+.++|+.+...++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 46789999999999987 566899999988522 112345567899999999 59999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|+|.|+.|.|.++|.. .-.+++++..+|+.|+..|+.|||.+ +||||||||+|||+|++.++||+|||++.
T Consensus 101 VFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccceee
Confidence 9999999999999973 45689999999999999999999999 99999999999999999999999999999
Q ss_pred eccccc---cccccccccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 465 MINSAN---LAQALFAYKAPEAIQS------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 465 ~~~~~~---~~~~~~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
.+.... ...||++|+|||.+.- ..|+..+|+||+|||||.|+.|..||.+.. .-.+.+.+.+|
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR~ImeG 243 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLRMIMEG 243 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHHHHHhc
Confidence 987763 4679999999999852 358889999999999999999999997521 11233444555
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
... +- .+.+.+......+|+.+||+.||.+|.|++|+++|-
T Consensus 244 kyq-F~------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 244 KYQ-FR------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred ccc-cC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 421 11 223456677899999999999999999999999883
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.07 Aligned_cols=256 Identities=18% Similarity=0.259 Sum_probs=194.2
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence 3457899999999999985 468999999986432 22345677999999999999999999999998899999999975
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 -~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 88 -DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred -CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 9999886432 3478889999999999999999998 9999999999999999999999999998765322
Q ss_pred --ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC-----------
Q 045652 470 --NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG----------- 535 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----------- 535 (621)
....++..|+|||++.+ ..++.++||||+||++|||+||+.||.... ..+....+.......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST----VKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCChHHhhccccc
Confidence 23346788999999865 568999999999999999999999986422 111122121111100
Q ss_pred -ccccccccchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 -RVTDLLDPEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 -~~~~~~d~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+..... ...+....++.+++.+||+.||.+|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000100000 0011223568899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=339.35 Aligned_cols=254 Identities=19% Similarity=0.203 Sum_probs=193.2
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
|.+.+.||+|+||.||+|.. .+++.||+|... .+.+.+|++++++++||||+++++++......++|||++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 45567899999999999984 568999999754 2346789999999999999999999999999999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 167 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 167 TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 6898888642 3588999999999999999999998 9999999999999999999999999998754221
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcc---hHHHHHHHhhcCc-------
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID---VVEWVASAFSEGR------- 536 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~---~~~~~~~~~~~~~------- 536 (621)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||..........+ ....+........
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 234578899999999988999999999999999999999988764322111111 1111111110000
Q ss_pred ---cccc---------cccchhc-CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 ---VTDL---------LDPEIAS-STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ---~~~~---------~d~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... ..+.... .......+.++.+|+.+||+.||++|||++|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0000000 00011335678999999999999999999999975
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=324.67 Aligned_cols=244 Identities=19% Similarity=0.242 Sum_probs=193.9
Q ss_pred cCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 319 LGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 319 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
||+|+||.||++.. .+++.||+|.+..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 4689999999864322 2235677899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
..++..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+... .
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 988753221 234689999999999999999999998 9999999999999999999999999998766443 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+......... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~-----------~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRILNDSV-----------TY 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhcccCC-----------CC
Confidence 235778899999999999999999999999999999999998642211 011111111111100 01
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
.......+.+++.+||+.||++|| +++++++|
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 123346788999999999999999 77788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=319.30 Aligned_cols=242 Identities=24% Similarity=0.412 Sum_probs=196.8
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.+.||+|+||.||++.+.++..+|+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 86 (256)
T cd05114 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86 (256)
T ss_pred EeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence 346799999999999998888899999887433 3356788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---- 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~---- 470 (621)
.++++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 87 LNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99987432 3588999999999999999999998 99999999999999999999999999987653321
Q ss_pred -cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 -LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 -~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+....+ ..+.. ...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~~~i----~~~~~--~~~~----- 223 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVVEMI----SRGFR--LYRP----- 223 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH----HCCCC--CCCC-----
Confidence 1223457999999988889999999999999999999 899986421 11222222 11110 0111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
......+.+++.+||+.+|++||++.|+++.|
T Consensus 224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=319.99 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=200.0
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++|+||+++++++...+..+++|||+++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 4467999999999999854 58899999987543 345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc--
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-- 471 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 471 (621)
|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 89 L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 89 LLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred HHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999996433 34589999999999999999999998 999999999999999999999999999877644321
Q ss_pred ---ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 472 ---AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 472 ---~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...+..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+ ....+..+. .+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~~-~~~~~~~~~-----~~---- 224 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQ-VYELLEKGY-----RM---- 224 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHH-HHHHHHCCC-----CC----
Confidence 122457999999998899999999999999999998 888876321 111 111121111 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
......+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01122346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.59 Aligned_cols=241 Identities=21% Similarity=0.326 Sum_probs=198.1
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeC
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRT 379 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (621)
.+++++. .+.++||+|+||+|+++.. .+++.+|||.+++.. ..+.+....|.+|+... +||.++.++..|...
T Consensus 364 ~~~l~~F--~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDF--RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccce--EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 3444443 3568999999999999994 458899999998753 34456677888888887 599999999999999
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
++.|+||||+.||++..+.+ ...+++..+.-++..|+.||+|||++ +||+||||.+|||+|.+|++||+|
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecc
Confidence 99999999999999655543 34699999999999999999999999 999999999999999999999999
Q ss_pred eecceecc----ccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 460 FGFYTMIN----SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 460 fG~a~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
||+++..- ...+..||+.|||||++.+..|+.++|+|||||+||||+.|..||.. +++.++.+.+ +.+.
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g----ddEee~FdsI---~~d~ 584 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG----DDEEEVFDSI---VNDE 584 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHH---hcCC
Confidence 99998643 33567899999999999999999999999999999999999999974 2333333332 1111
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEM 576 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 576 (621)
+ ..+.-...+..+|++++|.++|++|..+
T Consensus 585 -------~-----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -------V-----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------C-----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 1122344678999999999999999865
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=332.32 Aligned_cols=245 Identities=16% Similarity=0.277 Sum_probs=195.8
Q ss_pred HcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999985 458999999997532 22345678899999998 6999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---- 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 468 (621)
+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 82 DLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 999888632 4589999999999999999999999 999999999999999999999999999875321
Q ss_pred cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCC-CCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGN-GGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....++..|+|||++.+..++.++|||||||++|||++|+.||....... ......++....+...... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C--
Confidence 123457889999999999999999999999999999999999996432211 1112223333333322211 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCc------HHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLE------MREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~ 582 (621)
+......+.+++.+||+.||.+||+ +.++++|
T Consensus 225 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 ---PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1122356889999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.28 Aligned_cols=260 Identities=26% Similarity=0.344 Sum_probs=202.7
Q ss_pred hhHHHHHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeC
Q 045652 308 LPDLMKAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRT 379 (621)
Q Consensus 308 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (621)
++.-.|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34456778899999999999999632 24789999987432 23345678899999999 799999999988754
Q ss_pred -CeeEEEEeecCCCChhHHhhcCCCC------------------------------------------------------
Q 045652 380 -DEKLLVYEYIPGGSLLYLLHGDRGP------------------------------------------------------ 404 (621)
Q Consensus 380 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 404 (621)
...+++|||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4578999999999999998643210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc------ccccccc
Q 045652 405 --SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA------NLAQALF 476 (621)
Q Consensus 405 --~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------~~~~~~~ 476 (621)
....+++..+.+++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++..+... ....++.
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 013689999999999999999999998 9999999999999999999999999999875322 1223456
Q ss_pred cccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHH
Q 045652 477 AYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEM 555 (621)
Q Consensus 477 ~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 555 (621)
.|+|||++.+..++.++|||||||++|||++ |..||..... . +.....+..+.... ......
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~---~----~~~~~~~~~~~~~~----------~~~~~~ 302 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---D----EEFCRRLKEGTRMR----------APEYAT 302 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc---c----HHHHHHHhccCCCC----------CCccCC
Confidence 7999999999999999999999999999998 9999864211 1 11111222211100 011233
Q ss_pred HHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 556 EQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 556 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
..+.+++.+||+.+|++||++.|++++|+++..
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=334.82 Aligned_cols=242 Identities=19% Similarity=0.227 Sum_probs=196.8
Q ss_pred HHHHHHcCcCCcccEEEEEEcC--CcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD--GVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
|.+.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 3456789999999999998533 3689999886432 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 112 y~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 112 FVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999743 3588999999999999999999999 99999999999999999999999999998765
Q ss_pred cc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 468 SA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 468 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
.. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .. .+...+..+... .
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~----~~~~~i~~~~~~------~- 247 (340)
T PTZ00426 183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE----PL----LIYQKILEGIIY------F- 247 (340)
T ss_pred CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC----HH----HHHHHHhcCCCC------C-
Confidence 43 34567889999999998889999999999999999999999997421 11 111122222110 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+......+.+++.+||+.||++|+ +++++++|
T Consensus 248 ----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 ----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111234578999999999999995 89998877
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.22 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=210.7
Q ss_pred HHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
....+||-|.||.||.|.|+. .-.||||.+++.. ...++|.+|+.+|+.++|||+|+++|+|..+...|||+|||.+|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 346789999999999999765 6789999998655 44788999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 472 (621)
+|.+||++.. ...++.-..+.++.||+.|++||..+ ++|||||..+|+|+.++..+|++|||+++.+......
T Consensus 349 NLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 349 NLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 9999998654 34567677789999999999999999 9999999999999999999999999999998765332
Q ss_pred -----cccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 473 -----QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 473 -----~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
.-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+ + ..+...+..+.. +
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------l-SqVY~LLEkgyR-------M- 485 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------L-SQVYGLLEKGYR-------M- 485 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------H-HHHHHHHhcccc-------c-
Confidence 22356999999999999999999999999999998 888887432 2 234444443321 1
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
..+..+++.+.+||..||+.+|.+||++.|+-+.++.+..
T Consensus 486 --~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 486 --DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1235667889999999999999999999999999987654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.69 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=200.2
Q ss_pred HHHHHHHcCcCCcccEEEEEEc-CCc----EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA-DGV----TVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
.|...+.||+|+||.||+|.+. ++. .||+|.++... ....+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 3456688999999999999853 333 48999987543 34567788999999999999999999998764 56799
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 87 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999997532 3588899999999999999999998 999999999999999999999999999987
Q ss_pred cccccc------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 466 INSANL------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 466 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
...... ...+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+ +......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~----~~~----~~~~~~~~~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASE----ISSILEKGERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHH----HHHHHhCCCCC
Confidence 643221 123457999999998899999999999999999998 999986321 111 12222221110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.....+...+.+++.+||..+|++||++.+++.+|..+....
T Consensus 231 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001122356889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.43 Aligned_cols=257 Identities=19% Similarity=0.273 Sum_probs=192.8
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+.
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH- 86 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence 35678999999999999954 689999999874322 223457789999999999999999999999999999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 87 TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 6888887643 23578889999999999999999999 9999999999999999999999999998764322
Q ss_pred --ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---cc-----
Q 045652 470 --NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---VT----- 538 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~----- 538 (621)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....+ ..+..+.+........ ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhccchhhc
Confidence 23446788999999865 4588999999999999999999999974321 1111111111111000 00
Q ss_pred cccccchhc---C------CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIAS---S------TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~---~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...++.... . .........+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000 0 0000122467899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=331.29 Aligned_cols=246 Identities=17% Similarity=0.288 Sum_probs=195.3
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|.. .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3689999999999995 45889999998743 223345677899988877 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc---
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--- 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 468 (621)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 9999888642 3588999999999999999999999 999999999999999999999999999875322
Q ss_pred -cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC-CcchHHHHHHHhhcCccccccccchh
Q 045652 469 -ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG-GIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
.....++..|+|||++.+..++.++|||||||++|||++|+.||........ ......++...+...... +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~- 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------I- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC------C-
Confidence 1234578899999999999999999999999999999999999964322111 112223333333222210 1
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCc------HHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLE------MREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~ 582 (621)
+......+.+++.+||+.||++||+ +.++++|
T Consensus 225 ----p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 ----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ----CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1123356889999999999999998 4677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.43 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=203.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|.. .+++.||||.++.. .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 457899999999999984 46899999987532 23345678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++..... ....++...+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999988853221 234578889999999999999999998 99999999999999999999999999988765432
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.... .+...... .+..... +.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-----~~~~~~~~-~~~~~~~-----~~-- 227 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLFSLCQ-KIEQCDY-----PP-- 227 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc-----ccHHHHHH-HHhcCCC-----CC--
Confidence 2356678999999988889999999999999999999999986321 11122211 1111111 10
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
.........+.+++.+||..+|++||++.++++.|++++
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111234467899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=329.80 Aligned_cols=238 Identities=19% Similarity=0.313 Sum_probs=192.8
Q ss_pred HHcCcCCcccEEEEEE----cCCcEEEEEEccCCC----hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKESS----AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.||+|+||.||+++. .+++.||+|.++... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5699999999999984 357899999987432 12334577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999998643 3577888889999999999999998 999999999999999999999999999875422
Q ss_pred c----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ....+... ..+.. .
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~-~~~~~------~ 218 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKI-LKGKL------N 218 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHH-HcCCC------C
Confidence 2 23457889999999998889999999999999999999999986421 11111111 11111 0
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+ +......+.+++.+||+.||++|| ++.+++++
T Consensus 219 ~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 L-----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C-----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0 112235688999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.91 Aligned_cols=247 Identities=25% Similarity=0.444 Sum_probs=201.1
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYG 86 (261)
T ss_pred eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCC
Confidence 34557899999999999998778899999987543 33567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL- 471 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 471 (621)
+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 87 SLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999996432 24589999999999999999999998 999999999999999999999999999987653211
Q ss_pred -cc---ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 472 -AQ---ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 472 -~~---~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
.. .+..|+|||++.+..++.++||||||+++|||+| |+.||.... ...... .+..... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~----~~~~~~~--~------ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----NAEVLQ----QVDQGYR--M------ 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH----HHHcCCC--C------
Confidence 11 2246999999998899999999999999999999 998986421 111111 1111110 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
.........+.+++.+||+.+|++||++.++++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0012234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=321.05 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=204.6
Q ss_pred HHHcCcCCcccEEEEEE------cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.||+|+||.||+|.. .++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 46799999999999973 235679999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 390 PGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 390 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
++++|.+++..... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.++|+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEEC
Confidence 99999999975331 1224589999999999999999999999 99999999999999999999999
Q ss_pred eeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHH
Q 045652 459 EFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 459 DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
|||++...... ....++..|+|||++.+..++.++|||||||++|||+| |+.||..... .... ..
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~----~~ 237 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVI----EC 237 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HH
Confidence 99998765332 12234567999999998899999999999999999999 9999864221 1111 12
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
+..+..... ....+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 238 ~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 222221111 112345689999999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.54 Aligned_cols=238 Identities=21% Similarity=0.276 Sum_probs=193.2
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.||+|+||.||++.. .+++.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999984 568999999987432 223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
+|..++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 999988642 358899999999999999999997 6 8999999999999999999999999998754221
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||++.+..++.++|||||||++|||+||+.||.... ..... ..+..... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~----~~~~~----~~i~~~~~------~~-- 215 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLF----ELILMEEI------RF-- 215 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC----HHHHH----HHHhcCCC------CC--
Confidence 23457889999999998899999999999999999999999986421 11111 11111110 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+.....++.+++.+||+.||++|+ ++.++++|
T Consensus 216 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 ---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112235688999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.54 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=199.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc-C-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-D-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 344578999999999999843 3 67889998765555555678889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.++++.... ....+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 149 gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 149 GGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999998864221 234588999999999999999999998 9999999999999999999999999999876432
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+.... .+... +
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~~-~~~~~----~- 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQVL-YGKYD----P- 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH-hCCCC----C-
Confidence 22347889999999998899999999999999999999999986321 111111111 11111 0
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||..||++||++.+++.+
T Consensus 291 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 -----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 011233568999999999999999999999764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.53 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=209.8
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEEEc--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceE
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAMMA--------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLA 374 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 374 (621)
.|.+....|.+.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 45566666778899999999999999742 12478999887432 33456788999999999 7999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCC
Q 045652 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLK 443 (621)
Q Consensus 375 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlk 443 (621)
++...+..+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+. +|+|||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlk 161 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLA 161 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----Ceeccccc
Confidence 99999999999999999999999975321 1234588999999999999999999998 99999999
Q ss_pred CCCEEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccc
Q 045652 444 SSNIFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLT 516 (621)
Q Consensus 444 p~NIll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 516 (621)
|+||+++.++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999988654321 1222356999999998899999999999999999998 888875321
Q ss_pred CCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
..+.. ..+..+..... .......+.+++.+||+.+|++||++.|+++.|+++......
T Consensus 242 -------~~~~~-~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 242 -------VEELF-KLLKEGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred -------HHHHH-HHHHcCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 11211 11221111110 112335788999999999999999999999999999865444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=327.07 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=204.8
Q ss_pred HHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 311 LMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
-.+.-.+.||.|+||.||-|+ ..+.+.||||++.-+.. ..-+++.+|++.|++++|||+|.+.|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 344456789999999999999 55688999999974433 23457889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
|||- |+-.+++.-.+ +++.+-++..|..+.+.||+|||+. +.||||||..|||+++.|.+||+|||.|...
T Consensus 106 EYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhc
Confidence 9995 58888875433 4688889999999999999999999 9999999999999999999999999999999
Q ss_pred cccccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 467 NSANLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 467 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.+.+.+.||+.|||||++. .+.|+-|+||||+|++..||.-.++|++.+. .+..+..+-++.. |
T Consensus 177 ~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-------AMSALYHIAQNes------P 243 (948)
T KOG0577|consen 177 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNES------P 243 (948)
T ss_pred CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-------HHHHHHHHHhcCC------C
Confidence 9999999999999999984 5789999999999999999999999987532 2222222222111 1
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+. ..+....+.+++..||++-|.+|||.+++++|
T Consensus 244 tLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 24556779999999999999999999998876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.83 Aligned_cols=258 Identities=22% Similarity=0.371 Sum_probs=214.0
Q ss_pred ccCChhHHHHHHHHHcCcCCcccEEEEEEcC---C--cEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEE
Q 045652 304 GVFGLPDLMKAAAEVLGNGGLGSSYKAMMAD---G--VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHY 377 (621)
Q Consensus 304 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 377 (621)
..+++..-.....++||.|-||.||+|.+.+ | -.||||..+.. .....+.|..|.-+|++++|||||+++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3455554445567899999999999998533 2 46899999863 4556888999999999999999999999996
Q ss_pred eCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 378 RTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
+ ...|+|||.++.|.|..+|+.+. ..++......++.||+.||+|||+. .+|||||..+|||+....-+||
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceeee
Confidence 4 57899999999999999998643 4588888899999999999999999 9999999999999999999999
Q ss_pred Eeeecceecccccccccc-----ccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHH
Q 045652 458 SEFGFYTMINSANLAQAL-----FAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 458 ~DfG~a~~~~~~~~~~~~-----~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
+|||+++.+........+ ..|||||.+....++.++|||-|||.+||++. |..||....+.+- ...
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------I~~ 604 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------IGH 604 (974)
T ss_pred cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------EEE
Confidence 999999998776544433 46999999999999999999999999999986 9999987654321 111
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
+.+|. +.+.++.+++.+..|+.+||.+||.+||.+.|+...|.++..
T Consensus 605 iEnGe----------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGE----------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCC----------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 12221 123346677889999999999999999999999999987765
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=314.75 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=201.2
Q ss_pred hHHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 309 PDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 309 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
..-.+.+.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3345677899999999999999988888999999875432 3567899999999999999999999874 4568899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 82 MSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999997532 24589999999999999999999998 999999999999999999999999999977643
Q ss_pred ccc-----ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 469 ANL-----AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 ~~~-----~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
... ..++..|+|||++.+..++.++||||||+++|||++ |..||.... ..+..+.+ ..+..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~~~~----~~~~~----- 221 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVLEQV----ERGYR----- 221 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH----HcCCC-----
Confidence 221 123457999999988889999999999999999999 888886421 11222221 11110
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
+ ......+..+.+++.+||..+|++|||+.++.+.|++
T Consensus 222 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 M-----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C-----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0112334579999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.20 Aligned_cols=245 Identities=20% Similarity=0.264 Sum_probs=192.9
Q ss_pred cCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 319 LGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 319 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
||+|+||.||++.. .+|+.||+|.+.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 458999999986422 12234456799999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---cc
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---NL 471 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~ 471 (621)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 98886432 33588999999999999999999998 9999999999999999999999999998776443 22
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..++..|+|||++.+..++.++|||||||++|||++|+.||..... ............ ..... . ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~---~~~~~~~~~~~~-~~~~~----~------~~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE---KVAKEELKRRTL-EDEVK----F------EH 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc---hhhHHHHHHHhh-ccccc----c------cc
Confidence 4567889999999888899999999999999999999999864221 111111111111 11100 0 01
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.....++.+++.+||+.||++||+++|+++++.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 123456899999999999999999977765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=316.29 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=200.4
Q ss_pred HHHHHcCcCCcccEEEEEEcC----CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.+.+.||+|+||.||+|.+.. ...||||.++... ......|.+|+.++++++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 456789999999999998642 4689999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 87 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 87 MENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred CCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999997533 3689999999999999999999998 999999999999999999999999999987642
Q ss_pred cc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 AN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.. ....+..|+|||.+.+..++.++||||||+++|||++ |..||..... .... ..+..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~----~~~~~~~~~--- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVI----KAVEDGYRL--- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHH----HHHHcCCCC---
Confidence 11 1223457999999998899999999999999999998 9999864221 1111 122211100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
+ .....+..+.+++.+||+.+|++||++.|++++|+++
T Consensus 228 -~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -P------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=329.23 Aligned_cols=238 Identities=21% Similarity=0.299 Sum_probs=191.7
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999954 58899999987432 22345667888888877 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc---
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--- 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 468 (621)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 9999988643 3588999999999999999999998 999999999999999999999999999875422
Q ss_pred -cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 -ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...+. ..+..+... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----~~~~~----~~i~~~~~~---~----- 215 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN----EDDLF----EAILNDEVV---Y----- 215 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHH----HHHhcCCCC---C-----
Confidence 123457889999999998899999999999999999999999996421 11111 112211110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcH------HHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEM------REAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 582 (621)
+.....++.+++.+||+.||++||++ +++++|
T Consensus 216 ---~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 ---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ---CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11233568899999999999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.71 Aligned_cols=238 Identities=23% Similarity=0.317 Sum_probs=192.3
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999854 57899999987432 23345577899998876 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 9999988643 3588899999999999999999999 9999999999999999999999999998764222
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .....+ .. ..+.. ..|
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~----~~~~~~---~i-~~~~~---~~p---- 216 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN----EDDLFE---SI-LHDDV---LYP---- 216 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC----HHHHHH---HH-HcCCC---CCC----
Confidence 23457889999999998899999999999999999999999997421 111111 11 11110 001
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-------cHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRL-------EMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~~ 582 (621)
.....++.+++.+||+.||++|| ++.+++++
T Consensus 217 ----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 ----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11235688999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.31 Aligned_cols=258 Identities=19% Similarity=0.255 Sum_probs=191.2
Q ss_pred HHHHHHcCcCCcccEEEEEE-c-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCCcccceEEEEe-----CC
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-A-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRL---RHSNVLAPLAYHYR-----TD 380 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 380 (621)
|.+.+.||+|+||.||+|.. . +++.||+|.++... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 34567899999999999985 2 46889999886432 22234566777777766 69999999999863 34
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 5789999996 69999986432 34588999999999999999999999 9999999999999999999999999
Q ss_pred ecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC--
Q 045652 461 GFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG-- 535 (621)
Q Consensus 461 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 535 (621)
|+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~----~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGE 230 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCCCCh
Confidence 999876433 23456788999999988899999999999999999999999987422 122222222111100
Q ss_pred -ccc-------cccccchhc--CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 -RVT-------DLLDPEIAS--STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 -~~~-------~~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... ..+.+.... ....+.....+.+++.+||+.||++|||+.|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000000000 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.06 Aligned_cols=239 Identities=26% Similarity=0.401 Sum_probs=191.7
Q ss_pred HHcCcCCcccEEEEEEcC-------------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeE
Q 045652 317 EVLGNGGLGSSYKAMMAD-------------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKL 383 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (621)
+.||+|+||.||+|...+ ...|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998432 2368999887655555667889999999999999999999999988999
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC-------cE
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE-------PL 456 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-------~k 456 (621)
+||||+++++|..++.... ..+++..+++++.||+.||+|||+. +|+||||||+|||++.++. ++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999886432 3588999999999999999999998 9999999999999987664 89
Q ss_pred EEeeecceeccccccccccccccCccccc-CCCCCcchhhHHHHHHHHHHH-hCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 457 ISEFGFYTMINSANLAQALFAYKAPEAIQ-SGKVTPKCDVYCLGIIILEIL-TGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 457 l~DfG~a~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvvl~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
++|||++..........++..|+|||.+. +..++.++|||||||++|||+ +|..||.... ..+ ... +..
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~-~~~-~~~ 223 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-------LAE-KER-FYE 223 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-------hhH-HHH-HHh
Confidence 99999987776555566778899999886 466899999999999999998 5888765321 111 111 111
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+.. .. .......+.+|+.+||+.||++||++.++++++
T Consensus 224 ~~~-~~----------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQC-ML----------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCc-cC----------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 110 00 011235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=311.68 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=194.8
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999985 46899999987643 234456789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc---
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL--- 471 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--- 471 (621)
.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99996432 3588999999999999999999998 999999999999999999999999999876433211
Q ss_pred ---ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 472 ---AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 472 ---~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+......
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~~~~--------- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQGVRL--------- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCC---------
Confidence 112346999999998889999999999999999998 8888753221 1111111111100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
......+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 216 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 -PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 011223457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.51 Aligned_cols=246 Identities=23% Similarity=0.246 Sum_probs=197.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 346799999999999985 4689999999864321 223457789999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999998886432 24589999999999999999999998 99999999999999999999999999988764332
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...++..|+|||++.+..++.++||||+||++|||++|+.||.... .....+.+...+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~---------- 222 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK----EKVKREEVERRVKEDQE---------- 222 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc----hhhHHHHHHHHhhhccc----------
Confidence 2356788999999998889999999999999999999999997422 11111222222221110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
.........+.+++.+||+.||++|| ++++++++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 -EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01123345689999999999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.71 Aligned_cols=244 Identities=19% Similarity=0.251 Sum_probs=191.4
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 356799999999999984 458899999986432 2334568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc--
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-- 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 468 (621)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 85 GGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999743 3578888999999999999999998 999999999999999999999999998753210
Q ss_pred -------------------------------------------------cccccccccccCcccccCCCCCcchhhHHHH
Q 045652 469 -------------------------------------------------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLG 499 (621)
Q Consensus 469 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 499 (621)
.....||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0123578899999999988899999999999
Q ss_pred HHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhh--cccCCCCCCCcHH
Q 045652 500 IIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRA--CTQSDPEQRLEMR 577 (621)
Q Consensus 500 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~~ 577 (621)
|++|||+||+.||..... ... ........... ... .......++.+++.+ |+..+|..||++.
T Consensus 236 ~il~elltG~~Pf~~~~~----~~~---~~~i~~~~~~~-----~~~---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP----TET---QLKVINWENTL-----HIP---PQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hHHHHHHhCCCCCcCCCH----HHH---HHHHHcccccc-----CCC---CCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999999974221 111 11111100000 000 011233567788877 5566777799999
Q ss_pred HHHHH
Q 045652 578 EAVRR 582 (621)
Q Consensus 578 evl~~ 582 (621)
|+++|
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.50 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=201.0
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-C-----CCcccceEEEEeCCeeEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-H-----SNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 384 (621)
.|.+.++||+|+||.|.+|. ..+++.||||+++..... ..+-..|+.+|..|+ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 34566889999999999999 556999999999865433 455668999999996 4 489999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC--CcEEEeeec
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN--EPLISEFGF 462 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~ 462 (621)
|+|.+. -+|.++++.+. ...++...+..++.||+.||.+||+. +|||+||||+||||.+.+ .+||+|||.
T Consensus 266 VfELL~-~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eehhhh-hhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999995 59999998765 45699999999999999999999998 999999999999998554 699999999
Q ss_pred ceeccccc-cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC------
Q 045652 463 YTMINSAN-LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG------ 535 (621)
Q Consensus 463 a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------ 535 (621)
+....... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+ +...+....+.+.+...
T Consensus 338 Sc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG----~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 338 SCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG----DNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC----CCHHHHHHHHHHHhCCCCHHHHH
Confidence 98876543 33456679999999999999999999999999999999765543 33333333332211100
Q ss_pred ---cccccccc---------------------------------chh-c-----CCCCHHHHHHHHHHHhhcccCCCCCC
Q 045652 536 ---RVTDLLDP---------------------------------EIA-S-----STNSPGEMEQLLEIGRACTQSDPEQR 573 (621)
Q Consensus 536 ---~~~~~~d~---------------------------------~~~-~-----~~~~~~~~~~l~~li~~cl~~dP~~R 573 (621)
+....++. ..+ . ..........+.+++++||..||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 00000000 000 0 00011334678999999999999999
Q ss_pred CcHHHHHHHH
Q 045652 574 LEMREAVRRI 583 (621)
Q Consensus 574 ps~~evl~~L 583 (621)
+|..++++|-
T Consensus 494 ~tp~qal~Hp 503 (586)
T KOG0667|consen 494 ITPAQALNHP 503 (586)
T ss_pred CCHHHHhcCc
Confidence 9999999883
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=329.78 Aligned_cols=262 Identities=22% Similarity=0.339 Sum_probs=205.8
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCCcccceEEE
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLR-HSNVLAPLAYH 376 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 376 (621)
.+.++.-.+.+.+.||+|+||.||+|.+. .++.||+|+++... ....+.+.+|+++|.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35556556667899999999999999853 24689999997542 233457889999999997 99999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHhhcCCC-----------------------------------------------------
Q 045652 377 YRTDEKLLVYEYIPGGSLLYLLHGDRG----------------------------------------------------- 403 (621)
Q Consensus 377 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 403 (621)
...+..++||||+++|+|.+++++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred ----------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCC
Q 045652 404 ----------------------------------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLK 443 (621)
Q Consensus 404 ----------------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlk 443 (621)
.....+++..+++++.|++.||+|||+. +|+|||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlk 266 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLA 266 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCC
Confidence 0112467888899999999999999998 99999999
Q ss_pred CCCEEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCccc
Q 045652 444 SSNIFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLT 516 (621)
Q Consensus 444 p~NIll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 516 (621)
|+|||+++++.+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999987653221 1234567999999988889999999999999999998 888886421
Q ss_pred CCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
. .+.....+..+.. +. .+......+.+++.+||..+|++||+++|+++.|+++.
T Consensus 347 ~-------~~~~~~~~~~~~~-----~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 M-------NEQFYNAIKRGYR-----MA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred c-------hHHHHHHHHcCCC-----CC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 1111111211110 00 01123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=317.54 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=197.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
|.+.+.||+|+||.||+|... .+..||+|++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 445678999999999998742 25679999986432 23456788999999999999999999999988999999
Q ss_pred EeecCCCChhHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 386 YEYIPGGSLLYLLHGDRGP-----SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
|||+++++|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEEECCC
Confidence 9999999999999653311 123467888999999999999999998 9999999999999999999999999
Q ss_pred ecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 461 GFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 461 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
|+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+ ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~----~~~~~~----~~~ 235 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS----NEQVLR----FVM 235 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH----HHH
Confidence 9987653321 1233567999999998889999999999999999999 688876421 111111 111
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.+..... ....+..+.+++.+||+.||++|||+.|++++|+
T Consensus 236 ~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 2111110 1123356899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.92 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=198.9
Q ss_pred HHHHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLV 385 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 385 (621)
+.+.+.||+|+||.||++.. .++..||+|.++.......+.+.+|++++++++||||+++++++... ...++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 44567899999999999974 35789999999876666667899999999999999999999987543 457899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 86 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 86 MEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999996432 3588999999999999999999999 999999999999999999999999999887
Q ss_pred cccccc-------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCC--------CCCcchHHHHHH
Q 045652 466 INSANL-------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNG--------NGGIDVVEWVAS 530 (621)
Q Consensus 466 ~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~--------~~~~~~~~~~~~ 530 (621)
...... ...+..|+|||++.+..++.++|||||||++|||++|..|+...... .........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 643221 11234599999998888999999999999999999987765421110 000000111111
Q ss_pred HhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
...... ........+..+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKNNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhcCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 111110 00111233467999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.59 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=206.0
Q ss_pred ChhHHHHHHHHHcCcCCcccEEEEEEc--------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEE
Q 045652 307 GLPDLMKAAAEVLGNGGLGSSYKAMMA--------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYH 376 (621)
Q Consensus 307 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 376 (621)
.+..-.|.+.+.||+|+||.||++... +...+|+|.++.. .......+.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 343445567789999999999999742 2357999998754 233456788899999999 799999999999
Q ss_pred EeCCeeEEEEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCC
Q 045652 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSS 445 (621)
Q Consensus 377 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~ 445 (621)
...+..++||||+++|+|.+++...... ....+++.++++++.|++.||+|||+. +++||||||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~ 169 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAAR 169 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHH
Confidence 9999999999999999999999754321 123589999999999999999999998 9999999999
Q ss_pred CEEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCC
Q 045652 446 NIFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNG 518 (621)
Q Consensus 446 NIll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 518 (621)
||+++.++.+||+|||.++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-- 247 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 247 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC--
Confidence 9999999999999999987654321 1123357999999988889999999999999999998 888875311
Q ss_pred CCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 519 NGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
. +.+...+..+...+ .......++.+++.+||..+|++||++.++++.|+++....
T Consensus 248 -----~-~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 248 -----V-EELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -----H-HHHHHHHHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 11222222221111 11223457889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=313.66 Aligned_cols=244 Identities=22% Similarity=0.400 Sum_probs=198.1
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 35678899999999999998777889999986433 23456888999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL- 471 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 471 (621)
+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 85 CLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999997433 3589999999999999999999998 999999999999999999999999999876543211
Q ss_pred ----ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 472 ----AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 472 ----~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...+..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.... ...+. ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~----~~~~~-----~~~-- 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEVVES----VSAGY-----RLY-- 221 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH----HHcCC-----cCC--
Confidence 112346999999998899999999999999999999 8888864221 111111 11110 000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.....+..+.+++.+||..+|++|||+.|+++.|
T Consensus 222 ---~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 ---RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0122345799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=312.58 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=199.0
Q ss_pred HHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.|.+.+.||+|+||.||+|...+...||+|.++.... ..+.+.+|++++++++||||+++++++. ....++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 3556678999999999999977777899999875332 3467899999999999999999999874 4567999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+..+....
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 85 GSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999997432 23578999999999999999999998 99999999999999999999999999997664332
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
...++..|+|||+..+..++.++||||||+++|||+| |..||..... .. +......+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~~----~~~~~~~~~~-------- 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----RE----VLDQVERGYR-------- 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----HH----HHHHHhcCCC--------
Confidence 1224457999999988889999999999999999999 7888764211 11 1111111110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.......+..+.+++.+||+.||++||++.++++.|++.
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001123456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.40 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=198.2
Q ss_pred HHHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 385 (621)
.+.+.||+|+||.||++.. .++..||+|.++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4567899999999988652 357899999987543 23456788999999999999999999988764 357899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeecccccc
Confidence 999999999999963 2489999999999999999999998 999999999999999999999999999887
Q ss_pred ccccc-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 466 INSAN-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 466 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
..... ...++..|+|||.+.+..++.++||||||+++|||+||..|+...... ..+...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhh
Confidence 64321 122345699999998888999999999999999999999997642210 000000000000000011
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
+..+.... .......+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111100 0111233467999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.49 Aligned_cols=249 Identities=19% Similarity=0.303 Sum_probs=198.1
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 345678999999999999995 5688999999875544445678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 90 GGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999998632 3578999999999999999999998 9999999999999999999999999998866432
Q ss_pred ---ccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 ---NLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....++..|+|||.+. ...++.++|||||||++|||++|+.||........ ... ..... ...+
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~-----~~~~~---~~~~ 229 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFL-----MSKSN---FQPP 229 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---hee-----eecCC---CCCC
Confidence 2234677899999874 34578899999999999999999999863221100 000 00000 0001
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
... ........+.+++.+||..+|++||++++++++|
T Consensus 230 ~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 0112346789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.84 Aligned_cols=251 Identities=21% Similarity=0.340 Sum_probs=199.6
Q ss_pred HHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 567899999999999999853 25789999997543 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC
Q 045652 386 YEYIPGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE 454 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~ 454 (621)
+||+++++|.+++..... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCCc
Confidence 999999999999853210 1123578889999999999999999998 9999999999999999999
Q ss_pred cEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHH
Q 045652 455 PLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEW 527 (621)
Q Consensus 455 ~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 527 (621)
+||+|||+++...... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~-- 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDVI-- 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHH--
Confidence 9999999987653321 2234567999999988889999999999999999998 777875321 11121
Q ss_pred HHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 528 VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 528 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
..+..+.... .....+..+.+++.+||+.+|++||++++++..|+.
T Consensus 237 --~~i~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 --EMIRNRQVLP----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHcCCcCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222221110 112344568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.15 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=193.4
Q ss_pred HHHHcCcCCcccEEEEEE----cCCcEEEEEEccCCC----hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM----ADGVTVVVKRMKESS----AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||+++. .+++.||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 346799999999999974 357899999986421 22345678899999999 599999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 84 LDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999998642 3588999999999999999999998 999999999999999999999999999876
Q ss_pred cccc-----ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 466 INSA-----NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 466 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.... ....+|..|+|||++.+. .++.++|||||||++|||+||+.||...... .....+...+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~---- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRILKC---- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHhcC----
Confidence 5322 234578899999999765 4789999999999999999999999642211 1111222211111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
++.. .......+.+++.+||+.||++|| +++++++|
T Consensus 227 --~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --DPPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 112335688999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.22 Aligned_cols=239 Identities=23% Similarity=0.323 Sum_probs=189.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHH---hcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRL---GRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..|+|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 346799999999999985 468999999987432 22234566676655 56689999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|..+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 83 YAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred CCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999988853 3589999999999999999999998 99999999999999999999999999987542
Q ss_pred cc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... .. +... .+..+...
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~----~~---~~~~-~i~~~~~~----- 219 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD----EE---EVFD-SIVNDEVR----- 219 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----HH---HHHH-HHHhCCCC-----
Confidence 21 23457889999999998899999999999999999999999986421 11 1111 11111110
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
. +......+.+++.+||+.||++|| ++.+++++
T Consensus 220 -~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 -Y-----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -C-----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0 112335688999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.56 Aligned_cols=263 Identities=23% Similarity=0.382 Sum_probs=207.5
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEEE--------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEE
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAMM--------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAY 375 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 375 (621)
+.+....+.+.+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 444555566778999999999999973 124579999987432 33456788999999999 89999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCC
Q 045652 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKS 444 (621)
Q Consensus 376 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp 444 (621)
+......++||||+++|+|.+++...... ....+++..+..++.||+.||+|||++ +|+||||||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp 165 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAA 165 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeeccccc
Confidence 99999999999999999999999754321 124578899999999999999999998 999999999
Q ss_pred CCEEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccC
Q 045652 445 SNIFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517 (621)
Q Consensus 445 ~NIll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 517 (621)
+||+++.++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~- 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP- 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-
Confidence 99999999999999999998764321 1223457999999988889999999999999999998 777875321
Q ss_pred CCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
..+ +...+..+.... .....+..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 245 ------~~~-~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 ------VEE-LFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ------HHH-HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 112 112222221100 01233467889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.26 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=204.7
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|.+.+.||+|+||.||++.. .+++.++||.+... .......+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 45678899999999999994 57899999987643 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++..... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 84 ADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999998864221 234689999999999999999999998 999999999999999999999999999876643
Q ss_pred cc----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 AN----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.. ...++..|+|||.+.+..++.++||||||+++|||++|..||.... .+...... .+.... .+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~-~~~~~~-----~~~ 227 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCK-KIEQCD-----YPP 227 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc-----chHHHHhh-hhhcCC-----CCC
Confidence 22 2356778999999988889999999999999999999999986321 11111111 111111 011
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
. ........+.+++.+||+.||++|||+.+|++.++++.
T Consensus 228 ~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 L----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 11234567999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.15 Aligned_cols=237 Identities=19% Similarity=0.302 Sum_probs=188.0
Q ss_pred HcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.||+|+||.||+|.. .+++.||+|.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999999999985 458899999987432 22334556677777654 8999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 82 DLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 999998643 3588899999999999999999998 9999999999999999999999999998764321
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...+. ..+.... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~----~~~~~----~~i~~~~------~~~--- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED----EDELF----DSILNDR------PHF--- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC----HHHHH----HHHHcCC------CCC---
Confidence 23457889999999998899999999999999999999999987421 11111 1111111 101
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHH-HHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMR-EAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 582 (621)
+.....++.+++.+||+.||++||++. +++++
T Consensus 216 --~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 216 --PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 112335678999999999999999875 55443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=333.07 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=190.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC-----eeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD-----EKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 386 (621)
+.+.||+|+||.||+|.. .+++.||||+++.. .......+.+|++++++++||||+++++++.... ..++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 446799999999999984 46899999998642 2223456889999999999999999999886432 479999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 84 ELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9995 6899988632 3589999999999999999999999 9999999999999999999999999998764
Q ss_pred ccc-------ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh----
Q 045652 467 NSA-------NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS---- 533 (621)
Q Consensus 467 ~~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 533 (621)
... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.... .......+.....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~----~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----VVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCCH
Confidence 321 12357788999999865 678999999999999999999999986421 1111111111100
Q ss_pred -------cCcccccc---ccchhc--CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 -------EGRVTDLL---DPEIAS--STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 -------~~~~~~~~---d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.....+.+ .+.... ....+.....+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 000000 00011233567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=316.25 Aligned_cols=238 Identities=21% Similarity=0.315 Sum_probs=188.8
Q ss_pred HcCcCCcccEEEEEEcC-------------------------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccc
Q 045652 318 VLGNGGLGSSYKAMMAD-------------------------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 372 (621)
.||+|+||.||+|.... ...|++|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 24589999876544445678889999999999999999
Q ss_pred eEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC
Q 045652 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452 (621)
Q Consensus 373 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~ 452 (621)
++++.+....++||||+++|+|..++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEecc
Confidence 999999999999999999999999986432 3578999999999999999999998 99999999999999865
Q ss_pred C-------CcEEEeeecceeccccccccccccccCcccccC-CCCCcchhhHHHHHHHHHHH-hCCCCCCcccCCCCCcc
Q 045652 453 N-------EPLISEFGFYTMINSANLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEIL-TGKFPSQYLTNGNGGID 523 (621)
Q Consensus 453 ~-------~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~ell-tg~~P~~~~~~~~~~~~ 523 (621)
+ .+|++|||++..........++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||..... ..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP----SE 229 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh----HH
Confidence 4 379999998866544444556778999998865 56899999999999999995 68988864221 11
Q ss_pred hHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
... .+.... ... ......+.+++.+||+.+|++||++.+++++|
T Consensus 230 ~~~----~~~~~~-------~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KER----FYEKKH-------RLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH----HHHhcc-------CCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 111100 000 11124688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=317.27 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=197.7
Q ss_pred HHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|.. .++..|++|.++... ......+.+|++++++++||||+++++++......++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence 457899999999999973 346789999997433 33446788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcE
Q 045652 389 IPGGSLLYLLHGDRG------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k 456 (621)
+++++|.+++..... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCCCcEE
Confidence 999999999853321 1123578899999999999999999998 999999999999999999999
Q ss_pred EEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHH
Q 045652 457 ISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVA 529 (621)
Q Consensus 457 l~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 529 (621)
|+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++ |..||.... ...+.+
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~~~~~~--- 237 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----NQEVIE--- 237 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHH---
Confidence 9999999765332 12233457999999988889999999999999999998 888886321 111222
Q ss_pred HHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 530 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
......... ........+.+++.+||+.||++||++.+++++|..
T Consensus 238 -~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -MVRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222111110 011234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=314.57 Aligned_cols=250 Identities=21% Similarity=0.350 Sum_probs=195.8
Q ss_pred HHHHcCcCCcccEEEEEEcC-Cc--EEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeE
Q 045652 315 AAEVLGNGGLGSSYKAMMAD-GV--TVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 383 (621)
+.+.||+|+||.||+|...+ +. .||+|.++.. .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999998644 32 6899988643 334467788999999999999999999987542 2468
Q ss_pred EEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 384 LVYEYIPGGSLLYLLHGDRG-PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
++|||+++|+|.+++..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCCc
Confidence 99999999999998743221 1234589999999999999999999998 999999999999999999999999999
Q ss_pred ceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 463 YTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 463 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
++.+.... ....+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ... +...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~----~~~~~~~~ 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----NSE----IYDYLRQG 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC----HHH----HHHHHHcC
Confidence 88764321 2234557999999998899999999999999999999 788886421 111 11222222
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.... ........+.+++.+||+.||++|||+.+++++|+++
T Consensus 231 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 0122345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.21 Aligned_cols=237 Identities=19% Similarity=0.301 Sum_probs=189.4
Q ss_pred HcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 318 VLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.||+|+||.||+|... +++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999954 47899999987532 12334566788888764 8999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---- 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 468 (621)
+|.+++... ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 82 DLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 999998642 3588899999999999999999998 999999999999999999999999999875322
Q ss_pred cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 469 ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+. +.... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~----i~~~~------~~~--- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD----EEELFQS----IRMDN------PCY--- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC----HHHHHHH----HHhCC------CCC---
Confidence 123457889999999998899999999999999999999999986421 1111111 11111 111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHH-HHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMR-EAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 582 (621)
+......+.+++.+||+.||++||++. +++++
T Consensus 216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 216 --PRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred --CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 111235688999999999999999997 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.24 Aligned_cols=243 Identities=22% Similarity=0.384 Sum_probs=197.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.+.||+|+||.||++...++..||+|.++... ...+.+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 456799999999999998777789999987543 3356789999999999999999999999988889999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc---
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL--- 471 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--- 471 (621)
.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 87 ~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 87 LNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99997432 2589999999999999999999998 999999999999999999999999999876543221
Q ss_pred --ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 472 --AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 472 --~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+.... +..+....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~----~~~~~~~~--------- 221 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEK----VSQGLRLY--------- 221 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHH----HhcCCCCC---------
Confidence 123457999999988889999999999999999998 9999864221 111111 11111100
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
........+.+++.+||+.+|++||++.++++.|+
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 -RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112367899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=315.54 Aligned_cols=250 Identities=22% Similarity=0.394 Sum_probs=198.2
Q ss_pred HHHHcCcCCcccEEEEEEcC----CcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe------e
Q 045652 315 AAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE------K 382 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 382 (621)
+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|++.++.++||||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45789999999999998532 378999998743 23345678999999999999999999998876554 6
Q ss_pred EEEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 383 LLVYEYIPGGSLLYLLHGDRG-PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
+++|||+++|+|..++..... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECCcc
Confidence 899999999999999864331 1234689999999999999999999998 99999999999999999999999999
Q ss_pred cceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 462 FYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 462 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+++...... ....+..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+..+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~----~~~~~~~----~~~ 230 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE----NHEIYDY----LRH 230 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH----HHc
Confidence 998764332 1223457999999988889999999999999999999 888886422 1122222 121
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
+.... ........+.+++.+||+.||++||++.|+++.|+++
T Consensus 231 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 0123346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=318.70 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=200.2
Q ss_pred HHHHHcCcCCcccEEEEEEcC-C--cEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEee
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-G--VTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.+.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 345789999999999998644 3 35788888743 334456789999999999 799999999999998899999999
Q ss_pred cCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 389 IPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
+++++|.++++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCeEEE
Confidence 9999999999753311 123588999999999999999999998 9999999999999999999999
Q ss_pred Eeeecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 458 SEFGFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 458 ~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
+|||++...... .....+..|+|||++.+..++.++|||||||++|||++ |..||..... .+.. ..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~-~~~~ 232 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELY-EKLP 232 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH-HHHh
Confidence 999998643321 11222456999999988889999999999999999997 9999864211 1111 1111
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.+.. +.. .......+.+|+.+||+.+|.+||++.++++.|+.+....
T Consensus 233 ~~~~-----~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 233 QGYR-----MEK-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred cCCC-----CCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1110 000 1123356899999999999999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.90 Aligned_cols=238 Identities=21% Similarity=0.286 Sum_probs=189.6
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|... +|+.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999954 58899999987432 12345566788888765 899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc---
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--- 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 468 (621)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 9999998642 3578899999999999999999998 999999999999999999999999999875321
Q ss_pred -cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 -ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+ .+.... +...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~~----~~~~~~------~~~~- 216 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFE----SIRVDT------PHYP- 216 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHH----HHHhCC------CCCC-
Confidence 233457889999999999999999999999999999999999996421 111111 111111 1111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHH-HHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMR-EAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 582 (621)
.....++.+++.+||+.||++||++. ++++|
T Consensus 217 ----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 217 ----RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred ----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11235688999999999999999985 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=319.32 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=202.3
Q ss_pred HHHHHHHHcCcCCcccEEEEEEcC------CcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCee
Q 045652 311 LMKAAAEVLGNGGLGSSYKAMMAD------GVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEK 382 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (621)
-.|.+.+.||+|+||.||++.... ...+|+|.+... .......+.+|+++++++ +|+||+++++++...+..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 344556789999999999998532 368999998753 233446688999999999 799999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC
Q 045652 383 LLVYEYIPGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP 451 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~ 451 (621)
+++|||+++|+|..+++.... .....+++..+++++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLVTE 167 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeEEEcC
Confidence 999999999999999964321 1245689999999999999999999998 9999999999999999
Q ss_pred CCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcch
Q 045652 452 ENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDV 524 (621)
Q Consensus 452 ~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 524 (621)
++.+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~- 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEE- 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----HHH-
Confidence 9999999999988764321 1223457999999988889999999999999999997 888876321 111
Q ss_pred HHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
+......+.... ........+.+++.+||..||++|||+.|+++.|+++.
T Consensus 243 ---~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ---LFKLLKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 112222211100 11223457899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=318.89 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=200.6
Q ss_pred HHHHHHcCcCCcccEEEEEEcC-----------------CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD-----------------GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLA 374 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 374 (621)
|.+.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 4567889999999999987532 2468999987543 345678899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHhhcCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPS------HDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 375 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
++...+..+++|||+++++|.+++....... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~Nil 162 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCL 162 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchhcee
Confidence 9999999999999999999999997544211 23689999999999999999999998 9999999999999
Q ss_pred eCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCcccCCCC
Q 045652 449 ISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT--GKFPSQYLTNGNG 520 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~P~~~~~~~~~ 520 (621)
++.++.++|+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---- 238 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---- 238 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC----
Confidence 9999999999999987653321 2234567999999988889999999999999999998 667775322
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
..+....+...+......... ......+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 122222222221111111000 011223367999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=317.76 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=200.8
Q ss_pred HHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..+++|
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 35678999999999999843 23578999886443 334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCE
Q 045652 387 EYIPGGSLLYLLHGDRG-------------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNI 447 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI 447 (621)
||+.+++|.+++..... .....+++..++.++.|++.||.|||+. +|+||||||+||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~ni 158 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAARNV 158 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----CeehhhhhhheE
Confidence 99999999999864321 1123588999999999999999999998 999999999999
Q ss_pred EeCCCCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCC
Q 045652 448 FISPENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNG 520 (621)
Q Consensus 448 ll~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~ 520 (621)
++++++.+||+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---- 234 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---- 234 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC----
Confidence 9999999999999998765322 12234567999999988889999999999999999999 999986321
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
...+.+ ....+. ... ........+.+++.+||+.+|++||++.|+++.|+++..+
T Consensus 235 ~~~~~~----~~~~~~-----~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 PERLFN----LLKTGY-----RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHH----HHhCCC-----CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111222 221111 000 0122335788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=335.66 Aligned_cols=243 Identities=20% Similarity=0.278 Sum_probs=193.8
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 3467999999999999954 58999999987432 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 85 GGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999743 3589999999999999999999999 99999999999999999999999999987542210
Q ss_pred ------------------------------------------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC
Q 045652 471 ------------------------------------------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTG 508 (621)
Q Consensus 471 ------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg 508 (621)
...||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 12478899999999988999999999999999999999
Q ss_pred CCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc---HHHHHHH
Q 045652 509 KFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE---MREAVRR 582 (621)
Q Consensus 509 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 582 (621)
..||.... . .+....... .. .....+ . .....+.+.+++.+|+. +|.+|++ +.|+++|
T Consensus 236 ~~Pf~~~~----~---~~~~~~i~~-~~-~~~~~~---~---~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDN----P---QETYRKIIN-WK-ETLQFP---D---EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCC----H---HHHHHHHHc-CC-CccCCC---C---CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99997421 1 111111111 10 000000 0 01223567889999996 9999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=307.17 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=201.5
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhh---HHHHHHHHHHHhcCCCCCcccceEEEEeCC
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMA---RDAFDTEVRRLGRLRHSNVLAPLAYHYRTD 380 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 380 (621)
..++.++ ...+.||+|.-|+||+++..+ +..+|+|++.+..... ..+.+.|.+||+.++||.++.+|+.++.+.
T Consensus 73 ~l~l~~f--~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 73 SLGLRHF--RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred ccCHHHH--HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 3444444 467899999999999999654 6899999997654332 345677999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..|+|||||+||+|..+++++. .+.+++..+.-++.+|+-||+|||-. |||.|||||+||||.++|++.|+||
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeec
Confidence 9999999999999999988654 56799999999999999999999998 9999999999999999999999999
Q ss_pred ecceeccc-----------------------------------c-------------------------ccccccccccC
Q 045652 461 GFYTMINS-----------------------------------A-------------------------NLAQALFAYKA 480 (621)
Q Consensus 461 G~a~~~~~-----------------------------------~-------------------------~~~~~~~~y~a 480 (621)
.++..... . ....||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 87532100 0 01124556999
Q ss_pred cccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHH
Q 045652 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLE 560 (621)
Q Consensus 481 PE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 560 (621)
||++.+...+.++|+|+|||++|||+.|..||.+..+. ..+.. .+.+ .+. ....+.....+.+
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---~Tl~N----Iv~~---------~l~-Fp~~~~vs~~akD 366 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---ETLRN----IVGQ---------PLK-FPEEPEVSSAAKD 366 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---hhHHH----HhcC---------CCc-CCCCCcchhHHHH
Confidence 99999999999999999999999999999999864332 11111 1111 111 1112355578999
Q ss_pred HHhhcccCCCCCCCc----HHHHHHH
Q 045652 561 IGRACTQSDPEQRLE----MREAVRR 582 (621)
Q Consensus 561 li~~cl~~dP~~Rps----~~evl~~ 582 (621)
||++.|.+||.+|.. +.||.+|
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999997 7777765
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.36 Aligned_cols=238 Identities=22% Similarity=0.306 Sum_probs=192.6
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|... +++.||+|+++... ....+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999854 57899999987432 22345677899999888 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 9999988643 3589999999999999999999998 9999999999999999999999999998653221
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .... ...+..... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~----~~~i~~~~~------~~-- 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDEL----FQSILEDEV------RY-- 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHH----HHHHHcCCC------CC--
Confidence 22347888999999999999999999999999999999999986421 1111 111111111 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcH-----HHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEM-----REAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 582 (621)
+......+.+++.+||+.||++||++ .+++++
T Consensus 216 ---~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 ---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11233568999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=318.87 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=199.1
Q ss_pred HHHHHHHHHcCcCCcccEEEEEEcC---------------CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccce
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAMMAD---------------GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPL 373 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 373 (621)
.-.|.+.+.||+|+||.||++...+ ...||+|.++.. .....+.+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3445667889999999999987532 235899998754 334456799999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHhhcCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCC
Q 045652 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGP-------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSN 446 (621)
Q Consensus 374 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~N 446 (621)
+++...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRN 159 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhh
Confidence 9999999999999999999999998643210 112478899999999999999999998 99999999999
Q ss_pred EEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCcccCC
Q 045652 447 IFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT--GKFPSQYLTNG 518 (621)
Q Consensus 447 Ill~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~P~~~~~~~ 518 (621)
|+++.++.+||+|||++....... ...++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 999999999999999987653321 1223567999999988889999999999999999998 5667654221
Q ss_pred CCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 519 NGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
......+...+......... ...+..+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 ---EQVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 12222222211111000000 001123457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=316.92 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=199.7
Q ss_pred HHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
..++||+|+||.||++.. .++..+++|.+........+.+.+|++++++++|+||+++++++......+++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 467899999999999963 23668999998877666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 389 IPGGSLLYLLHGDRG----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
+++++|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCCCEEEC
Confidence 999999999975431 1123588999999999999999999998 99999999999999999999999
Q ss_pred eeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHH
Q 045652 459 EFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 459 DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
|||++....... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+... .
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~----~ 236 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----TEAIE----C 236 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----HHHHH----H
Confidence 999987653321 1223567999999998899999999999999999998 8888863211 11111 1
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
...+.... .....+..+.+++.+||+.||++||++.|+++.|+
T Consensus 237 ~~~~~~~~----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGRELE----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111000 01123356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.78 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=201.1
Q ss_pred hHHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 309 PDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 309 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
..-.+.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 344455678899999999999998889999999987543 23567889999999999999999999864 5668999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 82 MENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999986533 24688999999999999999999998 999999999999999999999999999877652
Q ss_pred cc-----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 469 AN-----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 ~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
.. ...++..|+|||++....++.++||||||+++|||++ |+.||.... ..+....+ ..+....
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~----~~~~~~~--- 223 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT----NPEVIQNL----ERGYRMP--- 223 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC----hHHHHHHH----HcCCCCC---
Confidence 21 1233467999999988889999999999999999999 999986422 11122211 1111000
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
.....+.++.+++.+||+.+|++||++++++..|+.
T Consensus 224 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011233579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=315.69 Aligned_cols=247 Identities=20% Similarity=0.338 Sum_probs=196.4
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 3457899999999999984 56899999998643 334456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 84 GSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred CChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence 9997542 367888899999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....++..|+|||++.+..++.++|||||||++|+|++|+.||................. ...... .+...
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~--- 221 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDED-----PPVLP--- 221 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccC-----CCCCC---
Confidence 334577889999999988999999999999999999999999875332221111111111 111111 01110
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
......++.+++.+||+.+|++||+++|++++-
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 112335689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=325.74 Aligned_cols=244 Identities=17% Similarity=0.281 Sum_probs=194.2
Q ss_pred HcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 689999999999985 457899999997532 22345678999999888 6999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---- 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 468 (621)
+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 82 DLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 999888632 3589999999999999999999999 999999999999999999999999999875321
Q ss_pred cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 469 ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
.....++..|+|||++.+..++.++|||||||++|||++|+.||...... ......+.+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~------~--- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN-PDMNTEDYLFQVILEKPIR------I--- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC-cccccHHHHHHHHHhCCCC------C---
Confidence 12345788999999999999999999999999999999999999643321 1112222333322221110 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcH------HHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEM------REAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 582 (621)
+......+.+++.+||+.||++|+++ .++++|
T Consensus 223 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 --PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11223567899999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.28 Aligned_cols=246 Identities=24% Similarity=0.426 Sum_probs=201.1
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.+.||+|+||.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 45688999999999999874 78999999976544 56778999999999999999999999998889999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc-c
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-A 472 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 472 (621)
|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++....... .
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~ 159 (256)
T cd05039 87 LVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159 (256)
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence 999997432 23689999999999999999999999 999999999999999999999999999887643322 2
Q ss_pred cccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 473 QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 473 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..+..|+|||++....++.++||||||+++|||++ |..||.... ..+ +...+..+.... . .
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~----~~~~~~~~~~~~-----~-----~ 221 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKD----VVPHVEKGYRME-----A-----P 221 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC----HHH----HHHHHhcCCCCC-----C-----c
Confidence 23457999999988889999999999999999997 999986321 111 112222111000 0 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
...+..+.+++.+||..+|++||++.|+++.|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 12346789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.28 Aligned_cols=242 Identities=26% Similarity=0.438 Sum_probs=196.8
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
++||+|+||.||+|...++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998788999999987543 333457889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-----
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN----- 470 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~----- 470 (621)
+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9986432 3578999999999999999999998 99999999999999999999999999987653321
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....+..|+|||++.+..++.++||||||+++||+++ |..||..... .. .......+....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~----~~~~~~~~~~~~---------- 214 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQ----AREQVEKGYRMS---------- 214 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HH----HHHHHHcCCCCC----------
Confidence 1233457999999988889999999999999999998 9999864211 11 111111111000
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.....+..+.+++.+||..+|++||++.|+++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 01223467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=303.45 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=207.4
Q ss_pred hHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 309 PDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 309 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
++-.+.+.++||+|+||.||+|. ...|+.||||.+... .+.+++.+|+.+|++++.|++|++||.|......|+|||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 34556788999999999999998 456999999998643 347889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||..|+..+.++.. .+.+++.++..++...++||+|||.. .-+|||||..|||++.+|.+||+|||.|-.++
T Consensus 109 YCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred hcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 99999999999753 46799999999999999999999987 67799999999999999999999999998765
Q ss_pred cc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.. +...||+.|||||++..-.|+.++||||+|++..||.-|++||.....- +..+ .-|
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------RAIF--------MIP 242 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------RAIF--------MIP 242 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------ceeE--------ecc
Confidence 43 5677899999999999999999999999999999999999998753321 1111 001
Q ss_pred chhc--CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIAS--STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+. ...+.....++-+++++||.+.|++|-|+.++++|
T Consensus 243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1111 11123445789999999999999999999999887
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.60 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=196.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 3467999999999999954 68999999987432 1335668899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 85 GGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 99999999743 4588999999999999999999998 99999999999999999999999999987654332
Q ss_pred ---------------------------------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC
Q 045652 471 ---------------------------------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517 (621)
Q Consensus 471 ---------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 517 (621)
...++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence 2347788999999999999999999999999999999999997422
Q ss_pred CCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc-HHHHHHH
Q 045652 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE-MREAVRR 582 (621)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 582 (621)
............ .....+. .....+.+.+++.+|+. ||.+||+ ++|++++
T Consensus 235 ------~~~~~~~i~~~~--~~~~~p~------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 ------LQETYNKIINWK--ESLRFPP------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHHHHhccC--CcccCCC------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111111100 0000000 11134678899999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.03 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=200.9
Q ss_pred HHHHHHHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--Ce
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DE 381 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 381 (621)
+-.|.+.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 44567788999999999999973 347899999987443 33456789999999999999999999998875 45
Q ss_pred eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCc
Confidence 789999999999999986432 3589999999999999999999999 99999999999999999999999999
Q ss_pred cceeccccc-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC--------CCCCcchHH
Q 045652 462 FYTMINSAN-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN--------GNGGIDVVE 526 (621)
Q Consensus 462 ~a~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~--------~~~~~~~~~ 526 (621)
+++.+.... ...++..|+|||++.+..++.++|||||||++|||+|++.|+..... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 988664321 22344569999999888899999999999999999998766432110 000011111
Q ss_pred HHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 527 WVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.+ .....+... ......+..+.+|+.+||+.+|++||++.++++.|+++
T Consensus 235 ~~-~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LV-RVLEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHHHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 111111100 01123446799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.47 Aligned_cols=241 Identities=20% Similarity=0.348 Sum_probs=193.5
Q ss_pred HcCcCCcccEEEEEE---cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 318 VLGNGGLGSSYKAMM---ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.||+|+||.||+|.+ .++..+|+|+++... ....+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357899999986432 334577899999999999999999999875 45678999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL- 471 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 471 (621)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999999632 3588999999999999999999998 999999999999999999999999999877643211
Q ss_pred ------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 472 ------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 472 ------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
..++..|+|||.+....++.++|||||||++|||++ |+.||.... ..+..+. +..+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~----i~~~~~~~----- 218 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK----GNEVTQM----IESGERME----- 218 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH----HHCCCCCC-----
Confidence 122457999999988889999999999999999998 999986421 1122222 22221111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
. +...+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 ~-----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 C-----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C-----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 122346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.37 Aligned_cols=244 Identities=20% Similarity=0.237 Sum_probs=189.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++.+++|+||+++++++.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 356899999999999985 458999999987432 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 85 GGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999743 3588999999999999999999998 9999999999999999999999999998754321
Q ss_pred --------------------------------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 045652 470 --------------------------------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511 (621)
Q Consensus 470 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P 511 (621)
....||..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 123578899999999988999999999999999999999999
Q ss_pred CCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhccc--CCCCCCCcHHHHHHH
Q 045652 512 SQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQ--SDPEQRLEMREAVRR 582 (621)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~evl~~ 582 (621)
|.... .......+ . .... ....|. . .....++.+++.+++. .++..||++.|+++|
T Consensus 236 f~~~~----~~~~~~~i---~-~~~~-~~~~p~---~---~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSET----PQETYKKV---M-NWKE-TLIFPP---E---VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCC----HHHHHHHH---H-cCcC-cccCCC---c---CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 96421 11111111 1 1100 000010 0 1122456677776543 233456899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=320.27 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=200.2
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCc--EEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEee
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGV--TVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.+.+.||+|+||.||+|... ++. .+++|.++.. .......+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 34578999999999999854 344 4688877643 233456788999999999 899999999999999999999999
Q ss_pred cCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 389 IPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
+++++|.++++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCCcEEe
Confidence 9999999999754311 123588999999999999999999998 9999999999999999999999
Q ss_pred Eeeecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 458 SEFGFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 458 ~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
+|||++...... .....+..|+|||++.+..++.++|||||||++|||+| |..||..... .+..+ ...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~----~~~ 237 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYE----KLP 237 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHHHH----HHh
Confidence 999998643221 11223457999999988889999999999999999998 9999864221 11111 111
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
.+.. .. ........+.+++.+||+.+|++||++.+++++|+++.....
T Consensus 238 ~~~~-----~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 QGYR-----LE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCCc-----CC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1100 00 011223568899999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.67 Aligned_cols=238 Identities=22% Similarity=0.342 Sum_probs=187.7
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHH-HHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVR-RLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3689999999999995 468999999986432 112234445544 56789999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 9999998642 3588899999999999999999999 9999999999999999999999999998754221
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... ..... +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~-~~~~~------~-- 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEMYDNIL-NKPLR------L-- 215 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-------HHHHHHHHH-cCCCC------C--
Confidence 23457889999999999899999999999999999999999986421 111111111 11100 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHH----HHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMR----EAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----evl~~ 582 (621)
.+.....+.+++.+||+.||++||++. |++++
T Consensus 216 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 216 ---KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 112245689999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.24 Aligned_cols=248 Identities=22% Similarity=0.341 Sum_probs=195.5
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCc----EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGV----TVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
.+.+.||+|+||.||+|.+. ++. .|++|.+.... .....++..|+.++++++||||+++++++. ....++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence 35688999999999999853 344 47888875432 233467788999999999999999999875 455789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++|+|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 89 LSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred eCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999997432 3589999999999999999999998 99999999999999999999999999998653
Q ss_pred cc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 468 SA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 468 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
.. ....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ... ...+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~----~~~~~~~~~~~- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEV----PDLLEKGERLA- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHH----HHHHHCCCcCC-
Confidence 32 12234567999999988899999999999999999998 9999864211 111 12222221110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.+ ......+.+++.+||..||++|||+.|+++.|..+..
T Consensus 232 -~~--------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 -QP--------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CC--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11 1122457889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.36 Aligned_cols=243 Identities=20% Similarity=0.226 Sum_probs=191.6
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....|+||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 457899999999999984 568999999986432 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 85 GGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999742 3578889999999999999999999 9999999999999999999999999998632110
Q ss_pred --------------------------------------------------ccccccccccCcccccCCCCCcchhhHHHH
Q 045652 470 --------------------------------------------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLG 499 (621)
Q Consensus 470 --------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 499 (621)
....||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 013478889999999988999999999999
Q ss_pred HHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCC---CcH
Q 045652 500 IIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR---LEM 576 (621)
Q Consensus 500 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~ 576 (621)
|++|||++|..||.... ..+... ....... .+.-| .......++.+++.+|+. +|.+| +++
T Consensus 236 vil~elltG~~Pf~~~~----~~~~~~---~i~~~~~--~~~~p------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 236 AIMFECLIGWPPFCSEN----SHETYR---KIINWRE--TLYFP------DDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhhcCCCCCCCCC----HHHHHH---HHHccCC--ccCCC------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999986421 111111 1111000 00000 011223568899999997 77765 599
Q ss_pred HHHHHH
Q 045652 577 REAVRR 582 (621)
Q Consensus 577 ~evl~~ 582 (621)
.|+++|
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=312.09 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=197.5
Q ss_pred HHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-CCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-TDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 390 (621)
.+.+.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.++++++|+|++++++++.. .+..++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 344567899999999999976 47889999986443 35678899999999999999999997654 456899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 84 KGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999997543 23588999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.... +..+....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~~----~~~~~~~~--------- 219 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPR----VEKGYKMD--------- 219 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH----HhcCCCCC---------
Confidence 22334557999999988889999999999999999998 999886311 1111111 21111110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.....+..+.+++.+||+.+|++|||+.+++++|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1123346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.97 Aligned_cols=265 Identities=22% Similarity=0.366 Sum_probs=207.3
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEEEc--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEE
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAMMA--------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAY 375 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 375 (621)
+.++...+.+.+.||+|+||.||+|... ....||+|.++... ......+.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 4445555567889999999999999742 24579999987432 33456788999999999 69999999999
Q ss_pred EEeCCeeEEEEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCC
Q 045652 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKS 444 (621)
Q Consensus 376 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp 444 (621)
+...+..++||||+++|+|.+++..... .....+++.++..++.|++.||.|||++ +|+||||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp 162 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAA 162 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----Ceeeccccc
Confidence 9988889999999999999999975331 1224589999999999999999999998 999999999
Q ss_pred CCEEeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccC
Q 045652 445 SNIFISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517 (621)
Q Consensus 445 ~NIll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 517 (621)
+||+++.++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~- 241 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP- 241 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-
Confidence 99999999999999999997664321 1122356999999988889999999999999999999 888875321
Q ss_pred CCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
..+..+ ....+..... ......++.+++.+||+.+|++||++.|+++.|+++......
T Consensus 242 ---~~~~~~----~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 242 ---VEELFK----LLREGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred ---HHHHHH----HHHcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 111122 2222211110 122345688999999999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.09 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=201.0
Q ss_pred hhHHHHHHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeC
Q 045652 308 LPDLMKAAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRT 379 (621)
Q Consensus 308 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (621)
++.-.|.+.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3444567889999999999999973 347899999997543 23345688999999999 689999999988654
Q ss_pred -CeeEEEEeecCCCChhHHhhcCCCC------------------------------------------------------
Q 045652 380 -DEKLLVYEYIPGGSLLYLLHGDRGP------------------------------------------------------ 404 (621)
Q Consensus 380 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 404 (621)
...++||||+++|+|.++++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999999999998643210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc------c
Q 045652 405 --------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA------N 470 (621)
Q Consensus 405 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------~ 470 (621)
....+++..+.+++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 012478888999999999999999998 9999999999999999999999999998765322 1
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..... . ..+......+..... +
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~----~~~~~~~~~~~~~~~--~------ 304 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---D----EEFCRRLKEGTRMRA--P------ 304 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---c----HHHHHHHhccCCCCC--C------
Confidence 1233467999999988889999999999999999997 8888864211 1 111112222211100 0
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
......+.+++.+||+.||++||++.|++++|+.+.+
T Consensus 305 --~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 --DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122468999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.98 Aligned_cols=242 Identities=22% Similarity=0.389 Sum_probs=193.6
Q ss_pred HcCcCCcccEEEEEEc---CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMA---DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35679999987543 334567899999999999999999999875 456899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc--
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-- 471 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 471 (621)
|.+++... ...+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99998643 23589999999999999999999998 999999999999999999999999999876533211
Q ss_pred -----ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 472 -----AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 472 -----~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
...+..|+|||.+....++.++|||||||++||+++ |..||..... .+. ...+..+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~----~~~~~~~~~~~------ 218 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEV----MSFIEQGKRLD------ 218 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHH----HHHHHCCCCCC------
Confidence 122457999999988889999999999999999996 9999864321 111 12222221110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.+.....++.+++.+||..||++||++.++.+.|+.+
T Consensus 219 ----~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 ----CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1123346788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.53 Aligned_cols=238 Identities=20% Similarity=0.281 Sum_probs=191.5
Q ss_pred HHcCcCCcccEEEEEE----cCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 3578999999874321 234456789999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 9999999863 23589999999999999999999998 9999999999999999999999999998765332
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ...... . +..... .+
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~~~~~~---~-i~~~~~------~~- 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----RKETMT---M-ILKAKL------GM- 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----HHHHHH---H-HHcCCC------CC-
Confidence 23457888999999998889999999999999999999999986421 111111 1 111111 00
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
+......+.+++.+||+.||++||+ +.+++.+
T Consensus 218 ----p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 218 ----PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1123356889999999999999999 4555543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.33 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=196.5
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC--------eeE
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--------EKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~ 383 (621)
+.+.||+|+||.||+|. ..+|+.||||++... .......+.+|+..+..++|+||+++++.+...+ ..+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 45679999999999998 456999999998643 3344567889999999999999999887765432 257
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+||||+++|+|.++++.... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 99999999999999974332 235689999999999999999999998 9999999999999999999999999998
Q ss_pred eecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 464 TMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 464 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
+.+... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+.... .+..
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-------~~~~~~~~~~-~~~~ 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-------NMEEVMHKTL-AGRY 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHh-cCCC
Confidence 765432 2345788999999999989999999999999999999999998632 1122222221 1111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. .+.....++.+++.+||+.||++||++.+++++
T Consensus 263 ~~----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DP----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 112334678999999999999999999999876
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=312.23 Aligned_cols=243 Identities=23% Similarity=0.381 Sum_probs=197.1
Q ss_pred HHcCcCCcccEEEEEEcC--C--cEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMAD--G--VTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998543 3 3699999986655 556789999999999999999999999988 888999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999975431 4689999999999999999999998 9999999999999999999999999998876442
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+.. .... .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~~~~---~~~~--~--- 220 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS----GSQILKKIDK---EGER--L--- 220 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHh---cCCc--C---
Confidence 12335568999999998899999999999999999999 999986321 1122222211 1110 0
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
......+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001123467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.08 Aligned_cols=240 Identities=21% Similarity=0.269 Sum_probs=191.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCC-CcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHS-NVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|... +++.||+|+++.. .....+.+..|++++..++|+ +|+++++++...+..|+||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 4567999999999999854 4789999998743 223456678899999999765 5888889998889999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 84 NGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999998642 3578999999999999999999998 999999999999999999999999999875321
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....++..|+|||++.+..++.++|||||||++|||+||+.||.... ..+.... +..... ..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~~~~----i~~~~~------~~ 220 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED----EDELFQS----IMEHNV------SY 220 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHH----HHcCCC------CC
Confidence 123457889999999999899999999999999999999999986421 1111111 111110 01
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcH-----HHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEM-----REAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 582 (621)
+......+.+++.+||..||++|++. +++++|
T Consensus 221 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 -----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11233568899999999999999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.39 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=195.9
Q ss_pred HHcCcCCcccEEEEEEcC-Cc--EEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMAD-GV--TVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999644 43 5788888743 334456788999999999 799999999999999999999999999
Q ss_pred CChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 392 GSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 392 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
|+|.+++...... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 9999999754311 123578999999999999999999998 9999999999999999999999999
Q ss_pred ecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 461 GFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 461 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
|++...... .....+..|+|||++....++.++|||||||++|||++ |..||.... ..+..+ .+..+.
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~----~~~~~~----~~~~~~ 228 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYE----KLPQGY 228 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC----HHHHHH----HHhCCC
Confidence 998643211 11223456999999988889999999999999999997 999986421 111111 111111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
..+ . .......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 229 ~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLE-----K-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC-----C-----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 0 1123356889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.70 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=204.3
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 34577999999999999965 7899999988632 2233567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|..++..... ....+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 85 DAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred CCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999864321 234588999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ....+... .+..+....
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~-~~~~~~~~~------ 227 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCK-KIEKCDYPP------ 227 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHh-hhhcCCCCC------
Confidence 22346678999999988889999999999999999999999986321 12222111 111111110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
.........+.+++.+||..+|++||++.++++.|+++.
T Consensus 228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 011234457899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.74 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=198.6
Q ss_pred HHHHHHcCcCCcccEEEEEEc-----------------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-----------------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLA 374 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 374 (621)
|.+.+.||+|+||.||++... ++..||+|.++.. .....+.+.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 445678999999999998532 2447899998754 3345678999999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHhhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGP------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 375 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
++...+..++||||+++++|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~Nil 162 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCL 162 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChheEE
Confidence 999999999999999999999999754321 123478889999999999999999999 9999999999999
Q ss_pred eCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCcccCCCC
Q 045652 449 ISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT--GKFPSQYLTNGNG 520 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~P~~~~~~~~~ 520 (621)
++.++.++|+|||+++.+.... ....+..|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--- 239 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh---
Confidence 9999999999999987653321 1223457999999888889999999999999999998 6778764221
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.+........+....... ..+ ....++..+.+++.+||+.||++||++.|+++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 -EQVIENTGEFFRDQGRQV-YLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred -HHHHHHHHHHHhhccccc-cCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 112221111111111000 000 01223367899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.17 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=189.9
Q ss_pred HcCcCCcccEEEEEEcC---CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMAD---GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 4679999887543 2334578899999999999999999999998888999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc---
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN--- 470 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 470 (621)
|.++++..........++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999754322233567778889999999999999998 99999999999999999999999999986543221
Q ss_pred ---cccccccccCcccccCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 471 ---LAQALFAYKAPEAIQSG-------KVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~-------~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||..... .+.... .... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~~~---~~~~-~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVLTY---TVRE-QQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh----HHHHHH---Hhhc-ccCC
Confidence 22345679999998532 35789999999999999996 9999864321 111111 1111 1111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
..++... ......+.+++.+|| .+|++|||++||++.|+
T Consensus 230 ~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1122111 122345788999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.89 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=197.5
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 34456799999999999998777789999886543 33567889999999999999999998875 45678999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.++++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 86 SLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999997532 23578999999999999999999998 99999999999999999999999999997664321
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||...+..++.++||||||+++|||+| |+.||.... ..+..+++ ..+.. +
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~~----~~~~~-----~--- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV----NREVLEQV----ERGYR-----M--- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HcCCC-----C---
Confidence 1234567999999988889999999999999999999 898986422 11111211 11110 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
......+..+.+++.+||..||++||+++++++.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=339.08 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=190.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 356799999999999985 458899999987432 2234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc--
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-- 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 468 (621)
+|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 85 GGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999998643 3578888999999999999999998 999999999999999999999999999753210
Q ss_pred -------------------------------------------------cccccccccccCcccccCCCCCcchhhHHHH
Q 045652 469 -------------------------------------------------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLG 499 (621)
Q Consensus 469 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 499 (621)
.....||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0112477889999999988999999999999
Q ss_pred HHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc---H
Q 045652 500 IIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE---M 576 (621)
Q Consensus 500 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~ 576 (621)
|++|||++|+.||..... .+.......... ....| ......+++.+++.+|+ .+|++|++ +
T Consensus 236 vil~elltG~~Pf~~~~~-------~~~~~~i~~~~~--~~~~p------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP-------LETQMKVINWQT--SLHIP------PQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHHhCCCCCCCCCH-------HHHHHHHHccCC--CcCCC------CcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 999999999999974211 111111111000 00000 01123356777787775 59999997 8
Q ss_pred HHHHHH
Q 045652 577 REAVRR 582 (621)
Q Consensus 577 ~evl~~ 582 (621)
.|+++|
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.88 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=196.9
Q ss_pred HHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|... .+..|++|.+.... ......+.+|+.++++++|+||+++++++.+....++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 34578999999999999864 35789999886443 334567899999999999999999999999988999999
Q ss_pred eecCCCChhHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC---CcEEEeee
Q 045652 387 EYIPGGSLLYLLHGDRGP--SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN---EPLISEFG 461 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG 461 (621)
||+++++|.+++...+.. ....+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+||+|||
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999754321 123589999999999999999999998 999999999999998765 58999999
Q ss_pred cceecccccc------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 462 FYTMINSANL------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 462 ~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+++.+..... ...+..|+|||++.+..++.++|||||||++|||++ |..||..... ....+ .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~----~~~~ 236 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVME----FVTG 236 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH----HHHc
Confidence 9987633211 112357999999988899999999999999999997 9999864221 11111 1111
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
..... .+...+..+.+++.+||+.+|++||++.+++++|+
T Consensus 237 ~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11000 01223457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.30 Aligned_cols=244 Identities=16% Similarity=0.231 Sum_probs=194.3
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 3457899999999999985 458899999986421 223455778999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.+++.. ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 126 ~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 126 PGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999863 2477888889999999999999998 9999999999999999999999999998876432
Q ss_pred -----ccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSG----KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||.... ............. ..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~--~~ 266 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMDHKN--SL 266 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCC--cC
Confidence 234578899999998643 47899999999999999999999997421 1111111111110 00
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCC--CCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQ--RLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 582 (621)
..+ ........+.+++.+||+.+|++ |+++.|+++|
T Consensus 267 ~~~------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFP------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 11123467899999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=310.36 Aligned_cols=250 Identities=19% Similarity=0.302 Sum_probs=200.2
Q ss_pred HHHHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+-.|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 334677899999999999999954 4788999998766655667889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|..++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 84 CAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred cCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEccccccccccc
Confidence 9999999888642 24589999999999999999999998 999999999999999999999999999876532
Q ss_pred c----ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 469 A----NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
. ....++..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+...... ....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~-~~~~ 227 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKS-EPPT 227 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-------HHHHHHHHhhc-CCCC
Confidence 2 2345678899999984 3457889999999999999999999986421 11111111111 1001
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
... .......+.+++.+||+.||++||++.+++++-
T Consensus 228 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 228 LAQ--------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 100 112335789999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=334.81 Aligned_cols=255 Identities=19% Similarity=0.204 Sum_probs=193.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
|.+.+.||+|+||.||+|... .++.||||.... ..+.+|+++|++++|+|||++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 445678999999999999954 478999996432 235689999999999999999999999999999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|..++.... ..+++.+++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 244 ~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 244 SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 68988886432 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred ----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc--cc---
Q 045652 470 ----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT--DL--- 540 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--- 540 (621)
....+|..|+|||++.+..++.++|||||||++|||++|..|+...............+.+.+...... ++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 123578899999999999999999999999999999999877654322211111112222222211110 00
Q ss_pred c----------------ccchhcC--CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 L----------------DPEIASS--TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~----------------d~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. .+..... .........+.+|+.+||+.||++|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000000 0000122468899999999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.50 Aligned_cols=240 Identities=20% Similarity=0.372 Sum_probs=191.5
Q ss_pred HHcCcCCcccEEEEEEcC--------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 317 EVLGNGGLGSSYKAMMAD--------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.||+|+||.||+|.... ...|++|.+........+.+..|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 235888888655555567788999999999999999999999998999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC--------cEEEee
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE--------PLISEF 460 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Df 460 (621)
+++|+|.++++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999997543 3588999999999999999999999 9999999999999988765 589999
Q ss_pred ecceeccccccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCC-CCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 461 GFYTMINSANLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGK-FPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 461 G~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
|++..........++..|+|||++.+. .++.++|||||||++|||++|. .|+.... ..... .... ..
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-------~~~~~-~~~~-~~-- 221 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-------SQKKL-QFYE-DR-- 221 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-------HHHHH-HHHH-cc--
Confidence 998776655556678889999999764 5799999999999999999995 4543211 11111 1111 10
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
..+ +.....++.+++.+||+.||++|||++++++.|+
T Consensus 222 ----~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----HQL-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----ccC-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001 1112256899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.36 Aligned_cols=244 Identities=22% Similarity=0.294 Sum_probs=195.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 346799999999999985 468999999987532 2245668899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999997532 3589999999999999999999999 99999999999999999999999999998764332
Q ss_pred -----cccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 471 -----LAQALFAYKAPEAIQ------SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 471 -----~~~~~~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ...............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~ 229 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKTYNNIMNFQRFLK 229 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHHHHHHHcCCCccC
Confidence 235788999999986 45678999999999999999999999864211 111112111111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ...+.....+.+++.+||+ +|++||++.++++|
T Consensus 230 ~--------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 F--------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C--------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0112234568899999998 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.84 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=198.5
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||+|.. .+++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 46799999999999985 46899999988632 3445677899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.++++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999997542 34688999999999999999999998 99999999999999999999999999988765432
Q ss_pred --cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 --LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 --~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...++..|+|||+..+..++.++|||||||++|||++|+.||.... ... .......+.... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~----~~~~~~~~~~~~-----~--- 221 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN----QGA----LILKIIRGVFPP-----V--- 221 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHH----HHHHHHcCCCCC-----C---
Confidence 2345678999999998889999999999999999999999986422 111 111111111111 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 --SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11334678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.57 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=188.6
Q ss_pred HcCcCCcccEEEEEEcC---CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMAD---GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 4578888876432 3345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++...........++...+.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999765433334457788899999999999999999 9999999999999999999999999998654222
Q ss_pred --ccccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 470 --NLAQALFAYKAPEAIQS-------GKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+ .......... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~---~~~~~~~~~~-~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQ---VLKQVVREQD-IK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HH---HHHHHhhccC-cc
Confidence 12234557999998742 356889999999999999999 7788763211 11 1111122111 11
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
..++.. .......+.+++..|| .||++|||++||++.|
T Consensus 230 ~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111211 1223356777888898 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=328.78 Aligned_cols=243 Identities=24% Similarity=0.378 Sum_probs=202.5
Q ss_pred HcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChhH
Q 045652 318 VLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 396 (621)
+||+|.||+||.|+ ..+...+|||.+.+.+....+-+..||.+.++|+|.|||+++|.+.+++..-+.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999 45578899999988777777888999999999999999999999999998999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC-CCCCcEEEeeecceeccc----ccc
Q 045652 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS-PENEPLISEFGFYTMINS----ANL 471 (621)
Q Consensus 397 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~----~~~ 471 (621)
+++...++- .-++..+-.+.+||++||.|||+. .|||||||-+|||++ -.|.+||+|||-++.+.. ...
T Consensus 662 LLrskWGPl--KDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWGPL--KDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHhccCCC--ccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 998776532 126677788999999999999999 999999999999997 578899999998887643 255
Q ss_pred ccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 472 AQALFAYKAPEAIQSG--KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
..||..|||||++..+ .|+.++|||||||++.||.||++||..+.... ...+.-|-.+ +. +.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------AAMFkVGmyK--vH-----P~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------AAMFKVGMYK--VH-----PP 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------Hhhhhhccee--cC-----CC
Confidence 6788999999999765 48999999999999999999999997543211 1122222111 11 22
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.+...+...+|.+|+.+||.+||+++++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 345667889999999999999999999999864
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.10 Aligned_cols=246 Identities=30% Similarity=0.466 Sum_probs=200.3
Q ss_pred HHcCcCCcccEEEEEEcC----CcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMAD----GVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|.... +..|++|.++..... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999643 789999999865433 367889999999999999999999999998899999999999
Q ss_pred CChhHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 392 GSLLYLLHGDRGP----SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 392 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
++|.+++...... ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999754210 125689999999999999999999998 99999999999999999999999999998765
Q ss_pred cc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 468 SA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 468 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
.. ....++..|+|||.+....++.++||||+|+++|||++ |..||.... ..++.+ ....+...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~----~~~~~~~~-- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEVLE----YLRKGYRL-- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HHHHHH----HHHcCCCC--
Confidence 43 23345678999999988889999999999999999999 688987431 111212 22211100
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
......+.++.+++.+||+.+|++|||+.|++++|+
T Consensus 227 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 --------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011223467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=325.74 Aligned_cols=236 Identities=23% Similarity=0.363 Sum_probs=186.9
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHH-HHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVR-RLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999985 468999999986432 122344555554 56789999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc---
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--- 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 468 (621)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 999988863 24588999999999999999999998 999999999999999999999999999875322
Q ss_pred -cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 -ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... .... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~-~~~~--~~------ 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNIL-HKPL--VL------ 215 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHH-cCCc--cC------
Confidence 123457889999999999999999999999999999999999986421 111111111 1110 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAV 580 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 580 (621)
.+.....+.+++.+|++.||++||++++.+
T Consensus 216 ---~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 ---RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 112335688999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.09 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=202.7
Q ss_pred ChhHHHHHHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEe
Q 045652 307 GLPDLMKAAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR 378 (621)
Q Consensus 307 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 378 (621)
.+....+.+.+.||+|+||.||++.. ..+..||+|.++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 34444455678999999999999973 124589999987543 33456789999999999 79999999999999
Q ss_pred CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
.+..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++|+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEEC
Confidence 999999999999999999997433 23389999999999999999999998 99999999999999999999999
Q ss_pred eeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHH
Q 045652 459 EFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 459 DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... .......
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~~~ 256 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFYKL 256 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHHHH
Confidence 999987654321 1223567999999998899999999999999999998 9999864221 1111111
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
...+... .........+.+++.+||..+|++||++.|+++.|++.
T Consensus 257 ~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 2211100 00112235789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.06 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=200.6
Q ss_pred HHHHHHHHHcCcCCcccEEEEEEcC------CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCee
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAMMAD------GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK 382 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (621)
...+.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3344556889999999999998532 4689999987443 33456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGP-----SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
++||||+++++|.+++...... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEE
Confidence 9999999999999999754321 123478899999999999999999998 9999999999999999999999
Q ss_pred Eeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHH
Q 045652 458 SEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530 (621)
Q Consensus 458 ~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 530 (621)
+|||+++.+.... ...++..|+|||.+.+..++.++|||||||++||++| |..||.... .....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~~~~~~--- 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS----NEEVLKF--- 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC----HHHHHHH---
Confidence 9999987653321 2234568999999988889999999999999999998 888885321 1122222
Q ss_pred HhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
...+..... +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 -~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 -VIDGGHLDL----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HhcCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 112111111 1122467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.21 Aligned_cols=253 Identities=20% Similarity=0.340 Sum_probs=201.9
Q ss_pred HHHHHcCcCCcccEEEEEEcC-----CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-CCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-TDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.. ....++++
T Consensus 9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 88 (280)
T cd05043 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLY 88 (280)
T ss_pred EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEE
Confidence 345789999999999999655 788999998754 33446678899999999999999999998876 46688999
Q ss_pred eecCCCChhHHhhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 387 EYIPGGSLLYLLHGDRGP---SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
||+++++|.+++...... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 999999999998654311 124689999999999999999999998 9999999999999999999999999999
Q ss_pred eeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 464 TMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 464 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
+.+.... ...++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..++..++ ..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~----~~~~ 236 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAYL----KDGY 236 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC----HHHHHHHH----HcCC
Confidence 8653321 1234567999999988889999999999999999999 999986421 11222221 1111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
. . ......+.++.+++.+||..||++|||+.++++.|+.+..
T Consensus 237 ~-----~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 R-----L-----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C-----C-----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0 0011233578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.09 Aligned_cols=249 Identities=19% Similarity=0.287 Sum_probs=198.4
Q ss_pred HHHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 311 LMKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
-.|.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3567789999999999999985 458999999987655445566889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++... ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999998642 3588999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----ccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 ----NLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... ..+.. ...... ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~~~~~-~~~~~~---~~ 228 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFL-MTKSNF---QP 228 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------hhHHh-hhccCC---CC
Confidence 2345678899999874 456889999999999999999999998642210 00100 011110 00
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.... .......+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Ccccc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11100 01123468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.22 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=201.7
Q ss_pred HHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 311 LMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
-.+.+.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 3345668899999999999998788899999987543 335678999999999999999999999998889999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 85 KGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999997533 24589999999999999999999998 99999999999999999999999999987764321
Q ss_pred -----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 471 -----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 471 -----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+.+ ..+. . .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~~~~~~~----~~~~-~-~---- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT----NREVLEQV----ERGY-R-M---- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HcCC-C-C----
Confidence 1223457999999998889999999999999999999 999986321 11122211 1110 0 0
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
......+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011224578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=308.31 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=191.5
Q ss_pred HHcCcCCcccEEEEEEc----CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-CCeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-TDEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 390 (621)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 2457999998643 33446778899999999999999999998764 456789999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999997432 3467788899999999999999998 9999999999999999999999999998755321
Q ss_pred -------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 -------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK-FPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
....++..|+|||.+.+..++.++|||||||++|||++|. .||... ...+.... ...+...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~----~~~~~~~~----~~~~~~~--- 221 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DSFDITVY----LLQGRRL--- 221 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHH----HhcCCCC---
Confidence 1223456799999998888999999999999999999965 444321 11112211 1111100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.. ....+..+.+++.+||..+|++||++.|+++.|+++..
T Consensus 222 --~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 --LQ-----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00 11123568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=339.19 Aligned_cols=243 Identities=20% Similarity=0.248 Sum_probs=191.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 457899999999999984 458999999986432 1234567899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc--
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-- 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 468 (621)
+|+|.+++... ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 85 GGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999743 3578888899999999999999998 999999999999999999999999999753210
Q ss_pred ---------------------------------------------cccccccccccCcccccCCCCCcchhhHHHHHHHH
Q 045652 469 ---------------------------------------------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIIL 503 (621)
Q Consensus 469 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ 503 (621)
.....||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 01235788999999999999999999999999999
Q ss_pred HHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC---cHHHHH
Q 045652 504 EILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL---EMREAV 580 (621)
Q Consensus 504 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~evl 580 (621)
||++|+.||..... .+...... ... .....+ ........+.+++.+|+ .+|.+|+ ++.|++
T Consensus 236 ell~G~~Pf~~~~~-------~~~~~~i~-~~~-~~~~~~------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 236 EMLVGQPPFLADTP-------AETQLKVI-NWE-TTLHIP------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred ehhhCCCCCCCCCH-------HHHHHHHh-ccC-ccccCC------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999974221 11111111 100 000000 01123356777888876 5999999 899999
Q ss_pred HH
Q 045652 581 RR 582 (621)
Q Consensus 581 ~~ 582 (621)
+|
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 87
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.82 Aligned_cols=236 Identities=21% Similarity=0.322 Sum_probs=185.5
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHH-HHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEV-RRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999954 57889999986432 11223344444 457888999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc---
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--- 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 468 (621)
++|.+++... ..+....+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 9999998742 3477888889999999999999999 999999999999999999999999999875422
Q ss_pred -cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 -ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .....+. ... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~---i~~-~~~---------- 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEMYDN---ILN-KPL---------- 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC----HHHHHHH---HHh-CCc----------
Confidence 123457889999999999999999999999999999999999986421 1111111 111 110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAV 580 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 580 (621)
...+.....+.+++.+||+.||.+||++.+.+
T Consensus 214 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 00122345688999999999999999877443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.72 Aligned_cols=246 Identities=23% Similarity=0.420 Sum_probs=198.2
Q ss_pred HHHHcCcCCcccEEEEEEc-CC---cEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DG---VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
..+.||+|+||.||+|... ++ ..+++|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4578999999999999864 23 37999998754 3344667899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999996432 4589999999999999999999998 9999999999999999999999999998766432
Q ss_pred cc-------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 NL-------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 ~~-------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.. ...+..|+|||++....++.++|||||||++|||++ |+.||.... ..+.... +..+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~----~~~~~~~----i~~~~~~--- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS----NHEVMKA----INDGFRL--- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC----HHHHHHH----HhcCCCC---
Confidence 11 112346999999988889999999999999999998 999986421 1112221 1111100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.41 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=198.7
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCc----EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGV----TVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
.+.+.||+|+||.||+|.+ .++. .||+|.++.. .....+.+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence 3457899999999999984 3444 4899998743 34446678899999999999999999999875 45789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 89 LMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999743 23589999999999999999999999 99999999999999999999999999998764
Q ss_pred cccc------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 468 SANL------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 468 ~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
.... ...+..|+|||.+.+..++.++|||||||++|||++ |..||.... ...+..+ +..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~----~~~~~~~~- 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----AREIPDL----LEKGERLP- 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH----HHCCCcCC-
Confidence 3221 123457999999988889999999999999999998 888886321 1112222 22211100
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
........+.+++.+||+.||++||++.++++.|+++....
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01223457889999999999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=313.05 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=199.7
Q ss_pred HHHHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeE
Q 045652 311 LMKAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKL 383 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (621)
-.|.+.+.||+|+||.||+|... .+..||+|.++... ......+.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34556788999999999999743 24589999886443 233456789999999999999999999999989999
Q ss_pred EEEeecCCCChhHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 384 LVYEYIPGGSLLYLLHGDRG-----PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
+||||+++|+|.+++..... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999974321 1123467788899999999999999998 99999999999999999999999
Q ss_pred eeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHH
Q 045652 459 EFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 459 DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+ +...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~-~~~~ 233 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQ-VLKF 233 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHH
Confidence 999987653321 1223557999999988899999999999999999998 7888764211 11 1111
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
+..+..... .......+.+++.+||+.||++|||+.++++.|++..
T Consensus 234 ~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111110 1122357999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.97 Aligned_cols=246 Identities=23% Similarity=0.328 Sum_probs=206.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChh---hHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 387 (621)
|.+.+.||+|.||.||+++.. +|+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+++.|++....++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 345588999999999999954 4999999999754332 3568899999999998 9999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC----CCcEEEeeecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE----NEPLISEFGFY 463 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a 463 (621)
++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++
T Consensus 117 L~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred ecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999743 389999999999999999999998 99999999999999744 47999999999
Q ss_pred eecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 464 TMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 464 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
...... ....||+.|+|||++....|+..+||||+||++|.|++|..||..... ..... .+..+.. ++
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~----~~~~~----~i~~~~~-~f 257 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE----FEIFL----AILRGDF-DF 257 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh----hHHHH----HHHcCCC-CC
Confidence 988763 456789999999999999999999999999999999999999985332 11111 2222222 11
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
. ...++.....+.+++..|+..||.+|+|+.++++|-
T Consensus 258 ~------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 258 T------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred C------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 1 122455677899999999999999999999999973
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.49 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=193.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC-----eeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD-----EKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ 386 (621)
+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..|+||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 457899999999999995 46899999998643 2234567889999999999999999999998776 789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 84 ELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9996 588888753 34689999999999999999999999 9999999999999999999999999999865
Q ss_pred ccc-----ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc--
Q 045652 467 NSA-----NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT-- 538 (621)
Q Consensus 467 ~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 538 (621)
... ....++..|+|||++.+. .++.++|||||||++|||++|+.||..... .+....+..........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP----IQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHcCCCCHHHH
Confidence 432 123457789999998764 479999999999999999999999964321 11111111111100000
Q ss_pred -------------cccc-cchhc-CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 -------------DLLD-PEIAS-STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 -------------~~~d-~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... +.... ........+++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 00000 00011224678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=307.99 Aligned_cols=243 Identities=23% Similarity=0.393 Sum_probs=195.1
Q ss_pred HHcCcCCcccEEEEEEcC----CcEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMAD----GVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|.+.. +..||+|.+..... ...+.+.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999997422 26899999875443 34567889999999999999999999875 4567999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL 471 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 471 (621)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999743 2588999999999999999999998 999999999999999999999999999886643321
Q ss_pred -------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 472 -------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 472 -------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
..++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+....+ ......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~~~~----~~~~~~----- 217 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAML----ESGERL----- 217 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHH----HcCCcC-----
Confidence 112346999999988899999999999999999998 999986421 12222222 111100
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
......+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011223357899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=323.92 Aligned_cols=240 Identities=21% Similarity=0.275 Sum_probs=191.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++..+ +|++|+++++++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 3567999999999999854 57899999987432 22334566788888877 5899999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 84 NGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999988642 3588999999999999999999998 999999999999999999999999999876432
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....+++.|+|||++.+..++.++|||||||++|||+||+.||.... ...+... +..... ..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~----i~~~~~------~~ 220 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQS----IMEHNV------AY 220 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC----HHHHHHH----HHhCCC------CC
Confidence 123457889999999999999999999999999999999999996421 1112221 111111 00
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcH-----HHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEM-----REAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 582 (621)
+.....++.+++.+||+.||++|++. .+++++
T Consensus 221 -----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 221 -----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11234568899999999999999984 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=307.74 Aligned_cols=243 Identities=21% Similarity=0.328 Sum_probs=195.4
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-----AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
...+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 3467899999999999985 458999999886432 1123568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 85 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 85 YMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred ECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999998742 3578889999999999999999998 99999999999999999999999999987653
Q ss_pred cc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 468 SA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 468 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
.. ....++..|+|||++.+..++.++||||||+++|||++|+.||.... ....+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~--- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQPTN--- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-------hHHHHHHHhccCCC---
Confidence 32 12345668999999998889999999999999999999999986321 11111111111110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.. .......+.+++.+||..+|++|||+.|++++
T Consensus 226 --~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 --PQL-----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCC-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 12234568899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.56 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=192.6
Q ss_pred HHHHcCcC--CcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNG--GLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.++||+| +|++||++.. .+|+.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7889999984 568999999987432 334456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 9999999986432 23588999999999999999999998 9999999999999999999999999865433211
Q ss_pred -----------ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 470 -----------NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 470 -----------~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~-----~~~ 226 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKL-----NGT 226 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHh-----cCC
Confidence 12234567999999975 458999999999999999999999997432110 000000 000
Q ss_pred cccccc-------------------cch----------------hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHH
Q 045652 537 VTDLLD-------------------PEI----------------ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581 (621)
Q Consensus 537 ~~~~~d-------------------~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 581 (621)
.....+ ... ............+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000000 000 000011123467899999999999999999999998
Q ss_pred H
Q 045652 582 R 582 (621)
Q Consensus 582 ~ 582 (621)
+
T Consensus 307 ~ 307 (327)
T cd08227 307 H 307 (327)
T ss_pred C
Confidence 6
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.05 Aligned_cols=246 Identities=22% Similarity=0.397 Sum_probs=197.5
Q ss_pred HHHHcCcCCcccEEEEEEcC-C---cEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMAD-G---VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|.... + ..||+|.++.. .....+.|..|+.++++++||||+++++++.+....++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 45789999999999998543 3 36999998754 3445678999999999999999999999999989999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++.... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999987432 3589999999999999999999998 9999999999999999999999999998765332
Q ss_pred cc-------cc--ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 470 NL-------AQ--ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 470 ~~-------~~--~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.. .. .+..|+|||++.+..++.++|||||||++|||++ |..||.... ..+..+++ .... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~----~~~~~~~i----~~~~--~ 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVINAI----EQDY--R 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC----HHHHHHHH----HcCC--c
Confidence 11 11 1346999999998899999999999999999886 999986421 11222222 1110 0
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
. ....+.+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 230 -----~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -----L---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00123345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=296.08 Aligned_cols=260 Identities=22% Similarity=0.361 Sum_probs=213.8
Q ss_pred ChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEE
Q 045652 307 GLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 307 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 384 (621)
.++|+++-+.+.||+|+|+.|--+. ..+|..+|||++.+.....+....+|++++.+.+ |+||++++++|+++...||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 3678888899999999999999998 7789999999998887778888999999999995 9999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC---cEEEeee
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE---PLISEFG 461 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG 461 (621)
|||.|.||.|..+|++ ...+++.++.+++.+|+.||.|||.+ ||.||||||+|||...... +||+||.
T Consensus 154 VfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999984 45689999999999999999999999 9999999999999986654 7999998
Q ss_pred cceecccc-----------ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcc--
Q 045652 462 FYTMINSA-----------NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID-- 523 (621)
Q Consensus 462 ~a~~~~~~-----------~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~-- 523 (621)
+..-+... ....|+..|||||+.. ...|+.++|.||||||+|-|+.|..||.+....+-+.+
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 86544211 1223445699999863 34689999999999999999999999987655333321
Q ss_pred -----hHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 524 -----VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 524 -----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
-.+.+...+++|.. ++-| ..+.....+..+++...+..|+.+|.++.+++.+
T Consensus 305 e~Cr~CQ~~LFesIQEGkY-eFPd------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKY-EFPD------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CccHHHHHHHHHHHhccCC-cCCh------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 22334445555542 2222 2235666788999999999999999999999985
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=328.03 Aligned_cols=245 Identities=16% Similarity=0.226 Sum_probs=192.9
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 345578999999999999954 5889999998642 122345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 125 ~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 125 MPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999863 2478888999999999999999999 999999999999999999999999999987643
Q ss_pred c-----ccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 469 A-----NLAQALFAYKAPEAIQSG----KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 469 ~-----~~~~~~~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
. ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.... ................
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~ 267 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-------LVGTYSKIMDHKNSLN 267 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCcccC
Confidence 2 234578899999998654 37889999999999999999999997421 1111222211111000
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCC--CCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQ--RLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 582 (621)
. .........+.+++.+|+..++.+ |+++.|+++|
T Consensus 268 -----~---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 -----F---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----C---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 011123456788899999865543 8899999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=312.78 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=199.6
Q ss_pred HHHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 445678999999999999853 46789999987543 34456789999999999999999999999998899999
Q ss_pred EeecCCCChhHHhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 386 YEYIPGGSLLYLLHGDRG-----------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
|||+++++|.+++..... .....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~nil 162 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATRNCL 162 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHhheE
Confidence 999999999999974321 1123578889999999999999999998 9999999999999
Q ss_pred eCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCC
Q 045652 449 ISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGG 521 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 521 (621)
++.++.++|+|||++....... ....+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~----- 237 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA----- 237 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 9999999999999987653321 1223456999999988899999999999999999998 888875321
Q ss_pred cchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
..+.. ..+..+.... .....+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 238 --~~~~~-~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 --HEEVI-YYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHH-HHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 2222222111 011234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.32 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=198.0
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
...+.||+|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++......++||||++++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~ 102 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence 3456799999999999984 568999999987655555677889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 103 ~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 103 SLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999863 2478899999999999999999998 9999999999999999999999999988765432
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ............ ...
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~~~~~~~-~~~-------- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT-PEL-------- 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHHHhcCCC-CCC--------
Confidence 223567789999999888899999999999999999999999864211 111111111110 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.........+.+++.+||..||++||++.|++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0112334568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=306.95 Aligned_cols=237 Identities=24% Similarity=0.406 Sum_probs=190.5
Q ss_pred HHcCcCCcccEEEEEEcC-C----------cEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 317 EVLGNGGLGSSYKAMMAD-G----------VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999999654 3 25788877654333 6788899999999999999999999988 778999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-------CcEEE
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-------EPLIS 458 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~ 458 (621)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeC
Confidence 99999999999997533 2588999999999999999999998 999999999999999888 79999
Q ss_pred eeecceeccccccccccccccCcccccCC--CCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 459 EFGFYTMINSANLAQALFAYKAPEAIQSG--KVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 459 DfG~a~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
|||++..........++..|+|||++.+. .++.++|||||||++|||++ |..||..... .....+ +...
T Consensus 151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~----~~~~~~----~~~~ 222 (259)
T cd05037 151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS----SEKERF----YQDQ 222 (259)
T ss_pred CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc----hhHHHH----HhcC
Confidence 99999876655455566789999999876 78999999999999999999 5777654321 111111 1111
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.. ... .....+.+++.+||..+|++|||+.|+++.|
T Consensus 223 ~~-------~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 HR-------LPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CC-------CCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 000 0115789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=316.55 Aligned_cols=245 Identities=22% Similarity=0.260 Sum_probs=195.1
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+.+++.+.+.+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 46799999999999985 468999999886432 22234577899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999886432 24588999999999999999999998 99999999999999999999999999987654322
Q ss_pred --cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 --LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 --~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.......... ...
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~----~~~~~~~~~~~~~------~~~--- 224 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVQ------EEY--- 224 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc----hHHHHHhhhhhhh------hhc---
Confidence 2357789999999998899999999999999999999999997422110 0011111111000 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
.......+.+++.+||+.||++||| ++|+++|
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 --SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1123356889999999999999999 8899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=322.17 Aligned_cols=232 Identities=21% Similarity=0.330 Sum_probs=184.0
Q ss_pred HcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHH-HHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 318 VLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVR-RLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6899999999999964 58899999986432 122334555554 678899999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 82 ELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence 99988863 23578888999999999999999998 9999999999999999999999999998753221
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... ....... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~-i~~~~~----------- 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDN-ILHKPL----------- 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHH-HhcCCC-----------
Confidence 23457889999999998899999999999999999999999986421 1111111 111110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMR 577 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 577 (621)
..+......+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00122335688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.33 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=198.6
Q ss_pred HHHHHcCcCCcccEEEEEEc----CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 314 AAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.+.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 35678999999999999853 23479999987532 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..+..
T Consensus 87 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 87 MENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999997432 3589999999999999999999998 999999999999999999999999999887643
Q ss_pred ccc-------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 469 ANL-------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 469 ~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
... ...+..|+|||++.+..++.++||||||+++||+++ |..||..... .+....+ .++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~~~----~~~~~--- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIKAI----EEGYR--- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHHHH----hCCCc---
Confidence 321 112346999999998889999999999999999886 9999864221 1122221 11110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
. ......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 --~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --L-----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --C-----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=336.20 Aligned_cols=261 Identities=20% Similarity=0.300 Sum_probs=189.9
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--------CeeE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--------DEKL 383 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~ 383 (621)
|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++... ...+
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 34567899999999999985 458999999886432 2345799999999999999999987542 1356
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeec
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGF 462 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~ 462 (621)
+||||+++ +|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 144 lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 99999975 77776643211 234688999999999999999999999 999999999999999665 699999999
Q ss_pred ceecccc---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc--
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR-- 536 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 536 (621)
++.+... ....++..|+|||++.+. .++.++|||||||++|||++|..||.... ..+....+...+....
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS----SVDQLVRIIQVLGTPTED 293 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCHH
Confidence 9876432 234567889999998654 68999999999999999999999986422 1122222211111100
Q ss_pred --------cccccccchh----cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhh
Q 045652 537 --------VTDLLDPEIA----SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQ 587 (621)
Q Consensus 537 --------~~~~~d~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 587 (621)
..+..-+... ....+...+.++.+|+.+||++||.+|||+.|+++| +..+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000000000 000011234578999999999999999999999987 44443
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=310.37 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=204.6
Q ss_pred HHHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 311 LMKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
-.|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 34567899999999999999854 58899999876432 33467789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++... ..+++..+..++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNV---HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHh---cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999988642 3588999999999999999999963 1799999999999999999999999999865532
Q ss_pred c--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCC----CCcchHHHHHHHhhcCccccccc
Q 045652 469 A--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGN----GGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
. ....++..|+|||++.+..++.++|||||||++|+|+||+.||....... ....+.+.+........
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 230 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------ 230 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------
Confidence 2 23457788999999988889999999999999999999999997533211 11112222222221110
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
+.+ .....+..+.+++.+||+.||++|||+.|++++..-++
T Consensus 231 ~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 PRL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 000 01123457899999999999999999999998754443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=310.68 Aligned_cols=247 Identities=19% Similarity=0.313 Sum_probs=198.8
Q ss_pred HHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.|.+.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.++++++|+||+++++++..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4567889999999999999964 489999999987666667788999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|..++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 93 GGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99998887543 23588999999999999999999998 9999999999999999999999999988764322
Q ss_pred ---ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 ---NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
....++..|+|||++. ...++.++|||||||++|||++|+.||.... ..+.+.... ....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~-~~~~---- 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIA-KSEP---- 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-------HHHHHHHHh-cCCC----
Confidence 2334667899999984 3457889999999999999999999986421 111111111 1111
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.. ........++.+++.+||..||++||++.|++++
T Consensus 233 -~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 -PTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -ccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 100 0112233568899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.50 Aligned_cols=191 Identities=25% Similarity=0.375 Sum_probs=157.8
Q ss_pred HHcCcCCcccEEEEEEc---CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA---DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 391 (621)
++||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 57999999999999854 46889999987542 23456789999999999999999998865 345789999985
Q ss_pred CChhHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe----CCCCCcEEEeeecc
Q 045652 392 GSLLYLLHGDRG----PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI----SPENEPLISEFGFY 463 (621)
Q Consensus 392 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a 463 (621)
++|.+++..... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 588888753321 1123588999999999999999999999 99999999999999 45678999999999
Q ss_pred eecccc-------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 464 TMINSA-------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 464 ~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
+..... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876432 234567889999998764 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=315.70 Aligned_cols=254 Identities=19% Similarity=0.331 Sum_probs=202.0
Q ss_pred ccCChhHHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEcc--CCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCC
Q 045652 304 GVFGLPDLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMK--ESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTD 380 (621)
Q Consensus 304 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 380 (621)
..+.+..-.|.+.++||+||.+.||++...+.+.+|+|++. ..+....+.|.+|+..|.+|+ |.+||++++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 34566777888999999999999999999888899998775 345566788999999999995 999999999999999
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..||||||- ..+|..+|+.... .+....+..+..|++.++.++|++ ||||.||||.|+|+- .|.+||+||
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEE-eeeEEeeee
Confidence 999999996 4599999986542 233226778999999999999999 999999999999998 678999999
Q ss_pred ecceecccc------ccccccccccCcccccCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcc
Q 045652 461 GFYTMINSA------NLAQALFAYKAPEAIQSG-----------KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID 523 (621)
Q Consensus 461 G~a~~~~~~------~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 523 (621)
|+|..+... ....||+.||+||.+... +.+.++||||+|||||+|+.|+.||....
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------- 576 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------- 576 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------
Confidence 999988654 345789999999998532 25689999999999999999999997421
Q ss_pred hHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+. ++..+.+|...-.+.......+++++++.||..||.+||++.|+|++
T Consensus 577 --n~~a------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 --NQIA------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHH------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1111 12223333211111111112339999999999999999999999986
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.49 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=197.3
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.||+|+||.||++.. .++..+|+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 3456799999999999985 45888999988644 233456688999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
++|.++++.. ..+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 84 GSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC----CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999743 458889999999999999999997 4 7999999999999999999999999998765332
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc----------
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT---------- 538 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 538 (621)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .................
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhcCccccccccCCcccccCCC
Confidence 334567789999999888899999999999999999999999863221 11111110000000000
Q ss_pred ----------ccccc---chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 539 ----------DLLDP---EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 539 ----------~~~d~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
+..+. .............++.+++.+||..||++||+++|++++.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000 00000000123456899999999999999999999998843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=304.74 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=196.6
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
++||+|+||.||++...+++.|++|.++..... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999766999999998754333 5677899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-----
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN----- 470 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~----- 470 (621)
+++.... ..+++..++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9996432 3578889999999999999999998 99999999999999999999999999987654221
Q ss_pred -cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 -LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 -~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+..|+|||.+.+..++.++|||||||++|||+| |..||..... ...... +.... ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~~~----~~~~~--~~-------- 214 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTRER----IESGY--RM-------- 214 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHHHH----HhcCC--CC--------
Confidence 1122456999999988899999999999999999999 7888764221 111111 11110 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
......+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011233457999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.69 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=190.8
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 384 (621)
.+.+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.... ..++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 3457899999999999985 45899999998643 2334566789999999999999999999986543 4689
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+++ +|.+.++ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 104 v~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 104 VMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred EEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 9999965 6766664 2378888999999999999999999 99999999999999999999999999987
Q ss_pred ecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCC-----------CCcchHHHH--
Q 045652 465 MINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGN-----------GGIDVVEWV-- 528 (621)
Q Consensus 465 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-----------~~~~~~~~~-- 528 (621)
..... ....++..|+|||++.+..++.++|||||||++|||++|+.||....... ........+
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 65332 23456788999999999999999999999999999999999997432100 000000000
Q ss_pred --HHHhhcC-ccc-----cccccch-hc-CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 529 --ASAFSEG-RVT-----DLLDPEI-AS-STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 529 --~~~~~~~-~~~-----~~~d~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
....... ... +...... .. ..........+.+++.+||+.||++|||+.|+++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000 000 0000000 00 000011235689999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=308.51 Aligned_cols=250 Identities=21% Similarity=0.373 Sum_probs=199.5
Q ss_pred HHHHHHcCcCCcccEEEEEEcC----CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 3456789999999999998543 3578999887554 4456789999999999999999999998865 55789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 87 LAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999997432 3589999999999999999999998 99999999999999999999999999987764
Q ss_pred cccc-----ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 468 SANL-----AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 468 ~~~~-----~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.... ...+..|+|||.+....++.++||||||+++|||++ |..||..... .+.... +..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~----~~~~~~~--- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGR----IENGERL--- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHH----HHcCCcC---
Confidence 3321 122357999999988889999999999999999996 9999864321 111111 1111100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
......+..+.+++.+||..+|++|||+.++++.|+++...
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01123345789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.30 Aligned_cols=245 Identities=24% Similarity=0.259 Sum_probs=195.1
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++|+||+.+.+++...+..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 35799999999999985 468999999986432 22234577899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99998886432 23589999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++|||||||++|||++|..||..... ....+.+......... .
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~~~~~~~--~-------- 223 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRRVLETEE--V-------- 223 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhhcccc--c--------
Confidence 224567899999999888999999999999999999999999874211 1111112222211110 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
........+.+|+.+||+.||++||+ +.+++.+
T Consensus 224 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 -YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01223356789999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=308.51 Aligned_cols=244 Identities=22% Similarity=0.363 Sum_probs=198.9
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 456778999999999999985 457899999887432 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+...
T Consensus 85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999998853 3578899999999999999999998 9999999999999999999999999998766433
Q ss_pred c----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 N----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ~----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
. ...++..|+|||++.+..++.++|||||||++|||++|+.|+..... ..... ....+. .+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~----~~~~~~-----~~~~ 221 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLF----LIPKNS-----PPTL 221 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch----hhHHh----hhhcCC-----CCCC
Confidence 2 23456789999999988899999999999999999999999863221 11111 111111 1111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.......+.+++.+||+.+|++||++.+++++-
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 222 -----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred -----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 122345689999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=320.98 Aligned_cols=256 Identities=18% Similarity=0.266 Sum_probs=193.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 4578999999999999854 57899999987432 22334577899999999999999999999999999999999975
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 89 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 89 DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 8888876432 3478889999999999999999998 9999999999999999999999999998765332
Q ss_pred -ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---cc------
Q 045652 470 -NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---VT------ 538 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~------ 538 (621)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... .+....+...+.... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV----EDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 22346778999998865 4689999999999999999999999864221 111111211111000 00
Q ss_pred cccccchhcC------CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 539 DLLDPEIASS------TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 539 ~~~d~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+..+...... ...+....++.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000000000 00112345688999999999999999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.24 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=199.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.++||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 3468999999999999854 5899999998743 23345678999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 391 GGSLLYLLHGDRG------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 391 ~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|++|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999864211 0123467788899999999999999998 99999999999999999999999999997
Q ss_pred ecccc----------------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc
Q 045652 465 MINSA----------------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI 522 (621)
Q Consensus 465 ~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 522 (621)
..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~----~ 237 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG----R 237 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch----h
Confidence 65210 123478899999999999999999999999999999999999864211 1
Q ss_pred chHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-cHHHHHHHHHHhhcc
Q 045652 523 DVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-EMREAVRRIVEIQQS 589 (621)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~~~ 589 (621)
.... . .. ..++... ......+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus 238 ki~~---~----~~---i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISY---R----DV---ILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh---h----hh---ccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1100 0 00 0011000 00123345688999999999999996 567777778776543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.80 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=199.1
Q ss_pred HHHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
|...+.||+|+||.||+|...+ ++.|++|.+..... .+.+.+|++++++++|+||+++++++......++++||+++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 4567889999999999999655 78999999875432 67899999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 83 GSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999998643 24689999999999999999999998 99999999999999999999999999988765432
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...++..|+|||++.+..++.++||||||+++|+|++|+.||...... +.+.. ...... +.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~-----~~--- 218 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RAIFM-IPNKPP-----PT--- 218 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-------hhhhh-hccCCC-----CC---
Confidence 234667899999998889999999999999999999999998742211 00000 000000 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..........+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 01112234578999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=308.95 Aligned_cols=246 Identities=21% Similarity=0.310 Sum_probs=193.4
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeC------CeeE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRT------DEKL 383 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~ 383 (621)
.|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++.++ +|+||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 345678899999999999985 458899999986543 3346788999999999 699999999998753 3578
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+|+||||+||++++++.++|+|||++
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999987532 24588999999999999999999998 9999999999999999999999999998
Q ss_pred eecccc----ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 464 TMINSA----NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 464 ~~~~~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
...... ....++..|+|||++. +..++.++|||||||++|||++|+.||..... .... .....
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~-~~~~~- 230 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRAL-FLIPR- 230 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHH-HHHhc-
Confidence 765332 2345677899999986 34588899999999999999999999863211 1111 11111
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....... .......+.+++.+||..||.+|||+.|++++
T Consensus 231 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NPAPRLK---------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCC---------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1000000 11233568999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=307.22 Aligned_cols=245 Identities=27% Similarity=0.436 Sum_probs=198.0
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.+.||+|+||.||++...++..+++|.++... ...+.+.+|++++++++|+||+++++++.. ...+++|||+++++
T Consensus 9 ~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05073 9 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGS 86 (260)
T ss_pred eEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence 3457899999999999997778889999887543 345678899999999999999999999877 77899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc--
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-- 471 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 471 (621)
|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+........
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 87 LLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred HHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999997533 24578889999999999999999998 999999999999999999999999999876543211
Q ss_pred ---ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 472 ---AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 472 ---~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
..++..|+|||++....++.++|||||||++|+++| |+.||.... ....... +..+....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~----~~~~~~~~-------- 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRA----LERGYRMP-------- 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----HHHHHHH----HhCCCCCC--------
Confidence 223456999999988889999999999999999999 899986421 1112222 11111100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
.....+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 012234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.20 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=199.0
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 344567899999999999995 5689999999876555556778899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 100 GGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999863 3478889999999999999999998 99999999999999999999999999987654332
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .........+ . +.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-------~~~~~~~~~~-~-----~~-- 234 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNG-T-----PE-- 234 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------hheeeeccCC-C-----CC--
Confidence 234667899999999888999999999999999999999998642210 0000000000 0 00
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..........+.+++.+||+.+|++||++.+++++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 -LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112234568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.16 Aligned_cols=247 Identities=20% Similarity=0.332 Sum_probs=200.4
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.|.+.+.||+|+||.||++.. .++..||+|.++.......+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 467889999999999999985 4689999999986666666789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 86 GGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999986432 3589999999999999999999999 9999999999999999999999999987655332
Q ss_pred ---ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 ---NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
....++..|+|||.+. ...++.++||||||+++|||++|+.||.... ..+.+.. +..+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-------~~~~~~~-~~~~~~~~~~ 229 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-------PMRVLLK-ILKSEPPTLD 229 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-------HHHHHHH-HhcCCCCCcC
Confidence 2234677899999874 3457889999999999999999999986421 1111111 1111111110
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||+.+|++||++.+++++
T Consensus 230 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 --------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 012233568899999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.39 Aligned_cols=254 Identities=14% Similarity=0.189 Sum_probs=194.3
Q ss_pred HHHHHHcCcCCcccEEEEEEc---CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA---DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|||++
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 455678999999999999743 3578999988643 23468999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
. ++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++......
T Consensus 169 ~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 169 K-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred C-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 5 688888842 34689999999999999999999998 9999999999999999999999999998765432
Q ss_pred c------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc-----
Q 045652 470 N------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT----- 538 (621)
Q Consensus 470 ~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 538 (621)
. ...+|..|+|||++.+..++.++|||||||++|||++|+.||........ ......+.+.+......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS-SSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc-HHHHHHHHHHhccCccccCCcc
Confidence 1 23578899999999988999999999999999999999999975433221 11111122211111000
Q ss_pred ------------cccccchhcC--CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 ------------DLLDPEIASS--TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ------------~~~d~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....+..... ........++.+++.+||..||++|||+.|++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0001123467889999999999999999999987
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.43 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=204.0
Q ss_pred HHHHHHcCcCCcccEEEEEEcC--C--cEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD--G--VTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
....++||+|+||.|++|.|.. | ..||||.++..... ....|.+|+.+|.+|+|||++++||+..+ ....||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3467999999999999998643 3 57899999866544 67899999999999999999999999877 67889999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
.++.|+|.+.|+.. ....|.......++.|||.|++||.++ ++|||||..+|+|+-....+||+|||+.+.+.
T Consensus 191 LaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999862 245688888899999999999999999 99999999999999999999999999998876
Q ss_pred cccc-------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 468 SANL-------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 468 ~~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.... ..-.+.|.|||.+...+++.++|||+|||++|||+| |..||.+.. ...+. +.+.++.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----g~qIL----~~iD~~e--- 332 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----GIQIL----KNIDAGE--- 332 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----HHHHH----Hhccccc---
Confidence 5422 123457999999999999999999999999999998 788987532 12222 2222211
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
++ ..++.+.+++.+++++||..+|++|||+..+.+.+-..
T Consensus 333 ----rL---pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 333 ----RL---PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ----cC---CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 11 22356778899999999999999999999998655433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.31 Aligned_cols=257 Identities=19% Similarity=0.250 Sum_probs=189.6
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCCcccceEEEEeC-----Cee
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRL---RHSNVLAPLAYHYRT-----DEK 382 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~~ 382 (621)
.+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+++++++ +||||+++++++... ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 3456799999999999985 468999999886432 11233456777777665 699999999988652 347
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred EEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCc
Confidence 89999997 48988886432 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR--- 536 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 536 (621)
+...... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC----HHHHHHHHHHHhCCCChhh
Confidence 8876433 22346778999999988899999999999999999999999886421 1111111111111000
Q ss_pred ccc-------ccccchhc--CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VTD-------LLDPEIAS--STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~~-------~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... ...+.... ....+.....+.+++.+||+.||++|||+.|++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000000 00012334568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=305.35 Aligned_cols=243 Identities=21% Similarity=0.295 Sum_probs=197.0
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||++.. .+++.||+|.++.. .....+.+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 346799999999999985 46899999988632 3344567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.+++.... ...++...++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+.......
T Consensus 84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999886432 23578899999999999999999998 99999999999999999999999999987664432
Q ss_pred --cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 --LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 --~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.... ...... ....+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~-~~~~~~~~~~-------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLIL-KVCQGSYKPL-------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHH-HHhcCCCCCC--------
Confidence 2446778999999988889999999999999999999999986311 111111 1112211110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.||++||++.+++..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=309.01 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=201.0
Q ss_pred HHHHHHcCcCCcccEEEEEEc-----CCcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-----DGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLL 384 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 384 (621)
+.+.+.||+|+||.||+|.+. ++..||||.++..... ..+.+.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999853 3689999999755433 46789999999999999999999999877 456899
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 86 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999997532 2589999999999999999999998 99999999999999999999999999988
Q ss_pred eccccc-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCC-------cchHHHHHH
Q 045652 465 MINSAN-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG-------IDVVEWVAS 530 (621)
Q Consensus 465 ~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~-------~~~~~~~~~ 530 (621)
...... ....+..|+|||.+.+..++.++||||||+++|||+||..|+......... ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765321 122344699999998889999999999999999999999997642211100 001111111
Q ss_pred HhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.+..... .......+.++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 238 ~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 001122336799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.37 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=189.7
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+..|..++..+. |++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 46799999999999985 468999999987432 223456778999998886 5778889999998899999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 85 GGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999998642 3589999999999999999999998 9999999999999999999999999998754322
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+ ..... ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~~~~i----~~~~~------~~- 220 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED----EDELFQSI----MEHNV------SY- 220 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHH----HhCCC------CC-
Confidence 23447889999999998899999999999999999999999987421 11111111 11111 00
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcH-----HHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEM-----REAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 582 (621)
+......+.+++.+||+.+|.+|++. +++.+|
T Consensus 221 ----p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 221 ----PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 11223568899999999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.31 Aligned_cols=256 Identities=18% Similarity=0.156 Sum_probs=189.2
Q ss_pred HHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.|.+.+.||+|+||.||+|... +++.||+|+..... ...|+.++++++||||+++++++......++||||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 3556688999999999999954 47889999754322 3469999999999999999999999999999999995
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
++|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 -~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 141 -SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred -CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 6888888643 24589999999999999999999998 9999999999999999999999999998754322
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc---chHHHHHHHhhcCc-----cc-
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI---DVVEWVASAFSEGR-----VT- 538 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~-----~~- 538 (621)
....++..|+|||++.+..++.++|||||||++|||+++..|+.......... .....+...+.... ..
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 23457889999999998899999999999999999999766654322111000 00111111111000 00
Q ss_pred --------ccccc-chhc-C------CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 --------DLLDP-EIAS-S------TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 --------~~~d~-~~~~-~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+++. .... . .........+.+++.+||+.||++|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00000 0000 0 0001123456679999999999999999999976
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.21 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=187.1
Q ss_pred HcCcCCcccEEEEEEcCC---cEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMADG---VTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||++...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975443 356677765432 3346788999999999999999999999999989999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS----- 468 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 468 (621)
|.++++.... ....+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999975432 133467777889999999999999998 999999999999999999999999998764321
Q ss_pred -cccccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 469 -ANLAQALFAYKAPEAIQS-------GKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.... ..+.+...... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~~-~~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-------DREVLNHVIKD-QQVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhh-cccc
Confidence 123345678999998743 245789999999999999997 466765321 11222222222 1222
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
..++.+.. .....+.+++..|| .+|++||+++++++.|
T Consensus 229 ~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLEL-----PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCC-----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 33333322 23356788999999 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.32 Aligned_cols=250 Identities=21% Similarity=0.358 Sum_probs=198.5
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
|.+.+.||+|+||.||++... +++.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456789999999999999965 6899999988643 33345678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
+++|..++.... ....+++..+..++.|++.||.|||+ . +|+|+||||+||+++.++.+||+|||++..+...
T Consensus 83 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 83 AGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred CCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcC----CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999987432 13468999999999999999999996 4 8999999999999999999999999998765332
Q ss_pred --ccccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 --NLAQALFAYKAPEAIQSG------KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+... ..+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~-~~~~~~--- 228 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET----YANIFAQLSAI-VDGDPP--- 228 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc----hhhHHHHHHHH-hhcCCC---
Confidence 233466789999998544 35889999999999999999999986421 11111111111 111110
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
........++.+++.+||+.+|++||++.+++.+-
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 229 -------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred -------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 11123456789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.24 Aligned_cols=245 Identities=16% Similarity=0.232 Sum_probs=192.1
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 44578999999999999954 58899999986321 223455788999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.+++.. ..++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 126 PGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 99999999863 2478888899999999999999999 9999999999999999999999999999876432
Q ss_pred -----ccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSG----KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.... .................
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~ 268 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNHKNSLTF 268 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCcccC
Confidence 234578899999998653 37899999999999999999999997421 11111222111110010
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCC--CCcHHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQ--RLEMREAVRRI 583 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~L 583 (621)
.........+.+++.+||..++.+ |+++.|+++|.
T Consensus 269 --------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 --------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 011233466889999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.97 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=191.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 456799999999999995 45899999998642 12234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 85 GGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999642 23588899999999999999999999 99999999999999999999999999987654322
Q ss_pred -----cccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 471 -----LAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 471 -----~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
...++..|+|||++.. ..++.++|||||||++|||++|+.||... ...+.............+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGKIMNHKEHFQF 229 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-------CHHHHHHHHHcCCCcccC
Confidence 2357889999999863 45788999999999999999999998632 112222222211110110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCC--CCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPE--QRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~Rps~~evl~~ 582 (621)
..........+.+++.+|+..+++ .|+++.++++|
T Consensus 230 -------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 -------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011112345678888887765443 47899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=304.75 Aligned_cols=242 Identities=21% Similarity=0.411 Sum_probs=196.1
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.+.||+|+||.||++.+.++..+|+|.++... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred EEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 457799999999999998778899999887433 2346788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---- 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~---- 470 (621)
.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 87 SDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99987432 3478999999999999999999998 99999999999999999999999999987653321
Q ss_pred -cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 -LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 -~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+ .+..+. ....+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~----~~~~~~--~~~~~~---- 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS----NSEVVE----TINAGF--RLYKPR---- 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC----HHHHHH----HHhCCC--CCCCCC----
Confidence 1123457999999988889999999999999999998 899986311 111111 111111 111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.....+.+++.+||+.+|++||++.|++++|
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.30 Aligned_cols=244 Identities=21% Similarity=0.341 Sum_probs=200.1
Q ss_pred HHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4556788999999999999854 58899999887432 344567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 99999999863 3478889999999999999999998 9999999999999999999999999998766432
Q ss_pred c----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 N----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ~----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
. ...++..|+|||++.+..++.++|||||||++|||+||+.||...... .... ......
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~----~~~~~~--------- 217 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVLF----LIPKNN--------- 217 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHhh----hhhcCC---------
Confidence 2 234567799999998888999999999999999999999998642210 1110 111111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
........+..+.+++.+||+.+|++||++.+++++-
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 0111234567789999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.70 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=198.8
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
|.+.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456788999999999999954 58899999986443 3345678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.....
T Consensus 83 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 83 GGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999998632 588999999999999999999998 9999999999999999999999999999876543
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||++.+..++.++||||||+++|||+||+.||..... .... ..+..... +...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~-~~~~~~~~-----~~~~ 219 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVL-FLIPKNNP-----PSLE 219 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHH-HHhhhcCC-----CCCc
Confidence 233466789999999988899999999999999999999999864221 1111 11111111 1111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ......+.+++.+||..+|++||++++++++
T Consensus 220 ~----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 G----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 1134568899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.54 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=190.5
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||++... +++.||+|+++... ......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999854 58999999986432 22345678899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 86 GDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred ccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999743 3588999999999999999999999 9999999999999999999999999998654211
Q ss_pred -------------------------------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 045652 470 -------------------------------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPS 512 (621)
Q Consensus 470 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 512 (621)
....||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 1234788999999999999999999999999999999999999
Q ss_pred CcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc---HHHHHHH
Q 045652 513 QYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE---MREAVRR 582 (621)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 582 (621)
..... . ....... .......+.+ . .....++.+++.+|+ .||.+|++ +.|+++|
T Consensus 237 ~~~~~----~---~~~~~i~-~~~~~~~~p~----~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETP----Q---ETYRKVM-NWKETLVFPP----E---VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCH----H---HHHHHHH-cCCCceecCC----C---CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 64221 1 1111111 1000000000 0 112356788888876 49999985 6788776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=310.84 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=196.2
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
...||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 56799999999999985 45889999998765555567789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++...... .
T Consensus 107 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 107 TDIVTH------TRMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 998853 3478899999999999999999998 9999999999999999999999999998654322 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.... .......+...+ .+....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~~~~~~---------~~~~~~--- 240 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP----PLQAMRRIRDNL---------PPRVKD--- 240 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcC---------CCcccc---
Confidence 2346778999999988889999999999999999999999986321 111111111110 111100
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||..||++|||++|++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233568889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.61 Aligned_cols=246 Identities=19% Similarity=0.315 Sum_probs=203.4
Q ss_pred HHHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
..++..||.|+||.||+|..++ +...|.|++........+.|.-||+||..++||+||++++.|+..+..+++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3466779999999999999654 556678888877777889999999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc---
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--- 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 468 (621)
|-....+-.- ...+++.++.-+++|++.||.|||+. +|||||||..|||++-+|.++|+|||.+.....
T Consensus 114 GAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 114 GAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred chHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999888653 35699999999999999999999999 999999999999999999999999998765432
Q ss_pred -cccccccccccCcccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 469 -ANLAQALFAYKAPEAI-----QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
...+.||+.|||||+. .+.+|+.++||||||++|.||..+.+|-..+ ..++.+.. +......-++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-------npMRVllK-iaKSePPTLlq 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLK-IAKSEPPTLLQ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-------chHHHHHH-HhhcCCCcccC
Confidence 3567899999999986 4678999999999999999999999885532 22222222 22222222222
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
| ......+.+++.+||.+||..||++.++++|
T Consensus 258 P--------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 P--------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c--------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2 2334568999999999999999999999876
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=312.10 Aligned_cols=242 Identities=21% Similarity=0.361 Sum_probs=197.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+++++.++||||+++++++...+..++||||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 346799999999999984 5689999999875554456778899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc---
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN--- 470 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 470 (621)
|..++.. ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 103 L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 103 LTDVVTE------TCMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 9998863 3488999999999999999999999 99999999999999999999999999987654332
Q ss_pred -cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 471 -LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 471 -~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+..... ...... .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~~~~~~-~~~~~~--------~ 236 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIAT-NGTPEL--------Q 236 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-cCCccc--------C
Confidence 23467789999999888899999999999999999999999864211 111111111 111111 0
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||..||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 112234568899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.61 Aligned_cols=250 Identities=22% Similarity=0.392 Sum_probs=200.0
Q ss_pred HHHHHHcCcCCcccEEEEEEcC-C----cEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD-G----VTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
+.+.+.||+|+||.||+|...+ | ..||+|.+.... ......+.+|+.++++++||||+++++++.. ...++||
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 3456889999999999998532 3 368999887543 3345678899999999999999999999887 7889999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 88 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 88 QLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999997533 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred ccccc------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 467 NSANL------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 467 ~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
..... ...+..|+|||.+....++.++||||||+++||+++ |+.||.... ..++ ...+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~----~~~~~~~~~~- 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----AVEI----PDLLEKGERL- 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC----HHHH----HHHHhCCCCC-
Confidence 43321 112457999999988889999999999999999998 999986421 1112 2222222110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+......+.+++.+||..||++||++.++++.|+++...
T Consensus 231 ---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00112234688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=306.82 Aligned_cols=245 Identities=24% Similarity=0.424 Sum_probs=194.6
Q ss_pred HcCcCCcccEEEEEEcC-------CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 318 VLGNGGLGSSYKAMMAD-------GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.||+|+||.||+|...+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998543 2579999876432 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-----CcEEEeeec
Q 045652 390 PGGSLLYLLHGDRGP--SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-----EPLISEFGF 462 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~ 462 (621)
++++|.+++...... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999753221 223478999999999999999999998 999999999999999887 899999999
Q ss_pred ceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 463 YTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 463 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
+....... ....+..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+.... +..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~----~~~~~~~----~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN----NQEVLQH----VTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC----HHHHHHH----HhcC
Confidence 87653221 1233567999999998899999999999999999998 999986321 1111111 1111
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
... ......+..+.+++.+||..+|++||++.++++.|+
T Consensus 230 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred Ccc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 100 011233467899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=301.82 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=199.7
Q ss_pred HHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.+.||+|+||.||.+. ..+++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 345789999999999998 455889999987643 23445678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 83 GGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred CCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999997542 24588999999999999999999998 99999999999999999999999999988764432
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||.+.+..++.++||||||+++|||++|..||.... ..+.+.... .+.....
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~-~~~~~~~------ 221 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIV-QGNYTPV------ 221 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHH-cCCCCCC------
Confidence 3446778999999988889999999999999999999999986311 112222221 1211110
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.......+.+++.+||..+|++||++.|+++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 123345688999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.44 Aligned_cols=242 Identities=23% Similarity=0.382 Sum_probs=195.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCC------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|...+++.+|+|.++... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 456799999999999998889999999886432 12235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 84 VPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999642 3578899999999999999999998 999999999999999999999999998875421
Q ss_pred c----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc-Ccc
Q 045652 469 A----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-GRV 537 (621)
Q Consensus 469 ~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~ 537 (621)
. ....++..|+|||++.+..++.++|||||||++|+|++|+.||..... .......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGL- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHHHhhhccCC-
Confidence 1 123467789999999988899999999999999999999999864211 1111111000 11
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.. .......+.+++.+||+.+|++||++.|++++
T Consensus 227 ----~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 ----MPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ----CCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0111 12234568999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.63 Aligned_cols=253 Identities=20% Similarity=0.250 Sum_probs=191.0
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 384 (621)
.+.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++.... ..++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 3457899999999999984 45889999998743 2334566778999999999999999999886532 4689
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 v~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 100 VMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred Ehhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 9999965 7777664 2478888999999999999999998 99999999999999999999999999998
Q ss_pred ecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHH-----------
Q 045652 465 MINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVAS----------- 530 (621)
Q Consensus 465 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~----------- 530 (621)
..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHH
Confidence 76443 234577889999999988999999999999999999999999864211 111111100
Q ss_pred --------Hhhc-Cccccccccchhc-------CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 531 --------AFSE-GRVTDLLDPEIAS-------STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 531 --------~~~~-~~~~~~~d~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... ........+.... ..........+.+++.+||+.||++|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000000 00011223568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=333.96 Aligned_cols=255 Identities=18% Similarity=0.244 Sum_probs=187.1
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCC------CCcccceEEEEeC-CeeEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH------SNVLAPLAYHYRT-DEKLL 384 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~l 384 (621)
|.+.++||+|+||.||+|.. .+++.||||+++.... ....+..|+.++++++| .+++++++++... ...++
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 44567899999999999985 4588999999974322 23445677777777754 4588888888764 46789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCC----------
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPEN---------- 453 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~---------- 453 (621)
|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~----gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTEL----HLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEecCCcccccccccc
Confidence 99998 77898888642 358999999999999999999997 5 899999999999998765
Q ss_pred ------CcEEEeeecceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHH
Q 045652 454 ------EPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 454 ------~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 526 (621)
.+||+|||.+...... ....+|..|+|||++.+..|+.++|||||||++|||++|+.||.... ..+...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~ 355 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD----NLEHLH 355 (467)
T ss_pred cCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHH
Confidence 4899999987654332 34567889999999999999999999999999999999999997422 112111
Q ss_pred HHHHHhhc---------------------Cccccccccchh----c--CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHH
Q 045652 527 WVASAFSE---------------------GRVTDLLDPEIA----S--STNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579 (621)
Q Consensus 527 ~~~~~~~~---------------------~~~~~~~d~~~~----~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 579 (621)
.+...+.. +......++... . ..........+.+|+.+||+.||++|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 11111100 000000011000 0 00000123568899999999999999999999
Q ss_pred HHH
Q 045652 580 VRR 582 (621)
Q Consensus 580 l~~ 582 (621)
++|
T Consensus 436 L~H 438 (467)
T PTZ00284 436 TTH 438 (467)
T ss_pred hcC
Confidence 987
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.35 Aligned_cols=237 Identities=18% Similarity=0.246 Sum_probs=184.7
Q ss_pred cCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcC---CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 319 LGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAFDTEVRRLGRL---RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 319 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
||+|+||.||+|+. .+++.||||++..... .....+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 4589999999864321 1223345567777665 699999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 999998864 24588999999999999999999999 9999999999999999999999999998754221
Q ss_pred --ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 --NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+ +...+..+.. .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-------~~~-~~~~i~~~~~------~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-------TQQ-MYRNIAFGKV------RFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-------HHH-HHHHHHcCCC------CCC
Confidence 234578899999998754 48999999999999999999999986421 111 1112221111 010
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCC----cHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRL----EMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~ 582 (621)
. ......+.+++.+||+.||++|| ++.++++|
T Consensus 218 ~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 K----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred C----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 11235678999999999999998 56666664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=305.97 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=201.8
Q ss_pred HHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|...+.||+|.|+.|-+|+ .-+|..||||++.+.. ......+.+|++-|+.++|||||++|++.......|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 3456889999999999998 4579999999997653 334556779999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC-CCCCcEEEeeecceeccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS-PENEPLISEFGFYTMINS 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~ 468 (621)
.+|+|++||.++. ..+.+....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+.+
T Consensus 100 D~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred CCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999997543 4688999999999999999999998 899999999998764 668899999999988766
Q ss_pred c---ccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A---NLAQALFAYKAPEAIQSGKVT-PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~---~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....|...|.|||++.+..|+ +++||||||||||-|+.|+.||....+.+ .... ++|=
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTm------------ImDC- 234 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTM------------IMDC- 234 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhh------------hhcc-
Confidence 5 345677889999999999886 68999999999999999999998533211 1111 1111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....+.....+..+||..||..||.+|.+.+||..+
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 112234566789999999999999999999999865
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.32 Aligned_cols=244 Identities=22% Similarity=0.414 Sum_probs=195.2
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
|.+.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..++||||++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 34568899999999999975 67889999986532 346788999999999999999999998654 579999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-cc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NL 471 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~ 471 (621)
+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 84 ~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~ 156 (254)
T cd05083 84 NLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN 156 (254)
T ss_pred CHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccCCC
Confidence 9999997532 23578999999999999999999998 9999999999999999999999999998765432 22
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+ .......+.... .
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~-~~~~~~~~~~~~----------~ 218 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-------LKE-VKECVEKGYRME----------P 218 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-------HHH-HHHHHhCCCCCC----------C
Confidence 233457999999988899999999999999999998 999886421 111 111222111000 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 12334678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.58 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=192.7
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
..||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 3699999999999984 457889999988666666778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecceecccc----c
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~----~ 470 (621)
+++..... ....++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++...... .
T Consensus 94 ~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 94 ALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred HHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 99975321 11127788889999999999999998 9999999999999986 678999999998765332 2
Q ss_pred cccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 LAQALFAYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...++..|+|||++.... ++.++||||||+++|+|++|+.||...... ....+...... ..+.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~-------~~~~~--- 233 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK-------IHPEI--- 233 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc-------cCCCC---
Confidence 234677899999986543 789999999999999999999998642210 00011000000 00111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.....++.+++.+||+.+|++|||+.|++.+
T Consensus 234 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 --PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 12334568899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.71 Aligned_cols=241 Identities=20% Similarity=0.327 Sum_probs=196.0
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
...||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34799999999999985 46899999998754444566788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
..++.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 998753 3488999999999999999999998 9999999999999999999999999998655332 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ....... . ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~----~~~~~~~-----~---~~ 239 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAMKRL----RDSPPPK-----L---KN 239 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----hccCCCC-----c---cc
Confidence 3456788999999988889999999999999999999999986321 11111111 1111000 0 00
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11223568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.65 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=191.3
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKL 383 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 383 (621)
|.+.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 34567899999999999984 45889999998743 233356678999999999999999999987543 3468
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 106 lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 106 IVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 99999965 7777774 2378888999999999999999998 9999999999999999999999999999
Q ss_pred eecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc------
Q 045652 464 TMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE------ 534 (621)
Q Consensus 464 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------ 534 (621)
+..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+...+..
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHHH
Confidence 876443 234577889999999999999999999999999999999999964221 1111111110000
Q ss_pred ------------Cc--cccc----cccchhc---CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 ------------GR--VTDL----LDPEIAS---STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ------------~~--~~~~----~d~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+ .... ..+.... ..........+.+++.+||+.||.+|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0000 0000000 00001123568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=318.53 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=191.5
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKL 383 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 383 (621)
|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 45678899999999999984 468899999987532 22345677899999999999999999987543 3468
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 97 LVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCccc
Confidence 999998 7899888752 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc-----
Q 045652 464 TMINSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR----- 536 (621)
Q Consensus 464 ~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----- 536 (621)
+..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+........
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND----YIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHH
Confidence 876443 33457888999999876 568999999999999999999999986421 1111111111110000
Q ss_pred ------cccccc--cchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 ------VTDLLD--PEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ------~~~~~d--~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...... +..... .......+.+.+++.+||+.||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 0001122457899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.86 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=198.4
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+++++
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 346799999999999985 4578999999876555566789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 87 LQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 999987432 4588999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 NLAQALFAYKAPEAIQSG---KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||.+... .++.++||||||+++|||+||+.||..... .+.... ...... ..+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-------~~~~~~-~~~~~~---~~~~-- 225 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-------MRALFL-ISKSNF---PPPK-- 225 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HHhccC---CCcc--
Confidence 223456789999998776 789999999999999999999999864221 111111 111100 0000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.........++.+++.+||..+|++|||+.+++.+
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 -LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01123445678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.61 Aligned_cols=241 Identities=27% Similarity=0.439 Sum_probs=194.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChh---------hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM---------ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (621)
+...||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 346799999999999985 45889999988643211 23568899999999999999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 84 FLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999642 3578889999999999999999998 99999999999999999999999999987
Q ss_pred ecccc----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 465 MINSA----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 465 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
..... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~-~~ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAIFKI-GE 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHHHHHH-hc
Confidence 76421 112356789999999888899999999999999999999999874211 1111111 11
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ..+.. .......+.+++.+||+.||++||++.|++++
T Consensus 227 ~-----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 N-----ASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred c-----CCCcC-----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1 11111 12234678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.86 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=196.7
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCc----EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGV----TVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
...+.||+|+||.||+|.+ .++. .||+|.+.... ......+.+|+.++++++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 3567899999999999984 3444 57899887543 23345688999999999999999999998654 4679999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 89 LMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred hcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEcccccccccc
Confidence 999999999987432 3578899999999999999999998 99999999999999999999999999998664
Q ss_pred ccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 468 SAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 468 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.... .....+ ....+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~~~~----~~~~~~~~~- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TREIPD----LLEKGERLP- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHHCCCCCC-
Confidence 321 1223567999999988899999999999999999997 888986321 111122 222111100
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
........+.+++.+||..+|++||++.++++.|+++....
T Consensus 232 ---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 ---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 01122356889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.49 Aligned_cols=191 Identities=25% Similarity=0.376 Sum_probs=157.1
Q ss_pred HHcCcCCcccEEEEEEc---CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA---DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 391 (621)
.+||+|+||.||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999854 35789999987543 23457789999999999999999998864 456789999986
Q ss_pred CChhHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe----CCCCCcEEEeeecc
Q 045652 392 GSLLYLLHGDRG----PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI----SPENEPLISEFGFY 463 (621)
Q Consensus 392 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a 463 (621)
++|.+++..... .....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 488877753221 1223588899999999999999999998 99999999999999 56678999999999
Q ss_pred eecccc-------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 464 TMINSA-------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 464 ~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
+..... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876432 22346788999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.91 Aligned_cols=246 Identities=31% Similarity=0.463 Sum_probs=194.9
Q ss_pred HHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHH--HHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||++.... ++.||+|++......... ...+|+.++++++||||+++++++.+....++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 3579999999999999654 678999999866543322 3456999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc----c
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN----S 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~----~ 468 (621)
+|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.++|+|||.+.... .
T Consensus 84 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 84 SLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp BHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccc-----cccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc
Confidence 99999972 34589999999999999999999999 99999999999999999999999999987531 2
Q ss_pred cccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 ANLAQALFAYKAPEAIQ-SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||... ...+....+........ . ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~----~~~~~~~~~~~~~~~~~-~---~~---- 222 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES----NSDDQLEIIEKILKRPL-P---SS---- 222 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS----SHHHHHHHHHHHHHTHH-H---HH----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc----cchhhhhhhhhcccccc-c---cc----
Confidence 23445677899999998 788999999999999999999999998742 11111111111111000 0 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..........+.+++.+||+.||++||++.+++++
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001112679999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=291.60 Aligned_cols=265 Identities=20% Similarity=0.283 Sum_probs=199.6
Q ss_pred HHHHHHHcCcCCcccEEEEEEcC-----CcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEe-CCeeE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMAD-----GVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYR-TDEKL 383 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 383 (621)
.|.....||+|.||.||+|..++ .+.+|+|+++.... .......+|+.+++.++|||++.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 34567789999999999996322 34799999975422 223455689999999999999999999887 67789
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC----CCcEEEe
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE----NEPLISE 459 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 459 (621)
+++||.+. +|.+.|+-++....+.++...+..|+.||+.|+.|||+. -|+||||||.|||+..+ |.+||+|
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEeec
Confidence 99999976 999999866655567899999999999999999999998 79999999999999988 8999999
Q ss_pred eecceecccc-------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC-----CcchHH
Q 045652 460 FGFYTMINSA-------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG-----GIDVVE 526 (621)
Q Consensus 460 fG~a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-----~~~~~~ 526 (621)
||+++.+..+ .....|+.|+|||.+.+. .|+++.||||.|||+.||+|-++-|......-. ..+..+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987654 345568899999999875 599999999999999999998877765332111 112223
Q ss_pred HHHHHhhcCccccccccchhcCCCC------------------------HHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 527 WVASAFSEGRVTDLLDPEIASSTNS------------------------PGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~~~~~~~~------------------------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+...+......+ .|.+...+.. ....+...+|+.++|..||-+|.|+++++++
T Consensus 260 rIf~vLG~Pt~~~--Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKD--WPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCcccc--chhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 3322222111000 0111100000 0012347889999999999999999999987
Q ss_pred H
Q 045652 583 I 583 (621)
Q Consensus 583 L 583 (621)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 4
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=310.91 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=194.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||+++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 4567999999999999965 58999999886432 22345678999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
++|..++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 85 TVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 888887653 23589999999999999999999998 99999999999999999999999999998765433
Q ss_pred ---cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc-----------C
Q 045652 471 ---LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-----------G 535 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------~ 535 (621)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .+....+...... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD----VDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChHHhhhcccc
Confidence 2345678999999875 4588999999999999999999999874321 1111111111100 0
Q ss_pred c-cccccccchhcCC----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 R-VTDLLDPEIASST----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~-~~~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ......+...... ..+.....+.+++.+||+.||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 0000000000000 011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=300.05 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=195.6
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-CeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-DEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 389 (621)
.+.+.||+|++|.||++.. .+++.||+|.+... .....+.+.+|++++++++|+|++++++.+... ...+++|||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 3457899999999999985 45789999998643 233456788999999999999999999887643 4578999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 83 EGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999997532 24589999999999999999999998 9999999999999999999999999998776432
Q ss_pred ----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||... +........ ..+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-------~~~~~~~~~-~~~~~~~------ 221 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-------DMNSLVYRI-IEGKLPP------ 221 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHH-HhcCCCC------
Confidence 2234667899999999888999999999999999999999998631 111222221 1121110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||+.||++||++.+++++
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112344678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=341.79 Aligned_cols=249 Identities=18% Similarity=0.268 Sum_probs=191.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|... ++..||+|.+... .......+..|+.++++++|||||+++++|... ...||||||+
T Consensus 17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 4578999999999999954 4788999988643 333456788999999999999999999988654 4688999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccC---CCCCccCCCCCCCEEeCCC--------------
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA---HLDLPHGNLKSSNIFISPE-------------- 452 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~---~~~ivH~Dlkp~NIll~~~-------------- 452 (621)
++|+|.++|..... ....+++..++.|+.||+.||+|||+... ..+||||||||+||||+.+
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999974321 13468999999999999999999998410 1259999999999999642
Q ss_pred ---CCcEEEeeecceecccc---ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcch
Q 045652 453 ---NEPLISEFGFYTMINSA---NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV 524 (621)
Q Consensus 453 ---~~~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 524 (621)
..+||+|||++..+... ....+|+.|+|||++.+ ..++.++||||||||||||+||+.||.... ..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~------~~ 249 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN------NF 249 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC------cH
Confidence 34899999999876432 23457889999999854 458999999999999999999999996321 11
Q ss_pred HHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+...+.... .+. .......+.+||..||..+|.+||++.|++.+
T Consensus 250 -~qli~~lk~~p-------~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 250 -SQLISELKRGP-------DLP----IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred -HHHHHHHhcCC-------CCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 11222222111 010 11223568999999999999999999999964
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.92 Aligned_cols=255 Identities=19% Similarity=0.268 Sum_probs=192.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 3467999999999999854 68999999986432 2234667899999999999999999999999999999999997
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 83 MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 68988886433 235689999999999999999999998 9999999999999999999999999998765432
Q ss_pred --ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC-----------
Q 045652 470 --NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG----------- 535 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----------- 535 (621)
....++..|+|||.+.+. .++.++|||||||++|||+||+.||..... .+........+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE----IDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHhCCCChhhhhcchhh
Confidence 122346789999988654 578999999999999999999999864211 00000000000000
Q ss_pred -----ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 -----RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 -----~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
............ .......++.+++.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRS--AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHH--hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.08 Aligned_cols=255 Identities=19% Similarity=0.277 Sum_probs=192.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||++ +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 4577999999999999854 58899999986432 2234567789999999999999999999999999999999997 5
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9998886432 3578899999999999999999998 9999999999999999999999999998765322
Q ss_pred -ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc---Cccccccc--
Q 045652 470 -NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE---GRVTDLLD-- 542 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 542 (621)
....++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... .+....+...+.. ........
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCChhhchhhhccc
Confidence 12345678999998865 3578899999999999999999999864221 1112212111110 00000000
Q ss_pred -------cchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 -------PEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 -------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+..... .........+.+|+.+||+.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0011234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=302.73 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=195.0
Q ss_pred HHHHcCcCCcccEEEEEEc----CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------ee
Q 045652 315 AAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EK 382 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 382 (621)
+.+.||+|+||.||+|... +++.||||.++.. .....+.+.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999843 3689999988743 2334567889999999999999999999886542 23
Q ss_pred EEEEeecCCCChhHHhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 383 LLVYEYIPGGSLLYLLHGDR-GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
++++||+++|+|.+++.... ......+++..+++++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECccc
Confidence 68999999999998875332 11223578899999999999999999998 99999999999999999999999999
Q ss_pred cceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 462 FYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 462 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+++...... ...++..|++||.+....++.++|||||||++|||++ |+.||.... ..+...++ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~----~~~~~~~~----~~ 230 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE----NSEIYNYL----IK 230 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC----HHHHHHHH----Hc
Confidence 988654321 1223457999999988889999999999999999999 888876321 11121211 11
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
..... ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 ~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11000 0122345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=316.54 Aligned_cols=246 Identities=20% Similarity=0.256 Sum_probs=192.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++..++|+||+++++++.+.+..|+||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4467999999999999854 58899999986421 2234557889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999997432 3588889999999999999999998 99999999999999999999999999987764432
Q ss_pred -----cccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 471 -----LAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 471 -----~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~- 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHEERFQ- 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-------HHHHHHHHHcCCCccc-
Confidence 2357889999999865 468899999999999999999999986321 1121212111110000
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCC--CCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQ--RLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 582 (621)
. .........++.+++.+|+..++++ |++++++++|
T Consensus 229 ----~--p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----F--PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----C--CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0111223467889999999876554 4689998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.66 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=197.0
Q ss_pred HHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
..+.||+|+||.||+|+.. +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4567999999999999853 2467999988754433 45779999999999999999999999998889999999
Q ss_pred ecCCCChhHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 388 YIPGGSLLYLLHGDRGP----SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
|+++++|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcccccc
Confidence 99999999999754311 112589999999999999999999998 9999999999999999999999999998
Q ss_pred eecccc-----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 464 TMINSA-----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 464 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~----~~~~~~~ 236 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLN----RLQAGKL 236 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHH----HHHcCCc
Confidence 654321 22234567999999988889999999999999999999 7888753221 11111 1111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
... .....+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 237 ~~~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELP---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 100 01123357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.64 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=198.0
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.+.||+|+||.||++.. .+|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 3456899999999999984 46899999988632 23345678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++.... ...+++.+++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 83 GGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999987432 23578899999999999999999998 99999999999999999999999999987764432
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||++.+..++.++|||||||++|+|++|+.||... +..+.+..... +....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~-~~~~~------- 220 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-------NMKNLVLKIIR-GSYPP------- 220 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-------CHHHHHHHHhc-CCCCC-------
Confidence 234667899999998888999999999999999999999998631 11222222221 11110
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||+.+|++||++.|++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 012234568999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.57 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=191.5
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++... +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 3467999999999999854 47889999986422 2233457889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999997432 3588899999999999999999998 9999999999999999999999999998765322
Q ss_pred ----ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 470 ----NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
....+|..|+|||++. ...++.++|||||||++|||++|+.||... +..+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~~- 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-------SLVETYGKIMNHKERFQ- 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-------CHHHHHHHHhCCCcccc-
Confidence 2245788999999986 346889999999999999999999998632 12222222221111000
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCC--CCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQ--RLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 582 (621)
. ..........+.+++.+|+..++++ |+++.|+++|
T Consensus 229 ----~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ----F--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----C--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 1111233467888999988664444 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=298.93 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=200.9
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|++++++++||||+++++++......++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 45688999999999999965 58999999987543 34456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
++|.+++.... ..++...+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 84 GSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999997532 468889999999999999999999 7 9999999999999999999999999998765332
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.+........ +...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~------~~~~-- 225 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQYIVNEPP------PRLP-- 225 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHHHhcCCC------CCCC--
Confidence 224567789999999988999999999999999999999999864321 11122222222222111 0010
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||..||++|||+.+++.+
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 --SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01144668999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.83 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=197.2
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 556788999999999999854 58999999886332 23345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
++ |++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 97 CL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 96 57777775322 3589999999999999999999998 999999999999999999999999999987766
Q ss_pred cccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ANLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....++..|+|||++. ...++.++||||||+++|||+||+.||.... ........ ..... +..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-------~~~~~~~~-~~~~~-----~~~ 234 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHI-AQNDS-----PTL 234 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-------HHHHHHHH-hcCCC-----CCC
Confidence 65666778899999874 4568899999999999999999999986321 11111111 11100 000
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
........+.+++.+||..||++||++.+++.+..
T Consensus 235 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 235 ----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 11224467899999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=300.66 Aligned_cols=245 Identities=23% Similarity=0.381 Sum_probs=195.8
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 457799999999999984 668999999986432 1234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceec
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMI 466 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~ 466 (621)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||.+...
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 84 WMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred ccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999742 3578899999999999999999999 999999999999998776 5999999998766
Q ss_pred ccc--------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 467 NSA--------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 467 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|..||..... ......+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~-- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATT-- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCC--
Confidence 432 123456789999999888899999999999999999999999863211 111111111111100
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ..........+.+++.+||..+|++||++.|++++
T Consensus 229 ---~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 ---A-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---C-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0 11123345678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=300.68 Aligned_cols=242 Identities=21% Similarity=0.349 Sum_probs=189.7
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-----AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 385 (621)
...+.||+|+||.||+|.. .++..|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 3457899999999999985 458999999886321 12345688999999999999999999988763 567899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 85 MEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 9999999999999642 3478899999999999999999998 999999999999999999999999999876
Q ss_pred cccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 466 INSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 466 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
.... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-------~~~~~~~~~~~~~-- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-------AMAAIFKIATQPT-- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-------hHHHHHHHhcCCC--
Confidence 5321 12346778999999998889999999999999999999999986421 1121221111110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.+ .....+.+.+++ +||..+|++||+++|+++|
T Consensus 227 ---~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 ---NPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ---CCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1111 122234566666 6888999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=302.22 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=196.8
Q ss_pred HHHHHHcCcCCcccEEEEEEcC--CcEEEEEEccCC----------ChhhHHHHHHHHHHHhc-CCCCCcccceEEEEeC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD--GVTVVVKRMKES----------SAMARDAFDTEVRRLGR-LRHSNVLAPLAYHYRT 379 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 379 (621)
|.+.+.||+|+||.||+|.... ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456889999999999999654 688999987532 22234557788888875 7999999999999999
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
+..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCC----ceeecCCCHHHEEECCCCcEEEe
Confidence 999999999999999988853211 23458899999999999999999996 5 79999999999999999999999
Q ss_pred eeecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 459 EFGFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 459 DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
|||.+...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||... +...... .+.++
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-------~~~~~~~-~~~~~ 228 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-------NMLSLAT-KIVEA 228 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-------CHHHHHH-HHhhc
Confidence 99998876543 2344677899999999888999999999999999999999998631 1111111 11111
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
..... ........+.+++.+||+.||++||++.|+..+++
T Consensus 229 ~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPL---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcC---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11100 01122356899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=304.64 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.+.||+|+||.||+|.. .+|+.|++|++.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 3456799999999999995 468999999987543 334567889999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++.... ..+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 82 PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 999999986432 4589999999999999999999998 99999999999999999999999999988765432
Q ss_pred -----cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc--------
Q 045652 471 -----LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR-------- 536 (621)
Q Consensus 471 -----~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------- 536 (621)
...++..|+|||.+.+. .++.++||||+|+++|||++|..||.... .......+...+....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN----DIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC----HHHHHHHHHHHcCCCChHHHhhcc
Confidence 23467789999998654 46899999999999999999977765321 1122222222111100
Q ss_pred ----cccccccchhc---CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 ----VTDLLDPEIAS---STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ----~~~~~d~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......+.... ....+.....+.+++.+||+.+|++||+++++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00011234778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=297.73 Aligned_cols=242 Identities=25% Similarity=0.362 Sum_probs=195.6
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-----AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
..+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++|+||+++++++......+++|||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 3467999999999999965 78999999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 84 VPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999742 3578999999999999999999998 999999999999999999999999999876543
Q ss_pred c---ccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A---NLAQALFAYKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ...............
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~------ 221 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-------GVAAVFKIGRSKELP------ 221 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-------HHHHHHHHHhcccCC------
Confidence 3 2344677899999987666 8999999999999999999999986422 111111111101110
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.........+.+++.+||+.+|++||++.+++.+
T Consensus 222 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0112234668899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.24 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=200.9
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+...+.||+|+||.||++.. .++..||+|.+... .......+.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55678899999999999985 46889999998643 223345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+. |+|.+.+... ...+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 107 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 96 4787777533 23589999999999999999999998 999999999999999999999999999887766
Q ss_pred cccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ANLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||.... ............. .
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~-~------- 242 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNES-P------- 242 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccC-C-------
Confidence 66667788899999974 4568899999999999999999999986421 1111111111111 0
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..........+.+++.+||+.+|.+||++.++++++..+...
T Consensus 243 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 243 --TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 011123345689999999999999999999999987665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=298.12 Aligned_cols=244 Identities=28% Similarity=0.485 Sum_probs=196.8
Q ss_pred HHHHcCcCCcccEEEEEEcC-----CcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMAD-----GVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||++...+ +..||+|.++..... ..+.+..|+++++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 34679999999999999644 388999999755433 567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 83 MEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred cCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999997432 11289999999999999999999999 999999999999999999999999999877654
Q ss_pred cc-----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 469 AN-----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 ~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
.. ...++..|+|||.+.+..++.++||||+|+++|||++ |..||... ......+. ...+....
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~~----~~~~~~~~--- 224 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLEY----LKKGYRLP--- 224 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHH----HhcCCCCC---
Confidence 31 1225578999999988889999999999999999998 77887531 11112221 11111110
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.....+.++.+++.+||..||++|||+.|+++.|
T Consensus 225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0112346789999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=298.88 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=197.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 389 (621)
+.+.||.|+||.||++.. .+++.||+|.+... .....+.+..|++++++++|+||+++++++.. ....+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 456799999999999984 56889999988643 33445678899999999999999999998764 34578999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH-----TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
++++|.+++..... ....+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 84 EGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred cCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999975321 2356899999999999999999999 66 89999999999999999999999999988
Q ss_pred eccccc----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 465 MINSAN----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 465 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
...... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.... . ..+...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~----~~~~~~~~~~~~~~- 229 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----Q----LQLASKIKEGKFRR- 229 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----H----HHHHHHHhcCCCCC-
Confidence 765432 2346778999999988889999999999999999999999987421 1 11222222222111
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+ .......+.+++.+||+.+|++||++.+++++
T Consensus 230 ----~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ----I-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----C-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 12334678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=304.90 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=192.4
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEe-----CCeeEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR-----TDEKLLV 385 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv 385 (621)
|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.. .+..++|
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 34567899999999999985 458899999876432 2345678899999999 69999999998853 3457999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 99 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 99 LELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEEEccCCceee
Confidence 999999999998863221 234688899999999999999999998 999999999999999999999999999877
Q ss_pred cccc----ccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 466 INSA----NLAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 466 ~~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
.... ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... ...+.. .....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------~~~~~~-~~~~~ 245 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MRALFK-IPRNP 245 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------hHHHhh-ccccC
Confidence 6432 23457788999998753 4578999999999999999999999864221 111111 11111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.....++ ......+.+++.+||+.||++|||+.|++++.
T Consensus 246 ~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 246 PPTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0111111 11234688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=299.42 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=198.9
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.||.|+||.||+|.. .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 3457799999999999985 468899999986432 23467789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
++|.++++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 84 ~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 84 GSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred CcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999975331 24688999999999999999999998 99999999999999999999999999987654332
Q ss_pred -------cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 471 -------LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 471 -------~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
...++..|+|||++... .++.++|||||||++|||++|+.||...... +......... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~~------~ 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVLMLTLQND------P 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhHHHHhcCC------C
Confidence 22467789999998766 7899999999999999999999998643211 1111111110 0
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+..............+.+++.+||..||++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111112345678999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.52 Aligned_cols=256 Identities=18% Similarity=0.271 Sum_probs=192.0
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|.. .+|+.||+|.++... ......+.+|++++++++||||+++++++.+....++|+||++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 82 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD- 82 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-
Confidence 346799999999999995 468999999986432 2223567789999999999999999999999999999999996
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 83 QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 58888776432 3589999999999999999999998 9999999999999999999999999998765432
Q ss_pred --ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc------cccc
Q 045652 470 --NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR------VTDL 540 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 540 (621)
....++..|+|||++.+. .++.++|||||||++|||+||..|+..... .....+.+...+.... ....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 123456789999998764 478999999999999999999998653211 1111111111111000 0000
Q ss_pred cc----cchhc----CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LD----PEIAS----STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d----~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+ +.... ....+.....+.+++.+||+.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 00000 00112234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.09 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=198.5
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.|.+.+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 445667899999999999984 4688999999875544556778899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++.+ ..+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 100 GGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999863 2478889999999999999999999 99999999999999999999999999887654332
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||.+....++.++|||||||++|++++|+.||...... ..+......+. +
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-------~~~~~~~~~~~------~--- 233 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNGT------P--- 233 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-------hheeehhcCCC------C---
Confidence 234667799999998888999999999999999999999999642211 00000000000 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...........+.+++.+||..+|++||++.+++.|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112234568899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.57 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=193.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 4578999999999999965 58999999886432 22356788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
++|..+... ...+++.+++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 85 TVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999887653 23489999999999999999999998 99999999999999999999999999987754322
Q ss_pred ---cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc-----------C
Q 045652 471 ---LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-----------G 535 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------~ 535 (621)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ..+....+...... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS----DIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc----hHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2335678999999865 457889999999999999999998885321 11111111111100 0
Q ss_pred cc-ccccccchhc----CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 RV-TDLLDPEIAS----STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~~-~~~~d~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. .....+.... ....+.....+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 0000000000 00012335679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=304.99 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=193.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChh-----hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM-----ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|.. .+++.||+|.++..... ....+..|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 456799999999999985 46899999998754322 345567899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+ +++|.+++.... ..+++..++.++.||++||+|||++ +|+|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 84 M-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred c-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9 899999997432 2589999999999999999999999 999999999999999999999999999987654
Q ss_pred cc----cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC--------
Q 045652 469 AN----LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG-------- 535 (621)
Q Consensus 469 ~~----~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-------- 535 (621)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|..||... ...+....+...+...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD----SDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC----ccHHHHHHHHHHcCCCchhhhhhc
Confidence 32 2234567999998854 46789999999999999999997766532 1112222221111100
Q ss_pred -ccccccccc----hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 -RVTDLLDPE----IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 -~~~~~~d~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......... .............+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 00000012234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.02 Aligned_cols=243 Identities=23% Similarity=0.381 Sum_probs=195.6
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCC---CCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLR---HSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e 387 (621)
|...+.||+|+||.||+|.. .+++.||+|.++.. .....+.+.+|+.++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 45678899999999999995 56899999998643 2334567889999999997 9999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 83 YAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred cCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 9999999999863 2588999999999999999999998 99999999999999999999999999987764
Q ss_pred ccc----cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 468 SAN----LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 468 ~~~----~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
... ...++..|+|||.+.++ .++.++|||||||++|+|++|..||..... ...+. ..... ..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~-~~~~~-----~~ 219 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMM-LIPKS-----KP 219 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhhhh-ccccC-----CC
Confidence 432 23466789999998654 578999999999999999999999864221 11111 01110 01
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.+.. .....++.+++.+||+.||++||++.|++++
T Consensus 220 ~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 PRLED----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 1134578999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=300.70 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=193.8
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh----------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCee
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA----------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK 382 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (621)
...+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 3457899999999999985 4689999998753211 1234678899999999999999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred EEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999743 3588899999999999999999998 999999999999999999999999999
Q ss_pred ceecccc------ccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 463 YTMINSA------NLAQALFAYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 463 a~~~~~~------~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+...... ....++..|+|||.+.... ++.++||||||+++||+++|..||.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-------AIAAMFKLGNK 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-------hHHHHHHhhcc
Confidence 8765322 1234667899999987654 8899999999999999999999985311 11111111111
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.....+.+.. .......+.+++.+||..+|++||++.+++++
T Consensus 228 -~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 -RSAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -ccCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111111 12334678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=298.80 Aligned_cols=241 Identities=20% Similarity=0.317 Sum_probs=190.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-----SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 386 (621)
+.+.||+|+||.||++.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 356799999999999985 45899999987532 122346788999999999999999999988764 4578999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++... ..+++..+++++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 86 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 86 EHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 999999999998642 3478888999999999999999998 9999999999999999999999999998754
Q ss_pred ccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 467 NSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 467 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~--- 226 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQPT--- 226 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHHHHHhcCCC---
Confidence 321 22346778999999988889999999999999999999999986321 1111111111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+ ..+......+.+++.+|+. +|++||+++|++++
T Consensus 227 --~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --NP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --CC-----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11 1123344678889999995 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.00 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=194.8
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEcc----CCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe--eEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMK----ESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE--KLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 387 (621)
..+.||+|+|-+||+|.. .+|..||--.++ .......+.|..|+++|+.|+||||+++|.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346799999999999995 347787733332 1234456889999999999999999999999988665 669999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecceec
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFYTMI 466 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~ 466 (621)
.+..|+|..|+++. +.++...+.+|++||++||.|||++ .++|+|||||-+||+|+. -|.+||+|+|+|...
T Consensus 124 L~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred cccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999999854 4578889999999999999999997 447999999999999985 579999999999887
Q ss_pred ccc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 467 NSA--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 467 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
... ....||+.|||||+.. ..|+..+||||||+.|+||+|+..||..-.+ ...+.+.+..|.....+.
T Consensus 197 r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~sl~-- 266 (632)
T KOG0584|consen 197 RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAALS-- 266 (632)
T ss_pred hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHHhh--
Confidence 654 4467999999999987 7899999999999999999999999974322 223333333332211111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. -..+++.+||.+|+.. ..+|||+.|+|++
T Consensus 267 ---k----V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 ---K----VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---c----cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 0 1124689999999999 9999999999976
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=303.05 Aligned_cols=246 Identities=21% Similarity=0.333 Sum_probs=192.2
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEe------CCeeE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR------TDEKL 383 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~ 383 (621)
.|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 345567899999999999995 458899999886443 3345688999999999 69999999999853 35678
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus 96 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 9999999999999987533 23578888899999999999999998 9999999999999999999999999998
Q ss_pred eecccc----ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 464 TMINSA----NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 464 ~~~~~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
...... ....++..|+|||.+. ...++.++|||||||++|||++|+.||..... ...+... ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-------~~~~~~~-~~ 240 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-------MRALFLI-PR 240 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-------HhhhhhH-hh
Confidence 765322 2345677899999875 34688899999999999999999999864221 0101000 00
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. .+.. .....+..+.+++.+||+.||.+||++.|++++
T Consensus 241 ~~-----~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 NP-----PPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CC-----CCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 0000 011234579999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.85 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=208.0
Q ss_pred hHHHHHHHHHcCcCCcccEEEEEE-cCC----cEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCee
Q 045652 309 PDLMKAAAEVLGNGGLGSSYKAMM-ADG----VTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK 382 (621)
Q Consensus 309 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (621)
+|......++||+|+||+||+|.+ .+| .+||+|++.+.. ....+++..|+-+|.+++|||+++++++|.... .
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 344445678999999999999984 333 578999887543 445678999999999999999999999998766 7
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
.||++||+.|+|.++++.++ ..+-....+.|..|||+||.|||.+ ++|||||-.+|||+.....+||.|||+
T Consensus 773 qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgl 844 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGL 844 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecch
Confidence 79999999999999998754 4577888999999999999999999 999999999999999999999999999
Q ss_pred ceecccccccc------ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 463 YTMINSANLAQ------ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 463 a~~~~~~~~~~------~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
++......... ..+.|||-|.+....|+.++|||||||++||++| |..|++.... +.+...+..+
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~g 916 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKG 916 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhcc
Confidence 99886653322 2346999999999999999999999999999998 9999876432 2233333333
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.. + ..++-+.-++.-++.+||..|++.||+++++...+.++..
T Consensus 917 eR-------L---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 917 ER-------L---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cc-------C---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 21 1 2234556678999999999999999999999999887754
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.48 Aligned_cols=243 Identities=22% Similarity=0.359 Sum_probs=197.7
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.|...+.||+|+||.||+|.. .+++.||+|...... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 345667899999999999985 468899999876432 233567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++..+...
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999863 3478999999999999999999998 9999999999999999999999999998766443
Q ss_pred c----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 N----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ~----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
. ...++..|+|||.+.+..++.++|||||||++|+|++|..||..... ..... ........ .+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~-~~~~~~~~-----~~ 221 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLF-LIPKNNPP-----TL 221 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHH-HHhcCCCC-----CC
Confidence 2 23456789999999888899999999999999999999999863211 11111 11111110 01
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 -----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12234568899999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=296.71 Aligned_cols=243 Identities=21% Similarity=0.297 Sum_probs=195.6
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
..+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 456799999999999985 46889999988643 233456788999999999999999999999989999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceecccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSA- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~- 469 (621)
++|.+++.... ...+++..+..++.|++.||+|||++ +|+|+||||+||+++.++ .+||+|||++......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999997533 23578999999999999999999998 999999999999998654 5799999998876543
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+...... .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~------- 221 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSG-TFAPI------- 221 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhc-CCCCC-------
Confidence 22446778999999998889999999999999999999999986421 11112111111 10110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 222 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ---SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11234568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.01 Aligned_cols=263 Identities=17% Similarity=0.228 Sum_probs=184.4
Q ss_pred HHHHHHcCcCCcccEEEEEEcC--CcEEEEE------------------EccCCChhhHHHHHHHHHHHhcCCCCCcccc
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD--GVTVVVK------------------RMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 372 (621)
|.+.+.||+|+||.||++.... +..+++| .++ ........+++|+.+|++++||||+++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 4566899999999999987432 2222222 111 112234568899999999999999999
Q ss_pred eEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC
Q 045652 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452 (621)
Q Consensus 373 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~ 452 (621)
++++...+..|+|+|++. ++|.+++...............+..++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFLNCD 303 (501)
T ss_pred eEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCC
Confidence 999999999999999985 5787777543321122344567788999999999999998 99999999999999999
Q ss_pred CCcEEEeeecceeccccc-----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHH
Q 045652 453 NEPLISEFGFYTMINSAN-----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEW 527 (621)
Q Consensus 453 ~~~kl~DfG~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 527 (621)
+.+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++|..++...........+.+.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998764431 245788999999999999999999999999999999988654321111111111111
Q ss_pred HHHHhh--cCccc-------ccccc--------chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 528 VASAFS--EGRVT-------DLLDP--------EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 528 ~~~~~~--~~~~~-------~~~d~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+. .+. ..... +.++. .+............+.+++.+||+.||++|||+.|++.+
T Consensus 384 ~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 ID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11 000 00000 00000 000000000122457788999999999999999999986
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.26 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=194.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
..+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+++++.++|+||+++++++......++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 3467999999999999965 489999999875432 244568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 85 GGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred CCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999987432 24689999999999999999999998 99999999999999999999999999876543211
Q ss_pred ---------------------------------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC
Q 045652 471 ---------------------------------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517 (621)
Q Consensus 471 ---------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 517 (621)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 12356779999999988899999999999999999999999864221
Q ss_pred CCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc----HHHHHHH
Q 045652 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE----MREAVRR 582 (621)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~~ 582 (621)
.......... .. .. .........+.+++.+||..||++||+ ++|++.+
T Consensus 238 -------~~~~~~~~~~-~~------~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 -------DETFSNILKK-EV------TF---PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred -------HHHHHHHhcC-Cc------cC---CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1111111111 10 00 001124567999999999999999999 7777664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.34 Aligned_cols=241 Identities=21% Similarity=0.330 Sum_probs=196.3
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.+.||+|++|.||++.. .+++.|++|+++.......+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 46899999999999984 56889999998755545566788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+...... .
T Consensus 104 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 104 TDIVTH------TRMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred HHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999864 3478899999999999999999998 9999999999999999999999999987654332 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+.. +..... +... .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-------~~~~~~~-~~~~~~-----~~~~---~ 237 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-------PLQAMKR-IRDNLP-----PKLK---N 237 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHH-HHhcCC-----CCCc---c
Confidence 2346778999999988889999999999999999999999986311 1111111 111110 0000 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11234579999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.49 Aligned_cols=243 Identities=21% Similarity=0.339 Sum_probs=196.9
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.....||+|+||.||++.. .++..||+|++..........+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 3457899999999999985 568999999986555455677899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceeccccccc
Confidence 99998752 2478899999999999999999998 9999999999999999999999999988765332
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||.+.+..++.++||||||+++|||++|..||.... .......+..... +...
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~----~~~~~~~~~~~~~---------~~~~-- 237 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIRDNLP---------PKLK-- 237 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhCC---------cccC--
Confidence 22346778999999988889999999999999999999999986321 1111111111110 0000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||+.+|.+||++.+++++
T Consensus 238 -~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 011233568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.40 Aligned_cols=240 Identities=18% Similarity=0.251 Sum_probs=185.8
Q ss_pred HcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHh---cCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLG---RLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.||+|+||.||++.. .+++.||+|.+.... ......+.+|..+++ ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 458999999886432 111223444544443 3479999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 99999988642 3589999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQ-SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||.+. +..++.++|||||||++|||++|..||...... . ...+...... ....+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~-~~~~~~~~~~------~~~~~-- 218 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----D-KHEIDRMTLT------VNVEL-- 218 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc----C-HHHHHHHhhc------CCcCC--
Confidence 2345788999999986 456899999999999999999999999743221 1 1111111110 00111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+......+.+++.+||+.||++|| +++|+++|
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 123346789999999999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.79 Aligned_cols=244 Identities=26% Similarity=0.420 Sum_probs=200.5
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++.+++|+||+++++++......++||||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4578999999999999965 499999999876543 44678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
+|.+++... ..+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999743 458999999999999999999999 8 99999999999999999999999999988765432
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...++..|+|||.+.+..++.++||||||+++|+|+||+.||..... ....+.+.... ..... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~-~~~~~-----~~-- 223 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAIC-DGPPP-----SL-- 223 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHh-cCCCC-----CC--
Confidence 23466789999999888899999999999999999999999865321 11112111111 11111 01
Q ss_pred CCCCHH-HHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPG-EMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... .+..+.+++.+||..+|++||++.|++++
T Consensus 224 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34679999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.76 Aligned_cols=242 Identities=20% Similarity=0.252 Sum_probs=190.7
Q ss_pred cCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 319 LGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 319 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
||+|+||.||+|.. .+|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 468999999986432 12344567899999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---cc
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---NL 471 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~ 471 (621)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 99997543 23589999999999999999999998 9999999999999999999999999988765432 22
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+....... .. ...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~------~~-----~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLEM------AV-----EYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhccccc------cc-----cCC
Confidence 345668999999988889999999999999999999999986432110 111111111100 00 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
......+.+++.+||+.||++|| ++.+++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 22345789999999999999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.45 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=199.2
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|+||+++++++......++|+||++++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 45678999999999999965 688999999976544 4667889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 101 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 101 SLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 9999997532 3689999999999999999999998 9999999999999999999999999987665433
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......... ......
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~-------- 236 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-------LRALFLITT-KGIPPL-------- 236 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-cCCCCC--------
Confidence 223356789999999888899999999999999999999999863211 111111111 111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.........+.+++.+||+.+|.+||++.+++++-
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 11112346789999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.51 Aligned_cols=245 Identities=20% Similarity=0.226 Sum_probs=191.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3467999999999999854 47899999987543 2234567899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 85 GGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999643 3588999999999999999999998 9999999999999999999999999987632100
Q ss_pred ------------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHH
Q 045652 470 ------------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 470 ------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
....++..|+|||.+.+..++.++|||||||++|||++|..||.... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-------~~~~~~~~ 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-------PEELFGQV 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHH
Confidence 11235667999999988889999999999999999999999986321 11111111
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.. +.. ..+. .....+..+.+++.+||+.||++||++.++.+.|+
T Consensus 229 ~~-~~~---~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 IS-DDI---EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred Hh-ccc---CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11 110 0010 01123456899999999999999999655555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.16 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=194.4
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +++.|++|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 3467999999999999864 5889999988643 233456789999999999999999999999999999999999998
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
+.+..+... ...+++.++..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 85 TLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 777665542 23488999999999999999999998 99999999999999999999999999988765432
Q ss_pred ----cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh------------
Q 045652 471 ----LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS------------ 533 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------ 533 (621)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||.... ..+..........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS----DIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHhhhccc
Confidence 23456679999999887 78999999999999999999999886421 1111111111100
Q ss_pred cC-----ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 EG-----RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 ~~-----~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ......++..............+.+++.+||..+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000001000001111225779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.67 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=196.1
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~g 392 (621)
+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++... +..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 57999999999999964 58899999987432 23456788999999999999999999998654 3679999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--c
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--N 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--~ 470 (621)
+|.+++..... ....++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 87 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (287)
T cd06621 87 SLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161 (287)
T ss_pred CHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence 99988753221 234578889999999999999999998 9999999999999999999999999998765432 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCC-CCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNG-NGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ....+...++. ......+.+. ..
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~----~~ 233 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELKDE----PG 233 (287)
T ss_pred cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhhccC----CC
Confidence 334567899999999889999999999999999999999998743210 11112222211 1111111000 00
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
......+.+.+++.+||+.+|++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0012346789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=299.75 Aligned_cols=257 Identities=19% Similarity=0.250 Sum_probs=193.9
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 387 (621)
|...+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++++++... ...++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 556789999999999999965 588999999874332 2234567899999999999999999998877 78999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|++ ++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 87 ~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 87 YVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 997 49998886432 3589999999999999999999998 99999999999999999999999999988765
Q ss_pred cc----ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc--------
Q 045652 468 SA----NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-------- 534 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 534 (621)
.. ....++..|+|||.+.+. .++.++||||||+++|||++|..||..... .+....+...+..
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----IDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchHHHHH
Confidence 43 223456779999998754 468999999999999999999999864221 1111111111100
Q ss_pred ---------CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 ---------GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ---------~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..........+............+.+++.+||+.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000010001000125668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.17 Aligned_cols=245 Identities=25% Similarity=0.399 Sum_probs=195.9
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
...+.||+|+||.||+|.. .+++.|++|.++.... ...+.+..|+.++++++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 3457899999999999985 4689999999875443 356788999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 83 GGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999742 3478888999999999999999998 99999999999999999999999999987764321
Q ss_pred --------cccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 471 --------LAQALFAYKAPEAIQSGK---VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 471 --------~~~~~~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
...++..|+|||++.+.. ++.++||||||+++|||++|+.||..... .. ..... ...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~---~~~~~-~~~~~--- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EF---QIMFH-VGAGH--- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hH---HHHHH-HhcCC---
Confidence 134567899999998766 88999999999999999999999864221 11 11111 11111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.+.. .......+.+++.+||+.+|++||++.|++.+
T Consensus 224 --~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 --KPPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --CCCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111 11224568899999999999999999998853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.85 Aligned_cols=254 Identities=19% Similarity=0.304 Sum_probs=191.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3567999999999999854 68999999886432 2234578899999999999999999999999999999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|..++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 83 QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 68998886433 34689999999999999999999998 9999999999999999999999999998765432
Q ss_pred --ccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC-----------
Q 045652 470 --NLAQALFAYKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG----------- 535 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----------- 535 (621)
....++..|+|||.+.+.. ++.++|||||||++|||+||+.||..... .....+ +.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFR-IFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH-HHHHhCCCChhhhhhhhHH
Confidence 1223467899999887644 68899999999999999999999864211 001111 11110000
Q ss_pred -----ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 -----RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 -----~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
............. .+.....+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 01223567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.55 Aligned_cols=240 Identities=23% Similarity=0.296 Sum_probs=195.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 3467999999999999854 58999999986432 2235668899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 85 ~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 85 GGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 99999999743 4588999999999999999999998 9999999999999999999999999998876443
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... . .........+.. .+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~----~~~~~~~~~~~~------~~---- 217 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----P----IQIYEKILEGKV------RF---- 217 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----H----HHHHHHHhcCCc------cC----
Confidence 23356778999999988888999999999999999999999986321 1 111111111111 01
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+......+.+++.+||..||++|+ +++|++++
T Consensus 218 -~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 -PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112235788999999999999999 77787765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.86 Aligned_cols=246 Identities=25% Similarity=0.340 Sum_probs=191.6
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeC-----CeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRT-----DEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e 387 (621)
+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++... +..++|||
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 346799999999999985 468899999986533 2345678899999999 799999999998754 35789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 105 y~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 105 LCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred ECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 9999999998864221 234688999999999999999999998 99999999999999999999999999987654
Q ss_pred cc----ccccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSG-----KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
.. ....++..|+|||.+... .++.++|||||||++|||++|+.||..... .+.+... ......
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~~~~~~~-~~~~~~ 251 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VKTLFKI-PRNPPP 251 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------HHHHHHH-hcCCCC
Confidence 32 233467789999997543 368899999999999999999999864221 1111111 111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.+ .......+.+++.+||+.+|++||++.|++++
T Consensus 252 ~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 12233568999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=302.17 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=193.9
Q ss_pred HHcCcC--CcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNG--GLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+| +||.||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 8999999985 46999999998643 233456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+......
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 99999987543 23588999999999999999999998 9999999999999999999999999854332111
Q ss_pred ---------ccccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHH--------
Q 045652 470 ---------NLAQALFAYKAPEAIQSG--KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVAS-------- 530 (621)
Q Consensus 470 ---------~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 530 (621)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLDI 233 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCccc
Confidence 112234569999998763 4789999999999999999999998643210 000000000
Q ss_pred --------Hhh-----------cCc-----cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HH
Q 045652 531 --------AFS-----------EGR-----VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IV 584 (621)
Q Consensus 531 --------~~~-----------~~~-----~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~ 584 (621)
... +.. .....+..+ ...........+.+++.+||+.||++|||+.|++++ ++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 000 000 000000000 111123456789999999999999999999999987 44
Q ss_pred Hhhc
Q 045652 585 EIQQ 588 (621)
Q Consensus 585 ~i~~ 588 (621)
.+..
T Consensus 313 ~~~~ 316 (328)
T cd08226 313 QVKE 316 (328)
T ss_pred HHHH
Confidence 4443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.14 Aligned_cols=251 Identities=20% Similarity=0.309 Sum_probs=192.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 467899999999999985 458999999986432 344567889999999996 9999999999999889999999985
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
+++.++...........+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE---LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc---CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4665543211101134689999999999999999999963 17999999999999999999999999998765432
Q ss_pred -ccccccccccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 -NLAQALFAYKAPEAIQSG---KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+..... +. .+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~-----~~~~ 231 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK-GD-----PPIL 231 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC-CC-----CCcC
Confidence 233567789999998765 68999999999999999999999986421 11222222111 11 1111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... ........+.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 112345678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=300.63 Aligned_cols=260 Identities=18% Similarity=0.245 Sum_probs=192.8
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455566666666666554 6899999998643 34456779999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......
T Consensus 83 ~~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 83 YGSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred CCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 999999997543 23578889999999999999999999 9999999999999999999999999988654321
Q ss_pred ----------ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh----
Q 045652 470 ----------NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS---- 533 (621)
Q Consensus 470 ----------~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 533 (621)
....++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKVRGTVPCLLD 232 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCccccc
Confidence 12234567999999865 35889999999999999999999999743211 111111110000
Q ss_pred c-------Ccccc----ccccch---hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 534 E-------GRVTD----LLDPEI---ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 534 ~-------~~~~~----~~d~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
. ..... ..++.. ...........++.+++.+||..||++|||+++++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0 00000 000000 00111223446789999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=279.37 Aligned_cols=254 Identities=20% Similarity=0.315 Sum_probs=198.0
Q ss_pred ccCChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCC
Q 045652 304 GVFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTD 380 (621)
Q Consensus 304 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 380 (621)
..-.+.|+. ....||.|+.|.|++++ ..+|...|||.+... .....+++...++++.+-+ .|+||+.+|||..+.
T Consensus 87 ~~~dindl~--~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 87 YQADINDLE--NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred cccChHHhh--hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 334455553 56789999999999998 456899999999754 4455667778888777664 899999999999999
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..++.||.|. ..+..++++-. ..+++..+-++..-+++||.||.++ .+|+|||+||+|||+|+.|++|++||
T Consensus 165 dV~IcMelMs-~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeK---H~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 165 DVFICMELMS-TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred hHHHHHHHHH-HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHh---cceeecccCccceEEccCCCEEeecc
Confidence 9999999984 46677766433 4578777888999999999999976 38999999999999999999999999
Q ss_pred ecceecccc---ccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 461 GFYTMINSA---NLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 461 G~a~~~~~~---~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
|++-.+... ....|.+.|||||.+. ...|+.++||||||+.++||.||+.||..- +.+.+....+ ..+
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c---~tdFe~ltkv---ln~ 310 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC---KTDFEVLTKV---LNE 310 (391)
T ss_pred cccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC---CccHHHHHHH---Hhc
Confidence 998776543 3456778899999985 346899999999999999999999999742 2223332222 211
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. . |.+... ....+.+.+++..||.+|+.+||...++++|
T Consensus 311 -e-P----P~L~~~---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 -E-P----PLLPGH---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -C-C----CCCCcc---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 1 122111 1245679999999999999999999999876
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.09 Aligned_cols=247 Identities=20% Similarity=0.296 Sum_probs=200.8
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeC----CeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRT----DEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~lv~e~ 388 (621)
..++||-|-.|.|..+. ..+++.+|+|++... ...++|+++.-.. .|||||.++++|+.. ...++|||.
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 45899999999999998 556999999998743 2345778776666 599999999998753 346799999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeeccee
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTM 465 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~ 465 (621)
|+||.|...++.++ ...+++.++-.|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+|+.
T Consensus 141 meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 141 MEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred ccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEecccccccc
Confidence 99999999998654 45799999999999999999999999 9999999999999974 44699999999988
Q ss_pred cccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 466 INSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
.... ....-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||..... ..+..-++..+..++. ++-+
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~gqy-~FP~ 288 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTGQY-EFPE 288 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhccCc-cCCC
Confidence 6543 234457889999999988999999999999999999999999975332 3333444455555542 2222
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
..+....+...++|+.+|+.+|.+|.|+.|++.+=.
T Consensus 289 ------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 289 ------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 234677788999999999999999999999998743
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=292.68 Aligned_cols=240 Identities=20% Similarity=0.250 Sum_probs=193.7
Q ss_pred cCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 319 LGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 319 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 48999999986432 23456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---cc
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---NL 471 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~ 471 (621)
.+++.+. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 9999743 3488899999999999999999998 9999999999999999999999999998876543 22
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||..... +..+........... . ..+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-----~-----~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGK-----L-----EFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCC-----C-----CCC
Confidence 3467789999999888899999999999999999999999874321 112222222110000 0 001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
......+.+++.+||..+|++||+ ++|++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 122467999999999999999999 6777653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.36 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=194.0
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCC------eeEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTD------EKLL 384 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~l 384 (621)
|.+.+.||+|+||.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.... ..++
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 345678999999999999964 578999999875443 356789999999999 6999999999997654 3789
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 87 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 9999999999998864321 134688999999999999999999998 99999999999999999999999999987
Q ss_pred ecccc----ccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 465 MINSA----NLAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 465 ~~~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
..... ....++..|+|||++.. ..++.++|||||||++|+|++|+.||..... ........ ..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~-~~ 233 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRALFKIP-RN 233 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHHHHHhh-cc
Confidence 65432 23346778999998753 3477899999999999999999999863211 11111111 11
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... . .........+.+++.+||..||++|||+.|++++
T Consensus 234 ~~~~-----~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PPPT-----L---KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCC-----C---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 1 1112244678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.75 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=195.2
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||++... +|..||+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999954 58899999986431 233567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceeccccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSAN- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~- 470 (621)
+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 85 DLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999997533 23578999999999999999999998 999999999999999886 46999999987664432
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...++..|+|||++.+..++.++||||||+++|||++|..||... ...+.+..... +.....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~-~~~~~~------- 222 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-------NLHQLVLKICQ-GYFAPI------- 222 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHhc-ccCCCC-------
Confidence 234677899999998888999999999999999999999998632 12222222221 111110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.....+.+++.+||..+|++|||+.|++++
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11233568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.80 Aligned_cols=256 Identities=19% Similarity=0.268 Sum_probs=190.4
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
..+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+.+
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 3467999999999999954 689999999864322 2234567899999999999999999999999999999999975
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 88 DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9999886432 3578999999999999999999998 9999999999999999999999999998754321
Q ss_pred -ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---c-------
Q 045652 470 -NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---V------- 537 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~------- 537 (621)
....++..|+|||++.+ ..++.++||||+|+++|||++|+.||..... ..+....+........ .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD---VEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 12234677999999865 4588999999999999999999999864221 1111111111110000 0
Q ss_pred --cc----cc-ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 --TD----LL-DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 --~~----~~-d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. .. ...+............+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 00 00000000001112567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.18 Aligned_cols=256 Identities=17% Similarity=0.251 Sum_probs=188.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++||||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 346799999999999985 468899999986432 2223457789999999999999999999999999999999995 6
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 88 DLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 777776532 23477888899999999999999998 9999999999999999999999999998764322
Q ss_pred -ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC------------
Q 045652 470 -NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG------------ 535 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------------ 535 (621)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+....+...+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD---VFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh---HHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 223457789999998754 578899999999999999999999864321 011111111100000
Q ss_pred -ccccccc----cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 -RVTDLLD----PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 -~~~~~~d----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....... +..............+.+++.+|+..||++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 0000000001123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.18 Aligned_cols=242 Identities=19% Similarity=0.251 Sum_probs=196.2
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 3467999999999999964 58999999986432 2345678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 84 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 84 GGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999643 3588999999999999999999998 9999999999999999999999999998776443
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...++........
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~----------- 218 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETAD----------- 218 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcccc-----------
Confidence 2344667899999998888999999999999999999999998743221 1222222211100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcH--HHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEM--REAVR 581 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl~ 581 (621)
...+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 01112234678999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=289.81 Aligned_cols=244 Identities=25% Similarity=0.419 Sum_probs=200.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 3467999999999999965 688999999986654456789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---c
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---N 470 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---~ 470 (621)
|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+...... .
T Consensus 84 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 84 LKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 999987432 4689999999999999999999998 9999999999999999999999999998877554 3
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....... ........
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~~~-------- 219 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-------PMKALFKIAT-NGPPGLRN-------- 219 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHHHHh-cCCCCcCc--------
Confidence 4556778999999988889999999999999999999999986421 1111111111 11111100
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124568999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=299.78 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=199.5
Q ss_pred HHHHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
+..|...+.||+|+||.||+|... ++..|++|.+... .....+.+.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344667789999999999999954 5789999988632 223345678899999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+. |++.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 94 ~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 94 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCccccee
Confidence 99996 58877775322 3478899999999999999999998 999999999999999999999999999987
Q ss_pred ccccccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 466 INSANLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 466 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
........++..|+|||.+. ...++.++|||||||++|||++|+.||.... ........ ..+..
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~-~~~~~----- 231 (308)
T cd06634 165 MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHI-AQNES----- 231 (308)
T ss_pred ecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-------HHHHHHHH-hhcCC-----
Confidence 76666666788999999974 3568889999999999999999999986421 11111111 11111
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
+.. ........+.+++.+||+.+|++||++.+++++.....
T Consensus 232 ~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000 01233456889999999999999999999998855443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=297.79 Aligned_cols=247 Identities=20% Similarity=0.324 Sum_probs=188.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHH-HhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRR-LGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||++... +|+.||+|+++... ......+..|+.+ ++.++||||+++++++...+..+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 3467999999999999854 69999999987542 2223445556665 566789999999999999999999999996
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++..... ....+++..++.++.|++.||+|||++ .+++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 84 TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSK---LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhc---CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 688888764332 235689999999999999999999974 27999999999999999999999999998765432
Q ss_pred -ccccccccccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 -NLAQALFAYKAPEAIQS----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....++..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... ..+.+........ +.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------~~ 227 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLKQVVEEPS------PQ 227 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHHHHHhcCC------CC
Confidence 22346778999998864 4568899999999999999999999863211 1111211111111 11
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ....+.++.+++.+||..+|++||++.+++++
T Consensus 228 ~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 11234568999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.96 Aligned_cols=259 Identities=18% Similarity=0.248 Sum_probs=190.8
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCe-----eEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDE-----KLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~lv 385 (621)
+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++ ||||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 456799999999999995 468999999876432 122356788999999995 6999999999887665 7999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecce
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFYT 464 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~ 464 (621)
|||+++ +|.+++..........+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 999985 898888654322234689999999999999999999998 9999999999999998 8899999999987
Q ss_pred ecccc----ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc-
Q 045652 465 MINSA----NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT- 538 (621)
Q Consensus 465 ~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 538 (621)
..... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..||..... ......+..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHhCCCChhh
Confidence 65332 12235677999998865 4579999999999999999999999864221 11111111111000000
Q ss_pred --c---ccc----cchh---cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 --D---LLD----PEIA---SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 --~---~~d----~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ..+ +... .....+.....+.+++.+||..||++||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000 0000 000012344678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=292.87 Aligned_cols=235 Identities=18% Similarity=0.276 Sum_probs=186.1
Q ss_pred cCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCCChhH
Q 045652 319 LGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396 (621)
Q Consensus 319 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 396 (621)
||+|+||.||++.. .++..+|+|.+....... .|+.....+ +||||+++++++...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 59999999999984 568899999986432111 122222222 69999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceecccccccccc
Q 045652 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSANLAQAL 475 (621)
Q Consensus 397 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~ 475 (621)
++... ..+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++..........++
T Consensus 99 ~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 169 (267)
T PHA03390 99 LLKKE-----GKLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169 (267)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence 99743 2689999999999999999999998 999999999999999998 9999999999887766666788
Q ss_pred ccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHH
Q 045652 476 FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEM 555 (621)
Q Consensus 476 ~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 555 (621)
..|+|||++.+..++.++||||||+++|||++|+.||..... ...+...+.... . .. ........
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~-~~-----------~~~~~~~~ 234 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQ-Q-KK-----------LPFIKNVS 234 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhh-c-cc-----------CCcccccC
Confidence 899999999988899999999999999999999999974221 111111211111 0 00 00112344
Q ss_pred HHHHHHHhhcccCCCCCCCc-HHHHHHH
Q 045652 556 EQLLEIGRACTQSDPEQRLE-MREAVRR 582 (621)
Q Consensus 556 ~~l~~li~~cl~~dP~~Rps-~~evl~~ 582 (621)
..+.+++.+||+.+|.+||+ ++|+++|
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 67899999999999999996 6888864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=291.51 Aligned_cols=240 Identities=20% Similarity=0.211 Sum_probs=186.7
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChh---hHHHHHHHHHHH-hcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM---ARDAFDTEVRRL-GRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|.. .+++.||+|.++..... ....+..|..++ ...+|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 45899999998754321 122344555444 455899999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL 471 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 471 (621)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence 9999999643 3578899999999999999999998 999999999999999999999999999887655555
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..++..|+|||.+.+..++.++||||||+++|||++|..||.... .... . .....+... ..+ ...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~---~-~~~~~~~~~--~~~-----~~~ 217 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET----PDAV---F-DNILSRRIN--WPE-----EVK 217 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC----HHHH---H-HHHHhcccC--CCC-----ccc
Confidence 567788999999988889999999999999999999999986421 1111 1 111111110 000 001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHH
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAV 580 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl 580 (621)
......+.+++.+||+.+|++||++.++.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 246 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQ 246 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence 12346789999999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=298.37 Aligned_cols=244 Identities=21% Similarity=0.244 Sum_probs=198.4
Q ss_pred HHcCcCCcccEEEEE-EcCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
++||+|+||.||-+. ..+|+.+|.|.+.+..- ....-..+|-.+|.+++.+.||.+-..|+..+..++||..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 579999999999998 55699999998864432 22334568999999999999999998899999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.-+|.... ...++++.++-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|+|+|..+....
T Consensus 271 DLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 271 DLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 9999997654 35799999999999999999999999 99999999999999999999999999999886543
Q ss_pred -cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 471 -LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 471 -~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
...||.+|||||++....|+...|.||+||++|||+.|+.||.... .....+.+.+...+.. ..
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K----eKvk~eEvdrr~~~~~-----------~e 408 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK----EKVKREEVDRRTLEDP-----------EE 408 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh----hhhhHHHHHHHHhcch-----------hh
Confidence 3478999999999999999999999999999999999999997421 1111112222222111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
.+....++..+|....|.+||++|.. +++|.+|
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 12344567888889999999999974 5566554
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.10 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=202.5
Q ss_pred HHHcCcCCcccEEEEE-EcCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEEEEe
Q 045652 316 AEVLGNGGLGSSYKAM-MADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLLVYE 387 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 387 (621)
.+.||+|+||.||+++ ..+|+.||||.++.. ....++..-+|+++|++++|+|||++++.-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4679999999999999 667999999999753 3345678889999999999999999999865543 4689999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC--CCC--CcEEEeeecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS--PEN--EPLISEFGFY 463 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfG~a 463 (621)
||.+|||...+.+-. ....+++.+.+.++.+++.||.|||++ +|+||||||.||++- .+| ..||+|||.|
T Consensus 98 yC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999997533 356799999999999999999999998 999999999999985 333 4799999999
Q ss_pred eeccccc---cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 464 TMINSAN---LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 464 ~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
+.+.+.. ...||..|.+||++.. ..|+..+|.|||||++||.+||..||..........++.-.+...-..+.. -
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~-i 250 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA-I 250 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee-E
Confidence 9987763 4568999999999984 789999999999999999999999998654432222222211111111100 0
Q ss_pred ccccchh----------c-CCCCHHHHHHHHHHHhhcccCCCCCCC--cHHHHHHHHHHhhc
Q 045652 540 LLDPEIA----------S-STNSPGEMEQLLEIGRACTQSDPEQRL--EMREAVRRIVEIQQ 588 (621)
Q Consensus 540 ~~d~~~~----------~-~~~~~~~~~~l~~li~~cl~~dP~~Rp--s~~evl~~L~~i~~ 588 (621)
..++... . ..........+-.++..+|..+|++|. ...+....+..|..
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 0011100 0 111234456677888899999999998 66666666666654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.28 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=192.7
Q ss_pred HHHHcCcCCcccEEEEEEc---CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMA---DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 386 (621)
+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 3467999999999999954 47899999987632 33346678899999999999999999999988 7789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC----CCCcEEEeeec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP----ENEPLISEFGF 462 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfG~ 462 (621)
||+++ +|.+++..........++...+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 99965 777777543322234688999999999999999999998 9999999999999999 89999999999
Q ss_pred ceecccc-------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc-----chHHHHH
Q 045652 463 YTMINSA-------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI-----DVVEWVA 529 (621)
Q Consensus 463 a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~-----~~~~~~~ 529 (621)
+...... ....++..|+|||.+.+. .++.++|||||||++|||++|+.||.......... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 8865432 123456789999988654 58899999999999999999999987543221000 0001111
Q ss_pred HHhhcC------------ccccccccchhcCC---CC-------HHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 530 SAFSEG------------RVTDLLDPEIASST---NS-------PGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 530 ~~~~~~------------~~~~~~d~~~~~~~---~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+... ......+....... .. ......+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000 00000000000000 00 0233568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=335.50 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=195.4
Q ss_pred HHcCcCCcccEEEEE-EcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+||.|.||.||-|. ..+|+..|+|-++-. .......+.+|+.++..+.|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 579999999999998 567999999987632 23345667899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+.+...+ ..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++|||.|..+...
T Consensus 1321 La~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1321 LASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999997433 244555567889999999999999 9999999999999999999999999999887544
Q ss_pred ----ccccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 ----NLAQALFAYKAPEAIQSGK---VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....||+.|||||++.+.. ...+.||||+|||+.||+||+.||..+++ ...++ -.+..|....
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIM----y~V~~gh~Pq--- 1461 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIM----YHVAAGHKPQ--- 1461 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHH----hHHhccCCCC---
Confidence 2356899999999997543 56789999999999999999999986543 11222 2223333211
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.....+-.+++..||..||+.|.++.|++++
T Consensus 1462 -------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 -------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 123355678899999999999999999888765
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.85 Aligned_cols=254 Identities=19% Similarity=0.295 Sum_probs=192.4
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|++|.||+|.. .+|..||+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 457899999999999985 469999999986432 2234567889999999999999999999999999999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++.... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 82 LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 69999986433 23689999999999999999999998 9999999999999999999999999998765322
Q ss_pred --ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC-----------
Q 045652 470 --NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG----------- 535 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----------- 535 (621)
....++..|+|||++.+. .++.++||||||+++|||++|+.||..... .....+.+ +.....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIF-RTLGTPDEDVWPGVTSL 230 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-HHhCCCChHHhhhhhhc
Confidence 122346789999988654 578999999999999999999999864221 00111111 000000
Q ss_pred -----ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 -----RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 -----~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+... ...+.....+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLS--KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchh--hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 0012233578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=295.49 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=190.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeC--CeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRT--DEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++||||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 356799999999999984 468999999987532 222234457899999985 99999999999987 7899999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||++......
T Consensus 83 ~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 83 D-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred C-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 6 58888876432 3589999999999999999999998 9999999999999999 99999999999876433
Q ss_pred c---cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh-----------c
Q 045652 470 N---LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS-----------E 534 (621)
Q Consensus 470 ~---~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----------~ 534 (621)
. ...++..|+|||++.. ..++.++|||||||++|||++|..||.... ..+....+..... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN----ELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC----HHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 2 2345678999997654 557899999999999999999999986422 1222222221111 0
Q ss_pred CccccccccchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRVTDLLDPEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~~~~~d~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+..... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0012345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.67 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=198.5
Q ss_pred HHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.+.||+|.|+.|.+|. .-++..||||.+++.. ....+.+.+|+++|+.++|||||+++.+.......|+||||+.
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 356789999999999998 4459999999998653 2334568899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|.+++++..+. .+....+..++.|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+...
T Consensus 139 ~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 139 GGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred CchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeecccc
Confidence 999999998544 455578889999999999999999 9999999999999999999999999999988654
Q ss_pred --ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 --NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||++-. -..+.+.+ ..+.+ ++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rv----l~gk~------rI- 274 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRV----LRGKY------RI- 274 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----cccccchh----eeeee------cc-
Confidence 45678889999999998876 579999999999999999999997421 11111110 00000 00
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+.-...+..++++++|..+|.+|++++++.++-
T Consensus 275 ----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 275 ----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ----cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111224577899999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.64 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=193.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|++|.||+|... +|+.||||.++... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 4567999999999999964 58999999987543 22345677899999999999999999999999999999999975
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 83 ~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 83 DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 8988886433 234689999999999999999999998 9999999999999999999999999998765332
Q ss_pred -ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---c---c--c
Q 045652 470 -NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---V---T--D 539 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~---~--~ 539 (621)
....++..|++||++.+. .++.++|||||||++|+|++|+.||..... .+....+........ . . .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 223456789999988654 578999999999999999999999864321 111111111110000 0 0 0
Q ss_pred ccccchhc------CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIAS------STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........ ....+.....+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 00011234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.41 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=193.9
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+...+.||+|+||.||+|.. .+++.|++|.+... .....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 34456799999999999985 45889999998643 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+. +++.+++... ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 95 5787777532 23588999999999999999999998 999999999999999999999999999876555
Q ss_pred cccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ANLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....++..|+|||++. ...++.++|||||||++|||++|..||.... ....+....... .....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~-~~~~~---- 241 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQND-SPTLQ---- 241 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcC-CCCCC----
Confidence 55566788899999984 4568899999999999999999999986421 111111111111 11110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.+|++||++.+++.+
T Consensus 242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223458899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.17 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=198.8
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~ 389 (621)
..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+||+++++.+... ...++||||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3467999999999999965 68999999987543 24567889999999999999999999999988 7899999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 84 SGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999743 2689999999999999999999998 9999999999999999999999999998876543
Q ss_pred c------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 N------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 ~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
. ...++..|+|||.+.+..++.++||||||+++|+|++|..||.... +....+..........
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~----- 223 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPP----- 223 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCc-----
Confidence 2 2446678999999988889999999999999999999999987432 1111111111101100
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.........+.+++.+|+..||++||++.|++++
T Consensus 224 -----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 -----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0112224679999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=304.99 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=191.2
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 384 (621)
...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++... ...++
T Consensus 19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 98 (353)
T cd07850 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98 (353)
T ss_pred EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence 3457899999999999985 46899999998642 233345677899999999999999999988643 34689
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 99 v~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 99 VMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 999995 588888752 278888999999999999999998 99999999999999999999999999998
Q ss_pred eccccc---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh--------
Q 045652 465 MINSAN---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS-------- 533 (621)
Q Consensus 465 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-------- 533 (621)
...... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .+....+...+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH----IDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhcCCCCHHHHH
Confidence 765432 23466789999999999999999999999999999999999864221 111111100000
Q ss_pred ----------cCc-------cccccccchhc---CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 ----------EGR-------VTDLLDPEIAS---STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 ----------~~~-------~~~~~d~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+ ..+........ ..........+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000000000 00011335678899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=257.78 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=194.9
Q ss_pred HHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|.-.++||+|.||+||+|+ +.+++.||+|+++-. ++.......+|+-+++.++|.|||+++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4456889999999999999 556899999988643 3334556789999999999999999999998899999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
. .+|..+.... ...++......++.|+++||.|+|++ ++.|||+||+|.||+.+|++|++|||+++.++-+
T Consensus 84 d-qdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 84 D-QDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred h-HHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 5 4898888643 35688889999999999999999999 9999999999999999999999999999987654
Q ss_pred ----ccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh------cCcc-
Q 045652 470 ----NLAQALFAYKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS------EGRV- 537 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~- 537 (621)
.....|..|++|.++.+.+ |++..|+||.|||+.|+.....|... +.++.+...+.+. +.++
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp------g~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP------GNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC------CCcHHHHHHHHHHHhCCCccccCC
Confidence 2344677899999998765 89999999999999999974444332 1233333333332 1111
Q ss_pred --ccccccc----hhcCCCC----HHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 --TDLLDPE----IASSTNS----PGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 --~~~~d~~----~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.++-|.. ......+ +.....-.+++++.+.-+|.+|+++++++++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111 1111111 1222334789999999999999999998865
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=289.57 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=198.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||++.. .+++.+++|.+... .......+.+|++++++++|+||+++++++......++||||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 456799999999999984 46889999998643 233456778999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++.+... ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 158 (256)
T cd08530 84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158 (256)
T ss_pred CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc
Confidence 999999865321 235689999999999999999999998 9999999999999999999999999998776443
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ... .......+....
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~----~~~----~~~~~~~~~~~~---------- 220 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS----MQD----LRYKVQRGKYPP---------- 220 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHH----HHHHHhcCCCCC----------
Confidence 22345678999999998889999999999999999999999986421 111 111122221111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......++.+++.+||..+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=281.66 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=199.2
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHH---HHHHHHHHhcCCCCCcccceEEEEeCCe
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDA---FDTEVRRLGRLRHSNVLAPLAYHYRTDE 381 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (621)
.+.++. ...++||+|.||.|.+++ ..+++.+|+|++++..-.++++ -..|-++|+..+||.+..+...|...+.
T Consensus 165 vTm~dF--dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 165 VTMEDF--DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred eccchh--hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 344444 357899999999999998 6679999999998654333333 4578999999999999999888999999
Q ss_pred eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.|+||||..||.|.-+|.+ .+.+++....-+-.+|+.||.|||++ +||.||||.+|.|+|.+|++||+|||
T Consensus 243 lCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecc
Confidence 9999999999999998874 34578888888999999999999999 99999999999999999999999999
Q ss_pred cceec----cccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 462 FYTMI----NSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 462 ~a~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
+++.- .......||+.|+|||++....|+.++|+|.+|||+|||+.|+.||... +...+.+.+.. ..
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~----dh~kLFeLIl~----ed- 384 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK----DHEKLFELILM----ED- 384 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc----chhHHHHHHHh----hh-
Confidence 99753 2335678999999999999999999999999999999999999999742 12222222211 11
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+ ..+....++...|+...|.+||.+|. .++||.++
T Consensus 385 --~--------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 385 --L--------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --c--------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 0 01122335678888999999999996 46677655
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=292.26 Aligned_cols=239 Identities=23% Similarity=0.311 Sum_probs=190.8
Q ss_pred cCcCCcccEEEEEEcC-CcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 319 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
||+|+||.||++...+ |+.|++|.+..... ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999654 89999999875433 3456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 469 (621)
.+++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9999742 3589999999999999999999998 9999999999999999999999999988754322
Q ss_pred -------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 -------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....++..|+|||......++.++||||||+++|||++|+.||.... ...... ....+... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~----~~~~~~~~---~ 220 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET----PEEIFQ----NILNGKIE---W 220 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHH----HHhcCCcC---C
Confidence 12235567999999988889999999999999999999999986421 111111 11111110 0
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+ ........+.+++.+||+.+|++|||+.++.+.|
T Consensus 221 ~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 221 P------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred C------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 0011246789999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=296.61 Aligned_cols=246 Identities=15% Similarity=0.216 Sum_probs=178.6
Q ss_pred HHHHHHcCcCCcccEEEEEEcC----CcEEEEEEccCCChhh-H----------HHHHHHHHHHhcCCCCCcccceEEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKESSAMA-R----------DAFDTEVRRLGRLRHSNVLAPLAYHY 377 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~niv~l~~~~~ 377 (621)
|.+.+.||+|+||.||+|...+ +..+|+|......... . .....+...+..++|+||+++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 3456789999999999998544 3456666543221110 0 11223444566778999999999766
Q ss_pred eCC----eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC
Q 045652 378 RTD----EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453 (621)
Q Consensus 378 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~ 453 (621)
... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 94 FKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGNN 163 (294)
T ss_pred EecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCC
Confidence 543 3468888874 4676666532 2356788899999999999999998 999999999999999999
Q ss_pred CcEEEeeecceecccc-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc
Q 045652 454 EPLISEFGFYTMINSA-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI 522 (621)
Q Consensus 454 ~~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 522 (621)
.++|+|||+++.+... ....+|..|+|||+..+..++.++|||||||++|||++|+.||.......
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--- 240 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--- 240 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch---
Confidence 9999999999765321 22357889999999999999999999999999999999999997542211
Q ss_pred chHHHH----HHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 523 DVVEWV----ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 523 ~~~~~~----~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
...... ...+..+. . ..+..+..+.+++..|++.+|++||++.++++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~--------~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHEGK--------I----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhhhh--------h----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111 11111111 0 0122346789999999999999999999999865
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=301.55 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=200.6
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC-----eeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD-----EKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 385 (621)
.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 34578999999999999964 48999999987543 334567889999999999999999999988765 78999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||++ ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 83 ~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 83 TELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred ecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99997 5898888642 3689999999999999999999999 999999999999999999999999999987
Q ss_pred ccccc-------cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc-
Q 045652 466 INSAN-------LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR- 536 (621)
Q Consensus 466 ~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 536 (621)
..... ...++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+....+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY----IDQLNLIVEVLGTPSE 228 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHhcCCCCh
Confidence 65432 23456679999999877 789999999999999999999999864321 111111111111000
Q ss_pred ----------cccccc---c--chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhccC
Q 045652 537 ----------VTDLLD---P--EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQSD 590 (621)
Q Consensus 537 ----------~~~~~d---~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~~ 590 (621)
..+.+. . ........+.....+.+++.+||+.+|++||++.+++.+ ++.+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 000000 0 000000011234678999999999999999999999987 66665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=286.23 Aligned_cols=242 Identities=22% Similarity=0.379 Sum_probs=197.9
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..+++|||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 34578999999999999854 578999999876543 456778999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 83 ~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 83 NGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999998743 4689999999999999999999998 99999999999999999999999999998775443
Q ss_pred c----ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 L----AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ~----~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
. ..++..|+|||...+..++.++||||+|+++|+|++|+.||.... . ......... ... +..
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~-~~~~~~~~~-~~~-----~~~- 219 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------P-MAALFRIVQ-DDH-----PPL- 219 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------H-HHHHHHHhc-cCC-----CCC-
Confidence 2 346778999999988788999999999999999999999986321 1 111111111 110 001
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||..+|++||++.|++.+
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 12234578899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.85 Aligned_cols=258 Identities=19% Similarity=0.316 Sum_probs=191.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC-----eeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD-----EKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 387 (621)
+.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.... ..++|+|
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 457899999999999984 568999999986432 233456788999999999999999999876543 4789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+. ++|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 89 LME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred hcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 996 488887753 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred ccc-------cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc--
Q 045652 468 SAN-------LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV-- 537 (621)
Q Consensus 468 ~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 537 (621)
... ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... .......+...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~----~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD----YLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCCHHH
Confidence 321 2345678999998754 568999999999999999999999986421 11111111111110000
Q ss_pred -ccccc-------------cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhh
Q 045652 538 -TDLLD-------------PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQ 587 (621)
Q Consensus 538 -~~~~d-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 587 (621)
..+.+ +........+.....+.+++.+||+.||++|||+.|++++ ++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 0000000001234568999999999999999999999988 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=298.62 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=190.6
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 456799999999999995 4589999999864321 1233466899999999999999999998765 4579999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
. ++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 91 ~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 91 E-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred C-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 6 48888886432 4589999999999999999999999 9999999999999999999999999998876543
Q ss_pred ----ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC--ccc-ccc
Q 045652 470 ----NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG--RVT-DLL 541 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~ 541 (621)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+....... ... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS----EIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCChhhchhhh
Confidence 12234567999999865 457899999999999999999999986422 122222222111100 000 000
Q ss_pred ------ccchhcC--C----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 542 ------DPEIASS--T----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 542 ------d~~~~~~--~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
....... . ......+.+.+++.+||+.||++|||+.|+++|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000000 0 0011246688999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=280.43 Aligned_cols=260 Identities=19% Similarity=0.274 Sum_probs=198.9
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCCh-hhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCe
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA-MARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDE 381 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (621)
.|+-++++ -...||.|+||+|++-. .+.|+..|||+++.... ...+++..|.+...+- +.||||++||.+..++.
T Consensus 60 ~F~~~~Lq--dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQ--DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHH--HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 34444443 35679999999999987 45699999999985543 4566788888876665 68999999999999999
Q ss_pred eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.|+.||.|. .+|..+.+.-.......+++...-+|..-.++||.||... ..|||||+||+|||++..|.+||+|||
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~---lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE---LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH---hhhhhccCChhheEEecCCCEeeeccc
Confidence 999999994 5776554321111235688888888888999999999876 379999999999999999999999999
Q ss_pred cceecccc---ccccccccccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 462 FYTMINSA---NLAQALFAYKAPEAIQ--SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 462 ~a~~~~~~---~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
.+-.+..+ ....|...|||||.+. +..|+.++||||||++|||+.||++||.... ++.+.+........
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~Vv~gdp 287 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQVVIGDP 287 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHHHcCCC
Confidence 98766443 2345667899999985 3358999999999999999999999987432 34555544443222
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. .+............+..++..||.+|-.+||...+++++
T Consensus 288 -p-----~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 -P-----ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -C-----eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 122222223455679999999999999999999988765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.88 Aligned_cols=240 Identities=19% Similarity=0.262 Sum_probs=185.3
Q ss_pred HcCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHHHHHH---HHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 318 VLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAFDTEV---RRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|. ..++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999985 4588999998864321 1122233443 34445579999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 9999998863 23589999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||.+.++ .++.++||||+||++|||++|+.||...... ... .+...... ..+.+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~----~~~-~~~~~~~~------~~~~~-- 218 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKH-EIDRMTLT------MAVEL-- 218 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc----chH-HHHHHhhc------cCCCC--
Confidence 234577889999998754 6899999999999999999999998743211 111 11111110 01111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+......+.+++.+||..+|.+|| ++.+++++
T Consensus 219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112246789999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.61 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=191.6
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhh--------------HHHHHHHHHHHhcCCCCCcccceEEEEeC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMA--------------RDAFDTEVRRLGRLRHSNVLAPLAYHYRT 379 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 379 (621)
+.+.||+|+||.||+|... +++.||||.++...... ...+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999854 68999999886432211 12467899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
+..++||||+. ++|.+++.. ...+++.....++.|++.||+|||+. +|+|+||||+||+++.++.++|+|
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEECC
Confidence 99999999996 699998863 23588999999999999999999998 999999999999999999999999
Q ss_pred eecceecccc------------------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC
Q 045652 460 FGFYTMINSA------------------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG 520 (621)
Q Consensus 460 fG~a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 520 (621)
||++...... ....++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~---- 238 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN---- 238 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----
Confidence 9998765411 112345679999998764 47899999999999999999999986432
Q ss_pred CcchHHHHHHHhhcCccc---cc------------cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 521 GIDVVEWVASAFSEGRVT---DL------------LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~---~~------------~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
..+....+.......... .. ..+.... ........+.+++.+||+.+|++||++.|++.+-
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT--IFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH--hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 122222222211111000 00 0000000 0112245688999999999999999999999753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=293.98 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=195.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|++|.||+|.. .+++.+++|.++.... .....+.+|++++++++|+||+++++++......++||||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 346799999999999985 4689999999875432 2456788999999999999999999999999999999999975
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
+|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 83 -~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 83 -DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred -CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 8888886432 4689999999999999999999998 99999999999999999999999999987765432
Q ss_pred ---cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---cccccc-
Q 045652 471 ---LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---VTDLLD- 542 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d- 542 (621)
...++..|+|||.+.+. .++.++||||||+++|+|+||+.||.... ..+....+........ .....+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS----EIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCCchHhcccchhh
Confidence 23356679999998776 78999999999999999999999886321 1111111111111100 000000
Q ss_pred --------cc---hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 --------PE---IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 --------~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+. .......+.....+.+++.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 00000112345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.20 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=193.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|... +++.+|+|+++... ......+.+|++++++++|+|++++++++... +..++||||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3467999999999999965 48999999997653 33345688999999999999999999999888 7899999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 83 ~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 83 DH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 75 8988886432 4689999999999999999999998 9999999999999999999999999998876543
Q ss_pred c-----cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC---ccccc
Q 045652 470 N-----LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG---RVTDL 540 (621)
Q Consensus 470 ~-----~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 540 (621)
. ...++..|+|||.+.+ ..++.++||||||+++|||+||+.||.... .......+....... .....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST----ELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCchhhcccc
Confidence 2 2234567999998764 457899999999999999999999986422 111122221111100 00000
Q ss_pred --------------cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 --------------LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 --------------~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....+. ......+...+.+++.+||..+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00000125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=286.89 Aligned_cols=242 Identities=21% Similarity=0.320 Sum_probs=191.6
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-----SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 385 (621)
.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 3457899999999999985 45899999987422 123446788999999999999999999998764 457899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 85 VEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 9999999999998642 3478889999999999999999998 999999999999999999999999999876
Q ss_pred cccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 466 INSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 466 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
.... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+.+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~-~ 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFKIATQPT-K 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHHHHHHcCCC-C
Confidence 5321 12346778999999988889999999999999999999999986321 1111222111111 0
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+ ..+......+.+++.+||. +|..||++.+++.|
T Consensus 228 ----~-----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 ----P-----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----C-----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1 1122344678999999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.60 Aligned_cols=248 Identities=20% Similarity=0.275 Sum_probs=192.9
Q ss_pred HHHHcCcCCcccEEEEEE----cCCcEEEEEEccCCC----hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM----ADGVTVVVKRMKESS----AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||++.. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+......++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 346799999999999874 357889999987432 22345678999999999 599999999999988999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 84 LDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999863 23588899999999999999999998 999999999999999999999999999876
Q ss_pred ccccc-----cccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 466 INSAN-----LAQALFAYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 466 ~~~~~-----~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
..... ...++..|+|||.+.+.. .+.++||||||+++|||++|..||..... ......+........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~-- 228 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE----QNSQSEISRRILKSK-- 228 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc----cchHHHHHHHHHccC--
Confidence 53321 234677899999987654 78899999999999999999999863211 111111111111110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
+.. .......+.+++.+||+.||++|||+.++.+.|+..
T Consensus 229 ----~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 ----PPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000 112335688999999999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=294.72 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=193.5
Q ss_pred HHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCC--eeEEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTD--EKLLV 385 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~~lv 385 (621)
.|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||+++++++...+ ..++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4567789999999999999954 5889999988542 223345677899999999 9999999999986543 57999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||++ ++|..++... .+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 88 ~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 88 FEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred ecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99997 5999988632 578889999999999999999998 999999999999999999999999999876
Q ss_pred ccccc---------cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc-
Q 045652 466 INSAN---------LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE- 534 (621)
Q Consensus 466 ~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~- 534 (621)
..... ...++..|+|||.+.+ ..++.++||||||+++|||+||+.||..... .+....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~----~~~~~~~~~~~~~~ 232 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST----LNQLEKIIEVIGPP 232 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCC
Confidence 53321 2245678999998754 4578999999999999999999999864221 1111111110000
Q ss_pred ----------Cccccccc----cchh-cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhh
Q 045652 535 ----------GRVTDLLD----PEIA-SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQ 587 (621)
Q Consensus 535 ----------~~~~~~~d----~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 587 (621)
.....+++ .... .....+.....+.+++.+||+.||++|||+.+++++ +....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00000000 0000 000011234678999999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.66 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=191.3
Q ss_pred HHHcCcCCcccEEEEEEcC-CcEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCCcccceEEEEeCCe-----eEE
Q 045652 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESS--AMARDAFDTEVRRLGRL---RHSNVLAPLAYHYRTDE-----KLL 384 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~~l 384 (621)
.+.||+|+||.||+|.... ++.||+|.++... ......+.+|+.+++++ +|+||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 4679999999999999754 8999999987432 22234566788877666 59999999999988776 899
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
+|||+. ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 84 ~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 84 VFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred Eehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999996 48988886433 23589999999999999999999998 99999999999999999999999999987
Q ss_pred eccccc---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC-cc---
Q 045652 465 MINSAN---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG-RV--- 537 (621)
Q Consensus 465 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 537 (621)
...... ...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+....+....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS----EADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC----hHHHHHHHHHHcCCCChHhcC
Confidence 764432 2335677999999998899999999999999999999998876422 111111111111100 00
Q ss_pred ------ccccccchhc--CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 ------TDLLDPEIAS--STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ------~~~~d~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......... ....+.....+.+++.+||+.||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 00112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=285.37 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=199.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||++... ++..|++|++.... ....+.+.+|++++++++|+|++++++.+......++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 4467999999999999954 58999999987543 24567788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
++|.+++..... ....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 999999975421 235689999999999999999999998 99999999999999999999999999987764432
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...++..|+|||...+..++.++||||+|+++|+|++|+.||.... ..+.... ........ +
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~-~~~~~~~~-----~-- 223 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALK-ILKGQYPP-----I-- 223 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHH-HhcCCCCC-----C--
Confidence 2345677999999988889999999999999999999999986421 1111111 11111111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||..+|++||++.|++++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11233578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.58 Aligned_cols=255 Identities=19% Similarity=0.269 Sum_probs=186.4
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC--------eeE
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--------EKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~ 383 (621)
+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 4567999999999999854 58999999886332 222345668999999999999999999987654 348
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+||||+. ++|.+++... ...+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 96 lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 9999996 5888887642 23589999999999999999999998 9999999999999999999999999998
Q ss_pred eeccccc--------cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh-
Q 045652 464 TMINSAN--------LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS- 533 (621)
Q Consensus 464 ~~~~~~~--------~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~- 533 (621)
....... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~----~~~~~~~~~~~~~~ 242 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT----EQHQLTLISQLCGS 242 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCC
Confidence 7654321 12345679999988654 47889999999999999999999886422 1111111111110
Q ss_pred --cCccccc-----cc----c-----chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 --EGRVTDL-----LD----P-----EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 --~~~~~~~-----~d----~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....... .+ + ..............+.+++.+||..||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 00 0 000000000112457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.35 Aligned_cols=244 Identities=18% Similarity=0.277 Sum_probs=190.7
Q ss_pred HHHHcCcCCcccEEEEEE----cCCcEEEEEEccCCCh----hhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM----ADGVTVVVKRMKESSA----MARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||++.. .+|..||+|+++.... ...+.+.+|+++++++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 456799999999999985 3689999999874321 2346678899999999 599999999999988889999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 84 LDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999998642 3578889999999999999999998 999999999999999999999999999876
Q ss_pred ccccc-----cccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 466 INSAN-----LAQALFAYKAPEAIQSG--KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 466 ~~~~~-----~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
..... ...++..|+|||.+... .++.++||||||+++|+|++|..||..... .....+....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~-~~-- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILK-SE-- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhc-cC--
Confidence 54321 23467789999998653 478899999999999999999999863211 1111121111111 10
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+. ........+.+++.+||+.||++|| ++.+++.+
T Consensus 229 ----~~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----PP-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CC-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 0122345688999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.05 Aligned_cols=261 Identities=19% Similarity=0.286 Sum_probs=195.5
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----CeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-----DEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 385 (621)
.+.+.||+|+||.||+|.. .+++.||||.++.. .......+.+|+.+++.++|+||+++++++... ...++|
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence 3456799999999999984 46899999998643 222345677899999999999999999987654 247999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 88 ~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 88 YELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 99995 689888863 24589999999999999999999998 999999999999999999999999999887
Q ss_pred cccc----ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc------
Q 045652 466 INSA----NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE------ 534 (621)
Q Consensus 466 ~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------ 534 (621)
.... ....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.... .......+......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD----YVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCCChHHh
Confidence 6433 22345678999998864 468999999999999999999999986421 11111111111000
Q ss_pred -----Cccc-------cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhccC
Q 045652 535 -----GRVT-------DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQSD 590 (621)
Q Consensus 535 -----~~~~-------~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~~ 590 (621)
.... ...++... ...+.....+.+++.+||+.+|++|||++|++++ +..+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0000 00000000 0012345678999999999999999999999999 76665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=301.62 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=191.5
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEe----CCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 3456799999999999984 469999999987532 2334567789999999999999999998763 34578999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 88 e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 88 DLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9995 6899988632 3489999999999999999999998 9999999999999999999999999998765
Q ss_pred cccc--------cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh----
Q 045652 467 NSAN--------LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS---- 533 (621)
Q Consensus 467 ~~~~--------~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 533 (621)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY----VHQLKLILSVLGSPSE 233 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh----HHHHHHHHHHhCCChh
Confidence 4321 2245678999999865 4689999999999999999999999864211 111111111100
Q ss_pred -------cCccccccccc-hhcCC----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 534 -------EGRVTDLLDPE-IASST----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 534 -------~~~~~~~~d~~-~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.....+..+.. ..... ..+.....+.+++.+||+.+|++||++.+++.+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000000 00000 0122356799999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=316.43 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=208.8
Q ss_pred cCChhHHHHHHHHHcCcCCcccEEEEEEc--------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceE
Q 045652 305 VFGLPDLMKAAAEVLGNGGLGSSYKAMMA--------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLA 374 (621)
Q Consensus 305 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 374 (621)
.|.+++-...+.+.||+|.||.|++|... ....||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34444333355669999999999999732 14579999998543 34577899999999999 5999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhHHhhcCC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCC
Q 045652 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDR---------GPSHD--ELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLK 443 (621)
Q Consensus 375 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlk 443 (621)
+|...+..++|+||++.|+|.++++..+ ..... .++..+.+.++.|||.|++||++. ++|||||-
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLA 445 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----Cccchhhh
Confidence 9999899999999999999999998766 11122 389999999999999999999999 89999999
Q ss_pred CCCEEeCCCCCcEEEeeecceeccccccc-----c--ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcc
Q 045652 444 SSNIFISPENEPLISEFGFYTMINSANLA-----Q--ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYL 515 (621)
Q Consensus 444 p~NIll~~~~~~kl~DfG~a~~~~~~~~~-----~--~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 515 (621)
.+|||+.++..+||+|||+|+........ . -...|||||.+....|+.|+|||||||+|||++| |..||...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999975443221 1 1345999999999999999999999999999998 88898642
Q ss_pred cCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 516 TNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
. ...++ .+.+.+|...+ .+..+..++.++|+.||+.+|++||++.++.+.++...
T Consensus 526 ~---~~~~l----~~~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 P---PTEEL----LEFLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred C---cHHHH----HHHHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1 01122 22344443211 12334577899999999999999999999999998853
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.27 Aligned_cols=261 Identities=22% Similarity=0.304 Sum_probs=200.3
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-C-C----CcccceEEEEeCCeeEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-H-S----NVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~~l 384 (621)
.|.+..++|+|.||.|-.+.. ..+..||||+++... ..+++..-|+++|+++. + | -+|.+.++|.-.++.++
T Consensus 90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi 168 (415)
T KOG0671|consen 90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI 168 (415)
T ss_pred ceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence 456778999999999999984 448999999998543 34677788999999993 2 2 37888889999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-------------
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP------------- 451 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~------------- 451 (621)
|+|.+ |.++.+++..+. ...++..++..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 169 vfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 169 VFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred EEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCCcc
Confidence 99998 679999997654 45688999999999999999999999 9999999999999842
Q ss_pred -------CCCcEEEeeecceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcc
Q 045652 452 -------ENEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID 523 (621)
Q Consensus 452 -------~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 523 (621)
+..++|+|||.|+..... .....|..|+|||++.+-.++.++||||+||||+|+.||...|..-.+.+ ...
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E-HLa 319 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE-HLA 319 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH-HHH
Confidence 234889999999887654 45667889999999999999999999999999999999998887533211 111
Q ss_pred hHHHHH--------------HHhhcCccc--------------cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc
Q 045652 524 VVEWVA--------------SAFSEGRVT--------------DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE 575 (621)
Q Consensus 524 ~~~~~~--------------~~~~~~~~~--------------~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 575 (621)
+++.+. +.+..+++. +...|..........+..+|++|+.+||..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 222211 111111110 0001110011112355567999999999999999999
Q ss_pred HHHHHHH
Q 045652 576 MREAVRR 582 (621)
Q Consensus 576 ~~evl~~ 582 (621)
+.|++.|
T Consensus 400 l~EAL~H 406 (415)
T KOG0671|consen 400 LREALSH 406 (415)
T ss_pred HHHHhcC
Confidence 9999976
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.40 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=188.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 3467999999999999854 68999999986432 2234568899999999999999999999999999999999996
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecceecccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~- 469 (621)
++|.+++.... ...+++..+..++.||+.||+|||++ +++|+||||+||+++. ++.+||+|||++......
T Consensus 85 ~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 85 LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 58888875432 22357888889999999999999998 9999999999999985 457899999998765332
Q ss_pred ---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc----
Q 045652 470 ---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL---- 541 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 541 (621)
....++..|+|||.+.+. .++.++|||||||++|+|+||+.||..... .+....+........ ....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~ 232 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFKIFRILGTPN-EETWPGVT 232 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCC-hhhccccc
Confidence 223456789999988654 578999999999999999999999864221 111111111111000 0000
Q ss_pred ---c-----cchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 542 ---D-----PEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 542 ---d-----~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+ +..... ...+.....+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 0012234568899999999999999999999975
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=289.00 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=192.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh-hhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA-MARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +++.|++|++..... .......+|+..+++++ |+||+++++++...+..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4577999999999999965 478999999865432 22334567999999999 999999999999999999999999 7
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 82 GNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred CCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 89999887533 24689999999999999999999998 9999999999999999999999999998876543
Q ss_pred -ccccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---------cc
Q 045652 470 -NLAQALFAYKAPEAIQ-SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---------VT 538 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 538 (621)
....++..|+|||++. ...++.++||||||+++|||++|+.||..... .+....+...+.... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE----IDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh----HHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 2234567899999875 44578999999999999999999998864221 111111111000000 00
Q ss_pred cccccchhcC------CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASS------TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+...... ...+.....+.+++.+||+.||++||+++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 0001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.76 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=190.6
Q ss_pred HHHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESS-AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.+.||+|+||.||+|...+ ++.||||.++... ......+.+|+.++.+.. ||||+++++++.+....+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 3567899999999999999754 8999999987543 233455667887777775 999999999999999999999998
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
. +++..++.... ..+++..+..++.|++.||+|||+ . +|+||||+|+||+++.++.+||+|||++..+..
T Consensus 97 ~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~----~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 97 S-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred C-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC----CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 5 47777765422 368999999999999999999997 5 899999999999999999999999999876543
Q ss_pred cc---cccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 AN---LAQALFAYKAPEAIQSGK----VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ~~---~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.. ...++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... . .+.......... .
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~~~~~~~~~~~-~--- 237 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---E---FEVLTKILQEEP-P--- 237 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---H---HHHHHHHhcCCC-C---
Confidence 22 223566899999987553 78899999999999999999999863211 1 111111111110 0
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
... .......++.+++.+||..||++||++.+++++-
T Consensus 238 --~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 --SLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 000 0112345789999999999999999999999774
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=292.06 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=191.3
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC---------
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--------- 380 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 380 (621)
|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 445678999999999999964 58899999986432 223456778999999999999999999987654
Q ss_pred -eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 381 -EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 381 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
..++||||+++ ++...+... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEeCc
Confidence 68999999976 777777532 23589999999999999999999998 999999999999999999999999
Q ss_pred eecceeccccc-----cccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 460 FGFYTMINSAN-----LAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 460 fG~a~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
||++....... ....+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~----~~~~~~~~~~~~~ 235 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ----ELAQLELISRLCG 235 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhC
Confidence 99988764322 1234567999998864 357899999999999999999999986321 1122222222111
Q ss_pred cCcc---ccc--------cccchhc----CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 EGRV---TDL--------LDPEIAS----STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 ~~~~---~~~--------~d~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... ..+ .++.... .......+..+.+++.+||+.||++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000 000 0000000 00011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=286.84 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=194.1
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++||||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 467999999999999965 48999999987542 3334667889999999999999999999999999999999997 5
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.+.......
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 9999997532 3589999999999999999999998 99999999999999999999999999987764432
Q ss_pred --cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc------ccc-
Q 045652 471 --LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV------TDL- 540 (621)
Q Consensus 471 --~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 540 (621)
....+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....+......... ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS----EIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 22335679999998766 78999999999999999999998886422 11111111111110000 000
Q ss_pred -cccchhcC------CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 -LDPEIASS------TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 -~d~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+...... ...+.....+.+++.+||..||++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 0011224679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.89 Aligned_cols=245 Identities=20% Similarity=0.267 Sum_probs=200.6
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|.+.++||+|+||.|..+++ .+++.||+|++.+.. ......|..|-.+|..-+.+-|+.++..|.+..+.|+||||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 45789999999999999985 568999999997632 22345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|+||+|-.++.+. ..+++..+..++..|+.||.-||+. |+|||||||+|||||.+|++||+|||.+..+..
T Consensus 157 ~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999642 3588888999999999999999998 999999999999999999999999999887764
Q ss_pred c-----ccccccccccCccccc----C-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 469 A-----NLAQALFAYKAPEAIQ----S-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 469 ~-----~~~~~~~~y~aPE~~~----~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
. ....|||.|++||++. + +.|++.+|+||+||++|||+.|..||.. ..+++....++......
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-------dslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-------DSLVETYGKIMNHKESL 300 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-------HHHHHHHHHHhchhhhc
Confidence 3 4567999999999985 3 5799999999999999999999999973 23444444444332211
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc---HHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE---MREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 582 (621)
.+ + .....+++..+||.+.+. +|+.|.. +.|+..|
T Consensus 301 ~F-------P-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 301 SF-------P-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CC-------C-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11 1 123356778888888775 7888987 8888776
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.25 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=186.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--------------
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-------------- 379 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------------- 379 (621)
+.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 456799999999999985 45899999998765555567788999999999999999999876543
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEE
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLIS 458 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~ 458 (621)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEEEC
Confidence 34689999996 589888752 3488999999999999999999998 9999999999999984 5578999
Q ss_pred eeecceecccc-------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHH
Q 045652 459 EFGFYTMINSA-------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVAS 530 (621)
Q Consensus 459 DfG~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 530 (621)
|||++...... ....++..|+|||.+.. ..++.++|||||||++|||++|+.||..... .........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~~~~~~~ 233 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE----LEQMQLILE 233 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH
Confidence 99998765332 11235667999998754 5688899999999999999999999964221 011110000
Q ss_pred HhhcCc----------ccc-----ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 531 AFSEGR----------VTD-----LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 531 ~~~~~~----------~~~-----~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...... ... ...+........+....++.+++.+||+.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 000 0000000000001233568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=283.79 Aligned_cols=245 Identities=22% Similarity=0.288 Sum_probs=190.9
Q ss_pred HHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKES-----SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
.+.+.||+|+||.||++.... +..+++|.++.. .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 345789999999999998543 445556655431 12234456789999999999999999999998889999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||++....
T Consensus 83 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 83 YCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred eCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998864321 235689999999999999999999998 9999999999999985 569999999987664
Q ss_pred cc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||... .......... .+.. +
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-------~~~~~~~~~~-~~~~-----~ 223 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-------NFLSVVLRIV-EGPT-----P 223 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHH-cCCC-----C
Confidence 32 2334667899999998888999999999999999999999998531 1122221111 1111 1
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. .......++.+++.+||+.+|++||++.|++++
T Consensus 224 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 S-----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C-----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=293.81 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=185.4
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC--------eeE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--------EKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~ 383 (621)
+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.. ..+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 346799999999999995 458999999885432 122345678999999999999999999876543 358
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+||||+.+ +|...+... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||++
T Consensus 92 lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 92 MVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred EEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 99999964 777777532 24689999999999999999999998 9999999999999999999999999998
Q ss_pred eeccccc---------------cccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHH
Q 045652 464 TMINSAN---------------LAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEW 527 (621)
Q Consensus 464 ~~~~~~~---------------~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 527 (621)
....... ...++..|+|||.+.+. .++.++|||||||++|||++|+.||..... ....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~----~~~~~~ 238 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD----IDQLHL 238 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 7653321 11335679999987654 588999999999999999999999864221 111111
Q ss_pred HHHHhhcCc---------ccc--------ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 528 VASAFSEGR---------VTD--------LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 528 ~~~~~~~~~---------~~~--------~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+........ +.. ...+.... ........+.+++.+||+.||++|||+.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111110000 000 00000000 001122568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=296.10 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=189.3
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEEE
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv 385 (621)
+.+.||+|+||.||++. ..++..||||++... .....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 45679999999999998 456899999998643 2223456789999999999999999999987653 35899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+ +++|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 99 ~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 99 MPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 9999 7799888852 3588999999999999999999998 999999999999999999999999999887
Q ss_pred cccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHH-----------h
Q 045652 466 INSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASA-----------F 532 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------~ 532 (621)
.... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+... +
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----LDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHHHHhh
Confidence 6443 22346778999999875 4588999999999999999999999864211 0010000000 0
Q ss_pred hcCc-------cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 533 SEGR-------VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 533 ~~~~-------~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... +.......+. ...+.....+.+++.+|++.||++|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFR--SLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchHH--HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000 0011233568899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=292.60 Aligned_cols=242 Identities=21% Similarity=0.349 Sum_probs=199.5
Q ss_pred HHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.++||+|.||+||-|+ .++|+.||||++.+.. ......+++|+.||++++||.||.+.-.|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5899999999999998 5679999999987542 23457789999999999999999999999999999999999955
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC---CCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE---NEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~ 469 (621)
+..++|.... ...+++.....++.||+.||.|||.+ +|+|+||||+|||+... -++||+|||+|+.+...
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 6555554332 35688888888999999999999999 99999999999999754 37999999999999775
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....||+.|+|||++....|...-|+||.|||+|--++|.+||.. +.++.+.+... . + +.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE------dEdIndQIQNA----a---F----My 783 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE------DEDINDQIQNA----A---F----MY 783 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC------ccchhHHhhcc----c---c----cc
Confidence 456799999999999999999999999999999999999999963 23343433211 1 1 11
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....+.+.....++||...|+..-.+|.|..+.+.|
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 123345667889999999999999999998887765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=296.30 Aligned_cols=259 Identities=21% Similarity=0.309 Sum_probs=191.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv 385 (621)
+.+.||+|+||.||+|.. .+++.||+|+++.. .......+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 346899999999999985 46899999998643 2223456789999999999999999999987543 46899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+||+.. +|..++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 999964 7776652 2488899999999999999999998 999999999999999999999999999876
Q ss_pred cccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh----------
Q 045652 466 INSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS---------- 533 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------- 533 (621)
.... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD----YLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCHHHHHHh
Confidence 5432 22345678999999876 468899999999999999999999986421 1111111111000
Q ss_pred -cCccccccc--cchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhcc
Q 045652 534 -EGRVTDLLD--PEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQS 589 (621)
Q Consensus 534 -~~~~~~~~d--~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~ 589 (621)
......... +..... ...+.....+.+++.+||+.||++||++.|++.| ++..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000000 000000 0001233568899999999999999999999977 7766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=288.03 Aligned_cols=240 Identities=20% Similarity=0.278 Sum_probs=194.0
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|... +++.|++|++... .....+.+.+|++++++++ |+||+++++++...+..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 4467999999999999854 6899999998642 2233467889999999998 999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 85 PNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 999999999743 3689999999999999999999998 9999999999999999999999999998765432
Q ss_pred c------------------------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchH
Q 045652 470 N------------------------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVV 525 (621)
Q Consensus 470 ~------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 525 (621)
. ...++..|+|||......++.++||||||++++++++|+.||.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~--- 228 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN----EY--- 228 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc----HH---
Confidence 2 1234567999999988889999999999999999999999987422 11
Q ss_pred HHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcH----HHHHHH
Q 045652 526 EWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEM----REAVRR 582 (621)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~ 582 (621)
....... .... ..+....+.+.+++.+||+.+|++||++ ++++++
T Consensus 229 ~~~~~~~-~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 229 LTFQKIL-KLEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHH-hcCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111111 1100 0012224668999999999999999999 777754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=278.71 Aligned_cols=232 Identities=22% Similarity=0.290 Sum_probs=189.1
Q ss_pred cCcCCcccEEEEEEc-CCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 319 LGNGGLGSSYKAMMA-DGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 319 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
||+|+||.||++... +++.+++|.+..... ...+.+..|++++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 489999999865322 2456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 9999743 3588999999999999999999998 9999999999999999999999999998776442 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...++..|+|||...+...+.++|+||||+++|+|++|+.||.... . ......... ... ..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~----~---~~~~~~~~~-~~~------~~----- 212 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED----R---KEIYEKILK-DPL------RF----- 212 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----H---HHHHHHHhc-CCC------CC-----
Confidence 3445678999999988888999999999999999999999986421 1 111111111 110 00
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMRE 578 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~e 578 (621)
+......+.+++.+||..||++||++.+
T Consensus 213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1112456899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=293.98 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=186.2
Q ss_pred HHHcCcCCcccEEEEEEc-C--CcEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeC----CeeEEE
Q 045652 316 AEVLGNGGLGSSYKAMMA-D--GVTVVVKRMKES--SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRT----DEKLLV 385 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~lv 385 (621)
.+.||+|+||.||++... + +..||+|++... .....+.+.+|+++++++ +||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 467999999999999953 3 779999988642 222345678899999999 599999999875432 346889
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 85 EELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred Eeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 99985 689988863 34588999999999999999999998 999999999999999999999999999876
Q ss_pred cccc--------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 466 INSA--------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 466 ~~~~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+...+....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD----YVDQLNQILQVLGTPD 230 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC----HHHHHHHHHHHhCCCC
Confidence 5432 12346778999998765 468999999999999999999999986421 1111111111110000
Q ss_pred ---cccccc-------------cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 ---VTDLLD-------------PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ---~~~~~d-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+.+ +........+.....+.+++.+||+.||++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0000000011224578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.86 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=189.7
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-CCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-TDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.. ....+++|||+
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~ 92 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92 (328)
T ss_pred EEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence 3457899999999999984 47899999987532 22234667899999999999999999999876 45788999998
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
+++|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+......
T Consensus 93 -~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 93 -GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred -ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 5689888853 3477888889999999999999998 9999999999999999999999999998765433
Q ss_pred -ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh-----------cCc
Q 045652 470 -NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS-----------EGR 536 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 536 (621)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+..... ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH----VNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHHhccchh
Confidence 22345678999998765 5689999999999999999999999864221 011110111000 000
Q ss_pred ccccccc-chhcC----CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VTDLLDP-EIASS----TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~~~~d~-~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+.+.. ..... ...+.....+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000 0011234678999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=309.88 Aligned_cols=243 Identities=25% Similarity=0.358 Sum_probs=180.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--------------
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-------------- 378 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------------- 378 (621)
..+.||+|+||.||+++. -||+.||||++.-. .......+.+|+..|.+|+|||||+++..+.+
T Consensus 483 EL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~ 562 (1351)
T KOG1035|consen 483 ELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD 562 (1351)
T ss_pred HHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence 457899999999999994 47999999999744 23334567899999999999999998743210
Q ss_pred -----------------------------------------C--------------------------------------
Q 045652 379 -----------------------------------------T-------------------------------------- 379 (621)
Q Consensus 379 -----------------------------------------~-------------------------------------- 379 (621)
.
T Consensus 563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~ 642 (1351)
T KOG1035|consen 563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL 642 (1351)
T ss_pred hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence 0
Q ss_pred --------------------------CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccC
Q 045652 380 --------------------------DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433 (621)
Q Consensus 380 --------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 433 (621)
...||-||||+.-++.++++++.... .....++++.+|+.||.|+|+.
T Consensus 643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~-- 716 (1351)
T KOG1035|consen 643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQ-- 716 (1351)
T ss_pred CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhC--
Confidence 01367889999878888876443110 3456789999999999999999
Q ss_pred CCCCccCCCCCCCEEeCCCCCcEEEeeecceecc----------------------ccccccccccccCcccccCC---C
Q 045652 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN----------------------SANLAQALFAYKAPEAIQSG---K 488 (621)
Q Consensus 434 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~----------------------~~~~~~~~~~y~aPE~~~~~---~ 488 (621)
|||||||||.||++|++..+||+|||+|.... ......||.-|+|||++.+. .
T Consensus 717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 99999999999999999999999999998721 01234577789999999765 4
Q ss_pred CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccC
Q 045652 489 VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQS 568 (621)
Q Consensus 489 ~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~ 568 (621)
|+.|+|+||+|||++||+. ||.. .++-. .+...++.+.+... + ....+..+.-.++|.+|+++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~T------sMERa-~iL~~LR~g~iP~~--~-----~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGT------SMERA-SILTNLRKGSIPEP--A-----DFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCc------hHHHH-HHHHhcccCCCCCC--c-----ccccccchHHHHHHHHHhcC
Confidence 9999999999999999995 5542 11111 12223334433322 0 01123334557799999999
Q ss_pred CCCCCCcHHHHHHH
Q 045652 569 DPEQRLEMREAVRR 582 (621)
Q Consensus 569 dP~~Rps~~evl~~ 582 (621)
||++|||+.|+|+.
T Consensus 858 dP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 858 DPSKRPTATELLNS 871 (1351)
T ss_pred CCccCCCHHHHhhc
Confidence 99999999999853
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=277.87 Aligned_cols=219 Identities=21% Similarity=0.260 Sum_probs=174.9
Q ss_pred CCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChhHHhhc
Q 045652 322 GGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHG 400 (621)
Q Consensus 322 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 400 (621)
|.||.||++.. .+++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999994 568999999987543 233455555666799999999999999999999999999999999864
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-cccccccccc
Q 045652 401 DRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NLAQALFAYK 479 (621)
Q Consensus 401 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~ 479 (621)
. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...... ....++..|+
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~ 149 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence 3 3489999999999999999999998 9999999999999999999999999987665443 2233456799
Q ss_pred CcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHH
Q 045652 480 APEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLL 559 (621)
Q Consensus 480 aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~ 559 (621)
|||.+.+..++.++||||+|+++|||++|+.|+...... .... ..+ .+ +......+.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~--~~~---~~-----~~~~~~~~~ 206 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTH--TTL---NI-----PEWVSEEAR 206 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccc--ccc---CC-----cccCCHHHH
Confidence 999998888999999999999999999999886521100 0000 000 00 112335688
Q ss_pred HHHhhcccCCCCCCCcHH
Q 045652 560 EIGRACTQSDPEQRLEMR 577 (621)
Q Consensus 560 ~li~~cl~~dP~~Rps~~ 577 (621)
+++.+||+.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=290.72 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=187.3
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEEEE
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLLVY 386 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 386 (621)
.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 35799999999999984 568999999987432 22345678899999999999999999988643 3367888
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
+++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 102 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred hhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 887 7899888753 3488999999999999999999998 9999999999999999999999999998765
Q ss_pred ccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC--cc-cccc
Q 045652 467 NSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG--RV-TDLL 541 (621)
Q Consensus 467 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~ 541 (621)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+....... .. ..+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHhhcc
Confidence 433 22356778999998865 4688999999999999999999999853211 11111111100000 00 0000
Q ss_pred c----------cchhcC---CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 542 D----------PEIASS---TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 542 d----------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+ +..... .........+.+++.+||+.||++||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000 0001124568899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.93 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=190.0
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe------eEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE------KLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv 385 (621)
+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 3467999999999999964 5889999998643 22234567789999999999999999998766554 8999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9998 6799998863 3589999999999999999999998 999999999999999999999999999877
Q ss_pred cccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc-------
Q 045652 466 INSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR------- 536 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 536 (621)
.... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+........
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCHHHHhhc
Confidence 6433 23446678999999865 3678999999999999999999999864211 111111111110000
Q ss_pred ----ccccc-------ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 ----VTDLL-------DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ----~~~~~-------d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....+ .+..... .......+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEV--FSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHH--hccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 0000000 01124678999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=293.66 Aligned_cols=237 Identities=21% Similarity=0.310 Sum_probs=191.9
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+...+|.|+|+.|-++. ..+++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.+..+.|+|||++.|+
T Consensus 326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred cccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 44569999999999998 5568999999997552 2234677666666 6999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe-CCCCCcEEEeeecceecccc-c
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI-SPENEPLISEFGFYTMINSA-N 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG~a~~~~~~-~ 470 (621)
-+.+.+.... .+. .++..|+.+|+.|+.|||++ |||||||||+|||+ +..++++|+|||.++..... .
T Consensus 402 ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 402 ELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD 471 (612)
T ss_pred HHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence 8888876332 233 67778999999999999999 99999999999999 58999999999999887665 1
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...-|..|.|||++....|++++||||||++||+|++|+.||.....+ ..+...+..+...
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s------------ 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS------------ 532 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc------------
Confidence 224466799999999999999999999999999999999999753322 2222233322211
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
........+|+.+||+.||.+||+|.++..|-..
T Consensus 533 -~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 -ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3445678999999999999999999999987544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=266.64 Aligned_cols=258 Identities=17% Similarity=0.281 Sum_probs=189.8
Q ss_pred HHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccC--CChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--------Ce
Q 045652 313 KAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKE--SSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--------DE 381 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~ 381 (621)
|.-..+||+|.||.||+|+ ..+|+.||+|+.-- ..........+|+++|..++|+|++.+++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3445789999999999998 44588899886532 1222233456899999999999999999887542 34
Q ss_pred eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.|+||.+|+. +|..++... ...++..++.+++.++..||.|+|+. .|+|||+||+|+||+.++.+||+|||
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeeccc
Confidence 7899999976 898888632 35689999999999999999999998 99999999999999999999999999
Q ss_pred cceecccccc--------ccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHh
Q 045652 462 FYTMINSANL--------AQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAF 532 (621)
Q Consensus 462 ~a~~~~~~~~--------~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 532 (621)
+++.+..... ...|..|++||.+.+ ..|+++.|||..|||+.||+||.+-+... ........+....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn----teqqql~~Is~Lc 245 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN----TEQQQLHLISQLC 245 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC----hHHHHHHHHHHHh
Confidence 9987654322 233678999999876 46999999999999999999998776542 2222233332222
Q ss_pred hc---Cccccccccc---------hhcCC--CCHHH------HHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 533 SE---GRVTDLLDPE---------IASST--NSPGE------MEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 533 ~~---~~~~~~~d~~---------~~~~~--~~~~~------~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.. ..+.....-. +.... ..++. ..+..+|+.+++..||.+|+++.+++.|-
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11 1111110000 00000 00111 23678999999999999999999998774
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=314.85 Aligned_cols=141 Identities=22% Similarity=0.321 Sum_probs=125.4
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||||+++... ......+.+|+.+++.++||||+++++++......|+||||++
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 3467999999999999965 68999999987432 2334678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
+++|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999643 3578889999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=268.19 Aligned_cols=260 Identities=18% Similarity=0.269 Sum_probs=205.4
Q ss_pred hhHHHHHHHHHcCcCCcccEEEEEEcC------CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-
Q 045652 308 LPDLMKAAAEVLGNGGLGSSYKAMMAD------GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT- 379 (621)
Q Consensus 308 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 379 (621)
+.........++-+|.||.||+|.+.+ .+.|.+|.++.. ++.....+..|.-.+..+.|||+..+.+++.++
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 333333455678999999999996543 456777877643 344566788999999999999999999998765
Q ss_pred CeeEEEEeecCCCChhHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcE
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRG---PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL 456 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k 456 (621)
...++++.++.-|+|+.++...++ ...+.++-.+...++.|++.|++|||++ +|||.||..+|.+||+..++|
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----CcccchhhhhcceehhheeEE
Confidence 457889999999999999973332 2345677888899999999999999999 999999999999999999999
Q ss_pred EEeeecceecccccc------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHH
Q 045652 457 ISEFGFYTMINSANL------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVA 529 (621)
Q Consensus 457 l~DfG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 529 (621)
|+|=.+++.+-+... ......||+||.+....|+.++|||||||+||||+| |+.||...+. ..+.
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------fEm~ 508 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------FEME 508 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------HHHH
Confidence 999999887654422 234567999999999999999999999999999998 9999864322 1233
Q ss_pred HHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 530 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+.+|. ++.. +.+++.++..+|..||..+|++||++++++..|.+....
T Consensus 509 ~ylkdGy-------RlaQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 509 HYLKDGY-------RLAQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHhccc-------eecC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 3334332 1112 235667899999999999999999999999999887543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.69 Aligned_cols=232 Identities=21% Similarity=0.288 Sum_probs=187.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+..+||+|+||.|.+|..+ +.+.+|||++++.. ..+.+--..|-++|... +-|.++++..+|...+..|+||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 4578999999999999854 47889999998642 22233334677777766 4678999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc--
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN-- 467 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~-- 467 (621)
.||+|..+++.- ..+.++.+.-++.+||-||-|||++ +|+.||||.+|||+|.+|++||+|||+++.--
T Consensus 433 nGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 433 NGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred cCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999743 4577788899999999999999999 99999999999999999999999999987532
Q ss_pred --ccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 468 --SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 468 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
......||+.|+|||++...+|+..+|+|||||+||||+.|+.||++ +++.++.+.+ .+..
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG----eDE~elF~aI----~ehn--------- 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG----EDEDELFQAI----MEHN--------- 566 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHH----HHcc---------
Confidence 23557789999999999999999999999999999999999999985 2223333322 2211
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRL 574 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 574 (621)
...+.....+..++....|.+.|.+|.
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112334556788899999999999996
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=252.64 Aligned_cols=253 Identities=18% Similarity=0.278 Sum_probs=195.1
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCC--eeEEEEe
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTD--EKLLVYE 387 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e 387 (621)
.|.+.+++|+|.|+.||.|. ..+.+.++||+++... .+.+.+|+.||+.|+ ||||+++++...+.. ...||+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46788999999999999998 5568899999998543 567889999999997 999999999987754 4579999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeecceec
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTMI 466 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~ 466 (621)
|+.+.+...+. +.++...+..++.++++||.|+|+. ||+|||+||.|++||.. -.++|+|+|+|.+.
T Consensus 116 ~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 116 YVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99998887765 3578888999999999999999999 99999999999999954 46999999999988
Q ss_pred ccccc---ccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc-----
Q 045652 467 NSANL---AQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV----- 537 (621)
Q Consensus 467 ~~~~~---~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~----- 537 (621)
.+... ...+..|.-||.+.. ..|+..-|+|||||++..|+..+.||....+ ..+..-.+...+....+
T Consensus 184 Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d---N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC---CHHHHHHHHHHhChHHHHHHHH
Confidence 76532 345567889999865 4688999999999999999999999986432 22221112211111100
Q ss_pred --ccccccchhc---------------CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 --TDLLDPEIAS---------------STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 --~~~~d~~~~~---------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.-.+||+... .....-..++.++++.+.|..|..+|+|++|++.|
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0012222111 11111223678999999999999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=272.30 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=192.5
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC---h----hhHHHHHHHHHHHhcCCCCCcccceEEEEeC-Cee
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS---A----MARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-DEK 382 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 382 (621)
.|-...+||+|+|+.||+|. ....+.||||+-.... . ...+...+|.+|.+.|+||.||++|+|+.-+ +..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 34567899999999999998 5568899999754211 1 1123456899999999999999999998654 567
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC---CCCCcEEEe
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS---PENEPLISE 459 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D 459 (621)
|-|+|||+|.+|.-+|+.+ +.+++.++..|+.||+.||.||.+. .++|||-||||.|||+. ..|.+||.|
T Consensus 544 CTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeee
Confidence 8999999999999999743 4689999999999999999999976 34799999999999996 457899999
Q ss_pred eecceecccc-----------ccccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcch
Q 045652 460 FGFYTMINSA-----------NLAQALFAYKAPEAIQSG----KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV 524 (621)
Q Consensus 460 fG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 524 (621)
||+++.+... ....||..|++||.+.-+ +.+.|+||||.|||+|..+.|+.||..... ..++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---QQdI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---QQDI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---HHHH
Confidence 9999987543 224578899999998533 478899999999999999999999975211 1111
Q ss_pred HHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.+..+...-... .+..+....+..++|++||.+.-++|....++..+
T Consensus 694 -------LqeNTIlkAtEVq---FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 694 -------LQENTILKATEVQ---FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred -------Hhhhchhcceecc---CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1111111111111 11123445678899999999999999998888754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=288.56 Aligned_cols=254 Identities=17% Similarity=0.294 Sum_probs=177.6
Q ss_pred HHHHHcCcCCcccEEEEEE-----------------cCCcEEEEEEccCCChhhHHH--------------HHHHHHHHh
Q 045652 314 AAAEVLGNGGLGSSYKAMM-----------------ADGVTVVVKRMKESSAMARDA--------------FDTEVRRLG 362 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~l~ 362 (621)
.+.++||+|+||.||+|.. .+++.||||+++.......++ ...|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3467899999999999963 235689999987543332333 334777777
Q ss_pred cCCCCCc-----ccceEEEEe--------CCeeEEEEeecCCCChhHHhhcCCCC-------------------CCCCCC
Q 045652 363 RLRHSNV-----LAPLAYHYR--------TDEKLLVYEYIPGGSLLYLLHGDRGP-------------------SHDELT 410 (621)
Q Consensus 363 ~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~ 410 (621)
+++|.++ ++++++|.. .+..++||||+++++|.++++...+. ....++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8876654 677787753 34679999999999999999743211 112356
Q ss_pred HHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-----cccccccccCccccc
Q 045652 411 WPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-----LAQALFAYKAPEAIQ 485 (621)
Q Consensus 411 ~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~y~aPE~~~ 485 (621)
+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ....++.|+|||.+.
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 788899999999999999998 99999999999999999999999999987654321 122367899999875
Q ss_pred CCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCcccCCCCC-----cchHHHHHHHhhcCcc
Q 045652 486 SGK--------------------V--TPKCDVYCLGIIILEILTGKF-PSQYLTNGNGG-----IDVVEWVASAFSEGRV 537 (621)
Q Consensus 486 ~~~--------------------~--~~~~DvwSlGvvl~elltg~~-P~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 537 (621)
... | ..+.||||+||++|+|++|.. |+......... .+...|. ......
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~~- 460 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQK- 460 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhcccC-
Confidence 322 1 134799999999999999875 65432111111 1111111 111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCC---CCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDP---EQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~~ 582 (621)
.+ + ...........+++.+||..+| .+|+|++|+++|
T Consensus 461 ---~~--~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 ---YD--F---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ---CC--c---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 0 0112334678999999999866 689999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=286.60 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=199.4
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEe-----CCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR-----TDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e 387 (621)
+.+.||+|.+|.||+++ .++++.+|+|++.... ...++++.|.++|+.. .|||++.++|++.. ++..|||||
T Consensus 23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 34679999999999998 5679999999987543 3356788899999988 69999999999875 467899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||.+|+..++++... ...+.|..+..|++.++.||.+||.. .++|||||-.|||++.++.+||+|||.+..++
T Consensus 102 fC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred ccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999998654 46789999999999999999999998 89999999999999999999999999998875
Q ss_pred cc----ccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 468 SA----NLAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
.. ....||+.|||||++.- ..|+..+|+||||++..||.-|.+|+.++.. ++..+.-.+
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----------mraLF~IpR-- 242 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----------MRALFLIPR-- 242 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------hhhhccCCC--
Confidence 53 56778999999999853 3478899999999999999999999875432 111121110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
--.|.+ ..+..-..++.++|..||.+|-++||++.++++|
T Consensus 243 -NPPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 -NPPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -CCCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 001111 1134556789999999999999999999998865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=262.29 Aligned_cols=235 Identities=25% Similarity=0.352 Sum_probs=191.2
Q ss_pred CcccEEEEEEcC-CcEEEEEEccCCChhh-HHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChhHHhhc
Q 045652 323 GLGSSYKAMMAD-GVTVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHG 400 (621)
Q Consensus 323 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 400 (621)
+||.||+|...+ ++.+++|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999754 8999999997654433 67899999999999999999999999999999999999999999999874
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---cccccccc
Q 045652 401 DRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---NLAQALFA 477 (621)
Q Consensus 401 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~~~~~~~ 477 (621)
.. .+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+...... ....++..
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 32 288999999999999999999998 9999999999999999999999999998877553 34456678
Q ss_pred ccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHH
Q 045652 478 YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQ 557 (621)
Q Consensus 478 y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 557 (621)
|++||.+....++.++||||||+++++|++|..||.... ..... ........... ..........
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~----~~~~~~~~~~~--------~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLEL----FKKIGKPKPPF--------PPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHH----HHHHhccCCCC--------ccccccCCHH
Confidence 999999988889999999999999999999999986421 11111 11111111100 0000013457
Q ss_pred HHHHHhhcccCCCCCCCcHHHHHH
Q 045652 558 LLEIGRACTQSDPEQRLEMREAVR 581 (621)
Q Consensus 558 l~~li~~cl~~dP~~Rps~~evl~ 581 (621)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=285.94 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=183.8
Q ss_pred HHHHHcCcCCccc-EEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGS-SYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
...+++|.|+-|+ ||+|.. +|+.||||++-... .+...+|+..|+.- +|||||++++.-.+....|+..|.|.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 3467899999875 789988 68899999986432 34567999999988 59999999999888899999999995
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---C--CCcEEEeeecceec
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---E--NEPLISEFGFYTMI 466 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfG~a~~~ 466 (621)
.+|.+++... +.......-...+.++.|+++||++||+- +||||||||+||||+. + ..++|+|||+++.+
T Consensus 587 ~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 587 CSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5999999864 11111111134567899999999999998 9999999999999986 3 36899999999987
Q ss_pred ccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCcccCCCCCcchHHHHHHHhhcCcc-
Q 045652 467 NSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTG-KFPSQYLTNGNGGIDVVEWVASAFSEGRV- 537 (621)
Q Consensus 467 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 537 (621)
... ....||-+|+|||++....-+.++||||+|||+|+.++| .+||..... +. ..+..+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--------R~--~NIl~~~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--------RQ--ANILTGNYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--------hh--hhhhcCccc
Confidence 543 334578899999999988888899999999999999996 899874211 00 01111110
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+.+ .+++ +..+||.+|++++|..||++.+|+.|
T Consensus 732 L~~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 000100 1112 78999999999999999999999966
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=257.82 Aligned_cols=241 Identities=17% Similarity=0.276 Sum_probs=199.4
Q ss_pred HHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEee
Q 045652 314 AAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES---SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
....+||+|+|+.|..++ .++.+.+|+|++++. ...+.+-.+.|-.+..+. +||.+|-+..+|..+...++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 356789999999999998 556889999998753 223344566777777777 699999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc-
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN- 467 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~- 467 (621)
++||+|.-+++++ +.++++.+..+..+|+.||.|||++ ||+.||||.+|||+|..|++||.|+|+++.--
T Consensus 333 v~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999888754 4688999999999999999999999 99999999999999999999999999987532
Q ss_pred ---ccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 468 ---SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 468 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
......||+.|+|||++.+..|+..+|+|++||+++||+.|+.||+-....+.+....+++.+.+.+.++.- |
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---p- 479 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---P- 479 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---c-
Confidence 235678999999999999999999999999999999999999999876666666666666666665544321 1
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRL 574 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 574 (621)
.........+++.-|++||.+|.
T Consensus 480 -------rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 -------RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------ceeehhhHHHHHHhhcCCcHHhc
Confidence 11223456778899999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.50 Aligned_cols=254 Identities=21% Similarity=0.246 Sum_probs=161.6
Q ss_pred HHHHcCcCCcccEEEEEEc-C----CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEE------EEeCCeeE
Q 045652 315 AAEVLGNGGLGSSYKAMMA-D----GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY------HYRTDEKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~~~~ 383 (621)
+.+.||+|+||.||+|... + +..||+|++..... .+.+..| .+....+.+++.++.. .......+
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 4578999999999999954 4 68999998864322 1111111 1122222233322221 23456789
Q ss_pred EEEeecCCCChhHHhhcCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 384 LVYEYIPGGSLLYLLHGDRGP---------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
+||||+.+++|.++++..... .........+..++.||+.||+|||++ +|+||||||+|||
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDLKP~NIL 287 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDVKPQNII 287 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcCCHHHEE
Confidence 999999999999998743210 001112334567999999999999998 9999999999999
Q ss_pred eCC-CCCcEEEeeecceecccc-----ccccccccccCcccccCC----------------------CCCcchhhHHHHH
Q 045652 449 ISP-ENEPLISEFGFYTMINSA-----NLAQALFAYKAPEAIQSG----------------------KVTPKCDVYCLGI 500 (621)
Q Consensus 449 l~~-~~~~kl~DfG~a~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwSlGv 500 (621)
++. ++.+||+|||+++.+... ....+++.|+|||.+... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 986 578999999999865332 334567889999965322 2345679999999
Q ss_pred HHHHHHhCCCCCCcccC------CCCCcchHHHHHHHhhcCccccccccchhcC-CCCHHHHHHHHHHHhhcccCCCCCC
Q 045652 501 IILEILTGKFPSQYLTN------GNGGIDVVEWVASAFSEGRVTDLLDPEIASS-TNSPGEMEQLLEIGRACTQSDPEQR 573 (621)
Q Consensus 501 vl~elltg~~P~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~R 573 (621)
++|||+++..|+..... .....+...|..... . . ..+..... ...........+|+.+||+.||++|
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~-~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-P-R----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-c-c----cchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999998766432000 000011111110000 0 0 00000000 0000112345689999999999999
Q ss_pred CcHHHHHHH
Q 045652 574 LEMREAVRR 582 (621)
Q Consensus 574 ps~~evl~~ 582 (621)
||++|+++|
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=239.47 Aligned_cols=204 Identities=22% Similarity=0.330 Sum_probs=166.8
Q ss_pred CChhHHHHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCee
Q 045652 306 FGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEK 382 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (621)
|+++.-.......||+|++|.|-+-+ ..+|+..|+|+++.. .....+...+|+.+..+. ..|.+|+++|.+....+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 66665555567889999999998877 567999999999754 233455677888876655 699999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
++.||.|. -+|..+..+-- .....+++..+-+|+..+..||.|||++. .++|||+||+||||+.+|++|+||||.
T Consensus 121 wIcME~M~-tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEccccc
Confidence 99999995 48876654211 12456888888999999999999999983 799999999999999999999999999
Q ss_pred ceeccccc---cccccccccCccccc----CCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 463 YTMINSAN---LAQALFAYKAPEAIQ----SGKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 463 a~~~~~~~---~~~~~~~y~aPE~~~----~~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
+-.+..+- ...|...|||||.+. ...|+.|+||||||+.+.||.++++||..
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 88775542 234666899999985 33699999999999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=271.55 Aligned_cols=242 Identities=19% Similarity=0.250 Sum_probs=198.3
Q ss_pred HHHcCcCCcccEEEEEEcCC-cEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMADG-VTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
...||-|+||.|-++..+.. ..+|+|.+++. +....+.+..|-.+|...+.|.||++|-.|.+....|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 45799999999999986443 34888888754 233355677899999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
|.|+..++.. ..+.......++..+++|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+....
T Consensus 505 GElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 505 GELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred chhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999743 4577778888999999999999999 99999999999999999999999999999987653
Q ss_pred --cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 --LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 --~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...||+.|.|||++.....+.++|.||||+++|||++|.+||...+. +.....+.+.+..-.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktYn~ILkGid~i~------------ 639 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTYNLILKGIDKIE------------ 639 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHhhhhhhh------------
Confidence 46799999999999999999999999999999999999999985322 222222322221111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRRI 583 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~L 583 (621)
.+........+++++..+.+|.+|.. +.|+.+|-
T Consensus 640 -~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 640 -FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred -cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11233456788999999999999984 78888774
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=273.13 Aligned_cols=202 Identities=22% Similarity=0.351 Sum_probs=171.7
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHH---HHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARD---AFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.||-|+||.|.++... +...+|+|.+++.+-..+. ..+.|-.||...+.+-||++|..|.+.+..|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 56999999999999843 4678999999876544333 4567999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---- 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 468 (621)
++..+|-+. ..|.+..+..++.++..|+++.|.. |+|||||||+|||||.+|++||.|||++.-+.-
T Consensus 715 DmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999998743 4578888888999999999999998 999999999999999999999999999853310
Q ss_pred -----c-------------------------------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHH
Q 045652 469 -----A-------------------------------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEIL 506 (621)
Q Consensus 469 -----~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 506 (621)
. ....||..|+|||++....|+.-+|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 0124667799999999999999999999999999999
Q ss_pred hCCCCCCcccCCCCCcchHHH
Q 045652 507 TGKFPSQYLTNGNGGIDVVEW 527 (621)
Q Consensus 507 tg~~P~~~~~~~~~~~~~~~~ 527 (621)
.|+.||...+..+....+..|
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh
Confidence 999999876666555555555
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=250.59 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=190.4
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----CeeEEEEee
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-----DEKLLVYEY 388 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 388 (621)
+.||-|+||.||.+.. .+|+.||.|++.... -...+.+-+|+++|..++|.|++..++...-. .+.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4599999999999984 569999999986432 23456677999999999999999998876543 246788999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|. .+|...+- +.+.++...+.-+++||++||.|||+. +|.||||||.|.|++.+..+||+|||+++....
T Consensus 139 mQ-SDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 MQ-SDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HH-hhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence 85 48888875 456788888888999999999999999 999999999999999999999999999998765
Q ss_pred ccc-----ccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc--------
Q 045652 469 ANL-----AQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-------- 534 (621)
Q Consensus 469 ~~~-----~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 534 (621)
... ...|..|+|||++.+. .|+.+.||||.|||+.||+..+..|.. .+..+..+.+...+..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA----q~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA----AGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc----cChHHHHHHHHHHhCCCcHHHHHH
Confidence 432 3346689999999875 599999999999999999988877753 2222333322222211
Q ss_pred ---Cccccccc-----cchh---cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 535 ---GRVTDLLD-----PEIA---SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 535 ---~~~~~~~d-----~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
|....+++ |... ........-.+...+.+.++..||++|.+..+++.++.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111 1110 00111122345677889999999999999999998864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=251.91 Aligned_cols=129 Identities=23% Similarity=0.342 Sum_probs=109.7
Q ss_pred HHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-----C---CCcccceEEEEeC----
Q 045652 313 KAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-----H---SNVLAPLAYHYRT---- 379 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~---- 379 (621)
|.+.++||=|.|++||+|. ..+.+.||+|+.+.. ....+....||++|++++ | .+||+++++|...
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 4456889999999999998 556889999998753 344667789999999984 3 3799999999764
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI 449 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll 449 (621)
.+.+||+|++ |.+|..+|.... .+.++...+.+|++||+.||.|||.++ +|||-||||+|||+
T Consensus 159 ~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 159 QHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL 221 (590)
T ss_pred cEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence 5789999999 779999997654 456899999999999999999999985 89999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-31 Score=263.55 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=198.7
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC------CCCcccceEEEEeCCeeEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR------HSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~l 384 (621)
.|.+.-..|+|-|++|.+|.. ..|..||||+++.. ....+.=++|+++|++|. --|+++++-.|...++.||
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 344556789999999999984 44889999999854 334555678999999994 3589999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecc
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFY 463 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a 463 (621)
|||-+ ..+|.++|+..+ ..-.|....+..++.|+..||..|... +|+|.||||+|||+++.. .+||||||.|
T Consensus 512 VFE~L-slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 512 VFEPL-SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred Eehhh-hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcceeeeccCccc
Confidence 99998 569999998655 345688889999999999999999988 999999999999999755 6899999999
Q ss_pred eecccccc--ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHH--------HHhh
Q 045652 464 TMINSANL--AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVA--------SAFS 533 (621)
Q Consensus 464 ~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~--------~~~~ 533 (621)
........ ...+..|.|||++.+-+|+...|+||.||.||||.||+..|.+.++. ++..... ..+.
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN----~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN----QMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH----HHHHHHHHhcCCCcHHHhh
Confidence 88765432 22344699999999999999999999999999999999888765431 1111111 0111
Q ss_pred cCcc---------------------------cccccc------chhc----CCCCHHHHHHHHHHHhhcccCCCCCCCcH
Q 045652 534 EGRV---------------------------TDLLDP------EIAS----STNSPGEMEQLLEIGRACTQSDPEQRLEM 576 (621)
Q Consensus 534 ~~~~---------------------------~~~~d~------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 576 (621)
.+.+ ...+.| .+.. +...+....+|.+|+..|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 1110 000111 0101 11224556789999999999999999999
Q ss_pred HHHHHH
Q 045652 577 REAVRR 582 (621)
Q Consensus 577 ~evl~~ 582 (621)
.++|+|
T Consensus 741 nqAL~H 746 (752)
T KOG0670|consen 741 NQALKH 746 (752)
T ss_pred HHHhcC
Confidence 999976
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=235.47 Aligned_cols=207 Identities=29% Similarity=0.503 Sum_probs=181.6
Q ss_pred cCcCCcccEEEEEEcC-CcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChhH
Q 045652 319 LGNGGLGSSYKAMMAD-GVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396 (621)
Q Consensus 319 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 396 (621)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999654 899999999755432 35678999999999999999999999999899999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecceecccc----cc
Q 045652 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFYTMINSA----NL 471 (621)
Q Consensus 397 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~----~~ 471 (621)
++.... ..+++..+..++.+++++|+|||+. +++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 987432 3588999999999999999999999 9999999999999999 899999999998876543 23
Q ss_pred ccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 472 AQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
..+...|++||..... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4456679999999877 788999999999999998
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2478899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=229.44 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=184.9
Q ss_pred HHHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEE-EEeCCeeEEEEee
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAY-HYRTDEKLLVYEY 388 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e~ 388 (621)
.|.+.+.||+|.||.+-+++++ ..+.+++|.+... .....+|.+|..---.| .|.||+.-|++ |+..+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4678899999999999999854 4788999988743 34467888998776666 48999998876 5556677799999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC--CCCCcEEEeeecceec
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS--PENEPLISEFGFYTMI 466 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~~ 466 (621)
++.|+|..-+.. ..+-+....+++.|+++||.|||++ ++||||||.+||||- +...+||+|||..+..
T Consensus 104 aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 104 APRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred CccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999988753 3466777789999999999999999 999999999999994 3347999999998766
Q ss_pred ccc-ccccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 467 NSA-NLAQALFAYKAPEAIQSG-----KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 467 ~~~-~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
+.. ....-+..|.+||..... ...+.+|||.||+++|..+||++||.-... ......+|. .+..+....
T Consensus 174 g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~--~d~~Y~~~~--~w~~rk~~~- 248 (378)
T KOG1345|consen 174 GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI--MDKPYWEWE--QWLKRKNPA- 248 (378)
T ss_pred CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--cCchHHHHH--HHhcccCcc-
Confidence 543 233445679999986432 357889999999999999999999983221 112222222 222221111
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 585 (621)
++.. .....+.+..+.++-+.++|++|--+.++.+..+.
T Consensus 249 ----~P~~--F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 249 ----LPKK--FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ----Cchh--hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 1111 11223567888899999999999766666655443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=257.20 Aligned_cols=192 Identities=22% Similarity=0.343 Sum_probs=165.7
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChh--------hHHHHHHHHHHHhcCC---CCCcccceEEEEeCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAM--------ARDAFDTEVRRLGRLR---HSNVLAPLAYHYRTD 380 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 380 (621)
|.+.+.+|.|+||.|+.|.++ +...|+||.+.+.+-. ....+-.||.||..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 446789999999999999954 4678899988654211 1122457999999997 999999999999999
Q ss_pred eeEEEEeec-CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 381 EKLLVYEYI-PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 381 ~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
.+||+||-- ++.+|.++|.. ...+++.++.-|+.||+.|+++||+. +|||||||-+||.++.+|-+||+|
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEee
Confidence 999999974 67799999974 35689999999999999999999999 999999999999999999999999
Q ss_pred eecceecccc--ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCC
Q 045652 460 FGFYTMINSA--NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQ 513 (621)
Q Consensus 460 fG~a~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~ 513 (621)
||.+...... ....||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999887654 56789999999999999887 456899999999999999988875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=237.16 Aligned_cols=255 Identities=21% Similarity=0.283 Sum_probs=183.3
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv 385 (621)
-.+.+|.|.- .|..+. .-.++.||+|++.... ....+...+|...+..+.|+||++++.++.-. .+.|+|
T Consensus 21 nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 21 NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 3456777777 555554 2348899999875331 12234566899999999999999999998653 346899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||| ..+|.+.++. +++-..+..|+.|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.
T Consensus 100 ~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 100 MELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhhcc
Confidence 9999 5699998862 356677889999999999999999 999999999999999999999999999987
Q ss_pred cccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC-----------CCCCcchHHHHH--
Q 045652 466 INSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN-----------GNGGIDVVEWVA-- 529 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~-----------~~~~~~~~~~~~-- 529 (621)
.... .....+..|.|||++.+..|.+.+||||.||++.||++|+.-|.+... +..+....+.+.
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 6544 334566789999999998899999999999999999999987753211 000111111110
Q ss_pred -HHhhcCc-------ccccc-ccchhc-CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 530 -SAFSEGR-------VTDLL-DPEIAS-STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 530 -~~~~~~~-------~~~~~-d~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.+-+.. ..+.+ |-.... ....+-....+.+++.+||..||++|.+++++|+|
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000 00000 000000 01112334568899999999999999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=260.62 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=197.1
Q ss_pred HHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
...+.+|.|+||.||+++ ...++..|+|.++-....+..-+++|+-+++..+|||||.+++.+...+..++.||||.+|
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 345789999999999999 4568999999998766666777889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---- 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 468 (621)
+|.+..+. ...+++-++....+..++||+|||+. +-+|||||-.||++++.|.+|++|||.+..++.
T Consensus 98 slQdiy~~-----TgplselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 98 SLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred cccceeee-----cccchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 99988763 45688888999999999999999998 877999999999999999999999999876643
Q ss_pred cccccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc-c
Q 045652 469 ANLAQALFAYKAPEAI---QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP-E 544 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~ 544 (621)
.....||+.|||||+. ..+.|..++|||+.|+...|+---+.|.+.... + + +..... +..++| .
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------m-r-~l~LmT----kS~~qpp~ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------M-R-ALFLMT----KSGFQPPT 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------H-H-HHHHhh----ccCCCCCc
Confidence 3567899999999987 356799999999999999999887777543221 0 0 001111 111111 1
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+... ..-.+.+.++++.|+.++|++||+++.++.|
T Consensus 237 lkDk---~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 237 LKDK---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccCC---ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1111 2233568899999999999999999887754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=231.22 Aligned_cols=191 Identities=28% Similarity=0.442 Sum_probs=167.9
Q ss_pred HHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999765 899999999865443 56788999999999999999999999998889999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++..... .+++..+..++.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999975331 178899999999999999999998 9999999999999999999999999998877544
Q ss_pred -ccccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 470 -NLAQALFAYKAPEAI-QSGKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 234456679999998 666788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=233.60 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=189.1
Q ss_pred HHHHHHcCcCCcccEEEEEEc----CCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 387 (621)
|...++||.|+|++||++... ..+.||+|.+..... ...+..|+++|..+. +.||+++.+++..++...+|||
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 345789999999999999832 468999999875443 345889999999995 8999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeecceec
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTMI 466 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~ 466 (621)
|++.....+++. .++..++..+++.+..||.++|.. |||||||||+|+|.+.. +.-.|.|||+|...
T Consensus 116 ~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 116 YFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred ccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhHHHH
Confidence 999999988875 377889999999999999999999 99999999999999854 46789999998621
Q ss_pred c-----------------c-c------------------------------ccccccccccCcccccCC-CCCcchhhHH
Q 045652 467 N-----------------S-A------------------------------NLAQALFAYKAPEAIQSG-KVTPKCDVYC 497 (621)
Q Consensus 467 ~-----------------~-~------------------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS 497 (621)
. . . ....||++|+|||++... .-++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 0 0 012367889999998654 4688999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCCCCcchHHHH--------HH-HhhcCc--ccc---------------ccc-cchhc---
Q 045652 498 LGIIILEILTGKFPSQYLTNGNGGIDVVEWV--------AS-AFSEGR--VTD---------------LLD-PEIAS--- 547 (621)
Q Consensus 498 lGvvl~elltg~~P~~~~~~~~~~~~~~~~~--------~~-~~~~~~--~~~---------------~~d-~~~~~--- 547 (621)
.|||++-+++++.||....++-+ .+.+.+ ++ ....|+ +.+ -++ ..+..
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~--al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDAD--ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred ccceeehhhccccccccCccccc--hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999975433211 111110 00 011111 110 000 00000
Q ss_pred -----CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 -----STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+..+.+++.+|+..||.+|.|++|+|+|
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00011122468999999999999999999999987
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-27 Score=269.68 Aligned_cols=191 Identities=18% Similarity=0.189 Sum_probs=138.2
Q ss_pred cCCC-CCcccceEEE-------EeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCC
Q 045652 363 RLRH-SNVLAPLAYH-------YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434 (621)
Q Consensus 363 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 434 (621)
.++| +||..++++| ......+++|||+ +++|.+++... ...+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 3445 5777888877 2234567888987 66999999632 24589999999999999999999999
Q ss_pred CCCccCCCCCCCEEeCC-------------------CCCcEEEeeecceecccc--------------------cccccc
Q 045652 435 LDLPHGNLKSSNIFISP-------------------ENEPLISEFGFYTMINSA--------------------NLAQAL 475 (621)
Q Consensus 435 ~~ivH~Dlkp~NIll~~-------------------~~~~kl~DfG~a~~~~~~--------------------~~~~~~ 475 (621)
+|+||||||+||||+. ++.+|++|||+++..... ....+|
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999954 445667777776542110 012356
Q ss_pred ccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHH
Q 045652 476 FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEM 555 (621)
Q Consensus 476 ~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 555 (621)
+.|||||++.+..|+.++|||||||+||||++|..|+... ......+ ... ...+.. ....
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~~~~----~~~----~~~~~~------~~~~ 238 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTMSSL----RHR----VLPPQI------LLNW 238 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHHHHH----HHh----hcChhh------hhcC
Confidence 7799999999999999999999999999999998875421 0111111 100 011110 1112
Q ss_pred HHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 556 EQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 556 ~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....+++.+||+++|.+||++.|++++
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 345688889999999999999999876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=209.99 Aligned_cols=169 Identities=20% Similarity=0.230 Sum_probs=127.7
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL 471 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 471 (621)
|+|.++++.. ...+++.+++.|+.|++.||+|||++ + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc-
Confidence 6899999743 23599999999999999999999987 4 999999999999999 99988765543
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..++..|+|||++.+..++.++|||||||++|||+||+.||..... .......+........ +.. ....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~------~~~--~~~~ 132 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPADD------PRD--RSNL 132 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccCC------ccc--cccH
Confidence 3578899999999999999999999999999999999999864211 1111111111111100 000 0011
Q ss_pred HHHHH--HHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 552 PGEME--QLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 552 ~~~~~--~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
..... .+.+++.+||..||++||++.|+++++..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 12222 68999999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=215.24 Aligned_cols=153 Identities=22% Similarity=0.301 Sum_probs=120.0
Q ss_pred HHHHcCcCCcccEEEEEEc--CCcEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA--DGVTVVVKRMKES-----SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++|++++|+|++..+.. .+..++|||
T Consensus 22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEE
Confidence 4578999999999999854 5778899986532 22345679999999999999999863322 246799999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCC-CCCCEEeCCCCCcEEEeeecceec
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNL-KSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
|++|++|... .. .. ...++.|++++|.|||++ +|+|||| ||+|||++.++.+||+|||+++.+
T Consensus 99 ~~~G~~L~~~-~~-----~~------~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 99 WTEGVPLHLA-RP-----HG------DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred ccCCCCHHHh-Cc-----cc------hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 9999999632 10 01 146789999999999998 9999999 999999999999999999999876
Q ss_pred cccc------------cccccccccCcccccC
Q 045652 467 NSAN------------LAQALFAYKAPEAIQS 486 (621)
Q Consensus 467 ~~~~------------~~~~~~~y~aPE~~~~ 486 (621)
.... ...+++.|+|||++..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4321 2335667999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-24 Score=197.02 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=187.3
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
...+|.+...|..|+|+++ |..+++|++... .......|..|.-.|+-+.||||+.+++.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 4567899999999999995 455667777532 3334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 472 (621)
+|+..+++.. .-..+-.++++++.++++|++|||+..+ -|..--|.+..+++|++.+++|+- +-.++--+....
T Consensus 273 slynvlhe~t---~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarism-ad~kfsfqe~gr 346 (448)
T KOG0195|consen 273 SLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVGR 346 (448)
T ss_pred HHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheec-ccceeeeecccc
Confidence 9999998654 2346778899999999999999998621 244456889999999999888741 111111111222
Q ss_pred cccccccCcccccCCCCC---cchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 473 QALFAYKAPEAIQSGKVT---PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 473 ~~~~~y~aPE~~~~~~~~---~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
.-.+.||+||.++..+-+ .++|+|||.+++|||.|...||.....-+.+..+ - .+-+.+.
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------a-----leglrv~----- 409 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------A-----LEGLRVH----- 409 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------h-----hcccccc-----
Confidence 234679999999866533 5799999999999999999999865543222211 0 1111222
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
.++.....+.+|+.-|+..||.+||.+..++-.|+++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 23455677899999999999999999999998888764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=207.74 Aligned_cols=256 Identities=16% Similarity=0.186 Sum_probs=191.5
Q ss_pred HHHHHHcCcCCcccEEEEEEcCC--cEEEEEEccCCChhhHHHHHHHHHHHhcCCC----CCcccceEEE-EeCCeeEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADG--VTVVVKRMKESSAMARDAFDTEVRRLGRLRH----SNVLAPLAYH-YRTDEKLLV 385 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~lv 385 (621)
|.+.+.||+|+||.||.+..... ..+|+|............+..|+.++..+.. +++..+++.. ......++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 44668899999999999996543 5788887764432222267789999998873 5888888888 467788999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-----CCcEEEee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-----NEPLISEF 460 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df 460 (621)
|+.+ |.+|.++..... ...++...+++|+.|++.+|.+||+. |++||||||+|+++... ..+.|.||
T Consensus 100 M~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred Eecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9998 889999885443 46799999999999999999999999 99999999999999865 35899999
Q ss_pred ecceecc---c-----------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHH
Q 045652 461 GFYTMIN---S-----------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 461 G~a~~~~---~-----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 526 (621)
|+++... . .....||..|.++....+...+.+.|+||++.++.|++.|..||........ ..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~~ 247 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----KS 247 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----HH
Confidence 9998221 1 1124488999999999999999999999999999999999999975432211 11
Q ss_pred HHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 527 WVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.+.......... . .....+..+.++...+-..+..++|....+...|+......
T Consensus 248 ~~~~~~~~~~~~----~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 248 KFEKDPRKLLTD----R------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHhhhhccc----c------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111111111100 0 01112244566666666689999999999999988776654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=191.77 Aligned_cols=264 Identities=17% Similarity=0.177 Sum_probs=196.1
Q ss_pred HHHHHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeec
Q 045652 312 MKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
-|++.++||+|+||.++.|. +-+++.||||.-...+ ..-++..|.+..+.|. .+.|...+.+-.+..+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 35678999999999999998 6679999999754322 2345778888888885 688988887777777888999998
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-----CcEEEeeecce
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-----EPLISEFGFYT 464 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~a~ 464 (621)
|.+|++++.-. .+.++.+.+..+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+|+
T Consensus 107 -GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 107 -GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred -CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88999988643 35699999999999999999999999 999999999999998654 47899999999
Q ss_pred ecccc-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 465 MINSA-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 465 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
.+..+ ....||.+||+--...+..-+.+-|+=|+|-++.+.+.|..||.++...... .-.+.+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~kYeKIG 252 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----EKYEKIG 252 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----HHHHHhc
Confidence 87543 3345788999999888889999999999999999999999999986643221 1111222
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCCCccc
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDART 597 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~~~~ 597 (621)
+.. .....+.. +...+.++..-+.-.-..+-.+-|...=+..-+..+.+..+..+...
T Consensus 253 e~K--r~T~i~~L----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~ 310 (449)
T KOG1165|consen 253 ETK--RSTPIEVL----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGE 310 (449)
T ss_pred ccc--ccCCHHHH----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccc
Confidence 111 11000000 12223445444444455677788887777777777766655554433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-21 Score=200.68 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=191.7
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChh---hHHHHHHHHHHHhcCCCC-CcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHS-NVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
..+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++++++......+++++|+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 3457899999999999976 78899988754322 367789999999999988 79999999977777899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceecccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSA 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~ 469 (621)
++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 82 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 82 GGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999777633211 3688889999999999999999999 899999999999999988 7999999998765432
Q ss_pred ----------ccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 470 ----------NLAQALFAYKAPEAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 470 ----------~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
....++..|+|||.+.+ ..++...|+||+|++++++++|..||...... .........+....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence 34457788999999987 57889999999999999999999996542211 01111111111111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. .......... .......+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSN-PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccc-cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000000000 01223568889999999999999999888775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=227.47 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=180.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEcc----C-CChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMK----E-SSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
...++|.|++|.|+.+.. ......+.|..+ . .... ....+..|+.+-..++|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998887763 234444444332 1 1111 11225678888888999999988887777666666699
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||++ +|..++... ..++..++..++.|++.|++|||+. ||.|||+|++|++++.++.+||+|||.+....
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 999999743 3578888899999999999999999 99999999999999999999999999887653
Q ss_pred cc--------ccccccccccCcccccCCCCCc-chhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 468 SA--------NLAQALFAYKAPEAIQSGKVTP-KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 468 ~~--------~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
.+ ....|+-.|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... .......+..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~ 545 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRN 545 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccc
Confidence 32 2234666799999999999986 5899999999999999999998644322211 0000000000
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...-+ .......+.+...++.+||+.||.+|.|+++|++.
T Consensus 546 ~~~~~----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFEGP----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccCh----HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000 00112334567889999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-22 Score=182.12 Aligned_cols=192 Identities=19% Similarity=0.271 Sum_probs=159.3
Q ss_pred HHHHcCcCCcccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCC-CCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH-SNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.++||.|+||.+|.|. ..+|..||||.-.... ....+..|.++.+.|++ ..|..+..|..+.....+||+.+ |.
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Cc
Confidence 45789999999999998 6779999999765332 23456789999999975 56777777888888889999998 88
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC---CCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE---NEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~ 469 (621)
+|.+++.-. ...++..+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||+++.+.+.
T Consensus 96 sLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 96 SLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 999988632 35689999999999999999999999 99999999999999743 45889999999876432
Q ss_pred -----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC
Q 045652 470 -----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517 (621)
Q Consensus 470 -----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 517 (621)
....||..|.+--...+..-+.+.|+=|+|.+|...-.|..||.+...
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 334578889888777777778899999999999999999999997654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=185.20 Aligned_cols=140 Identities=19% Similarity=0.214 Sum_probs=109.5
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChh--h------------------------HHHHHHHHHHHhcCCCCCcc
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM--A------------------------RDAFDTEVRRLGRLRHSNVL 370 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~niv 370 (621)
..||+|+||.||+|...+|+.||||+++..... . .....+|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 469999999999999878999999998753211 0 11224599999999888875
Q ss_pred cceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCCCccCCCCCCCEEe
Q 045652 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL-HTELAHLDLPHGNLKSSNIFI 449 (621)
Q Consensus 371 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~~ivH~Dlkp~NIll 449 (621)
....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+. +|+||||||+|||+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEE
Confidence 5444322 234899999998877654321 23578889999999999999999 688 99999999999999
Q ss_pred CCCCCcEEEeeecceeccc
Q 045652 450 SPENEPLISEFGFYTMINS 468 (621)
Q Consensus 450 ~~~~~~kl~DfG~a~~~~~ 468 (621)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred E-CCcEEEEEccccccCCC
Confidence 8 57899999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=214.23 Aligned_cols=156 Identities=35% Similarity=0.566 Sum_probs=101.5
Q ss_pred cHHHHHHHHHHcCCCCCCCCCCCCCCCCCCCCCCceeeEEeCC------CcEEEEEecCCCCeeeeCcccccccCCCCCC
Q 045652 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLK------GIVTGLYINSMGLSGKIDVDALTELTGLRGL 75 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~~~l~~w~~~~~~c~~~~~~w~gv~c~~------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L 75 (621)
+|++||+++|+++..+.. .+|+ .++|.+..+.|.||.|.. ..|+.|+|++++|+|.+|. .+..|.+|
T Consensus 372 ~~~~aL~~~k~~~~~~~~-~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~----~i~~L~~L 444 (623)
T PLN03150 372 EEVSALQTLKSSLGLPLR-FGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN----DISKLRHL 444 (623)
T ss_pred hHHHHHHHHHHhcCCccc-CCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH----HHhCCCCC
Confidence 488999999999976533 4896 578876666799999952 1366666666666666653 34455666
Q ss_pred CEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcccCc
Q 045652 76 RAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNK 155 (621)
Q Consensus 76 ~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~ 155 (621)
+.|+|++|+|+|.||.. ++.+++|+.|+|++|+|+|.+|..+++|++|++|+|++|+|+|.+|.
T Consensus 445 ~~L~Ls~N~l~g~iP~~-~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~--------------- 508 (623)
T PLN03150 445 QSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA--------------- 508 (623)
T ss_pred CEEECCCCcccCcCChH-HhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCCh---------------
Confidence 66666666666666655 56666666666666666666666666666666666666666665554
Q ss_pred cccccCccccc----cccCCCCCCCCCCCCCCCCCc
Q 045652 156 LEGEIPASLLR----FNASSFSGNAGLCGKNLGVEC 187 (621)
Q Consensus 156 l~g~ip~~~~~----~~~~~~~~n~~~c~~~~~~~c 187 (621)
.+.. +....+.+|+++|+.+....|
T Consensus 509 -------~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 509 -------ALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred -------HHhhccccCceEEecCCccccCCCCCCCC
Confidence 3221 123356788888986654455
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-22 Score=188.15 Aligned_cols=165 Identities=14% Similarity=0.116 Sum_probs=128.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHH---------HHHHHHHHHhcCCCCCcccceEEEEeC------
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARD---------AFDTEVRRLGRLRHSNVLAPLAYHYRT------ 379 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~------ 379 (621)
+.++||.|+||.||++.. ++..+|+|.+++....... .+++|+..+.++.|++|..+.+++...
T Consensus 35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 347899999999999766 5778999999754322222 268999999999999999999986643
Q ss_pred --CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 380 --DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 380 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
...++||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||+++.++ ++|
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCCC-EEE
Confidence 34789999999999987732 222 3466999999999999 999999999999999988 999
Q ss_pred EeeecceeccccccccccccccCcccccCCCCCcchhhHHHHHHHHHHH
Q 045652 458 SEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEIL 506 (621)
Q Consensus 458 ~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 506 (621)
+|||........... ..+.....|..++|+||||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 999987655322111 11334455778999999999987554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=178.32 Aligned_cols=139 Identities=22% Similarity=0.283 Sum_probs=111.5
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChh--------------------------hHHHHHHHHHHHhcCCCCCcc
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM--------------------------ARDAFDTEVRRLGRLRHSNVL 370 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~niv 370 (621)
..||+|+||.||+|...+|+.||||+++..... ....+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 469999999999999778999999998754210 012346899999999999886
Q ss_pred cceEEEEeCCeeEEEEeecCCCChhHH-hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEE
Q 045652 371 APLAYHYRTDEKLLVYEYIPGGSLLYL-LHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 371 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIl 448 (621)
....+... ..++||||++++++... +. ...++......++.|++.++.++|+ . +|+||||||+||+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIl 150 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNIL 150 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEE
Confidence 65555433 34899999998865433 32 2346778889999999999999999 8 9999999999999
Q ss_pred eCCCCCcEEEeeecceeccc
Q 045652 449 ISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~ 468 (621)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=173.75 Aligned_cols=178 Identities=16% Similarity=0.130 Sum_probs=135.3
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChh----hHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM----ARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|++|. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45799999999997766 6788888877654321 2235889999999995 5889998886 34699999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCC-CCCCEEeCCCCCcEEEeeecceecccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNL-KSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
|.+|.+.+.. ....++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||++......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9998754321 1135788999999999999 9999999 799999999999999999999865432
Q ss_pred cc-----------------ccccccccCcccccCC-CCC-cchhhHHHHHHHHHHHhCCCCCCc
Q 045652 470 NL-----------------AQALFAYKAPEAIQSG-KVT-PKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 470 ~~-----------------~~~~~~y~aPE~~~~~-~~~-~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
.. ...++.|++|+..... ..+ ...+.++-|.-+|.++|+..+...
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 21 1123456666644321 233 567899999999999999988653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-22 Score=215.02 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=172.8
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCC-hhhHHHHHHHHHH--HhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS-AMARDAFDTEVRR--LGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
...+.||.+.|=+|.+|+..+|. |+||++-+.. ....+.|.++++- ...++|||++.+.-+-..+...|||-+|+.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 34578999999999999988887 8889875443 3334444443333 445589999998877666777789999985
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec--cc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI--NS 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~--~~ 468 (621)
. +|++.+.. +.-+..-+.+-|+.|++.||.-+|.. ||+|||||.+||||+.-..+.|+||...+.. ..
T Consensus 105 h-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 105 H-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred h-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 4 99998852 33467777888999999999999999 9999999999999999999999999876543 11
Q ss_pred ccc---------ccccccccCcccccCC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHH
Q 045652 469 ANL---------AQALFAYKAPEAIQSG----------K-VTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEW 527 (621)
Q Consensus 469 ~~~---------~~~~~~y~aPE~~~~~----------~-~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 527 (621)
.+. ...-..|+|||.+... . .+++.||||+||++.||++ |++||.. .+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----------SQ- 243 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----------SQ- 243 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----------HH-
Confidence 111 1112359999987431 2 5788999999999999998 6777652 11
Q ss_pred HHHHhhcCccccccccch-hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 528 VASAFSEGRVTDLLDPEI-ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 528 ~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
... ++.+. -.+++. .... +...+.+++..|++.||++|.++++.++.-.
T Consensus 244 L~a-Yr~~~---~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 244 LLA-YRSGN---ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHh-HhccC---ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 100 01110 011110 0000 0125889999999999999999999998843
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=196.10 Aligned_cols=214 Identities=24% Similarity=0.385 Sum_probs=164.4
Q ss_pred HhcCCCCCcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccC
Q 045652 361 LGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHG 440 (621)
Q Consensus 361 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~ 440 (621)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.+.+... ...++|.-...++++|+.||+|||.. + ...|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s--~-i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNS--P-IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcC--c-ceeee
Confidence 45789999999999999999999999999999999999752 35688888999999999999999976 2 22799
Q ss_pred CCCCCCEEeCCCCCcEEEeeecceeccc------cccccccccccCcccccCCC-------CCcchhhHHHHHHHHHHHh
Q 045652 441 NLKSSNIFISPENEPLISEFGFYTMINS------ANLAQALFAYKAPEAIQSGK-------VTPKCDVYCLGIIILEILT 507 (621)
Q Consensus 441 Dlkp~NIll~~~~~~kl~DfG~a~~~~~------~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwSlGvvl~ellt 507 (621)
.+++.|.++|....+||+|||+...... ........-|.|||.+.+.. .+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9999999999999999999999776632 11111223599999987531 4677999999999999999
Q ss_pred CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 508 GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 508 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
.+.||..........+++..+.. .....+.|.+.... +..+++..++.+||..+|++||+++++-..++.+.
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99999864433322233333322 11223334332221 33347899999999999999999999999988776
Q ss_pred cc
Q 045652 588 QS 589 (621)
Q Consensus 588 ~~ 589 (621)
..
T Consensus 226 ~~ 227 (484)
T KOG1023|consen 226 KG 227 (484)
T ss_pred cc
Confidence 53
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-21 Score=201.22 Aligned_cols=224 Identities=19% Similarity=0.270 Sum_probs=180.5
Q ss_pred cCcCCcccEEEEE----EcCCcEEEEEEccCCChh--hHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCC
Q 045652 319 LGNGGLGSSYKAM----MADGVTVVVKRMKESSAM--ARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 319 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+|+|+||.|+++. ...|..+|+|.+++.... .+.....|..++..++ ||.+|++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999876 223778899988754321 1224456888888887 99999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL 471 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 471 (621)
|+|...+.. ...++......+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 82 g~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 82 GDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred chhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999887753 34567777778888999999999999 999999999999999999999999999988766666
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..||..|||||++. .....+|.||||++++||+||..||.. +....+... ....+
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~---------------~~~~p 207 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKA---------------ELEMP 207 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhh---------------ccCCc
Confidence 68899999999997 567899999999999999999999874 222222110 11223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcH
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEM 576 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~ 576 (621)
......+.+++..++..+|..|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 4555678888999999999999754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=178.70 Aligned_cols=228 Identities=21% Similarity=0.332 Sum_probs=146.0
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCC----------CCcccceEEEEe----
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRH----------SNVLAPLAYHYR---- 378 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~~---- 378 (621)
+.||.|+++.||.+... +++.+|+|++.... ....+.+++|.-....+.+ -.++..++...-
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 46999999999999965 48999999875222 2245667666655555332 223333333221
Q ss_pred -----CC--------eeEEEEeecCCCChhHHhhc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCC
Q 045652 379 -----TD--------EKLLVYEYIPGGSLLYLLHG---DRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNL 442 (621)
Q Consensus 379 -----~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl 442 (621)
.. ..+++|+-+ .+||.+++.. ... ....+....++.+..|+++.+++||+. |++|+||
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlVHgdi 171 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSY----GLVHGDI 171 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHT----TEEEST-
T ss_pred cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhc----ceEeccc
Confidence 11 135788887 4589887642 110 122344555677789999999999999 9999999
Q ss_pred CCCCEEeCCCCCcEEEeeecceecccccc-ccccccccCcccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 045652 443 KSSNIFISPENEPLISEFGFYTMINSANL-AQALFAYKAPEAIQS--------GKVTPKCDVYCLGIIILEILTGKFPSQ 513 (621)
Q Consensus 443 kp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvvl~elltg~~P~~ 513 (621)
||+|++++.+|.++|+||+.....+.... ...+..|.+||.... ..++.+.|.|++|+++|.|.+|..||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 99999999999999999998777655433 344567999997643 257889999999999999999999997
Q ss_pred cccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCC
Q 045652 514 YLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573 (621)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 573 (621)
......... + .+ .. +.+.++.+..||..+|++||++|
T Consensus 252 ~~~~~~~~~----~----------------~f--~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADPE----W----------------DF--SR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTSG----G----------------GG--TT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCcccccc----c----------------cc--hh-cCCcCHHHHHHHHHHccCCcccC
Confidence 533211110 0 01 11 22666789999999999999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=169.40 Aligned_cols=132 Identities=14% Similarity=0.126 Sum_probs=103.8
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-----CCCCcccceEEEEeCC---eeE-EEEe
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-----RHSNVLAPLAYHYRTD---EKL-LVYE 387 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~e 387 (621)
+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|+++++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 3334444 69988755444567789999999999 5799999999998864 333 7899
Q ss_pred e--cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhccCCCCCccCCCCCCCEEeCCC----CCcEEEee
Q 045652 388 Y--IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI-GYLHTELAHLDLPHGNLKSSNIFISPE----NEPLISEF 460 (621)
Q Consensus 388 ~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Df 460 (621)
| +.+++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++.. ..++|+||
T Consensus 86 ~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 86 FDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred CCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 9 5579999999642 24444 35678888888 999999 99999999999999743 37999995
Q ss_pred ec
Q 045652 461 GF 462 (621)
Q Consensus 461 G~ 462 (621)
+.
T Consensus 154 ~G 155 (210)
T PRK10345 154 IG 155 (210)
T ss_pred CC
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=168.29 Aligned_cols=142 Identities=23% Similarity=0.322 Sum_probs=109.3
Q ss_pred HHHHHHcCcCCcccEEEEE--EcCCcEEEEEEccCCCh------------------------hhHHHHHHHHHHHhcCCC
Q 045652 313 KAAAEVLGNGGLGSSYKAM--MADGVTVVVKRMKESSA------------------------MARDAFDTEVRRLGRLRH 366 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~h 366 (621)
|.+.+.||+|+||.||+|. ..+|+.||+|+++.... .....+.+|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3566889999999999998 56799999999874321 012346789999999975
Q ss_pred CC--cccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC-CccCCCC
Q 045652 367 SN--VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD-LPHGNLK 443 (621)
Q Consensus 367 ~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~-ivH~Dlk 443 (621)
.. +.+++++ ...++||||+++++|...... ...+...+...++.|++.+|++||+. + |+|||||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dik 176 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKE----GELVHGDLS 176 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCC
Confidence 33 3333332 235899999999888765422 12345556788999999999999999 9 9999999
Q ss_pred CCCEEeCCCCCcEEEeeecceeccc
Q 045652 444 SSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 444 p~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|+||+++ ++.++|+|||.+.....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999 88999999999875543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=203.06 Aligned_cols=155 Identities=36% Similarity=0.575 Sum_probs=107.9
Q ss_pred cHHHHHHHHHHcCCCC-CCCCCCCCCCCCCCCCCCceeeEEeC-CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEe
Q 045652 2 SESEALLKLKSSFTNA-KALDSWMPSTAPCRGGEEEWSGVVCL-KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIY 79 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~-~~l~~w~~~~~~c~~~~~~w~gv~c~-~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~ 79 (621)
+|..||++||+++.++ +.+.+|+.+.++|. |.||+|. .++|+.|+|++++++|.++. .+..|++|+.|+
T Consensus 29 ~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~-----w~gv~c~~~~~v~~L~L~~~~i~~~~~~----~~~~l~~L~~L~ 99 (968)
T PLN00113 29 EELELLLSFKSSINDPLKYLSNWNSSADVCL-----WQGITCNNSSRVVSIDLSGKNISGKISS----AIFRLPYIQTIN 99 (968)
T ss_pred HHHHHHHHHHHhCCCCcccCCCCCCCCCCCc-----CcceecCCCCcEEEEEecCCCccccCCh----HHhCCCCCCEEE
Confidence 4789999999999765 46889987778885 9999996 57999999999999998763 455667777888
Q ss_pred cCCCcccccCCcccccCCCCCCEEeCccCcccccCC----------------------CCCCCCCCcCeeeccCcccccc
Q 045652 80 LDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLP----------------------PSLFKLPHLTELHLESNQFNGT 137 (621)
Q Consensus 80 l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p----------------------~~~~~l~~L~~l~l~~N~l~g~ 137 (621)
|++|+++|.+|.+.+..+++|++|+|++|+++|.+| ..++++++|++|+|++|.+.+.
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence 888888777777655566666666666666655554 4445555555555555555555
Q ss_pred CCCC--CCCCccEEEcccCccccccCcccc
Q 045652 138 IPSF--DQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 138 ~p~~--~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
+|.. .+++|++|+|++|+++|.+|..+.
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 209 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELG 209 (968)
T ss_pred CChhhhhCcCCCeeeccCCCCcCcCChHHc
Confidence 5542 345555555555555555555443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=161.71 Aligned_cols=134 Identities=25% Similarity=0.452 Sum_probs=113.7
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCCh--------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSA--------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.||+|++|.||+|.. +|..|++|+...... .....+.+|++++..++|++|.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 677899997653221 1234578899999999999998888888888888999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
++|++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998632 11 7788999999999999998 999999999999999 78899999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-18 Score=193.19 Aligned_cols=184 Identities=21% Similarity=0.298 Sum_probs=146.4
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC---CCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR---HSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|...+|+.||+|+-+..... +|--=.+++.+|+ -+-|..+...+.-.+..+||+||.+.
T Consensus 702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 45789999999999999878999999987755432 1222233444444 23455555555667778999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-------CCCcEEEeeecce
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-------ENEPLISEFGFYT 464 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~DfG~a~ 464 (621)
|+|.+++. ..+.++|..++.++.|+++-++.||.. +|||+||||+|+||.. ...++|+|||.+.
T Consensus 779 Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 779 GTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999997 345688999999999999999999999 9999999999999952 3358999999886
Q ss_pred eccc---c---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 045652 465 MINS---A---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKF 510 (621)
Q Consensus 465 ~~~~---~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 510 (621)
.+.- . .....|-.+-.+|+..+.+++.++|.|.++.+++-|+.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 6532 2 22334567889999999999999999999999999999974
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.4e-18 Score=165.47 Aligned_cols=191 Identities=18% Similarity=0.227 Sum_probs=135.4
Q ss_pred CCCCcccceEEEEeC---------------------------CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHH
Q 045652 365 RHSNVLAPLAYHYRT---------------------------DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKI 417 (621)
Q Consensus 365 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 417 (621)
+|||||+++++|.+. ...|+||.-++. +|.+++..+ ..+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHHH
Confidence 699999999887531 235899998854 999999632 3555566778
Q ss_pred HHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC--CCC--CcEEEeeecceecccc----------ccccccccccCccc
Q 045652 418 VQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS--PEN--EPLISEFGFYTMINSA----------NLAQALFAYKAPEA 483 (621)
Q Consensus 418 ~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfG~a~~~~~~----------~~~~~~~~y~aPE~ 483 (621)
+.|+++|+.|||.+ ||.|||+|++|||+. +|+ .+.|+|||++-.-... -...|.-.-||||+
T Consensus 347 laQlLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 99999999999999 999999999999984 444 4679999987543221 11234456899999
Q ss_pred ccCCC------CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHH
Q 045652 484 IQSGK------VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQ 557 (621)
Q Consensus 484 ~~~~~------~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 557 (621)
....+ .-.|+|.|+.|.+.||+++..-||.. .++...+. +.+++.++..+ +..+++.
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~-----r~Yqe~qLPal----------p~~vpp~ 485 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDT-----RTYQESQLPAL----------PSRVPPV 485 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheech-----hhhhhhhCCCC----------cccCChH
Confidence 86432 23589999999999999999999874 11111111 11233222211 2344567
Q ss_pred HHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 558 LLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 558 l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+.+++...|+.||.+|++..-+...|
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHH
Confidence 88999999999999999866555444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=159.66 Aligned_cols=131 Identities=27% Similarity=0.472 Sum_probs=108.5
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCC--------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESS--------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.||+|+||.||+|.+ ++..|++|...... ......+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999865321 112356778999999999988777777777777789999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875311 0 7899999999999998 999999999999999 889999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=157.83 Aligned_cols=137 Identities=21% Similarity=0.269 Sum_probs=108.0
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh----------------------hhHHHHHHHHHHHhcCCCCC--
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA----------------------MARDAFDTEVRRLGRLRHSN-- 368 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n-- 368 (621)
|.+.+.||+|+||.||++...+|+.||||+++.... .....+.+|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 456688999999999999988899999998653220 01223678999999998874
Q ss_pred cccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 369 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
+...++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||+
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nil 157 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNIL 157 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEE
Confidence 444433 3456899999999998765420 23457889999999999998 9999999999999
Q ss_pred eCCCCCcEEEeeecceeccc
Q 045652 449 ISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-18 Score=174.10 Aligned_cols=170 Identities=24% Similarity=0.366 Sum_probs=127.9
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..|+.|++|...+|.++|.+.+ .....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhh
Confidence 4679999999999999997554 34567788899999999999999 5 7889999999999999999999999
Q ss_pred ecceeccccc----------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHH
Q 045652 461 GFYTMINSAN----------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVA 529 (621)
Q Consensus 461 G~a~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 529 (621)
|+........ ...+|..||+||.+.+..|+.|+||||||++|+|+++ -..++... ...
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~ 469 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------ATL 469 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hhh
Confidence 9987654332 3457788999999999999999999999999999997 22222210 011
Q ss_pred HHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHH
Q 045652 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAV 580 (621)
Q Consensus 530 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 580 (621)
..++++.+. |... ...+.-..|+.+++...|.+||++.++.
T Consensus 470 ~d~r~g~ip----~~~~------~d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 470 TDIRDGIIP----PEFL------QDYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhhhcCCCC----hHHh------hcCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 122333322 1111 1112345688899999999999555543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=177.93 Aligned_cols=133 Identities=23% Similarity=0.410 Sum_probs=108.7
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEE-ccCC-C------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKR-MKES-S------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
..+.||+|+||.||++.+.... +++|+ ..+. . ....+.+.+|++++++++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3578999999999999875443 33333 2211 1 112356889999999999999998888888777889999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++. ....++.+++.+|.|||+. +|+||||||+|||+ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998874 2467899999999999998 99999999999999 5788999999998653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-17 Score=181.45 Aligned_cols=199 Identities=20% Similarity=0.231 Sum_probs=136.8
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
++++|..|+||.||.++++ +.+.+|+|+ .+.... .+- ++.....|.+| |+
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-----lRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-----LRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcc-cccchh-----hhc--cccccCCccee---------------------ch
Confidence 5688999999999999854 367788843 322211 110 33333344333 34
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS----- 468 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----- 468 (621)
=...++. ...++. +.+.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+.+..-.
T Consensus 138 c~tllk~-----~g~lPv--------dmvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 138 CATLLKN-----IGPLPV--------DMVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred hhhhccc-----CCCCcc--------hhhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 4444432 122332 227899999998 999999999999999999999999998764310
Q ss_pred --------------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 469 --------------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 469 --------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
.....+|+.|+|||++....|+..+|+|++|+|+||.+.|..||+..+. .+++..+....-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp----eelfg~visd~i- 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVISDDI- 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH----HHHHhhhhhhhc-
Confidence 1234688999999999999999999999999999999999999986332 222222211110
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCc
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLE 575 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 575 (621)
.+ .........++.+++.+.|+.+|..|--
T Consensus 276 -~w----------pE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 -EW----------PEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred -cc----------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 00 1112334467899999999999999963
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.2e-16 Score=140.96 Aligned_cols=134 Identities=22% Similarity=0.184 Sum_probs=111.4
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCC--CCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH--SNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .+++++++++...+..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 568999999999999754 7899999865433 5678899999999976 5899998888777889999999988777
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
..+ +......++.+++.+|+++|.. ...+++|+|++|+||+++..+.++++|||.+...
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~-~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQL-PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCC-CceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 532 4456678899999999999974 1126999999999999999899999999987653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=143.02 Aligned_cols=136 Identities=25% Similarity=0.346 Sum_probs=98.2
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChh--hHHH----------------------HHHHHHHHhcCCCCC--cc
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM--ARDA----------------------FDTEVRRLGRLRHSN--VL 370 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--iv 370 (621)
+.||+|+||.||+|...+++.||||+++..... .... ...|...+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 569999999999999878999999987643211 1111 135666666665443 34
Q ss_pred cceEEEEeCCeeEEEEeecCCCChhHH-hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEE
Q 045652 371 APLAYHYRTDEKLLVYEYIPGGSLLYL-LHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 371 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIl 448 (621)
+.+++ ...++||||++++.+... +... ... .+...++.+++.++.++|. . +|+|+||||+||+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nil 147 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNIL 147 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEE
Confidence 44432 246899999998554321 1110 011 5677899999999999998 7 9999999999999
Q ss_pred eCCCCCcEEEeeecceeccc
Q 045652 449 ISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~ 468 (621)
++ ++.++|+|||.+.....
T Consensus 148 i~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE-CCcEEEEECcccccccC
Confidence 99 89999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.8e-15 Score=145.06 Aligned_cols=137 Identities=23% Similarity=0.347 Sum_probs=106.0
Q ss_pred HHHHcC-cCCcccEEEEEEcCCcEEEEEEccCCC-------------hhhHHHHHHHHHHHhcCCCCCc--ccceEEEEe
Q 045652 315 AAEVLG-NGGLGSSYKAMMADGVTVVVKRMKESS-------------AMARDAFDTEVRRLGRLRHSNV--LAPLAYHYR 378 (621)
Q Consensus 315 ~~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~ 378 (621)
....|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|++| ++.+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 346788 8999999999874 6788898774311 1223567889999999998875 667766443
Q ss_pred CCe----eEEEEeecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC
Q 045652 379 TDE----KLLVYEYIPG-GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453 (621)
Q Consensus 379 ~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~ 453 (621)
... .++||||++| .+|.+++.. ..++.. .+.+|+.+|.+||+. ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPDG 179 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCC
Confidence 322 3599999997 689988853 124432 367899999999999 999999999999999999
Q ss_pred CcEEEeeecceec
Q 045652 454 EPLISEFGFYTMI 466 (621)
Q Consensus 454 ~~kl~DfG~a~~~ 466 (621)
.++|+|||.+...
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-16 Score=174.52 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=183.5
Q ss_pred HHHHcCcCCcccEEEEEEcC--CcEEEEEEccCCC--hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMAD--GVTVVVKRMKESS--AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
..+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-+.+. |+|++.+++...+.+..+++++|.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 44569999999999887533 4567777665432 223344556888888887 999999999999999999999999
Q ss_pred CCCChhHHh-hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceec
Q 045652 390 PGGSLLYLL-HGDRGPSHDELTWPARLKIVQGIARGIGYLH-TELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMI 466 (621)
Q Consensus 390 ~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~ 466 (621)
.++++...+ +... ...+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus 104 ~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 104 DGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccccccccCCc----cCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999888 4221 13455566789999999999999 77 899999999999999999 9999999999876
Q ss_pred cc-c------ccccc-cccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 467 NS-A------NLAQA-LFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 467 ~~-~------~~~~~-~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
.. . ....+ ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|+... +.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~---~~- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK---GR- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc---cc-
Confidence 55 2 22346 8889999999874 45678999999999999999999987543221 1112221111 00
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.....+........+++.+++..+|..|.+.+++...
T Consensus 250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --------cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0011122334567888899999999999998887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=147.24 Aligned_cols=140 Identities=21% Similarity=0.295 Sum_probs=100.1
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhH----------------------------------------HHHHH
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMAR----------------------------------------DAFDT 356 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 356 (621)
+.||.|++|.||+|+..+|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999999999999999865321100 02445
Q ss_pred HHHHHhcCC-----CCCcccceEEE-EeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 045652 357 EVRRLGRLR-----HSNVLAPLAYH-YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIAR-GIGYLH 429 (621)
Q Consensus 357 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH 429 (621)
|++.+.+++ ++++ .+-.++ ......+|||||++|++|.++..... ... .+.+++.+++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHHHHHH
Confidence 666555552 3333 222222 22455799999999999988764221 112 23456666666 477889
Q ss_pred hccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 430 ~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
.. |++|+|+||.||+++.++.++++|||++..+..
T Consensus 275 ~~----g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RD----GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hC----CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88 999999999999999999999999999887754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.5e-14 Score=134.57 Aligned_cols=202 Identities=24% Similarity=0.318 Sum_probs=139.3
Q ss_pred HHHHhcCCCCCcccceEEEEeCC-----eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc
Q 045652 358 VRRLGRLRHSNVLAPLAYHYRTD-----EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432 (621)
Q Consensus 358 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 432 (621)
..-|-++.|.|||+++.|+.+.. ...++.|||..|++.++|++.+. ....+......+|+.||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34455667999999999876543 36799999999999999986442 234577778889999999999999985
Q ss_pred CCCCCccCCCCCCCEEeCCCCCcEEEeeeccee---ccc-----cccccccccccCcccccCCCCCcchhhHHHHHHHHH
Q 045652 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTM---INS-----ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILE 504 (621)
Q Consensus 433 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~---~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~e 504 (621)
.+.|+|+++.-+-|++..++-+|+.--.-... ... .....+.++|.|||.-.....+.++|||+||...+|
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 34689999999999999988887642111000 000 011234568999998877778889999999999999
Q ss_pred HHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 505 ILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 505 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
|..+..--. +.+......+.+...+. .+.. ..=.+++.+|++..|..||+|++++.|.
T Consensus 275 mailEiq~t---nseS~~~~ee~ia~~i~------~len------------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 275 MAILEIQST---NSESKVEVEENIANVII------GLEN------------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHheeccC---CCcceeehhhhhhhhee------eccC------------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 998764311 11111111111111110 0000 0123567899999999999999998774
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.1e-14 Score=145.52 Aligned_cols=249 Identities=21% Similarity=0.269 Sum_probs=177.6
Q ss_pred CChhHHHHHHHHHcCc--CCcccEEEEEE---cCCcEEEEEEccC--CChhhHHHHHHHHHHHhcCC-CCCcccceEEEE
Q 045652 306 FGLPDLMKAAAEVLGN--GGLGSSYKAMM---ADGVTVVVKRMKE--SSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHY 377 (621)
Q Consensus 306 ~~~~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 377 (621)
++..+....+.+.+|. |.+|.||.+.. .++..+|+|+-+. ........-.+|+....+++ |+|.++.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444444456678999 99999999875 4588899998432 22223333346777777774 999999888888
Q ss_pred eCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhccCCCCCccCCCCCCCEEeCCC-
Q 045652 378 RTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIAR----GIGYLHTELAHLDLPHGNLKSSNIFISPE- 452 (621)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~~ivH~Dlkp~NIll~~~- 452 (621)
..+..++-+|++ +.+|..+.+.-.. -++....+..+.+... ||.++|+. +++|-|+||.||++..+
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheeccccc
Confidence 899999999998 5788888875332 2455556666777777 99999998 99999999999999999
Q ss_pred CCcEEEeeecceecccccc---------ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcc
Q 045652 453 NEPLISEFGFYTMINSANL---------AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID 523 (621)
Q Consensus 453 ~~~kl~DfG~a~~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 523 (621)
...+++|||+...+..... ..+...|++||... +-++...|+|++|.++.+..++..+.......
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----- 333 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS----- 333 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-----
Confidence 8899999999888765421 13455799999875 56889999999999999999987765432110
Q ss_pred hHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.|. .++.+. .+ .........++...+..|++.+|-.|++.+.+..+
T Consensus 334 --~W~--~~r~~~-----ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 334 --SWS--QLRQGY-----IP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred --Ccc--cccccc-----Cc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 010 011110 00 01111122345558889999999999998877643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=4e-12 Score=118.08 Aligned_cols=130 Identities=16% Similarity=0.207 Sum_probs=95.8
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCccc-ceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA-PLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
+.|+.|.++.||++... +..|++|....... ....+.+|+++++.+.+.+++. ++.+ .....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 46889999999999874 77899998764432 1234678999999987655544 4433 333468999999998875
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccC-CCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA-HLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
..- . ....++.+++++|+.||+... +..++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 320 1 112457899999999998721 22359999999999999 6789999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-12 Score=139.90 Aligned_cols=141 Identities=19% Similarity=0.233 Sum_probs=92.6
Q ss_pred HHcCcCCcccEEEEEEcC-CcEEEEEEccCCChh----------------------------------hHH------HHH
Q 045652 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAM----------------------------------ARD------AFD 355 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~------~~~ 355 (621)
+.||+|++|.||+|+.++ |+.||||+.+..-.. ..+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 689999999999999877 999999998743110 011 133
Q ss_pred HHHHHHhcCC----CCCcccceEEEEe-CCeeEEEEeecCCCChhHHhhc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 045652 356 TEVRRLGRLR----HSNVLAPLAYHYR-TDEKLLVYEYIPGGSLLYLLHG-DRGPSHDELTWPARLKIVQGIARGIGYLH 429 (621)
Q Consensus 356 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 429 (621)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.- ..+.....+....+..++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4554444442 4444444444443 4567899999999999874211 111111122222233333443 3
Q ss_pred hccCCCCCccCCCCCCCEEeCCCC----CcEEEeeecceeccc
Q 045652 430 TELAHLDLPHGNLKSSNIFISPEN----EPLISEFGFYTMINS 468 (621)
Q Consensus 430 ~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~~ 468 (621)
.. |++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 278 ~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 899999999999999988 899999999887754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.9e-11 Score=124.33 Aligned_cols=164 Identities=24% Similarity=0.310 Sum_probs=127.6
Q ss_pred EEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCC
Q 045652 331 MMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELT 410 (621)
Q Consensus 331 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~ 410 (621)
+..++.+|.|+..+.......+...+-++.|+.++||||+++++.++..+..|+|+|-+. .|..++.+ +.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LG 102 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hH
Confidence 356788999988876655445567788899999999999999999999999999999984 67777753 33
Q ss_pred HHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc----ccccccccCcccccC
Q 045652 411 WPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQALFAYKAPEAIQS 486 (621)
Q Consensus 411 ~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----~~~~~~y~aPE~~~~ 486 (621)
.....-.+.||+.||.|||+.+ +++|++|.-+-|+++..|+.||++|.++........ ......|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 4455567899999999998653 899999999999999999999999998765433221 111224677776532
Q ss_pred CCCCcchhhHHHHHHHHHHHhCC
Q 045652 487 GKVTPKCDVYCLGIIILEILTGK 509 (621)
Q Consensus 487 ~~~~~~~DvwSlGvvl~elltg~ 509 (621)
.. ...|.|-|||+++|++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 22 4579999999999999994
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.8e-12 Score=140.91 Aligned_cols=84 Identities=36% Similarity=0.562 Sum_probs=79.7
Q ss_pred CCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEc
Q 045652 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNL 151 (621)
Q Consensus 74 ~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l 151 (621)
.++.|+|++|.|+|.+|.+ ++.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|.. .+++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~-i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHH-HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 4788999999999999997 899999999999999999999999999999999999999999999975 6899999999
Q ss_pred ccCcccc
Q 045652 152 SSNKLEG 158 (621)
Q Consensus 152 ~~N~l~g 158 (621)
++|+|+|
T Consensus 498 s~N~l~g 504 (623)
T PLN03150 498 NGNSLSG 504 (623)
T ss_pred cCCcccc
Confidence 9999986
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.8e-11 Score=111.12 Aligned_cols=137 Identities=13% Similarity=0.134 Sum_probs=99.1
Q ss_pred HcCcCCcccEEEEEEcC-------CcEEEEEEccCCC----------------------hhhHHHHH----HHHHHHhcC
Q 045652 318 VLGNGGLGSSYKAMMAD-------GVTVVVKRMKESS----------------------AMARDAFD----TEVRRLGRL 364 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~l 364 (621)
.||.|--+.||.|...+ +..+|||+.+... ...++.+. +|++.|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 58999999999998543 4799999865210 00122333 899999999
Q ss_pred CC--CCcccceEEEEeCCeeEEEEeecCCCChhH-HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCCCccC
Q 045652 365 RH--SNVLAPLAYHYRTDEKLLVYEYIPGGSLLY-LLHGDRGPSHDELTWPARLKIVQGIARGIGYL-HTELAHLDLPHG 440 (621)
Q Consensus 365 ~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~~ivH~ 440 (621)
.. -++.+.+++ ...++||||+.+..+.. .++ ...++..+...+..+++.+|..| |+. +|||+
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk------d~~~~~~~~~~i~~~i~~~l~~l~H~~----glVHG 149 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK------DAKLNDEEMKNAYYQVLSMMKQLYKEC----NLVHA 149 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh------ccccCHHHHHHHHHHHHHHHHHHHHhC----CeecC
Confidence 54 455566654 46789999997654422 222 12244456677889999999999 787 99999
Q ss_pred CCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 441 NLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 441 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
||++.||+++ ++.+.|+|||.+....++
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 9999999997 467999999988776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-11 Score=128.48 Aligned_cols=241 Identities=20% Similarity=0.204 Sum_probs=172.3
Q ss_pred HHHcCcCCcccEEEEEE--cCCcEEEEEEccCCChhhHHH--HHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMM--ADGVTVVVKRMKESSAMARDA--FDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
...||.|.|+.|+.... .++..|++|.+.+.......+ -..|+.+...+ .|.+++.+...+......|+--|||+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 35799999999999873 458899999886543322222 23566666666 48899998888888888889999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeecceecccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTMINSA 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~ 469 (621)
++++...+. ....+....++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||++..+.-.
T Consensus 350 ~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 350 GGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred CcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhcccccccccccee
Confidence 999876652 233466777889999999999999998 89999999999999986 78899999988643221
Q ss_pred --ccccccccc-cCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 --NLAQALFAY-KAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 --~~~~~~~~y-~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
........| .+++......+..+.|+||||.-+.|.+++..--... ..|. .+..+...
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------~~~~--~i~~~~~p-------- 481 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------VQSL--TIRSGDTP-------- 481 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCccc---------ccce--eeeccccc--------
Confidence 122223334 3566666677889999999999999999987431110 0110 01111111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
..+....++..+.+.+...++..||.+.+...+.+.++
T Consensus 482 ---~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 482 ---NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 11222256777888999999999999998887765554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-10 Score=102.94 Aligned_cols=130 Identities=28% Similarity=0.459 Sum_probs=101.9
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCC--------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESS--------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+++|+-+.+|.+.+. |..+++|.-..+. ....+.-.+|++++.+++--.|...+-+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999764 4446666533221 112345668999999997667766666777888889999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++.... +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888632 245778888889999999 999999999999999665 99999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=112.31 Aligned_cols=143 Identities=21% Similarity=0.255 Sum_probs=108.6
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCC--CcccceEEEEeCC---eeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHS--NVLAPLAYHYRTD---EKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~ 390 (621)
+.|+.|.++.||++...+|+.+++|....... .....+.+|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987778999998764332 1345688999999999764 4566777765532 5689999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc--------------------------------------
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL-------------------------------------- 432 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 432 (621)
|.++...+.. ..++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765421 24677777888888999998888531
Q ss_pred --------------CCCCCccCCCCCCCEEeCC--CCCcEEEeeeccee
Q 045652 433 --------------AHLDLPHGNLKSSNIFISP--ENEPLISEFGFYTM 465 (621)
Q Consensus 433 --------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~ 465 (621)
....++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245789999999999998 56688999997654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-12 Score=114.33 Aligned_cols=117 Identities=26% Similarity=0.390 Sum_probs=100.6
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...+|.|.|++|.++- +|+ ++..|.+|+.|++++|++. ++|.+ +++|++|+.|+++-|.+. .+|..|++++.
T Consensus 32 ~s~ITrLtLSHNKl~~-vpp----nia~l~nlevln~~nnqie-~lp~~-issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTV-VPP----NIAELKNLEVLNLSNNQIE-ELPTS-ISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred hhhhhhhhcccCceee-cCC----cHHHhhhhhhhhcccchhh-hcChh-hhhchhhhheecchhhhh-cCccccCCCch
Confidence 5689999999999985 553 5667889999999999999 89998 899999999999999998 79999999999
Q ss_pred cCeeeccCccccc-cCCCC--CCCCccEEEcccCccccccCcccccccc
Q 045652 124 LTELHLESNQFNG-TIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNA 169 (621)
Q Consensus 124 L~~l~l~~N~l~g-~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~~ 169 (621)
|+.|||..|+|+- .+|.. .+..|+.|+|++|.|. .+|..++++..
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~ 151 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTN 151 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcc
Confidence 9999999999974 56753 5688899999999998 78877666554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.8e-10 Score=100.54 Aligned_cols=141 Identities=23% Similarity=0.383 Sum_probs=106.1
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCC--------ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKES--------SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
..|-+|+-+.|+++.+ .|+..+||.-... ....+....+|+++|.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4678999999999988 5777777753221 123456678899999999766666666677777778899999
Q ss_pred cCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC---cEEEeeecce
Q 045652 389 IPG-GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE---PLISEFGFYT 464 (621)
Q Consensus 389 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~ 464 (621)
++| .++.+++..... ..........++.+|-..+.-||.. +|+|+||..+||++..++. +.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 478888865431 1222223367889999999999999 9999999999999987663 5799999864
Q ss_pred e
Q 045652 465 M 465 (621)
Q Consensus 465 ~ 465 (621)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.1e-11 Score=129.75 Aligned_cols=236 Identities=19% Similarity=0.211 Sum_probs=158.7
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChh---hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+-+-+|+++.++.+.- ..|...++|........ ..+....+-.++-..+||-+++...-+......+|+++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 4677899999988762 23444444444322211 1222333333443345666666555555567789999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---- 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 468 (621)
+|...++... ..+..........+..+++|||.. .+.|+|++|.|+++..++..++.|||.......
T Consensus 890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CchhhhhcCC-----CcccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999998544 233333345667788899999987 689999999999999999999999984322100
Q ss_pred -------------------------------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC
Q 045652 469 -------------------------------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517 (621)
Q Consensus 469 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 517 (621)
.....+|..|.+||...+......+|+|++|++++|.++|..||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0112356779999999999999999999999999999999999875332
Q ss_pred CCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHH
Q 045652 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMR 577 (621)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 577 (621)
+.+.+.+..+. ...............+++.+.+..+|.+|..|.
T Consensus 1041 --------q~~f~ni~~~~--------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 --------QQIFENILNRD--------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred --------hhhhhccccCC--------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11111111111 111112233445678888899999999998876
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.1e-11 Score=122.33 Aligned_cols=106 Identities=30% Similarity=0.451 Sum_probs=71.8
Q ss_pred cccCCCCCCCEEecCCCccc-ccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---C
Q 045652 67 TELTGLRGLRAIYLDKNQFS-GEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---D 142 (621)
Q Consensus 67 ~~l~~l~~L~~l~l~~N~l~-g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~ 142 (621)
++|+.|+.|+.+++..|+|. ..||++ +-.|..|+.||||+|+|. ..|..+-...++-.|+||+|++. +||.. .
T Consensus 72 GELs~Lp~LRsv~~R~N~LKnsGiP~d-iF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfin 148 (1255)
T KOG0444|consen 72 GELSDLPRLRSVIVRDNNLKNSGIPTD-IFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFIN 148 (1255)
T ss_pred hhhccchhhHHHhhhccccccCCCCch-hcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHh
Confidence 34555666677777777663 237777 445777888888888887 67777777777778888888876 67754 4
Q ss_pred CCCccEEEcccCccccccCcccccc---ccCCCCCCC
Q 045652 143 QPTLVRLNLSSNKLEGEIPASLLRF---NASSFSGNA 176 (621)
Q Consensus 143 ~~~L~~l~l~~N~l~g~ip~~~~~~---~~~~~~~n~ 176 (621)
+..|-+||||+|+|. .+|+.+.++ ....+++||
T Consensus 149 LtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 149 LTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred hHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 567777888888887 666654433 333455554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.4e-09 Score=101.85 Aligned_cols=142 Identities=13% Similarity=0.113 Sum_probs=100.6
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChh-hH----------HHHHHHHHHHhcCCCCCc--ccceEEEEe----
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM-AR----------DAFDTEVRRLGRLRHSNV--LAPLAYHYR---- 378 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~ni--v~l~~~~~~---- 378 (621)
.+.+-.-....|++... +|+.|.||........ .. ..+.+|.+.+.++...+| .+.+++.+.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444455777766 6788999977533211 01 137789999988854444 344556543
Q ss_pred -CCeeEEEEeecCCC-ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-----
Q 045652 379 -TDEKLLVYEYIPGG-SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP----- 451 (621)
Q Consensus 379 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----- 451 (621)
....++|||++++. +|.+++.... ........+..++.+++..+.-||.. ||+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCC
Confidence 23468999999876 7988885321 12345566778999999999999999 9999999999999985
Q ss_pred --CCCcEEEeeeccee
Q 045652 452 --ENEPLISEFGFYTM 465 (621)
Q Consensus 452 --~~~~kl~DfG~a~~ 465 (621)
+..+.++||+.+..
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46789999997753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.3e-10 Score=84.35 Aligned_cols=61 Identities=33% Similarity=0.551 Sum_probs=55.3
Q ss_pred CCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccc
Q 045652 73 RGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQF 134 (621)
Q Consensus 73 ~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l 134 (621)
++|+.|+|++|+|+ .||+++|..+++|++|+|++|.++...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 36889999999999 79988899999999999999999987778899999999999999975
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.9e-09 Score=97.86 Aligned_cols=127 Identities=28% Similarity=0.391 Sum_probs=84.2
Q ss_pred cEEEEEEcCCcEEEEEEccCCC--------------------------hhhHHHHHHHHHHHhcCCCC--CcccceEEEE
Q 045652 326 SSYKAMMADGVTVVVKRMKESS--------------------------AMARDAFDTEVRRLGRLRHS--NVLAPLAYHY 377 (621)
Q Consensus 326 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 377 (621)
.||.|...+|..+|||+.+... .......++|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998899999999865310 01123467899999999765 455655442
Q ss_pred eCCeeEEEEeecC--CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhccCCCCCccCCCCCCCEEeCCCCC
Q 045652 378 RTDEKLLVYEYIP--GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY-LHTELAHLDLPHGNLKSSNIFISPENE 454 (621)
Q Consensus 378 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~~ivH~Dlkp~NIll~~~~~ 454 (621)
..++||||++ |..+..+... .++......++.+++..+.. +|.. ||+|+||.+.||+++++ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-e
Confidence 4579999998 6555544321 11133445678888886665 4677 99999999999999987 8
Q ss_pred cEEEeeecceeccc
Q 045652 455 PLISEFGFYTMINS 468 (621)
Q Consensus 455 ~kl~DfG~a~~~~~ 468 (621)
+.++|||.+.....
T Consensus 145 ~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 145 VYIIDFGQAVDSSH 158 (188)
T ss_dssp EEE--GTTEEETTS
T ss_pred EEEEecCcceecCC
Confidence 99999998876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.7e-10 Score=100.28 Aligned_cols=96 Identities=30% Similarity=0.536 Sum_probs=82.6
Q ss_pred ccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CC
Q 045652 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQ 143 (621)
Q Consensus 66 ~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~ 143 (621)
++.|..+.+.+.|-||+|+++ .+||. +..+.+|+.|++++|+++ .+|.+++++++|+.|+++-|+|. .+|.. .+
T Consensus 26 ~~gLf~~s~ITrLtLSHNKl~-~vppn-ia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~ 101 (264)
T KOG0617|consen 26 LPGLFNMSNITRLTLSHNKLT-VVPPN-IAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSF 101 (264)
T ss_pred cccccchhhhhhhhcccCcee-ecCCc-HHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCC
Confidence 345556677888889999999 79998 899999999999999999 79999999999999999999997 67753 68
Q ss_pred CCccEEEcccCcccc-ccCcccc
Q 045652 144 PTLVRLNLSSNKLEG-EIPASLL 165 (621)
Q Consensus 144 ~~L~~l~l~~N~l~g-~ip~~~~ 165 (621)
|.|+.|||++|+|+- .+|..+.
T Consensus 102 p~levldltynnl~e~~lpgnff 124 (264)
T KOG0617|consen 102 PALEVLDLTYNNLNENSLPGNFF 124 (264)
T ss_pred chhhhhhccccccccccCCcchh
Confidence 999999999999974 4665443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2e-08 Score=96.21 Aligned_cols=140 Identities=24% Similarity=0.337 Sum_probs=100.2
Q ss_pred HHHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCC----------------------hhhHHHHHHHHHHHhcCCCC
Q 045652 310 DLMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS----------------------AMARDAFDTEVRRLGRLRHS 367 (621)
Q Consensus 310 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~ 367 (621)
...+++.+.||-|.-+.||.|....|.++|||.=+... ...+...++|.++|.+|.-.
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 34556788999999999999999999999999643110 11234567899999999654
Q ss_pred --CcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCC
Q 045652 368 --NVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSS 445 (621)
Q Consensus 368 --niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~ 445 (621)
.+.+.+++ +...+||||++|-.|...- ++....-.++..|+.-+.-+-.. ||||+|+.+-
T Consensus 170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSef 231 (304)
T COG0478 170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEF 231 (304)
T ss_pred CCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchh
Confidence 66666654 4568999999986665332 11222234444555544444455 9999999999
Q ss_pred CEEeCCCCCcEEEeeecceecc
Q 045652 446 NIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 446 NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||+++++|.+.++||-.+....
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred eEEEecCCCEEEEeCcccccCC
Confidence 9999999999999997665443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.8e-08 Score=100.12 Aligned_cols=170 Identities=21% Similarity=0.286 Sum_probs=126.2
Q ss_pred cccEEEEE-EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe----CCeeEEEEeecCC-CChhHH
Q 045652 324 LGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVYEYIPG-GSLLYL 397 (621)
Q Consensus 324 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 397 (621)
-.+.|++. ..||..|++|+++............-+++++++.|.|+|++.+++.. +...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35778988 56899999999954332222233456788999999999999998863 3457899999985 567665
Q ss_pred hhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 398 LHGDRG----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 398 l~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
...... .....+++..+|.++.|+..||.++|+. |+.-+-|.|.+|+++.+.+++|+..|....+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 432221 1233577889999999999999999999 99899999999999999999998887765543
Q ss_pred ccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 045652 468 SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKF 510 (621)
Q Consensus 468 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 510 (621)
.... |-+.+ -.+-|.=.||.+++.|.||..
T Consensus 445 ~d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3220 11111 135688999999999999964
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.4e-08 Score=114.11 Aligned_cols=52 Identities=15% Similarity=-0.051 Sum_probs=38.8
Q ss_pred cHHHHHHHHHHcCCCCCCCCC----CCCCCCCCCCCC-----------CceeeEEeCCCcEEEEEec
Q 045652 2 SESEALLKLKSSFTNAKALDS----WMPSTAPCRGGE-----------EEWSGVVCLKGIVTGLYIN 53 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~~~l~~----w~~~~~~c~~~~-----------~~w~gv~c~~~~v~~l~l~ 53 (621)
+|.+.++++.+.|..|+.+.+ |...+++|..+. ..=.-|.|..+.||.+.+-
T Consensus 63 ~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~ 129 (754)
T PRK15370 63 EEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVT 129 (754)
T ss_pred HHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCcccccccc
Confidence 588999999999999988777 998899997665 3344578865555544443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.5e-07 Score=93.13 Aligned_cols=264 Identities=15% Similarity=0.201 Sum_probs=160.3
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEE----EE--eCCe-eEEEEee
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAY----HY--RTDE-KLLVYEY 388 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~--~~~~-~~lv~e~ 388 (621)
..||+|+.+.+|-.--- + -.+.|+.......... +-++.|.+. .||-+-.-+.+ .. +.+. .-+.|..
T Consensus 17 r~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 17 RPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred ccccCCccceeeecchh-h-chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 45899999999965321 1 1234666544332222 123334343 56643331111 11 1222 5578888
Q ss_pred cCCCC-hhHHhhc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 389 IPGGS-LLYLLHG-DRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 389 ~~~gs-L~~~l~~-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
+.+.- ...++.. .+..+.....|.-.++.+..++.+.+-||.. |.+-+|+.++|+|+.+++.+.|.|=.....-
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccceeec
Confidence 76542 2222221 1223456789999999999999999999999 8888999999999999999999985433322
Q ss_pred cccc---cccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 467 NSAN---LAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTG-KFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 467 ~~~~---~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
.... ...+...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+.......-.-.+ ..+..+..
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g~f 244 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHGRF 244 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhccee
Confidence 2222 223556799999754 33456789999999999999986 999987543221111111 01111111
Q ss_pred ccccccc---h--hcCCCCHHHHHHHHHHHhhcccCC--CCCCCcHHHHHHHHHHhhccCCC
Q 045652 538 TDLLDPE---I--ASSTNSPGEMEQLLEIGRACTQSD--PEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 538 ~~~~d~~---~--~~~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~evl~~L~~i~~~~~~ 592 (621)
...-+.. . +......-.++.+..+..+|+... +.-|||++-.+..|..+..+...
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 1111100 0 011222334466777888888763 67899999999999888765443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1e-09 Score=114.33 Aligned_cols=83 Identities=28% Similarity=0.343 Sum_probs=56.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+|-|||++|.|.. .| .+|..-+++-.|+||+|++. +||...|-+|+-|-+||||+|.|. .+|+.+..|..|
T Consensus 103 ~dLt~lDLShNqL~E-vP----~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~L 175 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLRE-VP----TNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSML 175 (1255)
T ss_pred ccceeeecchhhhhh-cc----hhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhh
Confidence 346677777777753 33 34555556667777777776 677776777777777777777776 567677777777
Q ss_pred CeeeccCccc
Q 045652 125 TELHLESNQF 134 (621)
Q Consensus 125 ~~l~l~~N~l 134 (621)
++|+|++|.|
T Consensus 176 qtL~Ls~NPL 185 (1255)
T KOG0444|consen 176 QTLKLSNNPL 185 (1255)
T ss_pred hhhhcCCChh
Confidence 7777777755
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.2e-09 Score=113.13 Aligned_cols=110 Identities=25% Similarity=0.262 Sum_probs=64.9
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.+..|+|+.|+++. +.. +.|.+|+.|+.|+||+|.+. .|-.+.+.-.++|..|+||+|+++-.-|.+|.-|..|+
T Consensus 270 kme~l~L~~N~l~~-vn~---g~lfgLt~L~~L~lS~NaI~-rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le 344 (873)
T KOG4194|consen 270 KMEHLNLETNRLQA-VNE---GWLFGLTSLEQLDLSYNAIQ-RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLE 344 (873)
T ss_pred ccceeecccchhhh-hhc---ccccccchhhhhccchhhhh-eeecchhhhcccceeEeccccccccCChhHHHHHHHhh
Confidence 46778888887753 222 34556666777777777776 34433355666677777777777654455555566666
Q ss_pred eeeccCccccccCCCC---CCCCccEEEcccCccccccC
Q 045652 126 ELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~ip 161 (621)
+|+|++|.++ .+-.. .+++|+.|||++|.|++.|-
T Consensus 345 ~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 345 ELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred hhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 6666666554 23222 34556666666666655543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.8e-10 Score=111.90 Aligned_cols=113 Identities=25% Similarity=0.410 Sum_probs=60.4
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccc-------------
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG------------- 112 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g------------- 112 (621)
+++.+++.+|.+.. +|+. .-.++.|+.||..+|-+. +||++ ++.|.+|.-|||..|++.-
T Consensus 161 ~l~~l~~~~n~l~~-l~~~----~i~m~~L~~ld~~~N~L~-tlP~~-lg~l~~L~~LyL~~Nki~~lPef~gcs~L~El 233 (565)
T KOG0472|consen 161 KLSKLDLEGNKLKA-LPEN----HIAMKRLKHLDCNSNLLE-TLPPE-LGGLESLELLYLRRNKIRFLPEFPGCSLLKEL 233 (565)
T ss_pred HHHHhhccccchhh-CCHH----HHHHHHHHhcccchhhhh-cCChh-hcchhhhHHHHhhhcccccCCCCCccHHHHHH
Confidence 34556666666543 3321 112445555555555555 55555 5555555555555555541
Q ss_pred --------cCCCCCC-CCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccccc
Q 045652 113 --------RLPPSLF-KLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRF 167 (621)
Q Consensus 113 --------~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~ 167 (621)
.+|.+.. ++++|..|||..|+++ ..|+. ..++|..||||||.++ .+|.+++++
T Consensus 234 h~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl 297 (565)
T KOG0472|consen 234 HVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL 297 (565)
T ss_pred HhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence 3443333 4555556666666665 45543 3456666666666666 456555554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-09 Score=119.52 Aligned_cols=125 Identities=27% Similarity=0.434 Sum_probs=79.0
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
++..|.+.+|.|+...- +-|.+..+|+.|+|++|+|. ++|...+.++..|+.|+||+|+|+ .+|..+.+|..|+
T Consensus 360 ~Lq~LylanN~Ltd~c~----p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCF----PVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH 433 (1081)
T ss_pred HHHHHHHhcCcccccch----hhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence 34455555666554332 34556667777777777776 677776677777777777777777 5777777777777
Q ss_pred eeeccCccccccCCCC-CCCCccEEEcccCccc-cccCccc--cccccCCCCCCCC
Q 045652 126 ELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLE-GEIPASL--LRFNASSFSGNAG 177 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~-g~ip~~~--~~~~~~~~~~n~~ 177 (621)
+|...+|+|. .+|.. ..+.|+.+|||.|+|+ +.+|..+ .++.-..++||.+
T Consensus 434 tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 434 TLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred HHhhcCCcee-echhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 7777777776 56654 4667777777777775 2344332 2344455666654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.73 E-value=7e-09 Score=95.26 Aligned_cols=60 Identities=30% Similarity=0.472 Sum_probs=14.5
Q ss_pred CCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCC-CCCCCcCeeeccCcccc
Q 045652 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSL-FKLPHLTELHLESNQFN 135 (621)
Q Consensus 72 l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~ 135 (621)
|.+|+.|+|++|+++ .|+. +..++.|+.|+|++|.++. ++..+ ..+++|++|+|++|++.
T Consensus 41 l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~ 101 (175)
T PF14580_consen 41 LDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKIS 101 (175)
T ss_dssp -TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---
T ss_pred hcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCC
Confidence 344455555555554 3431 3444555555555555542 32222 23445555555555443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.8e-07 Score=100.35 Aligned_cols=151 Identities=17% Similarity=0.314 Sum_probs=95.2
Q ss_pred hhHHHHHHH-HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhh------------------------------HH----
Q 045652 308 LPDLMKAAA-EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMA------------------------------RD---- 352 (621)
Q Consensus 308 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~---- 352 (621)
++++...+. +.|+.++-|.||+|++++|+.||||+.+..-... .+
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 333333333 5677899999999999999999999876431100 00
Q ss_pred ------HHHHHHHHHhcCC-----CCCcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 045652 353 ------AFDTEVRRLGRLR-----HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGI 421 (621)
Q Consensus 353 ------~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i 421 (621)
++.+|..-+.+++ .+++.-..=|..-.....|+|||++|-.+.+...-.. ..++.+. ++..+
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~---ia~~~ 273 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKE---LAELL 273 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHH---HHHHH
Confidence 2335555555552 3333322222233567889999999988887742111 2233222 23322
Q ss_pred HHH-HHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 422 ARG-IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 422 ~~~-L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
+++ +..+-.. |++|.|..|.||+++.++++.+.|||+...+.+.
T Consensus 274 ~~~f~~q~~~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 274 VRAFLRQLLRD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHHHHhc----CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 222 2222223 8999999999999999999999999998776543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.8e-09 Score=110.75 Aligned_cols=146 Identities=21% Similarity=0.323 Sum_probs=99.5
Q ss_pred HHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc-------------ccccccccCcccc
Q 045652 418 VQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-------------AQALFAYKAPEAI 484 (621)
Q Consensus 418 ~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~~y~aPE~~ 484 (621)
+.+++.||.|+|.. .++||++|.|++|.++..+..||+.|+++........ ......|.|||++
T Consensus 105 l~~v~dgl~flh~s---Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS---AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccC---cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34566999999976 3899999999999999999999999998765544211 1112359999999
Q ss_pred cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhh
Q 045652 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRA 564 (621)
Q Consensus 485 ~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~ 564 (621)
.....+.++|+||+||++|.+..|..+.....+ .............. .........+.++.+=+.+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~---~~~~~~~~~~~~~~-----------~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANG---GLLSYSFSRNLLNA-----------GAFGYSNNLPSELRESLKK 247 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccC---Ccchhhhhhccccc-----------ccccccccCcHHHHHHHHH
Confidence 988889999999999999999954444221111 11111110000000 0011123455678888889
Q ss_pred cccCCCCCCCcHHHHH
Q 045652 565 CTQSDPEQRLEMREAV 580 (621)
Q Consensus 565 cl~~dP~~Rps~~evl 580 (621)
++..++..||++.++.
T Consensus 248 ~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLL 263 (700)
T ss_pred HhcCCcccCcchhhhh
Confidence 9999999999776654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.8e-09 Score=113.79 Aligned_cols=110 Identities=26% Similarity=0.411 Sum_probs=93.7
Q ss_pred eeeEEeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC
Q 045652 37 WSGVVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP 116 (621)
Q Consensus 37 w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~ 116 (621)
|.-..|. .++.-|+|++|+|. .+|. ..+.+|..|+.|+||+|+|+ .||.. +.++..|++|...+|++. .+|
T Consensus 376 ~p~l~~~-~hLKVLhLsyNrL~-~fpa---s~~~kle~LeeL~LSGNkL~-~Lp~t-va~~~~L~tL~ahsN~l~-~fP- 446 (1081)
T KOG0618|consen 376 FPVLVNF-KHLKVLHLSYNRLN-SFPA---SKLRKLEELEELNLSGNKLT-TLPDT-VANLGRLHTLRAHSNQLL-SFP- 446 (1081)
T ss_pred hhhhccc-cceeeeeecccccc-cCCH---HHHhchHHhHHHhcccchhh-hhhHH-HHhhhhhHHHhhcCCcee-ech-
Confidence 5544443 36788999999987 4776 56777889999999999999 89977 889999999999999998 688
Q ss_pred CCCCCCCcCeeeccCcccc-ccCCCCCC-CCccEEEcccCc
Q 045652 117 SLFKLPHLTELHLESNQFN-GTIPSFDQ-PTLVRLNLSSNK 155 (621)
Q Consensus 117 ~~~~l~~L~~l~l~~N~l~-g~~p~~~~-~~L~~l~l~~N~ 155 (621)
++..++.|+.+||+.|+|+ +.+|.... ++|++|||++|.
T Consensus 447 e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 447 ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 8999999999999999997 45565544 999999999997
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.6e-07 Score=87.52 Aligned_cols=107 Identities=30% Similarity=0.457 Sum_probs=83.1
Q ss_pred HHHHHHHHHHHhcCCCC--CcccceEEEEeCC----eeEEEEeecCCC-ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 045652 351 RDAFDTEVRRLGRLRHS--NVLAPLAYHYRTD----EKLLVYEYIPGG-SLLYLLHGDRGPSHDELTWPARLKIVQGIAR 423 (621)
Q Consensus 351 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 423 (621)
.....+|...+.+|... .+.+.+++.+... ..++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 34567888888888533 3555666665532 357999999874 7999886422 2455667789999999
Q ss_pred HHHHHHhccCCCCCccCCCCCCCEEeCCCC---CcEEEeeecceec
Q 045652 424 GIGYLHTELAHLDLPHGNLKSSNIFISPEN---EPLISEFGFYTMI 466 (621)
Q Consensus 424 ~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~ 466 (621)
.++-||+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 999999999999999887 7999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.4e-09 Score=102.23 Aligned_cols=125 Identities=28% Similarity=0.430 Sum_probs=82.1
Q ss_pred cEEEEEecCCCCeeeeCcc--------------------cccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeC
Q 045652 46 IVTGLYINSMGLSGKIDVD--------------------ALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWF 105 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~--------------------~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l 105 (621)
.|+.++++.|++.. +|.. ....+..+++|..|+|++|-+. .||.+ ++.+..|+.|||
T Consensus 389 ~Vt~VnfskNqL~e-lPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e-~~~lv~Lq~Lnl 465 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCE-LPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEE-MGSLVRLQTLNL 465 (565)
T ss_pred ceEEEecccchHhh-hhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchh-hhhhhhhheecc
Confidence 49999999998753 4420 0023344556666677777666 56766 566666777777
Q ss_pred ccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCCccEEEcccCccccccCcccccccc---CCCCCCC
Q 045652 106 SNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASLLRFNA---SSFSGNA 176 (621)
Q Consensus 106 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n~ 176 (621)
|.|.|. .+|..+-.+..|+.+-.++|++. .+|.. .+.+|..|||.+|.+. .||+.++++.. ..+.|||
T Consensus 466 S~NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 466 SFNRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred cccccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCc
Confidence 777665 56666655656666555556664 44432 5678999999999998 89988877653 4566775
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.9e-08 Score=72.39 Aligned_cols=59 Identities=37% Similarity=0.502 Sum_probs=51.2
Q ss_pred CCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCcc
Q 045652 98 GALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKL 156 (621)
Q Consensus 98 ~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l 156 (621)
++|+.|+|++|+|+...+..|.++++|++|+|++|+++...|.. .+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999666678899999999999999998554543 689999999999986
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.5e-07 Score=105.35 Aligned_cols=18 Identities=33% Similarity=0.599 Sum_probs=11.9
Q ss_pred CCccEEEcccCccccccCc
Q 045652 144 PTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 144 ~~L~~l~l~~N~l~g~ip~ 162 (621)
.+|+.|+|++|+|++ +|.
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~ 359 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPT 359 (788)
T ss_pred cccceEecCCCccCC-CCC
Confidence 367777777777773 554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.6e-06 Score=81.47 Aligned_cols=137 Identities=18% Similarity=0.180 Sum_probs=100.2
Q ss_pred CcCCcccEEEEEEcCCcEEEEEEccCC-----C-hhhHHHHHHHHHHHhcCCCC--CcccceEEEE-eC----CeeEEEE
Q 045652 320 GNGGLGSSYKAMMADGVTVVVKRMKES-----S-AMARDAFDTEVRRLGRLRHS--NVLAPLAYHY-RT----DEKLLVY 386 (621)
Q Consensus 320 g~G~~g~Vy~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv~ 386 (621)
|+||.+.|++.... |..+-+|+-... . +.....|.+|+..|.+|... .+.+.. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888899997764 447888876411 1 33567899999999999533 344444 332 11 1257999
Q ss_pred eecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC--cEEEeeecc
Q 045652 387 EYIPG-GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE--PLISEFGFY 463 (621)
Q Consensus 387 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a 463 (621)
|-+.+ -+|.+++.... ..+.+...+..++.+++..+.-||+. |+.|+|+-+.||+++.++. ++++||.-+
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 98753 58888875332 23456677789999999999999999 9999999999999986676 999999865
Q ss_pred ee
Q 045652 464 TM 465 (621)
Q Consensus 464 ~~ 465 (621)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 43
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.4e-07 Score=104.24 Aligned_cols=80 Identities=25% Similarity=0.445 Sum_probs=51.9
Q ss_pred CCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCCCCCccEEEccc
Q 045652 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSS 153 (621)
Q Consensus 74 ~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~ 153 (621)
+|+.|+|++|+|+ .||.. + ..+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|....++|+.|+|++
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~-l--~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL~~L~Ls~ 292 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPAT-L--PDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEELRYLSVYD 292 (754)
T ss_pred CCCEEECCCCccc-cCChh-h--hccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCCcEEECCC
Confidence 5677777777776 56654 2 235667777777766 5665553 46777777777776 46655445777777777
Q ss_pred CccccccCc
Q 045652 154 NKLEGEIPA 162 (621)
Q Consensus 154 N~l~g~ip~ 162 (621)
|+|+ .+|.
T Consensus 293 N~Lt-~LP~ 300 (754)
T PRK15370 293 NSIR-TLPA 300 (754)
T ss_pred Cccc-cCcc
Confidence 7777 3454
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.6e-08 Score=100.58 Aligned_cols=107 Identities=28% Similarity=0.397 Sum_probs=71.8
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
|+++.|+|.+|-++. +.. .+|..|..|+.||||.|.++ +||...|..-.++++|+|++|.++..=-..|.++.+|
T Consensus 125 ghl~~L~L~~N~I~s-v~s---e~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL 199 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISS-VTS---EELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSL 199 (873)
T ss_pred cceeEEeeecccccc-ccH---HHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchh
Confidence 345556665554432 222 23455567777888888887 6776666666677788888888775555667777778
Q ss_pred CeeeccCccccccCCCC---CCCCccEEEcccCccc
Q 045652 125 TELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLE 157 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~ 157 (621)
..|.|++|+++ ++|.. .++.|+.|+|..|++.
T Consensus 200 ~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~ir 234 (873)
T KOG4194|consen 200 LTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIR 234 (873)
T ss_pred eeeecccCccc-ccCHHHhhhcchhhhhhcccccee
Confidence 88888888877 66642 3677777777777764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.9e-07 Score=102.20 Aligned_cols=75 Identities=28% Similarity=0.384 Sum_probs=38.5
Q ss_pred CCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcc
Q 045652 73 RGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLS 152 (621)
Q Consensus 73 ~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~ 152 (621)
++|++|+|++|+|+ .||.. .++|+.|+|++|.|+ .+|..+ .+|+.|+|++|+|+ .+|. ..++|+.|+|+
T Consensus 242 ~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~-~p~~L~~LdLS 310 (788)
T PRK15387 242 PELRTLEVSGNQLT-SLPVL----PPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPV-LPPGLQELSVS 310 (788)
T ss_pred CCCcEEEecCCccC-cccCc----ccccceeeccCCchh-hhhhch---hhcCEEECcCCccc-cccc-cccccceeECC
Confidence 45666666666666 45532 234555555555554 233311 23445555555554 3333 23456666666
Q ss_pred cCcccc
Q 045652 153 SNKLEG 158 (621)
Q Consensus 153 ~N~l~g 158 (621)
+|+|++
T Consensus 311 ~N~L~~ 316 (788)
T PRK15387 311 DNQLAS 316 (788)
T ss_pred CCcccc
Confidence 666663
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.7e-06 Score=81.65 Aligned_cols=139 Identities=17% Similarity=0.253 Sum_probs=86.0
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCC--cccceEEEEeCCeeEEEEeecCCCC-
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN--VLAPLAYHYRTDEKLLVYEYIPGGS- 393 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 393 (621)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 25567788876533 2345688999999986433 4667777777777889999998863
Q ss_pred hhHH---------------------hhcCCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhccCCCCCccC
Q 045652 394 LLYL---------------------LHGDRGPSHDELTWPARLK-IVQ----------GIAR-GIGYLHTELAHLDLPHG 440 (621)
Q Consensus 394 L~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~i~~-~L~~LH~~~~~~~ivH~ 440 (621)
+... +|.-. ........... +.. .+.. ...+|........++|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~---~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK---CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC---CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 2111 12110 00111111110 100 0111 12233322223357899
Q ss_pred CCCCCCEEeCCCCCcEEEeeecce
Q 045652 441 NLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 441 Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|+.|.||++++++ +.++||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.1e-06 Score=79.82 Aligned_cols=138 Identities=24% Similarity=0.318 Sum_probs=94.6
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCChhhH-------------------H-----HHHHHHHHHhcCC--CCCccc
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMAR-------------------D-----AFDTEVRRLGRLR--HSNVLA 371 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~-----~~~~E~~~l~~l~--h~niv~ 371 (621)
.|.+|.-+.||+|...++..+|||+.+......+ . -..+|..-|+++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4778888999999988899999999864321110 0 1236777777774 334445
Q ss_pred ceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeC
Q 045652 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFIS 450 (621)
Q Consensus 372 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~ 450 (621)
.+++. +..|||||+..... .....+.-.+...+...+..++++.+.-|-. . ++||+||..-|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a----~LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA----GLVHGDLSEYNILVH 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc----CcccccchhhheEEE
Confidence 55443 35799999954311 0111112223333567778888888887776 4 899999999999999
Q ss_pred CCCCcEEEeeecceecccc
Q 045652 451 PENEPLISEFGFYTMINSA 469 (621)
Q Consensus 451 ~~~~~kl~DfG~a~~~~~~ 469 (621)
++.+.|+|||.|....++
T Consensus 202 -~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 -DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -CCeEEEEECccccccCCC
Confidence 889999999988776543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.9e-07 Score=85.88 Aligned_cols=99 Identities=27% Similarity=0.376 Sum_probs=48.1
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccC-CCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRL-PPSLFKLPH 123 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~-p~~~~~l~~ 123 (621)
..+..|+|++|+++. | ..+..|+.|+.|+|++|+++ .|++.....+++|+.|+|++|++...- =..+..+++
T Consensus 42 ~~L~~L~Ls~N~I~~-l-----~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~ 114 (175)
T PF14580_consen 42 DKLEVLDLSNNQITK-L-----EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPK 114 (175)
T ss_dssp TT--EEE-TTS--S--------TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT
T ss_pred cCCCEEECCCCCCcc-c-----cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCC
Confidence 468899999999873 3 35777899999999999999 687652346999999999999997421 134677899
Q ss_pred cCeeeccCccccccCCCC------CCCCccEEEc
Q 045652 124 LTELHLESNQFNGTIPSF------DQPTLVRLNL 151 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~------~~~~L~~l~l 151 (621)
|++|+|.+|.++. .+.. ..|+|+.||-
T Consensus 115 L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 115 LRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TT-GGGG-STTHHHHHHHH-TT-SEETT
T ss_pred cceeeccCCcccc-hhhHHHHHHHHcChhheeCC
Confidence 9999999999873 3442 4578887764
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.2e-07 Score=62.34 Aligned_cols=37 Identities=49% Similarity=0.990 Sum_probs=28.3
Q ss_pred cHHHHHHHHHHcCCC-C-CCCCCCCCC--CCCCCCCCCceeeEEeC
Q 045652 2 SESEALLKLKSSFTN-A-KALDSWMPS--TAPCRGGEEEWSGVVCL 43 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~-~-~~l~~w~~~--~~~c~~~~~~w~gv~c~ 43 (621)
+|++||++||+++.. + +.+.+|+.+ ++||+ |.||+|+
T Consensus 3 ~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~-----W~GV~Cd 43 (43)
T PF08263_consen 3 QDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCS-----WSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCC-----STTEEE-
T ss_pred HHHHHHHHHHHhcccccCcccccCCCcCCCCCee-----eccEEeC
Confidence 589999999999995 4 579999976 78996 9999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.5e-06 Score=88.74 Aligned_cols=152 Identities=16% Similarity=0.254 Sum_probs=93.2
Q ss_pred hhHHHHHHH-HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhh-------------------------------HH---
Q 045652 308 LPDLMKAAA-EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMA-------------------------------RD--- 352 (621)
Q Consensus 308 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~--- 352 (621)
++++...+. +.||.-+.|.||+|+.++|+.||||+-+..-... .+
T Consensus 157 ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 157 IEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 444444443 6788999999999999999999999876431110 01
Q ss_pred ---HHHHHHHHHhcC----CCCCc---ccceEEEEe-CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 045652 353 ---AFDTEVRRLGRL----RHSNV---LAPLAYHYR-TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGI 421 (621)
Q Consensus 353 ---~~~~E~~~l~~l----~h~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i 421 (621)
+|.+|++-..++ .|-+. |.+=.++++ .....|+||||+|.-+.+.-.- ....++...+..-+.+.
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i----~~~gi~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI----DKRGISPHDILNKLVEA 312 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH----HHcCCCHHHHHHHHHHH
Confidence 133444433333 34441 112223333 3567899999999877654321 12235544433333333
Q ss_pred HHHHHHHHhccCCCCCccCCCCCCCEEeCC----CCCcEEEeeecceecccc
Q 045652 422 ARGIGYLHTELAHLDLPHGNLKSSNIFISP----ENEPLISEFGFYTMINSA 469 (621)
Q Consensus 422 ~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfG~a~~~~~~ 469 (621)
..-+-+-| |++|+|-.|.||++.. ++.+.+-|||+...+.+.
T Consensus 313 ~~~qIf~~------GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 313 YLEQIFKT------GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHhc------CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22222222 8999999999999994 668999999998776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=6.2e-06 Score=77.84 Aligned_cols=113 Identities=19% Similarity=0.282 Sum_probs=74.0
Q ss_pred CCcEEEEEEccCCChhhHHH---------HHHHHHHHhcCCCCC---cccceEEEEe-----CCeeEEEEeecCCCChhH
Q 045652 334 DGVTVVVKRMKESSAMARDA---------FDTEVRRLGRLRHSN---VLAPLAYHYR-----TDEKLLVYEYIPGGSLLY 396 (621)
Q Consensus 334 ~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~n---iv~l~~~~~~-----~~~~~lv~e~~~~gsL~~ 396 (621)
+|+.+++|..+.......+. ..+++..+.+++... .+.++.+... ....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 57888999887544322222 234455455554332 2332333222 233568999999988865
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 397 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
+.. ++. .++..+..++.-||+. |+.|+|..|.|++++++ .++++||+..+
T Consensus 133 ~~~---------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED---------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred chh---------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 532 222 3456777889999999 99999999999999955 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-07 Score=93.38 Aligned_cols=129 Identities=26% Similarity=0.330 Sum_probs=68.0
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeC-ccCcccccCCCCCCCCCCc
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWF-SNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l-~~N~l~g~~p~~~~~l~~L 124 (621)
..+.|+|..|+++- ||. ..+..|++|+.||||+|+++ .|-+..|..+.+|..|-| ++|+|+...-..|++|.+|
T Consensus 68 ~tveirLdqN~I~~-iP~---~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~sl 142 (498)
T KOG4237|consen 68 ETVEIRLDQNQISS-IPP---GAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSL 142 (498)
T ss_pred cceEEEeccCCccc-CCh---hhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHH
Confidence 35556666666653 554 33445556666666666666 455455666666555433 3366663222345566666
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCc-cc---cccccCCCCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPA-SL---LRFNASSFSGNAGLCG 180 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~-~~---~~~~~~~~~~n~~~c~ 180 (621)
+.|.|.-|++.-...+. .+++|..|.+-+|.+. .|+. .+ ..........|++.|.
T Consensus 143 qrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icd 203 (498)
T KOG4237|consen 143 QRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICD 203 (498)
T ss_pred HHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccc
Confidence 66666666665322221 4566666666666665 4443 22 2223334455665554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.20 E-value=9.2e-08 Score=99.38 Aligned_cols=123 Identities=24% Similarity=0.344 Sum_probs=86.0
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+|-++|+.|+++- +|. .+..| -|+.|-+++|+++ .+|.+ ++.+..|..||.+.|.+. .+|..++.+.+|
T Consensus 121 ~~lt~l~ls~NqlS~-lp~----~lC~l-pLkvli~sNNkl~-~lp~~-ig~~~tl~~ld~s~nei~-slpsql~~l~sl 191 (722)
T KOG0532|consen 121 EALTFLDLSSNQLSH-LPD----GLCDL-PLKVLIVSNNKLT-SLPEE-IGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSL 191 (722)
T ss_pred hHHHHhhhccchhhc-CCh----hhhcC-cceeEEEecCccc-cCCcc-cccchhHHHhhhhhhhhh-hchHHhhhHHHH
Confidence 456667777777763 442 22222 3778888888887 68877 667778888888888887 678888888888
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCccccccCccccccc---cCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGNAG 177 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~ 177 (621)
+.|++..|++....+....-.|..||+|.|+++ .||-++.++. ...++.||.
T Consensus 192 r~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 192 RDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred HHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence 888888888773333334456888999999998 8898776554 345566653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=72.32 Aligned_cols=130 Identities=22% Similarity=0.262 Sum_probs=88.5
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCccc-ceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA-PLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g 392 (621)
...+.|++|.+|.||++.+. |..+|+|+-+..+ .+..++.|+++|..+.-.++.+ ++.|. ...+.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 45688999999999999984 5588899876443 3678999999999998766654 33332 233559999998
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCC-CCCEEeCCCCCcEEEeeecceec
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLK-SSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DfG~a~~~ 466 (621)
.|.+.-.. .+-.++ ..++.. +|.-+. .||-|+.|. |..+++..+..+.|+||..|+.-
T Consensus 98 ~L~~~~~~--------~~rk~l----~~vlE~-a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG--------GDRKHL----LRVLEK-AYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc--------ccHHHH----HHHHHH-HHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 88766531 122222 333333 333322 288888886 55555555668999999988743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.1e-07 Score=95.56 Aligned_cols=181 Identities=17% Similarity=0.092 Sum_probs=130.4
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCC-cccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN-VLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+..-.++|+++++|+.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 344667899999999987333333345554322 34457899999999999 777777666677788999999876
Q ss_pred -ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 393 -SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 393 -sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
+-..... .....+...+...+...-.++|+|+|+. .=+|+| ||+..+ +..+..||+....+...
T Consensus 320 rs~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 320 RSSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred ccccccCC----hhhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCcccc
Confidence 2221110 1122344445556777788899999986 346998 777664 67899999988776543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPS 512 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 512 (621)
....++..++|||+.....+..+.|+|+.|+--.+|.-|..|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4556778899999999999999999999998777777776663
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.2e-06 Score=99.76 Aligned_cols=123 Identities=24% Similarity=0.232 Sum_probs=75.0
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+|+++.+. .++. .+..|++|+.|+|++|..-+.+|. ++.+++|+.|+|++|.....+|.++.++++|+
T Consensus 612 ~L~~L~L~~s~l~-~L~~----~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~ 684 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWD----GVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLE 684 (1153)
T ss_pred CCcEEECcCcccc-cccc----ccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCC
Confidence 4555666665554 2331 234566777777776654446663 56677777777777666667777777777777
Q ss_pred eeeccCccccccCCCC-CCCCccEEEcccCccccccCccccccccCCCCCC
Q 045652 126 ELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGN 175 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n 175 (621)
.|+|++|..-+.+|.. .+++|+.|+|++|...+.+|....++....+.+|
T Consensus 685 ~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n 735 (1153)
T PLN03210 685 DLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET 735 (1153)
T ss_pred EEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence 7777776444566654 5667777777777665566644333333333333
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.7e-07 Score=91.56 Aligned_cols=113 Identities=24% Similarity=0.236 Sum_probs=74.2
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCC-CCCCEEecCCCcccccCCcc---cccCCCCCCEEeCccCcccc----cCCCC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGL-RGLRAIYLDKNQFSGEIPPG---YFDEMGALRKLWFSNNKFRG----RLPPS 117 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l-~~L~~l~l~~N~l~g~ip~~---~~~~l~~L~~l~l~~N~l~g----~~p~~ 117 (621)
.+..|+++++.+++.-.......+..+ .+|+.|+|++|.+++..+.. .+..+++|+.|+|++|.+++ .++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 388888888887631111011234455 78888888888888432211 25566788888888888874 24444
Q ss_pred CCCCCCcCeeeccCccccccCCC------CCCCCccEEEcccCcccc
Q 045652 118 LFKLPHLTELHLESNQFNGTIPS------FDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 118 ~~~l~~L~~l~l~~N~l~g~~p~------~~~~~L~~l~l~~N~l~g 158 (621)
+..+++|++|+|++|.+++.-.. ...++|+.|++++|.+++
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 55667888888888887643221 135788888888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.1e-06 Score=98.60 Aligned_cols=118 Identities=21% Similarity=0.304 Sum_probs=95.7
Q ss_pred eeeEEeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC
Q 045652 37 WSGVVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP 116 (621)
Q Consensus 37 w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~ 116 (621)
|.|+.+ ...+..|+|+++...+.+| .+..+++|+.|+|++|..-..+|.. ++++++|+.|+|++|..-+.+|.
T Consensus 627 ~~~~~~-l~~Lk~L~Ls~~~~l~~ip-----~ls~l~~Le~L~L~~c~~L~~lp~s-i~~L~~L~~L~L~~c~~L~~Lp~ 699 (1153)
T PLN03210 627 WDGVHS-LTGLRNIDLRGSKNLKEIP-----DLSMATNLETLKLSDCSSLVELPSS-IQYLNKLEDLDMSRCENLEILPT 699 (1153)
T ss_pred cccccc-CCCCCEEECCCCCCcCcCC-----ccccCCcccEEEecCCCCccccchh-hhccCCCCEEeCCCCCCcCccCC
Confidence 666633 3468889998876555565 4677899999999998776799987 89999999999999776668998
Q ss_pred CCCCCCCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCccc
Q 045652 117 SLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164 (621)
Q Consensus 117 ~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~ 164 (621)
.+ ++++|+.|+|++|...+.+|.. ..+|+.|+|++|.++ .+|..+
T Consensus 700 ~i-~l~sL~~L~Lsgc~~L~~~p~~-~~nL~~L~L~~n~i~-~lP~~~ 744 (1153)
T PLN03210 700 GI-NLKSLYRLNLSGCSRLKSFPDI-STNISWLDLDETAIE-EFPSNL 744 (1153)
T ss_pred cC-CCCCCCEEeCCCCCCccccccc-cCCcCeeecCCCccc-cccccc
Confidence 76 8999999999999776777754 468999999999987 678643
|
syringae 6; Provisional |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.5e-05 Score=77.05 Aligned_cols=75 Identities=17% Similarity=0.192 Sum_probs=52.7
Q ss_pred cCcCCc-ccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCCCChhH
Q 045652 319 LGNGGL-GSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396 (621)
Q Consensus 319 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 396 (621)
|-.|.. ..||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344444 788998764 4688888876433 335678999988884 4445567777766666889999999987764
Q ss_pred H
Q 045652 397 L 397 (621)
Q Consensus 397 ~ 397 (621)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.4e-05 Score=76.37 Aligned_cols=144 Identities=23% Similarity=0.229 Sum_probs=84.9
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCC--CcccceEEEEe---CCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHS--NVLAPLAYHYR---TDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~ 391 (621)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 457889999999999876 59999987654 4566788999999888533 35566664433 3346899999999
Q ss_pred CChhH----------------Hh---hcCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 045652 392 GSLLY----------------LL---HGDRGPSHDELTWPA---------RLKI------------VQGIAR-GIGYLHT 430 (621)
Q Consensus 392 gsL~~----------------~l---~~~~~~~~~~l~~~~---------~~~i------------~~~i~~-~L~~LH~ 430 (621)
..+.. .+ +... .......+.. .... ...+.. .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 87776 11 1110 0111111111 0000 112222 3444443
Q ss_pred cc---CCCCCccCCCCCCCEEeC-CCCCcEEEeeecce
Q 045652 431 EL---AHLDLPHGNLKSSNIFIS-PENEPLISEFGFYT 464 (621)
Q Consensus 431 ~~---~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~ 464 (621)
.. ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 234689999999999999 55555799998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.1e-07 Score=101.34 Aligned_cols=108 Identities=27% Similarity=0.328 Sum_probs=81.9
Q ss_pred ccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC-CCCCCCCcCeeeccCccccccCCCCCCCCc
Q 045652 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP-SLFKLPHLTELHLESNQFNGTIPSFDQPTL 146 (621)
Q Consensus 68 ~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L 146 (621)
.|..|..|+.|+|++|+|+ ..- .+..|+.|.+|||++|.|+ .+|. ....+. |+.|+|.||.++...--..+++|
T Consensus 182 SLqll~ale~LnLshNk~~-~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL~gie~LksL 256 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFT-KVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTLRGIENLKSL 256 (1096)
T ss_pred HHHHHHHhhhhccchhhhh-hhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhhhhHHhhhhh
Confidence 4556778999999999998 444 3778999999999999998 5665 344555 99999999999843333478899
Q ss_pred cEEEcccCccccc---cC-ccccccccCCCCCCCCCCC
Q 045652 147 VRLNLSSNKLEGE---IP-ASLLRFNASSFSGNAGLCG 180 (621)
Q Consensus 147 ~~l~l~~N~l~g~---ip-~~~~~~~~~~~~~n~~~c~ 180 (621)
+-|||++|-|++- .| -.+..+....+.|||-.|.
T Consensus 257 ~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 257 YGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9999999999862 12 1234555677899987774
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.4e-07 Score=85.31 Aligned_cols=80 Identities=29% Similarity=0.400 Sum_probs=40.1
Q ss_pred CCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC-CCCCccEEEc
Q 045652 73 RGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF-DQPTLVRLNL 151 (621)
Q Consensus 73 ~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~L~~l~l 151 (621)
+.++.|+||+|.+. .+-. +..|++|+.||||+|.|+ .+-.+=..|-++++|.|+.|.+. .+... .+-+|..||+
T Consensus 307 Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~LSGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TLSGLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEecccccee-eehh--hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hhhhhHhhhhheeccc
Confidence 45555555555555 3321 344555555555555554 23222234445555555555543 22222 2345666777
Q ss_pred ccCccc
Q 045652 152 SSNKLE 157 (621)
Q Consensus 152 ~~N~l~ 157 (621)
++|++.
T Consensus 382 ~~N~Ie 387 (490)
T KOG1259|consen 382 SSNQIE 387 (490)
T ss_pred cccchh
Confidence 777665
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.6e-05 Score=74.59 Aligned_cols=105 Identities=15% Similarity=0.132 Sum_probs=81.3
Q ss_pred HHHHHHHhcCCC-CCcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccC
Q 045652 355 DTEVRRLGRLRH-SNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433 (621)
Q Consensus 355 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 433 (621)
..|.-+++.+.+ +++.+++|+| ..++|.||...+++...-..- ......+|..+.+|+.++++.+.+++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888888876 6999999999 346899999877664220000 011246899999999999999999998644
Q ss_pred CCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 434 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
.. +.-.|++|+|+-+++++++|++|...+...
T Consensus 81 ~~-~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GF-FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred Cc-EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 43 777999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.2e-05 Score=87.95 Aligned_cols=149 Identities=15% Similarity=0.280 Sum_probs=91.2
Q ss_pred HHcCcCCcccEEEEEEcCC---cEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCCc--ccceEEEEeC---CeeEEEE
Q 045652 317 EVLGNGGLGSSYKAMMADG---VTVVVKRMKESS-AMARDAFDTEVRRLGRLR-HSNV--LAPLAYHYRT---DEKLLVY 386 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~ 386 (621)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4578899999999876553 467777764322 122456889999999995 6665 7777777654 4578999
Q ss_pred eecCCCChhH-----------------------HhhcCCCCC------CCCCCH--HHHHHHH---------------HH
Q 045652 387 EYIPGGSLLY-----------------------LLHGDRGPS------HDELTW--PARLKIV---------------QG 420 (621)
Q Consensus 387 e~~~~gsL~~-----------------------~l~~~~~~~------~~~l~~--~~~~~i~---------------~~ 420 (621)
||++|..+.+ .||.-.... .....+ .++..+. -.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9998764321 112111000 000011 1111111 11
Q ss_pred HHHHHHHHHhccCC-------CCCccCCCCCCCEEeCCC-CC-cEEEeeeccee
Q 045652 421 IARGIGYLHTELAH-------LDLPHGNLKSSNIFISPE-NE-PLISEFGFYTM 465 (621)
Q Consensus 421 i~~~L~~LH~~~~~-------~~ivH~Dlkp~NIll~~~-~~-~kl~DfG~a~~ 465 (621)
+...+.+|..+.+. ..+||+|+++.||+++.+ .. .-|.||+++..
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 33446677654432 359999999999999853 33 46999998754
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.4e-06 Score=57.36 Aligned_cols=36 Identities=31% Similarity=0.558 Sum_probs=22.6
Q ss_pred CCCEEecCCCcccccCCcccccCCCCCCEEeCccCccc
Q 045652 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFR 111 (621)
Q Consensus 74 ~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~ 111 (621)
+|++|+|++|+|+ .||++ +.+|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~-l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPE-LSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGH-GTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCch-HhCCCCCCEEEecCCCCC
Confidence 4666667777776 56664 566666666666666666
|
... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.5e-06 Score=89.48 Aligned_cols=114 Identities=24% Similarity=0.289 Sum_probs=83.6
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccc----cCCcccccCC-CCCCEEeCccCccccc----C
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSG----EIPPGYFDEM-GALRKLWFSNNKFRGR----L 114 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g----~ip~~~~~~l-~~L~~l~l~~N~l~g~----~ 114 (621)
...++.|+|+++.+.+..+. .+..+..-++|++|+|++|.+++ .+... +..+ ++|+.|+|++|.+++. +
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~-l~~~~~~L~~L~L~~n~l~~~~~~~~ 157 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKG-LKDLPPALEKLVLGRNRLEGASCEAL 157 (319)
T ss_pred cCceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHH-HHhCCCCceEEEcCCCcCCchHHHHH
Confidence 35899999999999764432 22222221569999999999983 23332 5566 8999999999999953 3
Q ss_pred CCCCCCCCCcCeeeccCcccccc----CCC--CCCCCccEEEcccCccccc
Q 045652 115 PPSLFKLPHLTELHLESNQFNGT----IPS--FDQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 115 p~~~~~l~~L~~l~l~~N~l~g~----~p~--~~~~~L~~l~l~~N~l~g~ 159 (621)
+..+..+.+|++|+|++|.+++. ++. ...++|+.|+|++|.+++.
T Consensus 158 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 158 AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 44566788999999999999853 221 1347999999999999754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.91 E-value=5.6e-06 Score=57.29 Aligned_cols=37 Identities=41% Similarity=0.636 Sum_probs=31.0
Q ss_pred CCCCEEeCccCcccccCCCCCCCCCCcCeeeccCcccc
Q 045652 98 GALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFN 135 (621)
Q Consensus 98 ~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 135 (621)
++|++|+|++|+|+ .+|+.+++|++|++|+|++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 47899999999999 58878999999999999999887
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.6e-06 Score=87.43 Aligned_cols=129 Identities=30% Similarity=0.447 Sum_probs=91.2
Q ss_pred eeeEEeCCCcEE---EEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCC-CCCEEeCccCcccc
Q 045652 37 WSGVVCLKGIVT---GLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMG-ALRKLWFSNNKFRG 112 (621)
Q Consensus 37 w~gv~c~~~~v~---~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~-~L~~l~l~~N~l~g 112 (621)
+.+..+....+. .+++..+.+...+ ..+..++.++.|++.+|.++ .||+. .+.+. +|+.|++++|++.
T Consensus 82 ~l~~~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~~l~~L~l~~n~i~-~i~~~-~~~~~~nL~~L~l~~N~i~- 153 (394)
T COG4886 82 SLDGSENLLNLLPLPSLDLNLNRLRSNI-----SELLELTNLTSLDLDNNNIT-DIPPL-IGLLKSNLKELDLSDNKIE- 153 (394)
T ss_pred cccccccccCCCCCceeeccccccccCc-----hhhhcccceeEEecCCcccc-cCccc-cccchhhcccccccccchh-
Confidence 344444333333 3555555543322 34455577889999999999 78886 66664 8999999999988
Q ss_pred cCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccc--cc-cccCCCCCC
Q 045652 113 RLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASL--LR-FNASSFSGN 175 (621)
Q Consensus 113 ~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~--~~-~~~~~~~~n 175 (621)
.+|..+..++.|+.|++++|+++ .+|.. ..+.|+.|++++|+++ .||... .. +......+|
T Consensus 154 ~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N 219 (394)
T COG4886 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219 (394)
T ss_pred hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence 67788889999999999999998 55554 6788999999999998 788752 22 444455555
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=4.5e-06 Score=83.44 Aligned_cols=91 Identities=26% Similarity=0.339 Sum_probs=41.7
Q ss_pred cCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCC--C-CCCCccEEEcccCccccccCccc
Q 045652 88 EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS--F-DQPTLVRLNLSSNKLEGEIPASL 164 (621)
Q Consensus 88 ~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~-~~~~L~~l~l~~N~l~g~ip~~~ 164 (621)
..|...|..|++|+.|+|++|++++.-+.+|..+.+|+.|.|..|+|. .+-. + .+..|+.|+|.+|+++-.-|..+
T Consensus 264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF 342 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAF 342 (498)
T ss_pred cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccc
Confidence 444444455555555555555555544445555555555555555543 1211 1 23445555555555553334332
Q ss_pred c---ccccCCCCCCCCCC
Q 045652 165 L---RFNASSFSGNAGLC 179 (621)
Q Consensus 165 ~---~~~~~~~~~n~~~c 179 (621)
. .+....+.+||+.|
T Consensus 343 ~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 343 QTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred cccceeeeeehccCcccC
Confidence 2 22233344555555
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00025 Score=66.94 Aligned_cols=127 Identities=19% Similarity=0.209 Sum_probs=88.9
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCC----------------hhhHHHHHHHHHHHhcCC------CCCcccceE
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESS----------------AMARDAFDTEVRRLGRLR------HSNVLAPLA 374 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~~ 374 (621)
..||+|+.=.||. +++.....||+.+... ....++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4689999988885 3456667788886544 122455667777666665 889999999
Q ss_pred EEEeCCeeEEEEeecCC------CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 375 YHYRTDEKLLVYEYIPG------GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 375 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
+.+++....+|+|.+.+ .+|.+++.. ..++. .. ...+-+-..||-+. .|+.+|++|.||+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~---~~~L~~f~~~l~~~----~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-EL---RQALDEFKRYLLDH----HIVIRDLNPHNIV 150 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-HH---HHHHHHHHHHHHHc----CCeecCCCcccEE
Confidence 99999888999988643 357777753 23444 32 33333445666666 8999999999999
Q ss_pred eCCCC----CcEEEe
Q 045652 449 ISPEN----EPLISE 459 (621)
Q Consensus 449 l~~~~----~~kl~D 459 (621)
+.... .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 97433 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 621 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-36 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-09 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-09 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 9e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 3e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-04 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-64
Identities = 94/302 (31%), Positives = 147/302 (48%), Gaps = 33/302 (10%)
Query: 301 GQKGVFGLPDLMKA-----AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDA-F 354
GQ F L +L A +LG GG G YK +ADG V VKR+KE + F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 355 DTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPAR 414
TEV + H N+L + E+LLVY Y+ GS+ L R S L WP R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKR 133
Query: 415 LKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA 474
+I G ARG+ YLH + + H ++K++NI + E E ++ +FG LA+
Sbjct: 134 QRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFG---------LAKL 183
Query: 475 L--------------FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQY-LTNGN 519
+ + APE + +GK + K DV+ G+++LE++TG+ +
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 520 GGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
+ +++WV E ++ L+D ++ + E+EQL+++ CTQS P +R +M E
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYK-DEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 580 VR 581
VR
Sbjct: 303 VR 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 6e-58
Identities = 79/328 (24%), Positives = 144/328 (43%), Gaps = 32/328 (9%)
Query: 279 SSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKA-----AAEVLGNGGLGSSYKAMMA 333
S+ + + N + LV + L DL +A ++G+G G YK ++
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 334 DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393
DG V +KR S+ + F+TE+ L RH ++++ + + +E +L+Y+Y+ G+
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPE 452
L L+G ++W RL+I G ARG+ YLHT + H D +KS NI +
Sbjct: 122 LKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD-----VKSINILLDEN 175
Query: 453 NEPLISEFGFYTMINSANLAQAL------------FAYKAPEAIQSGKVTPKCDVYCLGI 500
P I++FG + L Y PE G++T K DVY G+
Sbjct: 176 FVPKITDFGI------SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 501 IILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLE 560
++ E+L + + +++ EW + + G++ ++DP +A P + + +
Sbjct: 230 VLFEVLCARSAIVQ-SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR-PESLRKFGD 287
Query: 561 IGRACTQSDPEQRLEMREAVRRIVEIQQ 588
C E R M + + ++ +
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-53
Identities = 85/332 (25%), Positives = 142/332 (42%), Gaps = 65/332 (19%)
Query: 295 ELVLVNGQKGVFGLPDLMKA-----------AAEVLGNGGLGSSYKAMMADGVTVVVKRM 343
L + + + F +L +G GG G YK + + TV VK++
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 344 KESSAMA----RDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLH 399
+ + FD E++ + + +H N++ L + D+ LVY Y+P GSLL L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 400 GDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459
G L+W R KI QG A GI +LH E H+ H ++KS+NI + IS+
Sbjct: 123 CLDGTPP--LSWHMRCKIAQGAANGINFLH-ENHHI---HRDIKSANILLDEAFTAKISD 176
Query: 460 FGFYTMINSANLAQAL---------------FAYKAPEAIQSGKVTPKCDVYCLGIIILE 504
FG LA+A AY APEA+ G++TPK D+Y G+++LE
Sbjct: 177 FG---------LARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLE 226
Query: 505 ILTGK------FPSQYLTNGNGGIDVVEWVASAFSEGR-VTDLLDPEIASSTNSPGEMEQ 557
I+TG Q L ++ E + + D +D ++ + +E
Sbjct: 227 IITGLPAVDEHREPQLL---------LDIKEEIEDEEKTIEDYIDKKMNDA--DSTSVEA 275
Query: 558 LLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+ + C +R ++++ + + E+ S
Sbjct: 276 MYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-51
Identities = 69/339 (20%), Positives = 114/339 (33%), Gaps = 51/339 (15%)
Query: 283 GSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAA-----AEVLGNGGLGSSYKAMMADGVT 337
G HH +SGV G +L + EV G G +KA +
Sbjct: 2 GHHHHHHSSGVD-----------LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEY 49
Query: 338 VVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD----EKLLVYEYIPGGS 393
V VK + EV L ++H N+L + R + L+ + GS
Sbjct: 50 VAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS 108
Query: 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLP------HGNLKSSNI 447
L L + ++W I + +ARG+ YLH ++ L H ++KS N+
Sbjct: 109 LSDFLKANV------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162
Query: 448 FISPENEPLISEFGFYTMINSANLAQAL------FAYKAPEAIQSG-----KVTPKCDVY 496
+ I++FG + A Y APE ++ + D+Y
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222
Query: 497 CLGIIILEILTGKFPSQYLTNGNGGIDVVEWVAS-----AFSEGRVTDLLDPEIASSTNS 551
+G+++ E+ + + + E + E V P +
Sbjct: 223 AMGLVLWELASRCTAADG-PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK 281
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
M L E C D E RL RI ++Q+
Sbjct: 282 HAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 79/307 (25%), Positives = 121/307 (39%), Gaps = 37/307 (12%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
EV+G G G KA V +K+++ S R AF E+R+L R+ H N++
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA--- 433
+ LV EY GGSL +LHG + T + ++G+ YLH+
Sbjct: 71 --LNPVCLVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 434 -HLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQA-LFAYKAPEAIQSGKVT 490
H DL K N+ + L I +FG I + A+ APE + +
Sbjct: 127 IHRDL-----KPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
KCDV+ GII+ E++T + P I + V + P + +
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFD-------EIGGPAFRI----MWAVHNGTRPPLIKNL- 229
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDART---SQNILPTLDH 607
P +E L+ C DP QR M E V+ + + + D Q+ LP +
Sbjct: 230 -PKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
Query: 608 GCAENQE 614
G E
Sbjct: 286 GRVEPYV 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 69/284 (24%), Positives = 110/284 (38%), Gaps = 41/284 (14%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMK--ESSAMARDAFDTEVRRLGRLRHSNVLA--- 371
L G +K G +VVK +K + S F+ E RL H NVL
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 372 ----PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
P A H L+ ++P GSL +LH + +K +ARG+ +
Sbjct: 75 ACQSPPAPHP-----TLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDMARGMAF 126
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQ-- 485
LHT +P L S ++ I + IS S A A+ APEA+Q
Sbjct: 127 LHTL--EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA-PAWVAPEALQKK 183
Query: 486 -SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544
D++ +++ E++T + P L+N +++ VA EG L P
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSN----MEIGMKVA---LEG-----LRPT 231
Query: 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
I + +L++I C DP +R + V + ++Q
Sbjct: 232 IPPGI--SPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 75/284 (26%), Positives = 116/284 (40%), Gaps = 39/284 (13%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKES----SAMARDAFDTEVRRLGRLRHSNVLAP 372
E++G GG G Y+A G V VK + + + E + L+H N++A
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ LV E+ GG L +L G R + + IARG+ YLH E
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDE- 124
Query: 433 AHLDLPHGNLKSSNIFISPENEPL--------ISEFGFYTMINSANLAQALFAYK--APE 482
A + + H +LKSSNI I + E I++FG + A AY APE
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542
I++ + DV+ G+++ E+LTG+ P + + + V VA L
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAYGVA---MNK-----LA 232
Query: 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
I S+ P +L+E C DP R + ++ I
Sbjct: 233 LPIPSTC--PEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 34/282 (12%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E +G G G+ ++A G V VK + E A + F EV + RLRH N++ +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE--- 431
+ +V EY+ GSL LLH + + ++L RL + +A+G+ YLH
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSG 487
+ H +L KS N+ + + + +FG + S L+ A + APE ++
Sbjct: 160 IVHRNL-----KSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 488 KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547
K DVY G+I+ E+ T + P L VV V EI
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAVGF--------KCKRLEIPR 262
Query: 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+ ++ ++E C ++P +R + + + +S
Sbjct: 263 NL--NPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 69/322 (21%), Positives = 105/322 (32%), Gaps = 47/322 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
EVLG G G + K G +V+K + + F EV+ + L H NVL +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAH 434
Y+ + EYI GG+L ++ W R+ + IA G+ YLH+ + H
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGF-----YTMINSANLAQALFAYK---------- 479
DL S N + ++++FG L +
Sbjct: 132 RDL-----NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 480 ---APEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536
APE I K DV+ GI++ EI+ +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN----------- 235
Query: 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDAR 596
V LD + I C DPE+R + + ++
Sbjct: 236 VRGFLDRYCPPNCP-----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
Query: 597 TSQNILPTLDHGCAENQESGKS 618
Q L LD G E G+S
Sbjct: 291 GPQ--LEQLDRGFWETYRRGES 310
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 73/311 (23%), Positives = 113/311 (36%), Gaps = 48/311 (15%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTE--VRRLGRLRHSNVLAPLA 374
E++G G G+ YK + D V VK ++ R F E + R+ + H N+ +
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 375 YHYRTD-----EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
R E LLV EY P GSL L W + ++ + RG+ YLH
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 430 TELAHLDLP-----HGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--------- 475
TEL D H +L S N+ + + +IS+FG + L +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 476 ---FAYKAPEAIQS-------GKVTPKCDVYCLGIIILEIL---TGKFPSQYLTNGNGGI 522
Y APE ++ + D+Y LG+I EI T FP + +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 523 DVVEWVASAFSEGR---VTDLLDPEIASSTNS-PGEMEQLLEIGRACTQSDPEQRLEMRE 578
F + + + P+ + + L E C D E RL +
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308
Query: 579 AVRRIVEIQQS 589
A R+ E+
Sbjct: 309 AEERMAELMMI 319
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 45/289 (15%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-------ESSAMARDAFDTEVRRLGRLRHSN 368
+ +G GG G +K + D V +K + F EV + L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
++ + +V E++P G L + L + W +L+++ IA GI Y+
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYM 138
Query: 429 HTE---LAHLDLPHGNLKSSNIFISPENEPL-----ISEFGFYTMINSANLAQA-LFAYK 479
+ + H DL +S NIF+ +E +++FG + F +
Sbjct: 139 QNQNPPIVHRDL-----RSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWM 193
Query: 480 APEAI--QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
APE I + T K D Y +I+ ILTG+ P + G I + + EG
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS--YGKIKFINMIR---EEG-- 246
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
L P I P + ++E C DP++R V+ + E+
Sbjct: 247 ---LRPTIPEDC--PPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 54/206 (26%), Positives = 82/206 (39%), Gaps = 36/206 (17%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVC----LKGIVTGLYINSMGL 57
+ +ALL++K N L SW+P+T C W GV+C V L ++ + L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRT---WLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 58 SG---------------KIDVDALTELTG--------LRGLRAIYLDKNQFSGEIPPGYF 94
+ + + L G L L +Y+ SG IP
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-L 121
Query: 95 DEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQPTLVR-LNL 151
++ L L FS N G LPPS+ LP+L + + N+ +G IP L + +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 152 SSNKLEGEIPASL--LRFNASSFSGN 175
S N+L G+IP + L S N
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRN 207
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 33/164 (20%), Positives = 57/164 (34%), Gaps = 38/164 (23%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGA--LRKLWFSN 107
N +SG I D+ + L ++ + +N+ +G+IPP L + S
Sbjct: 156 FDGNR--ISGAIP-DSYGSFSKL--FTSMTISRNRLTGKIPP----TFANLNLAFVDLSR 206
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPT-LVRLNLSSNKLEGEIPASL-- 164
N G + ++HL N + L L+L +N++ G +P L
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 165 ------------------------LRFNASSFSGNAGLCGKNLG 184
RF+ S+++ N LCG L
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G+G G+ YK V V + + + AF EV L + RH N+L + Y
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 377 YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAH 434
T +L +V ++ G SL + LH + I + ARG+ YLH + + H
Sbjct: 89 -STAPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMI----NSANLAQALFAYK--APEAIQ--- 485
DL KS+NIF+ +N I +FG T S Q + APE I+
Sbjct: 144 RDL-----KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545
S + + DVY GI++ E++TG+ P + N + I++V DL ++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------RGSLSPDL--SKV 250
Query: 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
S+ P M++L+ C + ++R + I E+ +
Sbjct: 251 RSNC--PKRMKRLMA---ECLKKKRDERPSFPRILAEIEELAR 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 63/307 (20%), Positives = 111/307 (36%), Gaps = 47/307 (15%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
E +G G G ++ G V VK S + E+ + LRH N+L +A
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 377 YRTDEK----LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ + LV +Y GSL L+ +T +K+ A G+ +LH E+
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 433 AHLDLP----HGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--------FAYKA 480
H +LKS NI + I++ G +SA + Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 481 PEAI------QSGKVTPKCDVYCLGIIILEILTG----------KFPSQYLTNGNGGIDV 524
PE + + + + D+Y +G++ EI + P L + ++
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584
+ V L P I + S + + +I R C ++ RL + +
Sbjct: 280 MRKVV-------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 585 EIQQSDG 591
++ Q +G
Sbjct: 333 QLSQQEG 339
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-34
Identities = 38/175 (21%), Positives = 65/175 (37%), Gaps = 13/175 (7%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKI 61
E L+ K + L W + PC + GV C VT + ++S L+
Sbjct: 12 REIHQLISFKDVLPDKNLLPDWSSNKNPCT-----FDGVTCRDDKVTSIDLSSKPLNVGF 66
Query: 62 DVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP--SLF 119
+ + L L GL +++L + +G + F +L L S N G + SL
Sbjct: 67 SAVS-SSLLSLTGLESLFLSNSHINGSVSG--FKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 120 KLPHLTELHLESNQFNGTIP---SFDQPTLVRLNLSSNKLEGEIPASLLRFNASS 171
L L++ SN + +L L+LS+N + G + +
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 42/176 (23%), Positives = 62/176 (35%), Gaps = 33/176 (18%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
N + G +L L + + G P FD G++ L S N
Sbjct: 589 GAGNLLEFQGIRS----EQLNRLSTRNPCNITSRVYGGHTSP-TFDNNGSMMFLDMSYNM 643
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASL--- 164
G +P + +P+L L+L N +G+IP L L+LSSNKL+G IP ++
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 165 -----------------------LRFNASSFSGNAGLCGKNLGVECRNAKASAANK 197
F + F N GLCG L + A+
Sbjct: 704 TMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHH 759
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 39/134 (29%), Positives = 59/134 (44%), Gaps = 17/134 (12%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L I+ +SG + +++ L + + N FS IP + + AL+ L S NK
Sbjct: 183 LAISGNKISGDV------DVSRCVNLEFLDVSSNNFSTGIP--FLGDCSALQHLDISGNK 234
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL----- 164
G ++ L L++ SNQF G IP +L L+L+ NK GEIP L
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACD 294
Query: 165 ----LRFNASSFSG 174
L + + F G
Sbjct: 295 TLTGLDLSGNHFYG 308
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-23
Identities = 42/136 (30%), Positives = 54/136 (39%), Gaps = 17/136 (12%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L N LSG I + L L LR + L N GEIP + L L N
Sbjct: 425 LSFNY--LSGTI----PSSLGSLSKLRDLKLWLNMLEGEIPQELMY-VKTLETLILDFND 477
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASL--- 164
G +P L +L + L +N+ G IP + L L LS+N G IPA L
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 165 -----LRFNASSFSGN 175
L N + F+G
Sbjct: 538 RSLIWLDLNTNLFNGT 553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-22
Identities = 42/117 (35%), Positives = 53/117 (45%), Gaps = 5/117 (4%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L ++S SG I + L + L+ +YL N F+G+IPP L L S N
Sbjct: 373 LDLSSNNFSGPILPN-LCQNP-KNTLQELYLQNNGFTGKIPPT-LSNCSELVSLHLSFNY 429
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKLEGEIPASL 164
G +P SL L L +L L N G IP TL L L N L GEIP+ L
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 41/118 (34%), Positives = 51/118 (43%), Gaps = 9/118 (7%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L I+S G I L L L L +N+F+GEIP L L S N
Sbjct: 252 LNISSNQFVGPIPPLPLKSLQYL------SLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPS---FDQPTLVRLNLSSNKLEGEIPASL 164
F G +PP L L L SN F+G +P L L+LS N+ GE+P SL
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-22
Identities = 39/127 (30%), Positives = 58/127 (45%), Gaps = 12/127 (9%)
Query: 50 LYINSMGLSGKIDVDALTELTG-LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNN 108
L N +G+I L+G L + L N F G +PP + L L S+N
Sbjct: 276 LAENK--FTGEIP----DFLSGACDTLTGLDLSGNHFYGAVPPFFG-SCSLLESLALSSN 328
Query: 109 KFRGRLPP-SLFKLPHLTELHLESNQFNGTIPSFD---QPTLVRLNLSSNKLEGEIPASL 164
F G LP +L K+ L L L N+F+G +P +L+ L+LSSN G I +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 165 LRFNASS 171
+ ++
Sbjct: 389 CQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-19
Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 21/138 (15%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L ++ L+G+I + L+ L I L N+ +GEIP + L L SNN
Sbjct: 471 LILDFNDLTGEIP----SGLSNCTNLNWISLSNNRLTGEIPKW-IGRLENLAILKLSNNS 525
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKLEGEIPASL--- 164
F G +P L L L L +N FNGTIP+ F Q +++N + G+ +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKND 581
Query: 165 -------LRFNASSFSGN 175
N F G
Sbjct: 582 GMKKECHGAGNLLEFQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-12
Identities = 31/135 (22%), Positives = 45/135 (33%), Gaps = 35/135 (25%)
Query: 57 LSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWF---SNNKFRGR 113
L+G+I + L L + L N FSG IP E+G R L + + N F G
Sbjct: 502 LTGEI----PKWIGRLENLAILKLSNNSFSGNIPA----ELGDCRSLIWLDLNTNLFNGT 553
Query: 114 LPPSLFKLP--------------------HLTELHLESN--QFNGTIPS--FDQPTLVRL 149
+P ++FK E H N +F G T
Sbjct: 554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613
Query: 150 NLSSNKLEGEIPASL 164
N++S G +
Sbjct: 614 NITSRVYGGHTSPTF 628
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 60/306 (19%), Positives = 105/306 (34%), Gaps = 49/306 (16%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G G G + G V VK ++ A +TE+ + +RH N+L +A
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 377 YRTDEK----LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ L+ +Y GSL L L + LK+ G+ +LHTE+
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 433 AHLDLP----HGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--------FAYKA 480
H +LKS NI + I++ G S + Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 481 PEAI------QSGKVTPKCDVYCLGIIILEILTG----------KFPSQYLTNGNGGI-D 523
PE + + D+Y G+I+ E+ + P L + D
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
+ E V L P + +S + Q+ ++ C +P RL + +
Sbjct: 275 MREIV--------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 584 VEIQQS 589
++ +S
Sbjct: 327 AKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 62/295 (21%), Positives = 106/295 (35%), Gaps = 33/295 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
E +G G G ++ G V VK S +TE+ LRH N+L +A
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 377 YRTDEK----LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ L+ Y GSL L L + L+IV IA G+ +LH E+
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 433 AHLDLP----HGNLKSSNIFISPENEPLISEFGF-------YTMINSANLAQA-LFAYKA 480
H +LKS NI + + I++ G ++ N + Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 481 PEAIQS------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534
PE + + D++ G+++ E+ + + + V +F +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 535 GR---VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
R D P I + S + L ++ + C +P RL + + +I
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 55/296 (18%), Positives = 108/296 (36%), Gaps = 52/296 (17%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E++G G G Y V ++ + + AF EV + RH NV+ +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
++ G +L ++ + L +I Q I +G+GYLH + +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 434 HLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQAL---------FAYKAPEA 483
H DL KS N+F +N + I++FG +++ + + APE
Sbjct: 153 HKDL-----KSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 484 IQSGKV---------TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534
I+ + DV+ LG I E+ ++P + + + W
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAIIWQ------ 254
Query: 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
+ + P + S E+ +L C + E+R + + + ++ + +
Sbjct: 255 --MGTGMKPNL-SQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLPKRN 304
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 34/272 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK--ESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
+G G + YK + V V ++ + + R F E L L+H N++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 374 AYHYRTDEK----LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
T + +LV E + G+L L + + I +G+ +LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 430 TELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSANLAQAL--FAYKAPEAIQS 486
T + H +LK NIFI+ I + G T+ ++ + + APE +
Sbjct: 147 TR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE 204
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
DVY G+ +LE+ T ++P N A + RVT + P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQIY--RRVTSGVKPASF 251
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMRE 578
P E+++++E C + + ++R +++
Sbjct: 252 DKVAIP-EVKEIIE---GCIRQNKDERYSIKD 279
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 71/326 (21%), Positives = 117/326 (35%), Gaps = 53/326 (16%)
Query: 284 SSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKR 342
SS G +V+++ + +F + LG GG + DG +KR
Sbjct: 11 SSGRENLYFQGHMVIIDNKHYLFI---------QKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 343 MKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVYEYIPGGSLLYLL 398
+ R+ E H N+L +AY R E L+ + G+L +
Sbjct: 62 ILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
Query: 399 HGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLI 457
+ LT L ++ GI RG+ +H + AH D LK +NI + E +P++
Sbjct: 122 E-RLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD-----LKPTNILLGDEGQPVL 175
Query: 458 SEFGFYTMINS-------ANLAQALFA------YKAPEAIQS---GKVTPKCDVYCLGII 501
+ G A Q A Y+APE + + DV+ LG +
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 502 ILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEI 561
+ ++ G+ P Y G V V + S I S + QLL
Sbjct: 236 LYAMMFGEGP--YDMVFQKGDSVALAVQNQLS-----------IPQSPRHSSALWQLL-- 280
Query: 562 GRACTQSDPEQRLEMREAVRRIVEIQ 587
+ DP QR + + ++ +Q
Sbjct: 281 -NSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV------ 369
E++G+GG G +KA DG T V+KR+K + + EV+ L +L H N+
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 370 ---------LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQ 419
+ + L + E+ G+L + RG D+ L++ +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK---VLALELFE 129
Query: 420 GIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--- 475
I +G+ Y+H++ L + DL K SNIF+ + I +FG T + +
Sbjct: 130 QITKGVDYIHSKKLINRDL-----KPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 476 FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y +PE I S + D+Y LG+I+ E+L
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 49/202 (24%), Positives = 76/202 (37%), Gaps = 21/202 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT--EVRRLGRL-RHSNVLAP 372
LG+G G +K DG VKR +D EV ++ +H +
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR- 121
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
L + L L E G SL + W ++ + +LH++
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQ 176
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF---AYKAPEAIQSG 487
L HLD+ K +NIF+ P + +FG + +A + Y APE +Q G
Sbjct: 177 GLVHLDV-----KPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-G 230
Query: 488 KVTPKCDVYCLGIIILEILTGK 509
DV+ LG+ ILE+
Sbjct: 231 SYGTAADVFSLGLTILEVACNM 252
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 58/298 (19%)
Query: 317 EVLGNGGLGSSYKAMMADGV---TVVVKRMKESSAMARDA-----FDTEVRRLGRLRHSN 368
+ LG GG+ + Y A D + V +K + F+ EV +L H N
Sbjct: 17 DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIP--PREKEETLKRFEREVHNSSQLSHQN 72
Query: 369 VLAPLAYHYRTDEKL--LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIG 426
+++ ++ LV EYI G +L + GP L+ + I GI
Sbjct: 73 IVS--MIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP----LSVDTAINFTNQILDGIK 125
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-----AYKAP 481
+ H + + H ++K NI I I +FG ++ +L Q Y +P
Sbjct: 126 HAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVV-----EWVASAFSEGR 536
E + D+Y +GI++ E+L G+ P NG + + + V + ++
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVPNVTTD-- 235
Query: 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR----LEMREAVRRIVEIQQSD 590
+ +I P + ++ T+ D R EM++ + ++ +++
Sbjct: 236 ----VRKDI------PQSLSNVIL---RATEKDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 68/296 (22%), Positives = 108/296 (36%), Gaps = 56/296 (18%)
Query: 317 EVLGNGGLGSSYKAMMADGV---TVVVKRMKESSAMARDA-----FDTEVRRLGRLRHSN 368
++G GG+G Y+A D V V +K M E+ ++ D E R GRL+ +
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPH 95
Query: 369 VLAPLAYHYRTDEKL--LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIG 426
V+ + + + + I G L +L +GP L P + IV+ I +
Sbjct: 96 VVP--IHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGP----LAPPRAVAIVRQIGSALD 148
Query: 427 YLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA-----LFAYKA 480
H H D+ K NI +S ++ + +FG + L Q Y A
Sbjct: 149 AAHAAGATHRDV-----KPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540
PE T + D+Y L ++ E LTG P Q G D + V A +
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQ----G----DQLS-VMGA----HINQ- 249
Query: 541 LDPEIASSTNS--PGEMEQLLEIGRACTQSDPEQR----LEMREAVRRIVEIQQSD 590
S+ P + + I R +PE R ++ A + D
Sbjct: 250 -AIPRPSTVRPGIPVAFDAV--IARG-MAKNPEDRYVTCGDLSAAAHAALATADQD 301
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 68/287 (23%), Positives = 109/287 (37%), Gaps = 45/287 (15%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E +G G G + + AD V VK +E + F E R L + H N++ +
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
+ +V E + GG L L + L L++V A G+ YL ++
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFG--------FYTMINSANLAQALFAYK--APEA 483
H DL + N ++ +N IS+FG Y K APEA
Sbjct: 236 HRDL-----AARNCLVTEKNVLKISDFGMSREEADGVYAASGGL----RQVPVKWTAPEA 286
Query: 484 IQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542
+ G+ + + DV+ GI++ E + G P L+N E+V GR L
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTREFVEKG---GR---LPC 336
Query: 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
PE P + +L+ C +P QR + + I++
Sbjct: 337 PE-----LCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 66/273 (24%), Positives = 105/273 (38%), Gaps = 46/273 (16%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
VLG G G Y V + +K + E + E+ L+H N++ Y
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---Y 84
Query: 376 H--YRTDEKLLVY-EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
+ + + ++ E +PGGSL LL GP + + I G+ YLH
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL--KDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 432 LAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFA----YKAPEAIQS 486
+ H D+ K N+ I+ + L IS+FG + N F Y APE I
Sbjct: 143 IVHRDI-----KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 487 GKV--TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544
G D++ LG I+E+ TGK P + ++ E A+ F +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP--F-------YELGEPQAAMF-----------K 237
Query: 545 IASSTNSPGEMEQLLEIGRA----CTQSDPEQR 573
+ P E + +A C + DP++R
Sbjct: 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 59/279 (21%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G+G G + + V +K ++E AM+ + F E + +L H ++
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
LV E++ G L L RG L + + G+ Y L
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAY----LEEAC 124
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---LAQALFAYK--APEAIQSGKVTP 491
+ H +L + N + +S+FG + F K +PE + +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 492 KCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
K DV+ G+++ E+ + GK P + +N +VVE +++ F R L P
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDISTGF---R---LYKPR-----L 229
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+ + Q++ C + PE R +R++ EI +S
Sbjct: 230 ASTHVYQIM---NHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 31/212 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAP 372
+ +G G Y+A + DGV V +K+++ M AR E+ L +L H NV+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK- 96
Query: 373 LAYH--YRTDEKLLVY-EYIPGGSLLYLL--HGDRGPSHDE---LTWPARLKIVQGIARG 424
Y+ + D +L + E G L ++ + E + VQ +
Sbjct: 97 --YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY-----FVQ-LCSA 148
Query: 425 IGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK 479
+ ++H+ + H D+ K +N+FI+ + + G +S A Y
Sbjct: 149 LEHMHSRRVMHRDI-----KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+PE I K D++ LG ++ E+ + P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 43/287 (14%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ LG+G G V VK +KE +M+ D F E + + +L H ++
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ +V EYI G LL L L L++ + G+ +L
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFL----ESHQ 124
Query: 437 LPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYK--APEAIQS 486
H +L + N + + +S+FG Y F K APE
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT-----KFPVKWSAPEVFHY 179
Query: 487 GKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545
K + K DV+ GI++ E+ + GK P TN +VV V S+G L P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVLKV----SQGHR--LYRPH- 228
Query: 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592
+ + Q++ +C PE+R ++ + I +++ D +
Sbjct: 229 ----LASDTIYQIM---YSCWHELPEKRPTFQQLLSSIEPLREKDKH 268
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 30/225 (13%), Positives = 67/225 (29%), Gaps = 27/225 (12%)
Query: 317 EVLGNGGLGSSYKAM------MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVL 370
+LG G Y+A + V+K K ++ + RL +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ H + +LV E G+LL ++ + + + + I +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPL-----------ISEFGFYTMINSANLAQALFA-- 477
++ HG++K N + + + G + A
Sbjct: 191 ----CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 478 ----YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNG 518
++ E + + + D + + + +L G + G
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 49/231 (21%), Positives = 78/231 (33%), Gaps = 44/231 (19%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV------ 369
VLG G G KA D +K+++ + +EV L L H V
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASLNHQYVVRYYAA 70
Query: 370 ------LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIA 422
+ L + EY G+L L+H + ++ + I
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQR---DEYWRLFRQIL 126
Query: 423 RGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA---- 477
+ Y+H++ + H DL K NIFI I +FG ++ + L +
Sbjct: 127 EALSYIHSQGIIHRDL-----KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 478 --------------YKAPEAIQ-SGKVTPKCDVYCLGIIILEILTGKFPSQ 513
Y A E + +G K D+Y LGII E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 39/288 (13%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
LG G G Y+ + +TV VK +KE M + F E + ++H N++ L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
R ++ E++ G+LL L E++ L + I+ + YL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK---- 337
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYKAPEAIQSG 487
+ H NL + N + + +++FG YT A + APE++
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP---IKWTAPESLAYN 394
Query: 488 KVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
K + K DV+ G+++ EI T G P + V E + + R + PE
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKDY---R---MERPEGC 444
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMD 594
E++ E+ RAC Q +P R E + + Q D
Sbjct: 445 P--------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 6e-20
Identities = 43/300 (14%), Positives = 77/300 (25%), Gaps = 50/300 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM---KESSAMARDAFDTEVRRLGRLRHSNVLAP 372
E L G + + +K E+S + RL +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 373 LAY--------------------------HYRTDEKLLVYEYIPGGSLLYLLH--GDRGP 404
Y LL+ L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186
Query: 405 SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464
+ A + + R L L HG+ N+FI P+ ++ +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ----SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 465 MINSANLAQALFAYKAPEAI---QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG 521
+ + A ++ AP + T + + LG+ I + P +T G G
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
+ ++ S T P ++ L+ D +RL EA+
Sbjct: 303 SWKRPSLRVPGTD-------SLAFGSCTPLPDFVKTLI---GRFLNFDRRRRLLPLEAME 352
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 38/222 (17%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLA--- 371
+ LG GG G ++A D +KR++ + +AR+ EV+ L +L H ++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 372 ------PLAYHYRTDEKLLVY---EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIA 422
+ K+ +Y + +L ++G E L I IA
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIFLQIA 128
Query: 423 RGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA---- 477
+ +LH++ L H DL K SNIF + ++ + +FG T ++ Q +
Sbjct: 129 EAVEFLHSKGLMHRDL-----KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 478 ------------YKAPEAIQSGKVTPKCDVYCLGIIILEILT 507
Y +PE I + K D++ LG+I+ E+L
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 35/264 (13%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
LG G G + V +K +K M+ +AF E + + +LRH ++ A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 377 YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
++E + +V EY+ GSLL L G+ G L P + + IA G+ Y+ +
Sbjct: 249 --SEEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYV----ERM 299
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINS---ANLAQALFAYK--APEAIQSGKVT 490
+ H +L+++NI + +++FG +I A F K APEA G+ T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 491 PKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549
K DV+ GI++ E+ T G+ P + N +V++ V + R + P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGY---R---MPCPP----- 404
Query: 550 NSPGEMEQLLEIGRACTQSDPEQR 573
P + L+ C + +PE+R
Sbjct: 405 ECPESLHDLM---CQCWRKEPEER 425
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-20
Identities = 29/133 (21%), Positives = 44/133 (33%), Gaps = 12/133 (9%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L I+ + GL L + + N F P F E+ L L S +
Sbjct: 426 LDISHTHTRVAFN----GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR 166
L P+ F L L L++ N F +L L+ S N + L
Sbjct: 482 LEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 167 FNAS----SFSGN 175
F +S + + N
Sbjct: 541 FPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 20/100 (20%), Positives = 29/100 (29%), Gaps = 3/100 (3%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
GL L + + F + L L S+ R L L L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 128 HLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASL 164
+ N F + L L+LS +LE P +
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 26/120 (21%), Positives = 37/120 (30%), Gaps = 7/120 (5%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + D TEL L L L + Q + P F+ + +L+ L S+N
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFL---DLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNN 505
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQP---TLVRLNLSSNKLEGEIPASLLR 166
F L L L N + Q +L LNL+ N
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 25/121 (20%), Positives = 42/121 (34%), Gaps = 9/121 (7%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L L+ + + L+ L+ + + N P YF + L L S+NK
Sbjct: 105 LVAVETNLASLEN----FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 110 FRGRLPPSLFKLPHLT----ELHLESNQFNGTIPS-FDQPTLVRLNLSSNKLEGEIPASL 164
+ L L + L L N N P F + L +L L +N + +
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 165 L 165
+
Sbjct: 221 I 221
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 18/121 (14%), Positives = 36/121 (29%), Gaps = 8/121 (6%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
L ++ L L+ + L + + I G + + L L +
Sbjct: 30 TKNLDLSFNPLRHLGS----YSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEG-EIPAS 163
N + + L L +L TL LN++ N ++ ++P
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 164 L 164
Sbjct: 145 F 145
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 26/108 (24%), Positives = 38/108 (35%), Gaps = 7/108 (6%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
I+ A L+ L L L N + G F + +L+KL +
Sbjct: 66 TIEDGAYQSLSHLSTL---ILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 120 KLPHLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASL 164
L L EL++ N F L L+LSSNK++ L
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 20/104 (19%), Positives = 31/104 (29%), Gaps = 4/104 (3%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK--FRGRLPPSLFKLPH 123
+ L+ L G ++ +L L S N F+G S F
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 124 LTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L L L N +F L L+ + L+ S+
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 20/134 (14%), Positives = 38/134 (28%), Gaps = 7/134 (5%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + + S + + L GL R + L + + G + + L L +
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHR-LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 110 ------FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPAS 163
+ + L +++ L S L L + K
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLK 323
Query: 164 LLRFNASSFSGNAG 177
L +F+ N G
Sbjct: 324 LKSLKRLTFTSNKG 337
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 26/118 (22%), Positives = 36/118 (30%), Gaps = 11/118 (9%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
+ + +D LT + L F + L N K
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSF---SLVSVTIERVKD---FSYNFGWQHLELVNCK 315
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKL--EGEIPASLL 165
F G+ P K L L SN+ D P+L L+LS N L +G S
Sbjct: 316 F-GQFPTLKLK--SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 15/88 (17%), Positives = 27/88 (30%), Gaps = 5/88 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK--LPHLTE 126
L L+ + N +L L + N F F + +
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 127 LHLESNQFNGTIPS--FDQPTLVRLNLS 152
L +E + PS P ++ LN++
Sbjct: 574 LLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 53/285 (18%), Positives = 107/285 (37%), Gaps = 43/285 (15%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ LG G G V +K +KE +M+ D F E + + L H ++
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ ++ EY+ G LL L R L++ + + + YL
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYL----ESKQ 140
Query: 437 LPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYK--APEAIQS 486
H +L + N ++ + +S+FG YT + F + PE +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-----KFPVRWSPPEVLMY 195
Query: 487 GKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545
K + K D++ G+++ EI + GK P + TN + E + ++G L P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHI----AQGLR--LYRPH- 244
Query: 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
+ ++ ++ +C ++R + + I+++ +
Sbjct: 245 ----LASEKVYTIM---YSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-20
Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 45/269 (16%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ LG G G + A V VK MK +M+ +AF E + L+H ++ A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ + ++ E++ GSLL L D G + P + IA G+ ++ +
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFI----EQRN 304
Query: 437 LPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYK--APEAIQS 486
H +L+++NI +S I++FG YT A F K APEAI
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK-----FPIKWTAPEAINF 359
Query: 487 GKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG-RVTDLLDPE 544
G T K DV+ GI+++EI+T G+ P ++N +V+ + G R + PE
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRAL----ERGYR---MPRPE 408
Query: 545 IASSTNSPGEMEQLLEIGRACTQSDPEQR 573
N P E+ ++ C ++ PE+R
Sbjct: 409 -----NCPEELYNIM---MRCWKNRPEER 429
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 63/281 (22%), Positives = 99/281 (35%), Gaps = 50/281 (17%)
Query: 317 EVLGNGGLGSSYKA--MMADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPL 373
+ +GGLG Y A +G VV+K + S A A+ E + L + H +++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 374 AY--HYRTDEKLLVY---EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ H + Y EY+ G SL +L + + I + YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYL 198
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGK 488
H + L + +LK NI ++ E LI + G + INS ++APE I
Sbjct: 199 H----SIGLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFGYLYGTPGFQAPE-IVRTG 252
Query: 489 VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548
T D+Y +G + + GR D L PE
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT--------------------R-NGRYVDGL-PEDDPV 290
Query: 549 TNSPGEMEQLLEIGRACTQSDPEQR----LEMREAVRRIVE 585
+ +LL R DP QR EM + ++
Sbjct: 291 LKTYDSYGRLL---RRAIDPDPRQRFTTAEEMSAQLTGVLR 328
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 48/308 (15%), Positives = 80/308 (25%), Gaps = 70/308 (22%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK---RMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
VLG + +A G + V + + A EV RL LR
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 373 LAYHYR--------------------------TDEKLLVYEYIPGGSLLYLLH--GDRGP 404
H R +L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 405 SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464
+H L ARL++ + R + LH H L H L+ +I + ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 465 MINSANLAQALFAYKAPEAIQS-----------GKVTPKCDVYCLGIIILEILTGKFPSQ 513
+ ++ ++ PE +T D + LG++I I P
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP-- 312
Query: 514 YLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
++ + S N P + LL + E R
Sbjct: 313 ------------------ITKDAALGGSEWIFRSCKNIPQPVRALL---EGFLRYPKEDR 351
Query: 574 LEMREAVR 581
L +A+
Sbjct: 352 LLPLQAME 359
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 66/287 (22%), Positives = 114/287 (39%), Gaps = 62/287 (21%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT--EVRRLGRL-RHSNVLAP 372
E +G+G GS +K + DG +KR K+ A + D + EV L +HS+V+
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75
Query: 373 LAYH--YRTDEKLLVY-EYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGIGY 427
Y + D+ +L+ EY GGSL + + E ++ + RG+ Y
Sbjct: 76 --YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE---AELKDLLLQVGRGLRY 130
Query: 428 LHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA--------- 477
+H+ L H+D+ K SNIFIS + P + ++N
Sbjct: 131 IHSMSLVHMDI-----KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 478 ----------YKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVE 526
+ A E +Q PK D++ L + ++ + + NG+ +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGD------Q 236
Query: 527 WVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
W +GR+ + P++ S E +LL + DPE+R
Sbjct: 237 W--HEIRQGRLPRI--PQVLSQ-----EFTELL---KVMIHPDPERR 271
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 37/265 (13%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
LG G G + V +K +K M+ +AF E + + +LRH ++ A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 377 YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
++E + +V EY+ GSLL L G+ G L P + + IA G+ Y+ +
Sbjct: 332 --SEEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYV----ERM 382
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINS---ANLAQALFAYK--APEAIQSGKVT 490
+ H +L+++NI + +++FG +I A F K APEA G+ T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 491 PKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG-RVTDLLDPEIASS 548
K DV+ GI++ E+ T G+ P + N +V++ V G R + P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQV----ERGYR---MPCPPECP- 490
Query: 549 TNSPGEMEQLLEIGRACTQSDPEQR 573
E L ++ C + +PE+R
Sbjct: 491 -------ESLHDLMCQCWRKEPEER 508
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 66/309 (21%), Positives = 113/309 (36%), Gaps = 41/309 (13%)
Query: 317 EVLGNGGLGSSYKAM------MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNV 369
LG+G G Y+ + V VK + E S F E + + H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLL-YLL-HGDRGPSHDELTWPARLKIVQGIARGIGY 427
+ + ++ + ++ E + GG L +L R L L + + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPL---ISEFGFYTMINSAN----LAQALFAYK- 479
L H ++ + N ++ I +FG I A+ A+ K
Sbjct: 156 L----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 480 -APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
PEA G T K D + G+++ EI + G P +N +V+E+V + G
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFV----TSGGR 263
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDART 597
+ P+ N PG + +++ C Q PE R + RI Q ++
Sbjct: 264 --MDPPK-----NCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 598 SQNILPTLD 606
P ++
Sbjct: 314 PIEYGPLVE 322
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 47/270 (17%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
E LG G G + V VK +K+ +M+ DAF E + +L+H ++ A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 377 YRTDEKLL-VYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
T E + + EY+ GSL+ +L + PS +LT L + IA G+ ++
Sbjct: 77 -VTQEPIYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI----EE 127
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYK--APEAI 484
+ H +L+++NI +S I++FG YT A F K APEAI
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-----KFPIKWTAPEAI 182
Query: 485 QSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543
G T K DV+ GI++ EI+T G+ P +TN +V++ + + R ++ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLERGY---R---MVRP 232
Query: 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
+ N P E+ QL+ R C + PE R
Sbjct: 233 D-----NCPEELYQLM---RLCWKERPEDR 254
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 4e-19
Identities = 49/308 (15%), Positives = 82/308 (26%), Gaps = 69/308 (22%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK---RMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
VLG + +A G + V + + A EV RL LR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 373 LAYHYR---------------------TDEKLLVYEY-----IPGGSLLYLLH--GDRGP 404
H R + + V +L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 405 SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464
+H L ARL++ + R + LH H L H L+ +I + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 465 MINSANLAQALFAYKAPEAI----------QSGKVTPKCDVYCLGIIILEILTGKFPSQY 514
++ ++ + PE +T D + LG+ I I P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--- 316
Query: 515 LTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL 574
++ + S N P + LL + E RL
Sbjct: 317 -----------------NTDDAALGGSEWIFRSCKNIPQPVRALL---EGFLRYPKEDRL 356
Query: 575 EMREAVRR 582
+A+
Sbjct: 357 LPLQAMET 364
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 66/309 (21%), Positives = 111/309 (35%), Gaps = 41/309 (13%)
Query: 317 EVLGNGGLGSSYKAM------MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNV 369
LG+G G Y+ + V VK + E S F E + + H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHD--ELTWPARLKIVQGIARGIGY 427
+ + ++ + ++ E + GG L L R L L + + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPL---ISEFGFYTMINSAN----LAQALFAYK- 479
L H ++ + N ++ I +FG I A A+ K
Sbjct: 197 L----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 480 -APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
PEA G T K D + G+++ EI + G P +N +V+E+V + G
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFV----TSGGR 304
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDART 597
+ P+ N PG + +++ C Q PE R + RI Q ++
Sbjct: 305 --MDPPK-----NCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 354
Query: 598 SQNILPTLD 606
P ++
Sbjct: 355 PIEYGPLVE 363
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 37/283 (13%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G G G G V VK +K A A+ F E + +LRHSN++ L
Sbjct: 199 QTIGKGEFGDVMLGD-YRGNKVAVKCIKND-ATAQA-FLAEASVMTQLRHSNLVQLLGVI 255
Query: 377 YRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
L +V EY+ GSL+ YL R L LK + + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYL----EG 307
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK--APEAIQSGKVTPK 492
+ H +L + N+ +S +N +S+FG +S K APEA++ K + K
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTK 366
Query: 493 CDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG-RVTDLLDPEIASSTN 550
DV+ GI++ EI + G+ P + DVV V +G + + P+
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV----EKGYK---MDAPD-----G 410
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNM 593
P + ++ + C D R + ++ I+ + ++
Sbjct: 411 CPPAVYDVM---KNCWHLDAATRPTFLQLREQLEHIRTHELHL 450
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 45/267 (16%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G G G G V VK +K A A+ F E + +LRHSN++ L
Sbjct: 27 QTIGKGEFGDVMLGD-YRGNKVAVKCIKND-ATAQA-FLAEASVMTQLRHSNLVQLLGVI 83
Query: 377 YRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
L +V EY+ GSL+ YL R L LK + + YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGF----YTMINSANLAQALFAYK--APEAIQSG 487
H DL + N+ +S +N +S+FG + K APEA++
Sbjct: 140 HRDLA-----ARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREK 189
Query: 488 KVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
K + K DV+ GI++ EI + G+ P + DVV V + + + P+
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEKGY---K---MDAPD-- 237
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQR 573
P + +++ + C D R
Sbjct: 238 ---GCPPAVYEVM---KNCWHLDAAMR 258
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 85/307 (27%)
Query: 317 EVLGNGGLGSSYKAMMADGV---TVVVKRMKESSAMARDA-----FDTEVRRLGRLRHSN 368
E+LG GG+ + A D V VK ++ +ARD F E + L H
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPA 73
Query: 369 VLA----------PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIV 418
++A Y +V EY+ G +L ++H GP +T ++++
Sbjct: 74 IVAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVH-TEGP----MTPKRAIEVI 122
Query: 419 QGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-- 476
+ + + H + H ++K +NI IS N + +FG +A+A+
Sbjct: 123 ADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFG---------IARAIADS 169
Query: 477 --------------AYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI 522
Y +PE + V + DVY LG ++ E+LTG+ P G+ +
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPV 225
Query: 523 DVVEWVASAFSEGRVTDLLDPEIASSTNS--PGEMEQLLEIGRACTQSDPEQR----LEM 576
V A+ V + DP S+ + +++ ++ +PE R EM
Sbjct: 226 SV------AYQ--HVRE--DPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEM 272
Query: 577 REAVRRI 583
R + R+
Sbjct: 273 RADLVRV 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK--RMKESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
+ +G G G + DG V+K + S+ R+ EV L ++H N++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ-- 87
Query: 374 AYH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDE---LTWPARLKIVQGIARGIGY 427
Y + + L +V +Y GG L ++ +G E L W VQ I + +
Sbjct: 88 -YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-----FVQ-ICLALKH 140
Query: 428 LHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-ANLAQALFA---YKAPE 482
+H + H D+ KS NIF++ + + +FG ++NS LA+A Y +PE
Sbjct: 141 VHDRKILHRDI-----KSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
++ K D++ LG ++ E+ T K
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 52/301 (17%), Positives = 107/301 (35%), Gaps = 64/301 (21%)
Query: 317 EVLGNGGLGSSYKAM--------MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN 368
E LG G +K + V++K + ++ ++F + +L H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
++ DE +LV E++ GSL L ++ + +L++ + +A + +
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHF- 128
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPL--------ISEFGFYTMINSANLAQALFA--- 477
L L HGN+ + NI + E + +S+ G ++ +
Sbjct: 129 ---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---------ISITVLPKDI 176
Query: 478 YK------APEAIQSGKV-TPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVA 529
+ PE I++ K D + G + EI + G P L + +++
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ----RKLQFY- 231
Query: 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+ L P+ E+ L+ C +P+ R R +R + +
Sbjct: 232 ---EDRHQ--LPAPK-------AAELANLI---NNCMDYEPDHRPSFRAIIRDLNSLFTP 276
Query: 590 D 590
D
Sbjct: 277 D 277
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 52/290 (17%), Positives = 95/290 (32%), Gaps = 65/290 (22%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAY 375
+VLG+G G+ M D V VKR+ D EV+ L H NV+ Y
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR---Y 83
Query: 376 H--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ + + E +L + + +H + ++Q G+ +LH
Sbjct: 84 FCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLG---LEPITLLQQTTSGLAHLH--- 135
Query: 433 AHLDLPHGNLKSSNIFISPENE-----PLISEFGFYTMINSANLAQALFA-------YKA 480
L++ H +LK NI IS N +IS+FG + + + + + A
Sbjct: 136 -SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 481 PEAIQS---GKVTPKCDVYCLGIIILEILTGKFP--------SQYLTNGNGGIDVVEWVA 529
PE + T D++ G + +++ + G +D +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254
Query: 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
R +L+ DP++R +
Sbjct: 255 HEDVIAR--ELI---------------------EKMIAMDPQKRPSAKHV 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 40/209 (19%), Positives = 77/209 (36%), Gaps = 31/209 (14%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+G G G ++ G VK+++ E+ L ++
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVP---L 115
Query: 376 H--YRTDEKLLVY-EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ R + ++ E + GGSL L+ G ++ L + G+ YLHT
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRA----LYYLGQALEGLEYLHTR- 169
Query: 433 AHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFAYK---------APE 482
+ HG++K+ N+ +S + + +FG + L ++L APE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ K D++ ++L +L G P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 46/210 (21%), Positives = 82/210 (39%), Gaps = 21/210 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPL 373
+G G G K +DG +V K + + + +EV L L+H N++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 374 -AYHYRTDEKL-LVYEYIPGGSLLYLL--HGDRGPSHDE---LTWPARLKIVQGIARGIG 426
RT+ L +V EY GG L ++ DE L + Q + +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-----MTQ-LTLALK 125
Query: 427 YLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-ANLAQALF---AYKAP 481
H + H +LK +N+F+ + + +FG ++N + A+ Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
E + K D++ LG ++ E+ P
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 65/306 (21%)
Query: 317 EVLGNGGLGSSYKAMMADG------VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVL 370
LG G G + A + + V VK +KE+S AR F E L L+H +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLL-YL---------LHGDRGPSHDELTWPARLKIVQG 420
L+V+EY+ G L +L L G + L L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 421 IARGIGYL------HTELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMI 466
+A G+ YL H +LA + N + I +FG Y +
Sbjct: 167 VAAGMVYLAGLHFVHRDLA----------TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216
Query: 467 NSANLAQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGID 523
+ + + PE+I K T + DV+ G+++ EI T GK P L+N +
Sbjct: 217 GG----RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----E 268
Query: 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
++ + ++GR L P P E+ ++ R C Q +P+QR +++ R+
Sbjct: 269 AIDCI----TQGRE--LERPR-----ACPPEVYAIM---RGCWQREPQQRHSIKDVHARL 314
Query: 584 VEIQQS 589
+ Q+
Sbjct: 315 QALAQA 320
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 54/301 (17%)
Query: 317 EVLGNGGLGSSYKAM------MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVL 370
LG G G + A D + V VK +K+ + AR F E L L+H +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLL-YL----------LHGDRGPSHDELTWPARLKIVQ 419
D ++V+EY+ G L +L + G + EL L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 420 GIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANL 471
IA G+ YL A H +L + N + I +FG Y +
Sbjct: 141 QIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--- 193
Query: 472 AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
+ + PE+I K T + DV+ G+I+ EI T GK P L+N +V+E +
Sbjct: 194 -HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIECI 248
Query: 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
++GRV L P P E+ ++ C Q +P+QRL ++E + + + +
Sbjct: 249 ----TQGRV--LERPR-----VCPKEVYDVM---LGCWQREPQQRLNIKEIYKILHALGK 294
Query: 589 S 589
+
Sbjct: 295 A 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 70/307 (22%), Positives = 126/307 (41%), Gaps = 51/307 (16%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
+V+G G G + ++V +K +K + R F E +G+ H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL--- 428
++ ++V EY+ GSL L + T + +++GIA G+ YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSDM 166
Query: 429 ---HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA-----QALFAYK- 479
H +LA + NI I+ +S+FG ++ A +
Sbjct: 167 GYVHRDLA----------ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 480 -APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
+PEAI K T DV+ GI++ E+++ G+ P ++N DV++ V EG
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAV----DEGYR 268
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDART 597
L P + P + QL+ C Q D R + + V + ++ ++ G++ T
Sbjct: 269 --LPPPM-----DCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318
Query: 598 SQNILPT 604
S P+
Sbjct: 319 SAAARPS 325
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 54/266 (20%), Positives = 93/266 (34%), Gaps = 47/266 (17%)
Query: 277 ASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAM-MADG 335
S G+S ++ VG+ V + + VL GG Y+A + G
Sbjct: 3 GPGSLGGASGRDQSDFVGQTVELGELRLRVR---------RVLAEGGFAFVYEAQDVGSG 53
Query: 336 VTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEK-------LLVYE 387
+KR+ + A EV + +L H N++ + E+ L+
Sbjct: 54 REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113
Query: 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH---TELAHLDLPHGNLKS 444
+ G L+ L + S L+ LKI R + ++H + H D LK
Sbjct: 114 ELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD-----LKV 166
Query: 445 SNIFISPENEPLISEFGFYTMINSANLAQALF----------------AYKAPEAIQ--S 486
N+ +S + + +FG T I+ Y+ PE I S
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 487 GK-VTPKCDVYCLGIIILEILTGKFP 511
+ K D++ LG I+ + + P
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 54/299 (18%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVL 370
+LG G GS +A + V V VK +K + D F E + H +V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 371 APLA------YHYRTDEKLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIAR 423
+ R +++ ++ G L +LL G + L ++ + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 424 GIGYL------HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQ 473
G+ YL H +LA + N ++ + +++FG I S +
Sbjct: 149 GMEYLSSRNFIHRDLA----------ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 474 ALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
+ K A E++ T DV+ G+ + EI+T G+ P + N ++ ++
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN----AEIYNYL-- 252
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
G L P E+ L+ C +DP+QR + I
Sbjct: 253 --IGGNR--LKQPP-----ECMEEVYDLM---YQCWSADPKQRPSFTCLRMELENILGH 299
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 64/265 (24%), Positives = 109/265 (41%), Gaps = 35/265 (13%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVV-VKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
LG G G Y+ + V VK +KE M + F E + ++H N++ L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 376 HYRTDEKLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
R ++ E++ G+LL YL R + E++ L + I+ + YL
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYL----EK 129
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---ANLAQALFAYK--APEAIQSGKV 489
+ H +L + N + + +++FG ++ A A F K APE++ K
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 490 TPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548
+ K DV+ G+++ EI T G P + V E + + R + PE
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKDY---R---MERPEGCP- 238
Query: 549 TNSPGEMEQLLEIGRACTQSDPEQR 573
E++ E+ RAC Q +P R
Sbjct: 239 -------EKVYELMRACWQWNPSDR 256
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 3e-17
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLA--- 371
E LG GG G + + G V +K+ +E S R+ + E++ + +L H NV++
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 372 ---PLAYHYRTDEKLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
L D LL EY GG L YL + E R ++ I+ + Y
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP--IR-TLLSDISSALRY 136
Query: 428 LHT-ELAHLDLPHGNLKSSNIFISPENEPL---ISEFGFYTMINSANLAQALF---AYKA 480
LH + H DL K NI + P + L I + G+ ++ L Y A
Sbjct: 137 LHENRIIHRDL-----KPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
PE ++ K T D + G + E +TG P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 23/100 (23%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L ++L N I F + L L S+N + +L +L EL
Sbjct: 93 FAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELL 151
Query: 129 LESNQFNGTIPS----FDQPTLVRLNLSSNKLEGEIPASL 164
L +N+ F +L +L LSSN+++ P
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 28/125 (22%), Positives = 40/125 (32%), Gaps = 15/125 (12%)
Query: 69 LTGLRGLRAIYLDKNQFS-------GEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK- 120
L GL L + L N + P + + L L +N F +P +FK
Sbjct: 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKD 558
Query: 121 LPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNAS----SFSG 174
L L + L N N S +Q +L LNL N + +
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 175 NAGLC 179
N C
Sbjct: 619 NPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 5/107 (4%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTE 126
L L+ + L N+ S + F L +L +N + + + F +L
Sbjct: 68 LCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLIT 125
Query: 127 LHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLLRFNASS 171
L L N + T + Q L L LS+NK++ L F SS
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 22/119 (18%), Positives = 44/119 (36%), Gaps = 13/119 (10%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMG--ALRKLWFSNNKFRGRLPPSLFKLPHLTE 126
L L+ + L N+ + D +L+KL S+N+ + P + L
Sbjct: 141 QVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFG 199
Query: 127 LHLESNQFNGTIPS-----FDQPTLVRLNLSSNKLEGEIPASLLRFNASS-----FSGN 175
L L + Q ++ ++ L+LS+++L + L ++ S N
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 27/119 (22%), Positives = 45/119 (37%), Gaps = 8/119 (6%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + +S I+ DA + L L L L N+ E+ + + + +++ S NK
Sbjct: 386 LNLTKNKISK-IESDAFSWLGHLEVL---DLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNG--TIPSF--DQPTLVRLNLSSNKLEGEIPASL 164
+ S +P L L L + PS L L+LS+N + L
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-14
Identities = 25/121 (20%), Positives = 36/121 (29%), Gaps = 14/121 (11%)
Query: 57 LSG-KIDVDALTELTGLRGLRAIYLDKNQFSG-EIPPGYFDEMGALRKLWFSNNKFRGRL 114
LS K + L+ + L + + P F + L L SNN +
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-I 495
Query: 115 PPSLFK-LPHLTELHLESNQ--------FNGTIPSF--DQPTLVRLNLSSNKLEGEIPAS 163
+ + L L L L+ N G F L LNL SN +
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 164 L 164
Sbjct: 556 F 556
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-14
Identities = 22/102 (21%), Positives = 34/102 (33%), Gaps = 6/102 (5%)
Query: 69 LTGLRGLRAIYLDKNQFS-GEIPPGYFDEMG--ALRKLWFSNNKFRGRLPPSLFKLPHLT 125
TGL L+ + L + S + F + L L + NK + L HL
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408
Query: 126 ELHLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASL 164
L L N+ + + + + LS NK S
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-14
Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 6/101 (5%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHL 124
+ L GL L + L+ N F IP F ++ L+ + N LP S+F L
Sbjct: 529 IYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNT-LPASVFNNQVSL 586
Query: 125 TELHLESNQFNGTIPSFDQP---TLVRLNLSSNKLEGEIPA 162
L+L+ N P L L++ N + +
Sbjct: 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 24/96 (25%), Positives = 36/96 (37%), Gaps = 5/96 (5%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLE 130
+ + L NQ +P F L L N L P L + LP L L+L+
Sbjct: 24 PTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQ 81
Query: 131 SNQFNGTIP-SFDQPT-LVRLNLSSNKLEGEIPASL 164
N+ + +F T L L+L SN ++
Sbjct: 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 24/104 (23%), Positives = 39/104 (37%), Gaps = 7/104 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR-LPPSLFK---LPHL 124
L+ L + ++ N G I F + L+ L SN+ R L F L
Sbjct: 325 FQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383
Query: 125 TELHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L+L N+ + +F L L+L N++ E+ R
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 23/126 (18%), Positives = 40/126 (31%), Gaps = 14/126 (11%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L +++ LS L L + L N + + F + L + N
Sbjct: 227 LSLSNSQLST-TSNTTFLGL-KWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNN 283
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIP----------SFDQ-PTLVRLNLSSNKLEG 158
+ SL L ++ L+L+ + +I SF L LN+ N + G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 159 EIPASL 164
Sbjct: 344 IKSNMF 349
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 24/110 (21%), Positives = 37/110 (33%), Gaps = 14/110 (12%)
Query: 69 LTGLRGLRAIYLDKNQFSG--------EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK 120
L GL +R + L ++ +I F + L L +N G
Sbjct: 292 LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
Query: 121 LPHLTELHLESNQF------NGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
L +L L L ++ N T S L LNL+ NK+ +
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 41/293 (13%)
Query: 317 EVLGNGGLGSSYKAMMADG------VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNV 369
LG G G Y+ + V +K + E +S R F E + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLL-YLL----HGDRGPSHDELTWPARLKIVQGIARG 424
+ L + L++ E + G L YL P + +++ IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN----LAQALFAYK- 479
+ YL H +L + N ++ + I +FG I + + L +
Sbjct: 151 MAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 480 -APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
+PE+++ G T DV+ G+++ EI T + P Q L+N V+ +V EG +
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFV----MEGGL 258
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
L P+ N P + +L+ R C Q +P+ R E + I E +
Sbjct: 259 --LDKPD-----NCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKEEMEPG 301
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 61/295 (20%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
EV+G G G Y + D + VK + + F TE + H NVL+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 372 PLAYHYRTDEKLL-VYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYL- 428
L R++ L V Y+ G L ++ + P+ +L + +A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYLA 145
Query: 429 -----HTELAHLDLPHGNLKSSNIFISPENEPLISEFG---------FYTMINSANLAQA 474
H +LA + N + + +++FG +Y++ N A
Sbjct: 146 SKKFVHRDLA----------ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG---A 192
Query: 475 LFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531
K A E++Q+ K T K DV+ G+++ E++T G P + D+ ++
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYL--- 245
Query: 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
+GR LL PE P + +++ C E R E V RI I
Sbjct: 246 -LQGRR--LLQPE-----YCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAI 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 46/294 (15%), Positives = 92/294 (31%), Gaps = 39/294 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
++LG G + ++ G +K S D E L +L H N++ A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 375 -YHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
T L+ E+ P GSL L E + + + G+ +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE--FLIVLRD-VVGGMNHLREN 131
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPL----ISEFGFYTMINSANLAQALF---AYKAPEA 483
+ H ++ K NI + +++FG + +L+ Y P+
Sbjct: 132 GIVHRNI-----KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 484 IQSGKV--------TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535
+ + D++ +G+ TG P + +V+ + + G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 536 RVTDLLDPEIASSTN----------SPGEMEQLLEIGRACTQSDPEQRLEMREA 579
++ + E S G L + ++D E+ +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 62/289 (21%), Positives = 99/289 (34%), Gaps = 61/289 (21%)
Query: 317 EVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA 371
LG G GS G V VK+++ S + F E++ L L ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 372 PLAYHYRTDEK--LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
Y + LV EY+P G L L R L L I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLG 144
Query: 430 TE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK----- 479
+ H D L + NI + E I++FG LA+ L Y
Sbjct: 145 SRRCVHRD-----LAARNILVESEAHVKIADFG---------LAKLLPLDKDYYVVREPG 190
Query: 480 -------APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531
APE++ + + DV+ G+++ E+ T + V +
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 532 FSEGRVTDLLD-------PEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
R+ +LL+ P P E+ +L+ + C P+ R
Sbjct: 251 ---SRLLELLEEGQRLPAPP-----ACPAEVHELM---KLCWAPSPQDR 288
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 26/127 (20%), Positives = 47/127 (37%), Gaps = 14/127 (11%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIP-------PGYFDEMGAL 100
T + + + K+ T L L ++ I + N+ +
Sbjct: 252 TDVEVYNCPNLTKLP----TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 101 RKLWFSNNKFR-GRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEG 158
+ ++ N + + SL K+ L L NQ G +P+F L LNL+ N++
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITE 367
Query: 159 EIPASLL 165
IPA+
Sbjct: 368 -IPANFC 373
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 18/118 (15%), Positives = 32/118 (27%), Gaps = 10/118 (8%)
Query: 56 GLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLP 115
+ D L +I L N+ + + L + S N F P
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FP 529
Query: 116 PSLFKLPHLTELHLE------SNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLL 165
L + N+ P P+L +L + SN + + +
Sbjct: 530 TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT 586
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 22/113 (19%), Positives = 42/113 (37%), Gaps = 12/113 (10%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYF-DEMGALRKLWFSNNKFRG-------RLPPSLFKLPH 123
+ + N+ IP + + + + FS N+ L P+ FK +
Sbjct: 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 124 LTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNASSFSG 174
++ ++L +NQ + L +NL N L IP + L+ +F
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKN 486
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 20/126 (15%), Positives = 36/126 (28%), Gaps = 29/126 (23%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIP------------------PGYFDEMGALRKLWFSNNK 109
+ L LR Y+ + F E +D + L + N
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPT----------LVRLNLSSNKL-EG 158
+LP L LP + +++ N+ D + + + N L
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320
Query: 159 EIPASL 164
+ SL
Sbjct: 321 PVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 19/112 (16%), Positives = 39/112 (34%), Gaps = 9/112 (8%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLT 125
T L ++ L + NQ G++P F L L + N+ +P + +
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLPA--FGSEIKLASLNLAYNQITE-IPANFCGFTEQVE 380
Query: 126 ELHLESNQFNGTIPSFDQ----PTLVRLNLSSNKLEGEIPASLLRFNASSFS 173
L N+ IP+ + ++ S N++ + + + F
Sbjct: 381 NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 23/197 (11%), Positives = 47/197 (23%), Gaps = 39/197 (19%)
Query: 11 KSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLK-GIVTGLYINSMGLSGKIDVDALTEL 69
+ +W + G GV G VTGL + G SG++ +
Sbjct: 48 SQQGFGTQPGANWNFNKELDMWGA--QPGVSLNSNGRVTGLSLEGFGASGRVP----DAI 101
Query: 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKL-------------------------- 103
L L + L + + A
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161
Query: 104 ---WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKLEG 158
+++ + + S T++ SN + L + + ++
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVA 220
Query: 159 EIPASLLRFNASSFSGN 175
E S ++
Sbjct: 221 ENICEAWENENSEYAQQ 237
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 21/106 (19%), Positives = 32/106 (30%), Gaps = 15/106 (14%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKL---------WFSNNKFRGRLPPSL 118
T L L I L N FS P + L N+ P +
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPT----QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGI 562
Query: 119 FKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
P LT+L + SN + P + L++ N + +
Sbjct: 563 TLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 9/82 (10%), Positives = 19/82 (23%), Gaps = 5/82 (6%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTE 126
+T L + + N + + L +N +
Sbjct: 560 EGITLCPSLTQLQIGSNDIRK-VNEKITPN---ISVLDIKDNPNISIDLSYVCPYIEAGM 615
Query: 127 LHLESNQFNGTIPSFDQPTLVR 148
L ++ I D + R
Sbjct: 616 YMLFYDK-TQDIRGCDALDIKR 636
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 45/274 (16%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
V+G G G Y D + +K + + +AF E + L H NVLA
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 372 PLAYHYRTDE-KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ + ++ Y+ G LL + + T + +ARG+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYL-- 140
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYK--A 480
A H +L + N + +++FG Y + A K A
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH--RHARLPVKWTA 196
Query: 481 PEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539
E++Q+ + T K DV+ G+++ E+LT G P +++ D+ ++ ++GR
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFL----AQGRR-- 246
Query: 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
L PE P + Q++ + C ++DP R
Sbjct: 247 LPQPE-----YCPDSLYQVM---QQCWEADPAVR 272
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 53/298 (17%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKE--SSAMARDAFDTEVRRLGRLRHSNVL 370
++LG G GS + + + V VK MK SS + F +E + H NV+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 371 APLA-----YHYRTDEKLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARG 424
L + +++ ++ G L YLL+ + LK + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 425 IGYL------HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQA 474
+ YL H +LA + N + + +++FG I S + A
Sbjct: 160 MEYLSNRNFLHRDLA----------ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 475 LFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASA 531
K A E++ T K DV+ G+ + EI T G P + N ++ +++
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN----HEMYDYL--- 262
Query: 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
G L PE + E+ +++ +C ++DP R ++ ++ +S
Sbjct: 263 -LHGHR--LKQPE-----DCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 21/101 (20%), Positives = 29/101 (28%), Gaps = 3/101 (2%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTE 126
GL L+ + + F + L L S + L L
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452
Query: 127 LHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPASL 164
L + N F S F T L L+LS +LE
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 23/120 (19%), Positives = 35/120 (29%), Gaps = 8/120 (6%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L I+ D GL L + + N F F L L S
Sbjct: 427 LYLDISYTNTKIDFD----GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 108 NKFRGRLPPSLFK-LPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASL 164
+ + +F L L L++ N S +L L+ S N++E
Sbjct: 483 CQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 6/100 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
+ L+ + L + + I + + L L + N + P F L L L
Sbjct: 52 FSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENL 109
Query: 128 HLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEG-EIPASL 164
+ Q TL +LN++ N + ++PA
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 20/110 (18%), Positives = 37/110 (33%), Gaps = 6/110 (5%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
+ ++L G LR + L N I F + L+ L F ++ + S F
Sbjct: 364 FSGCCSYSDL-GTNSLRHLDLSFNGAI--IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 120 K-LPHLTELHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L L L + F +L L ++ N + +++
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 25/110 (22%), Positives = 39/110 (35%), Gaps = 8/110 (7%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + + T L L L K Q +I G FD + L+ L S+N
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFL---DLSKCQLE-QISWGVFDTLHRLQLLNMSHNN 508
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPSFDQ--PTLVRLNLSSNKL 156
L S + L L+ L N+ + +L NL++N +
Sbjct: 509 LLF-LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 11/106 (10%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG-RLPPSLFKLPHLTEL 127
+GL L + + + + + ++ L+KL ++N +LP L +L +
Sbjct: 100 FSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158
Query: 128 HLESNQFNGTIPSFD-------QPTLVRLNLSSNKLEGEIPASLLR 166
L N I D + L++S N ++ I +
Sbjct: 159 DLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQ 202
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 18/104 (17%), Positives = 32/104 (30%), Gaps = 7/104 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKL-----PH 123
+ L L+ + + N P YF + L + S N + + + +
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQV 182
Query: 124 LTELHLESNQFNGTIPS-FDQPTLVRLNLSSNKLEGEIPASLLR 166
L + N + F L L L N I + L+
Sbjct: 183 NLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 25/118 (21%), Positives = 37/118 (31%), Gaps = 9/118 (7%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
I+ A L L L L N PG F + +L L K L
Sbjct: 70 TIEDKAWHGLHHLSNL---ILTGNPIQS-FSPGSFSGLTSLENLVAVETKLAS-LESFPI 124
Query: 120 K-LPHLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLLRFNASSFS 173
L L +L++ N + F LV ++LS N ++ L +
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 20/93 (21%), Positives = 29/93 (31%), Gaps = 5/93 (5%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQ 133
+ I L N + F L+ L S + + + L HL+ L L N
Sbjct: 34 TKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNP 91
Query: 134 FNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASL 164
P SF +L L KL +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 15/87 (17%), Positives = 29/87 (33%), Gaps = 7/87 (8%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L ++ L I L L+ L + N + +++++ +L L S N+
Sbjct: 478 LDLSKCQLEQ-ISWGVFDTLHRLQLL---NMSHNNLLF-LDSSHYNQLYSLSTLDCSFNR 532
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFN 135
L L +L +N
Sbjct: 533 IET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 20/125 (16%), Positives = 35/125 (28%), Gaps = 11/125 (8%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE-----IPPGYFDEMGALRKLW 104
L + S I L L GL R L +F E P + + +
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHR---LILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 105 F--SNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPA 162
F + L +++ + L L++ +L+ + P
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPT 324
Query: 163 SLLRF 167
L F
Sbjct: 325 LDLPF 329
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 18/100 (18%), Positives = 29/100 (29%), Gaps = 8/100 (8%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF---KLPHLTEL 127
L L+++ L N+ S + +L L S N + L L
Sbjct: 326 DLPFLKSLTLTMNKGSI---SFKKVALPSLSYLDLSRNALSF-SGCCSYSDLGTNSLRHL 381
Query: 128 HLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L N +F L L+ + L+ S
Sbjct: 382 DLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 23/123 (18%), Positives = 40/123 (32%), Gaps = 7/123 (5%)
Query: 50 LYINSMGLSG-KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNN 108
+ I+ L+ D + + L + A+ L + + L
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPK--HFKWQSLSIIRC 317
Query: 109 KFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFN 168
+ + P LP L L L N+ + + P+L L+LS N L S
Sbjct: 318 QLKQ-FPT--LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 169 ASS 171
+S
Sbjct: 375 TNS 377
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 67/277 (24%), Positives = 113/277 (40%), Gaps = 52/277 (18%)
Query: 317 EVLGNGGLGSSYKAM-----MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
+V+G G G YK M V V +K +K + R F E +G+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL-- 428
+ +++ EY+ G+L L G E + + +++GIA G+ YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN 165
Query: 429 ----HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ-----ALFAYK 479
H +LA + NI ++ +S+FG ++ A +
Sbjct: 166 MNYVHRDLA----------ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 480 --APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGR 536
APEAI K T DV+ GI++ E++T G+ P L+N +V++ + F R
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGF---R 268
Query: 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
L P + P + QL+ C Q + +R
Sbjct: 269 ---LPTPM-----DCPSAIYQLM---MQCWQQERARR 294
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 23/116 (19%), Positives = 46/116 (39%), Gaps = 10/116 (8%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
V + ++ ++ +++ + + L L+ L +++ I F + +L L
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFL---KVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 107 NNKFRGRLPPSLF-KLPHLTELHLESNQFNGT-IP--SFDQPT-LVRLNLSSNKLE 157
N+F +L F L +L L L +G + F T L L L N ++
Sbjct: 88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 25/92 (27%), Positives = 38/92 (41%), Gaps = 7/92 (7%)
Query: 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELH 128
+ L + L +N+ + +I F + L KL S N G + +F L L L
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLD 353
Query: 129 LESNQFNGTIP--SFDQ-PTLVRLNLSSNKLE 157
L N + SF P L L L +N+L+
Sbjct: 354 LSYNHI-RALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 10/99 (10%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
KID +A LT L L L +N I F+ + L L S N R L F
Sbjct: 313 KIDDNAFWGLTHLLKL---NLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSF 367
Query: 120 -KLPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSN 154
LP+L EL L++NQ ++P FD+ +L ++ L +N
Sbjct: 368 LGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 23/93 (24%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESN 132
G++ L K++ + F L +L + N+ ++ + F L HL +L+L N
Sbjct: 276 GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 133 QFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPA 162
G+I S F+ L L+LS N + +
Sbjct: 334 FL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGD 364
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 15/76 (19%), Positives = 31/76 (40%), Gaps = 8/76 (10%)
Query: 66 LTEL-----TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF- 119
L + L L + L N + F + L++L N+ + +P +F
Sbjct: 335 LGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
Query: 120 KLPHLTELHLESNQFN 135
+L L ++ L +N ++
Sbjct: 393 RLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 21/113 (18%), Positives = 32/113 (28%), Gaps = 17/113 (15%)
Query: 58 SGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPS 117
+ + LT L L L N P +F M L + NK + +
Sbjct: 117 GAVLSGNFFKPLTSLEML---VLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEE 172
Query: 118 LFK---LPHLTELHLESNQF---------NGTIPSFD-QPTLVRLNLSSNKLE 157
H T L L S + ++ L+LS N +
Sbjct: 173 DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 18/127 (14%), Positives = 34/127 (26%), Gaps = 26/127 (20%)
Query: 64 DALTELTGLRGLRAIYLDKNQFS-------GEIPPGYFDEMGALRKLWFSNNKFRGRLPP 116
+ L G + L G G + ++ L S N F+ +
Sbjct: 172 EDLLNFQGKH-FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 117 SLFKLPHLTELH-------------LESNQF----NGTIPSFDQPTLVRLNLSSNKLEGE 159
F T++ F N T + + +LS +K+
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-A 289
Query: 160 IPASLLR 166
+ S+
Sbjct: 290 LLKSVFS 296
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 17/122 (13%), Positives = 31/122 (25%), Gaps = 18/122 (14%)
Query: 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW----------FSNNKFRGRLPPSLF 119
+R + L N+ I + + F
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 120 KLPHLTELHLESNQFNGTIPS--FDQPTLVRL-----NLSSNKLEGEIPASLLRFNASSF 172
K +T L L N F ++ FD ++ + S N + + +F
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 173 SG 174
G
Sbjct: 270 KG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 9e-04
Identities = 15/51 (29%), Positives = 24/51 (47%), Gaps = 4/51 (7%)
Query: 61 IDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFR 111
+ + L L+ L LD NQ +P G FD + +L+K+W N +
Sbjct: 362 LGDQSFLGLPNLKEL---ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 43/294 (14%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
EV+G G G Y + D + VK + + F TE + H NVL+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 372 PLAYHYRTDEKLL-VYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L R++ L V Y+ G L ++ + P+ +L + +A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL- 208
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL------AQALFAYK--AP 481
A H +L + N + + +++FG + A K A
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540
E++Q+ K T K DV+ G+++ E++T G P + D+ ++ +GR L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYL----LQGRR--L 315
Query: 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMD 594
L PE P + +++ C E R E V RI I +
Sbjct: 316 LQPE-----YCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 61/279 (21%), Positives = 104/279 (37%), Gaps = 57/279 (20%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
+++G+G G + V V +K +K + R F +E +G+ H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL--- 428
R ++V EY+ GSL L G + T + +++G+ G+ YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 429 ---HTELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFA 477
H +LA + N+ + +S+FG +
Sbjct: 171 GYVHRDLA----------ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG---GKIP 217
Query: 478 YK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534
+ APEAI + DV+ G+++ E+L G+ P +TN DV+ V +
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISSVEEGY-- 271
Query: 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
R L P P + QL+ C D QR
Sbjct: 272 -R---LPAPM-----GCPHALHQLM---LDCWHKDRAQR 298
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 63/290 (21%), Positives = 98/290 (33%), Gaps = 62/290 (21%)
Query: 317 EVLGNGGLGSSYKAMMA-----DGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
LG G G G V VK +K S E+ L L H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 371 APLAYHYRTDEK--LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
L+ E++P GSL L ++ ++ +LK I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYL 142
Query: 429 HTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK---- 479
+ H DL + N+ + E++ I +FG L +A+ Y
Sbjct: 143 GSRQYVHRDL-----AARNVLVESEHQVKIGDFG---------LTKAIETDKEYYTVKDD 188
Query: 480 --------APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
APE + K DV+ G+ + E+LT S + I +
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 531 AFSEGRVTDLLD-------PEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
R+ + L P N P E+ QL+ R C + P R
Sbjct: 249 VT---RLVNTLKEGKRLPCPP-----NCPDEVYQLM---RKCWEFQPSNR 287
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 53/276 (19%), Positives = 100/276 (36%), Gaps = 54/276 (19%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
+G G G ++ + + V +K K +S R+ F E + + H +++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 372 PLAYHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYL- 428
+ T+ + ++ E G L +L L + ++ + YL
Sbjct: 81 LIGVI--TENPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE 133
Query: 429 -----HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---LAQALFAYK- 479
H ++A + N+ +S + + +FG + + ++ K
Sbjct: 134 SKRFVHRDIA----------ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 480 -APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
APE+I + T DV+ G+ + EIL G P Q + N DV+ + + R
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGE---R- 235
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
L P N P + L+ C DP +R
Sbjct: 236 --LPMPP-----NCPPTLYSLM---TKCWAYDPSRR 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 54/291 (18%), Positives = 99/291 (34%), Gaps = 47/291 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
LG G G +K G+ + K + E R+ E++ L ++
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
Y E + E++ GGSL +L L K+ + +G+ YL +
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKH-- 151
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-------FAYKAPEAIQSG 487
+ H ++K SNI ++ E + +FG S L ++ +Y +PE +Q
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQGT 205
Query: 488 KVTPKCDVYCLGIIILEILTGKFP---SQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544
+ + D++ +G+ ++E+ G++P VE A+ T
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 545 IASSTNSPGE--MEQLLEIG--------------------RACTQSDPEQR 573
+ P E L I C +P +R
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E +G G G +K + V +K + E + + E+ L + V
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK--- 84
Query: 375 YH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
Y+ Y D KL ++ EY+ GGS L LL L I++ I +G+ YLH+E
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHSE 138
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQS 486
H D+ K++N+ +S E +++FG + + + F + APE I+
Sbjct: 139 KKIHRDI-----KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 487 GKVTPKCDVYCLGIIILEILTGKFP 511
K D++ LGI +E+ G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 39/280 (13%), Positives = 79/280 (28%), Gaps = 56/280 (20%)
Query: 317 EVLGNGGLGSSYKAMMADGV---TVVVKRMKESSAMA---RDAFDTEVRRLGRLRHSNVL 370
G ++A+ D V + + + + RL R+ V
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L + L+V E+I GGSL + P ++ +Q +A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP-------VGAIRAMQSLAAAADAAH- 146
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVT 490
+ S + +S + + ++ A A
Sbjct: 147 ---RAGVALSIDHPSRVRVSIDGDVVL----------------AYPATMPD-------AN 180
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
P+ D+ +G + +L ++P +G +A A D I +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSG-------LAPA-----ERDTAGQPIEPADI 228
Query: 551 SPGEMEQLLEIGRACTQSDPEQRL--EMREAVRRIVEIQQ 588
Q+ + Q D R + +++ +
Sbjct: 229 DRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVAD 268
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 25/102 (24%), Positives = 40/102 (39%), Gaps = 7/102 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
GL L + + N F P F E+ L L S + +L P+ F L L L
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVL 204
Query: 128 HLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASLLR 166
++ N F ++ +F +L L+ S N + L+
Sbjct: 205 NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 21/102 (20%), Positives = 33/102 (32%), Gaps = 6/102 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
GL L + + F + L L S+ R +F L L L
Sbjct: 97 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVL 155
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+ N F F + L L+LS +LE ++ +
Sbjct: 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 196
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 22/125 (17%), Positives = 36/125 (28%), Gaps = 12/125 (9%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFS-GEIPPGYFDEMGALRKLWF 105
T L + S L + +LT L L L N S +L+ L
Sbjct: 30 ATRLELESNKLQ-SLPHGVFDKLTQLTKL---SLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 106 SNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS---FDQ-PTLVRLNLSSNKLEGEIP 161
S N + + L L L + + + F L+ L++S
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAF 142
Query: 162 ASLLR 166
+
Sbjct: 143 NGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 25/93 (26%), Positives = 37/93 (39%), Gaps = 8/93 (8%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
T LR L + L + Q ++ P F+ + +L+ L S+N F L +K L L L
Sbjct: 171 FTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVL 228
Query: 128 HLESNQFNGTIP--SFD--QPTLVRLNLSSNKL 156
N T +L LNL+ N
Sbjct: 229 DYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 17/88 (19%), Positives = 32/88 (36%), Gaps = 8/88 (9%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L ++ L ++ A L+ L+ L + N F + + + +L+ L +S N
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVL---NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234
Query: 110 FRGRLPPSLFK--LPHLTELHLESNQFN 135
+ L L+L N F
Sbjct: 235 IM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 11/93 (11%)
Query: 78 IYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFN- 135
I + + +P G +L +NK + LP +F KL LT+L L SN +
Sbjct: 12 IRCNSKGLT-SVPTGIPSS---ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 136 GTIPSF---DQPTLVRLNLSSNKLEGEIPASLL 165
S +L L+LS N + + ++ L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 98
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 47/204 (23%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G G G+ Y AM +A G V +++M ++ E+ + ++ N++ Y
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN---Y 82
Query: 376 H--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
Y ++L +V EY+ GGSL ++ + + + + + +LH+
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSG 487
+ H D +KS NI + + +++FGF I ++ + APE +
Sbjct: 137 VIHRD-----IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
PK D++ LGI+ +E++ G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 28/102 (27%), Positives = 42/102 (41%), Gaps = 8/102 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTEL 127
T L L ++ L N + I F + LR L S+N L LF L L L
Sbjct: 60 PTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVL 117
Query: 128 HLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L +N + +F+ L +L LS N++ P L++
Sbjct: 118 LLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 33/124 (26%), Positives = 54/124 (43%), Gaps = 13/124 (10%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L ++ L+ I +A + LR L L N + F ++ AL L N
Sbjct: 67 HSLLLSHNHLN-FISSEAFVPVPNLRYL---DLSSNHLH-TLDEFLFSDLQALEVLLLYN 121
Query: 108 NKFRGRLPPSLF-KLPHLTELHLESNQF----NGTIPSFDQ-PTLVRLNLSSNKLEGEIP 161
N + + F + L +L+L NQ I ++ P L+ L+LSSNKL+ ++P
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLP 179
Query: 162 ASLL 165
+ L
Sbjct: 180 LTDL 183
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 20/110 (18%)
Query: 73 RGLRAI-----------YLDKNQFSGEIPPGY-FDEMGALRKLWFSNNKFRGRLPPSLF- 119
+ L + L N S + + + L L S+N + F
Sbjct: 28 QQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFV 85
Query: 120 KLPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+P+L L L SN + T+ F L L L +N + + +
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 4/103 (3%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTE 126
+L L L+++ L N+ + F E L L + + + + S F+ L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 127 LHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLLRF 167
L+L + + + FD P L LNL N
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 19/101 (18%), Positives = 28/101 (27%), Gaps = 5/101 (4%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLT 125
T + L L + L + Q I F L L + N + + L
Sbjct: 51 TTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALK 108
Query: 126 ELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASL 164
L + +Q TL L L SN +
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 21/100 (21%), Positives = 34/100 (34%), Gaps = 5/100 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSG--EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLT 125
GL L+ + L N F +G L L S + F L +
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSLKMMN 503
Query: 126 ELHLESNQFNGTIPS-FDQPTLVRLNLSSNKLEGEIPASL 164
+ L N+ + + LNL+SN + +P+ L
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLL 543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 25/113 (22%), Positives = 43/113 (38%), Gaps = 7/113 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L+G + L+ ++ + S I L L+ +N P F L L
Sbjct: 101 LSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 129 LESNQFN----GTIPSFDQPTLVRLNLSSNKLEGEIPAS--LLRFNASSFSGN 175
++N + + S Q T + LNL+ N + G P + F + +F G
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 24/117 (20%), Positives = 37/117 (31%), Gaps = 11/117 (9%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTE 126
L GL L+ + L N+F + +L L N R L + L +L E
Sbjct: 296 GLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 127 LHLESNQFNGTIPSFDQ----PTLVRLNLSSNKLEGEIPASLLRFNAS----SFSGN 175
L L + + Q L LNLS N+ + + +
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFT 410
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 21/102 (20%), Positives = 31/102 (30%), Gaps = 7/102 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L + L + + F + L+ L S++ LF LP L L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPALQHL 454
Query: 128 HLESNQFNGTIP----SFDQ-PTLVRLNLSSNKLEGEIPASL 164
+L+ N F S L L LS L +
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 25/120 (20%), Positives = 36/120 (30%), Gaps = 9/120 (7%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSG-EIPPGYFDEMGALRKLWFSNN 108
L I ++ L L LR + L + + + L+ L S N
Sbjct: 330 LSIKGNTKRLELGTGCLE---NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 109 KFRGRLPPSLFK-LPHLTELHLESNQFNGTIP--SFDQPT-LVRLNLSSNKLEGEIPASL 164
+ L FK P L L L + F L LNLS + L+
Sbjct: 387 EPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 26/114 (22%), Positives = 40/114 (35%), Gaps = 13/114 (11%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
GL+ + L S E+P G + L+KL S NKF L P LT L
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSG-LVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHL 330
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGL 178
++ N + + + L L+LS + +E + L
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIET------SDCCNLQLRNLSHL 378
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 14/96 (14%), Positives = 23/96 (23%), Gaps = 5/96 (5%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLE 130
+ N I F + L L + + + F+ L L L
Sbjct: 32 PNSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLT 89
Query: 131 SNQFNGTIP-SFDQPT-LVRLNLSSNKLEGEIPASL 164
+N + P L L + L
Sbjct: 90 ANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 21/100 (21%), Positives = 38/100 (38%), Gaps = 8/100 (8%)
Query: 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGA--LRKLWFSNNKFRGRLPPSLFK-LPHLTE 126
+ ++ L + +I P F+ + + + + F + + F L E
Sbjct: 225 STIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQE 282
Query: 127 LHLESNQFNGTIPS--FDQPTLVRLNLSSNKLEGEIPASL 164
L L + + +PS TL +L LS+NK E S
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 16/121 (13%), Positives = 27/121 (22%), Gaps = 13/121 (10%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALR--KLWFSNNKFRGRLPPSLFKLPH 123
L + L+ + N + + L + N G + P F
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAV 203
Query: 124 LTELHLESNQFNGTIPSFDQ----PTLVRLNLSSNKLEGEIPASLLRFNASS-----FSG 174
L+ Q I + +L E PA S
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 175 N 175
+
Sbjct: 264 H 264
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 23/110 (20%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L ++ LS ID A T L + + L N+ + + + L ++N
Sbjct: 481 LVLSFCDLSS-IDQHAFTSLKMMNHV---DLSHNRLTS-SSIEALSHLKGIY-LNLASNH 534
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
+ PSL L ++L N + T + L + KLE
Sbjct: 535 ISI-ILPSLLPILSQQRTINLRQNPLDCTCSN--IYFLEWYKENMQKLED 581
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 32/142 (22%), Positives = 53/142 (37%), Gaps = 16/142 (11%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L+++ GL ++ L L+ L YL N +P F ++G L L+ N+
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYL---YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLL 165
+P F+ L L L L N+ + F L+ L L +N L +P L
Sbjct: 165 IS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEAL 221
Query: 166 RFNAS----SFSGNAGLCGKNL 183
+ + N +C
Sbjct: 222 APLRALQYLRLNDNPWVCDCRA 243
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 66 LTEL-TGL-RGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LP 122
L + G+ + I+L N+ S +P F L LW +N R+ + F L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80
Query: 123 HLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L +L L N ++ F L L+L L+ E+ L R
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 58/281 (20%), Positives = 104/281 (37%), Gaps = 62/281 (22%)
Query: 317 EVLGNGGLGSSYKAMMADG-----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
+VLG+G G+ YK + + V +K ++E +S A E + + + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L + L+ + +P G LL + + + L IA+G+ YL
Sbjct: 81 RLLGIC--LTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYL- 133
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK------ 479
L H +L + N+ + I++FG LA+ L A Y
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFG---------LAKLLGAEEKEYHAEGGKV 181
Query: 480 -----APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFS 533
A E+I T + DV+ G+ + E++T G P + ++ +
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL----E 233
Query: 534 EG-RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
+G R L P I ++ ++ R C D + R
Sbjct: 234 KGER---LPQPPIC-----TIDVYMIM---RKCWMIDADSR 263
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 22/206 (10%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVK---RMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
VLG G G G VK + + +++ EV+ L +L H N++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
+ + LV E GG L D S + +I++ + GI Y+H
Sbjct: 92 YEF-FEDKGYFYLVGEVYTGGELF-----DEIISRKRFSEVDAARIIRQVLSGITYMH-- 143
Query: 432 LAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQ 485
+ H +LK N+ S ++ + I +FG T ++ + Y APE +
Sbjct: 144 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP 511
G KCDV+ G+I+ +L+G P
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 47/303 (15%), Positives = 94/303 (31%), Gaps = 39/303 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
++LG G + ++ G +K S D E L +L H N++ A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 375 -YHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
T L+ E+ P GSL L E + + + G+ +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE--FLIVLRD-VVGGMNHLREN 131
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPL----ISEFGFYTMINSANLAQALF---AYKAPEA 483
+ H ++ K NI + +++FG + +L+ Y P+
Sbjct: 132 GIVHRNI-----KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 484 IQSGKV--------TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535
+ + D++ +G+ TG P + +V+ + + G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 536 RVTDLLDPEIASSTN----------SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE 585
++ + E S G L + ++D E+ + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
Query: 586 IQQ 588
I
Sbjct: 307 ILH 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 49/234 (20%)
Query: 319 LGNGGLGSSYKA---MMADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
LG G GS + M + V +K +K+ + + E + + +L + ++ +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL----- 428
E L LV E GG L L G R E+ +++ ++ G+ YL
Sbjct: 78 VC--QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 429 -HTELAHLDLPHGNLKSSNIFISPENEPLISEFG----------FYTMINSANLAQALFA 477
H +LA + N+ + + IS+FG +YT + +
Sbjct: 132 VHRDLA----------ARNVLLVNRHYAKISDFGLSKALGADDSYYTA-----RSAGKWP 176
Query: 478 YK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
K APE I K + + DV+ G+ + E L+ G+ P + + +V+ ++
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
EV+G+G A V +KR+ E + D E++ + + H N+++
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS--- 77
Query: 375 YH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLK------IVQGIARGI 425
Y+ + ++L LV + + GGS+L ++ + L I++ + G+
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK------ 479
YLH + H ++K+ NI + + I++FG SA LA +
Sbjct: 135 EYLHKN-GQI---HRDVKAGNILLGEDGSVQIADFGV-----SAFLATGGDITRNKVRKT 185
Query: 480 --------APEAIQSGKV-TPKCDVYCLGIIILEILTGKFP 511
APE ++ + K D++ GI +E+ TG P
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 30/94 (31%), Positives = 35/94 (37%), Gaps = 12/94 (12%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
L EL L YL N+ +PPG L KL +NN LP L L
Sbjct: 121 RGLGELQEL------YLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLE 172
Query: 123 HLTELHLESNQFNGTIPS--FDQPTLVRLNLSSN 154
+L L L+ N TIP F L L N
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 13/122 (10%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
T L+++ L + L T L L LD+ + + ++ + L L S+
Sbjct: 34 TILHLSENLLY-TFSLATLMPYTRLTQL---NLDRAELT-KLQV--DGTLPVLGTLDLSH 86
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPASL 164
N+ + LP LP LT L + N+ ++P L L L N+L+ +P L
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGL 143
Query: 165 LR 166
L
Sbjct: 144 LT 145
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 35/108 (32%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 66 LTEL---TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KL 121
LT+L L L + L NQ +P + AL L S N+ LP L
Sbjct: 67 LTKLQVDGTLPVLGTLDLSHNQLQ-SLPLL-GQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 122 PHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L EL+L+ N+ T+P P L +L+L++N L E+PA LL
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLN 169
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 17/76 (22%), Positives = 29/76 (38%), Gaps = 8/76 (10%)
Query: 89 IPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPSFDQ-PTL 146
+PP + L S N + LT+L+L+ + + P L
Sbjct: 25 LPPDLPKD---TTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVL 79
Query: 147 VRLNLSSNKLEGEIPA 162
L+LS N+L+ +P
Sbjct: 80 GTLDLSHNQLQ-SLPL 94
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 59/298 (19%)
Query: 317 EVLGNGGLGSSYKAMMADG------VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNV 369
E LG G YK + V +K +K+ + R+ F E RL+H NV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSH-----------DELTWPARLKIV 418
+ L + +++ Y G L L S L P + +V
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 419 QGIARGIGYL------HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470
IA G+ YL H +LA + N+ + + IS+ G + + +A+
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLA----------TRNVLVYDKLNVKISDLGLFREVYAADYY 184
Query: 471 --LAQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVV 525
L +L + APEAI GK + D++ G+++ E+ + G P +N DVV
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVV 240
Query: 526 EWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
E + +V L P+ + P + L+ C P +R ++ R+
Sbjct: 241 EMI----RNRQV--LPCPD-----DCPAWVYALM---IECWNEFPSRRPRFKDIHSRL 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+G G G A G V VK M R+ EV + +H NV+
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---M 107
Query: 376 H--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
+ Y E+L ++ E++ GG+L ++ L + + + + + YLH +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSG 487
+ H D +KS +I ++ + +S+FGF I+ + + APE I
Sbjct: 162 VIHRD-----IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS 216
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
+ D++ LGI+++E++ G+ P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 19/108 (17%), Positives = 36/108 (33%), Gaps = 11/108 (10%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF--KLPH 123
L L + LD NQ EIP + + L FS+NK + +P +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYV 645
Query: 124 LTELHLESNQFNG-------TIPSFDQPTLVRLNLSSNKLEGEIPASL 164
+ + N+ ++ + + LS N+++
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 18/106 (16%), Positives = 31/106 (29%), Gaps = 10/106 (9%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
L I L N+ + + L + S N F P L
Sbjct: 723 NYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF 781
Query: 128 HLE------SNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLL 165
+ N+ P P+L++L + SN + ++ L
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLT 826
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 23/133 (17%), Positives = 38/133 (28%), Gaps = 30/133 (22%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIP------------------PGYFDEMGALRKLWFSNNK 109
+ L L+ IY + F+ + + + L + N
Sbjct: 443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-----------PTLVRLNLSSNKLEG 158
+LP L+ LP L L++ N+ P + + N LE
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE- 561
Query: 159 EIPASLLRFNASS 171
E PAS
Sbjct: 562 EFPASASLQKMVK 574
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 23/100 (23%), Positives = 34/100 (34%), Gaps = 7/100 (7%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+ ++ Y+ N +M L L +NK R + LT+L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDL 600
Query: 128 HLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASL 164
L+ NQ IP + L S NKL+ IP
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 17/100 (17%), Positives = 27/100 (27%), Gaps = 12/100 (12%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFR-------GRLPPSLFKLPHLTEL 127
+ L N+ P F + + SNN + LT +
Sbjct: 675 ASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733
Query: 128 HLESNQFNGTIPSFDQ---PTLVRLNLSSNKLEGEIPASL 164
L N+ F P L +++S N P
Sbjct: 734 DLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQP 772
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 9e-13
Identities = 20/133 (15%), Positives = 37/133 (27%), Gaps = 36/133 (27%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG---------RLPPSL 118
+ L+ L + L ++P ++ L+ L + N+ RL
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDF-LYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544
Query: 119 FKLPHLTELHLESNQFNG------------------------TIPSFDQPT-LVRLNLSS 153
P + ++ N + +F L L L
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDY 604
Query: 154 NKLEGEIPASLLR 166
N++E EIP
Sbjct: 605 NQIE-EIPEDFCA 616
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 17/119 (14%), Positives = 38/119 (31%), Gaps = 12/119 (10%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGY-FDEMGALRKLWFSNNKFRGRLPPSLF------KL 121
+ + N+ IP + + + + FS NK ++ K
Sbjct: 615 CAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKG 672
Query: 122 PHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGL 178
+ + + L N+ + + LS+N + IP + L+ ++ L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 14/112 (12%), Positives = 31/112 (27%), Gaps = 18/112 (16%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGA-----LRKLWFSNNKFRGRLPPSLF-KL 121
+ + ++ N+ M + S N+ + P LF
Sbjct: 639 NAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATG 696
Query: 122 PHLTELHLESNQ--------FNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASL 164
++ + L +N ++ L ++L NKL +
Sbjct: 697 SPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDF 747
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 7e-12
Identities = 19/120 (15%), Positives = 37/120 (30%), Gaps = 18/120 (15%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW---------FSNNKFRGRLPPSL 118
T L L + + N FS P + +L N+ + P +
Sbjct: 748 RATTLPYLSNMDVSYNCFS-SFPT----QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
Query: 119 FKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKL-EGEIPASL--LRFNASSFSGN 175
P L +L + SN + P L L+++ N ++ + + +
Sbjct: 803 TTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 14/86 (16%), Positives = 32/86 (37%), Gaps = 2/86 (2%)
Query: 87 GEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQP 144
G+ P D G + L + +GR+P ++ +L L L ++ + F ++
Sbjct: 312 GDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL 371
Query: 145 TLVRLNLSSNKLEGEIPASLLRFNAS 170
T +++ L ++
Sbjct: 372 TPDMSEERKHRIRMHYKKMFLDYDQR 397
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 24/227 (10%), Positives = 51/227 (22%), Gaps = 80/227 (35%)
Query: 12 SSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLK-GIVTGLYINSMGLSGKIDVDALTELT 70
+ N +W + G+ GV G VTGL + G G++ +
Sbjct: 291 GTINNTIHSLNWNFNKELDMWGD--QPGVDLDNNGRVTGLSLAGFGAKGRVP----DAIG 344
Query: 71 GLRGLRAIYLDKNQFSG------------------------EIPPGYFDEMGALRKLWFS 106
L L+ + + + + D L
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404
Query: 107 NNKFRG----------------------------RLPPSLFKLPHLTELHLESNQFNGTI 138
+ + ++ +L L ++ ++ F
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 139 P--------------------SFDQ-PTLVRLNLSSNKLEGEIPASL 164
S+ L + L + ++P L
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 14/95 (14%), Positives = 30/95 (31%), Gaps = 8/95 (8%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
++L + N+ + P G +L +L +N R + L P L
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTG-ITTCPSLIQLQIGSNDIRK-VDEKL--TPQLY 830
Query: 126 ELHLESNQF----NGTIPSFDQPTLVRLNLSSNKL 156
L + N ++ + + + L +
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 53/275 (19%), Positives = 101/275 (36%), Gaps = 52/275 (18%)
Query: 317 EVLGNGGLGSSYKAMMADG----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
+G G G ++ + + V +K K +S R+ F E + + H +++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 372 PLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL-- 428
+ T+ + ++ E G L L + L + + ++ + YL
Sbjct: 456 LIGVI--TENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLES 509
Query: 429 ----HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---LAQALFAYK-- 479
H ++A + N+ +S + + +FG + + ++ K
Sbjct: 510 KRFVHRDIA----------ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538
APE+I + T DV+ G+ + EIL G P Q + N DV+ + + R
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENG---ER-- 610
Query: 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
L P N P + L+ C DP +R
Sbjct: 611 -LPMPP-----NCPPTLYSLM---TKCWAYDPSRR 636
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 42/215 (19%)
Query: 317 EVLGNGGLGSSYKAM-----MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA 371
+ LG G GS G V VK+++ S+ F+ E+ L L+H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 372 PLAYHYRTDEK--LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
Y + L+ EY+P GSL L + + L+ I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLG 162
Query: 430 TE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK----- 479
T+ H DL + NI + EN I +FG L + L YK
Sbjct: 163 TKRYIHRDL-----ATRNILVENENRVKIGDFG---------LTKVLPQDKEYYKVKEPG 208
Query: 480 -------APEAIQSGKVTPKCDVYCLGIIILEILT 507
APE++ K + DV+ G+++ E+ T
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 74/304 (24%), Positives = 118/304 (38%), Gaps = 49/304 (16%)
Query: 317 EVLGNGGLGSSYKAMMAD------GVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSN 368
+ LG G G +A +TV VK +K S R+A +E++ L L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPAR-------------L 415
++ L L++ EY G LL L R T PA L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL---- 471
+A+G+ +L A + H +L + NI ++ I +FG I + +
Sbjct: 149 SFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 472 AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
A K APE+I + T + DV+ GI + E+ + G P G+ V
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVDSKF 257
Query: 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
EG +L PE ++P EM ++ + C +DP +R ++ V+ I +
Sbjct: 258 YKMIKEGFR--MLSPE-----HAPAEMYDIM---KTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 589 SDGN 592
N
Sbjct: 308 ESTN 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 42/215 (19%)
Query: 317 EVLGNGGLGSSYKAM-----MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA 371
+ LG G GS G V VK+++ S+ F+ E+ L L+H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 372 PLAYHYRTDEK--LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
Y + L+ EY+P GSL L + + L+ I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLG 131
Query: 430 TE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK----- 479
T+ H DL + NI + EN I +FG L + L +K
Sbjct: 132 TKRYIHRDL-----ATRNILVENENRVKIGDFG---------LTKVLPQDKEFFKVKEPG 177
Query: 480 -------APEAIQSGKVTPKCDVYCLGIIILEILT 507
APE++ K + DV+ G+++ E+ T
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 28/120 (23%), Positives = 45/120 (37%), Gaps = 10/120 (8%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + L+ I +AL+ L GL + L + I F + L+ L S+
Sbjct: 157 LTLEKCNLT-SIPTEALS---HLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWP 211
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+ + P+ +LT L + +P L LNLS N + I S+L
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 29/102 (28%), Positives = 38/102 (37%), Gaps = 8/102 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L LR + L N+ IP G F + L KL S NK L +F+ L +L L
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSL 133
Query: 128 HLESNQFNGTIPS---FDQPTLVRLNLSSNKLEGEIPASLLR 166
+ N I +L +L L L IP L
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALS 173
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 29/114 (25%), Positives = 45/114 (39%), Gaps = 11/114 (9%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
+T L I L+ + A+ L LR + L N S I E+ L+++
Sbjct: 226 LTSLSITHCNLT-AVPYLAVR---HLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLV 280
Query: 107 NNKFRGRLPPSLFK-LPHLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSNKL 156
+ + P F+ L +L L++ NQ T+ F L L L SN L
Sbjct: 281 GGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 19/102 (18%), Positives = 31/102 (30%), Gaps = 7/102 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L L+++ + N I F + +L +L +P L L L
Sbjct: 124 FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVL 181
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L N I F + L L +S + + L
Sbjct: 182 RLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 26/134 (19%), Positives = 44/134 (32%), Gaps = 16/134 (11%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L I+ + + L L L ++ + + +P + LR L S N
Sbjct: 205 LEISHWPYLDTMTPNCLYGLN----LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLL 165
+ S+ L L E+ L Q + F L LN+S N+L + S+
Sbjct: 260 IS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVF 316
Query: 166 RFNAS----SFSGN 175
+ N
Sbjct: 317 HSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 21/68 (30%), Positives = 30/68 (44%), Gaps = 3/68 (4%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L L L+ I L Q + + P F + LR L S N+ L S+F + +L L
Sbjct: 268 LHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETL 325
Query: 128 HLESNQFN 135
L+SN
Sbjct: 326 ILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 26/95 (27%), Positives = 37/95 (38%), Gaps = 11/95 (11%)
Query: 76 RAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQF 134
RA+ + +F +P G E R L N+ + L F PHL EL L N
Sbjct: 14 RAVLCHRKRFV-AVPEGIPTE---TRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV 68
Query: 135 NGTIPSF---DQPTLVRLNLSSNKLEGEIPASLLR 166
+ + L L L SN+L+ IP +
Sbjct: 69 -SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 5/64 (7%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
+ + L+ ++ A GL LR + + NQ + + F +G L L +
Sbjct: 275 QEIQLVGGQLA-VVEPYAFR---GLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS 329
Query: 108 NKFR 111
N
Sbjct: 330 NPLA 333
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 21/205 (10%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPL 373
+ LG+G G V +K ++++ S + EV L L H N++
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ + LV E GG L D + I++ + G+ YLH
Sbjct: 103 DF-FEDKRNYYLVMECYKGGELF-----DEIIHRMKFNEVDAAVIIKQVLSGVTYLH--- 153
Query: 433 AHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQS 486
++ H +LK N+ S ++ + I +FG + + + Y APE ++
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR- 211
Query: 487 GKVTPKCDVYCLGIIILEILTGKFP 511
K KCDV+ +G+I+ +L G P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 23/204 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E LG G GS YKA+ G V +K++ S + E+ + + +V+ Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVK---Y 89
Query: 376 H--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
+ Y + L +V EY GS+ ++ LT I+Q +G+ YLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHFMR 145
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSG 487
H D+ K+ NI ++ E +++FG + + + APE IQ
Sbjct: 146 KIHRDI-----KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 488 KVTPKCDVYCLGIIILEILTGKFP 511
D++ LGI +E+ GK P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 21/90 (23%), Positives = 40/90 (44%), Gaps = 7/90 (7%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHL 129
L LR I N+ + +I G F+ + ++ ++N+ + +F L L L L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLML 112
Query: 130 ESNQFNGTIP--SFDQ-PTLVRLNLSSNKL 156
SN+ + SF ++ L+L N++
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 7/88 (7%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHL 129
G G+ I L N+ + F + +L+ L +N+ + F L + L L
Sbjct: 79 GASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136
Query: 130 ESNQFNGTIP--SFDQ-PTLVRLNLSSN 154
NQ T+ +FD +L LNL +N
Sbjct: 137 YDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 78 IYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNG 136
+ L+ N+F+ G F ++ LRK+ FSNNK + F + E+ L SN+
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94
Query: 137 TIPS--FDQ-PTLVRLNLSSNKLEGEIPA 162
+ F +L L L SN++ +
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGN 122
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 3/66 (4%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHL 129
GL L+ + L N+ + + F + ++R L +N+ + P F L L+ L+L
Sbjct: 103 GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNL 160
Query: 130 ESNQFN 135
+N FN
Sbjct: 161 LANPFN 166
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 21/203 (10%)
Query: 318 VLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPL 373
LG G G+ Y A + +K + ++ EV LRH N+L L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL-RL 74
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-E 431
++ ++ L+ EY P G++ L I + +A + Y H+
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITE-LANALSYCHSKR 129
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL---FAYKAPEAIQSGK 488
+ H D+ K N+ + E I++FG+ S + L Y PE I+
Sbjct: 130 VIHRDI-----KPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEGRM 183
Query: 489 VTPKCDVYCLGIIILEILTGKFP 511
K D++ LG++ E L GK P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 36/218 (16%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRM--KESSAMARDAFDTEVRRLGRLRH--SNVLAP 372
+ +G+GG ++ + +K + +E+ D++ E+ L +L+ ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR- 92
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
L + TD+ + +V E L L + R + + + +H
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF------AYKAPEAI 484
+ H DL K +N I + + +FG + + Y PEAI
Sbjct: 147 GIVHSDL-----KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 485 QS-----------GKVTPKCDVYCLGIIILEILTGKFP 511
+ K++PK DV+ LG I+ + GK P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L R + + L+ Q EI F ++KL+ N R LPP +F+ +P LT L
Sbjct: 65 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 122
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
LE N + ++P F P L L++S+N LE I +
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ 162
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 18/121 (14%), Positives = 40/121 (33%), Gaps = 9/121 (7%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
Y + + + ++T L + + + ++P D + L ++ +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ 80
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLL 165
+ F + +L++ N +P F P L L L N L +P +
Sbjct: 81 IE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 137
Query: 166 R 166
Sbjct: 138 H 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 21/98 (21%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
++ L +Y+ N+ + Y + L+ L S+N + + + L L+
Sbjct: 268 FVKMQRLERLYISNNRLV-ALN-LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324
Query: 129 LESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
L+ N T+ TL L LS N + +L R
Sbjct: 325 LDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRALFR 361
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 17/98 (17%), Positives = 33/98 (33%), Gaps = 8/98 (8%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L + + N I F +L+ L S+N+ + SL P L +
Sbjct: 137 FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHAN 192
Query: 129 LESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
+ N + T+ + L+ S N + + +
Sbjct: 193 VSYNLLS-TLA--IPIAVEELDASHNSIN-VVRGPVNV 226
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 19/101 (18%), Positives = 39/101 (38%), Gaps = 9/101 (8%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLE 130
L + L N + + L ++ S N+ ++ F + L L++
Sbjct: 225 NVELTILKLQHNNLT---DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYIS 280
Query: 131 SNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNA 169
+N+ + + PTL L+LS N L + + +F+
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 15/99 (15%), Positives = 27/99 (27%), Gaps = 5/99 (5%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+ L+ + L N + + L L+ +N L S L L
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQP-QFDRLENLYLDHNSIV-TLKLSTH--HTLKNL 344
Query: 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
L N ++ + R + +I L
Sbjct: 345 TLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 62/300 (20%), Positives = 113/300 (37%), Gaps = 45/300 (15%)
Query: 317 EVLGNGGLGSSYKAMMAD------GVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSN 368
+ LG G G +A + V VK +K + A ++A +E++ + L +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDR---------GPSHDELTWPARLKIVQ 419
++ L L++ EY G LL L ++ + L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 420 GIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQAL 475
+A+G+ +L A + H ++ + N+ ++ + I +FG I + + A
Sbjct: 172 QVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 476 FAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAF 532
K APE+I T + DV+ GI++ EI + G P GI V
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP-------GILVNSKFYKLV 280
Query: 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592
+G + P +P + ++ +AC +P R ++ + E Q D
Sbjct: 281 KDGYQ--MAQPA-----FAPKNIYSIM---QACWALEPTHRPTFQQICSFLQEQAQEDRR 330
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 47/234 (20%), Positives = 93/234 (39%), Gaps = 47/234 (20%)
Query: 318 VLGNGGLGSSYKAMMADG---VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLAPL 373
LG G GS + + + V +K +K+ + + E + + +L + ++ +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL----- 428
+ + +LV E GG L L G R E+ +++ ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 429 -HTELAHLDLPHGNLKSSNIFISPENEPLISEFG----------FYTMINSANLAQALFA 477
H LA + N+ + + IS+FG +YT + +
Sbjct: 458 VHRNLA----------ARNVLLVNRHYAKISDFGLSKALGADDSYYTA-----RSAGKWP 502
Query: 478 YK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
K APE I K + + DV+ G+ + E L+ G+ P + + +V+ ++
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI 552
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 60/298 (20%), Positives = 106/298 (35%), Gaps = 64/298 (21%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
+LG G G Y+ + + + V VK K+ + ++ F +E + L H +++
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 372 PLAYHYRTDE-KLLVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYL- 428
+ +E ++ E P G L YL L + I + + YL
Sbjct: 78 LIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYLE 130
Query: 429 -----HTELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQAL 475
H ++A NI ++ + +FG Y +
Sbjct: 131 SINCVHRDIA----------VRNILVASPECVKLGDFGLSRYIEDEDYYKA-----SVTR 175
Query: 476 FAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAF 532
K +PE+I + T DV+ + + EIL+ GK P +L N DV+ +
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVL---- 227
Query: 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
+G L P+ P + L+ C DP R E V + ++ Q +
Sbjct: 228 EKGDR--LPKPD-----LCPPVLYTLM---TRCWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 44/224 (19%), Positives = 85/224 (37%), Gaps = 36/224 (16%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRM--KESSAMARDAFDTEVRRLGRLRH--SNVLAP 372
+ +G+GG ++ + +K + +E+ D++ E+ L +L+ ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR- 73
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
L + TD+ + +V E L L + R + + + +H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA------YKAPEAI 484
+ H DL K +N I + + +FG + + + Y PEAI
Sbjct: 128 GIVHSDL-----KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 485 Q-----------SGKVTPKCDVYCLGIIILEILTGKFPSQYLTN 517
+ K++PK DV+ LG I+ + GK P Q + N
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 44/217 (20%), Positives = 81/217 (37%), Gaps = 33/217 (15%)
Query: 317 EVLGNG--GLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---EVRRLGRLRHSNVL 370
V+G G L + A G V V+R+ + + + E+ H N++
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIV 89
Query: 371 APLAYH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
Y + D +L +V ++ GS L+ +EL I+QG+ + + Y
Sbjct: 90 P---YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY---ILQGVLKALDY 143
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI-------NSANLAQALFA--- 477
+H H ++K+S+I IS + + +S + +
Sbjct: 144 IHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 478 -YKAPEAIQSGKV--TPKCDVYCLGIIILEILTGKFP 511
+ +PE +Q K D+Y +GI E+ G P
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 7/95 (7%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLE 130
L ++LD N+ + ++ + L KL S N + PHL ELHL
Sbjct: 191 PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLN 248
Query: 131 SNQFNGTIPS--FDQPTLVRLNLSSNKLEGEIPAS 163
+N+ +P D + + L +N + I ++
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSN 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 13/124 (10%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
L + + ++ +I L+ L + L N+ S +I PG F + L +L+ S
Sbjct: 54 TALLDLQNNKIT-EIKDGDFK---NLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLS 108
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSNKL-EGEIPA 162
N+ + LP + L EL + N+ + F+ ++ + L +N L I
Sbjct: 109 KNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 163 SLLR 166
+
Sbjct: 165 GAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 11/107 (10%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L GL L + L N S + G LR+L +NNK ++P L ++ ++
Sbjct: 212 LKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 129 LESNQ--------FNGTIPSFDQPTLVRLNLSSNKLE-GEIPASLLR 166
L +N F + + + ++L SN ++ EI S R
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 27/112 (24%), Positives = 43/112 (38%), Gaps = 14/112 (12%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
KI A L L L YL KNQ E+P L++L N+ ++ S+F
Sbjct: 90 KISPGAFAPLVKLERL---YLSKNQLK-ELPEKMPK---TLQELRVHENEIT-KVRKSVF 141
Query: 120 K-LPHLTELHLESNQF-NGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L + + L +N + I + F L + ++ + IP L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP 192
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 22/117 (18%), Positives = 43/117 (36%), Gaps = 18/117 (15%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L ++ +S +D +L LR L +L+ N+ ++P G + ++ ++ NN
Sbjct: 221 LGLSFNSIS-AVDNGSLANTPHLREL---HLNNNKLV-KVPGG-LADHKYIQVVYLHNNN 274
Query: 110 FRGRLPPSLF-------KLPHLTELHLESNQFNGT-IPS--FDQ-PTLVRLNLSSNK 155
+ + F K + + L SN I F + L + K
Sbjct: 275 IS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 11/96 (11%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQ 133
LR + ++P + L NNK + FK L +L L L +N+
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPPD---TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87
Query: 134 FNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+ I +F L RL LS N+L+ E+P + +
Sbjct: 88 IS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 63/290 (21%), Positives = 101/290 (34%), Gaps = 64/290 (22%)
Query: 317 EVLGNGGLGSSYKAMM-----ADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
LG G G G V VK +K + R + E+ L L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 371 APLA--YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
LV EY+P GSL L + L Q I G+ YL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150
Query: 429 HTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK---- 479
H + H DL + N+ + + I +FG LA+A+ Y+
Sbjct: 151 HAQHYIHRDL-----AARNVLLDNDRLVKIGDFG---------LAKAVPEGHEYYRVRED 196
Query: 480 --------APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530
APE ++ K DV+ G+ + E+LT T I + +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG--- 253
Query: 531 AFSEGRVTDLLD-------PEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
+ R+T+LL+ P+ P E+ L+ + C +++ R
Sbjct: 254 QMTVLRLTELLERGERLPRPD-----KCPAEVYHLM---KNCWETEASFR 295
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 53/234 (22%), Positives = 88/234 (37%), Gaps = 42/234 (17%)
Query: 317 EVLGNGGLGS----SYKAMMADGVTVVVKRMKE---SSAMARDAFDTEVRRLGRLRHSNV 369
E LG+G G + A V+V VK +K S A D F EV + L H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ + +V E P GSLL L +G + +A G+GYL
Sbjct: 84 IRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYL 137
Query: 429 HTE-LAHLDLPHGNLKSSNIFISPENEPLISEFG----------FYTMINSANLAQALFA 477
++ H DL + N+ ++ + I +FG Y M
Sbjct: 138 ESKRFIHRDL-----AARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-----QEHRKVP 187
Query: 478 YK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
+ APE++++ + D + G+ + E+ T G+ P L ++ +
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKI 237
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 49/267 (18%), Positives = 92/267 (34%), Gaps = 45/267 (16%)
Query: 274 SRKASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAMMA 333
S +S E + V G+ + +G+GG ++ +
Sbjct: 28 QHMDSPDLGTDDDDKASSSANECISVKGRIYSIL---------KQIGSGGSSKVFQVLNE 78
Query: 334 DGVTVVVKRM--KESSAMARDAFDTEVRRLGRLRH--SNVLAPLAYHYRTDEKL-LVYEY 388
+K + +E+ D++ E+ L +L+ ++ L + TD+ + +V E
Sbjct: 79 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR-LYDYEITDQYIYMVMEC 137
Query: 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNI 447
L L + R + + + +H + H DL K +N
Sbjct: 138 -GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL-----KPANF 186
Query: 448 FISPENEPLISEFGFYTMINSANLAQALF------AYKAPEAIQS-----------GKVT 490
I + + +FG + + Y PEAI+ K++
Sbjct: 187 LIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTN 517
PK DV+ LG I+ + GK P Q + N
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIIN 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 47/253 (18%), Positives = 86/253 (33%), Gaps = 44/253 (17%)
Query: 343 MKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDR 402
SS DA ++RR+ N + L + + +L + +R
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NR 154
Query: 403 GPSHDELTWPARLKIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFG 461
S ++ L I IA + +LH++ L H DL K SNIF + ++ + +FG
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL-----KPSNIFFTMDDVVKVGDFG 209
Query: 462 FYTMINSANLAQALFA----------------YKAPEAIQSGKVTPKCDVYCLGIIILEI 505
T ++ Q + Y +PE I + K D++ LG+I+ E+
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269
Query: 506 LTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRAC 565
L +TD+ + + + Q + +
Sbjct: 270 LYSFSTQMERVR------------------IITDVRNLKFPL--LFTQKYPQEHMMVQDM 309
Query: 566 TQSDPEQRLEMRE 578
P +R E +
Sbjct: 310 LSPSPTERPEATD 322
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 41/227 (18%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAY 375
++LG G G+ G V VKRM D E++ L H NV+
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIR-YYC 76
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
TD L + E +L L+ + + +++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 433 AHLDLPHGNLKSSNIFISPENEP-------------LISEFGFYTMINSANLAQALFA-- 477
L + H +LK NI +S + LIS+FG ++S +
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 478 ------YKAPEAIQSG-------KVTPKCDVYCLGIIILEILTGKFP 511
++APE ++ ++T D++ +G + IL+
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 13/111 (11%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
KI A + L L+ L Y+ KN EIPP +L +L +N+ R ++P +F
Sbjct: 92 KIHEKAFSPLRKLQKL---YISKNHLV-EIPPNLPS---SLVELRIHDNRIR-KVPKGVF 143
Query: 120 K-LPHLTELHLESNQF-NGTIPS--FDQPTLVRLNLSSNKLEGEIPASLLR 166
L ++ + + N N FD L L +S KL IP L
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE 193
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 26/92 (28%), Positives = 41/92 (44%), Gaps = 8/92 (8%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
GL+ L A+ L N+ S +I F + L+KL+ S N +PP+L L EL
Sbjct: 74 FKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELR 129
Query: 129 LESNQFNGTIP--SFDQ-PTLVRLNLSSNKLE 157
+ N+ +P F + + + N LE
Sbjct: 130 IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 15/126 (11%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L+++ + I+++ L + L L L NQ I G + LR+L NNK
Sbjct: 198 LHLDHNKIQ-AIELEDLLRYSKLYRL---GLGHNQIR-MIENGSLSFLPTLRELHLDNNK 252
Query: 110 FRGRLPPSLFKLPHLTELHLESNQ--------FNGTIPSFDQPTLVRLNLSSNKLE-GEI 160
R+P L L L ++L +N F + ++L +N + E+
Sbjct: 253 LS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311
Query: 161 PASLLR 166
+ R
Sbjct: 312 QPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 22/104 (21%), Positives = 36/104 (34%), Gaps = 6/104 (5%)
Query: 66 LTELTG--LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFR-GRLPPSLFKLP 122
L E+ L + + N+ ++P G F + + + N P F
Sbjct: 114 LVEIPPNLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 123 HLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
L L + + IP TL L+L NK++ I L
Sbjct: 173 KLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQ-AIELEDLL 214
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 28/92 (30%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 69 LTGLRGLRAIYLDKNQF-SGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+GLR + I + N + PG FD + L L S K +P L L EL
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNEL 198
Query: 128 HLESNQFNGTIPSFD---QPTLVRLNLSSNKL 156
HL+ N+ I D L RL L N++
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESN 132
+ L N S E+ F + L L NNK ++ F L L +L++ N
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN 112
Query: 133 QFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
IP +LV L + N++ ++P +
Sbjct: 113 HLV-EIPPNLPSSLVELRIHDNRIR-KVPKGVFS 144
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 12/73 (16%), Positives = 27/73 (36%), Gaps = 9/73 (12%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGA------LRKLWFSNNKFR-GRLPPSLFK- 120
L L+ L+ +YL N + ++ F +G + NN + P+ F+
Sbjct: 260 LPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
Query: 121 LPHLTELHLESNQ 133
+ + + +
Sbjct: 319 VTDRLAIQFGNYK 331
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 30/171 (17%), Positives = 62/171 (36%), Gaps = 28/171 (16%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWP-- 412
E++ + +++ L +++ ++YEY+ S+L + + + P
Sbjct: 93 ELQIITDIKNEYCLT-CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 413 -ARLKIVQGIARGIGYLHTEL--AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469
+ I++ + Y+H E H D+ K SNI + +S+FG S
Sbjct: 152 VIK-CIIKSVLNSFSYIHNEKNICHRDV-----KPSNILMDKNGRVKLSDFGE-----SE 200
Query: 470 NLAQALF-------AYKAPEAIQSGKVT--PKCDVYCLGIIILEILTGKFP 511
+ + PE + K D++ LGI + + P
Sbjct: 201 YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 4e-14
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L R + + L+ Q EI F ++KL+ N R LPP +F+ +P LT L
Sbjct: 71 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 128
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
LE N + ++P F P L L++S+N LE I +
Sbjct: 129 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQ 168
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 17/118 (14%), Positives = 39/118 (33%), Gaps = 9/118 (7%)
Query: 53 NSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG 112
+ + + ++T L + + + ++P D + L ++ +
Sbjct: 32 VHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 88
Query: 113 RLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+ F + +L++ N +P F P L L L N L +P +
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 4/89 (4%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
++ L +Y+ N+ + Y + L+ L S+N + + + L L+
Sbjct: 274 FVKMQRLERLYISNNRLV-ALN-LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 129 LESNQFNGTIPSFDQPTLVRLNLSSNKLE 157
L+ N T+ TL L LS N +
Sbjct: 331 LDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 17/98 (17%), Positives = 33/98 (33%), Gaps = 8/98 (8%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L + + N I F +L+ L S+N+ + SL P L +
Sbjct: 143 FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHAN 198
Query: 129 LESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
+ N + T+ + L+ S N + + +
Sbjct: 199 VSYNLLS-TLA--IPIAVEELDASHNSIN-VVRGPVNV 232
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 19/101 (18%), Positives = 39/101 (38%), Gaps = 9/101 (8%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLE 130
L + L N + + L ++ S N+ ++ F + L L++
Sbjct: 231 NVELTILKLQHNNLT---DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYIS 286
Query: 131 SNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNA 169
+N+ + + PTL L+LS N L + + +F+
Sbjct: 287 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 21/189 (11%), Positives = 51/189 (26%), Gaps = 10/189 (5%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+ L+ + L N + + L L+ +N L S L L
Sbjct: 296 YGQPIPTLKVLDLSHNHLL-HVERNQP-QFDRLENLYLDHNSIV-TLKLSTH--HTLKNL 350
Query: 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGLCGKNLGVEC 187
L N ++ + R + +I L + + L
Sbjct: 351 TLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCK-ESDKPYLDRLL---- 405
Query: 188 RNAKASAANKNIHPPPPPHPAAENVDDSKKVIAAGVALSVMLVSIAIVVIIRIRRKRKAF 247
+ ++ + + A + ++ + + + + + + R
Sbjct: 406 QYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465
Query: 248 KVLEKESVQ 256
+ L E +Q
Sbjct: 466 QQLTNEQIQ 474
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 21/104 (20%), Positives = 34/104 (32%), Gaps = 6/104 (5%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLT 125
+ GL L + + F + L L S+ R +F L L
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLE 448
Query: 126 ELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPASLLR 166
L + N F F + L L+LS +LE ++ +
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 491
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 17/91 (18%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTEL 127
L+ + L + + I G + + L L + N + L F L L +L
Sbjct: 48 FFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKL 105
Query: 128 HLESNQFNGTIP-SFDQ-PTLVRLNLSSNKL 156
TL LN++ N +
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLI 136
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 29/112 (25%), Positives = 41/112 (36%), Gaps = 10/112 (8%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
I+ A L+ L L L N + G F + +L+KL L
Sbjct: 66 TIEDGAYQSLSHLSTL---ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPI 120
Query: 120 -KLPHLTELHLESNQFN--GTIPSFDQ-PTLVRLNLSSNKLEGEIPASLLRF 167
L L EL++ N F L L+LSSNK++ I + LR
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 25/124 (20%), Positives = 46/124 (37%), Gaps = 13/124 (10%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L L+ ++ + L L+ L + N P YF + L L S+NK
Sbjct: 105 LVAVETNLA-SLENFPIGHLKTLKEL---NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 110 FRGRLPPSLFK-LPHLT----ELHLESNQFNGTIP--SFDQPTLVRLNLSSNKLEGEIPA 162
+ + + + L + L L N N I +F + L +L L +N +
Sbjct: 161 IQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 163 SLLR 166
+ ++
Sbjct: 219 TCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 16/104 (15%), Positives = 28/104 (26%), Gaps = 6/104 (5%)
Query: 66 LTELTGLRGLRAIYLDKNQFSG-EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
L L + L +N S +L+ L S N + + L L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL 398
Query: 125 TELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPASLL 165
L + + F L+ L++S +
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 441
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + D TEL L L L + Q ++ P F+ + +L+ L ++N+
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFL---DLSQCQLE-QLSPTAFNSLSSLQVLNMASNQ 505
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPSFDQPTLVR-LNLSSNKLEG 158
+ +P +F L L ++ L +N ++ + P L R LN +S K +G
Sbjct: 506 LK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP--RIDYLSRWLNKNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 7/94 (7%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQ 133
+ + L N + F L+ L S + + + + L HL+ L L N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 134 FNGTIPS--FDQPT-LVRLNLSSNKLEGEIPASL 164
++ F + L +L L +
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPI 120
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 24/122 (19%), Positives = 40/122 (32%), Gaps = 7/122 (5%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALR----KLWFSNNKFRGRLPPSLFKLP 122
+ L L + L N+ I + + L S N + P FK
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 123 HLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKL-EGEIPASLLRFNASSFSGNAGLCGK 181
L +L L +N + + L L + L E +L +F+ S+ G L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 182 NL 183
Sbjct: 261 EF 262
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 26/132 (19%), Positives = 41/132 (31%), Gaps = 15/132 (11%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
+ + + +D L + + L + ++ + L
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFN---CLTNVSSFSLVSVTIE-RVKDFSYNFG--WQHLELV 312
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
N KF + P KL L L SN+ D P+L L+LS N L S
Sbjct: 313 NCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL------SFKG 363
Query: 167 FNASSFSGNAGL 178
+ S G L
Sbjct: 364 CCSQSDFGTTSL 375
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 43/232 (18%)
Query: 318 VLGNGGLGSSYKA---MMADGVTVVVKRMKE--SSAMARDAFDTEVRRLGRLRHSNVLAP 372
LG+G G+ K M TV VK +K + +D E + +L + ++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ E LV E G L YL + + +++V ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 431 E-LAHLDLPHGNLKSSNIFISPENEPLISEFG----------FYTMINSANLAQALFAYK 479
H DL + N+ + ++ IS+FG +Y + K
Sbjct: 136 SNFVHRDL-----AARNVLLVTQHYAKISDFGLSKALRADENYYKA-----QTHGKWPVK 185
Query: 480 --APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
APE I K + K DV+ G+++ E + G+ P + + +V +
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAML 233
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 25/100 (25%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L L+ ++L N IP F+ + +LR+L K + F+ L +L L
Sbjct: 132 FVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 128 HLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+L IP+ L L+LS N L I +
Sbjct: 191 NLAMCNLR-EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQ 228
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 7/94 (7%)
Query: 65 ALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPH 123
+ LT L L + L N S I PG F + L+KLW ++ + + + F L
Sbjct: 199 EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQS 256
Query: 124 LTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSN 154
L E++L N +P F L R++L N
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 11/117 (9%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L ++ + I++ A GL L + L N+ + IP G F + L++LW NN
Sbjct: 93 LQLSRNHIR-TIEIGAFN---GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP 147
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPA 162
+P F +P L L L + I +F+ L LNL+ L EIP
Sbjct: 148 IE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 32/119 (26%), Positives = 44/119 (36%), Gaps = 14/119 (11%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
GL LR + L EIP + L +L S N + P F+ L HL +L
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP--NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKL 236
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLRFNAS----SFSGNAGLC 179
+ +Q I FD +LV +NL+ N L +P L N C
Sbjct: 237 WMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 30/103 (29%), Positives = 44/103 (42%), Gaps = 9/103 (8%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
LR L + L +N I G F+ + L L +N+ +P F L L EL
Sbjct: 84 FKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKEL 141
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSS-NKLEGEIPASLLR 166
L +N +IPS F++ P+L RL+L +L I
Sbjct: 142 WLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFE 182
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 28/99 (28%), Positives = 38/99 (38%), Gaps = 8/99 (8%)
Query: 73 RGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLES 131
R + L +NQ I F + L L S N R + F L +L L L
Sbjct: 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFD 121
Query: 132 NQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLRF 167
N+ TIP+ F L L L +N +E IP+
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 25/102 (24%), Positives = 41/102 (40%), Gaps = 9/102 (8%)
Query: 69 LTGLRGLRAIYL-DKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+ LR + L + + S I G F+ + LR L + R P+L L L EL
Sbjct: 156 FNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDEL 212
Query: 128 HLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L N + I SF L +L + ++++ I +
Sbjct: 213 DLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD 252
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 62/271 (22%), Positives = 112/271 (41%), Gaps = 42/271 (15%)
Query: 317 EVLGNGGLGSSYKAMMADG-----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
+VLG+G G+ +K + + V +K +++ S + A + +G L H++++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L L LV +Y+P GSLL + RG L L IA+G+ YL
Sbjct: 79 RLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYL- 131
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQALFAYK--APEA 483
+ H NL + N+ + ++ +++FG ++ + ++A K A E+
Sbjct: 132 ---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 484 IQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542
I GK T + DV+ G+ + E++T G P L +V + + R L
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLLEKGE---R---LAQ 238
Query: 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
P+I + + + C D R
Sbjct: 239 PQICT--------IDVYMVMVKCWMIDENIR 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 73/305 (23%), Positives = 114/305 (37%), Gaps = 48/305 (15%)
Query: 317 EVLGNGGLGSSYKAM------MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRL-RHSN 368
+ LG G G +A A TV VK +KE ++ A +E++ L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 369 VLAPLAYHYRTDEKLLV-YEYIPGGSLLYLLHGDRGPSH-----------DELTWPARLK 416
V+ L + L+V E+ G+L L R D LT +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 417 IVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----A 472
+A+G+ +L A H +L + NI +S +N I +FG I
Sbjct: 153 YSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 473 QALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVA 529
A K APE I T + DV+ G+++ EI + G P G+ + E
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFC 261
Query: 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
EG + P+ + EM Q + C +P QR E V + + Q+
Sbjct: 262 RRLKEGTR--MRAPD-----YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQA 311
Query: 590 DGNMD 594
+ D
Sbjct: 312 NAQQD 316
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 25/96 (26%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D+L L G L +Y++ Q + +G LR L + R + P F P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 123 HLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKL 156
L+ L+L N ++ +L L LS N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 21/86 (24%), Positives = 32/86 (37%), Gaps = 5/86 (5%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
LYI + +++ L GL LR + + K+ + P F L +L S N
Sbjct: 36 LYIENQQHLQHLELRDLR---GLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNA 91
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFN 135
L + L EL L N +
Sbjct: 92 LE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 6e-14
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 32/209 (15%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVK-----RMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
LG G Y+A + G+ V +K M ++ + R EV+ +L+H ++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILE- 75
Query: 373 LAYHYRTDEK--LLVYEYIPGGSLLYLLHGDRGP-SHDELTWPARLKIVQGIARGIGYLH 429
Y+Y D LV E G + L P S +E AR + Q I G+ YLH
Sbjct: 76 -LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE----ARHFMHQ-IITGMLYLH 129
Query: 430 T-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF------AYKAPE 482
+ + H DL SN+ ++ I++FG T + + + + Y +PE
Sbjct: 130 SHGILHRDL-----TLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPE 182
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ DV+ LG + +L G+ P
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 46/209 (22%), Positives = 78/209 (37%), Gaps = 29/209 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK-----RMKESSAMARDAFDTEVRRLGRLRHSNVL 370
LG GG ++ K + + + E+ L H +V+
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVV 78
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ ++ + +V E SLL L + + E AR ++ I G YLH
Sbjct: 79 G-FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----AR-YYLRQIVLGCQYLH 132
Query: 430 T-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF------AYKAPE 482
+ H DL K N+F++ + E I +FG T + + Y APE
Sbjct: 133 RNRVIHRDL-----KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPE 185
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ + + DV+ +G I+ +L GK P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 64/306 (20%), Positives = 118/306 (38%), Gaps = 50/306 (16%)
Query: 317 EVLGNGGLGSSYKAM--------MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRL-RH 366
+ LG G G A + VTV VK +K+ ++ +E+ + + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 367 SNVLAPLAYHYRTDEKLLVYEYIPGGSLL-YL----------LHGDRGPSHDELTWPARL 415
N++ L + ++ EY G+L YL + +++T+ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL---- 471
+ARG+ YL A H +L + N+ ++ N I++FG IN+ +
Sbjct: 161 SCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 472 AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
K APEA+ T + DV+ G+++ EI T G P + ++ + +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----ELFKLL 272
Query: 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
EG + P N E+ ++ R C + P QR ++ V + I
Sbjct: 273 ----KEGHR--MDKPA-----NCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 589 SDGNMD 594
N +
Sbjct: 319 LTTNEE 324
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 51/268 (19%), Positives = 104/268 (38%), Gaps = 30/268 (11%)
Query: 262 VSVPNKSRDVDVSRKASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAA----- 316
V +P R + G S + + + K + P +K
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159
Query: 317 ---EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAP 372
E LG G G ++ A G K + ++ E++ + LRH ++
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN- 218
Query: 373 LAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
L + D ++ ++YE++ GG L + + +++ ++ ++ + +G+ ++H
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 432 -LAHLDLPHGNLKSSNI-FISPENEPL-ISEFGFYTMINSANLAQALFA---YKAPEAIQ 485
HLDL K NI F + + L + +FG ++ + + APE +
Sbjct: 275 NYVHLDL-----KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 486 SGKVTPKCDVYCLGII--ILEILTGKFP 511
V D++ +G++ IL L+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYIL--LSGLSP 355
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARL 415
E+ LRH N+L + ++ +++ L+ E+ P G L L +
Sbjct: 64 EIEIQSHLRHPNIL-RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR----SAT 118
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL 475
+ + +A + Y H + H ++K N+ + + E I++FG+ + A +L
Sbjct: 119 FMEE-LADALHYCHE----RKVIHRDIKPENLLMGYKGELKIADFGW------SVHAPSL 167
Query: 476 F--------AYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y PE I+ K D++C G++ E L G P
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 42/119 (35%), Positives = 61/119 (51%), Gaps = 12/119 (10%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L + S LS + A LT LR L YL+ N+ +P G F E+ L LW ++
Sbjct: 40 KKLDLQSNKLS-SLPSKAFHRLTKLRLL---YLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 108 NKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPA 162
NK + LP +F +L +L EL L+ NQ ++P FD T L L+L N+L+ +P
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 14/103 (13%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
L L L ++ N+ +P G FD++ L +L N+ + LPP +F L
Sbjct: 82 KELKNLETL------WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133
Query: 123 HLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPA 162
LT L L N+ ++P FD+ T L L L +N+L+ +P
Sbjct: 134 KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPE 174
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 13/95 (13%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D+LT+LT L L N+ +P G FD++ +L++L NN+ + R+P F KL
Sbjct: 130 DSLTKLTYL------SLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLT 181
Query: 123 HLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSN 154
L L L++NQ +P +FD L L L N
Sbjct: 182 ELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 22/205 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E LG+G G ++ + A G V K + + + E+ + +L H ++ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN-LHD 115
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
+ ++ L+ E++ GG L + E + Q G+ ++H +
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAE--VINYMRQ-ACEGLKHMHEHSIV 171
Query: 434 HLDLPHGNLKSSNI-FISPENEPL-ISEFGFYTMINSANLAQALFA---YKAPEAIQSGK 488
HLD+ K NI + + + I +FG T +N + + A + APE +
Sbjct: 172 HLDI-----KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 489 VTPKCDVYCLGII--ILEILTGKFP 511
V D++ +G++ +L L+G P
Sbjct: 227 VGFYTDMWAIGVLGYVL--LSGLSP 249
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 29/209 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK-----RMKESSAMARDAFDTEVRRLGRLRHSNVL 370
LG GG ++ K + + + E+ L H +V+
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVV 104
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ ++ + +V E SLL L + + E AR + Q I G YLH
Sbjct: 105 G-FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----ARYYLRQ-IVLGCQYLH 158
Query: 430 T-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF------AYKAPE 482
+ H DL K N+F++ + E I +FG T + + Y APE
Sbjct: 159 RNRVIHRDL-----KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPE 211
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ + + DV+ +G I+ +L GK P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 45/209 (21%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
LG+G G YKA G K ++ S + + E+ L H ++
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK---L 81
Query: 376 H--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
Y D KL ++ E+ PGG++ ++ LT P + + + + +LH++
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKR 137
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI--- 484
+ H D LK+ N+ ++ E + +++FG + F + APE +
Sbjct: 138 IIHRD-----LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 485 --QSGKVTPKCDVYCLGIIILEILTGKFP 511
+ K D++ LGI ++E+ + P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 8/89 (8%)
Query: 78 IYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNG 136
I L++N IPPG F LR++ SNN+ L P F L L L L N+
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 137 TIPS--FDQ-PTLVRLNLSSNKLEGEIPA 162
+P F+ +L L L++NK+ +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRV 121
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHL 129
GLR L ++ L N+ + E+P F+ + +L+ L + NK L F L +L L L
Sbjct: 78 GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSL 135
Query: 130 ESNQFNGTIP--SFDQ-PTLVRLNLSSN 154
N+ TI +F + ++L+ N
Sbjct: 136 YDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 16/66 (24%), Positives = 29/66 (43%), Gaps = 3/66 (4%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHL 129
GL L+ + L+ N+ + + F ++ L L +NK + + F L + +HL
Sbjct: 102 GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHL 159
Query: 130 ESNQFN 135
N F
Sbjct: 160 AQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 10/83 (12%)
Query: 88 EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQ- 143
EIP + + ++ N + +PP F L + L +NQ + + F
Sbjct: 25 EIPTNLPETI---TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL 79
Query: 144 PTLVRLNLSSNKLEGEIPASLLR 166
+L L L NK+ E+P SL
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFE 101
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 65/286 (22%), Positives = 106/286 (37%), Gaps = 60/286 (20%)
Query: 317 EVLGNGGLGSSYKAMMADG---VTVVVKRMKE-SSAMARDAFDTEVRRLGRL-RHSNVLA 371
+V+G G G KA + + +KRMKE +S F E+ L +L H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLL-YL----------LHGDRGPSHDELTWPARLKIVQG 420
L L EY P G+LL +L + L+ L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYK- 479
+ARG+ YL + H +L + NI + I++FG L++ Y
Sbjct: 151 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFG---------LSRGQEVYVK 197
Query: 480 -----------APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEW 527
A E++ T DV+ G+++ EI++ G P +T ++ E
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEK 253
Query: 528 VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
+ +G L P N E+ L+ R C + P +R
Sbjct: 254 L----PQGYR--LEKPL-----NCDDEVYDLM---RQCWREKPYER 285
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D LT L L L +NQ +P G FD++ L L ++N+ + LP +F KL
Sbjct: 106 DKLTNLKEL------VLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLT 157
Query: 123 HLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKL 156
+LTEL L NQ ++P FD+ T L L L N+L
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 14/103 (13%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
LT LT L L NQ +P G FD++ L++L N+ + LP +F KL
Sbjct: 82 KELTNLTYL------ILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT 133
Query: 123 HLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPA 162
+LT L+L NQ ++P FD+ T L L+LS N+L+ +P
Sbjct: 134 NLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 22/73 (30%), Positives = 34/73 (46%), Gaps = 9/73 (12%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D LT LT L L NQ +P G FD++ L+ L N+ + +P +F +L
Sbjct: 154 DKLTNLTEL------DLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 205
Query: 123 HLTELHLESNQFN 135
L + L N ++
Sbjct: 206 SLQYIWLHDNPWD 218
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 16/80 (20%), Positives = 36/80 (45%), Gaps = 7/80 (8%)
Query: 78 IYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGT 137
L K + + +E+ ++ ++ +N+ + + LP++ L L N+ +
Sbjct: 24 ANLKKKSVT-DAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVRYLALGGNKLH-D 77
Query: 138 IPSFDQPT-LVRLNLSSNKL 156
I + + T L L L+ N+L
Sbjct: 78 ISALKELTNLTYLILTGNQL 97
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 27/119 (22%), Positives = 48/119 (40%), Gaps = 6/119 (5%)
Query: 70 TGLRGLRAIYLDKNQFSG----EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHL 124
+ L ++L +N E+ F+ + L+ L+ ++N LPP +F L L
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTAL 506
Query: 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGLCGKNL 183
L L SN+ + L L++S N+L P + + + N +C L
Sbjct: 507 RGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 6/93 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L L+ + L I F + LR L ++K L P F+ L HL EL
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFEL 102
Query: 128 HLESNQFNGTIPSFD----QPTLVRLNLSSNKL 156
L + + L RL+LS N++
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 28/108 (25%), Positives = 39/108 (36%), Gaps = 7/108 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
GL L+ + L N E+ F + + + N + FK L L L
Sbjct: 310 FYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTL 367
Query: 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGN 175
L N TI P++ + LS NKL +P L N S N
Sbjct: 368 DLRDNALT-TIHFI--PSIPDIFLSGNKLV-TLPKINLTANLIHLSEN 411
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 21/107 (19%), Positives = 36/107 (33%), Gaps = 8/107 (7%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPH 123
LT++ L + L N + F + L+ L + + F+ LP+
Sbjct: 16 LTQVPQVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 124 LTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKL-EGEIPASLLR 166
L L L S++ + F L L L L + + R
Sbjct: 75 LRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 30/112 (26%), Positives = 52/112 (46%), Gaps = 10/112 (8%)
Query: 62 DVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR----LPPS 117
++D L L + L+ + L++N+FS E +L +L+ N + L
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474
Query: 118 LFK-LPHLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLL 165
+F+ L HL L+L N N ++P F L L+L+SN+L + + L
Sbjct: 475 VFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL 524
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 29/151 (19%), Positives = 49/151 (32%), Gaps = 20/151 (13%)
Query: 50 LYINSMGLSGK-IDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNN 108
L + GLS + L L L L KNQ F ++ +L+ + FS+N
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRL---DLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158
Query: 109 KFRGRLPPSLFK---LPHLTELHLESNQ--------FNGTIPSFDQPTLVRLNLSSNKLE 157
+ + + L+ L +N + + F L L++S N
Sbjct: 159 QIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217
Query: 158 GEIPASLLRF----NASSFSGNAGLCGKNLG 184
+I + A S + G G
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 9/111 (8%)
Query: 61 IDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK 120
D + L +R + L + F+ + L+ L + NK ++ F
Sbjct: 255 PDQNTFAGLARS-SVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFY 311
Query: 121 -LPHLTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASLLRF 167
L +L L+L N + S P + ++L N + I +F
Sbjct: 312 GLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKF 360
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 23/93 (24%), Positives = 35/93 (37%), Gaps = 7/93 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L+ L+ + L N+ + +I F + L+ L S N L S F LP + +
Sbjct: 286 FETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYI 343
Query: 128 HLESNQFNGTIPS---FDQPTLVRLNLSSNKLE 157
L+ N I L L+L N L
Sbjct: 344 DLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 26/118 (22%), Positives = 42/118 (35%), Gaps = 12/118 (10%)
Query: 65 ALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPH 123
ALT + + + I+L N+ +P + S N+ +PH
Sbjct: 373 ALTTIHFIPSIPDIFLSGNKLV-TLPKINL----TANLIHLSENRLENLDILYFLLRVPH 427
Query: 124 LTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGL 178
L L L N+F+ + P+L +L L N L+ L F G + L
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL---CWDVFEGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 20/81 (24%), Positives = 30/81 (37%), Gaps = 6/81 (7%)
Query: 94 FDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQFNGTIP--SF-DQPTLVRL 149
+ +L S N R + S F L L L L S TI +F + P L L
Sbjct: 20 PQVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRIL 78
Query: 150 NLSSNKLEGEIPASLLRFNAS 170
+L S+K+ + +
Sbjct: 79 DLGSSKIY-FLHPDAFQGLFH 98
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 20/128 (15%), Positives = 35/128 (27%), Gaps = 12/128 (9%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFD--EMGALRKLWFSNNKFRGRLPPSLFKLP-- 122
L L++I NQ + + + L + N R+ K
Sbjct: 142 PSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 123 ----HLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNA-SSFSGNA- 176
L L + N + I + + S L I + F+ N
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260
Query: 177 -GLCGKNL 183
GL ++
Sbjct: 261 AGLARSSV 268
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 28/130 (21%), Positives = 47/130 (36%), Gaps = 14/130 (10%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L L+ ++ + L L+ L + N P YF + L L S+
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKEL---NVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 108 NKFRGRLPPSLF-KLPHLT----ELHLESNQFNGTIP--SFDQPTLVRLNLSSNKLEGEI 160
NK + + + L + L L N N I +F + L L L +N+L+ +
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SV 215
Query: 161 PASLLRFNAS 170
P + S
Sbjct: 216 PDGIFDRLTS 225
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 16/88 (18%), Positives = 28/88 (31%), Gaps = 8/88 (9%)
Query: 79 YLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGT 137
L N + F L+ L S + + + + L HL+ L L N +
Sbjct: 34 DLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-S 90
Query: 138 IPS--FDQPT-LVRLNLSSNKLEGEIPA 162
+ F + L +L L +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLA-SLEN 117
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 16/67 (23%), Positives = 23/67 (34%), Gaps = 7/67 (10%)
Query: 100 LRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNK 155
+ L S N R L F P L L L + TI + L L L+ N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 156 LEGEIPA 162
++ +
Sbjct: 88 IQ-SLAL 93
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 61/306 (19%), Positives = 113/306 (36%), Gaps = 50/306 (16%)
Query: 317 EVLGNGGLGSSYKAMMAD--------GVTVVVKRMKE-SSAMARDAFDTEVRRLGRL-RH 366
+ LG G G A V VK +K ++ +E+ + + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 367 SNVLAPLAYHYRTDEKLLVYEYIPGGSLL-YL----------LHGDRGPSHDELTWPARL 415
N++ L + ++ EY G+L YL + ++L+ +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL---- 471
+ARG+ YL A H +L + N+ ++ +N I++FG I+ +
Sbjct: 195 SCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 472 AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
K APEA+ T + DV+ G+++ EI T G P + ++ + +
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----ELFKLL 306
Query: 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
EG + P N E+ ++ R C + P QR ++ V + I
Sbjct: 307 ----KEGHR--MDKPS-----NCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 589 SDGNMD 594
N +
Sbjct: 353 LTSNQE 358
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 41/119 (34%), Positives = 59/119 (49%), Gaps = 12/119 (10%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L + S GL+ + LT L L LD NQ + G FD++ L L +N
Sbjct: 38 EKLDLQSTGLA-TLSDATFRGLTKLTWL---NLDYNQLQT-LSAGVFDDLTELGTLGLAN 92
Query: 108 NKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPA 162
N+ LP +F L L +L+L NQ ++PS FD+ T L L L++N+L+ IPA
Sbjct: 93 NQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D LTEL L L NQ + +P G FD + L KL+ N+ + LP +F +L
Sbjct: 80 DDLTELGTL------GLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 123 HLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKL 156
L EL L +NQ +IP+ FD+ T L L+LS+N+L
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D LT+L L YL NQ +P G FD + L++L + N+ + +P F KL
Sbjct: 104 DHLTQLDKL------YLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 123 HLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSN 154
+L L L +NQ ++P +FD+ L + L N
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 25/73 (34%), Positives = 36/73 (49%), Gaps = 9/73 (12%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D LT+L L L+ NQ IP G FD++ L+ L S N+ + +P F +L
Sbjct: 128 DRLTKLKEL------RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLG 179
Query: 123 HLTELHLESNQFN 135
L + L NQF+
Sbjct: 180 KLQTITLFGNQFD 192
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 42/224 (18%)
Query: 317 EVLGNGGLGSSYKAMMADG-----VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVL 370
+VLG+G G+ YK + + V +K ++E +S A E + + + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L + L+ + +P G LL + + + L IA+G+ YL
Sbjct: 81 RLLGIC--LTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYL- 133
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YK------ 479
L H +L + N+ + I++FG LA+ L A Y
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFG---------LAKLLGAEEKEYHAEGGKV 181
Query: 480 -----APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTN 517
A E+I T + DV+ G+ + E++T G P +
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 67/324 (20%), Positives = 116/324 (35%), Gaps = 80/324 (24%)
Query: 317 EVLGNGGLGSSYKAMMADG------VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNV 369
+G G G ++A V VK +KE +SA + F E + + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE-------------------LT 410
+ L L++EY+ G L L + L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 411 WPARLKIVQGIARGIGYL------HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464
+L I + +A G+ YL H +LA + N + I++FG
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLA----------TRNCLVGENMVVKIADFGLSR 222
Query: 465 MINSANLAQALFAYK------------APEAIQSGKVTPKCDVYCLGIIILEILT-GKFP 511
I SA+ YK PE+I + T + DV+ G+++ EI + G P
Sbjct: 223 NIYSAD------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 512 SQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPE 571
+ + +V+ +V +G + L PE N P E+ L+ R C P
Sbjct: 277 YYGMAHE----EVIYYV----RDGNI--LACPE-----NCPLELYNLM---RLCWSKLPA 318
Query: 572 QRLEMREAVRRIVEI-QQSDGNMD 594
R R + + ++++G +
Sbjct: 319 DRPSFCSIHRILQRMCERAEGTVG 342
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 44/216 (20%), Positives = 77/216 (35%), Gaps = 32/216 (14%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVK-------------RMKESSAMARDAFDTEVRRLG 362
LG+G G +K ++ + E+ L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 363 RLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGI 421
L H N++ + + LV E+ GG L ++ + + I++ I
Sbjct: 102 SLDHPNIIKLFDV-FEDKKYFYLVTEFYEGGELF-----EQIINRHKFDECDAANIMKQI 155
Query: 422 ARGIGYLHTELAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF-- 476
GI YLH ++ H ++K NI + + I +FG + + +
Sbjct: 156 LSGICYLH----KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 477 -AYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y APE ++ K KCDV+ G+I+ +L G P
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 26/102 (25%), Positives = 37/102 (36%), Gaps = 8/102 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTEL 127
L L+A+ L N + I F +G+L L S N L S F L LT L
Sbjct: 72 LQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFL 129
Query: 128 HLESNQFNGTIPS---FDQ-PTLVRLNLSSNKLEGEIPASLL 165
+L N + T+ F L L + + +I
Sbjct: 130 NLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 7/97 (7%)
Query: 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESN 132
++++ L N+ + I L+ L ++N + F L L L L N
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 133 QFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+ S F +L LNL N + SL
Sbjct: 111 YL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS 146
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 16/114 (14%), Positives = 35/114 (30%), Gaps = 6/114 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTEL 127
+ L L+ + + +I F + L +L + + P + +++ L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHL 203
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGL 178
L Q + D ++ L L L+ + L +S
Sbjct: 204 ILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 18/125 (14%), Positives = 39/125 (31%), Gaps = 15/125 (12%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L I++ L + +L + + L L Q + + D ++ L +
Sbjct: 179 LEIDASDLQ-SYEPKSLKSIQNVSHL---ILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233
Query: 110 FRG----RLPPSLF----KLPHLTELHLESNQFNGTIPSFDQPT-LVRLNLSSNKLEGEI 160
L K + + + +Q + L+ L S N+L+ +
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-V 292
Query: 161 PASLL 165
P +
Sbjct: 293 PDGIF 297
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 5/92 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTEL 127
L L + L N + F + L+ L N ++ F L L EL
Sbjct: 120 FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179
Query: 128 HLESNQFNGTIP--SFDQ-PTLVRLNLSSNKL 156
++++ + S + L L +
Sbjct: 180 EIDASDLQ-SYEPKSLKSIQNVSHLILHMKQH 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 23/99 (23%), Positives = 42/99 (42%), Gaps = 10/99 (10%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFD---EMGALRKLWFSNNKFRGRLPPSLFK 120
D + + L LR LD FS E+ G + + R + ++ ++ L +
Sbjct: 219 DVTSSVECLE-LRDTDLDTFHFS-ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQ 275
Query: 121 LPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKL 156
+ L EL NQ ++P FD+ +L ++ L +N
Sbjct: 276 ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 28/122 (22%), Positives = 46/122 (37%), Gaps = 10/122 (8%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L + S G++ I+ D+ + L L L L N S + +F + +L L
Sbjct: 79 QALVLTSNGIN-TIEEDSFSSLGSLEHL---DLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 108 NKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKLEGEIPAS 163
N ++ SLF L L L + + I F T L L + ++ L+
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPK 192
Query: 164 LL 165
L
Sbjct: 193 SL 194
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 24/82 (29%), Positives = 36/82 (43%), Gaps = 10/82 (12%)
Query: 89 IPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQ-P 144
IP G + ++ L SNN+ + S + +L L L SN N TI F
Sbjct: 46 IPSGLTEA---VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 145 TLVRLNLSSNKLEGEIPASLLR 166
+L L+LS N L + +S +
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWFK 121
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 52/206 (25%), Positives = 80/206 (38%), Gaps = 23/206 (11%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVLAPL 373
+LG G G K VK + ++SA +D EV L +L H N++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
+V E GG L D + +I++ + GI Y+H
Sbjct: 88 EI-LEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 432 LAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQ 485
+ H DL K NI S ++ + I +FG T + Y APE ++
Sbjct: 142 IVHRDL-----KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP 511
G KCDV+ G+I+ +L+G P
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E LG G G ++ + + T + K +K + E+ L RH N+L L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILH-LHE 68
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
+ + E+L +++E+I G + + +E + Q + + +LH+ +
Sbjct: 69 SFESMEELVMIFEFISGLDIFERI-NTSAFELNERE--IVSYVHQ-VCEALQFLHSHNIG 124
Query: 434 HLDLPHGNLKSSNI-FISPENEPL-ISEFGFYTMINSANLAQALFA---YKAPEAIQSGK 488
H D+ + NI + + + + I EFG + + + LF Y APE Q
Sbjct: 125 HFDI-----RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 489 VTPKCDVYCLGII--ILEILTGKFP 511
V+ D++ LG + +L L+G P
Sbjct: 180 VSTATDMWSLGTLVYVL--LSGINP 202
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 47/244 (19%), Positives = 91/244 (37%), Gaps = 34/244 (13%)
Query: 284 SSHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKR 342
S GK +G + GQ+ + DL +G+G G +K G + VK+
Sbjct: 3 SGSSGKQTGYLTI---GGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQ 57
Query: 343 MK-ESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYH--YRTDEKL-LVYEYIPGGSLLYL 397
M+ + ++ + + ++ + T+ + + E + +
Sbjct: 58 MRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---CFGTFITNTDVFIAMELMGTCAEKLK 114
Query: 398 LHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457
L K+ I + + YL + + H ++K SNI + + +
Sbjct: 115 KRMQGPIPERILG-----KMTVAIVKALYYLKEKHGVI---HRDVKPSNILLDERGQIKL 166
Query: 458 SEFGFYT-MINSANLAQALFA----YKAPEAIQSGKV-----TPKCDVYCLGIIILEILT 507
+FG +++ A+ A Y APE I + DV+ LGI ++E+ T
Sbjct: 167 CDFGISGRLVDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224
Query: 508 GKFP 511
G+FP
Sbjct: 225 GQFP 228
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 28/106 (26%), Positives = 42/106 (39%), Gaps = 11/106 (10%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPP--GYFDEMGALRKLWFSNNKFRGRLPPSLF-K 120
LTEL L L NQ E+ +M +L++L S N
Sbjct: 345 GHLTELETL------ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 121 LPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
L L++ SN TI P + L+L SNK++ IP +++
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVK 442
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 28/122 (22%), Positives = 44/122 (36%), Gaps = 13/122 (10%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
T L I+ +S ++ + L+ LR L + N+ + F L L S
Sbjct: 23 TTILNISQNYIS-ELWTSDILSLSKLRIL---IISHNRIQ-YLDISVFKFNQELEYLDLS 77
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS---FDQ-PTLVRLNLSSNKLEGEIPA 162
+NK + +L L L N F+ +P F L L LS+ LE
Sbjct: 78 HNKLVK-ISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 163 SL 164
+
Sbjct: 134 PI 135
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 15/97 (15%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK--L 121
+ L L + +N S + G +L L S+N L ++F+
Sbjct: 371 TQMKSLQQL------DISQNSVSYDEKKGDCSWTKSLLSLNMSSNI----LTDTIFRCLP 420
Query: 122 PHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKL 156
P + L L SN+ +IP L LN++SN+L
Sbjct: 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 16/104 (15%), Positives = 31/104 (29%), Gaps = 15/104 (14%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
+ + + + + + ++ L FSNN L
Sbjct: 297 EIFSNMNIK------NFTVSG-TRMVHMLCPSKISPFLHLDFSNNLL-TDTVFENCGHLT 348
Query: 123 HLTELHLESNQFNGTIPS----FDQPT-LVRLNLSSNKLEGEIP 161
L L L+ NQ + Q L +L++S N + +
Sbjct: 349 ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 14/113 (12%), Positives = 34/113 (30%), Gaps = 4/113 (3%)
Query: 66 LTELT--GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123
L +++ L+ + L N F F M L+ L S + +
Sbjct: 81 LVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLN 139
Query: 124 LTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASLLRFNASSFSGN 175
++++ L + G + +L + +L + + +
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 20/114 (17%), Positives = 38/114 (33%), Gaps = 4/114 (3%)
Query: 47 VTGLYINSMGLSGKIDVDAL-TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWF 105
V I+++ L G++D T L+ L + + F ++ + F
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNF 307
Query: 106 SNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS-FDQ-PTLVRLNLSSNKLE 157
+ + R K+ L +N T+ L L L N+L+
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 14/65 (21%), Positives = 32/65 (49%), Gaps = 4/65 (6%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLE 130
++ + L N+ IP + AL++L ++N+ + +P +F L L ++ L
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVK-LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLH 476
Query: 131 SNQFN 135
+N ++
Sbjct: 477 TNPWD 481
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 16/103 (15%), Positives = 34/103 (33%), Gaps = 6/103 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
+ L + IY+ + ++ F + + + N + + P K LP L L
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110
Query: 128 HLESNQFNGTIPS----FDQPTLVRLNLSSNKLEGEIPASLLR 166
+ + P + L ++ N IP + +
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 24/124 (19%), Positives = 42/124 (33%), Gaps = 10/124 (8%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGA-LRKLWFS 106
L I + GL LT++ + + N + IP F + L
Sbjct: 108 KFLGIFNTGLK---MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIP--SFD--QPTLVRLNLSSNKLEGEIPA 162
NN F + F L ++L N++ I +F L++S + +P+
Sbjct: 165 NNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS 222
Query: 163 SLLR 166
L
Sbjct: 223 KGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 16/102 (15%), Positives = 37/102 (36%), Gaps = 7/102 (6%)
Query: 66 LTELTGL-RGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPH 123
+ + L + + L + IP F + + +++ S + +L F L
Sbjct: 23 IQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 124 LTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPA 162
+T + + + + I + P L L + + L+ P
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 24/109 (22%), Positives = 46/109 (42%), Gaps = 11/109 (10%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L I + +S D++A+ +LT L+ L + NQ S +I + + L L+ +NN+
Sbjct: 248 LEIGTNQIS---DINAVKDLTKLKML---NVGSNQIS-DISV--LNNLSQLNSLFLNNNQ 298
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
+ L +LT L L N I + + ++ ++
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 27/116 (23%), Positives = 40/116 (34%), Gaps = 13/116 (11%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L I + ++ D+ L L+ L L + NQ S I ++ L+ L +
Sbjct: 224 NSLKIGNNKIT---DLSPLANLSQLTWL---EIGTNQISD-INA--VKDLTKLKMLNVGS 274
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS-FDQ-PTLVRLNLSSNKLEGEIP 161
N+ L L L L L +NQ L L LS N + P
Sbjct: 275 NQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 6/97 (6%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
++ L L LR +YL+++ S I P + + L N L + L
Sbjct: 103 ISALQNLTNLRELYLNEDNISD-ISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 126 ELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIP 161
L + ++ + L L+L+ N++E P
Sbjct: 159 YLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 20/100 (20%), Positives = 41/100 (41%), Gaps = 7/100 (7%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+T + + L ++ + N+ + + P + L L N+ ++ L L
Sbjct: 214 ITPVANMTRLNSLKIGNNKITD-LSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLK 268
Query: 126 ELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASL 164
L++ SNQ + I + L L L++N+L E +
Sbjct: 269 MLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 13/117 (11%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
+T L + ++ + + L L + L+ NQ + P + L L+
Sbjct: 46 ITKLVVAGEKVAS------IQGIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIG 96
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPA 162
NK +L L +L EL+L + + I + LNL +N ++
Sbjct: 97 TNKITD--ISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-11
Identities = 19/97 (19%), Positives = 34/97 (35%), Gaps = 7/97 (7%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
L+ L+ + GL + + +++ + P + L L + N+ L L L
Sbjct: 148 LSPLSNMTGLNYLTVTESKVKD-VTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLH 202
Query: 126 ELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIP 161
NQ I L L + +NK+ P
Sbjct: 203 YFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 7/94 (7%)
Query: 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQ 133
G + + +I P ++ + + +L +T+L + +
Sbjct: 1 GAATLATLPAPIN-QIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEK 55
Query: 134 FNGTIPSFDQPT-LVRLNLSSNKLEGEIPASLLR 166
+I + T L LNL+ N++ P S L
Sbjct: 56 VA-SIQGIEYLTNLEYLNLNGNQITDISPLSNLV 88
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 16/101 (15%), Positives = 36/101 (35%), Gaps = 7/101 (6%)
Query: 65 ALTELTG-LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LP 122
A+ E+ + + + + +++L S N ++ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLS-QISAADLAPFT 58
Query: 123 HLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPA 162
L L+L SN + TL L+L++N ++ E+
Sbjct: 59 KLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 17/103 (16%), Positives = 34/103 (33%), Gaps = 10/103 (9%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHL 124
+ EL + ++ N S + + ++ +NNK L +
Sbjct: 92 VQELLVGPSIETLHAANNNIS-RVSCSRGQG---KKNIYLANNKIT-MLRDLDEGCRSRV 146
Query: 125 TELHLESNQFNG-TIPSFDQ--PTLVRLNLSSNKLEGEIPASL 164
L L+ N+ + TL LNL N + ++ +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 18/108 (16%), Positives = 31/108 (28%), Gaps = 7/108 (6%)
Query: 63 VDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLP 122
V+ L + L N ++ L+ L S+NK + P
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 123 HLTELHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLLRFN 168
+T + L +N+ I + L +L N N
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 14/93 (15%), Positives = 31/93 (33%), Gaps = 4/93 (4%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+ L+ + L N+ + + P F + + NNK + +L +L
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLA-FMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 126 ELHLESNQFNGTIPSFDQPTLVRL-NLSSNKLE 157
L N F+ R+ ++ ++
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHL 129
L L +YL N+ +P G F+++ +L L S N+ + LP +F KL L EL L
Sbjct: 50 ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELAL 107
Query: 130 ESNQFNGTIPS--FDQPT-LVRLNLSSNKL 156
+NQ ++P FD+ T L L L N+L
Sbjct: 108 NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 8/88 (9%)
Query: 79 YLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGT 137
L+ N +P G FDE+ +L +L+ NK + LP +F KL LT L+L +NQ +
Sbjct: 34 DLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 138 IPS--FDQPT-LVRLNLSSNKLEGEIPA 162
+P+ FD+ T L L L++N+L+ +P
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPD 117
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 9/73 (12%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D LT+L L L+ NQ +P G FD++ L+ L N+ + +P +F +L
Sbjct: 97 DKLTQLKEL------ALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 123 HLTELHLESNQFN 135
L + L N ++
Sbjct: 149 SLQYIWLHDNPWD 161
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 21/60 (35%), Positives = 34/60 (56%), Gaps = 6/60 (10%)
Query: 101 RKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKL 156
L N + LP +F +L LT+L+L N+ ++P+ F++ T L LNLS+N+L
Sbjct: 31 TYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL 88
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 62/295 (21%), Positives = 115/295 (38%), Gaps = 50/295 (16%)
Query: 317 EVLGNGGLGSSYKAM--------MADGVTVVVKRMKE-SSAMARDAFDTEVRRLGRL-RH 366
+ LG G G A + VTV VK +K+ ++ +E+ + + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 367 SNVLAPLAYHYRTDEKLLVYEYIPGGSLL-YL----------LHGDRGPSHDELTWPARL 415
N++ L + ++ EY G+L YL + +++T+ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL---- 471
+ARG+ YL A H +L + N+ ++ N I++FG IN+ +
Sbjct: 207 SCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 472 AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
K APEA+ T + DV+ G+++ EI T G P + ++ + +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----ELFKLL 318
Query: 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
EG + P N E+ ++ R C + P QR ++ V +
Sbjct: 319 ----KEGHR--MDKPA-----NCTNELYMMM---RDCWHAVPSQRPTFKQLVEDL 359
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 31/124 (25%), Positives = 42/124 (33%), Gaps = 29/124 (23%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
GL L + L N + IP G F+ + LR+LW NN +P F +P L L
Sbjct: 119 FNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRL 176
Query: 128 HL-ESNQ--------FNG---------------TIPSFDQ-PTLVRLNLSSNKLEGEIPA 162
L E + F G +P+ L L +S N EI
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFP-EIRP 235
Query: 163 SLLR 166
Sbjct: 236 GSFH 239
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
L L + L +N +I G F+ + +L L +N +P F+ L L EL
Sbjct: 95 FRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLREL 152
Query: 128 HLESNQFNGTIPS--FDQ-PTLVRLNLSS-NKLEGEIPASLLR 166
L +N +IPS F++ P+L+RL+L KLE I
Sbjct: 153 WLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFE 193
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 33/142 (23%), Positives = 52/142 (36%), Gaps = 17/142 (11%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + + I A GL L+ + L ++P + L +L S N
Sbjct: 176 LDLGELKKLEYISEGAFE---GLFNLKYLNLGMCNIK-DMP--NLTPLVGLEELEMSGNH 229
Query: 110 FRGRLPPSLFK-LPHLTELHLESNQFNGTIPS--FDQ-PTLVRLNLSSNKLEGEIPASLL 165
F + P F L L +L + ++Q + I FD +LV LNL+ N L +P L
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
Query: 166 RFNAS----SFSGNAGLCGKNL 183
N C ++
Sbjct: 287 TPLRYLVELHLHHNPWNCDCDI 308
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 23/96 (23%), Positives = 33/96 (34%), Gaps = 11/96 (11%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQ 133
+ + S E+P G R L N + + F+ L HL L L N
Sbjct: 56 FSKVVCTRRGLS-EVPQGIPSN---TRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 134 FNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
I +F+ +L L L N L IP+
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE 144
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 64/291 (21%), Positives = 109/291 (37%), Gaps = 57/291 (19%)
Query: 317 EVLGNGGLGSSYKAMMADG------VTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNV 369
+ LG G G KA TV VK +KE +S +E L ++ H +V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLL-YL------------------LHGDRGPSHDELT 410
+ + LL+ EY GSL +L P LT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 411 WPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470
+ I++G+ YL A + L H +L + NI ++ + IS+FG + +
Sbjct: 149 MGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 471 L----AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGID 523
+Q K A E++ T + DV+ G+++ EI+T G P +
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE----R 260
Query: 524 VVEWVASAFSEGRVTDLLD-PEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
+ + G ++ P+ N EM +L+ C + +P++R
Sbjct: 261 LFNLL----KTGHR---MERPD-----NCSEEMYRLM---LQCWKQEPDKR 296
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
++ L L L ++ NQ S P + L +L + N+ + +L L +LT
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD--IGTLASLTNLT 246
Query: 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165
+L L +NQ + P L L L +N++ P + L
Sbjct: 247 DLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGL 286
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 25/117 (21%), Positives = 43/117 (36%), Gaps = 11/117 (9%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
T L +N L ++ ++ L+ L + L N S P + L++L+F N
Sbjct: 290 TNLELNENQLED------ISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFYN 340
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
NK SL L ++ L NQ + P + + +L L+
Sbjct: 341 NKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYK 395
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 25/96 (26%), Positives = 32/96 (33%), Gaps = 5/96 (5%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+ L L L + L NQ S P + L +L N+ L L LT
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISN--ISPLAGLTALT 290
Query: 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
L L NQ P + L L L N + P
Sbjct: 291 NLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 30/112 (26%), Positives = 44/112 (39%), Gaps = 11/112 (9%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
VT L + +G+ + + L L I NQ + I P + L + +
Sbjct: 48 VTTLQADRLGIKS------IDGVEYLNNLTQINFSNNQLTD-ITP--LKNLTKLVDILMN 98
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
NN+ L L +LT L L +NQ P + L RL LSSN +
Sbjct: 99 NNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 31/101 (30%), Positives = 43/101 (42%), Gaps = 5/101 (4%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+T L L L + L+ NQ +I + L L +NN+ L L LT
Sbjct: 214 ITPLGILTNLDELSLNGNQLK-DIGT--LASLTNLTDLDLANNQISN--LAPLSGLTKLT 268
Query: 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
EL L +NQ + P L L L+ N+LE P S L+
Sbjct: 269 ELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 309
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 13/119 (10%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
T L + + +S ++ L GL L + L++NQ I P + L L
Sbjct: 268 TELKLGANQISN------ISPLAGLTALTNLELNENQLED-ISP--ISNLKNLTYLTLYF 318
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPT-LVRLNLSSNKLEGEIPASLL 165
N + L L L +N+ + + S T + L+ N++ P + L
Sbjct: 319 NNISD--ISPVSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISDLTPLANL 374
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 28/93 (30%), Positives = 40/93 (43%), Gaps = 6/93 (6%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+T L L L + L NQ + I P + L +L S+N +L L L
Sbjct: 105 ITPLANLTNLTGLTLFNNQITD-IDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQ 159
Query: 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
+L NQ P + TL RL++SSNK+
Sbjct: 160 QLSF-GNQVTDLKPLANLTTLERLDISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 15/96 (15%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+ T L L K + + ++ + L + + L +LT
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKS--IDGVEYLNNLT 71
Query: 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
+++ +NQ P + LV + +++N++ P
Sbjct: 72 QINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 11/116 (9%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
+ ++ + L ++T L D+ I + + L ++ FSNN+
Sbjct: 29 TVLGKTNVTDTVSQTDLDQVTTL------QADRLGIK-SIDG--VEYLNNLTQINFSNNQ 79
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165
+ P L L L ++ + +NQ P + L L L +N++ P L
Sbjct: 80 LTD-ITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 133
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 10/93 (10%), Positives = 27/93 (29%), Gaps = 5/93 (5%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
++ L L + + NQ S P + + +L ++ + P + +
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP---LANLTRITQLGLNDQAWTN-APVNYKANVSIP 401
Query: 126 ELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLE 157
+ D + +++ N
Sbjct: 402 NTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 12/96 (12%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D+L L L YL NQ +P G FD + L L N+ LP ++F +L
Sbjct: 61 DSLINLKEL------YLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLV 112
Query: 123 HLTELHLESNQFNGTIPS-FDQPT-LVRLNLSSNKL 156
HL EL + N+ +P ++ T L L L N+L
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 79 YLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGT 137
YL NQ + ++ PG FD + L++L+ +N+ LP +F L LT L L +NQ
Sbjct: 46 YLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 138 IPS--FDQPT-LVRLNLSSNKLEGEIPA 162
+PS FD+ L L + NKL E+P
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPR 129
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 6/61 (9%)
Query: 101 RKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKL 156
+ L+ +N+ +L P +F L +L EL+L SNQ +P FD T L L+L +N+L
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100
Query: 157 E 157
Sbjct: 101 T 101
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 34/211 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---EVRRLGRLRHSNVLAP 372
+G+G G+ Y A + + V +K+M S + + + EVR L +LRH N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ- 118
Query: 373 LAYH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
Y Y + LV EY GS LL + P L + G +G+ YLH
Sbjct: 119 --YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH 171
Query: 430 TE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-FA----YKAPEA 483
+ + H D+ K+ NI +S + +FG ++ +A A F + APE
Sbjct: 172 SHNMIHRDV-----KAGNILLSEPGLVKLGDFGS-----ASIMAPANSFVGTPYWMAPEV 221
Query: 484 IQSGKVT---PKCDVYCLGIIILEILTGKFP 511
I + K DV+ LGI +E+ K P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 22/124 (17%), Positives = 37/124 (29%), Gaps = 9/124 (7%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
L L I A + G L I + +N I F + L ++
Sbjct: 32 AIELRFVLTKLR-VIQKGAFS---GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 107 NNKFRGRLPPSLFK-LPHLTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPA 162
+ P F+ LP+L L + + +P V L++ N I
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 163 SLLR 166
+
Sbjct: 147 NSFV 150
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 29/122 (23%), Positives = 43/122 (35%), Gaps = 10/122 (8%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
+ I+ + I+ D + L L +R N I P F + L+ L SN
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIR--IEKANNLL-YINPEAFQNLPNLQYLLISNTG 115
Query: 110 FRGRLPPSLF-KLPHLTELHLESNQFNGTIP--SFD--QPTLVRLNLSSNKLEGEIPASL 164
+ LP L ++ N TI SF V L L+ N ++ EI S
Sbjct: 116 IK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA 173
Query: 165 LR 166
Sbjct: 174 FN 175
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 16/87 (18%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
G + D N E+P F L S + LP + +L +L
Sbjct: 174 FNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLE--NLKKLR 229
Query: 129 LESNQFNGTIPSFDQ-PTLVRLNLSSN 154
S +P+ ++ L+ +L+
Sbjct: 230 ARSTYNLKKLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 20/102 (19%), Positives = 36/102 (35%), Gaps = 8/102 (7%)
Query: 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGA-LRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
+ + N I F + LW + N + + S F L EL+
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELN 183
Query: 129 L-ESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L ++N +P F V L++S ++ +P+ L
Sbjct: 184 LSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLE 223
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 20/97 (20%), Positives = 34/97 (35%), Gaps = 4/97 (4%)
Query: 69 LTGLRGLRAIYLDKNQFSG-EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
L+ + L +N + + L L S N F +P S + L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
+L S + + TL L++S+N L+ L
Sbjct: 416 NLSSTGIR-VVKTCIPQTLEVLDVSNNNLD-SFSLFL 450
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 16/101 (15%), Positives = 30/101 (29%), Gaps = 6/101 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTEL 127
L L+ + L N + F + L+ L N + + F L L EL
Sbjct: 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 128 HLESNQFNGTIP--SFDQ-PTLVRLNLSSNKLEGEIPASLL 165
+++ S + L L ++ +
Sbjct: 154 EIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA-FLLEIFA 192
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 24/103 (23%), Positives = 38/103 (36%), Gaps = 8/103 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTEL 127
L L+ + L ++ + I F +G+L L S+N L S F L L L
Sbjct: 46 LRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYL 103
Query: 128 HLESNQFNGTIPS---FDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+L N + T+ F L L + + + EI
Sbjct: 104 NLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 23/140 (16%), Positives = 46/140 (32%), Gaps = 16/140 (11%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRG--LRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104
+N +G + D ++EL + +R +++ + + + ++++
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRIT 316
Query: 105 FSNNKFRGRLPPSLFK-LPHLTELHLESNQFNGTIP----SFDQ-PTLVRLNLSSNKLEG 158
N+K +P S + L L L L N P+L L LS N L
Sbjct: 317 VENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL-- 373
Query: 159 EIPASLLRFNASSFSGNAGL 178
++ L
Sbjct: 374 ----RSMQKTGEILLTLKNL 389
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 18/114 (15%), Positives = 35/114 (30%), Gaps = 4/114 (3%)
Query: 62 DVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK- 120
+ + L L+ + + + EI F + +L +L R K
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKS 170
Query: 121 LPHLTELHLESNQFNGTIPSFDQ--PTLVRLNLSSNKLEGEIPASLLRFNASSF 172
+ + L L ++ + F ++ L L L + L SS
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 23/117 (19%), Positives = 45/117 (38%), Gaps = 24/117 (20%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-------- 120
L L+ L ++ + +N F +P +R L S+ R + + +
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDS-CQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVS 439
Query: 121 ----------LPHLTELHLESNQFNGTIPSFDQPT-LVRLNLSSNKLEGEIPASLLR 166
LP L EL++ N+ T+P L+ + +S N+L+ +P +
Sbjct: 440 NNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLK-SVPDGIFD 494
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 11/91 (12%)
Query: 80 LDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQFNGTI 138
F+ IP G A++ L S NK + + +L L L+S++ N TI
Sbjct: 12 GRSRSFT-SIPSGLTA---AMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRIN-TI 65
Query: 139 P--SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
+F +L L+LS N L + +S
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLS-SLSSSWFG 95
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 9/91 (9%), Positives = 19/91 (20%), Gaps = 5/91 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTEL 127
GL L + + + + L ++ L L + L
Sbjct: 144 FAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYL 201
Query: 128 HLESNQFNG--TIPSFDQPTLVRLNLSSNKL 156
L P + + +
Sbjct: 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 15/72 (20%), Positives = 31/72 (43%), Gaps = 6/72 (8%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPH 123
L L L+ +Y+ +N+ +P L + S N+ + +P +F L
Sbjct: 443 LDSFSLFLPRLQELYISRNKLK-TLPDASL--FPVLLVMKISRNQLK-SVPDGIFDRLTS 498
Query: 124 LTELHLESNQFN 135
L ++ L +N ++
Sbjct: 499 LQKIWLHTNPWD 510
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 65/290 (22%), Positives = 109/290 (37%), Gaps = 54/290 (18%)
Query: 317 EVLGNGGLGSSYKAMMADG------VTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSN 368
+VLG+G G A + V VK +KE + R+A +E++ + +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLL-YL-----------------LHGDRGPSHDELT 410
++ L + L++EY G LL YL + + LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 411 WPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470
+ L +A+G+ +L H +L + N+ ++ I +FG I S +
Sbjct: 171 FEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 471 L----AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGID 523
A K APE++ G T K DV+ GI++ EI + G P GI
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP-------GIP 279
Query: 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
V G + P + E+ ++ ++C D +R
Sbjct: 280 VDANFYKLIQNGFK--MDQPF-----YATEEIYIIM---QSCWAFDSRKR 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 16/101 (15%), Positives = 36/101 (35%), Gaps = 7/101 (6%)
Query: 65 ALTELTG-LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LP 122
A+ E+ + + + + +++L S N ++ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLS-QISAADLAPFT 58
Query: 123 HLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPA 162
L L+L SN + TL L+L++N ++ E+
Sbjct: 59 KLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 17/104 (16%), Positives = 35/104 (33%), Gaps = 10/104 (9%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHL 124
+ EL + ++ N S + + ++ +NNK L +
Sbjct: 92 VQELLVGPSIETLHAANNNIS-RVSCSRGQG---KKNIYLANNKIT-MLRDLDEGCRSRV 146
Query: 125 TELHLESNQFNG-TIPSFDQ--PTLVRLNLSSNKLEGEIPASLL 165
L L+ N+ + TL LNL N + ++ ++
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 18/119 (15%), Positives = 39/119 (32%), Gaps = 4/119 (3%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+ L+ + L N+ + + P F + + NNK + +L +L
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLA-FMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 126 ELHLESNQFN-GTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGLCGKNL 183
L N F+ GT+ F ++ ++ + + C ++L
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 18/123 (14%), Positives = 39/123 (31%), Gaps = 15/123 (12%)
Query: 61 IDVDALTELTG-----LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG--- 112
+ + +LTG + ++P + D + AL++ + +G
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 113 -RLPPSLFKLPHLTELHLESNQFNGTIPS---FDQPTLVRLNLSSNKLEGEIPASLLRFN 168
RL E+ Q+ T+ + + L L+ E ++ R +
Sbjct: 326 ERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALD-EQVSNGRRAH 383
Query: 169 ASS 171
A
Sbjct: 384 AEL 386
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 30/82 (36%), Positives = 46/82 (56%), Gaps = 7/82 (8%)
Query: 79 YLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGT 137
L+ N+ +P G FD++ L KL S N+ + LP +F KL LT L+L N+ +
Sbjct: 34 ELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 138 IPS--FDQPT-LVRLNLSSNKL 156
+P+ FD+ T L L L +N+L
Sbjct: 91 LPNGVFDKLTQLKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 22/73 (30%), Positives = 40/73 (54%), Gaps = 9/73 (12%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
D LT+LT L YL +N+ +P G FD++ L++L N+ + +P +F +L
Sbjct: 73 DKLTKLTIL------YLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLT 124
Query: 123 HLTELHLESNQFN 135
L ++ L +N ++
Sbjct: 125 SLQKIWLHTNPWD 137
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E+LG G G +K A G+ + K +K ++ E+ + +L H+N++ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ-LYD 153
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
+ + + LV EY+ GG L + D + EL L + Q I GI ++H +
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII-DESYNLTELD--TILFMKQ-ICEGIRHMHQMYIL 209
Query: 434 HLDLPHGNLKSSNI-FISPENEPL-ISEFGFYTMINSANLAQALFA---YKAPEAIQSGK 488
HLDL K NI ++ + + + I +FG + F + APE +
Sbjct: 210 HLDL-----KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 489 VTPKCDVYCLGII--ILEILTGKFP 511
V+ D++ +G+I +L L+G P
Sbjct: 265 VSFPTDMWSVGVIAYML--LSGLSP 287
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 6/83 (7%)
Query: 78 IYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNG 136
+ L+ N+ G F + L KL N+ + P+ F H+ EL L N+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 137 TIPS--FDQPT-LVRLNLSSNKL 156
I + F L LNL N++
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQI 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 20/73 (27%), Positives = 31/73 (42%), Gaps = 9/73 (12%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLP 122
+ + + L L +N+ EI F + L+ L +N+ + P F L
Sbjct: 75 EGASHIQEL------QLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLN 126
Query: 123 HLTELHLESNQFN 135
LT L+L SN FN
Sbjct: 127 SLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 6/66 (9%)
Query: 101 RKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPS--FDQPT-LVRLNLSSNKL 156
+L ++N+ LF +LPHL +L L+ NQ I F+ + + L L NK+
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 157 EGEIPA 162
+ EI
Sbjct: 91 K-EISN 95
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLA 374
E++GNG G YK + G +K M + + E+ L + H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-IKQEINMLKKYSHHRNIAT--- 85
Query: 375 YH--------YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
Y+ D++L LV E+ GS+ L+ +G + E W A I + I RG+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIA--YICREILRGL 142
Query: 426 GYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKA 480
+LH + H D+ K N+ ++ E + +FG ++ + F + A
Sbjct: 143 SHLHQHKVIHRDI-----KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 481 PEAIQSGKVT-----PKCDVYCLGIIILEILTGKFP 511
PE I + K D++ LGI +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 20/91 (21%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L+ + L N D L L S + ++P L L+ L
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLD 280
Query: 129 LESNQFNGTIPSFDQ-PTLVRLNLSSNKLEG 158
L N+ + PS D+ P + L+L N
Sbjct: 281 LSYNRLD-RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 22/109 (20%), Positives = 30/109 (27%), Gaps = 12/109 (11%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIP---PGYFDEMGALRKLWFSNNKFR---GRLPPSLFKL 121
++ L + L N GE + L+ L N G
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 122 PHLTELHLESNQFNGTIPSFDQ---PTLVRLNLSSNKLE---GEIPASL 164
L L L N + L LNLS L+ +PA L
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKL 276
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 23/130 (17%), Positives = 40/130 (30%), Gaps = 10/130 (7%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + ++ + + A + GL+ + + + AL L S+N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNP 184
Query: 110 FRGRLPPS----LFKLPHLTELHLESNQFN---GTIPSF--DQPTLVRLNLSSNKLEGEI 160
G K P L L L + G + + L L+LS N L
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 161 PASLLRFNAS 170
A + +
Sbjct: 245 GAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 21/129 (16%), Positives = 34/129 (26%), Gaps = 10/129 (7%)
Query: 50 LYINSMGLSGKIDVDAL-TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNN 108
L + ++ ++G L L L + + L+ L +
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 109 KFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ------PTLVRLNLSSNKLE---GE 159
+ P L+ L L N G PTL L L + +E G
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 160 IPASLLRFN 168
A
Sbjct: 220 CSALAAARV 228
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 19/98 (19%), Positives = 33/98 (33%), Gaps = 7/98 (7%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKL---PHLT 125
G R L + + + + +L++L + R+ ++ L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 126 ELHLESNQFNGTIP----SFDQPTLVRLNLSSNKLEGE 159
EL LE+ + GT P P L LNL +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 44/219 (20%), Positives = 76/219 (34%), Gaps = 42/219 (19%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGR--------LRHS 367
+G G GS K + G + VKR++ + + E ++L
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD------EKEQKQLLMDLDVVMRSSDCP 81
Query: 368 NVLAPLAYH--YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARG 424
++ ++ + + E + S D + KI +
Sbjct: 82 YIVQ---FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL----AQALFA--- 477
+ +L L + H ++K SNI + + +FG S L A+ A
Sbjct: 138 LNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI-----SGQLVDSIAKTRDAGCR 189
Query: 478 -YKAPEAIQSGKVTP----KCDVYCLGIIILEILTGKFP 511
Y APE I + DV+ LGI + E+ TG+FP
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 24/99 (24%), Positives = 36/99 (36%), Gaps = 15/99 (15%)
Query: 62 DVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKL 121
D+ L+EL L L N+ + F L L S+N+ + + +
Sbjct: 71 DISFLSELRVL------RLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PM 120
Query: 122 PHLTELHLESNQFNGTIPS---FDQ-PTLVRLNLSSNKL 156
L L L N F+ +P F L L LS+ K
Sbjct: 121 ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQ 133
+A+ L +N S E+ + LR L S+N+ R L +F L L + N+
Sbjct: 54 TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 134 FNGTIPSFDQPTLVRLNLSSNKL 156
I +L L+LS N
Sbjct: 112 L-QNISCCPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 10/101 (9%)
Query: 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLE 130
+ +N F+ + + L+ L N + +++ L
Sbjct: 351 SPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 131 SNQFNGTIPS--FDQ-----PTLVRLNLSSNKLEGEIPASL 164
N ++ S +D+ +++ LNLSSN L G + L
Sbjct: 409 DVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 12/109 (11%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGA-LRKLWFSNN 108
S+ D + + L N + F + ++ L NN
Sbjct: 407 TLDVSLNSLNSHAYDRTCAWAES--ILVLNLSSNM----LTGSVFRCLPPKVKVLDLHNN 460
Query: 109 KFRGRLPPSLFKLPHLTELHLESNQFNGTIP--SFDQ-PTLVRLNLSSN 154
+ +P + L L EL++ SNQ ++P FD+ +L + L N
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 20/114 (17%), Positives = 36/114 (31%), Gaps = 4/114 (3%)
Query: 47 VTGLYINSMGLSGKIDVDALT-ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWF 105
V L I ++ ++ +ID + T T L+ L ++ F + +
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKML 336
Query: 106 SNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS-FDQ-PTLVRLNLSSNKLE 157
S + T L+ N F ++ L L L N L+
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 18/91 (19%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEM----GALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+ + ++ + + +D ++ L S+N G + L P + L
Sbjct: 399 TKNMSSLETLDVSLNS-LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVL 455
Query: 128 HLESNQFNGTIPS-FDQ-PTLVRLNLSSNKL 156
L +N+ +IP L LN++SN+L
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 21/101 (20%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 70 TGLRGLRAIYLDKNQF-SGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLP-HLTEL 127
+ L+ L+ + L +N + M +L L S N + L
Sbjct: 374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 128 HLESNQFNGTIPSFDQ--PTLVRLNLSSNKLEGEIPASLLR 166
+L SN G++ F P + L+L +N++ IP +
Sbjct: 434 NLSSNMLTGSV--FRCLPPKVKVLDLHNNRIM-SIPKDVTH 471
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 14/61 (22%), Positives = 29/61 (47%), Gaps = 4/61 (6%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQ 133
++ + L N+ IP + AL++L ++N+ + +P +F L L + L N
Sbjct: 452 VKVLDLHNNRIM-SIPKD-VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
Query: 134 F 134
+
Sbjct: 509 W 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 19/85 (22%), Positives = 29/85 (34%), Gaps = 3/85 (3%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLES 131
+ LR + L N F F + L L S KFR +L HL +
Sbjct: 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVA--HLHLSCILL 176
Query: 132 NQFNGTIPSFDQPTLVRLNLSSNKL 156
+ + I + +L N + L
Sbjct: 177 DLVSYHIKGGETESLQIPNTTVLHL 201
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 8/70 (11%)
Query: 42 CLKGIVTGLYINSMGLSG-KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGAL 100
CL V L +++ + DV L L L + NQ +P G FD + +L
Sbjct: 447 CLPPKVKVLDLHNNRIMSIPKDVTHLQALQEL------NVASNQLK-SVPDGVFDRLTSL 499
Query: 101 RKLWFSNNKF 110
+ +W +N +
Sbjct: 500 QYIWLHDNPW 509
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 47/250 (18%), Positives = 84/250 (33%), Gaps = 61/250 (24%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK-----RMKESSAMARDAFDTEVRRLGRLRHSNVL 370
+G G G A+ +K ++++ + + TEVR + +L H N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLL--HGDRGPSHDELTWPARL------------ 415
L Y ++ + LV E GG LL L D +
Sbjct: 92 -RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 416 ---------------------KIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNI-FISPE 452
I++ I + YLH + + H D+ K N F + +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI-----KPENFLFSTNK 205
Query: 453 NEPL-ISEFGFYTMINSANLAQALF--------AYKAPEAIQSG--KVTPKCDVYCLGII 501
+ + + +FG N + + APE + + PKCD + G++
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 502 ILEILTGKFP 511
+ +L G P
Sbjct: 266 LHLLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 38/226 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
EVLG+G + G +K +K+S A + + E+ L +++H N++ L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT-LED 73
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
Y + LV + + GG L DR T ++Q + + YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELF-----DRILERGVYTEKDASLVIQQVLSAVKYLHE---- 124
Query: 435 LDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQAL--FAYKAPEAIQSGKV 489
+ H +LK N+ +++P EN + I++FG M + ++ A Y APE +
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 490 TPKCDVYCLGII--IL-----------------EILTGK--FPSQY 514
+ D + +G+I IL +I G F S +
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-11
Identities = 32/119 (26%), Positives = 47/119 (39%), Gaps = 17/119 (14%)
Query: 44 KGI---VTGLYINSMGLSGKIDV-DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGA 99
KGI VT LY++ + LT + L N+ S + F M
Sbjct: 27 KGIPRDVTELYLDGNQFTLVPKELSNYKHLTLI------DLSNNRIS-TLSNQSFSNMTQ 79
Query: 100 LRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIP--SFDQPT-LVRLNLSSN 154
L L S N+ R +PP F L L L L N + +P +F+ + L L + +N
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK------ESSAMARDAFDTEVRRLGRLRHSNV 369
E LG+G K + G+ K +K ++R+ + EV L ++H NV
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ L Y + L+ E + GG L D + LT + ++ I G+ YL
Sbjct: 77 IT-LHEVYENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 429 HTE-LAHLDLPHGNLKSSNIFISPENEPL----ISEFGFYTMINSANLAQALFA---YKA 480
H+ +AH DL K NI + N P I +FG I+ N + +F + A
Sbjct: 131 HSLQIAHFDL-----KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 481 PEAIQSGKVTPKCDVYCLGII--ILEILTGKFP 511
PE + + + D++ +G+I IL L+G P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYIL--LSGASP 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 35/112 (31%), Positives = 49/112 (43%), Gaps = 11/112 (9%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
L EL L L AIY D N ++P D +L + NN P L LP LT
Sbjct: 188 LPELQNLPFLTAIYADNNSLK-KLP----DLPLSLESIVAGNNILE--ELPELQNLPFLT 240
Query: 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG--EIPASLLRFNASSFSGN 175
++ ++N T+P P+L LN+ N L E+P SL + S +
Sbjct: 241 TIYADNNLLK-TLPDL-PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS 290
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 25/99 (25%), Positives = 34/99 (34%), Gaps = 12/99 (12%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
L EL L L IY D N +P D +L L +N LP L L
Sbjct: 230 LPELQNLPFLTTIYADNNLLK-TLP----DLPPSLEALNVRDNYLT-DLPELPQSLTFLD 283
Query: 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
+ + P+ L LN SSN++ +
Sbjct: 284 VSENIFSGLSELPPN-----LYYLNASSNEIR-SLCDLP 316
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 20/90 (22%), Positives = 30/90 (33%), Gaps = 12/90 (13%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLES 131
R + L+ S +P L L S N LP L L +
Sbjct: 70 DRQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 132 NQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
+ P L L +S+N+LE ++P
Sbjct: 124 KALSDLPPL-----LEYLGVSNNQLE-KLP 147
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 23/94 (24%), Positives = 39/94 (41%), Gaps = 13/94 (13%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
L+ L + S ++PP L L SNN+ +LP L L +
Sbjct: 109 LPQSLKSLLVDNNNLKALS-DLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKII 158
Query: 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
+++N +P P+L + +N+LE E+P
Sbjct: 159 DVDNNSLK-KLPDL-PPSLEFIAAGNNQLE-ELP 189
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 23/118 (19%), Positives = 38/118 (32%), Gaps = 30/118 (25%)
Query: 66 LTELTG-LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
+ L L + + N+ E+P L +L S N +P +L
Sbjct: 309 IRSLCDLPPSLEELNVSNNKLI-ELPA----LPPRLERLIASFNHLA-EVPELP---QNL 359
Query: 125 TELHLESNQFN------------------GTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
+LH+E N +P Q L +L++ +N L E P
Sbjct: 360 KQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQ-NLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 9/80 (11%), Positives = 22/80 (27%), Gaps = 17/80 (21%)
Query: 100 LRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIP---------------SFDQP 144
L++ ++ +P + TE + +++ P
Sbjct: 13 LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR 71
Query: 145 TLVRLNLSSNKLEGEIPASL 164
L L++ L +P
Sbjct: 72 QAHELELNNLGLS-SLPELP 90
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 10/71 (14%), Positives = 26/71 (36%), Gaps = 6/71 (8%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
L E+ + L+ ++++ N E P D ++ L ++ + + L
Sbjct: 388 LAEVPELPQNLKQLHVETNPLR-EFP----DIPESVEDLRMNSERVVDPYEFAHETTDKL 442
Query: 125 TELHLESNQFN 135
+ E + +
Sbjct: 443 EDDVFEHHHHH 453
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK------ESSAMARDAFDTEVRRLGRLRHSNV 369
E LG+G K + G+ K +K ++R+ + EV L ++ H NV
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ L Y + L+ E + GG L D + L+ ++ I G+ YL
Sbjct: 78 IT-LHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 429 HTE-LAHLDLPHGNLKSSNIFISPENEPL----ISEFGFYTMINSANLAQALFA---YKA 480
HT+ +AH DL K NI + +N P+ + +FG I + +F + A
Sbjct: 132 HTKKIAHFDL-----KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 481 PEAIQSGKVTPKCDVYCLGII--ILEILTGKFP 511
PE + + + D++ +G+I IL L+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYIL--LSGASP 217
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 19/110 (17%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
L IN++ + + + ++ L+ L L + + + P + +L L S+
Sbjct: 69 KDLTINNIHAT---NYNPISGLSNLERL---RIMGKDVTSDKIPN-LSGLTSLTLLDISH 121
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKL 156
+ + + LP + + L N I P L LN+ + +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 17/112 (15%), Positives = 42/112 (37%), Gaps = 11/112 (9%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
+T + + ++ ++ D+ + ++ L ++ + P + L +L
Sbjct: 46 LTYITLANINVT---DLTGIEYAHNIKDL---TINNIHAT-NYNP--ISGLSNLERLRIM 96
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKL 156
P+L L LT L + + + +I + P + ++LS N
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 59 GKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSL 118
G+ +TE + L I L + ++ + ++ L +N P +
Sbjct: 31 GQSSTANITE-AQMNSLTYITLANINVT-DLTG--IEYAHNIKDLTINNIHATN-YNP-I 84
Query: 119 FKLPHLTELHLESNQF-NGTIPSFDQ-PTLVRLNLSSNKLEGEIPASL 164
L +L L + + IP+ +L L++S + + I +
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 4/77 (5%)
Query: 60 KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
D LT++ L + +I L N +I P + L+ L + +
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHD-YRG-IE 178
Query: 120 KLPHLTELHLESNQFNG 136
P L +L+ S G
Sbjct: 179 DFPKLNQLYAFSQTIGG 195
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
LG+G G + + G+ V+K + K+ S + + + E+ L L H N++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK-IF 86
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-L 432
+ + +V E GG LL + L+ ++++ + + Y H++ +
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIV-SAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 433 AHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQS 486
H DL K NI F + P+ I +FG + S + Y APE +
Sbjct: 146 VHKDL-----KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK- 199
Query: 487 GKVTPKCDVYCLGIIILEILTGKFP 511
VT KCD++ G+++ +LTG P
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 19/203 (9%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+G G G A+ + K++ + D F E+ + L H N++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR-LYE 73
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ + + LV E GG L +R +I++ + + Y H
Sbjct: 74 TFEDNTDIYLVMELCTGGELF-----ERVVHKRVFRESDAARIMKDVLSAVAYCH----K 124
Query: 435 LDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQSGK 488
L++ H +LK N F++ + PL + +FG + + Y +P+ ++ G
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GL 183
Query: 489 VTPKCDVYCLGIIILEILTGKFP 511
P+CD + G+++ +L G P
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPP 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK------ESSAMARDAFDTEVRRLGRLRHSNV 369
E LG+G K G K +K ++R+ + EV L +RH N+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ L + + L+ E + GG L D + LT + ++ I G+ YL
Sbjct: 71 IT-LHDIFENKTDVVLILELVSGGELF-----DFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 429 HTE-LAHLDLPHGNLKSSNIFISPENEPL----ISEFGFYTMINSANLAQALFA---YKA 480
H++ +AH DL K NI + +N P + +FG I + N + +F + A
Sbjct: 125 HSKRIAHFDL-----KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 481 PEAIQSGKVTPKCDVYCLGII--ILEILTGKFP 511
PE + + + D++ +G+I IL L+G P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYIL--LSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK------ESSAMARDAFDTEVRRLGRLRHSNV 369
E LG+G K + G+ K +K + R+ + EV L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ L Y + L+ E + GG L D + L+ ++ I G+ YL
Sbjct: 78 IT-LHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 429 HTE-LAHLDLPHGNLKSSNIFISPENEPL----ISEFGFYTMINSANLAQALFA---YKA 480
HT+ +AH DL K NI + +N P+ + +FG I + +F + A
Sbjct: 132 HTKKIAHFDL-----KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 481 PEAIQSGKVTPKCDVYCLGII--ILEILTGKFP 511
PE + + + D++ +G+I IL L+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYIL--LSGASP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 30/214 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK--------RMKESSAMARDAFDTEVRRLGRLRHS 367
+ LG+G G A V ++ A +TE+ L +L H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 368 NVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
++ + + ++ +V E + GG L D+ + L + + Y
Sbjct: 201 CIIK-IKNFFDAEDYYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 428 LHTE-LAHLDLPHGNLKSSNIFISPENEPL---ISEFGFYTMINSANLAQALF---AYKA 480
LH + H DL K N+ +S + E I++FG ++ +L + L Y A
Sbjct: 255 LHENGIIHRDL-----KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 481 PEAIQSGKV---TPKCDVYCLGIIILEILTGKFP 511
PE + S D + LG+I+ L+G P
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 61/236 (25%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDT--EVRRLGRLRHSNVLAPLA 374
+V+GNG G ++A + + V +K++ +D E++ + ++H NV+ A
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 375 YHYRTDEKL------LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG----IARG 424
+ Y +K LV EY+P +Y + + +++ + R
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRS 153
Query: 425 IGYLHTE-LAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFA----- 477
+ Y+H+ + H D +K N+ + P + L + +FG A+ L A
Sbjct: 154 LAYIHSIGICHRD-----IKPQNLLLDPPSGVLKLIDFG---------SAKILIAGEPNV 199
Query: 478 -------YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FPSQYLTNGNGGID 523
Y+APE I + T D++ G ++ E++ G+ FP G GID
Sbjct: 200 SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP------GESGID 249
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 8/92 (8%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
LT L L+ + + N+ + +P L L N+ RLP SL L
Sbjct: 233 LTSLPVLPSELKELMVSGNRLT-SLP----MLPSGLLSLSVYRNQLT-RLPESLIHLSSE 286
Query: 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKL 156
T ++LE N + + S +
Sbjct: 287 TTVNLEGNPLS-ERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 26/100 (26%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
LT L GL+ + + NQ + +P L KLW NN+ LP L
Sbjct: 173 LTSLPMLPSGLQELSVSDNQLA-SLP----TLPSELYKLWAYNNRLT-SLPAL---PSGL 223
Query: 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
EL + N+ + L L +S N+L +P
Sbjct: 224 KELIVSGNRLTSLPVLPSE--LKELMVSGNRLT-SLPMLP 260
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 19/101 (18%), Positives = 30/101 (29%), Gaps = 14/101 (13%)
Query: 66 LTEL--TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123
LT L + + + N + +P LR L S N+ LP L
Sbjct: 52 LTTLPDCLPAHITTLVIPDNNLT-SLP----ALPPELRTLEVSGNQLT-SLPVLPPGLLE 105
Query: 124 LTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
L+ L +L + N+L +P
Sbjct: 106 LSIFSNPLTHLPALPSG-----LCKLWIFGNQLT-SLPVLP 140
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 22/97 (22%), Positives = 31/97 (31%), Gaps = 15/97 (15%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
GL L L KLW N+ LP P L EL
Sbjct: 99 LPPGLLELSIFSNPLTHLPALPS--------GLCKLWIFGNQLT-SLPVLP---PGLQEL 146
Query: 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
+ NQ ++P+ L +L +N+L +P
Sbjct: 147 SVSDNQLA-SLPA-LPSELCKLWAYNNQLT-SLPMLP 180
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 26/104 (25%), Positives = 39/104 (37%), Gaps = 14/104 (13%)
Query: 66 LTELTG-LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
LT L GL+ + + N+ + +P L++L S N+ LP L
Sbjct: 213 LTSLPALPSGLKELIVSGNRLT-SLPV----LPSELKELMVSGNRLT-SLPMLP---SGL 263
Query: 125 TELHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASLLR 166
L + NQ +P S + +NL N L E LR
Sbjct: 264 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR 305
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 55/229 (24%), Positives = 83/229 (36%), Gaps = 42/229 (18%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVLAPL 373
+LG G G K VK + ++SA +D EV L +L H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK-L 86
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+V E GG L D + +I++ + GI Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHK-- 139
Query: 433 AHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQS 486
++ H +LK NI S ++ + I +FG T + Y APE ++
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR- 196
Query: 487 GKVTPKCDVYCLGII--IL-----------------EILTGK--FPSQY 514
G KCDV+ G+I IL + TGK F
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 66/293 (22%)
Query: 266 NKSRDVDVSRKASSSRRGSSHHGK-------NSGVGELVLVNGQKGVFGLPDLMK-AAAE 317
+ R + ++ S+ S V +V GQ P + +
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDR--PQEVSYTDTK 60
Query: 318 VLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDT--EVRRLGRLRHSNVLAPLA 374
V+GNG G Y+A + D G V +K++ + D E++ + +L H N++
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 375 YHYRTDEKL------LVYEYIPGGSLLYLLHGDRGPSHDELTWP-ARLKIVQGIARGIGY 427
+ Y + EK LV +Y+P +Y + + L +L + Q + R + Y
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAY 171
Query: 428 LHT-ELAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFA-------- 477
+H+ + H D +K N+ + P+ L + +FG A+ L
Sbjct: 172 IHSFGICHRD-----IKPQNLLLDPDTAVLKLCDFG---------SAKQLVRGEPNVSYI 217
Query: 478 ----YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FPSQYLTNGNGGID 523
Y+APE I + T DV+ G ++ E+L G+ FP G+ G+D
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP------GDSGVD 264
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 27/103 (26%), Positives = 45/103 (43%), Gaps = 15/103 (14%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
L+ L L+ + +D NQ + +P + L + NN+ LP L
Sbjct: 112 LSTLPELPASLKHLDVDNNQLT-MLP----ELPALLEYINADNNQLT-MLPELP---TSL 162
Query: 125 TELHLESNQFNGTIPSFDQPT-LVRLNLSSNKLEGEIPASLLR 166
L + +NQ +P + P L L++S+N LE +PA +R
Sbjct: 163 EVLSVRNNQLT-FLP--ELPESLEALDVSTNLLE-SLPAVPVR 201
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 27/110 (24%), Positives = 47/110 (42%), Gaps = 16/110 (14%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
L L L + N+ S +P + +L+ L NN+ LP L
Sbjct: 92 LISLPELPASLEYLDACDNRLS-TLP----ELPASLKHLDVDNNQLT-MLPEL---PALL 142
Query: 125 TELHLESNQFNGTIPSFDQPT-LVRLNLSSNKLEG--EIPASLLRFNASS 171
++ ++NQ +P + PT L L++ +N+L E+P SL + S+
Sbjct: 143 EYINADNNQLT-MLP--ELPTSLEVLSVRNNQLTFLPELPESLEALDVST 189
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 25/117 (21%), Positives = 35/117 (29%), Gaps = 14/117 (11%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124
LT L L + + NQ + +P + +L L S N LP + H
Sbjct: 152 LTMLPELPTSLEVLSVRNNQLT-FLP----ELPESLEALDVSTNLLE-SLPAVPVRNHHS 205
Query: 125 TE----LHLESNQFNGTIPS--FDQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGN 175
E N+ IP + L N L I SL + A
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG 261
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 14/79 (17%), Positives = 23/79 (29%), Gaps = 5/79 (6%)
Query: 88 EIPPGYFDEMGALRKLWFSNNKFRGRLPPSL--FKLPHLTELHLESNQFNGTIPSFDQPT 145
YF K R L + +EL L + ++P P
Sbjct: 24 GTYADYFSAWDKWEKQALPGEN-RNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPPQ 81
Query: 146 LVRLNLSSNKLEGEIPASL 164
+ L ++ N L +P
Sbjct: 82 ITVLEITQNALI-SLPELP 99
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 16/96 (16%), Positives = 25/96 (26%), Gaps = 7/96 (7%)
Query: 66 LTEL-TGLRGLRAIYLDKNQFSGEIPPGYFDEMG---ALRKLWFSNNKFRGRLPPSLFKL 121
LT L L A+ + N +P N+ +P ++ L
Sbjct: 172 LTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSL 229
Query: 122 PHLTELHLESNQFNG-TIPSFDQPTLVRLNLSSNKL 156
+ LE N + S Q T
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 30/213 (14%)
Query: 318 VLGNGGLGSSYKAMMADGVTVV-VKRMKESSAMARDA---FDTEVRRLGRLRHSNVLAPL 373
V+G G M V +K M + + R F E L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR-WITQL 126
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ ++ + L LV EY GG LL LL G+R P+ AR + + I I +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-----ARFYLAE-IVMAIDSVHR 180
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-----YKAPEAIQ 485
L H ++K NI + +++FG + + ++L A Y +PE +Q
Sbjct: 181 ----LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 486 S-------GKVTPKCDVYCLGIIILEILTGKFP 511
+ G P+CD + LG+ E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 27/104 (25%), Positives = 40/104 (38%), Gaps = 7/104 (6%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123
DA E GL L+++ L+ +P + L+ L N+ L P++ LP
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230
Query: 124 LTELHLESNQFNGTIP-SFDQ-PTLVRLNLSS-NKLEGEIPASL 164
L EL L P F L RL L + L +P +
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDI 273
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 15/108 (13%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+ L L+ + +D E+P + L L + N R LP S+ L L EL
Sbjct: 99 QAFRLSHLQHMTIDAAGLM-ELPDT-MQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155
Query: 128 HLESNQFNGTIP-SFDQPT----------LVRLNLSSNKLEGEIPASL 164
+ + +P L L L + +PAS+
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 9/115 (7%)
Query: 64 DALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123
D L + T G A+ L + P F + L+ + LP ++ +
Sbjct: 73 DLLEDAT-QPGRVALELRSVPLP-QFPDQAFR-LSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 124 LTELHLESNQFNGTIP-SFDQ-PTLVRLNLSS-NKLEGEIPASLLRFNASSFSGN 175
L L L N +P S L L++ + +L E+P L +AS
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 16/101 (15%), Positives = 29/101 (28%), Gaps = 5/101 (4%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+ L + + P F+L HL
Sbjct: 49 AWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQ 107
Query: 126 ELHLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASL 164
+ +++ +P + Q L L L+ N L +PAS+
Sbjct: 108 HMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASI 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 21/106 (19%), Positives = 35/106 (33%), Gaps = 10/106 (9%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIP--------PGYFDEMGALRKLWFSNNKFRGRLPPSLF 119
+ L LR + + E+P G + L+ L R LP S+
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203
Query: 120 KLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASL 164
L +L L + ++ + P+ P L L+L P
Sbjct: 204 NLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 17/99 (17%), Positives = 35/99 (35%), Gaps = 4/99 (4%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
+ L+ L+++ + + S + P + L +L PP L L
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPA-IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 128 HLESNQFNGTIP-SFDQ-PTLVRLNLSSNKLEGEIPASL 164
L+ T+P + L +L+L +P+ +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 13/67 (19%), Positives = 23/67 (34%), Gaps = 3/67 (4%)
Query: 68 ELTGLRGLRAIYL-DKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTE 126
G L+ + L D + +P + L KL RLP + +LP
Sbjct: 248 IFGGRAPLKRLILKDCSNLL-TLPLD-IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 127 LHLESNQ 133
+ + +
Sbjct: 306 ILVPPHL 312
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 35/215 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGR--------LRHS 367
LG G G K + G + VKR++ + E +RL +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN------SQEQKRLLMDLDISMRTVDCP 66
Query: 368 NVLAPLAYHYRTDEKLLVYEYIPGGSL--LYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
+ +R + + E + SL Y D+G + E KI I + +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE---DILGKIAVSIVKAL 122
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT-MINSANLAQALFA----YKA 480
+LH++L+ + H ++K SN+ I+ + + +FG +++ +A+ + A Y A
Sbjct: 123 EHLHSKLSVI---HRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCKPYMA 177
Query: 481 PEAIQSGKVTP----KCDVYCLGIIILEILTGKFP 511
PE I K D++ LGI ++E+ +FP
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 47/237 (19%), Positives = 86/237 (36%), Gaps = 56/237 (23%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDT--EVRRLGRLRHSNVLAPL 373
+ G G G+ G++V +K++ + R ++ L L H N++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQ 85
Query: 374 AYHYRTDEK-------LLVYEYIPGGSLLYLLHGDRGPSHDELTWP-ARLKIVQGIARGI 425
+Y Y E+ +V EY+P L+ + ++ + Q + R I
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKVFLFQ-LIRSI 142
Query: 426 GYLHTELA---HLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALFA---- 477
G LH H D +K N+ ++ + L + +FG A+ L
Sbjct: 143 GCLHLPSVNVCHRD-----IKPHNVLVNEADGTLKLCDFG---------SAKKLSPSEPN 188
Query: 478 --------YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FPSQYLTNGNGGID 523
Y+APE I + T D++ +G I E++ G+ F G+
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR------GDNSAG 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 35/152 (23%), Positives = 66/152 (43%), Gaps = 20/152 (13%)
Query: 370 LAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ L Y ++ D L +V EY+PGG L+ L+ P AR + + + +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-----ARFYTAE-VVLALDAI 184
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-----YKAPEA 483
H + H ++K N+ + +++FG +N + + A Y +PE
Sbjct: 185 H----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 484 IQS----GKVTPKCDVYCLGIIILEILTGKFP 511
++S G +CD + +G+ + E+L G P
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 13/109 (11%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L+++ + D+ +L +L L+ L L+ N S +I + L L+ NNK
Sbjct: 92 LFLDENKIK---DLSSLKDLKKLKSL---SLEHNGIS-DING--LVHLPQLESLYLGNNK 142
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
L +L L L LE NQ + I L L LS N +
Sbjct: 143 ITD--ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 20/100 (20%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 59 GKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSL 118
K V L + I + + + + + KL+ + NK + P L
Sbjct: 29 KKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLT-DIKP-L 83
Query: 119 FKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
L +L L L+ N+ + S L L+L N +
Sbjct: 84 TNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS 122
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 6e-09
Identities = 30/80 (37%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 79 YLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGT 137
YL NQ + ++ PG FD + L +L NN+ LP +F KL LT+L L NQ +
Sbjct: 36 YLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-S 92
Query: 138 IP--SFDQPT-LVRLNLSSN 154
IP +FD L + L +N
Sbjct: 93 IPRGAFDNLKSLTHIWLLNN 112
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
+LG G G K ++ G +K +K+ +A+D TE R L RH L
Sbjct: 155 LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FL 210
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L Y ++T ++L V EY GG L + L +R S D AR + I + YLH
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----ARFYGAE-IVSALDYLH 265
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQ 485
+E ++ + +LK N+ + + I++FG F Y APE ++
Sbjct: 266 SEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 486 SGKVTPKCDVYCLGIIILEILTGKFP 511
D + LG+++ E++ G+ P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 17/163 (10%)
Query: 356 TEVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPAR 414
E + RL H L + ++ DEKL Y G LL + S DE R
Sbjct: 79 RERDVMSRLDHPF-FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETC--TR 133
Query: 415 LKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQA 474
+ I + YLH + H +LK NI ++ + I++FG +++ +
Sbjct: 134 FYTAE-IVSALEYLHG----KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 475 LF------AYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
Y +PE + D++ LG II +++ G P
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 28/80 (35%), Positives = 46/80 (57%), Gaps = 7/80 (8%)
Query: 79 YLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGT 137
+L+ NQ + ++ PG FD + L++L+F++NK +P +F KL LT+L L N +
Sbjct: 39 WLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-S 95
Query: 138 IP--SFDQPT-LVRLNLSSN 154
IP +FD L + L +N
Sbjct: 96 IPRGAFDNLKSLTHIYLYNN 115
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 18/93 (19%), Positives = 39/93 (41%), Gaps = 7/93 (7%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
++ + GL+ ++ + L Q + ++ P + L+ L+ N+ + P L L +L
Sbjct: 100 VSAIAGLQSIKTLDLTSTQIT-DVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQ 154
Query: 126 ELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
L + + Q + + L L NK+
Sbjct: 155 YLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 23/112 (20%), Positives = 42/112 (37%), Gaps = 13/112 (11%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
+T L G++ ++ + L L GL L NQ + ++ P + + +L S
Sbjct: 43 ITTLSAFGTGVT---TIEGVQYLNNLIGL---ELKDNQIT-DLAP--LKNLTKITELELS 93
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
N + + + L + L L S Q + L L L N++
Sbjct: 94 GNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVTPLAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 7/93 (7%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
L L L + + L N + + +++ L ++ + L L +L
Sbjct: 78 LAPLKNLTKITELELSGNPLK-NVSA--IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQ 132
Query: 126 ELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
L+L+ NQ I L L++ + ++
Sbjct: 133 VLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 27/109 (24%), Positives = 50/109 (45%), Gaps = 11/109 (10%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
LY++ ++ ++ L LT L+ L + Q S ++ P + L L +
Sbjct: 132 QVLYLDLNQIT---NISPLAGLTNLQYL---SIGNAQVS-DLTP--LANLSKLTTLKADD 182
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKL 156
NK + P L LP+L E+HL++NQ + P + L + L++ +
Sbjct: 183 NKISD-ISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTI 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 23/164 (14%)
Query: 357 EVRRLGRLRHSNVLAPLAYH-YRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPA 413
EVR + L H N++ + T++ L L+ EY GG + YL+ R + A
Sbjct: 64 EVRIMKILNHPNIVK--LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-----A 116
Query: 414 RLKIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472
R + I + Y H + + H DL K+ N+ + + I++FGF
Sbjct: 117 R-SKFRQIVSAVQYCHQKRIVHRDL-----KAENLLLDADMNIKIADFGFSNEFTVGGKL 170
Query: 473 QAL---FAYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFP 511
A Y APE Q GK P+ DV+ LG+I+ +++G P
Sbjct: 171 DAFCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 42/228 (18%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
LG G Y+ +K +K++ + TE+ L RL H N++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIK-LKE 115
Query: 376 HYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ T ++ LV E + GG L DR + V+ I + YLH
Sbjct: 116 IFETPTEISLVLELVTGGELF-----DRIVEKGYYSERDAADAVKQILEAVAYLHE---- 166
Query: 435 LDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQAL---FAYKAPEAIQSGK 488
+ H +LK N+ + +P + PL I++FG ++ L + + Y APE ++
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 489 VTPKCDVYCLGII--IL------------------EILTGK--FPSQY 514
P+ D++ +GII IL IL + F S +
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 29/209 (13%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLA 374
+VLG G G + G +K + +S + EV + +++ L
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89
Query: 375 Y----HYRTDEKLLVYEYIPGGSLLYLLHGDR--GPSHDELTWPARLKIVQGIARGIGYL 428
H+ L++ E + GG L R T +I++ I I +L
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELF-----SRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 429 HTE-LAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF--AYKAPE 482
H+ +AH D+ K N+ + S ++ L +++FGF L + Y APE
Sbjct: 145 HSHNIAHRDV-----KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE 199
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ K CD++ LG+I+ +L G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 35/151 (23%), Positives = 52/151 (34%), Gaps = 17/151 (11%)
Query: 12 SSFTNAKALDSW--MPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKIDVDALTEL 69
F+ KA+D E S + V L++ L+ L L
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT------VLCHL 459
Query: 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHL 129
L + + L N+ +PP + L L S+N + + LP L EL L
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALE-NVDG-VANLPRLQELLL 515
Query: 130 ESNQFNGTIPSFDQ----PTLVRLNLSSNKL 156
+N+ + P LV LNL N L
Sbjct: 516 CNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 76 RAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFN 135
R ++L + + + +++ + L S+N+ R LPP+L L L L N
Sbjct: 444 RVLHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
Query: 136 GTIPSFDQ-PTLVRLNLSSNKLE 157
+ P L L L +N+L+
Sbjct: 500 -NVDGVANLPRLQELLLCNNRLQ 521
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 27/119 (22%), Positives = 45/119 (37%), Gaps = 15/119 (12%)
Query: 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFS 106
+T L ++ ++ ++ LT LT L N + + + L L
Sbjct: 44 LTSLDCHNSSITDMTGIEKLTGLTKL------ICTSNNIT-TLD---LSQNTNLTYLACD 93
Query: 107 NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165
+NK L + L LT L+ ++N+ + P L LN + N L EI S
Sbjct: 94 SNKLT-NLDVT--PLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT-EIDVSHN 147
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 28/118 (23%), Positives = 42/118 (35%), Gaps = 15/118 (12%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
T L + K+DV T+LT L N+ + E+ + L +L
Sbjct: 151 TELDCHLNKKITKLDVTPQTQLTTL------DCSFNKIT-ELD---VSQNKLLNRLNCDT 200
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165
N +L + + LT L SN+ I L + S N L E+ S L
Sbjct: 201 NNIT-KLDLN--QNIQLTFLDCSSNKLT-EIDVTPLTQLTYFDCSVNPLT-ELDVSTL 253
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 19/120 (15%), Positives = 33/120 (27%), Gaps = 16/120 (13%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
++DV T+L L + E+ + L L+ +N +
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLL------DCQAAGIT-ELD---LSQNPKLVYLYLNNTE 329
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEIPASLLRFN 168
L S L L + S + P L + + +P L N
Sbjct: 330 LT-ELDVS--HNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI-TMPKETLTNN 384
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 28/133 (21%), Positives = 45/133 (33%), Gaps = 24/133 (18%)
Query: 48 TGLYINSMGLSGKIDVDALTELT---------------GLRGLRAIYLDKNQFSGEIPPG 92
T L S ++ +D+ T LT L L + D N+ + ++
Sbjct: 67 TKLICTSNNIT-TLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLDVS 124
Query: 93 YFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLS 152
+ L L + N + S LTEL N+ + Q L L+ S
Sbjct: 125 ---QNPLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCS 178
Query: 153 SNKLEGEIPASLL 165
NK+ E+ S
Sbjct: 179 FNKIT-ELDVSQN 190
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 31/119 (26%), Positives = 44/119 (36%), Gaps = 15/119 (12%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
T L L+ +IDV T+LT L N+ ++ L L S
Sbjct: 130 TYLNCARNTLT-EIDVSHNTQLTEL------DCHLNKKITKLD---VTPQTQLTTLDCSF 179
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR 166
NK L S + L L+ ++N + L L+ SSNKL EI + L
Sbjct: 180 NKITE-LDVS--QNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLT-EIDVTPLT 233
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 13/98 (13%), Positives = 25/98 (25%), Gaps = 8/98 (8%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127
++T L L N + E+ L L + + L
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELDVSTLS---KLTTLHCIQTDLL-EIDLT--HNTQLIYF 280
Query: 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165
E + + L L+ + + E+ S
Sbjct: 281 QAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQN 317
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 17/108 (15%), Positives = 38/108 (35%), Gaps = 13/108 (12%)
Query: 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK 109
L + G++ ++D+ +L L YL+ + + E+ + L+ L N
Sbjct: 302 LDCQAAGIT-ELDLSQNPKLVYL------YLNNTELT-ELDVSHNT---KLKSLSCVNAH 350
Query: 110 FRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLE 157
+ + K+P L Q + + +S + L+
Sbjct: 351 IQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLD 396
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 51/208 (24%), Positives = 77/208 (37%), Gaps = 23/208 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPL 373
+ LG G + + + G K +K+ R E+ L + + L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
Y ++ L+ EY GG + L + E I Q I G+ YLH
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VIRLIKQ-ILEGVYYLHQNN 151
Query: 432 LAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQ 485
+ HLDL K NI S + I +FG I A + + Y APE +
Sbjct: 152 IVHLDL-----KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 486 SGKVTPKCDVYCLGII--ILEILTGKFP 511
+T D++ +GII +L LT P
Sbjct: 207 YDPITTATDMWNIGIIAYML--LTHTSP 232
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 46/218 (21%), Positives = 81/218 (37%), Gaps = 39/218 (17%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT------EVRRLGRLR---- 365
+LG GG G+ + + D + V +K + + + EV L ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 366 HSNVLAPLAYHYRTDEKLLVYEY-IPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIAR 423
H V+ L + + +LV E +P L Y+ +GP + +R Q +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGP---SRCFFGQ-VVA 150
Query: 424 GIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALF----- 476
I + H+ + H D+ K NI I + +FG A L +
Sbjct: 151 AIQHCHSRGVVHRDI-----KDENILIDLRRGCAKLIDFGS-----GALLHDEPYTDFDG 200
Query: 477 --AYKAPEAIQSGKVT-PKCDVYCLGIIILEILTGKFP 511
Y PE I + V+ LGI++ +++ G P
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 43/233 (18%), Positives = 81/233 (34%), Gaps = 42/233 (18%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK-----RMKESSAMARDAFDTEVRRLGRLRHSNVL 370
EV+G G + + G VK + S ++ + E L+H +++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L Y +D L +V+E++ G L + + R + + ++ I + Y H
Sbjct: 90 E-LLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 430 TE-LAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALFA----YKAP 481
+ H D +K + S + P+ + FG + + L + AP
Sbjct: 148 DNNIIHRD-----VKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 482 EAIQSGKVTPKCDVYCLGII--IL----------------EILTGK--FPSQY 514
E ++ DV+ G+I IL I+ GK +
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQ 255
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 28/97 (28%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 62 DVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKL 121
D+ +L +L L+ L L+ N S +I + L L+ NNK L +L
Sbjct: 104 DLSSLKDLKKLKSL---SLEHNGIS-DING--LVHLPQLESLYLGNNKITD--ITVLSRL 155
Query: 122 PHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
L L LE NQ + I L L LS N +
Sbjct: 156 TKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 20/100 (20%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 59 GKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSL 118
K V L + I + + + + + KL+ + NK + P L
Sbjct: 32 KKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLT-DIKP-L 86
Query: 119 FKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
L +L L L+ N+ + S L L+L N +
Sbjct: 87 ANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 31/107 (28%), Positives = 44/107 (41%), Gaps = 12/107 (11%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSN 107
LY+ + ++ D+ L+ LT L L L+ NQ S +I P + L+ L+ S
Sbjct: 137 ESLYLGNNKIT---DITVLSRLTKLDTL---SLEDNQIS-DIVP--LAGLTKLQNLYLSK 187
Query: 108 NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSN 154
N L L L +L L L S + P Q LV N N
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKN 231
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 28/211 (13%)
Query: 318 VLGNGGLGSSYKAMMADGVTVV-VKRMKESSAMARDA---FDTEVRRLGRLRHSNVLAPL 373
V+G G G + + V +K + + + R F E L + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK-WITTL 139
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
Y ++ D L LV +Y GG LL LL DR P AR + + + I +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-----ARFYLAE-MVIAIDSVHQ 193
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-----YKAPEAIQ 485
L H ++K NI + +++FG + Q+ A Y +PE +Q
Sbjct: 194 ----LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 486 S-----GKVTPKCDVYCLGIIILEILTGKFP 511
+ G+ P+CD + LG+ + E+L G+ P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 48/223 (21%), Positives = 79/223 (35%), Gaps = 49/223 (21%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRR----LGRLRHSNVLA 371
++LG G G + + VK +K+ + V++ L RLRH NV+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 372 PL--AYHYRTDEKL-LVYEYIPGGS--LL-YLLHGDRGPSHDELTWPARLKIVQGIARGI 425
L + +K+ +V EY G +L + R P A Q + G+
Sbjct: 71 -LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQ-----AHGYFCQ-LIDGL 122
Query: 426 GYLHTE-LAHLDL--------PHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF 476
YLH++ + H D+ G LK IS G ++
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLK-------------ISALGVAEALHPFAADDTCR 169
Query: 477 ------AYKAPEAIQSGKV--TPKCDVYCLGIIILEILTGKFP 511
A++ PE K D++ G+ + I TG +P
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 46/208 (22%), Positives = 77/208 (37%), Gaps = 29/208 (13%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLA 374
+ LG G K + VK + + E+ L H N++ L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK-LH 72
Query: 375 YHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-L 432
+ LV E + GG L +R + I++ + + ++H +
Sbjct: 73 EVFHDQLHTFLVMELLNGGELF-----ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 433 AHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALFA------YKAPEA 483
H DL K N+ F +N + I +FGF + N Q L Y APE
Sbjct: 128 VHRDL-----KPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPEL 180
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ CD++ LG+I+ +L+G+ P
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 44/237 (18%), Positives = 82/237 (34%), Gaps = 57/237 (24%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVLAPL 373
E LG G + + G+ K + ARD + E R +L+H N++ L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-L 70
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
+ + LV++ + GG L + + + + +Q I I Y H+
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 432 LAHLDLPHGNLKSSNI-FISPENEPLI--SEFG----------FYTMINSANLAQALFAY 478
+ H +L K N+ S + ++FG ++ + Y
Sbjct: 126 IVHRNL-----KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG-------Y 173
Query: 479 KAPEAIQSGKVTPKCDVYCLGII--IL-----------------EILTGK--FPSQY 514
+PE ++ + D++ G+I IL +I G +PS
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 18/203 (8%)
Query: 318 VLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPL 373
VLG GG G + G K++++ R E + L ++ + L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSL 249
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
AY Y T + L LV + GG L + ++ E A + I G+ LH E
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--AVFYAAE-ICCGLEDLHRE- 305
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGK 488
+ + +LK NI + IS+ G + + Y APE +++ +
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVVKNER 361
Query: 489 VTPKCDVYCLGIIILEILTGKFP 511
T D + LG ++ E++ G+ P
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSP 384
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 50/211 (23%), Positives = 81/211 (38%), Gaps = 34/211 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLA 374
+VLG G + + VK +++ R EV L + + H NVL +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
+ D LV+E + GGS+L +VQ +A + +LH + +A
Sbjct: 79 FFEEEDRFYLVFEKMRGGSIL-----SHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 434 HLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALFA-----------YK 479
H D LK NI P + P+ I +F + I + Y
Sbjct: 134 HRD-----LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 480 APEAIQSGKVT-----PKCDVYCLGII--IL 503
APE +++ +CD++ LG+I IL
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYIL 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 39/217 (17%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT------EVRRLGRLRHS-- 367
+LG+GG GS Y + ++D + V +K +++ EV L ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 368 NVLAPLAYHYRTDEKLLVYEYI-PGGSLL-YLLHGDRGP-SHDELTWPARLKIVQGIARG 424
V+ L + R D +L+ E P L ++ RG + AR Q +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEEL----ARSFFWQ-VLEA 161
Query: 425 IGYLHTE-LAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALF------ 476
+ + H + H D+ K NI I L + +FG A L ++
Sbjct: 162 VRHCHNCGVLHRDI-----KDENILIDLNRGELKLIDFGS-----GALLKDTVYTDFDGT 211
Query: 477 -AYKAPEAIQSGKVT-PKCDVYCLGIIILEILTGKFP 511
Y PE I+ + V+ LGI++ +++ G P
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 53/213 (24%), Positives = 77/213 (36%), Gaps = 40/213 (18%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
LG G G A+ V VK + + + + E+ L H NV+ H
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK-FYGH 73
Query: 377 YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LAH 434
R L EY GG L + D G + A+ Q +A G+ YLH + H
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD----AQRFFHQLMA-GVVYLHGIGITH 128
Query: 435 LDL--------PHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF------AYKA 480
D+ NLK IS+FG T+ N + L Y A
Sbjct: 129 RDIKPENLLLDERDNLK-------------ISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 481 PEAIQSGK--VTPKCDVYCLGIIILEILTGKFP 511
PE + + DV+ GI++ +L G+ P
Sbjct: 176 PELL-KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 33/210 (15%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLA 374
E +G G + + A + VK + +S + E+ L R +H N++
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKD 83
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE-LA 433
+ +V E + GG LL D+ + ++ I + + YLH + +
Sbjct: 84 VYDDGKYVYVVTELMKGGELL-----DKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 434 HLDLPHGNLKSSNI-FISPENEPL---ISEFGFYTMINSANLAQALF------AYKAPEA 483
H DL K SNI ++ P I +FGF + + N L + APE
Sbjct: 139 HRDL-----KPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEV 191
Query: 484 IQSGKVTPKCDVYCLGII--ILEILTGKFP 511
++ CD++ LG++ + LTG P
Sbjct: 192 LERQGYDAACDIWSLGVLLYTM--LTGYTP 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 44/213 (20%), Positives = 80/213 (37%), Gaps = 31/213 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK-----RMKESSAMARDAFDT---EVRRLGRLRHS 367
LG+G G + A+ VVVK ++ E + E+ L R+ H+
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 368 NVLAPLAYHYRTDEKL-LVYE-YIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARG 424
N++ + + LV E + G L ++ R A Q +
Sbjct: 90 NIIK-VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-----ASYIFRQ-LVSA 142
Query: 425 IGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL---FAYKA 480
+GYL + + H D+ K NI I+ + + +FG + L Y A
Sbjct: 143 VGYLRLKDIIHRDI-----KDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 481 PEAIQSGK--VTPKCDVYCLGIIILEILTGKFP 511
PE + G P+ +++ LG+ + ++ + P
Sbjct: 198 PEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 45/230 (19%), Positives = 81/230 (35%), Gaps = 42/230 (18%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVLAPL 373
E LG G + + + G + ARD + E R L+H N++ L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR-L 75
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ L+++ + GG L + + + + +Q I + + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELF-----EDIVAREYYSEADASHCIQQILEAVLHCHQ-- 128
Query: 433 AHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALFA----YKAPEAIQ 485
+ + H NLK N+ S + + +++FG + A FA Y +PE ++
Sbjct: 129 --MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 486 SGKVTPKCDVYCLGII--IL-----------------EILTGK--FPSQY 514
D++ G+I IL +I G FPS
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 30/214 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVK--------RMKESSAMARDAFDTEVRRLGRLRHS 367
+ LG+G G A V +K A +TE+ L +L H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 368 NVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
++ + + ++ +V E + GG L D+ + L + + Y
Sbjct: 76 CIIK-IKNFFDAEDYYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 428 LHTE-LAHLDLPHGNLKSSNI-FISPENEPL--ISEFGFYTMINSANLAQALF---AYKA 480
LH + H DL K N+ S E + L I++FG ++ +L + L Y A
Sbjct: 130 LHENGIIHRDL-----KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 481 PEAIQSGKV---TPKCDVYCLGIIILEILTGKFP 511
PE + S D + LG+I+ L+G P
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 27/208 (12%)
Query: 318 VLGNGGLGSSYKAMMADGVTV-VVKRMKESSAMARDAFD---TEVRRLGRLRHSNV--LA 371
++G GG G Y AD + +K + + + E L + + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 372 PLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
++Y + T +KL + + + GG L Y L S + R + I G+ ++H
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAE-IILGLEHMHN 310
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGF--YTMINSANLAQALFA----YKAPEAI 484
+ + +LK +NI + IS+ G + Y APE +
Sbjct: 311 ----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVL 362
Query: 485 QSGKV-TPKCDVYCLGIIILEILTGKFP 511
Q G D + LG ++ ++L G P
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 56/256 (21%), Positives = 89/256 (34%), Gaps = 42/256 (16%)
Query: 274 SRKASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPD--LMKAAAEVLGNGGLGSSYKAM 331
++K S K + L +K LG G G + M
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFG---RVM 58
Query: 332 MA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLAYHYRTDEKL- 383
+ G +K + + + + E R L + L L + ++ + L
Sbjct: 59 LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP-FLVKLEFSFKDNSNLY 117
Query: 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLK 443
+V EY+ GG + L R E AR Q I YLH LDL + +LK
Sbjct: 118 MVMEYVAGGEMFSHLR--RIGRFSEPH--ARFYAAQ-IVLTFEYLH----SLDLIYRDLK 168
Query: 444 SSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYKAPEAIQSGKVTPKCDV 495
N+ I + +++FGF +T+ + APE I S D
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-------ALAPEIILSKGYNKAVDW 221
Query: 496 YCLGIIILEILTGKFP 511
+ LG++I E+ G P
Sbjct: 222 WALGVLIYEMAAGYPP 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 19/205 (9%)
Query: 318 VLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPL 373
VLG GG G + M G K++ + R + E + L ++ + L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSL 250
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLH--GDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
AY + T L LV + GG + Y ++ + P E A Q I G+ +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR--AIFYTAQ-IVSGLEHLHQ 307
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQS 486
++ + +LK N+ + + IS+ G + + +A + APE +
Sbjct: 308 ----RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 487 GKVTPKCDVYCLGIIILEILTGKFP 511
+ D + LG+ + E++ + P
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 45/174 (25%), Positives = 63/174 (36%), Gaps = 40/174 (22%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPAR 414
E+ L H NV+ H R L EY GG L + P D A+
Sbjct: 55 EICINKMLNHENVVK-FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-----AQ 108
Query: 415 LKIVQGIARGIGYLHTE-LAHLDL--------PHGNLKSSNIFISPENEPLISEFGFYTM 465
Q +A G+ YLH + H D+ NLK IS+FG T+
Sbjct: 109 RFFHQLMA-GVVYLHGIGITHRDIKPENLLLDERDNLK-------------ISDFGLATV 154
Query: 466 INSANLAQALF------AYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFP 511
N + L Y APE + + DV+ GI++ +L G+ P
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELL-KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 46/229 (20%), Positives = 84/229 (36%), Gaps = 41/229 (17%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARD--AFDTEVRRLGRLRHSNVLAPL 373
E LG G + + G+ K + ARD + E R +L+H N++ L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-L 93
Query: 374 AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ + LV++ + GG L + + + + +Q I I Y H+
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIAYCHS-- 146
Query: 433 AHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQS 486
+ H NLK N+ S + + +++FG +N + Y +PE ++
Sbjct: 147 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 487 GKVTPKCDVYCLGII--IL-----------------EILTGK--FPSQY 514
+ D++ G+I IL +I G +PS
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 253
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 27/208 (12%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
+G G G K + +K M + + R+ E++ + L H L
Sbjct: 22 AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP-FL 77
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L Y ++ +E + +V + + GG L Y L + E T +L I + + + YL
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEET--VKLFICE-LVMALDYLQ 132
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL---FAYKAPEAIQS 486
+ H ++K NI + I++F M+ + Y APE S
Sbjct: 133 N----QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 487 GKV---TPKCDVYCLGIIILEILTGKFP 511
K + D + LG+ E+L G+ P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 52/208 (25%), Positives = 80/208 (38%), Gaps = 27/208 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAP 372
+ LG G G G V VK + + D E++ L RH +++
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK- 75
Query: 373 LAYH-YRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
Y T +V EY+ GG L Y+ R + AR Q I + Y H
Sbjct: 76 -LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-----ARRLFQQ-ILSAVDYCH 128
Query: 430 TE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF---AYKAPEAIQ 485
+ H DL K N+ + I++FG M++ + Y APE I
Sbjct: 129 RHMVVHRDL-----KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI- 182
Query: 486 SGK--VTPKCDVYCLGIIILEILTGKFP 511
SG+ P+ D++ G+I+ +L G P
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 11/97 (11%)
Query: 62 DVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKL 121
D+ L +LT L L +++N+ + L +L+ NN+ R SL L
Sbjct: 77 DLSPLKDLTKLEEL---SVNRNRLK-NLNGI---PSACLSRLFLDNNELRD--TDSLIHL 127
Query: 122 PHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
+L L + +N+ +I L L+L N++
Sbjct: 128 KNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 7/93 (7%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125
+ GL L K + ++ E+ ++ N+ + L + +L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVT-DLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLK 66
Query: 126 ELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
ELHL NQ + + L L+++ N+L+
Sbjct: 67 ELHLSHNQIS-DLSPLKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 20/99 (20%), Positives = 31/99 (31%), Gaps = 10/99 (10%)
Query: 62 DVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKL 121
D D+L L L L + N+ I + L L N+ L +L
Sbjct: 120 DTDSLIHLKNLEIL---SIRNNKLK-SIVM--LGFLSKLEVLDLHGNEIT-NTGG-LTRL 171
Query: 122 PHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEI 160
+ + L + P QP L N + +G
Sbjct: 172 KKVNWIDLTGQKCV-NEPVKYQPELYITNTVKD-PDGRW 208
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 57/282 (20%), Positives = 95/282 (33%), Gaps = 44/282 (15%)
Query: 251 EKESVQAVEVRVSVPNKSRDVDVSRKASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPD 310
E E +A + + K + NG + L D
Sbjct: 283 EGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD 342
Query: 311 --LMKAAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRL 361
+ VLG G G K M++ VK +K+ + D + E R L
Sbjct: 343 FNFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 395
Query: 362 GRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG 420
L L ++T ++L V EY+ GG L+Y + A +
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH----AVFYAAE- 450
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF-----------YTMINSA 469
IA G+ +L + + + +LK N+ + E I++FG T +
Sbjct: 451 IAIGLFFLQS----KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506
Query: 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
+ Y APE I D + G+++ E+L G+ P
Sbjct: 507 D-------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 27/168 (16%)
Query: 357 EVRRLGRLRHSNVLAPL--AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPA 413
E+ L +L H NV+ L ++ L +V+E + G ++ + P ++ A
Sbjct: 86 EIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQ---A 139
Query: 414 RLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ 473
R Q + +GI YLH + + H ++K SN+ + + I++FG ++
Sbjct: 140 R-FYFQDLIKGIEYLH----YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--- 191
Query: 474 ALF-------AYKAPEAIQSGKVT---PKCDVYCLGIIILEILTGKFP 511
AL A+ APE++ + DV+ +G+ + + G+ P
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLA 374
+VLG G G + +K +++ R EV R + +++ +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 375 YH---YRTDEKL-LVYEYIPGGSLLY--LLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ Y + L +V E + GG L GD+ + E A +I++ I I YL
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----AS-EIMKSIGEAIQYL 177
Query: 429 HTE-LAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSAN-LAQALFA--YKAP 481
H+ +AH D+ K N+ + S N L +++FGF S N L + Y AP
Sbjct: 178 HSINIAHRDV-----KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 482 EAIQSGKVTPKCDVYCLGII--IL 503
E + K CD++ LG+I IL
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYIL 256
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 43/177 (24%), Positives = 66/177 (37%), Gaps = 28/177 (15%)
Query: 404 PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463
D LT + +A+G+ +L A H +L + NI +S +N I +FG
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 464 TMINSANL----AQALFAYK--APEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLT 516
I A K APE I T + DV+ G+++ EI + G P
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--- 297
Query: 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR 573
G+ + E EG + P+ + EM Q + C +P QR
Sbjct: 298 ----GVKIDEEFCRRLKEGTR--MRAPD-----YTTPEMYQTM---LDCWHGEPSQR 340
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 8/87 (9%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFR--GRLPPSLFKLPHLTELHLESN 132
++ + LD ++ + G DE L L N LP KL L +L L N
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDN 74
Query: 133 QFNGTIPSFDQ--PTLVRLNLSSNKLE 157
+ +G + + P L LNLS NK++
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 20/93 (21%), Positives = 32/93 (34%), Gaps = 14/93 (15%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L + + I ++ L+KL S+N+ G L K P+LT L+
Sbjct: 38 TDEFEELEFLSTINVGLT-SIAN--LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 129 LESNQFNGTIPSFDQ-------PTLVRLNLSSN 154
L N+ I L L+L +
Sbjct: 95 LSGNK----IKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 45/231 (19%), Positives = 87/231 (37%), Gaps = 51/231 (22%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH---SNVLAP 372
LG G + + A M + V +K ++ +A + E++ L R+ + +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 373 LAYH---------YRTDEKL---LVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIV 418
A H ++ + +V+E + G +LL L+ + RG L V
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIP---------LIYV 133
Query: 419 QGIAR----GIGYLHTELA--HLDLPHGNLKSSNIFISPENEPL------ISEFGFYTMI 466
+ I++ G+ Y+H H D+ K N+ + + P I++ G
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDI-----KPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 467 NS--ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK--FPSQ 513
+ N Q Y++PE + D++ +I E++TG F
Sbjct: 189 DEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 44/225 (19%), Positives = 76/225 (33%), Gaps = 58/225 (25%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---------EVRRLGRLRH 366
+ +G+G G A V +K++ F E+ + + H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 367 SN------VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG 420
N V P + LV E + +L ++ + + Q
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHER------MSYLLYQ- 172
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA--- 477
+ GI +LH+ + H +LK SNI + + I +FG LA+
Sbjct: 173 MLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFG---------LARTAGTSFM 219
Query: 478 ---------YKAPEAIQSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE I D++ +G I+ E++ K FP
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 48/228 (21%), Positives = 82/228 (35%), Gaps = 53/228 (23%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDA--FDT---------EVRRLGRLR 365
+ +G G+ + ++G+ V +KR+ + + R E+R L
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 366 HSNVLAPL----AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGP-SHDELTWPARLKIVQ 419
H N+L + KL LV E + L ++H R S + + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI----QYFMYH 142
Query: 420 GIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA- 477
I G+ LH + H DL NI ++ N+ I +F LA+ A
Sbjct: 143 -ILLGLHVLHEAGVVHRDL-----HPGNILLADNNDITICDFN---------LAREDTAD 187
Query: 478 -----------YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE + Q T D++ G ++ E+ K F
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 47/261 (18%), Positives = 95/261 (36%), Gaps = 32/261 (12%)
Query: 266 NKSRDVDVSRKASSSRRGSSHHGKNSGVGELVLVNGQKGVFGLPD--LMKAAAEVLGNGG 323
+ D+ + S + GL D L++ V+G G
Sbjct: 9 HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLR----VIGRGS 64
Query: 324 LGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVLAPLAYH 376
K ++ ++ +K+ + D TE + + L L
Sbjct: 65 YA---KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121
Query: 377 YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
++T+ +L V EY+ GG L++ + R + AR + I+ + YLH
Sbjct: 122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH----ARFYSAE-ISLALNYLHE----R 172
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTM-INSANLAQALF----AYKAPEAIQSGKVT 490
+ + +LK N+ + E ++++G + + F Y APE ++
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYG 231
Query: 491 PKCDVYCLGIIILEILTGKFP 511
D + LG+++ E++ G+ P
Sbjct: 232 FSVDWWALGVLMFEMMAGRSP 252
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 59/225 (26%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---------EVRRLGRLRH 366
+G+G GS A+ G V +K++ F + E+ L ++H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 367 SNVLAPL-----AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG 420
NV+ L A R LV ++ L ++ + + Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEK------IQYLVYQ- 134
Query: 421 IARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-- 477
+ +G+ Y+H+ + H DL K N+ ++ + E I +FG LA+ A
Sbjct: 135 MLKGLKYIHSAGVVHRDL-----KPGNLAVNEDCELKILDFG---------LARHADAEM 180
Query: 478 --------YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE I D++ +G I+ E+LTGK F
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 37/213 (17%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---EVRRLGRLRHSNVLAP 372
+ LG G G G V VK + + D E++ L RH +++
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK- 80
Query: 373 LAYH-YRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
Y T + +V EY+ GG L Y+ R + +R Q ++ G+ Y H
Sbjct: 81 -LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE-----SRRLFQQILS-GVDYCH 133
Query: 430 TE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF--------AYKA 480
+ H DL K N+ + I++FG S ++ F Y A
Sbjct: 134 RHMVVHRDL-----KPENVLLDAHMNAKIADFGL-----SNMMSDGEFLRTSCGSPNYAA 183
Query: 481 PEAIQSGK--VTPKCDVYCLGIIILEILTGKFP 511
PE I SG+ P+ D++ G+I+ +L G P
Sbjct: 184 PEVI-SGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 42/207 (20%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
V+G G K ++ +K +K+ + D TE + + L
Sbjct: 16 VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L ++T+ +L V EY+ GG L++ + R + AR + I+ + YLH
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH----ARFYSAE-ISLALNYLH 127
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM-INSANLAQALF----AYKAPEAI 484
+ + +LK N+ + E ++++G + + F Y APE +
Sbjct: 128 E----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEIL 182
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
+ D + LG+++ E++ G+ P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 39/213 (18%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
+LG G G K ++ G +K +++ +A+D TE R L RH L
Sbjct: 12 LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FL 67
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L Y ++T ++L V EY GG L + L +R + + AR + I + YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAE-IVSALEYLH 122
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGF-----------YTMINSANLAQALFAY 478
+ D+ + ++K N+ + + I++FG T + Y
Sbjct: 123 S----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-------Y 171
Query: 479 KAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
APE ++ D + LG+++ E++ G+ P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 43/225 (19%), Positives = 76/225 (33%), Gaps = 58/225 (25%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---------EVRRLGRLRH 366
+ +G+G G A V +K++ F E+ + + H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 367 SN------VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQG 420
N V P + +V E + +L ++ + + Q
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHER------MSYLLYQ- 135
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA--- 477
+ GI +LH+ + H +LK SNI + + I +FG LA+
Sbjct: 136 MLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG---------LARTAGTSFM 182
Query: 478 ---------YKAPEAIQSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE I D++ +G I+ E++ G FP
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 26/86 (30%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQ 133
+R + LD + + G E L L N + L KLP L +L L N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 134 FNGTIPSFDQ--PTLVRLNLSSNKLE 157
G + + P L LNLS NKL+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 51/357 (14%), Positives = 104/357 (29%), Gaps = 104/357 (29%)
Query: 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHY 377
LG G + + + + V +K +K S+ + E+R L +R+S+ P
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 378 RT--DE----------KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARL--KIVQGIAR 423
D+ +V+E + G LL + + P KI+Q + +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII--KSNYQ---GLPLPCVKKIIQQVLQ 157
Query: 424 GIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN------------- 470
G+ YLHT+ + H ++K NI +S + + T +
Sbjct: 158 GLDYLHTKC---RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 471 -------------------------LAQALFA------------YKAPEAIQSGKVTPKC 493
L A + Y++ E +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 494 DVYCLGIIILEILTGKFPSQYLTNGNGGIDVV--------------EWVASA-------- 531
D++ + E+ TG + + + D + + +
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334
Query: 532 -------FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
++ + L + + S E + + PE+R E +R
Sbjct: 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 44/210 (20%), Positives = 83/210 (39%), Gaps = 36/210 (17%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
LG G G + + +G +K +K+ + + E L + H +
Sbjct: 13 TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFI 68
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ ++ +++ ++ +YI GG L LL + + A+ + + + YLH
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----AKFYAAE-VCLALEYLH 123
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGF--------YTMINSANLAQALFAYKAP 481
D+ + +LK NI + I++FGF YT+ + + Y AP
Sbjct: 124 ----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD-------YIAP 172
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
E + + D + GI+I E+L G P
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 20/90 (22%), Positives = 36/90 (40%), Gaps = 6/90 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
L+ L+ + + L N +I M LR L N + ++ L EL
Sbjct: 44 LSTLKACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99
Query: 129 LESNQFNGTIPSFDQ-PTLVRLNLSSNKLE 157
+ NQ ++ ++ L L +S+NK+
Sbjct: 100 ISYNQIA-SLSGIEKLVNLRVLYMSNNKIT 128
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 46/169 (27%), Positives = 68/169 (40%), Gaps = 34/169 (20%)
Query: 357 EVRRLGRLRHSNVLAPLAYH-YRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPA 413
E+ L LRH +++ Y T + +V EY GG L Y++ R +
Sbjct: 59 EISYLKLLRHPHIIK--LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDE-----G 110
Query: 414 RLKIVQGIARGIGYLHTE-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLA 472
R Q I I Y H + H DL K N+ + I++FG S +
Sbjct: 111 RRFFQQ-IICAIEYCHRHKIVHRDL-----KPENLLLDDNLNVKIADFGL-----SNIMT 159
Query: 473 QALF--------AYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFP 511
F Y APE I +GK P+ DV+ GI++ +L G+ P
Sbjct: 160 DGNFLKTSCGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 62/227 (27%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---------EVRRLGRLRH 366
+ +G+G G+ A+ G V +K++ F + E+R L +RH
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 367 SNVLA------PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLK--IV 418
NV+ P + LV ++ G L L+ H++L R++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK------HEKLG-EDRIQFLVY 135
Query: 419 QGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA 477
Q + +G+ Y+H + H DL K N+ ++ + E I +FG LA+ +
Sbjct: 136 Q-MLKGLRYIHAAGIIHRDL-----KPGNLAVNEDCELKILDFG---------LARQADS 180
Query: 478 ----------YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE I + T D++ +G I+ E++TGK F
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 67 TELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTE 126
+ T R + L + I + + FS+N+ R +L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKT 68
Query: 127 LHLESNQFNGTIPSFDQ--PTLVRLNLSSNKLE 157
L + +N+ DQ P L L L++N L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 26/207 (12%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
VLG G G K M+A G VK +K+ + D + TE R L R+ L
Sbjct: 30 VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L ++T ++L V E++ GG L++ + R AR + I + +LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR----ARFYAAE-IISALMFLH 141
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFY-TMINSANLAQALFA----YKAPEAI 484
+ + +LK N+ + E +++FG I + F Y APE +
Sbjct: 142 D----KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEIL 196
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFP 511
Q P D + +G+++ E+L G P
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 47/209 (22%), Positives = 76/209 (36%), Gaps = 50/209 (23%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPL- 373
+VLG G G + +K +++ R EV R + +++ +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 78
Query: 374 AYHYRTDEKLLVY---EYIPGGSLLYLLHGDR--GPSHDELTWPARLKIVQGIARGIGYL 428
Y + + E + GG L R T +I++ I I YL
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELF-----SRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 429 HTE-LAHLDLPHGNLKSSNI-FISP-ENEPL-ISEFGFYTMINSANLAQALFAYKAPEAI 484
H+ +AH D+ K N+ + S N L +++FGF A E
Sbjct: 134 HSINIAHRDV-----KPENLLYTSKRPNAILKLTDFGF-----------------AKE-T 170
Query: 485 QSGKVTPKCDVYCLGII--ILEILTGKFP 511
K CD++ LG+I IL L G +P
Sbjct: 171 TGEKYDKSCDMWSLGVIMYIL--LCG-YP 196
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 45/218 (20%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKE--------SSAMARDAFDTEVRRLGRLRHS 367
++G G G K G V +K+ E AM R E++ L +LRH
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-R-----EIKLLKQLRHE 84
Query: 368 NVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIG 426
N++ L + ++ LV+E++ L L G + + K + I GIG
Sbjct: 85 NLVN-LLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ-----KYLFQIINGIG 138
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF----------YTMINSANLAQALF 476
+ H +H + H ++K NI +S + +FGF Y + +
Sbjct: 139 FCH---SHNII-HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD-----DEVATRW 189
Query: 477 AYKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE + K DV+ +G ++ E+ G+ FP
Sbjct: 190 -YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 41/249 (16%), Positives = 87/249 (34%), Gaps = 72/249 (28%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKR-MKESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+ LG G G + + G +K+ +++ R E+ + L H N++ +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-----ELDIMKVLDHVNIIKLVD 67
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPAR-----LKIVQG--------- 420
Y Y T ++ P + +H + L ++
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 421 ----------------------IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPL-I 457
+ R +G++H+ L + H ++K N+ ++ ++ L +
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS----LGICHRDIKPQNLLVNSKDNTLKL 183
Query: 458 SEFGFYTMINSANLAQALFA------------YKAPEAI-QSGKVTPKCDVYCLGIIILE 504
+FG A+ L Y+APE + + + TP D++ +G + E
Sbjct: 184 CDFG---------SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 505 ILTGK--FP 511
++ GK F
Sbjct: 235 LILGKPLFS 243
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
V+G G G K ++A + V VK +++ + + + +E L + L
Sbjct: 45 VIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
L + ++T +KL V +YI GG L Y L +R AR + IA +GYLH
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR----ARFYAAE-IASALGYLH 156
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGF-----------YTMINSANLAQALFAY 478
+ L++ + +LK NI + + ++++FG T + Y
Sbjct: 157 S----LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-------Y 205
Query: 479 KAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
APE + D +CLG ++ E+L G P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 58/225 (25%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDT---------EVRRLGRLRH 366
+G+G GS A G+ V VK++ F + E+R L ++H
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 367 SNVLAPL-----AYHYRTDEKL-LVYEYIPGGSLLYLLHGDR-GPSHDELTWPARLKIVQ 419
NV+ L A + LV + G L ++ + H + I Q
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDH------VQFLIYQ 140
Query: 420 GIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA-- 477
I RG+ Y+H+ D+ H +LK SN+ ++ + E I +FG LA+
Sbjct: 141 -ILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFG---------LARHTADEM 186
Query: 478 --------YKAPEAI-QSGKVTPKCDVYCLGIIILEILTGK--FP 511
Y+APE + D++ +G I+ E+LTG+ FP
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 38/213 (17%)
Query: 318 VLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFD---TEVRRLGRLRHSNVL 370
+LG G G K +A +K +K+ + D + E R L L
Sbjct: 24 MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 371 APLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ ++T E L V EY+ GG L+Y + A + I G+ +LH
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR----ATFYAAE-IILGLQFLH 135
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGF-----------YTMINSANLAQALFAY 478
+ + + +LK NI + + I++FG T + + Y
Sbjct: 136 S----KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD-------Y 184
Query: 479 KAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
APE + K D + G+++ E+L G+ P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 51/221 (23%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKE--------SSAMARDAFDTEVRRLGRLRHS 367
+G G G +K G V +K+ E A+ R E+R L +L+H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-R-----EIRMLKQLKHP 62
Query: 368 NVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIG 426
N++ L +R +L LV+EY L L RG + I + +
Sbjct: 63 NLVN-LLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-----SITWQTLQAVN 116
Query: 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA--------- 477
+ H H + H ++K NI I+ + + +FG A+ L
Sbjct: 117 FCH---KHNCI-HRDVKPENILITKHSVIKLCDFG---------FARLLTGPSDYYDDEV 163
Query: 478 ----YKAPEAIQSGKV-TPKCDVYCLGIIILEILTGK--FP 511
Y++PE + P DV+ +G + E+L+G +P
Sbjct: 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 53/234 (22%), Positives = 87/234 (37%), Gaps = 44/234 (18%)
Query: 299 VNGQKGVFGLPD--LMKAAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARD 352
NG + L D + VLG G G K M++ VK +K+ + D
Sbjct: 10 NNGNRDRMKLTDFNFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDD 62
Query: 353 AFD---TEVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDE 408
+ E R L L L ++T ++L V EY+ GG L+Y +
Sbjct: 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 122
Query: 409 LTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF------ 462
A + IA G+ +L + + + +LK N+ + E I++FG
Sbjct: 123 ----AVFYAAE-IAIGLFFLQS----KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173
Query: 463 -----YTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
T + + Y APE I D + G+++ E+L G+ P
Sbjct: 174 DGVTTKTFCGTPD-------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 318 VLGNGGLGSSYKAMMADGVTVV-------VKRMKESSAMARDAFDT--EVRRLGRLRHSN 368
VLG G G K + ++ +K +K+++ RD T E L + H
Sbjct: 31 VLGQGSFG---KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP- 86
Query: 369 VLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
+ L Y ++T+ KL L+ +++ GG L L + + ++ + + + +A + +
Sbjct: 87 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAE-LALALDH 141
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM----INSANLAQALF----AYK 479
LH+ L + + +LK NI + E +++FG + I+ A + F Y
Sbjct: 142 LHS----LGIIYRDLKPENILLDEEGHIKLTDFG---LSKESIDHEKKAYS-FCGTVEYM 193
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511
APE + T D + G+++ E+LTG P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 12/37 (32%), Positives = 16/37 (43%), Gaps = 2/37 (5%)
Query: 100 LRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFN 135
+L + N LPP L LP L HL +N +
Sbjct: 33 TTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 43/178 (24%), Positives = 66/178 (37%), Gaps = 49/178 (27%)
Query: 357 EVRRLGRLRHSNVLAPLAYHYRTDEKL-LVYEYIPGGSLL-YLLHGDRGPSHDELTWPAR 414
E+ LRH N++ T L ++ EY GG L + + R S DE AR
Sbjct: 66 EIINHRSLRHPNIVR-FKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDE----AR 119
Query: 415 LKIVQGIARGIGYLHT-ELAHLDL----------PHGNLKSSNIFISPENEPLISEFGFY 463
Q ++ G+ Y H+ ++ H DL P LK I +FG+
Sbjct: 120 FFFQQLLS-GVSYCHSMQICHRDLKLENTLLDGSPAPRLK-------------ICDFGY- 164
Query: 464 TMINSANLAQALF--------AYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFP 511
S + AY APE + + DV+ G+ + +L G +P
Sbjct: 165 ----SKSSVLHSQPKSTVGTPAYIAPEVL-LRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 37/247 (14%)
Query: 285 SHHGKNSGVGELVLVNGQKGVFGLPDLMKAAAEVLGNGGLGSSYKAM-MADGVTVVVKRM 343
HH + +V GQ VF + +G G G A + V V +K++
Sbjct: 4 HHHMAAAAAAGPEMVRGQ--VFDVGPRYTNL-SYIGEGAYGMVCSAYDNLNKVRVAIKKI 60
Query: 344 K--ESSAMARDAFDTEVRRLGRLRHSNVLAPL----AYHYRTDEKL-LVYEYIPGGSLLY 396
E + E++ L R RH N++ A + + +V + + L
Sbjct: 61 SPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYK 118
Query: 397 LLHGDR-GPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENE 454
LL H + Q I RG+ Y+H+ + H DL K SN+ ++ +
Sbjct: 119 LLKTQHLSNDH------ICYFLYQ-ILRGLKYIHSANVLHRDL-----KPSNLLLNTTCD 166
Query: 455 PLISEFGFYTMINSANLAQALFA-------YKAPEAI-QSGKVTPKCDVYCLGIIILEIL 506
I +FG + + + Y+APE + S T D++ +G I+ E+L
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 507 TGK--FP 511
+ + FP
Sbjct: 227 SNRPIFP 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 43/218 (19%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH------SNV 369
+V+G G G KA V +K ++ R A E+R L LR NV
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA-EEIRILEHLRKQDKDNTMNV 161
Query: 370 LAPLAY-HYRTDEKL-LVYEYIPGGSLLYLL--HGDRGPSHDELTWPARLKIVQGIARGI 425
+ L +R + + +E + +L L+ + +G S L +V+ A I
Sbjct: 162 IHMLENFTFR--NHICMTFELL-SMNLYELIKKNKFQGFS---------LPLVRKFAHSI 209
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLIS--EFG--------FYTMINSANLAQAL 475
L + H +LK NI + + I +FG YT I Q+
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI------QSR 263
Query: 476 FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK--FP 511
F Y+APE I + D++ LG I+ E+LTG P
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 621 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.83 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.82 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.78 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.69 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.64 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.62 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.62 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.58 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.53 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.51 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.51 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.5 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.47 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.46 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.46 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.45 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.44 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.43 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.42 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.42 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.41 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.41 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.41 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.39 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.38 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.37 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.37 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.37 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.36 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.36 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.36 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.36 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.36 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.36 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.35 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.34 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.34 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.34 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.33 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.32 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.32 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.31 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.31 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.3 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.3 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.28 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.26 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.26 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.25 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.24 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.24 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.21 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.2 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.18 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.15 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.13 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.12 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.1 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.1 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.08 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.07 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.06 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.02 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.01 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.01 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.01 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.0 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.0 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.98 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.98 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.97 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.96 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.96 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.92 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.88 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.87 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.82 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.82 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.78 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.71 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.69 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.69 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.69 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.68 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.67 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.34 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.92 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.78 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.46 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.33 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.97 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.45 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.38 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.25 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.16 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.61 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.96 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 94.88 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.83 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 92.91 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.48 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.4 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.0 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.41 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 89.82 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.42 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 89.12 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 87.01 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.48 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 85.66 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.49 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 83.89 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-55 Score=440.61 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=209.6
Q ss_pred HHHcCcCCcccEEEEEEc------CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.+..+||||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 467999999999999853 47889999998777777889999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 390 PGGSLLYLLHGDR--------GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 390 ~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
++|+|.++|+..+ ......++|.+++.|+.||++||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcEEECCcc
Confidence 9999999997542 12345799999999999999999999998 99999999999999999999999999
Q ss_pred cceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 462 FYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 462 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+|+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ..++.. .+..
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~----~~~~~~----~i~~ 245 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----NNEVIE----CITQ 245 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHH----HHHH
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH----HHHc
Confidence 99876433 22357889999999999999999999999999999999 899997532 122222 2222
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
+.... .+..+++++.+|+.+||+.||++|||++|+++.|+++...
T Consensus 246 ~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 GRVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 32111 1123446789999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=444.35 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=206.3
Q ss_pred HHHcCcCCcccEEEEEEc------CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.+..+||||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 467999999999999864 47899999998877777889999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 390 PGGSLLYLLHGDRGP----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
++|+|.++++..... ....++|.+++.|+.||++||+|||++ +||||||||+|||++.++.+||+|
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCCcEEEcc
Confidence 999999999764321 234699999999999999999999998 999999999999999999999999
Q ss_pred eecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHh
Q 045652 460 FGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAF 532 (621)
Q Consensus 460 fG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 532 (621)
||+++..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ..++... +
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~----~~~~~~~----i 273 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS----NTEAIDC----I 273 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC----HHHHHHH----H
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC----HHHHHHH----H
Confidence 9999876432 23457889999999999999999999999999999999 899997432 1222222 2
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+... . .+..+++++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 274 ~~g~~~-----~-----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGREL-----E-----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCC-----C-----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCC-----C-----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222211 1 1123446789999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=436.37 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=205.7
Q ss_pred HHHcCcCCcccEEEEEEc------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 316 AEVLGNGGLGSSYKAMMA------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.+.||+|+||.||+|.+. +++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.+.+..+|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 467999999999999852 4689999999754 234467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 389 IPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
|++|+|.++|+..... ....++|.++++|+.||++||+|||++ +||||||||+|||+++++.+||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEE
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCCCCEEE
Confidence 9999999999754311 124589999999999999999999999 9999999999999999999999
Q ss_pred Eeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHH
Q 045652 458 SEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530 (621)
Q Consensus 458 ~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 530 (621)
+|||+++..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ..++.+
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~----~~~~~~---- 258 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDVVE---- 258 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC----HHHHHH----
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC----HHHHHH----
Confidence 999999876432 23457889999999999999999999999999999998 899997432 122222
Q ss_pred HhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.+..+.... .+..++..+.+|+.+||+.||++||||.||+++|+.+
T Consensus 259 ~i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 233332111 1223456789999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=430.74 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=202.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|+++|++++|||||++++++. .+..+||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 35679999999999998643 6999998743 3445678999999999999999999999875 45689999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.++|+... ..++|.+++.|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 117 sL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 117 SLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp BHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999997533 4599999999999999999999998 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 ---NLAQALFAYKAPEAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ...+...+..+.. .|
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-------~~~~~~~~~~~~~----~p 257 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-------RDQIIFMVGRGYA----SP 257 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHTTCC----CC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCC----CC
Confidence 33468999999999863 4689999999999999999999999974321 1122222222211 11
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
... .....++..+.+|+.+||+.||++||||.||+++|+.++.+.
T Consensus 258 ~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 258 DLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred Ccc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111 112344567899999999999999999999999999887643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=436.22 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=199.3
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..|||||||+
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3457899999999999995 56999999999643 34456789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
||+|.++|...+ ...+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 107 gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 107 GGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp TCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999997543 24578899999999999999999999 9999999999999999999999999999887543
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....||+.|||||++.+..|+.++|||||||++|||+||+.||... +..+.+..... +....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~-~~~~~------- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-------SMKNLVLKIIS-GSFPP------- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHH-TCCCC-------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-------CHHHHHHHHHc-CCCCC-------
Confidence 3356899999999999999999999999999999999999999742 12222222222 22111
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.....+.++.+|+.+||+.||++|||++|+++|
T Consensus 245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112334678999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=433.17 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=203.3
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..|||||||+||+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999995 46999999999755444566788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
.+++.. ..+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+... .
T Consensus 159 ~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 159 TDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp HHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999974 3489999999999999999999999 9999999999999999999999999999887543 3
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...||+.|||||++.+..|+.++|||||||++|||++|+.||... ...+....+ ........ ..
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i----~~~~~~~~--------~~ 292 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKMI----RDNLPPRL--------KN 292 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHH----HHSSCCCC--------SC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHH----HcCCCCCC--------Cc
Confidence 457899999999999999999999999999999999999999742 122222222 21111110 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.....+++.+|+.+||+.||++|||+.|+++|
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22345678999999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=415.80 Aligned_cols=240 Identities=21% Similarity=0.356 Sum_probs=194.8
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe----CCeeEEEEeec
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVYEYI 389 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 389 (621)
+.||+|+||.||+|.. .+++.||+|++... .....+.|.+|+++|++++|||||++++++.+ .+..|||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 4699999999999995 45899999998643 34456789999999999999999999999875 24478999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CccCCCCCCCEEeCC-CCCcEEEeeecceec
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD--LPHGNLKSSNIFISP-ENEPLISEFGFYTMI 466 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~ 466 (621)
++|+|.+++++. ..+++..+..|+.||+.||+|||++ + ||||||||+|||++. ++.+||+|||+|+..
T Consensus 112 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~----~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 112 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999743 4689999999999999999999998 6 999999999999984 789999999999865
Q ss_pred ccc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 467 NSA--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 467 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
... ....||+.|||||++.+ .|+.++|||||||++|||+||+.||.... . ...+...+..+.... .
T Consensus 183 ~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~------~-~~~~~~~i~~~~~~~----~ 250 (290)
T 3fpq_A 183 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------N-AAQIYRRVTSGVKPA----S 250 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------S-HHHHHHHHTTTCCCG----G
T ss_pred CCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC------c-HHHHHHHHHcCCCCC----C
Confidence 433 44578999999999864 69999999999999999999999996321 1 122222232222111 1
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ...++++.+|+.+||+.||++|||++|+++|
T Consensus 251 ~~-----~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 FD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1122468899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=423.95 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=201.9
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC----eeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD----EKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g 392 (621)
+.||+|+||.||+|++ +|+.||||+++.... ....++.|+..+.+++|||||++++++.+.+ ..+||||||++|
T Consensus 9 ~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 5799999999999998 689999999975432 2233456677777899999999999998754 578999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL----AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+|.++++. ..++|..+++++.|+++||+|||++. ..++||||||||+|||++.++.+||+|||+++....
T Consensus 87 sL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 87 SLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 99999974 34899999999999999999999752 234799999999999999999999999999987643
Q ss_pred cc--------cccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC-------CcchHHH
Q 045652 469 AN--------LAQALFAYKAPEAIQSG------KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG-------GIDVVEW 527 (621)
Q Consensus 469 ~~--------~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-------~~~~~~~ 527 (621)
.. ...||+.|||||++.+. .++.++|||||||++|||+||..||........ .....+.
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 21 23589999999999754 477899999999999999999887654322111 0111222
Q ss_pred HHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 528 VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 528 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
+...+... ..+|.++......+....+.+|+.+||+.||++||||.||++.|+++.+..
T Consensus 241 ~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 241 MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 22322222 223333322233456778999999999999999999999999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=426.80 Aligned_cols=247 Identities=19% Similarity=0.242 Sum_probs=203.4
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.++||+|+||.||+|+. .+|+.||||+++.... ..+|+.+|++++|||||++++++.+.+..|||||||+||+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 45799999999999995 4599999999975322 24799999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceecccc----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSA---- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~---- 469 (621)
.++++.. ..+++.++..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 138 ~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 138 GQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999743 3599999999999999999999999 999999999999999988 6999999999876432
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.... ...+...+.. ....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~---~~~~------- 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----RGPLCLKIAS---EPPP------- 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----CSCCHHHHHH---SCCG-------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHHc---CCCC-------
Confidence 22468999999999999999999999999999999999999997532 2222222211 1100
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
.. ..++..++.+.+++.+||+.||++|||+.|++++|.........
T Consensus 275 ~~--~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 275 IR--EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp GG--GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred ch--hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 00 01123446789999999999999999999999999887665443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=434.54 Aligned_cols=241 Identities=22% Similarity=0.334 Sum_probs=203.5
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|||||||+||+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999995 46999999999765555567789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----c
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~ 470 (621)
.+++.. ..+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 236 ~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 236 TDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp HHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred HHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 999964 3489999999999999999999999 9999999999999999999999999999887543 3
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...||+.|||||++.+..|+.++|||||||++|||++|+.||... ...+....+ ..... +.+ ..
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i----~~~~~-----~~~---~~ 369 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKMI----RDNLP-----PRL---KN 369 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHH----HHSCC-----CCC---SC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHH----HcCCC-----CCC---cc
Confidence 457899999999999999999999999999999999999999642 122222222 21111 111 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......++.+|+.+||+.||++|||+.|+++|
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12334678999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=430.86 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=207.9
Q ss_pred HHHHHcCcCCcccEEEEEEcC------CcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCC-CCcccceEEEEeC-CeeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD------GVTVVVKRMKESS-AMARDAFDTEVRRLGRLRH-SNVLAPLAYHYRT-DEKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~~~~l 384 (621)
.+.+.||+|+||.||+|.+.. ++.||||+++... ....+.|.+|+++|.+++| ||||+++|+|.+. +..++
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 456789999999999998532 3689999997543 3446779999999999965 8999999999765 56899
Q ss_pred EEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC
Q 045652 385 VYEYIPGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~ 453 (621)
|||||++|+|.++|+.... .....+++.+++.++.|||+||+|||++ +||||||||+|||+++++
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGG
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCccCccceeeCCCC
Confidence 9999999999999975431 1134589999999999999999999999 999999999999999999
Q ss_pred CcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHH
Q 045652 454 EPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 454 ~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 526 (621)
.+||+|||+|+.+... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||..... . +
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---~----~ 295 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---D----E 295 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---S----H
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH---H----H
Confidence 9999999999876432 23457889999999999999999999999999999998 8999974321 1 2
Q ss_pred HHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 527 WVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
.+...+.++.... . +...++++.+++.+||+.||++|||+.|++++|+++.+...
T Consensus 296 ~~~~~i~~g~~~~-----~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 296 EFCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HHHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHcCCCCC-----C-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 2223333332111 1 12234678999999999999999999999999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=410.59 Aligned_cols=239 Identities=21% Similarity=0.332 Sum_probs=187.8
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 346799999999999994 569999999986432 233567899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 96 GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 67999999743 4699999999999999999999999 9999999999999999999999999999876543
Q ss_pred --ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 --NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....||+.|||||++.+..| +.++||||+||++|||+||+.||... ....+ ...+..+... +
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~~~~~----~~~i~~~~~~------~- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVL----FKNISNGVYT------L- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHH----HHHHHHTCCC------C-
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----CHHHH----HHHHHcCCCC------C-
Confidence 34578999999999998876 57999999999999999999999641 11112 2222222211 1
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+...++++.+|+.+||+.||++|||++|+++|
T Consensus 232 ----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 232 ----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11234578999999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=422.23 Aligned_cols=242 Identities=17% Similarity=0.204 Sum_probs=202.1
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|.+.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 34567899999999999995 569999999996432 23356789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|+||+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 114 ~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 114 AKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999743 4589999999999999999999999 999999999999999999999999999998743
Q ss_pred c------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 469 A------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
. ....||+.|||||++.+..|+.++||||+||++|||+||+.||... ...++... +..+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~----i~~~~~----- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEGLIFAK----IIKLEY----- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHH----HHHTCC-----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHH----HHcCCC-----
Confidence 2 3456899999999999999999999999999999999999999642 11222222 222221
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+ +....+++.+|+.+||+.||++|||++|++.+
T Consensus 252 -~~-----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 -DF-----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -CC-----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -CC-----CcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 01 11233578999999999999999999997644
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=414.39 Aligned_cols=241 Identities=19% Similarity=0.256 Sum_probs=192.1
Q ss_pred HHHHHcCcCCcccEEEEEEc----CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 314 AAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
.+.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence 45578999999999999852 47899999987532 2223467899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||+||+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 107 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 107 FLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp CCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999743 3589999999999999999999999 99999999999999999999999999998653
Q ss_pred cc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.. ....||+.|||||++.+..|+.++|||||||++|||+||+.||... ...++... +..+...
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~----i~~~~~~----- 244 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK----DRKETMTM----ILKAKLG----- 244 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHH----HHHCCCC-----
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc----CHHHHHHH----HHcCCCC-----
Confidence 32 3456899999999999999999999999999999999999999742 11222222 2222110
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcH-----HHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEM-----REAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 582 (621)
. +...++++.+|+.+||+.||++|||+ +|+++|
T Consensus 245 -~-----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 245 -M-----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -C-----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -C-----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0 12234678999999999999999984 677654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=401.53 Aligned_cols=242 Identities=22% Similarity=0.368 Sum_probs=187.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------------
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------------ 380 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------------ 380 (621)
+.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 346899999999999995 46999999998643 3445678999999999999999999999987654
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..|+|||||++|+|.+++..... .....+..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEccC
Confidence 26899999999999999985442 23456777899999999999999999 9999999999999999999999999
Q ss_pred ecceecccc----------------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcch
Q 045652 461 GFYTMINSA----------------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV 524 (621)
Q Consensus 461 G~a~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 524 (621)
|+|+.+... ....||+.|||||++.+..|+.++|||||||++|||++ ||... .+.
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~------~~~ 233 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------MER 233 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH------HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc------cHH
Confidence 999876432 12358999999999999999999999999999999996 76521 111
Q ss_pred HHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+. ........ + . .....+.+.+|+.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~-~~~~~~~p----~-~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTLT-DVRNLKFP----P-L-----FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHH-HHHTTCCC----H-H-----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHH-HHhcCCCC----C-C-----CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 11111111 0 0 12334567889999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.04 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=197.2
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 384 (621)
.+.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++... +..||
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 3457899999999999995 56999999999753 233456788999999999999999999987643 56899
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|||||+ |+|.+++.. ...+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 137 vmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 137 VLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecceee
Confidence 999995 689999974 34699999999999999999999999 99999999999999999999999999998
Q ss_pred ecccc--------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 465 MINSA--------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 465 ~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
.+... ....||+.|||||++.+. .|+.++||||+||++|||++|+.||... ...+....+.......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~----~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK----NYVHQLQLIMMVLGTP 282 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS----SHHHHHHHHHHHHCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC----CHHHHHHHHHHhcCCC
Confidence 76322 345789999999998775 5699999999999999999999999742 2223333332222111
Q ss_pred ccccc--cc--------cchhc-CCC-----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 RVTDL--LD--------PEIAS-STN-----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~~~~~--~d--------~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..... .. ..+.. ... .+....++.+|+.+||..||++|||+.|+++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 10000 00 00000 000 01224678999999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=395.76 Aligned_cols=251 Identities=17% Similarity=0.292 Sum_probs=193.0
Q ss_pred HHHHcCcCCcccEEEEEEc----CCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+.+ +++.||||++..... ...+.+|+++|+.+ +|||||++++++.+.+..|+|||||
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 4568999999999999843 468999999875432 45678999999998 6999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeecceeccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTMINS 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~ 468 (621)
++|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 103 ~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 103 EHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999984 388999999999999999999999 99999999999999876 7999999999976532
Q ss_pred c--------------------------------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 045652 469 A--------------------------------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYL 515 (621)
Q Consensus 469 ~--------------------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~ 515 (621)
. ....||+.|||||++.+. .|+.++||||+||++|||+||+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1 123589999999999775 4899999999999999999999999642
Q ss_pred cCCCCCcchHHHHHHHhhcC-----------------cc-----c---------cccccch--------hcCCCCHHHHH
Q 045652 516 TNGNGGIDVVEWVASAFSEG-----------------RV-----T---------DLLDPEI--------ASSTNSPGEME 556 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~-----------------~~-----~---------~~~d~~~--------~~~~~~~~~~~ 556 (621)
. +..+....+....... .. . ....|.. ..........+
T Consensus 251 ~---~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 251 S---DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp S---SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred C---CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 2 1222222221111000 00 0 0000000 00011123346
Q ss_pred HHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 557 QLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 557 ~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
++.+|+.+||+.||++|||++|+++|
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 78999999999999999999999976
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=412.24 Aligned_cols=246 Identities=19% Similarity=0.350 Sum_probs=205.0
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+..|||||||+||
T Consensus 160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 3457899999999999995 469999999998777667788999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC--CCcEEEeeecceecccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE--NEPLISEFGFYTMINSA- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~~- 469 (621)
+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 240 ~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 240 ELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp BHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999643 24589999999999999999999999 99999999999999854 78999999999987654
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+.... +...... + .+..
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~----~~~~~~~----i~~~~~~-~-~~~~-- 379 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRN----VKSCDWN-M-DDSA-- 379 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHH----HHTTCCC-C-CSGG--
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHH----HHhCCCC-C-Cccc--
Confidence 33568999999999999999999999999999999999999997421 1222222 2211110 0 0100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......++.+|+.+||+.||++|||+.|+++|
T Consensus 380 ---~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 ---FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11234578999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=401.44 Aligned_cols=243 Identities=18% Similarity=0.231 Sum_probs=195.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHH---HHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAF---DTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.++||+|+||.||+|+. .+|+.||||++++... .....+ ..++.+++.++|||||+++++|.+.+..|+|||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 457899999999999995 4599999999864211 112222 345677788899999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||+||+|.++|... ..+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 273 y~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 273 LMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp CCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999743 3589999999999999999999999 99999999999999999999999999998875
Q ss_pred cc--ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 468 SA--NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 468 ~~--~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.. ....||+.|||||++.. ..|+.++||||+||++|||++|+.||..... .+..+ +.........
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~-i~~~i~~~~~------- 411 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHE-IDRMTLTMAV------- 411 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHH-HHHHHHHCCC-------
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHH-HHHhhcCCCC-------
Confidence 43 45679999999999964 5799999999999999999999999974321 11212 1122211111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
..+....+++.+|+.+||+.||++|++ ++||++|
T Consensus 412 ----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011223467899999999999999998 6888876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=370.58 Aligned_cols=267 Identities=26% Similarity=0.512 Sum_probs=226.8
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
.+.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998889999999988766666788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc------
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA------ 469 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------ 469 (621)
+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99975432 234689999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ........|.......+.+...+++.....
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 276 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWAVESHNNGQLEQIVDPNLADK- 276 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHHHHTHHHHTTTCCCSSSSSSCTTC-
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHHHHhhhccccccHHHhcChhhccc-
Confidence 223478899999999888999999999999999999999999975432 223445556555555566666666654332
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+.....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 3467888999999999999999999999999999988653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=368.77 Aligned_cols=269 Identities=32% Similarity=0.570 Sum_probs=223.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|...+++.||||++..... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 34 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 113 (326)
T 3uim_A 34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113 (326)
T ss_dssp STTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCB
T ss_pred cceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCC
Confidence 3578999999999999988899999999975432 223368899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++..... ....+++..+..++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||++......
T Consensus 114 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (326)
T 3uim_A 114 VASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191 (326)
T ss_dssp HHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE
T ss_pred HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccc
Confidence 9999986442 3456999999999999999999999863 337999999999999999999999999999876432
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccc-CCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLT-NGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.... .........+|+.............+.....
T Consensus 192 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 3uim_A 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271 (326)
T ss_dssp ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT
T ss_pred cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc
Confidence 22347889999999988889999999999999999999999996432 1233445666666666666666666655443
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
. ........+.+++.+||+.||++|||+.|++++|+..
T Consensus 272 ~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 272 N-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp S-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred c-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 3 3477888999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=362.29 Aligned_cols=248 Identities=23% Similarity=0.409 Sum_probs=207.8
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 46799999999999996 45899999999877777788899999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---- 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~---- 470 (621)
.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99997532 4589999999999999999999999 99999999999999999999999999998764321
Q ss_pred --------------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc--chHHHHHHHhhc
Q 045652 471 --------------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI--DVVEWVASAFSE 534 (621)
Q Consensus 471 --------------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~ 534 (621)
...+|+.|+|||++.+..++.++||||||+++|||++|..|+.......... .........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--- 243 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT---
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc---
Confidence 3357888999999999999999999999999999999999986533211111 111111100
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.....+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 244 ---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 ---------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0112234588999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.85 Aligned_cols=242 Identities=22% Similarity=0.365 Sum_probs=201.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 346799999999999984 5689999999875555556788999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 99999742 488999999999999999999999 9999999999999999999999999998876543
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ............. ... .
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~~~~~~-~~~--------~ 237 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNGT-PEL--------Q 237 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHCS-CCC--------S
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCC-CCC--------C
Confidence 23467889999999999999999999999999999999999986421 1111111111111 111 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112334678999999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.35 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=207.1
Q ss_pred HHHHHcCcCCcccEEEEEEc--------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA--------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKL 383 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 383 (621)
.+.+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 34578999999999999852 3568999999754 334567799999999999 8999999999999999999
Q ss_pred EEEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC
Q 045652 384 LVYEYIPGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~ 452 (621)
+||||+++|+|.+++..... .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTT
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhEEECCC
Confidence 99999999999999976432 1234589999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchH
Q 045652 453 NEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVV 525 (621)
Q Consensus 453 ~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 525 (621)
+.+||+|||+++..... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.... ..++.
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----~~~~~ 315 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEELF 315 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHH
Confidence 99999999999876432 22345678999999999999999999999999999999 999986422 12222
Q ss_pred HHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 526 EWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
. .+..+.... .+......+.+++.+||+.||++||++.|++++|+++...
T Consensus 316 ~----~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 K----LLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp H----HHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2 222221110 1123346789999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=355.87 Aligned_cols=249 Identities=21% Similarity=0.382 Sum_probs=206.3
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 3457899999999999998889999999997543 235678999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 92 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 92 LSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp HHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred HHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 999997533 4589999999999999999999999 9999999999999999999999999999866433
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+... .+..+. ....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~----~~~~~~----~~~~~~--~~~~----- 228 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVE----DISTGF--RLYK----- 228 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHH----HHHTTC--CCCC-----
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC----HHHHHH----HHhcCc--cCCC-----
Confidence 22345667999999998899999999999999999999 999986421 111111 111111 0000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.......+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 229 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 112235689999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=358.26 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=199.7
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
|.+.+.||+|+||.||+|.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 34557899999999999987 68899999987543 3445678999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD--LPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+|+|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++....
T Consensus 118 ~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 118 RGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp TCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred CCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999997532 122489999999999999999999998 8 99999999999999999999999999976543
Q ss_pred c----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....+|..|+|||++.+..++.++|||||||++|||++|+.||.... ..+.... ........
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~----~~~~~~~---~~~~~~~~------ 258 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN----PAQVVAA---VGFKCKRL------ 258 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC----HHHHHHH---HHHSCCCC------
T ss_pred cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH---HHhcCCCC------
Confidence 2 34567889999999999999999999999999999999999997421 1111111 11111100
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.........+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 259 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 ----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111233457899999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=360.34 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=205.6
Q ss_pred HHHHHcCcCCcccEEEEEEc----CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 314 AAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.+.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 131 (325)
T 3kul_A 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131 (325)
T ss_dssp EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence 34578999999999999963 3556999999754 444567899999999999999999999999998899999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++++|.++++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 132 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 132 MENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999997432 4589999999999999999999999 999999999999999999999999999987644
Q ss_pred cc-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 469 AN-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 469 ~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
.. ...+|..|+|||++.+..++.++|||||||++|||++ |..||.... ..+... .+..+...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----~~~~~~----~~~~~~~~-- 273 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVIS----SVEEGYRL-- 273 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHHHHH----HHHTTCCC--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC----HHHHHH----HHHcCCCC--
Confidence 31 1234567999999998899999999999999999999 999986422 111211 12211100
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCC
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNM 593 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 593 (621)
......+..+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus 274 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 274 --------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred --------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 011233467899999999999999999999999999998765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.09 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=201.3
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 46999999999999965 69999999997665556778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----cc
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----NL 471 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~~ 471 (621)
+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 131 ~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 131 DIVSQ------VRLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 99863 3589999999999999999999998 9999999999999999999999999998876442 33
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
..+|..|+|||++.+..++.++|||||||++|||++|+.||.... ....... +........ ...
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~----~~~~~~~----~~~~~~~~~--------~~~ 264 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAMKR----LRDSPPPKL--------KNS 264 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHH----HHHSSCCCC--------TTG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH----HhcCCCCCc--------Ccc
Confidence 467889999999999999999999999999999999999986421 1111111 111111111 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
......+.+++.+||+.||++|||+.|++++-
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 22345789999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=359.60 Aligned_cols=239 Identities=20% Similarity=0.329 Sum_probs=199.3
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 46799999999999996 67999999998643 3445667889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 100 EVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp BHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 999999743 3589999999999999999999999 9999999999999999999999999999766433
Q ss_pred ccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 NLAQALFAYKAPEAIQSGKVT-PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+|+.|+|||++.+..+. .++|||||||++|||++|+.||.... ..+ +...+..+... .
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~-~~~~i~~~~~~------~--- 233 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKE-LRERVLRGKYR------I--- 233 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHH-HHHHHHHCCCC------C---
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHH-HHHHHHhCCCC------C---
Confidence 345688899999999888765 79999999999999999999996421 111 12222222110 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+......+.+++.+||+.||++|||++|+++|
T Consensus 234 --p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 --PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11233568899999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=360.50 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=203.6
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC----eeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD----EKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+.. ++.||||+++... .....+++|+.++++++||||+++++++.... ..++||||++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred hhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 4578999999999999874 7999999997543 33455677999999999999999999998754 3699999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc------CCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL------AHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
+|+|.++++. ..+++..++.++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 106 KGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp TCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 9999999974 24899999999999999999999741 12279999999999999999999999999998
Q ss_pred ecccc------ccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc--------chH
Q 045652 465 MINSA------NLAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI--------DVV 525 (621)
Q Consensus 465 ~~~~~------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~--------~~~ 525 (621)
..... ....+|..|+|||++.+ ..++.++|||||||++|||+||+.||.......... ...
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 76433 22457889999999976 356778999999999999999999987533211100 001
Q ss_pred HHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 526 EWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+........ ..+.+............+.+|+.+||+.||++|||+.|+++.|++++..
T Consensus 260 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 260 EDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111 1111111112235567799999999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=353.76 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=204.0
Q ss_pred HHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 387 (621)
+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...++|||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 457899999999999984 35889999999877777778899999999999999999999998654 45899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 999999999997542 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred cc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC--------CCCCcchHHHHHHHh
Q 045652 468 SA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN--------GNGGIDVVEWVASAF 532 (621)
Q Consensus 468 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~--------~~~~~~~~~~~~~~~ 532 (621)
.. ....++..|+|||++.+..++.++||||||+++|||+||..|+..... ..........+...+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 32 223355679999999988999999999999999999999998764211 000011111111222
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
..+.. .......+.++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 246 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 246 KNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11110 1112234467999999999999999999999999999997653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=350.23 Aligned_cols=271 Identities=27% Similarity=0.516 Sum_probs=215.4
Q ss_pred ccCChhHHHHHHH-----------HHcCcCCcccEEEEEEcCCcEEEEEEccCC----ChhhHHHHHHHHHHHhcCCCCC
Q 045652 304 GVFGLPDLMKAAA-----------EVLGNGGLGSSYKAMMADGVTVVVKRMKES----SAMARDAFDTEVRRLGRLRHSN 368 (621)
Q Consensus 304 ~~~~~~~~~~~~~-----------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~n 368 (621)
..|++.++...+. +.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 3456666665432 5799999999999987 6889999998643 2334678999999999999999
Q ss_pred cccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 369 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
|+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||++ +|+||||||+||+
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil 165 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANIL 165 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEE
Confidence 9999999999999999999999999999997433 234689999999999999999999999 9999999999999
Q ss_pred eCCCCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc
Q 045652 449 ISPENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI 522 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 522 (621)
++.++.+||+|||++...... ....++..|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 999999999999998876432 22457889999998864 589999999999999999999999875432211
Q ss_pred chHHHHHHHhhc--CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 523 DVVEWVASAFSE--GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 523 ~~~~~~~~~~~~--~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
... +...... ..+...+++.+ ..........+.+++.+||+.||++|||+.+++++|+++..
T Consensus 243 -~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 -LLD-IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp -TTH-HHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred -HHH-HHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111 1111111 11222223222 12345677889999999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=365.45 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=196.0
Q ss_pred HHHHcCcCCcccEEEEEEc----CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+.. ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 4578999999999999854 5778999999754 3445678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.++++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 129 ENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp TTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999753 24589999999999999999999999 9999999999999999999999999999876433
Q ss_pred c-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 N-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++. ..+..+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~----~~~~~----~~i~~~~~---- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVI----KAVDEGYR---- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC----HHHHH----HHHHTTEE----
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHHHH----HHHHcCCC----
Confidence 1 1123567999999998899999999999999999998 999986421 11122 22222110
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.......+..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 269 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 ------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0011233467899999999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=364.70 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=204.7
Q ss_pred HHHHcCcCCcccEEEEEEc------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 4568999999999999843 4678999999754 34455678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC---CcEEEeeec
Q 045652 388 YIPGGSLLYLLHGDRG--PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN---EPLISEFGF 462 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~ 462 (621)
|+++|+|.+++..... .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 9999999999975432 1234689999999999999999999999 999999999999999555 599999999
Q ss_pred ceeccc------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 463 YTMINS------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 463 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
++.... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..++.. .+..+
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~----~~~~~~----~i~~~ 302 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQEVLE----FVTSG 302 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHH----HHHTT
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHHcC
Confidence 976532 223446778999999998899999999999999999998 999986421 112222 22221
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.... .....+..+.+|+.+||+.||++|||+.|++++|+.+....
T Consensus 303 ~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 GRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCC----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1110 11223456899999999999999999999999999887643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=353.16 Aligned_cols=266 Identities=19% Similarity=0.284 Sum_probs=207.7
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC--eeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--EKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 467999999999999965 48999999997533 234567889999999999999999999998765 67999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe----CCCCCcEEEeeecceecc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI----SPENEPLISEFGFYTMIN 467 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a~~~~ 467 (621)
++|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 94 GSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999997543 123489999999999999999999999 99999999999999 778889999999998765
Q ss_pred cc---ccccccccccCccccc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 468 SA---NLAQALFAYKAPEAIQ--------SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 468 ~~---~~~~~~~~y~aPE~~~--------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
.. ....+|..|+|||++. +..++.++|||||||++|||+||+.||...............+........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 43 2345788999999986 577999999999999999999999999754332222222222222111111
Q ss_pred ccccc---------ccchh-cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 537 VTDLL---------DPEIA-SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 537 ~~~~~---------d~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
+.... .+... ...........+.+++.+||+.||++|||++|++++..+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11000 00011 11223567788999999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=351.26 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=195.3
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCCcccceEEEEeC----CeeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGR--LRHSNVLAPLAYHYRT----DEKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~ 389 (621)
.+.||+|+||.||+|.. +++.||||++.... ...+.+|.+++.. ++||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 46799999999999988 78999999986432 3455566666665 7999999999987653 3478999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH--------TELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 89 EMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp TTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred cCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEEeeCC
Confidence 99999999953 35899999999999999999999 77 99999999999999999999999999
Q ss_pred cceeccccc--------cccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCcccC
Q 045652 462 FYTMINSAN--------LAQALFAYKAPEAIQSG------KVTPKCDVYCLGIIILEILTG----------KFPSQYLTN 517 (621)
Q Consensus 462 ~a~~~~~~~--------~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg----------~~P~~~~~~ 517 (621)
+++...... ...+|+.|+|||++.+. .++.++|||||||++|||+|| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 997764332 23678899999999876 456799999999999999999 777764332
Q ss_pred CCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 518 GNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.... ...+......... .+..............+.+++.+||+.||++|||+.|+++.|+++
T Consensus 239 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPS---FEDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCC---HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcc---hhhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221 1222222211111 111111111235678899999999999999999999999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=366.88 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=204.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|... +++.||||.++... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 3578999999999999975 68999999987542 334567889999999999999999999999888999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.++++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999997432 3589999999999999999999999 99999999999999999999999999998754321
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
...++..|+|||++.+..++.++|||||||++|||+| |..||..... .. +...+..+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~----~~~~~~~~~~~------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQ----TREFVEKGGRL------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HH----HHHHHHTTCCC-------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HH----HHHHHHcCCCC-------
Confidence 1234567999999998899999999999999999998 9999874321 11 22222222110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 335 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 ---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01122345788999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=350.08 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=204.4
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.+.||+|+||.||+|...++..||+|+++... ...+.+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (268)
T 3sxs_A 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90 (268)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcH
Confidence 456899999999999998888899999997543 2356789999999999999999999999998999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN---- 470 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~---- 470 (621)
.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 91 LNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp HHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 99997532 3589999999999999999999999 99999999999999999999999999998764432
Q ss_pred -cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 -LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 -~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+.... ...+. ....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~-~~~~~--~~~~------ 226 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVVLK-VSQGH--RLYR------ 226 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHH-HHTTC--CCCC------
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-------hHHHHHH-HHcCC--CCCC------
Confidence 2234567999999998889999999999999999999 999986422 1111111 11111 0001
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
+......+.+++.+||+.||++|||+.|++++|+.+++..
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1122356899999999999999999999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=351.38 Aligned_cols=250 Identities=20% Similarity=0.371 Sum_probs=203.4
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
|.+.+.||+|+||.||++...++..||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 345578999999999999998888999999985432 3567899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 105 CLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp BHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999997532 3589999999999999999999999 9999999999999999999999999999876433
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||++.+..++.++||||||+++|||+| |+.||..... ..... .+..+.. ...
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~~----~~~~~~~--~~~---- 242 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAE----HIAQGLR--LYR---- 242 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHH----HHHTTCC--CCC----
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHHH----HHhcccC--CCC----
Confidence 22345667999999998899999999999999999998 9999874221 11111 1111110 000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.......+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 243 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 243 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 112235689999999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=362.62 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=209.8
Q ss_pred HHHHHcCcCCcccEEEEEEc--------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA--------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKL 383 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 383 (621)
.+.+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 151 (382)
T 3tt0_A 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151 (382)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceE
Confidence 34578999999999999852 2368999999754 334457789999999999 8999999999999999999
Q ss_pred EEEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC
Q 045652 384 LVYEYIPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~ 452 (621)
+||||+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTT
T ss_pred EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcceEEEcCC
Confidence 999999999999999764321 124599999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchH
Q 045652 453 NEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVV 525 (621)
Q Consensus 453 ~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 525 (621)
+.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-------~- 299 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------V- 299 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------H-
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-------H-
Confidence 99999999999876432 22345678999999999999999999999999999999 999986421 1
Q ss_pred HHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCCC
Q 045652 526 EWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMD 594 (621)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~ 594 (621)
..+...+..+..... ......++.+++.+||+.||++|||++|++++|+++........
T Consensus 300 ~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 300 EELFKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHHHHTTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHHHHHcCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 112222222211110 12234578999999999999999999999999999987655443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=353.18 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=198.2
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 467999999999999964 58999999986432 22356788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc---
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--- 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--- 468 (621)
|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 90 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999743 3589999999999999999999999 999999999999999999999999999986432
Q ss_pred -cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 -ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+ .+...... .
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~----~i~~~~~~------~-- 224 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFE----LILMEEIR------F-- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHHCCCC------C--
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HHHHHH----HHHcCCCC------C--
Confidence 234568899999999999999999999999999999999999986421 111111 11111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+.....++.+++.+||+.||++|| +++|+++|
T Consensus 225 ---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112345789999999999999999 89999887
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=346.39 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=202.4
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 346799999999999985 46899999998532 33456788999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 95 GPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999743 3589999999999999999999999 9999999999999999999999999999766432
Q ss_pred ----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....+|+.|+|||++.+..++.++||||||+++|||+||+.||.... ............. ... ....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~-~~~-~~~~ 236 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-------AVSIAIKHIQDSV-PNV-TTDV 236 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-------HHHHHHHHHSSCC-CCH-HHHS
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhhccC-CCc-chhc
Confidence 23457889999999999999999999999999999999999996421 1121222222111 100 0000
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCC-cHHHHHHHHHHhhccC
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRL-EMREAVRRIVEIQQSD 590 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~~~~ 590 (621)
....+..+.+++.+||+.||++|| +++++.+.|+.+....
T Consensus 237 -----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 237 -----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 122346789999999999999999 8999999998876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=355.55 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=205.9
Q ss_pred HHHHcCcCCcccEEEEEEc------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 3467999999999999964 3489999999754 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 388 YIPGGSLLYLLHGDRGP-------------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
|+++|+|.+++...... ....+++.+++.++.||+.||.|||++ +|+||||||+|||
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl 206 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL 206 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEE
Confidence 99999999999754211 125689999999999999999999999 9999999999999
Q ss_pred eCCCCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCC
Q 045652 449 ISPENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGG 521 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 521 (621)
++.++.+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----- 281 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA----- 281 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC-----
Confidence 999999999999998765432 23446778999999998899999999999999999999 999986421
Q ss_pred cchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
. ..+...+..+..... ....+..+.+++.+||+.||++||++.+++++|+++....
T Consensus 282 --~-~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 --H-EEVIYYVRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp --H-HHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred --h-HHHHHHHhCCCcCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 112222222221111 1223457899999999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=368.12 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=203.8
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC-eeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD-EKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|++++||||+++++++.+.. ..++||||+++|+
T Consensus 197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 3468999999999999874 7899999998643 4577999999999999999999999988765 6899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-ccc
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NLA 472 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~ 472 (621)
|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 274 L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 274 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp HHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 999997543 23478999999999999999999999 9999999999999999999999999999865432 233
Q ss_pred cccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 473 QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 473 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
.++..|+|||++.+..++.++|||||||++|||+| |+.||..... .++...+ ..+... ..+
T Consensus 347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i----~~~~~~----------~~p 408 (450)
T 1k9a_A 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRV----EKGYKM----------DAP 408 (450)
T ss_dssp CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTHHHHH----HTTCCC----------CCC
T ss_pred CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----HcCCCC----------CCC
Confidence 56778999999999999999999999999999998 9999875322 2222222 222110 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 23446789999999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.62 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=196.0
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
.+.||+|+||.||+|.. .++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 46799999999999987 4789999999743 34678899999999999999999999875 4579999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC-cEEEeeecceecccc-cccc
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE-PLISEFGFYTMINSA-NLAQ 473 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~~~~-~~~~ 473 (621)
+++.... ....+++..++.++.|+++||+|||+.. ..+|+||||||+||+++.++. +||+|||++...... ....
T Consensus 88 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 88 NVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence 9997543 2235788999999999999999999921 118999999999999998887 799999998766433 3446
Q ss_pred ccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHH
Q 045652 474 ALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPG 553 (621)
Q Consensus 474 ~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 553 (621)
++..|+|||++.+..++.++||||||+++|||++|+.||..... ........ ...+.... . ...
T Consensus 165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~~-----~-----~~~ 228 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----PAFRIMWA-VHNGTRPP-----L-----IKN 228 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----SHHHHHHH-HHTTCCCC-----C-----BTT
T ss_pred CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----cHHHHHHH-HhcCCCCC-----c-----ccc
Confidence 78899999999998999999999999999999999999874221 11111111 11111111 1 112
Q ss_pred HHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 554 EMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 554 ~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
.+..+.+++.+||+.||++|||+.|++++|+.+......
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 335688999999999999999999999999999765543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.18 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=204.6
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||+++|+|
T Consensus 192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269 (454)
T ss_dssp EEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence 457899999999999999888999999998644 34678999999999999999999999985 6678999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 469 (621)
.++++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 270 LDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp HHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred HHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 99997432 12578899999999999999999999 9999999999999999999999999999876432
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++....++.++|||||||++|||+| |+.||.... ..++...+ ..+...
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~----~~~~~~~i----~~~~~~---------- 404 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRAL----ERGYRM---------- 404 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHH----HHTCCC----------
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HcCCCC----------
Confidence 22334668999999998899999999999999999999 999987422 11222222 221100
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 01123346789999999999999999999999999988653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=358.05 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=199.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence 3467999999999999954 589999999875432 135789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC----CcEEEeeecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN----EPLISEFGFY 463 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a 463 (621)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 96 ~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 96 LVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp CCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999964 34689999999999999999999999 999999999999998877 7999999999
Q ss_pred eecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 464 TMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 464 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
...... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+... .+..+...
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~~~~~~----~i~~~~~~-- 236 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLA----NITAVSYD-- 236 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHH----HHHTTCCC--
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHH----HHHhcCCC--
Confidence 877543 33568899999999998899999999999999999999999996421 111211 12211110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+++... ......+.+|+.+||..||++|||+.|+++|
T Consensus 237 ~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 FDEEFF-----SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCchhc-----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111 1223568999999999999999999999965
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=352.35 Aligned_cols=244 Identities=21% Similarity=0.293 Sum_probs=200.3
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.+.||+|+||.||+|... +++.||+|.++... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 467999999999999954 58899999987543 4456788999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC--CCCcEEEeeecceecccc---
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP--ENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~--- 469 (621)
.+++... ...+++.+++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++......
T Consensus 89 ~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 89 FERINTS----AFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp HHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 9999643 23589999999999999999999999 9999999999999997 789999999999887543
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....+++.|+|||++.+..++.++|||||||++|||++|..||.... ....... +..+... .++..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~----i~~~~~~--~~~~~---- 226 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIEN----IMNAEYT--FDEEA---- 226 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHH----HHHTCCC--CCHHH----
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----HHHHHHH----HHcCCCC--CChhh----
Confidence 23457889999999998889999999999999999999999996421 1112221 1111110 00100
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
....+.++.+++.+||..||++|||+.|+++|-
T Consensus 227 -~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 227 -FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp -HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 012245789999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=349.63 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=197.8
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|...+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 46799999999999998889999999987432 22356788999999999999999999999999999999999975 8
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 888886432 4589999999999999999999999 9999999999999999999999999999876432
Q ss_pred ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc---c---
Q 045652 470 NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL---D--- 542 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---d--- 542 (621)
....+|..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+............. +
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD----DDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST----TTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHHCCCChHHhhhhhccch
Confidence 23456889999999876 5689999999999999999999999975332 22333333322211110000 0
Q ss_pred ---cchh--cCC----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 ---PEIA--SST----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ---~~~~--~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... ... ..+....++.+|+.+||+.||++|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 000 001223578999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=358.93 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=196.1
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 5699999999999985 468999999998766666788999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe--CCCCCcEEEeeecceecccc---c
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI--SPENEPLISEFGFYTMINSA---N 470 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~~~~~---~ 470 (621)
+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..... .
T Consensus 175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 175 DRIIDES----YNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 9886432 3589999999999999999999999 99999999999999 56778999999999877543 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.... . .+.+........ ....+.
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~---~~~~~~i~~~~~--~~~~~~------ 311 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN----D---AETLNNILACRW--DLEDEE------ 311 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS----H---HHHHHHHHHTCC--CSCSGG------
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----H---HHHHHHHHhccC--CCChhh------
Confidence 3457889999999998899999999999999999999999996421 1 112222221111 000010
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......++.+|+.+||+.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11234678999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=346.75 Aligned_cols=250 Identities=20% Similarity=0.347 Sum_probs=201.8
Q ss_pred HHHcCcCCcccEEEEEEcC-C-------cEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 316 AEVLGNGGLGSSYKAMMAD-G-------VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
.+.||+|+||.||+|.... + ..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 4679999999999998433 3 5799999987666667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC--------cEEEe
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE--------PLISE 459 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~D 459 (621)
|+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 93 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999997532 3489999999999999999999999 9999999999999998887 99999
Q ss_pred eecceeccccccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 460 FGFYTMINSANLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 460 fG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
||++..........++..|+|||++.+ ..++.++|||||||++|||++|..|+.... +..... .......
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~-~~~~~~~-- 235 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL------DSQRKL-QFYEDRH-- 235 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHH-HHHHTTC--
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc------chHHHH-HHhhccC--
Confidence 999987766666678889999999987 679999999999999999999655543211 111111 1111110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
... ......+.+++.+||+.||++|||+.|++++|+++..+...
T Consensus 236 -----~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 236 -----QLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp -----CCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred -----CCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 000 01123588999999999999999999999999998765443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.25 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=203.1
Q ss_pred HHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCe-eEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDE-KLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~lv 385 (621)
+.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+.+. .++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 456899999999999973 235899999997643 34456799999999999 79999999999987654 8999
Q ss_pred EeecCCCChhHHhhcCCCCC------------------------------------------------------------
Q 045652 386 YEYIPGGSLLYLLHGDRGPS------------------------------------------------------------ 405 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~------------------------------------------------------------ 405 (621)
|||+++|+|.++++......
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 99999999999997643210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc------ccccccccc
Q 045652 406 -HDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA------NLAQALFAY 478 (621)
Q Consensus 406 -~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y 478 (621)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....+|..|
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 12289999999999999999999999 9999999999999999999999999999866332 234467789
Q ss_pred cCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHH
Q 045652 479 KAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQ 557 (621)
Q Consensus 479 ~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 557 (621)
+|||++.+..++.++|||||||++|||+| |+.||..... . +.+...+..+.... .......+
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~----~~~~~~~~~~~~~~----------~~~~~~~~ 324 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---D----EEFCRRLKEGTRMR----------APDYTTPE 324 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---S----HHHHHHHHHTCCCC----------CCTTCCHH
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---h----HHHHHHHHcCCCCC----------CCCCCCHH
Confidence 99999998999999999999999999998 9999864221 1 11222222221111 01123356
Q ss_pred HHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 558 LLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 558 l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
+.+++.+||+.||++|||+.|++++|+++...
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 89999999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.46 Aligned_cols=245 Identities=16% Similarity=0.247 Sum_probs=199.4
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (444)
T 3soa_A 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93 (444)
T ss_dssp EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCC
Confidence 3457899999999999985 568999999987543 3345678999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC---CCCCcEEEeeecceecc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS---PENEPLISEFGFYTMIN 467 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~ 467 (621)
+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 94 gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 94 GGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999998743 3589999999999999999999999 999999999999998 46789999999998765
Q ss_pred cc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.. ....+|+.|+|||++.+..++.++|||||||++|+|++|..||... ....+.. .+..+... ...+
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~----~~~~~~~----~i~~~~~~-~~~~ 235 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE----DQHRLYQ----QIKAGAYD-FPSP 235 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHH----HHHHTCCC-CCTT
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc----cHHHHHH----HHHhCCCC-CCcc
Confidence 43 2346889999999999889999999999999999999999998642 1112222 22222111 1011
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......+.+.+|+.+||+.||++|||+.|+++|
T Consensus 236 ------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 ------EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 112334678999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.25 Aligned_cols=248 Identities=21% Similarity=0.364 Sum_probs=205.4
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.+.||+|+||.||+|...+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (267)
T 3t9t_A 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL 90 (267)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred eeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence 4567999999999999988889999999985432 356789999999999999999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 469 (621)
.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 91 SDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred HHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99997532 3588999999999999999999999 9999999999999999999999999998876432
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...... .+..+.. ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~----~i~~~~~--~~------- 225 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVE----DISTGFR--LY------- 225 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHH----HHHTTCC--CC-------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----HHHHHH----HHhcCCc--CC-------
Confidence 22345667999999988889999999999999999999 899986421 111111 1221110 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
........+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 226 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0112235689999999999999999999999999998763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=347.05 Aligned_cols=250 Identities=19% Similarity=0.346 Sum_probs=194.3
Q ss_pred HHHHHHcCcCCcccEEEEEEcC----CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEe
Confidence 3455789999999999998533 567999998753 344567899999999999999999999997 4567899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 96 LCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp CCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999997532 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccc-----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 468 SAN-----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 468 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
... ...+++.|+|||++.+..++.++||||||+++|||++ |..||.... ..+....+ ..+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~----~~~~~~~i----~~~~~~~-- 237 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGRI----ENGERLP-- 237 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHH----HTTCCCC--
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC----HHHHHHHH----HcCCCCC--
Confidence 432 2334568999999988899999999999999999997 999987422 12222222 1111110
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.....+..+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 238 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1123346789999999999999999999999999988653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=353.04 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=206.9
Q ss_pred HHHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
|.+.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 34557899999999999985 23589999999754 344567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCC
Q 045652 386 YEYIPGGSLLYLLHGDRGP-------------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSN 446 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~N 446 (621)
|||+++++|.+++...... ....+++.+++.++.||+.||+|||++ +|+||||||+|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dikp~N 180 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDLAARN 180 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGG
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcccccchhe
Confidence 9999999999999754321 123489999999999999999999999 99999999999
Q ss_pred EEeCCCCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCC
Q 045652 447 IFISPENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGN 519 (621)
Q Consensus 447 Ill~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 519 (621)
|+++.++.+||+|||++...... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--- 257 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP--- 257 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999999876432 22345677999999998889999999999999999999 999986422
Q ss_pred CCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 520 GGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
...+.. .+..+.... ........+.+++.+||+.||++||++.|++++|+++...
T Consensus 258 -~~~~~~----~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 -PERLFN----LLKTGHRME----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp -GGGHHH----HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -HHHHHH----HhhcCCcCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 112222 222221110 1123346789999999999999999999999999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=351.34 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=199.9
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 93 (326)
T 2y0a_A 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93 (326)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34578999999999999964 589999999864322 23678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC----CcEEEeeec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN----EPLISEFGF 462 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~ 462 (621)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 94 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 94 ELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp ECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999964 24589999999999999999999999 999999999999999887 799999999
Q ss_pred ceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+ ..... .
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~----~~~~~-~ 235 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANV----SAVNY-E 235 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH----HHTCC-C
T ss_pred CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHH----HhcCC-C
Confidence 9877533 33457889999999998899999999999999999999999986421 11111111 11110 0
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+... ......+.+++.+||+.||++|||+.|+++|
T Consensus 236 -~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -FEDEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CCHHHH-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -cCcccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001110 1223568899999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.70 Aligned_cols=246 Identities=18% Similarity=0.296 Sum_probs=200.8
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 345678999999999999854 5899999998643 3344567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC---CcEEEeeecceec
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN---EPLISEFGFYTMI 466 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~ 466 (621)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++...
T Consensus 111 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 111 TGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999998642 4589999999999999999999999 999999999999998654 5999999999876
Q ss_pred ccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 467 NSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 467 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. .+..+... ...+
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~~~~----~i~~~~~~-~~~~ 252 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYA----QIKAGAYD-YPSP 252 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHHTCCC-CCTT
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHH----HHHhCCCC-CCcc
Confidence 543 23468889999999998899999999999999999999999986421 111222 22222111 0001
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+|+.+||+.||++|||+.|+++|
T Consensus 253 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 ------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 012334678999999999999999999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.52 Aligned_cols=242 Identities=21% Similarity=0.334 Sum_probs=194.6
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe-----------
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE----------- 381 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------- 381 (621)
+.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 3467999999999999965 7999999998743 33456789999999999999999999999866432
Q ss_pred ----------------------------------------------eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHH
Q 045652 382 ----------------------------------------------KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARL 415 (621)
Q Consensus 382 ----------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~ 415 (621)
.++||||+++++|.+++.... ......+..++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--CccchhhHHHH
Confidence 789999999999999998654 23456777899
Q ss_pred HHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----------------cccccccccc
Q 045652 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----------------NLAQALFAYK 479 (621)
Q Consensus 416 ~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----------------~~~~~~~~y~ 479 (621)
.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....+|+.|+
T Consensus 168 ~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999999 9999999999999999999999999999876543 2235788999
Q ss_pred CcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHH
Q 045652 480 APEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLL 559 (621)
Q Consensus 480 aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~ 559 (621)
|||++.+..++.++|||||||++|||++|..|+.. ... ............ ......+.+.
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~-~~~~~~~~~~~~----------~~~~~~~~~~ 303 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVR-IITDVRNLKFPL----------LFTQKYPQEH 303 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHH-HHHHHHTTCCCH----------HHHHHCHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHH-HHHHhhccCCCc----------ccccCChhHH
Confidence 99999999999999999999999999998776431 111 111111111110 0123446788
Q ss_pred HHHhhcccCCCCCCCcHHHHHHH
Q 045652 560 EIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 560 ~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+++.+||+.||++|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.19 Aligned_cols=269 Identities=15% Similarity=0.209 Sum_probs=205.2
Q ss_pred HHHHcCcCCcccEEEEEEcC------CcEEEEEEccCCChhhH-----------HHHHHHHHHHhcCCCCCcccceEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMAD------GVTVVVKRMKESSAMAR-----------DAFDTEVRRLGRLRHSNVLAPLAYHY 377 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~~~ 377 (621)
+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||+++++++.
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 34679999999999998654 47899999875542211 12345667788889999999999987
Q ss_pred eC----CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC--C
Q 045652 378 RT----DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS--P 451 (621)
Q Consensus 378 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~ 451 (621)
.. ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEESSC
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEecCC
Confidence 75 4478999999 99999999753 24599999999999999999999999 999999999999999 8
Q ss_pred CCCcEEEeeecceecccc-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC
Q 045652 452 ENEPLISEFGFYTMINSA-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG 520 (621)
Q Consensus 452 ~~~~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 520 (621)
++.+||+|||+++.+... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~--- 266 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK--- 266 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT---
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 899999999999876432 123388899999999999999999999999999999999999975321
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCCCccccCC
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDARTSQN 600 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~~~~~~~ 600 (621)
.............. .+..++++.+.. ...+.++.+++..||+.||++||++.++++.|+++.............+
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 267 DPKYVRDSKIRYRE-NIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp CHHHHHHHHHHHHH-CHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred CHHHHHHHHHHhhh-hHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 11222222222111 122222222211 1223578999999999999999999999999999987665544333333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=340.26 Aligned_cols=246 Identities=25% Similarity=0.438 Sum_probs=196.2
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhh-------HHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMA-------RDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 46799999999999996 568999999986432211 167899999999999999999999985544 79999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CccCCCCCCCEEeCCCCC-----cEEEee
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD--LPHGNLKSSNIFISPENE-----PLISEF 460 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl~Df 460 (621)
|+++|+|.+++... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +||+||
T Consensus 102 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 102 FVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp CCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 99999999988753 24689999999999999999999998 8 999999999999988776 999999
Q ss_pred ecceecccc-ccccccccccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 461 GFYTMINSA-NLAQALFAYKAPEAIQ--SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 461 G~a~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
|+++..... ....++..|+|||++. ...++.++|||||||++|||++|+.||..... ............+.
T Consensus 174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~- 247 (287)
T 4f0f_A 174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-----GKIKFINMIREEGL- 247 (287)
T ss_dssp TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC-----CHHHHHHHHHHSCC-
T ss_pred CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc-----cHHHHHHHHhccCC-
Confidence 999865443 3456788999999983 45688999999999999999999999974321 11111111111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
. +. .....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 248 ~----~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 R----PT-----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp C----CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred C----CC-----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 11 1123346789999999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=359.26 Aligned_cols=250 Identities=16% Similarity=0.284 Sum_probs=200.2
Q ss_pred HHHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-----AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
.|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 345668899999999999985 468999999985321 12367789999999999999999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC---cEEEeeec
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE---PLISEFGF 462 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~ 462 (621)
|||+++++|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 105 ~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999888753221 123589999999999999999999999 9999999999999987655 99999999
Q ss_pred ceecccc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 463 YTMINSA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 463 a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
+...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .. +...+..+...
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~----~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ER----LFEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HH----HHHHHHHTCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HH----HHHHHHcCCCC
Confidence 9877543 23457889999999999899999999999999999999999996411 11 11112212111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+... ......+.+|+.+||+.||++|||+.|+++|
T Consensus 251 --~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQW-----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCcccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111110 1223578999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.08 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=188.8
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh----hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA----MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|.. .++.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 36799999999999997 488999999874322 2346788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC---CccCCCCCCCEEeCC--------CCCcEEEee
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD---LPHGNLKSSNIFISP--------ENEPLISEF 460 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~---ivH~Dlkp~NIll~~--------~~~~kl~Df 460 (621)
++|.+++.. ..+++..++.++.|++.||.|||++ + |+||||||+||+++. ++.+||+||
T Consensus 91 ~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 91 GPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred CCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999852 3589999999999999999999998 7 899999999999986 678999999
Q ss_pred ecceecccc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 461 GFYTMINSA--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 461 G~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
|++...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ........... ...
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~ 232 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMN-KLA 232 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-------HHHHHHHHHTS-CCC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHhhhcC-CCC
Confidence 999866443 23467889999999998899999999999999999999999987421 11111111111 110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
. ......+..+.+++.+||+.||++|||+.|++++|+++
T Consensus 233 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 L---------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 01123346789999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=371.70 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=206.1
Q ss_pred HHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|.+.. +..||||.++... ...+.|.+|+++|++++||||+++++++...+..++||||+++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 345789999999999999754 8899999998543 34678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 302 ~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 302 NLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp BHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999997543 34589999999999999999999999 99999999999999999999999999998764321
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||++.+..++.++|||||||++|||+| |..||.... ...+.+.+ ..+...
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~----~~~~~~~~----~~~~~~-------- 438 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELL----EKDYRM-------- 438 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHHH----HTTCCC--------
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HcCCCC--------
Confidence 2234568999999998899999999999999999999 999987432 12222222 211100
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
..+...+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 439 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred --CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1112334678999999999999999999999999988753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.00 Aligned_cols=254 Identities=15% Similarity=0.137 Sum_probs=203.8
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 46799999999999995 5689999999864432 34578999999999 9999999999999999999999999 999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC-----cEEEeeecceeccc
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE-----PLISEFGFYTMINS 468 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~a~~~~~ 468 (621)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 91 L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 91 LEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred HHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 99999753 24689999999999999999999999 9999999999999998887 99999999987643
Q ss_pred c-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 469 A-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 469 ~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
. ....+|..|+|||++.+..++.++|||||||++|||++|+.||..... .+..+.+..... ...
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~----~~~~~~~~~i~~-~~~ 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA----DTLKERYQKIGD-TKR 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----SSHHHHHHHHHH-HHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----ccHHHHHHHHHh-hhc
Confidence 2 234578899999999999999999999999999999999999975321 122222211111 000
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
.. ..... . ...+ ++.+++.+||+.||.+||++.++++.|+++....+.
T Consensus 238 ~~--~~~~~-~---~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 238 AT--PIEVL-C---ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HS--CHHHH-T---TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cC--CHHHH-h---ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 00000 0 0112 799999999999999999999999999998776543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.16 Aligned_cols=245 Identities=18% Similarity=0.327 Sum_probs=202.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+....++||||+++|+
T Consensus 55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 4567999999999999854 689999999987666667789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC--CCCcEEEeeecceecccc--
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP--ENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~-- 469 (621)
|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 135 L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 135 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99998643 23589999999999999999999999 9999999999999984 467999999999887543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+ ...... .++.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~i----~~~~~~--~~~~---- 272 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQNV----KRCDWE--FDED---- 272 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH----HHCCCC--CCSS----
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC----HHHHHHHH----HhCCCC--CCcc----
Confidence 23467889999999999999999999999999999999999987421 11122211 111110 0110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......++.+++.+||+.||++|||+.|++++
T Consensus 273 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 -AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112334678999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=352.72 Aligned_cols=258 Identities=21% Similarity=0.362 Sum_probs=194.4
Q ss_pred HHHHHHcCcCCcccEEEEEEcC-C---cEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCee----
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD-G---VTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK---- 382 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 382 (621)
|.+.+.||+|+||.||+|.... + ..||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 3455789999999999998543 3 38999999754 334567899999999999999999999999887655
Q ss_pred --EEEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 383 --LLVYEYIPGGSLLYLLHGDRG-PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 383 --~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
++||||+++|+|.+++..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCCCCEEEee
Confidence 899999999999999864321 1223589999999999999999999999 999999999999999999999999
Q ss_pred eecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHh
Q 045652 460 FGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAF 532 (621)
Q Consensus 460 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 532 (621)
||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+....+ .
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----~~~~~~~~---~ 253 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE----NAEIYNYL---I 253 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHH---H
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC----hHHHHHHH---h
Confidence 99998764332 2335667999999998899999999999999999999 899987422 12222221 1
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
. +... ......+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 254 ~-~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 254 G-GNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp T-TCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred c-CCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 1 1100 11123346789999999999999999999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.42 Aligned_cols=248 Identities=16% Similarity=0.267 Sum_probs=197.5
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 4578999999999999964 58899999987542 22234578899999887 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 136 NGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999743 3589999999999999999999999 999999999999999999999999999986322
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC-CcchHHHHHHHhhcCccccccccc
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG-GIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.+...+......
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 280 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 280 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC------
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC------
Confidence 2345688999999999999999999999999999999999999964322111 111222232322222211
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcH------HHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEM------REAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 582 (621)
.+.....++.+|+.+||+.||++||++ .|+++|
T Consensus 281 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 281 -----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 112234578999999999999999985 677765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.22 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=201.7
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...++||||++
T Consensus 14 ~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence 346799999999999998 4889999998754 344567799999999999999999999999877 67899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD--LPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+|+|.+++.... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999998543 23589999999999999999999998 7 99999999999999999999999988765433
Q ss_pred cccccccccccCcccccCCCCCc---chhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ANLAQALFAYKAPEAIQSGKVTP---KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~~~~~~~---~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....+|+.|+|||++.+..++. ++|||||||++|||++|+.||.... ..+........+.. +..
T Consensus 166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~-----~~~ 232 (271)
T 3kmu_A 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-------NMEIGMKVALEGLR-----PTI 232 (271)
T ss_dssp -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-------HHHHHHHHHHSCCC-----CCC
T ss_pred -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-------hHHHHHHHHhcCCC-----CCC
Confidence 3446788999999998765544 7999999999999999999986421 11111222222111 111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
+...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 233 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 -----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 12234678999999999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=352.90 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=206.6
Q ss_pred HHHHHHHcCcCCcccEEEEEE--------cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCe
Q 045652 312 MKAAAEVLGNGGLGSSYKAMM--------ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDE 381 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (621)
.|.+.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 115 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence 344567899999999999985 34678999999754 334567789999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS 450 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~ 450 (621)
.++||||+++|+|.+++...... ....+++..++.++.||+.||.|||+. +|+||||||+||+++
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVT 191 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceEEEc
Confidence 99999999999999999864321 123589999999999999999999999 999999999999999
Q ss_pred CCCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcc
Q 045652 451 PENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGID 523 (621)
Q Consensus 451 ~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 523 (621)
.++.+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~ 267 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VEE 267 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----HHH
Confidence 9999999999999876543 22345677999999988889999999999999999999 999986421 111
Q ss_pred hHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
+. ..+..+.... ........+.+++.+||+.||++|||+.|++++|+++.....
T Consensus 268 ~~----~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 LF----KLLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HH----HHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HH----HHHhcCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 21 2222221110 112234578999999999999999999999999999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.62 Aligned_cols=261 Identities=19% Similarity=0.310 Sum_probs=190.5
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
|.+.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 45678999999999999985 458999999987443 2234678899999999999999999999999999999999997
Q ss_pred CCChhHHhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 391 GGSLLYLLHGDR-GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 391 ~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|.+++.... ......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 59999886432 11234589999999999999999999999 9999999999999999999999999999876432
Q ss_pred ----ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc---cc--
Q 045652 470 ----NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV---TD-- 539 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 539 (621)
....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+......... ..
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN----DEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCChhHhhhhh
Confidence 23457889999999976 468999999999999999999999997422 12222222222111000 00
Q ss_pred ---ccccchh-----------cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 ---LLDPEIA-----------SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ---~~d~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+... ...........+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000 000001233578999999999999999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=356.09 Aligned_cols=240 Identities=21% Similarity=0.290 Sum_probs=195.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..|+||||+
T Consensus 27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 3478999999999999954 5899999999743 223356678999999988 6999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 107 NGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999743 3589999999999999999999999 999999999999999999999999999986432
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..++.+ . +..+...
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~---~-i~~~~~~------- 242 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFE---A-ILNDEVV------- 242 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH---H-HHHCCCC-------
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----HHHHHH---H-HHcCCCC-------
Confidence 234568899999999998889999999999999999999999997421 112222 1 2211110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcH------HHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEM------REAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 582 (621)
.+......+.+++.+||+.||++||++ .|+++|
T Consensus 243 ----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 ----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 011233568899999999999999998 788875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=346.72 Aligned_cols=239 Identities=20% Similarity=0.303 Sum_probs=199.4
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 467999999999999964 68999999987432 12356678999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-c
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-N 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~ 470 (621)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 91 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 91 GELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp CBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 9999999743 3589999999999999999999999 9999999999999999999999999999876543 3
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... .... .
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~-~~~~------~----- 222 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILN-AELR------F----- 222 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHH-CCCC------C-----
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-CCCC------C-----
Confidence 4568899999999999999999999999999999999999996421 1122222221 1110 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
+.....++.+++.+||+.||++|| +++|+++|
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112335789999999999999999 89999876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.13 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=196.4
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|...+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 467999999999999988899999999865432 2346788999999999999999999999999999999999975 9
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 86 LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp HHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999987432 4589999999999999999999999 9999999999999999999999999998765432
Q ss_pred ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc--------cc
Q 045652 470 NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT--------DL 540 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 540 (621)
....+|..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+.......... ..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 234568899999999764 58999999999999999999999986421 112222222221111000 00
Q ss_pred cccchhc------CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIAS------STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.++.... ..........+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111000 00012234678999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=349.77 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=207.0
Q ss_pred HHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (621)
.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 105 (313)
T 1t46_A 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (313)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEE
Confidence 4457899999999999984 346899999997543 34567899999999999 899999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC
Q 045652 386 YEYIPGGSLLYLLHGDRGP-------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE 452 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~ 452 (621)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETT
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEcCC
Confidence 9999999999999754321 123589999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchH
Q 045652 453 NEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVV 525 (621)
Q Consensus 453 ~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 525 (621)
+.+||+|||++....... ...++..|+|||++.+..++.++||||||+++|||+| |+.||..... ...
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~-- 256 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSK-- 256 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SHH--
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---hhH--
Confidence 999999999998765432 2345678999999988899999999999999999999 9999864321 111
Q ss_pred HHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 526 EWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 526 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
+......+.. . ......+..+.+++.+||+.||++|||+.|++++|+++....
T Consensus 257 --~~~~~~~~~~-~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 --FYKMIKEGFR-M---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp --HHHHHHHTCC-C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --HHHHhccCCC-C---------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1112221110 0 001223467899999999999999999999999999887643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.66 Aligned_cols=240 Identities=20% Similarity=0.321 Sum_probs=189.8
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh--------------------------hhHHHHHHHHHHHhcCCCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA--------------------------MARDAFDTEVRRLGRLRHSN 368 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~n 368 (621)
.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 46799999999999985 4589999999864321 11356889999999999999
Q ss_pred cccceEEEEe--CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCC
Q 045652 369 VLAPLAYHYR--TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSN 446 (621)
Q Consensus 369 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~N 446 (621)
|+++++++.+ .+..++||||+++++|.+++. ...+++.+++.++.||+.||+|||++ +|+||||||+|
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~N 167 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDIKPSN 167 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGG
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHH
Confidence 9999999987 567899999999999987653 34689999999999999999999999 99999999999
Q ss_pred EEeCCCCCcEEEeeecceecccc----ccccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCcccCCC
Q 045652 447 IFISPENEPLISEFGFYTMINSA----NLAQALFAYKAPEAIQSGK---VTPKCDVYCLGIIILEILTGKFPSQYLTNGN 519 (621)
Q Consensus 447 Ill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 519 (621)
||++.++.+||+|||+++..... ....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---- 243 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE---- 243 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc----
Confidence 99999999999999999876543 2346788999999997655 478899999999999999999998632
Q ss_pred CCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 520 GGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...... ..+...... . + ........+.+++.+||+.||++|||+.|+++|
T Consensus 244 ---~~~~~~-~~~~~~~~~-~--~------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 ---RIMCLH-SKIKSQALE-F--P------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ---SHHHHH-HHHHHCCCC-C--C------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ---cHHHHH-HHHhcccCC-C--C------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111111 111111110 0 0 011233578999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.41 Aligned_cols=243 Identities=21% Similarity=0.333 Sum_probs=195.5
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 467999999999999965 689999999864432 234668899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.. ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 92 LFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp GGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999863 34589999999999999999999999 9999999999999999999999999999865322
Q ss_pred --ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 --NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......+ ..... ...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~----~~~~~---~~~---- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDW----KEKKT---YLN---- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHH----HTTCT---TST----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHH----hcccc---cCC----
Confidence 23467889999999987775 77999999999999999999999743211 1111111 11100 000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
........+.+|+.+||+.||++|||+.|++++-
T Consensus 230 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0123346688999999999999999999999873
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.77 Aligned_cols=248 Identities=17% Similarity=0.280 Sum_probs=198.8
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++||||+
T Consensus 13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~ 92 (345)
T 3a8x_A 13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 92 (345)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence 3467999999999999964 5899999999743 233456688999999988 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 93 NGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999743 3589999999999999999999999 999999999999999999999999999986422
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCC-CcchHHHHHHHhhcCccccccccc
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG-GIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+...+......
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 237 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 237 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------
Confidence 2345688999999999999999999999999999999999999964322111 111122222222222211
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcH------HHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEM------REAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 582 (621)
+ +......+.+++.+||+.||++||++ .|+++|
T Consensus 238 ~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 I-----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp C-----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred C-----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1 12234578999999999999999995 677765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.06 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=206.2
Q ss_pred HHHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|.... +..||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 345789999999999999654 8899999997543 34678899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 95 NLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred cHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999997543 34689999999999999999999999 99999999999999999999999999998765432
Q ss_pred ---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 471 ---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 471 ---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
...++..|+|||++.+..++.++||||||+++|+|++ |..||.... .....+.+ ......
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~----~~~~~~~~----~~~~~~-------- 231 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELL----EKDYRM-------- 231 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHHH----HTTCCC--------
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----hccCCC--------
Confidence 2335667999999998899999999999999999999 999986422 11222222 111100
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
......+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 232 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 01123346789999999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.50 Aligned_cols=247 Identities=21% Similarity=0.375 Sum_probs=196.0
Q ss_pred HHHHcCcCCcccEEEEEEc-CCc----EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGV----TVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|.+. +++ .||+|.++... ....+.+.+|+.++++++||||+++++++.+. ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 3468999999999999853 344 46888886432 34467899999999999999999999999865 47899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999997543 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred cc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 AN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.. ...+|..|+|||++.+..++.++|||||||++|||+| |+.||.... ...+... +..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~----~~~~~~~--- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSI----LEKGERL--- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHH----HHTTCCC---
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC----HHHHHHH----HHcCCCC---
Confidence 31 2334668999999999999999999999999999999 999987422 1222222 2211100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.........+.+++.+||+.||++||++.|++++|+.+..
T Consensus 239 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1112334578999999999999999999999999998865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.75 Aligned_cols=243 Identities=18% Similarity=0.290 Sum_probs=197.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 3578999999999999954 58899999986432 2235678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|..++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 99 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 99 GGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp TEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999743 4589999999999999999999999 9999999999999999999999999999876443
Q ss_pred --ccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 --NLAQALFAYKAPEAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....+|+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+ ..+.....
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~~-~~~~~~~~------- 237 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEIV-HTFETTVV------- 237 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHHH-HHHHHCCC-------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHHH-HHHhhccc-------
Confidence 34568899999999864 4589999999999999999999999974221 1111211 11111110
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCc-HHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLE-MREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 582 (621)
..+......+.+|+.+||+.||++||+ ++++++|
T Consensus 238 ----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 238 ----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 011223467899999999999999998 6776653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=351.41 Aligned_cols=246 Identities=21% Similarity=0.339 Sum_probs=181.7
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.||+|+||.||+|... +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 56999999999999964 5899999998643 3566789999999997 99999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC---CcEEEeeecceecccc--
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN---EPLISEFGFYTMINSA-- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~-- 469 (621)
.+++... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 94 FERIKKK-----KHFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999753 4589999999999999999999999 999999999999998765 7999999999876443
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.............+ +...+..+... . ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~-~-~~~~-- 239 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFS-F-EGEA-- 239 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCC-C-CSHH--
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCC-C-Cccc--
Confidence 234568889999999999999999999999999999999999975432211122222 22222222211 0 0000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......++.+|+.+||+.||++|||+.|+++|
T Consensus 240 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 ---WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ---HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ---ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01234678999999999999999999999866
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=340.03 Aligned_cols=255 Identities=19% Similarity=0.277 Sum_probs=196.5
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 467999999999999964 5899999998643 233457788999999999999999999999999999999999976
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
++.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 666665432 24589999999999999999999999 9999999999999999999999999999876432
Q ss_pred -ccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc---cc---
Q 045652 470 -NLAQALFAYKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD---LL--- 541 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 541 (621)
....+|..|+|||++.+.. ++.++|||||||++|||++|..||... ....+....+........... ..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC---CCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 3345688899999997765 899999999999999999999886532 112222222222221111000 00
Q ss_pred c-------c-chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 542 D-------P-EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 542 d-------~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+ + ........+.....+.+|+.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0 000001112345678999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.00 Aligned_cols=246 Identities=25% Similarity=0.328 Sum_probs=201.6
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+.
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 446799999999999995 568999999986432 2334678899999999999999999999999999999999997
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 138 -g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 208 (348)
T 1u5q_A 138 -GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 208 (348)
T ss_dssp -EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred -CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence 6888887532 24589999999999999999999999 99999999999999999999999999998887777
Q ss_pred cccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 471 LAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...+|+.|+|||++. ...++.++|||||||++|||++|+.||.... ....+........ .. ..
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~~-~~-----~~- 274 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNES-PA-----LQ- 274 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCC-CC-----CC-
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCC-CC-----CC-
Confidence 778899999999984 5678999999999999999999999986421 1222222222111 11 10
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.......+.+++.+||+.||++|||+.+++++..-.
T Consensus 275 ---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 275 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 112235688999999999999999999999875433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.88 Aligned_cols=240 Identities=22% Similarity=0.302 Sum_probs=196.3
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 46799999999999995 568999999986432 122357889999999999999999999999999999999999 7
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++... ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 93 g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 93 GELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 8999988643 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred -ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|+.|+|||++.+..+ ++++|||||||++|+|++|+.||........ .. .+..+.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~----~i~~~~----------- 224 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----FK----KVNSCV----------- 224 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----BC----CCCSSC-----------
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----HH----HHHcCC-----------
Confidence 34457889999999988776 7899999999999999999999974321110 00 000000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
...+......+.+++.+||+.||.+|||++|++++-.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0011223457899999999999999999999998743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.87 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=200.3
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++|+|
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 446799999999999998888899999998543 335789999999999999999999999865 678999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-----
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA----- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----- 469 (621)
.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 266 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 99996422 23589999999999999999999999 9999999999999999999999999999876432
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++|||||||++|||+| |+.||.... ..++.. .+..+...
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~~~~~~----~i~~~~~~---------- 400 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLD----QVERGYRM---------- 400 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHH----HHHTTCCC----------
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHHcCCCC----------
Confidence 22335678999999998899999999999999999999 999986422 112222 22222100
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+...+..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11123446789999999999999999999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.93 Aligned_cols=255 Identities=15% Similarity=0.174 Sum_probs=205.1
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +|+|++++++++......++||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 46799999999999995 569999999986433 234578899999999 7999999999999999999999999 999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC-----cEEEeeecceeccc
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE-----PLISEFGFYTMINS 468 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~a~~~~~ 468 (621)
|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 92 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 92 LEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 999997532 3589999999999999999999998 9999999999999987776 99999999987654
Q ss_pred c-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 469 A-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 469 ~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
. ....+|..|+|||++.+..++.++|||||||++|||++|+.||....... .......+.........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYERIGEKKQSTPL 242 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-HHHHHHHHHHHHHHSCH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-cHHHHHHHHhhccCccH
Confidence 3 23357889999999999999999999999999999999999997533211 11111111111111110
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
+.. ....+..+.+++.+||+.||++||+++++++.|+++......
T Consensus 243 -----~~~-----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 243 -----REL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -----HHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -----HHH-----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 000 012336789999999999999999999999999999876544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=360.37 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=199.7
Q ss_pred HHHHcCcC--CcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNG--GLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+| +||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence 45789999 99999999965 6999999998743 2344677889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+......
T Consensus 109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999997543 24589999999999999999999999 9999999999999999999999999987654221
Q ss_pred -----------ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc--
Q 045652 470 -----------NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-- 534 (621)
Q Consensus 470 -----------~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 534 (621)
....+|..|+|||++.+ ..++.++|||||||++|||++|+.||....... .....+......
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPCLL 258 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT---HHHHC---------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHhcCCCCccc
Confidence 22356788999999987 579999999999999999999999997532211 111110000000
Q ss_pred --------------------Cccccccc--------cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HH
Q 045652 535 --------------------GRVTDLLD--------PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IV 584 (621)
Q Consensus 535 --------------------~~~~~~~d--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~ 584 (621)
....+... ...............+.+|+.+||+.||++|||+.|+++| ++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 00000000 0000001112334679999999999999999999999987 44
Q ss_pred Hhh
Q 045652 585 EIQ 587 (621)
Q Consensus 585 ~i~ 587 (621)
++.
T Consensus 339 ~~~ 341 (389)
T 3gni_B 339 QIK 341 (389)
T ss_dssp GC-
T ss_pred HHh
Confidence 443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=351.93 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=194.7
Q ss_pred HHHHcCcCCcccEEEEEEc--C--CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-CCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMA--D--GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-TDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|... + +..||||.++.. .....+.+.+|+.++++++||||+++++++.. .+..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 3467999999999999853 2 246899998753 33456789999999999999999999998765 4578999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 173 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 173 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999997532 4578999999999999999999999 999999999999999999999999999986533
Q ss_pred c--------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 469 A--------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 469 ~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
. ....++..|+|||++.+..++.++|||||||++|||+| |..||.... ..+....+ ..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~----~~~~~~~~----~~~~~-- 314 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYL----LQGRR-- 314 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----SSCHHHHH----HTTCC--
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC----HHHHHHHH----HcCCC--
Confidence 2 12335567999999998999999999999999999999 666765422 22222222 11111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
... +...+..+.+++.+||+.||++|||+.|++++|+++......
T Consensus 315 ~~~--------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 315 LLQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 011 122335789999999999999999999999999999876544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=349.79 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=184.8
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 3467999999999999965 48899999997543 35678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeecceecccc-
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~- 469 (621)
|.+++... ..+++.+++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 135 L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 135 LFDRIVEK-----GYYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp HHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 99999742 3589999999999999999999999 9999999999999975 889999999999876543
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...+...... ...+
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~i~~~~~~-~~~~---- 273 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRRILNCEYY-FISP---- 273 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHHHHTTCCC-CCTT----
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHHHHhCCCc-cCCc----
Confidence 334578899999999998999999999999999999999999864211 11111222221111 0011
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+|+.+||+.||++|||+.|++++
T Consensus 274 --~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 --WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112334678999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=350.61 Aligned_cols=246 Identities=19% Similarity=0.264 Sum_probs=190.8
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 102 (361)
T 3uc3_A 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102 (361)
T ss_dssp EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCC
Confidence 3467999999999999965 689999999975432 34668899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC--cEEEeeecceeccc---
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE--PLISEFGFYTMINS--- 468 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~--- 468 (621)
|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 103 L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 103 LYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp HHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 99999642 3589999999999999999999999 9999999999999987765 99999999875432
Q ss_pred cccccccccccCcccccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 469 ANLAQALFAYKAPEAIQSGKVTPK-CDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
.....+|+.|+|||++.+..++.+ +|||||||++|||++|+.||...... ......+...... ... .
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~-~~~------~-- 241 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILSV-KYS------I-- 241 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHTT-CCC------C--
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhcC-CCC------C--
Confidence 234568899999999988887665 89999999999999999999753321 1222222222211 100 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.........+.+|+.+||+.||++|||+.|+++|-
T Consensus 242 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 242 -PDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp -CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred -CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 00112235789999999999999999999999884
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=350.29 Aligned_cols=239 Identities=21% Similarity=0.248 Sum_probs=199.4
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999964 68999999986432 12356788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-c
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-N 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~ 470 (621)
|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 126 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 126 GEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 9999999743 3589999999999999999999999 9999999999999999999999999999877543 3
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+ ...+..+... .
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~----~~~i~~~~~~------~----- 257 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQI----YEKIVSGKVR------F----- 257 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH----HHHHHHCCCC------C-----
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC----HHHH----HHHHHcCCCC------C-----
Confidence 4568999999999999999999999999999999999999996421 1111 1222222110 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
+......+.+++.+||+.||++||+ ++|+++|
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1123457899999999999999998 8888876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=355.29 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=190.1
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhc-CCCCCcccceEEEEe----CCeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGR-LRHSNVLAPLAYHYR----TDEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~~~ 390 (621)
+.||+|+||.||+|... +++.||||+++.. ..+.+|++++.+ .+||||+++++++.. ....|+||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 56999999999999854 5899999999642 346688888754 489999999999876 456899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeecceecc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTMIN 467 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 467 (621)
+|+|.+++.... ...+++.++..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 143 gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999997532 24589999999999999999999998 9999999999999997 7889999999998765
Q ss_pred cc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 468 SA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 468 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.. ....+|..|+|||++.+..++.++|||||||++|||++|+.||...............+ ..+... ...+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~-~~~~- 289 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE-FPNP- 289 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC-CCTT-
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc-CCCc-
Confidence 43 33457889999999999999999999999999999999999997533221111122221 111110 0000
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.......++.+|+.+||+.||++|||+.|+++|-.
T Consensus 290 -----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 290 -----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 11233467899999999999999999999999854
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=339.40 Aligned_cols=248 Identities=21% Similarity=0.376 Sum_probs=203.9
Q ss_pred HcCcCCcccEEEEEEc---CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMA---DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++ ..+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 7999999999999853 5788999999864 344567899999999999999999999998 5667899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 96 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 99999643 34589999999999999999999999 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....++..|+|||++.+..++.++||||||+++|||+| |+.||.... ..+.... +..+...
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~~----i~~~~~~------- 232 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEVMAF----IEQGKRM------- 232 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----THHHHHH----HHTTCCC-------
T ss_pred eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----HHHHHHH----HhcCCcC-------
Confidence 12234678999999988889999999999999999998 999986422 1222222 2222111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
..+...+..+.+++.+||+.||++||++.|++++|+.+..+...
T Consensus 233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 01123346799999999999999999999999999999765443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.24 Aligned_cols=268 Identities=19% Similarity=0.286 Sum_probs=209.0
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC--eeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--EKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 467999999999999965 48999999997533 233567889999999999999999999998765 67999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe----CCCCCcEEEeeecceecc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI----SPENEPLISEFGFYTMIN 467 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a~~~~ 467 (621)
|+|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 94 GSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp EEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999997533 123489999999999999999999999 99999999999999 777889999999998775
Q ss_pred ccc---cccccccccCcccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 468 SAN---LAQALFAYKAPEAIQS--------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 468 ~~~---~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
... ...+|..|+|||++.+ ..++.++|||||||++|||++|+.||..........+....+........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 442 3457889999999864 56788999999999999999999999754433322222222222111111
Q ss_pred ccccc---------ccchh-cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 537 VTDLL---------DPEIA-SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 537 ~~~~~---------d~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
+.... ..... ...........+.+++.+||+.||++||++.|+++.++++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 10000 00000 1122356778899999999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=352.46 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=205.5
Q ss_pred HHHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 105 (327)
T 3lxl_A 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM 105 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEE
T ss_pred hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEE
Confidence 3457899999999999983 4588999999987777777889999999999999999999999874 45688999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 106 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 106 EYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp ECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred eecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999997432 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred ccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCC-------CCCcchHHHHHHHh
Q 045652 467 NSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNG-------NGGIDVVEWVASAF 532 (621)
Q Consensus 467 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~-------~~~~~~~~~~~~~~ 532 (621)
... ....++..|+|||++.+..++.++||||||+++|||++|+.||...... .........+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 432 2234567799999999888999999999999999999999998642110 00011111111112
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
..+.. ..........+.+++.+||+.||++|||+.|++++|+.+......
T Consensus 258 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 258 EEGQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred hcccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 11110 111233446789999999999999999999999999998765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.56 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=196.5
Q ss_pred HHHHHHHcCcCCcccEEEEEEc----CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe----
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE---- 381 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 381 (621)
.|.+.+.||+|+||.||+|... ++..||+|+++.. .....+.+.+|+.++++++||||+++++++.+...
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3445678999999999999853 3458999998743 33445778999999999999999999999987653
Q ss_pred -eEEEEeecCCCChhHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 382 -KLLVYEYIPGGSLLYLLHGDRG-PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 382 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
.++||||+++++|.+++..... .....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECTTSCEEECS
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEEee
Confidence 4899999999999999853321 1245699999999999999999999999 999999999999999999999999
Q ss_pred eecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHh
Q 045652 460 FGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAF 532 (621)
Q Consensus 460 fG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 532 (621)
||++...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~~~---- 262 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ----NHEMYDYL---- 262 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHHH----
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC----HHHHHHHH----
Confidence 9999876432 22345678999999999999999999999999999999 888886422 12222221
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
..+.... .....+..+.+++.+||+.||++|||+.+++++|+++....
T Consensus 263 ~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LHGHRLK----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HTTCCCC----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HcCCCCC----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111110 01223357899999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.54 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=202.2
Q ss_pred HHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (621)
.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 4567899999999999985 245689999997542 33456789999999999 899999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCE
Q 045652 386 YEYIPGGSLLYLLHGDRGP------------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNI 447 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI 447 (621)
|||+++|+|.+++...... ....+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NI 203 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNV 203 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGE
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhE
Confidence 9999999999999754321 013489999999999999999999999 999999999999
Q ss_pred EeCCCCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCC
Q 045652 448 FISPENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNG 520 (621)
Q Consensus 448 ll~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~ 520 (621)
|++.++.+||+|||++...... ....+++.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 280 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--- 280 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc---
Confidence 9999999999999999876433 22345678999999988899999999999999999998 9999874321
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
. ..+...+..+... . ........+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 281 ~----~~~~~~~~~~~~~-----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 D----ANFYKLIQNGFKM-----D-----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp S----HHHHHHHHTTCCC-----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred H----HHHHHHHhcCCCC-----C-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 1 1112222222110 0 01223467899999999999999999999999999887643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.66 Aligned_cols=239 Identities=19% Similarity=0.290 Sum_probs=196.3
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999964 58999999997432 22345678899999887 89999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc--
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-- 468 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~-- 468 (621)
+|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 102 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999742 3589999999999999999999999 999999999999999999999999999986432
Q ss_pred --cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 469 --ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 469 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. .+..+.. ..
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~----~i~~~~~------~~- 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFH----SIRMDNP------FY- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHHCCC------CC-
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHHHH----HHHhCCC------CC-
Confidence 234568899999999999999999999999999999999999996421 111222 1211110 01
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHH-HHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMR-EAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 582 (621)
+......+.+++.+||+.||++||++. |+++|
T Consensus 238 ----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 238 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 112335789999999999999999997 77654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=343.59 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=202.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe----CCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 457899999999999995 5699999999876666677889999999999999999999999873 34678999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999874221 134689999999999999999999999 9999999999999999999999999988765321
Q ss_pred -------------ccccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 470 -------------NLAQALFAYKAPEAIQSGK---VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 470 -------------~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||........ ..... ..
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~~ 261 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALA----VQ 261 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHH----HH
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHH----hh
Confidence 1223578899999987554 78999999999999999999999864221111 11111 11
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
... . ..........+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 262 ~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 262 NQL-S---------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred ccC-C---------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 100 0 00112334679999999999999999999999999999875443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=342.64 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=200.8
Q ss_pred HHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 386 (621)
+.+.||+|+||.||+|.+ .+++.||+|+++... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 457899999999999983 458999999997432 33457789999999999999999999999876 5689999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999996432 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred ccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC-------CCCCcchHHHHHHHh
Q 045652 467 NSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN-------GNGGIDVVEWVASAF 532 (621)
Q Consensus 467 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~-------~~~~~~~~~~~~~~~ 532 (621)
... ....++..|+|||++.+..++.++||||||+++|||+||..|+..... ..........+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 543 233466679999999988999999999999999999999988642110 000111111111222
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
..+.. .......+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 257 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 21111 0112234467999999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.65 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=202.1
Q ss_pred HHHcCcCCcccEEEEEEcC-C---cEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCee-EEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMMAD-G---VTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK-LLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~~ 389 (621)
.+.||+|+||.||+|...+ + ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4679999999999998432 2 379999987543 34567889999999999999999999999876665 9999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
.+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 106 CHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999753 34589999999999999999999999 9999999999999999999999999999765332
Q ss_pred --------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 --------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
....++..|+|||.+.+..++.++||||||+++|||++|..|+... ....+....+ ..+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~---~~~~~~~~~~----~~~~~~--- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH---IDPFDLTHFL----AQGRRL--- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCGGGHHHHH----HTTCCC---
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc---CCHHHHHHHh----hcCCCC---
Confidence 2334567899999999999999999999999999999966665421 1122222222 111100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
.........+.+++.+||+.||++|||+.++++.|+++......
T Consensus 248 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 248 -------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 00122335789999999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=344.81 Aligned_cols=240 Identities=19% Similarity=0.297 Sum_probs=189.7
Q ss_pred HHHHcCcCCcccEEEEEE----cCCcEEEEEEccCCC----hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM----ADGVTVVVKRMKESS----AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
+.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 456899999999999986 468999999997542 223456789999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 101 EYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred eCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999743 3588999999999999999999999 9999999999999999999999999998764
Q ss_pred ccc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 467 NSA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 467 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+..... ...
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~-~~~----- 238 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-------RKKTIDKILK-CKL----- 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHH-TCC-----
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHh-CCC-----
Confidence 322 33457889999999998899999999999999999999999997421 1111111111 111
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
.+ +......+.+++.+||+.||++|| ++.|+++|
T Consensus 239 -~~-----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 -NL-----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -CC-----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CC-----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 00 112335789999999999999999 78888876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=344.49 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=195.1
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
+.||+|+||.||+|.. .+++.||||+++.......+.+.+|++++.++ +||||+++++++.+.+..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5699999999999994 56899999999766555577889999999985 799999999999999999999999999999
Q ss_pred hHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC---cEEEeeecceecccc--
Q 045652 395 LYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE---PLISEFGFYTMINSA-- 469 (621)
Q Consensus 395 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~~~-- 469 (621)
.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++......
T Consensus 99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKR-----RHFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999743 3589999999999999999999999 9999999999999998776 999999998765321
Q ss_pred ---------ccccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcch-------HHHH
Q 045652 470 ---------NLAQALFAYKAPEAIQS-----GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV-------VEWV 528 (621)
Q Consensus 470 ---------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~-------~~~~ 528 (621)
....+|..|+|||++.+ ..++.++|||||||++|||++|+.||............ ...+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 12347889999999865 56899999999999999999999999754322111110 1112
Q ss_pred HHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 529 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+..+... ...... ......+.+|+.+||+.||++|||+.|+++|
T Consensus 250 ~~~i~~~~~~-~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 250 FESIQEGKYE-FPDKDW------AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHCCCC-CCHHHH------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhccCcc-cCchhc------ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2222222110 000000 1123578999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.87 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=203.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcE--EEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVT--VVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|.. .++.. ||+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 457899999999999985 45664 499988743 233456788999999999 8999999999999999999999999
Q ss_pred CCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 390 PGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 390 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
++++|.+++..... .....+++.+++.++.||+.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCeEEEc
Confidence 99999999975430 1234689999999999999999999999 99999999999999999999999
Q ss_pred eeecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 459 EFGFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 459 DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+ +...+..
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-------~~~-~~~~~~~ 256 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAE-LYEKLPQ 256 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH-HHHHGGG
T ss_pred ccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-------HHH-HHHHhhc
Confidence 99998754322 23345678999999988889999999999999999998 999986421 111 1222222
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCC
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNM 593 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 593 (621)
+... .........+.+++.+||+.||++|||+.|++++|+++.......
T Consensus 257 ~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 257 GYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp TCCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 2100 011233467899999999999999999999999999998765543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=343.35 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=204.4
Q ss_pred HHHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--CeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--DEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 385 (621)
.+.+.||+|+||.||++.+ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 3457899999999998864 258899999997543 34567799999999999999999999999884 567899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 114 ~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999999642 389999999999999999999999 999999999999999999999999999987
Q ss_pred cccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCC-------CCCcchHHHHHHH
Q 045652 466 INSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNG-------NGGIDVVEWVASA 531 (621)
Q Consensus 466 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~-------~~~~~~~~~~~~~ 531 (621)
.... ....++..|+|||++.+..++.++||||||+++|||+||+.||...... .........+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 7543 2234566799999999888999999999999999999999998642110 0000000011111
Q ss_pred hhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 532 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
...+.. .......+..+.+|+.+||+.||++|||+.|+++.|+.+.+...
T Consensus 264 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 264 LERGER----------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhcccC----------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111110 11122344679999999999999999999999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=339.67 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=199.5
Q ss_pred HHHHcCcCCcccEEEEEEcC----CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|...+ +..||+|.++.. .....+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 45679999999999998543 346999998754 34456789999999999999999999999754 5678999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 9999999997532 3589999999999999999999999 9999999999999999999999999999876443
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....++..|+|||++.+..++.++||||||+++|||+| |+.||.... ..+....+. .+....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~----~~~~~~~~~----~~~~~~---- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDVIGVLE----KGDRLP---- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----GGGHHHHHH----HTCCCC----
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC----hHHHHHHHh----cCCCCC----
Confidence 22345678999999988899999999999999999998 999986422 122222221 111000
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
......+.+.+++.+||+.||++|||+.|++++|+++...
T Consensus 235 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 ------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0112335689999999999999999999999999988653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.75 Aligned_cols=259 Identities=21% Similarity=0.338 Sum_probs=199.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC--CCCCcccceEEEEeC----CeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL--RHSNVLAPLAYHYRT----DEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|... ++.||||++.... ...+.+|.+++..+ +||||+++++++... ...++||||
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 4578999999999999874 8999999986432 33445566666555 899999999999887 678999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL----AHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
+++|+|.++++. ..+++..++.++.|++.||+|||++. ...+|+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 117 HENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp CTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 999999999964 24899999999999999999999751 12379999999999999999999999999997
Q ss_pred eccccc--------cccccccccCcccccCCCCCcc------hhhHHHHHHHHHHHhC----------CCCCCcccCCCC
Q 045652 465 MINSAN--------LAQALFAYKAPEAIQSGKVTPK------CDVYCLGIIILEILTG----------KFPSQYLTNGNG 520 (621)
Q Consensus 465 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~------~DvwSlGvvl~elltg----------~~P~~~~~~~~~ 520 (621)
...... ...+|..|+|||++.+..++.+ +|||||||++|||+|| +.||........
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 764332 3357889999999987766655 9999999999999999 556554322221
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
. ...+......... .+.............++.+++.+||+.||++|||+.|++++|+++.+..
T Consensus 271 ~---~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 271 S---YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp C---HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred c---hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 1 1122222221111 1111111112367788999999999999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.99 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=198.6
Q ss_pred HHHcCcCCcccEEEEEEcC-----CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMMAD-----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.||+|+||.||+|.... +..||||+++.. .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4679999999999998543 246999999754 3344667899999999999999999999999989999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 129 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 129 ENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp TTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 999999999753 24589999999999999999999999 9999999999999999999999999999876432
Q ss_pred c-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 N-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++ ...+..+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~~----~~~~~~~~~~--- 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEV----MKAINDGFRL--- 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH----HHHHHTTCCC---
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC----HHHH----HHHHHCCCcC---
Confidence 1 1234567999999998899999999999999999999 999986421 1111 1222222100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.........+.+++.+||+.||++||++.|++++|+++....
T Consensus 270 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 270 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011233467899999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=337.69 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=192.1
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|... ..||+|+++.. .....+.+.+|++++++++||||+++++++ .....++||||++++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 4578999999999999863 35999998743 344567899999999999999999999965 566789999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 105 SLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 999999643 34589999999999999999999999 9999999999999999999999999998765431
Q ss_pred ---ccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 ---NLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....++..|+|||++. +..++.++||||||+++|||++|+.||..... .+.+......+.......
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~- 248 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSPDLS- 248 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHHHHHHTSCCCCTT-
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcccccCcchh-
Confidence 2345788999999986 56788999999999999999999999974221 112222222222111100
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
......+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 249 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 -----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0112334679999999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.68 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=203.5
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred hheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 3457899999999999998888899999997543 34678899999999999999999999875 556899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc---
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN--- 470 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 470 (621)
|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 94 LVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp HHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred HHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999996321 12589999999999999999999999 99999999999999999999999999998765432
Q ss_pred --cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 471 --LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 471 --~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+... .+..+...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~----~~~~~~~~--------- 229 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQ----NLERGYRM--------- 229 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHH----HHHTTCCC---------
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC----HHHHHH----HHhcccCC---------
Confidence 2334567999999988889999999999999999999 899986421 111111 22211100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.........+.+++.+||+.||++|||+.++++.|+++....
T Consensus 230 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 001223467899999999999999999999999999987643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=371.38 Aligned_cols=246 Identities=21% Similarity=0.377 Sum_probs=200.7
Q ss_pred HcCcCCcccEEEEEEc---CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMA---DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 5999999999999853 46789999998543 3356789999999999999999999999876 56899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc---
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN--- 470 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 470 (621)
|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 99999643 34589999999999999999999999 99999999999999999999999999998764321
Q ss_pred ----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 471 ----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
...+++.|+|||++.+..++.++|||||||++|||+| |+.||.... ..++... +..+...
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~----~~~~~~~----i~~~~~~------- 558 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEVMAF----IEQGKRM------- 558 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----SHHHHHH----HHTTCCC-------
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC----HHHHHHH----HHcCCCC-------
Confidence 1234568999999998899999999999999999998 999997532 2222222 2222211
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
..+..++..+.+|+.+||+.||++||++.++++.|+.+....
T Consensus 559 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 559 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111234467999999999999999999999999999886544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.69 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=202.7
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCCcccceEEEEeCC----eeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGR--LRHSNVLAPLAYHYRTD----EKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~ 388 (621)
+.+.||+|+||.||+|.. +++.||||++... ..+.+.+|++++.. ++||||+++++++.... ..++||||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 347899999999999998 5899999998643 34567788888887 78999999999998876 78999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH--------TELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 122 ~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 122 HEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECTTSCEEECCC
T ss_pred cCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999974 24899999999999999999999 66 9999999999999999999999999
Q ss_pred ecceecccc--------ccccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCccc
Q 045652 461 GFYTMINSA--------NLAQALFAYKAPEAIQSG------KVTPKCDVYCLGIIILEILTG----------KFPSQYLT 516 (621)
Q Consensus 461 G~a~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg----------~~P~~~~~ 516 (621)
|++...... ....++..|+|||++.+. .++.++|||||||++|||+|| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876543 233578899999999765 344789999999999999999 67776433
Q ss_pred CCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.... .. ..+...+..... .+..............+.+|+.+||+.||++|||+.|++++|+++....
T Consensus 272 ~~~~--~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 272 PSDP--SV-EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CSSC--CH-HHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCcc--cH-HHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 2211 11 222222222211 1211111122466778999999999999999999999999999997654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.69 Aligned_cols=258 Identities=20% Similarity=0.293 Sum_probs=198.0
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 457899999999999995 56899999998742 34456778999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999999864211 134589999999999999999999999 9999999999999999999999999998776443
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ....... ..+.........
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~-~~~~~~~~~~~~----- 259 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLC-KKIEQCDYPPLP----- 259 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHHH-HHHHTTCSCCCC-----
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----hhHHHHH-HHhhcccCCCCc-----
Confidence 23457788999999998899999999999999999999999986421 1111221 122222111110
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
.......+.+++.+||+.||++|||+.++++.|+++......
T Consensus 260 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 260 ----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 122345789999999999999999999999999999875443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.94 Aligned_cols=243 Identities=16% Similarity=0.227 Sum_probs=196.5
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 367999999999999964 589999999864221 1223477999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999999742 488999999999999999999999 9999999999999999999999999999876543
Q ss_pred ---ccccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 ---NLAQALFAYKAPEAIQSGK----VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||... ........+......-..
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~----- 294 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLTF----- 294 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHHHCCC-----
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC----ChhhHHHHHHhccccccC-----
Confidence 2456899999999997655 889999999999999999999999742 111222222111100000
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCC--CCcHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQ--RLEMREAVRRI 583 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~L 583 (621)
| .......++.+|+.+||..+|.+ ||+++|+++|-
T Consensus 295 p------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 295 P------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp C------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred C------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0 01123467899999999999988 99999999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=347.39 Aligned_cols=240 Identities=21% Similarity=0.273 Sum_probs=196.9
Q ss_pred HHHHcCcCCcccEEEEEEcC-CcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+... ++.||+|+++... ....+.+.+|..++..+ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 103 (353)
T 2i0e_A 24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 103 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence 34679999999999999654 8899999987432 22356678999999988 7999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 104 NGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999743 3589999999999999999999999 999999999999999999999999999986422
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+ . +...... .
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~---~-i~~~~~~------~ 240 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQ---S-IMEHNVA------Y 240 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH---H-HHHCCCC------C
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----HHHHHH---H-HHhCCCC------C
Confidence 234568899999999999999999999999999999999999996421 111222 1 2111110 0
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
+.....++.+|+.+||+.||++||+ ++|+++|
T Consensus 241 -----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 241 -----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1223467899999999999999995 5788766
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=359.19 Aligned_cols=245 Identities=19% Similarity=0.261 Sum_probs=197.0
Q ss_pred HHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChh---hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.++||+|+||.||+|+... ++.||+|+++..... ..+.+.+|+.++..++||||+++++++.+.+..|+|||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 4679999999999999654 889999998643211 123478999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 159 g~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 159 GDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 9999999753 24589999999999999999999999 9999999999999999999999999999776433
Q ss_pred ---ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 470 ---NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
....||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+....+.........
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~---- 302 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERFQF---- 302 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHHHCCC----
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC----ChhHHHHhhhhccccccC----
Confidence 2246899999999986 567999999999999999999999999742 112222222111110010
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCC--CCcHHHHHHH
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQ--RLEMREAVRR 582 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 582 (621)
| ........++.+|+.+||..+|++ ||+++|+++|
T Consensus 303 -p-----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 -P-----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -C-----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -C-----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1 011123467899999999998888 9999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=336.05 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=198.7
Q ss_pred HHHHcCcCCcccEEEEEEcC----CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-CCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-TDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|...+ ...||+|.++.. .....+.+.+|+.++++++||||+++++++.. .+..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 34679999999999998533 346899998753 33456778999999999999999999998654 4577999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 109 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 109 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred CCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999753 24588999999999999999999999 999999999999999999999999999986643
Q ss_pred c--------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 469 A--------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK-FPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 469 ~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
. ....++..|+|||.+.+..++.++||||||+++|||++|. .||... ...+....+. .+..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~~~~----~~~~-- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYLL----QGRR-- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS----CTTTHHHHHH----TTCC--
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC----CHHHHHHHHh----cCCC--
Confidence 2 2234566799999999889999999999999999999954 454421 1122222211 1110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
... ....+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 251 ~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 LLQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCC--------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000 11223568999999999999999999999999999987543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.30 Aligned_cols=261 Identities=14% Similarity=0.180 Sum_probs=195.8
Q ss_pred HHHHcCcCCcccEEEEEEc----CCcEEEEEEccCCChh-----------hHHHHHHHHHHHhcCCCCCcccceEEEEe-
Q 045652 315 AAEVLGNGGLGSSYKAMMA----DGVTVVVKRMKESSAM-----------ARDAFDTEVRRLGRLRHSNVLAPLAYHYR- 378 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 378 (621)
+.+.||+|+||.||+|... ++..||+|+....... ....+.+|+..++.++||||+++++++..
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 3467999999999999965 5788999998754321 12346678899999999999999999988
Q ss_pred ---CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC--
Q 045652 379 ---TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-- 453 (621)
Q Consensus 379 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-- 453 (621)
....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESSSTT
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccCCCC
Confidence 67789999999 99999999743 2689999999999999999999999 999999999999999887
Q ss_pred CcEEEeeecceecccc-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc
Q 045652 454 EPLISEFGFYTMINSA-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI 522 (621)
Q Consensus 454 ~~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 522 (621)
.+||+|||+++.+... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~ 267 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK---DP 267 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---CH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---cc
Confidence 9999999999876432 233578899999999998999999999999999999999999964211 11
Q ss_pred chHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCC
Q 045652 523 DVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNM 593 (621)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 593 (621)
............. ....+... ......+..+.+++.+||+.||++||++.++++.|+++.......
T Consensus 268 ~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 333 (345)
T 2v62_A 268 VAVQTAKTNLLDE-LPQSVLKW----APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPL 333 (345)
T ss_dssp HHHHHHHHHHHHT-TTHHHHHH----SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCC
T ss_pred HHHHHHHHhhccc-ccHHHHhh----ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCC
Confidence 1111111111111 01100000 000123457999999999999999999999999998776544443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=338.33 Aligned_cols=240 Identities=22% Similarity=0.259 Sum_probs=190.4
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|.+.++||+|+||.||+|... +++.||||++... .......+..|+..+.++ +||||+++++++.+.+..++||||
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~ 138 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEec
Confidence 344578999999999999965 6999999998643 233344555666666555 899999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+ +++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 139 ~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 139 C-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp C-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9 679999887532 3599999999999999999999999 999999999999999999999999999887654
Q ss_pred c---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 A---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
. ....+|+.|+|||++.+ .++.++|||||||++|||++|..|+... +. ...+..+. ..+..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~----~~~~~~~~----~~~~~ 273 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EG----WQQLRQGY----LPPEF 273 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HH----HHHHTTTC----CCHHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cH----HHHHhccC----CCccc
Confidence 3 33457889999999875 7999999999999999999997765421 11 11111111 11111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ......+.+++.+||+.||++|||+.|++++
T Consensus 274 ~-----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 T-----AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp H-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 1223678999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=348.21 Aligned_cols=256 Identities=24% Similarity=0.322 Sum_probs=190.0
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEe--------CCee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYR--------TDEK 382 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------~~~~ 382 (621)
|.+.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++++. ||||+++++++.. ....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 34557899999999999995 468999999987666666778999999999996 9999999999853 3347
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CccCCCCCCCEEeCCCCCcEEEee
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD--LPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
++||||+. |+|.+++.... ....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred EEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEEEecC
Confidence 89999995 79999886422 134599999999999999999999998 7 999999999999999999999999
Q ss_pred ecceeccccc----------------cccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCC
Q 045652 461 GFYTMINSAN----------------LAQALFAYKAPEAI---QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG 521 (621)
Q Consensus 461 G~a~~~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 521 (621)
|+++...... ...++..|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---- 258 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK---- 258 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH----
Confidence 9998764321 23477889999998 566789999999999999999999999864211
Q ss_pred cchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCCCcc
Q 045652 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDAR 596 (621)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~~~ 596 (621)
...+. ..... + ........+.+|+.+||+.||++|||+.|++++|+.+..........
T Consensus 259 ---~~~~~-----~~~~~---~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 259 ---LRIVN-----GKYSI---P------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp ---------------CCC---C------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred ---HHhhc-----CcccC---C------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 00000 00000 0 00111234788999999999999999999999999998765544333
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.14 Aligned_cols=239 Identities=21% Similarity=0.359 Sum_probs=198.5
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999964 699999999864321 2356788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 101 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 101 GELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999964 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred -ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ...+.. .+..+...
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~----~i~~~~~~--------- 234 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH----VPTLFK----KICDGIFY--------- 234 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS----SHHHHH----HHHTTCCC---------
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC----HHHHHH----HHhcCCcC---------
Confidence 34567889999999988765 689999999999999999999997421 112222 22222110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+......+.+++.+||+.||++|||+.|+++|
T Consensus 235 --~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 --TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 011223568999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.99 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=195.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCc----EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGV----TVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|... +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 3467999999999999853 344 38888875332 223345778999999999999999999885 5668999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 96 LPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp CTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred CCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999997532 3588899999999999999999999 999999999999999999999999999987643
Q ss_pred c------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 A------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
. ....++..|+|||++.+..++.++|||||||++|||+| |+.||.... .......+ ..+... .
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~----~~~~~~--~ 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----LAEVPDLL----EKGERL--A 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----TTHHHHHH----HTTCBC--C
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC----HHHHHHHH----HcCCCC--C
Confidence 3 22345678999999998899999999999999999999 999997432 12222222 211110 0
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.+ ......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 238 ~~--------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 238 QP--------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CC--------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CC--------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01 1122357889999999999999999999999998864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=342.49 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=192.7
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe----eEEEEe
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE----KLLVYE 387 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e 387 (621)
.+.||+|+||.||+|.. .+++.||||+++.. .......+.+|++++++++||||+++++++..... .++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 46799999999999995 56899999999754 23345678899999999999999999999876543 389999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.++++.. ..+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 97 ~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 97 YVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp CCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 99999999999743 3589999999999999999999999 99999999999999999999999999998664
Q ss_pred cc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 468 SA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 468 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~-- 238 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPIP-- 238 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCCC--
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCCC--
Confidence 32 22347889999999999999999999999999999999999996421 112222222221110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH-HHHhhc
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR-IVEIQQ 588 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~-L~~i~~ 588 (621)
+... ....+..+.+++.+||+.||++||++.+++++ +.++..
T Consensus 239 --~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 --PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp --HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred --cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1000 01234578999999999999999977666654 555543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.44 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=204.9
Q ss_pred HHHHcCcCCcccEEEEEE-----cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC--eeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-----ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD--EKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 387 (621)
+.+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 457899999999999983 358999999998766666788999999999999999999999987654 6789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 999999999997542 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccc-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccC--------CCCCcchHHHHHHHh
Q 045652 468 SAN-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN--------GNGGIDVVEWVASAF 532 (621)
Q Consensus 468 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~--------~~~~~~~~~~~~~~~ 532 (621)
... ...++..|+|||.+.+..++.++||||||+++|||+||..|+..... ..........+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 432 23355679999999888899999999999999999999988753210 000011111111222
Q ss_pred hcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 533 SEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 533 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+.. .......+.++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 277 ~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 277 KNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11110 011123446799999999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=342.13 Aligned_cols=256 Identities=20% Similarity=0.254 Sum_probs=194.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-----hhhHHHHHHHHHHHhcCC---CCCcccceEEEEeCC-----
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-----AMARDAFDTEVRRLGRLR---HSNVLAPLAYHYRTD----- 380 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~----- 380 (621)
+.+.||+|+||.||+|.. .+++.||||+++... ......+.+|++++++++ ||||+++++++....
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~ 92 (308)
T 3g33_A 13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92 (308)
T ss_dssp EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence 346799999999999994 568999999986321 112345667888777764 999999999998765
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred eEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4789999996 59999997543 23489999999999999999999999 9999999999999999999999999
Q ss_pred ecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 461 GFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 461 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
|+++..... ....+|..|+|||++.+..++.++|||||||++|||++|+.||... ...+....+.........
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN----SEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS----SHHHHHHHHHHHHCCCCT
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCh
Confidence 999766433 3346788999999999999999999999999999999999998642 222222223222211110
Q ss_pred ccc---c---ccchhcC-CC-----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDL---L---DPEIASS-TN-----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~---~---d~~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... . ....... .. .+.....+.+++.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 0 0000000 00 01234678999999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=365.08 Aligned_cols=245 Identities=22% Similarity=0.252 Sum_probs=201.3
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++|++++||||+++++++.+.+..++||||++|
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 367999999999999964 69999999986432 12345678999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 99999997543 23589999999999999999999999 9999999999999999999999999999877543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...+..... .
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~~~------~---- 407 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVPE------E---- 407 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHCCC------C----
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcccc------c----
Confidence 33568899999999998899999999999999999999999997532211 11222222221110 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
.......++.+|+.+||+.||++|| +++|+++|
T Consensus 408 -~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 -YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0122346789999999999999999 78999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.65 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=199.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe---------------
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--------------- 378 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------------- 378 (621)
+.+.||+|+||.||+|... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 3578999999999999965 69999999997543 346789999999999999999998865
Q ss_pred -CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 379 -TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 379 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEE
T ss_pred CcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCCEEE
Confidence 344789999999999999997432 24589999999999999999999999 9999999999999999999999
Q ss_pred Eeeecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 458 SEFGFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 458 ~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+|||++...... ....++..|+|||++.+..++.++||||||+++|||++|..|+... .. ....+..
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~-~~~~~~~ 233 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SK-FFTDLRD 233 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HH-HHHHHHT
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HH-HHHHhhc
Confidence 999999876543 3345788999999999989999999999999999999999886421 11 1111222
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
+... ......+.+++.+||+.||++|||+.|++++|+.+......
T Consensus 234 ~~~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 234 GIIS-------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp TCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cccc-------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1111 11234688999999999999999999999999998765443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=345.59 Aligned_cols=248 Identities=22% Similarity=0.384 Sum_probs=195.2
Q ss_pred HHHHcCcCCcccEEEEEEc-CCc----EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGV----TVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|... +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~ 97 (327)
T 3lzb_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECC
T ss_pred EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEe
Confidence 3468999999999999853 444 4678877543 3345678999999999999999999999998654 7899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999997543 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred c------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 A------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+... +..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~----~~~~~~~----~~~~~~~--- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSI----LEKGERL--- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHH----HHTTCCC---
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC----HHHHHHH----HHcCCCC---
Confidence 2 12334667999999999999999999999999999999 999987422 1222222 2211100
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.........+.+++.+||+.||++||++.|+++.|+++...
T Consensus 239 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 -------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 01122345689999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.60 Aligned_cols=255 Identities=17% Similarity=0.224 Sum_probs=198.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-----CCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-----HSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+..|++++++++ ||||+++++++...+..++||||
T Consensus 39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 117 (360)
T 3llt_A 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117 (360)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence 457899999999999996 56899999999743 344566788999999996 99999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-----------------
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP----------------- 451 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----------------- 451 (621)
+ +++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 118 ~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 118 L-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred C-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccccccccchhcccccc
Confidence 9 899999997543 23589999999999999999999999 9999999999999985
Q ss_pred --------CCCcEEEeeecceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCc
Q 045652 452 --------ENEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGI 522 (621)
Q Consensus 452 --------~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 522 (621)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~ 265 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE----HM 265 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS----HH
T ss_pred cccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc----HH
Confidence 788999999999876543 44567889999999999999999999999999999999999997422 11
Q ss_pred chHHHHHHHhhcC-----------cccccccc-----chhcCCCCH---------------HHHHHHHHHHhhcccCCCC
Q 045652 523 DVVEWVASAFSEG-----------RVTDLLDP-----EIASSTNSP---------------GEMEQLLEIGRACTQSDPE 571 (621)
Q Consensus 523 ~~~~~~~~~~~~~-----------~~~~~~d~-----~~~~~~~~~---------------~~~~~l~~li~~cl~~dP~ 571 (621)
+....+....... .....++. ......... ...+.+.+|+.+||+.||+
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 2222221111100 00000000 000000000 0115678999999999999
Q ss_pred CCCcHHHHHHH
Q 045652 572 QRLEMREAVRR 582 (621)
Q Consensus 572 ~Rps~~evl~~ 582 (621)
+|||++|+++|
T Consensus 346 ~Rpta~elL~h 356 (360)
T 3llt_A 346 LRPSPAELLKH 356 (360)
T ss_dssp GSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=370.40 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=204.3
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 3457899999999999999888899999998544 335789999999999999999999999865 67899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.++++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 348 L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 348 LLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp HHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred HHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999996422 23589999999999999999999999 9999999999999999999999999999876432
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..++.+ .+..+...
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~----~~~~~~----~i~~~~~~--------- 483 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLD----QVERGYRM--------- 483 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC----HHHHHH----HHHTTCCC---------
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHHcCCCC---------
Confidence 22335678999999998899999999999999999999 999986422 112222 22222110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.....+...+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 01123346789999999999999999999999999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.02 Aligned_cols=282 Identities=17% Similarity=0.242 Sum_probs=202.9
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|... +++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 467999999999999965 6899999998743321 12245579999999999999999999999999999999997 59
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 999887532 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---cccccccc-
Q 045652 470 NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---VTDLLDPE- 544 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~- 544 (621)
....+|..|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+........ ........
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS----TVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 23356889999999876 56899999999999999999999999742 22233333333222111 00000000
Q ss_pred hh-----cC------CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhccCCCCCccccCCccccccCCcc
Q 045652 545 IA-----SS------TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQSDGNMDARTSQNILPTLDHGCA 610 (621)
Q Consensus 545 ~~-----~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~~~~~~~~~~~~~~~~~~~~~~ 610 (621)
.. .. ...+.....+.+|+.+||+.||++|||++|+++| +..+...........+......+..+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~q~~ 312 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKE 312 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCCCC-
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHhhhh
Confidence 00 00 0011234578899999999999999999999987 4444443333333333344444444443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.42 Aligned_cols=256 Identities=24% Similarity=0.326 Sum_probs=204.1
Q ss_pred HHHHHcCcCCcccEEEEEE------cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCC-eeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTD-EKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~l 384 (621)
.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+ ..++
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l 109 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence 3457899999999999974 346899999997543 33456789999999999 7999999999988755 4899
Q ss_pred EEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC
Q 045652 385 VYEYIPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~ 453 (621)
||||+++++|.+++...... ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGG
T ss_pred EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCC
Confidence 99999999999999754321 012388999999999999999999999 999999999999999999
Q ss_pred CcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHH
Q 045652 454 EPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 454 ~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 526 (621)
.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||..... ..
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~---- 258 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DE---- 258 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---SH----
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch---hH----
Confidence 9999999999876432 22345678999999998899999999999999999998 9999864221 11
Q ss_pred HHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 527 WVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.+...+..+.... ........+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 259 ~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 259 EFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhccCccCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1112222221110 01123356899999999999999999999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.71 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=198.9
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (277)
T 3f3z_A 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91 (277)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence 34578999999999999964 47899999987655555778999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe---CCCCCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI---SPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~ 469 (621)
+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++......
T Consensus 92 ~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 92 ELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp BHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999988743 3589999999999999999999999 99999999999999 78889999999999876543
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....++..|+|||++.+ .++.++||||||+++|||++|+.||.... .. + +...+..+... . +...
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~---~-~~~~~~~~~~~-~--~~~~ 230 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT----DS---E-VMLKIREGTFT-F--PEKD 230 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HH---H-HHHHHHHCCCC-C--CHHH
T ss_pred cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC----HH---H-HHHHHHhCCCC-C--Cchh
Confidence 33457889999999865 49999999999999999999999986421 11 1 11112221110 0 0000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.||++|||+.|++++
T Consensus 231 ----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 231 ----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00223678999999999999999999999976
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=345.52 Aligned_cols=234 Identities=22% Similarity=0.327 Sum_probs=195.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh--------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA--------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 457899999999999984 5689999999875421 1234567899999999999999999999999999999
Q ss_pred EeecCCC-ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 386 YEYIPGG-SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 386 ~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|||+.+| +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 108 ~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999777 999999743 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecccc---ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 465 MINSA---NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 465 ~~~~~---~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
..... ....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .. ...
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------~~-----~~~ 240 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------TV-----EAA 240 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------GT-----TTC
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------HH-----hhc
Confidence 77543 23457889999999988776 8899999999999999999999864211 00 000
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+ .......+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~-------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 IHP-------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cCC-------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 11123568999999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=360.47 Aligned_cols=241 Identities=21% Similarity=0.269 Sum_probs=190.2
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 3457899999999999985 46899999998743 2233456778999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
++|+|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 231 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 231 NGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp SSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999743 358999999999999999999998 7 899999999999999999999999999976432
Q ss_pred c----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.. .... ....
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~---~i~~-~~~~------ 367 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFE---LILM-EEIR------ 367 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH---HHHH-CCCC------
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHH---HHHh-CCCC------
Confidence 2 34568899999999999999999999999999999999999996421 111111 1111 1110
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
.+......+.+|+.+||+.||++|| +++|+++|
T Consensus 368 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0112335789999999999999999 99999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.81 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=204.0
Q ss_pred HHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 34578999999999999853 37889999997543 344567899999999999999999999999989999999
Q ss_pred eecCCCChhHHhhcCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 387 EYIPGGSLLYLLHGDR-----GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
||+++|+|.+++.... ......+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999986421 01124578999999999999999999999 99999999999999999999999999
Q ss_pred cceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 462 FYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 462 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+++..... ....++..|+|||++.+..++.++||||||+++|||++ |..||.... ..+ +...+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~-~~~~~~~ 255 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQ-VLRFVME 255 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHH-HHHHHHT
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-------HHH-HHHHHHc
Confidence 99866433 22345678999999998899999999999999999999 888886421 111 1222222
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
+.... .....+..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 256 ~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 21111 012334568999999999999999999999999988754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=337.00 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=200.1
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (321)
T 2a2a_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34578999999999999964 589999999864322 13678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC----CcEEEeeec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN----EPLISEFGF 462 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~ 462 (621)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 95 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 95 ELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp CCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999742 4589999999999999999999999 999999999999999888 799999999
Q ss_pred ceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
+...... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... . .+.+.. +.....
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~---~~~~~~-i~~~~~-- 235 (321)
T 2a2a_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----K---QETLAN-ITSVSY-- 235 (321)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----H---HHHHHH-HHTTCC--
T ss_pred ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC----H---HHHHHH-HHhccc--
Confidence 9876543 33457889999999998999999999999999999999999986421 1 111111 111110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..++... ......+.+++.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 DFDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111111 1123568999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.99 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=201.0
Q ss_pred HHHHcCcCCcccEEEEEE------cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 456799999999999983 34778999999744 34456678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeec
Q 045652 388 YIPGGSLLYLLHGDRGP--SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGF 462 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~ 462 (621)
|+++++|.+++...... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+|||+
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 99999999999764321 224589999999999999999999999 9999999999999994 44699999999
Q ss_pred ceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 463 YTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 463 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
+...... ....++..|+|||++.+..++.++||||||+++|||+| |+.||.... .....+ .+..+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~----~~~~~ 261 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQEVLE----FVTSG 261 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHH----HHHTT
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC----HHHHHH----HHhcC
Confidence 8755322 23445778999999988899999999999999999998 999986421 111222 22221
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
.... ........+.+++.+||+.||++||++.|++++|+.+....
T Consensus 262 ~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 GRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1110 01223457899999999999999999999999999887643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=372.01 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=198.6
Q ss_pred HHcCcCCcccEEEEEEc---CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA---DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|+++|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 46999999999999643 46789999997532 334678999999999999999999999986 4568899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999743 4589999999999999999999999 9999999999999999999999999999876432
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+ +...+..+....
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~----~~~----~~~~i~~~~~~~---- 592 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSE----VTAMLEKGERMG---- 592 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHH----HHHHHHTTCCCC----
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----HHH----HHHHHHcCCCCC----
Confidence 12234577999999998899999999999999999998 999997422 111 222222222111
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.+...+.++.+|+.+||+.||++||++.++++.|+++..
T Consensus 593 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 ------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112334678999999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=335.97 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=195.4
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 3467999999999999964 68999999987542 3335778999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 118 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 118 GVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999743 3589999999999999999999999 9999999999999999999999999998766443
Q ss_pred ----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ...+...+..... .+..
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~----~~~~ 256 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ--------LSVMGAHINQAIP----RPST 256 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH--------HHHHHHHHHSCCC----CGGG
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch--------HHHHHHHhccCCC----Cccc
Confidence 23457888999999998899999999999999999999999986421 1122222221110 0000
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCC-cHHHHHHHHHHhhccCC
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRL-EMREAVRRIVEIQQSDG 591 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~~~~~ 591 (621)
..+..+..+.+++.+||+.||++|| +++++++.|++......
T Consensus 257 ----~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 257 ----VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ----TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ----cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0122335688999999999999999 99999999998765543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=336.42 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=195.9
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-CeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-DEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||++.. +|+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||++++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 3457899999999999987 58899999997543 456789999999999999999999997654 4689999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-cc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NL 471 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~ 471 (621)
+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 101 ~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 173 (278)
T 1byg_A 101 SLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173 (278)
T ss_dssp EHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeeccccccccccccC
Confidence 9999997432 12378899999999999999999999 9999999999999999999999999998766443 33
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
..++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+... .+..+.. + ..
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~~~~~----~~~~~~~-----~-----~~ 235 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVP----RVEKGYK-----M-----DA 235 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----GGGHHH----HHTTTCC-----C-----CC
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHhcCCC-----C-----CC
Confidence 456778999999988899999999999999999998 999986421 112222 1222111 0 01
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
....+..+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1233467899999999999999999999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=332.77 Aligned_cols=255 Identities=16% Similarity=0.215 Sum_probs=202.3
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEE-EeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH-YRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|++++++++|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46799999999999995 6799999999865432 34588999999999998877777666 4566789999999 899
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe---CCCCCcEEEeeecceecccc-
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI---SPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~- 469 (621)
|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999997432 3589999999999999999999999 99999999999999 48889999999999876543
Q ss_pred ----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 470 ----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 470 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||......... .....+.........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTPI-- 239 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHSCH--
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-hhhhhhcccccCCch--
Confidence 2345788899999999999999999999999999999999999864332222 222222111111000
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
+.. ....+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 240 ---~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 ---EVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ---HHH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ---HHH-----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 000 012235689999999999999999999999999999876554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.58 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=190.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv 385 (621)
+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 457899999999999985 45899999999753 334567788999999999999999999999654 356999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+++ +|.+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 146 ~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 146 MELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999975 5777664 2388999999999999999999999 999999999999999999999999999987
Q ss_pred cccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc------
Q 045652 466 INSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR------ 536 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------ 536 (621)
.... ....+|+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+....+...+....
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~----~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHHHHTT
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCHHHHHH
Confidence 6543 33567889999999999999999999999999999999999996421 1222222211111000
Q ss_pred --------------cccccccchh----cCCC---CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 --------------VTDLLDPEIA----SSTN---SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 --------------~~~~~d~~~~----~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.....-+... .... ......++.+|+.+||+.||++|||++|+++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000 01225679999999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.42 Aligned_cols=243 Identities=19% Similarity=0.337 Sum_probs=192.9
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCC--CCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRH--SNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++| |||+++++++...+..++|||+ .
T Consensus 13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~ 91 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 91 (343)
T ss_dssp EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-C
T ss_pred EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-C
Confidence 34679999999999999888999999998643 34455778999999999986 9999999999999999999995 5
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 92 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 92 NIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp SEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 88999999753 3589999999999999999999999 999999999999997 678999999999876433
Q ss_pred -----ccccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 470 -----NLAQALFAYKAPEAIQS-----------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +....+.....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~ 235 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIID 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHHHhc
Confidence 23457899999999864 678999999999999999999999996421 11222222221
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
...... . +......+.+++.+||+.||++|||+.|+++|..
T Consensus 236 ~~~~~~-----~-----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 236 PNHEIE-----F-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp TTSCCC-----C-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCcccC-----C-----cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 111000 0 1112246889999999999999999999998853
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=334.15 Aligned_cols=256 Identities=16% Similarity=0.210 Sum_probs=201.8
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEE-EeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH-YRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|++++++++|++++..+.++ ...+..++||||+ ++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 346799999999999995 5689999998754322 24578899999999998888877766 5567789999999 99
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe---CCCCCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI---SPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~ 469 (621)
+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 90 ~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 90 SLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999997432 3589999999999999999999999 99999999999999 78899999999999876443
Q ss_pred -----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 470 -----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 470 -----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
....++..|+|||++.+..++.++|||||||++|||++|+.||...................... ..
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~- 239 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH-
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hh-
Confidence 23457889999999999999999999999999999999999998644332222222211111111 00
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
+.. ....+..+.+++.+||+.||++|||+.++++.|+++....+.
T Consensus 240 ----~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 240 ----EVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ----hhh-----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 000 011235789999999999999999999999999999876554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.07 Aligned_cols=246 Identities=13% Similarity=0.167 Sum_probs=199.3
Q ss_pred HHHHcCcCCcccEEEEE------EcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC---CCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAM------MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR---HSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||+|. ..+++.||||+++... ...+.+|++++++++ |+||+++++++...+..++|
T Consensus 69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 34679999999999993 4568999999997654 456778888888886 99999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-----------CCC
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-----------ENE 454 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----------~~~ 454 (621)
|||+++|+|.+++..........+++..++.|+.||+.||+|||++ +|+||||||+|||++. ++.
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999753332345699999999999999999999998 9999999999999998 899
Q ss_pred cEEEeeecceeccc------cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHH
Q 045652 455 PLISEFGFYTMINS------ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWV 528 (621)
Q Consensus 455 ~kl~DfG~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 528 (621)
+||+|||+++.+.. .....+|..|+|||++.+..++.++|||||||++|||+||+.||....... .
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~------ 293 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--C------ 293 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--E------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--e------
Confidence 99999999976531 133457899999999999999999999999999999999999986432210 0
Q ss_pred HHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCC-CcHHHHHHHHHHhhccC
Q 045652 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR-LEMREAVRRIVEIQQSD 590 (621)
Q Consensus 529 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~evl~~L~~i~~~~ 590 (621)
..... .... ...+.+.+++..|++.+|.+| |+++++.+.|+++....
T Consensus 294 -------~~~~~----~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -------KPEGL----FRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------EECSC----CTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------eechh----cccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00000 1111 123457788999999999999 57888888888876653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.94 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=194.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-----SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 457899999999999985 45889999998643 234467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccC
Q 045652 389 IPGGSLLYLLHGDRGP-----------------------------------SHDELTWPARLKIVQGIARGIGYLHTELA 433 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 433 (621)
+++|+|.+++...... ....+++..++.++.||+.||+|||+.
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 187 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 9999999998521100 011235677889999999999999999
Q ss_pred CCCCccCCCCCCCEEeCCCC--CcEEEeeecceecccc--------ccccccccccCcccccC--CCCCcchhhHHHHHH
Q 045652 434 HLDLPHGNLKSSNIFISPEN--EPLISEFGFYTMINSA--------NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGII 501 (621)
Q Consensus 434 ~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~--------~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvv 501 (621)
+|+||||||+||+++.++ .+||+|||+++.+... ....+|+.|+|||++.+ ..++.++|||||||+
T Consensus 188 --~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp --TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred --CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 999999999999998776 8999999999876431 23457889999999965 678999999999999
Q ss_pred HHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHH
Q 045652 502 ILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581 (621)
Q Consensus 502 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 581 (621)
+|||++|+.||.... ..+.+......... ...+. .......+.+++.+||+.||++||++.|+++
T Consensus 266 l~el~~g~~pf~~~~-------~~~~~~~~~~~~~~--~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 266 LHLLLMGAVPFPGVN-------DADTISQVLNKKLC--FENPN------YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSSCSSCCSS-------HHHHHHHHHHCCCC--TTSGG------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCCCC-------hHHHHHHHHhcccc--cCCcc------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999986422 11222222221110 11111 1123467899999999999999999999998
Q ss_pred H
Q 045652 582 R 582 (621)
Q Consensus 582 ~ 582 (621)
+
T Consensus 331 h 331 (345)
T 3hko_A 331 H 331 (345)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=354.32 Aligned_cols=244 Identities=20% Similarity=0.231 Sum_probs=195.1
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|+. .+|+.||||++++... ...+.+.+|..++.+++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 36799999999999996 4699999999964321 1234578999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN- 470 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 470 (621)
|+|.+++.+.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999997432 3589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ----cccccccccCccccc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 471 ----LAQALFAYKAPEAIQ-------SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 471 ----~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
...||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~~--- 290 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS----TAETYGKIVHYKEHLS--- 290 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTHHHHCC---
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccCcC---
Confidence 346899999999987 4578999999999999999999999996421 1122222211100000
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCC---CcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQR---LEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~ 582 (621)
.|.. ....+.++.+|+.+||. +|++| |+++|+++|
T Consensus 291 --~p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 --LPLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --CC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --CCcc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0100 12234678999999999 99998 589999877
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=333.79 Aligned_cols=244 Identities=18% Similarity=0.299 Sum_probs=198.7
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 467999999999999854 5899999998643 3344577889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC---cEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE---PLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~~~ 469 (621)
+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 91 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 91 ELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp BHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999888643 3589999999999999999999999 9999999999999987665 999999999876544
Q ss_pred c---cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 N---LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ~---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
. ...++..|+|||++.+..++.++||||||+++|+|++|+.||.... ...... .+..+... ...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~----~~~~~~~~-~~~~--- 229 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYA----QIKAGAYD-YPSP--- 229 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHHTCCC-CCTT---
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----hhHHHH----HHHhcccc-CCch---
Confidence 2 3467889999999999999999999999999999999999986421 111111 11111111 0000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
........+.+++.+||+.||++|||+.|++++-
T Consensus 230 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 230 ---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred ---hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 0122346789999999999999999999999873
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.51 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=186.4
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCC--eeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTD--EKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~ 389 (621)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++++. ||||+++++++...+ ..|+|||||
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46799999999999985 56899999998643 3445667889999999997 999999999998654 689999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
+ ++|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 ~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 94 E-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp S-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred C-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7 599999874 3588999999999999999999999 9999999999999999999999999999865321
Q ss_pred -------------------------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcc
Q 045652 470 -------------------------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGID 523 (621)
Q Consensus 470 -------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 523 (621)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~ 238 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS----STMN 238 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC----CHHH
Confidence 22357888999999976 67999999999999999999999999742 1222
Q ss_pred hHHHHHHHhhcCcc-----------------------------ccccc---cchhcCCCCHHHHHHHHHHHhhcccCCCC
Q 045652 524 VVEWVASAFSEGRV-----------------------------TDLLD---PEIASSTNSPGEMEQLLEIGRACTQSDPE 571 (621)
Q Consensus 524 ~~~~~~~~~~~~~~-----------------------------~~~~d---~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 571 (621)
....+...+..... ...+. .............+++.+|+.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 22222211111000 00000 00000000012245789999999999999
Q ss_pred CCCcHHHHHHH
Q 045652 572 QRLEMREAVRR 582 (621)
Q Consensus 572 ~Rps~~evl~~ 582 (621)
+|||++|+++|
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999988
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=332.53 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=193.1
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred eecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence 3457899999999999995 458999999986442 33467889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe---CCCCCcEEEeeecceeccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI---SPENEPLISEFGFYTMINS 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~ 468 (621)
|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.....
T Consensus 105 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 105 GELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999998853211 124689999999999999999999999 99999999999999 4567899999999977643
Q ss_pred c---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 A---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
. ....++..|+|||++. ..++.++||||||+++|||++|+.||.... ..+....... .......
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-------~~~~~~~~~~-~~~~~~~---- 246 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-------LEEVQQKATY-KEPNYAV---- 246 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHH-CCCCCCC----
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-------HHHHHhhhcc-CCccccc----
Confidence 3 3445788999999986 578999999999999999999999986421 1111111111 1100000
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......+.+.+++.+||+.||++|||+.|++++
T Consensus 247 ----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 ----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001123568899999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.26 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=195.3
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 467999999999999854 47899999986432 12356788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 94 GTVYRELQKL-----SKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp EEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 9999999743 3589999999999999999999998 9999999999999999999999999998665432
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+... .+..... .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~----~~~~~~~-----------~ 225 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYK----RISRVEF-----------T 225 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHH----HHHHTCC-----------C
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHHHHH----HHHhCCC-----------C
Confidence 33467889999999999999999999999999999999999986421 111111 1111110 0
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.+......+.+++.+||+.||++|||+.|+++|-
T Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0112335688999999999999999999999884
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.70 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=197.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 4578999999999999964 689999999986555556678999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe---CCCCCcEEEeeecceecccc-
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI---SPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~- 469 (621)
|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 93 LFDRILER-----GVYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp HHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 99998643 3588999999999999999999999 99999999999999 78889999999998765443
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... .....+ .+..+... . ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~----~i~~~~~~-~-~~----- 228 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET----ESKLFE----KIKEGYYE-F-ES----- 228 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHH----HHHHCCCC-C-CT-----
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHH----HHHcCCCC-C-Cc-----
Confidence 23457889999999999999999999999999999999999986421 111111 22222110 0 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
......+..+.+++.+||+.||++|||+.|++++-
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 01123346789999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=336.01 Aligned_cols=244 Identities=21% Similarity=0.349 Sum_probs=198.3
Q ss_pred HcCcCCcccEEEEEE---cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 318 VLGNGGLGSSYKAMM---ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999964 346899999997542 23367799999999999999999999998 667789999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-- 470 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 470 (621)
+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 103 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999753 3589999999999999999999999 99999999999999999999999999998764432
Q ss_pred -----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 471 -----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 471 -----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+ +...+..+....
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~----~~~~~~~~~~~~----- 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSE----VTAMLEKGERMG----- 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHH----HHHHHHTTCCCC-----
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC----HHH----HHHHHHcCCCCC-----
Confidence 1234577999999988889999999999999999999 999987422 111 222222221111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.....+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 241 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 241 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1123346799999999999999999999999999988654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.09 Aligned_cols=240 Identities=20% Similarity=0.302 Sum_probs=178.3
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46799999999999996 5689999999864321 2246788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 96 GEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999743 24589999999999999999999999 9999999999999999999999999999876432
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ..... . .. ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~---~~~~~-~---~~---~~--- 230 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK----NT---LNKVV-L---AD---YE--- 230 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC-S---SC---CC---
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH----HH---HHHHh-h---cc---cC---
Confidence 2345788999999999888999999999999999999999998743211 00 00000 0 00 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+.....++.+++.+||+.||++|||+.+++++
T Consensus 231 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 231 --MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 011233578899999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=341.82 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=194.9
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 467999999999999964 48999999886443 334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 88 VLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp HHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred hHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999988643 3589999999999999999999999 9999999999999999999999999999876533
Q ss_pred -ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc-----------Cc
Q 045652 470 -NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-----------GR 536 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 536 (621)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ..+....+...... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS----DVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhccccccccccccccc
Confidence 23457888999999876 568999999999999999999999986422 11222222111110 00
Q ss_pred cc---cccccchhcC--CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VT---DLLDPEIASS--TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~---~~~d~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ...++..... ...+.....+.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000000000 0002234568999999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.11 Aligned_cols=241 Identities=22% Similarity=0.369 Sum_probs=193.4
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe----CCeeEEEEee
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVYEY 388 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 388 (621)
.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 35699999999999985 45889999998643 34456788999999999999999999999876 3457899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CccCCCCCCCEEeC-CCCCcEEEeeeccee
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD--LPHGNLKSSNIFIS-PENEPLISEFGFYTM 465 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~ 465 (621)
+++++|.+++... ..+++..++.++.|++.||.|||+. + |+||||||+||+++ .++.+||+|||++..
T Consensus 111 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 111 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999742 4588999999999999999999998 7 99999999999998 789999999999976
Q ss_pred cccc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 466 INSA--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 466 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.... ....++..|+|||++. ..++.++|||||||++|+|++|+.||.... .... +......+.....
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~-~~~~~~~~~~~~~--- 250 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQ-IYRRVTSGVKPAS--- 250 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHH-HHHHHTTTCCCGG---
T ss_pred ccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC------cHHH-HHHHHhccCCccc---
Confidence 5433 3345788999999886 469999999999999999999999986421 1111 1222222211111
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ....+.+.+++.+||+.||++|||+.|+++|
T Consensus 251 -~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 -FD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GG-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cC-----CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 1112568999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.69 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=196.0
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.+.||+|+||.||+|... +++.||||+++.... ...+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 25 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 34578999999999999964 589999999975432 235688888888 799999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-C---CcEEEeeecceecc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-N---EPLISEFGFYTMIN 467 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~---~~kl~DfG~a~~~~ 467 (621)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+..+ + .+||+|||+++...
T Consensus 101 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 101 GELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999743 3589999999999999999999999 99999999999998543 3 49999999998764
Q ss_pred cc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 468 SA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 468 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
.. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... +....+...+..+.... .
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~~~--~- 243 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKFSL--S- 243 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCCCC--C-
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCccc--C-
Confidence 43 234568899999999888899999999999999999999999974211 11122222233222110 0
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
...+......+.+|+.+||+.||++|||+.|+++|-.
T Consensus 244 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 244 ----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp ----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 0011234467899999999999999999999998743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=347.48 Aligned_cols=242 Identities=19% Similarity=0.337 Sum_probs=193.3
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCC--CCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLR--HSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 45789999999999999878999999998643 3445678999999999996 5999999999999999999999 56
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++.++..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+...
T Consensus 139 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 139 NIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp SEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 88999999753 3588899999999999999999999 999999999999996 588999999999876432
Q ss_pred -----ccccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 470 -----NLAQALFAYKAPEAIQS-----------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +....+.....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~~ 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIID 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHhC
Confidence 23458899999999865 368999999999999999999999996421 11222222221
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
...... . +......+.+|+.+||+.||++|||+.|++++-
T Consensus 283 ~~~~~~-----~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 283 PNHEIE-----F-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp TTSCCC-----C-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccccCC-----C-----CccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 111000 0 011135688999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.37 Aligned_cols=242 Identities=25% Similarity=0.349 Sum_probs=197.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||+|+++.. .......+.+|+..+.++ +||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 4578999999999999965 6999999998753 233456788999999999 89999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC------------------
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE------------------ 452 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~------------------ 452 (621)
+++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 95 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 95 GGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp TCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC--------------------
T ss_pred CCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999974321 124589999999999999999999999 99999999999999844
Q ss_pred -CCcEEEeeecceeccccccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHH
Q 045652 453 -NEPLISEFGFYTMINSANLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVAS 530 (621)
Q Consensus 453 -~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 530 (621)
..+||+|||.+..........++..|+|||++.+. .++.++|||||||++|||++|..|+... +...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~---- 238 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-------DQWH---- 238 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------HHHH----
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------hHHH----
Confidence 47999999999988777777789999999999765 5678999999999999999998775421 1111
Q ss_pred HhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+..+.... . .......+.+++.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~-----~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 EIRQGRLPR-----I-----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHTTCCCC-----C-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHcCCCCC-----C-----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 112222111 1 11233578999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.02 Aligned_cols=238 Identities=21% Similarity=0.336 Sum_probs=185.5
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHH-HhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRR-LGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|..+ ++.++||||+++++++.+.+..|+||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 4578999999999999964 58899999997542 2233456677776 57789999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 122 NGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999743 3588999999999999999999999 999999999999999999999999999976422
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... .... +
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~-~~~~------~ 258 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILN-KPLQ------L 258 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-------HHHHHHHHHH-SCCC------C
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHh-cccC------C
Confidence 234568899999999999999999999999999999999999996421 1122222221 1110 0
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAV 580 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 580 (621)
.+.....+.+|+.+||+.||++||++.+.+
T Consensus 259 -----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 -----KPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -----CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 112335689999999999999999985433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.13 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=196.0
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++++. ||||+++++++.+.+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 67999999999999854 58999999987532 234677899999999995 699999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~ 469 (621)
+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999986432 35689999999999999999999999 9999999999999998 789999999999877543
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+. ..... . .
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~----~~~~~-~-~---- 253 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED----NQETYLNIS----QVNVD-Y-S---- 253 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH----HTCCC-C-C----
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHHH----hcccc-c-C----
Confidence 23457889999999999999999999999999999999999986421 111111111 11100 0 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..........+.+++.+||+.||++|||++|++++
T Consensus 254 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 -EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 01112334678999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.27 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=196.1
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
..||+|+||.||+|.. .+++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 3699999999999995 568899999998666556778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecceecccc----c
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFYTMINSA----N 470 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~----~ 470 (621)
+++.... ....+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++...... .
T Consensus 108 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 108 ALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 9997543 234567889999999999999999999 9999999999999987 899999999999876432 3
Q ss_pred cccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 LAQALFAYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...++..|+|||++.+.. ++.++||||||+++|||++|+.||..... ............ ..+.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~------~~~~~--- 247 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQAAMFKVGMFK------VHPEI--- 247 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHHHHHHHHHHC------CCCCC---
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhHHHHhhcccc------ccccc---
Confidence 345788999999987643 88999999999999999999999864221 011111111100 01111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.||++||++.|++++
T Consensus 248 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 --PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12334678999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.85 Aligned_cols=258 Identities=16% Similarity=0.180 Sum_probs=202.3
Q ss_pred HHHHcCcCCcccEEEEEEcC---------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCccc--------------
Q 045652 315 AAEVLGNGGLGSSYKAMMAD---------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLA-------------- 371 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 371 (621)
+.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 34679999999999999653 789999998754 35779999999999999887
Q ss_pred -ceEEEEe-CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe
Q 045652 372 -PLAYHYR-TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI 449 (621)
Q Consensus 372 -l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll 449 (621)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENIFV 192 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEE
Confidence 6778776 67789999999 999999997542 24689999999999999999999999 99999999999999
Q ss_pred CCCC--CcEEEeeecceecccc-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCccc
Q 045652 450 SPEN--EPLISEFGFYTMINSA-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLT 516 (621)
Q Consensus 450 ~~~~--~~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 516 (621)
+.++ .+||+|||+++.+... ....++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999776432 22357889999999999899999999999999999999999997532
Q ss_pred CCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCCC
Q 045652 517 NGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNM 593 (621)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 593 (621)
. ....+.... ..+... ...+.+... .....+..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 273 ~--~~~~~~~~~-~~~~~~-~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 273 P--NTEDIMKQK-QKFVDK-PGPFVGPCG----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp T--CHHHHHHHH-HHHHHS-CCCEECTTS----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred c--CHHHHHHHH-HhccCC-hhhhhhhcc----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 1 111122221 111111 111111100 00122367999999999999999999999999999998776544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=359.58 Aligned_cols=246 Identities=18% Similarity=0.271 Sum_probs=199.4
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+....|+||||++||
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 46999999999999964 599999999964321 23467889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 99999975431 234689999999999999999999999 9999999999999999999999999999876543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+...+.....
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~---~~~-~~~~~~i~~~~~----------- 410 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VEN-KELKQRVLEQAV----------- 410 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC---CCH-HHHHHHHHHCCC-----------
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc---hhH-HHHHHHHhhccc-----------
Confidence 2246889999999999999999999999999999999999999753211 111 112222221111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcH-----HHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEM-----REAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 582 (621)
..+......+.+|+.+||+.||++||++ .++++|
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 0012234678999999999999999964 677754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.19 Aligned_cols=238 Identities=18% Similarity=0.195 Sum_probs=185.9
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccC---CChhhHHHHHHHH---HHHhcCCCCCcccce-------EEEEeCCe
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKE---SSAMARDAFDTEV---RRLGRLRHSNVLAPL-------AYHYRTDE 381 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~~~~ 381 (621)
.+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+ +++++++||||++++ +++.+.+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46799999999999994 5699999999863 2334567899999 555566899999998 77665532
Q ss_pred -----------------eEEEEeecCCCChhHHhhcCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCC
Q 045652 382 -----------------KLLVYEYIPGGSLLYLLHGDRGPS--HDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNL 442 (621)
Q Consensus 382 -----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dl 442 (621)
.++||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||++ +|+||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDi 232 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL 232 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence 78999999 689999997532111 12345688889999999999999999 9999999
Q ss_pred CCCCEEeCCCCCcEEEeeecceecccc-ccccccccccCcccccCC-----------CCCcchhhHHHHHHHHHHHhCCC
Q 045652 443 KSSNIFISPENEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSG-----------KVTPKCDVYCLGIIILEILTGKF 510 (621)
Q Consensus 443 kp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwSlGvvl~elltg~~ 510 (621)
||+|||++.++.+||+|||+++..... ....+ ..|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 999999999999999999999876543 23345 889999999877 89999999999999999999999
Q ss_pred CCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 511 PSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 511 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
||....... .... ... . ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 312 Pf~~~~~~~----~~~~------------~~~----~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 312 PITKDAALG----GSEW------------IFR----S---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp CC------C----CSGG------------GGS----S---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred CCccccccc----chhh------------hhh----h---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 986432111 0000 000 0 01223568999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=340.80 Aligned_cols=254 Identities=19% Similarity=0.251 Sum_probs=188.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 116 (329)
T 3gbz_A 38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE- 116 (329)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-
Confidence 457899999999999984 4689999999975432 234567899999999999999999999999999999999997
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC-----CCCCcEEEeeecceec
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS-----PENEPLISEFGFYTMI 466 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DfG~a~~~ 466 (621)
|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 117 ~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 117 NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 5999999743 3589999999999999999999999 999999999999994 4455999999999776
Q ss_pred ccc----ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc-
Q 045652 467 NSA----NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL- 540 (621)
Q Consensus 467 ~~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 540 (621)
... ....+|..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+............
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS----EIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTTST
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC----HHHHHHHHHHHhCCCchhhhh
Confidence 432 234568889999999874 48999999999999999999999986421 11222222221111000000
Q ss_pred --c-----ccchhcC-CC------CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 --L-----DPEIASS-TN------SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 --~-----d~~~~~~-~~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ....... .. ......++.+|+.+||+.||++|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 0000000 00 01123678999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=354.84 Aligned_cols=185 Identities=22% Similarity=0.323 Sum_probs=149.0
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----CeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-----DEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 385 (621)
.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++|++++||||+++++++... ...|+|
T Consensus 56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence 3457899999999999985 46899999998643 334567789999999999999999999998543 468999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 136 ~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 136 LEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp ECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred Eecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9998 5799999974 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cccc-------------------------------ccccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhC
Q 045652 466 INSA-------------------------------NLAQALFAYKAPEAI-QSGKVTPKCDVYCLGIIILEILTG 508 (621)
Q Consensus 466 ~~~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg 508 (621)
.... ....+|+.|+|||++ ....|+.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6421 123468889999986 456799999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.85 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=197.8
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 467999999999999964 6899999998754 34456789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc--cc
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS--AN 470 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~--~~ 470 (621)
|.+++... ..+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++..... ..
T Consensus 118 L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 118 LDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp HHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHH----CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhC----CEEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 99999743 358899999999999999999998 4 799999999999999999999999999876532 23
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC---------------
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG--------------- 535 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------------- 535 (621)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ............+
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA-----KELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH-----HHHHHHHC--------------------
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhcccccccCCCCCCCcccCCCc
Confidence 45678899999999999999999999999999999999999974221 0000000000000
Q ss_pred ------------ccccccccch---hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 536 ------------RVTDLLDPEI---ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 536 ------------~~~~~~d~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
...+..+... ............+.+|+.+||+.||++|||++|+++|-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0000000000 00001112345789999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.15 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=202.3
Q ss_pred HHHHcCcCCcccEEEEEEcC-C-----cEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMAD-G-----VTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 386 (621)
+.+.||+|+||.||+|.... + +.||+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 45789999999999998532 2 489999997543 34567799999999999 8999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 387 EYIPGGSLLYLLHGDRG---------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
||+++|+|.+++..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEEEGGGEEEB
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEECCCCeEEE
Confidence 99999999999864310 0124589999999999999999999999 9999999999999999999999
Q ss_pred Eeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHH
Q 045652 458 SEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVAS 530 (621)
Q Consensus 458 ~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 530 (621)
+|||++...... ....++..|+|||++.+..++.++|||||||++|||+| |..||..... . ..+..
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~----~~~~~ 278 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---N----SKFYK 278 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS---S----HHHHH
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch---h----HHHHH
Confidence 999999866432 22345678999999988899999999999999999999 8999864221 1 11111
Q ss_pred HhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 531 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
....+... ......+..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 279 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 279 LVKDGYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 22211100 0011223578999999999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=332.62 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=197.1
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 390 (621)
.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+ ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 467999999999999964 6899999998743 34456789999999999999999999998865 567899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC-----CccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD-----LPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+++|.+++..... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999964321 234589999999999999999999998 7 99999999999999999999999999877
Q ss_pred cccc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 466 INSA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 466 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... ..+ +...+..+....+
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~----~~~~i~~~~~~~~- 236 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKE----LAGKIREGKFRRI- 236 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHH----HHHHHHHTCCCCC-
T ss_pred eccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----HHH----HHHHHhhcccccC-
Confidence 6543 23457888999999998899999999999999999999999987421 111 1222222221111
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
.......+.+++.+||+.||++|||+.|+++++.
T Consensus 237 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 237 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1123457899999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.19 Aligned_cols=263 Identities=26% Similarity=0.365 Sum_probs=194.8
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHH--HhcCCCCCcccceEEEEeC-----CeeEEEEee
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRR--LGRLRHSNVLAPLAYHYRT-----DEKLLVYEY 388 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 388 (621)
.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++++... ...++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 46799999999999977 68999999986433 3334444444 4558999999999866532 246899999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccC-----CCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA-----HLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+++|+|.+++... ..++..++.++.||+.||+|||+... ..+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 94 YPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 9999999999743 35889999999999999999997521 227999999999999999999999999999
Q ss_pred eecccc------------ccccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcch
Q 045652 464 TMINSA------------NLAQALFAYKAPEAIQS-------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV 524 (621)
Q Consensus 464 ~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 524 (621)
+.+... ....+|..|+|||++.+ ..++.++|||||||++|||++|..||............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 876432 12357889999999976 45678999999999999999998876543321111111
Q ss_pred ----------HHHHHHHhhcCccccccccchhc-CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 525 ----------VEWVASAFSEGRVTDLLDPEIAS-STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 525 ----------~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
...+......... .+.+.. ..........+.+|+.+||+.||++|||++|+++.|+++......
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred hhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 0111111111111 111111 111234667899999999999999999999999999999865433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.53 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=199.0
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 467999999999999964 4789999998643 334567889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++... ..+++.+++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 126 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 126 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999998642 3589999999999999999999999 9999999999999999999999999999876432
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ..+.... +...... +
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~-~~~~~~~------~-- 260 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLR-IKKNEYS------I-- 260 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHH-HHHTCCC------C--
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHH-HhcCCCC------C--
Confidence 23457888999999998899999999999999999999999986421 1111111 1111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.......+.+++.+||+.||++|||+.|++++-
T Consensus 261 ---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 261 ---PKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 112235688999999999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.32 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=200.9
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 345678999999999999964 68999999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe---CCCCCcEEEeeeccee
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI---SPENEPLISEFGFYTM 465 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 465 (621)
+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 108 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 108 YTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999743 4589999999999999999999999 99999999999999 5678999999999987
Q ss_pred cccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 466 INSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
.... ....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++... +..+.... ..
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~----i~~~~~~~-~~ 248 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILKK----VEKGKYTF-EL 248 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH----HHHCCCCC-CS
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC----HHHHHHH----HHcCCCCC-CC
Confidence 6543 23457899999999875 69999999999999999999999997421 1222222 22222110 00
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+. .......+.+|+.+||+.||++|||+.|+++|-
T Consensus 249 ~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 249 PQ------WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp GG------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred cc------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 11 123346789999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.84 Aligned_cols=244 Identities=22% Similarity=0.356 Sum_probs=186.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|++++||||+++++++. .+..++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 456799999999999985 458999999986432 112235789999999999999999999974 5568999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC---CcEEEeeec
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN---EPLISEFGF 462 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~ 462 (621)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 218 ~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 218 LELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 999999999998864 34689999999999999999999999 999999999999997544 599999999
Q ss_pred ceecccc---ccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
++..... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+.+.+ ..+.
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~i----~~~~ 361 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQI----TSGK 361 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SCCHHHHH----HTTC
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hHHHHHHH----hcCC
Confidence 9876543 33457889999999853 5688999999999999999999999974221 11222222 1111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. . .+... ......+.+++.+||+.||++|||+.|+++|
T Consensus 362 ~~-~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 362 YN-F-IPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CC-C-CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-C-Cchhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11 0 01110 1223578999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.41 Aligned_cols=243 Identities=21% Similarity=0.340 Sum_probs=197.2
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 3467999999999999964 68999999986432 334678899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 91 ~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 91 ELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999863 34689999999999999999999999 9999999999999999999999999998765322
Q ss_pred ---ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ---NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....++..|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......+ ..... ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-----~~~~~--~~---- 228 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDW-----KEKKT--YL---- 228 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHH-----HTTCT--TS----
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHh-----hhccc--cc----
Confidence 23457888999999987765 77999999999999999999999743211 1111111 11110 00
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.........+.+++.+||+.||++|||+.|++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0012334578899999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=330.53 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=200.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 4568999999999999965 589999999864321 236789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC----CcEEEeeecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN----EPLISEFGFY 463 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a 463 (621)
|+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 89 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 89 LVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999642 3589999999999999999999999 999999999999999877 7999999999
Q ss_pred eecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 464 TMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 464 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... . .+.. ..+..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~---~~~~-~~~~~~~~--~ 229 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----K---QETL-TNISAVNY--D 229 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS----H---HHHH-HHHHTTCC--C
T ss_pred eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc----h---HHHH-HHhHhccc--C
Confidence 876543 23457888999999998899999999999999999999999986421 1 1111 11111110 0
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhcc
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQS 589 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~ 589 (621)
..+... ......+.+++.+||+.||++|||+.|++++ ++.+...
T Consensus 230 ~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 230 FDEEYF-----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp CCHHHH-----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred Ccchhc-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 111111 1223568999999999999999999999986 5555443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=340.05 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=195.1
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 4568999999999999964 4899999998643 233456788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 109 TILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred chHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999888763 23589999999999999999999999 9999999999999999999999999999776432
Q ss_pred --ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHh-----------hcC
Q 045652 470 --NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAF-----------SEG 535 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----------~~~ 535 (621)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+.... ...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS----DIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 334578889999999765 78999999999999999999999986422 111111111110 000
Q ss_pred c-cccccccchhcCCC----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 R-VTDLLDPEIASSTN----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~-~~~~~d~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ......+....... .+.....+.+|+.+||+.||++|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000111100000 11234679999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.91 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=191.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv 385 (621)
+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.... ..|+|
T Consensus 29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence 346799999999999996 56999999998643 3344567889999999999999999999997653 45999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+ +++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999 8899999974 3488999999999999999999999 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc-------
Q 045652 466 INSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR------- 536 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 536 (621)
.... ....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+........
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD----HLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcCCCCHHHHHHh
Confidence 6543 34567889999999877 679999999999999999999999997421 1222222221111000
Q ss_pred -----------cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 -----------VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 -----------~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.......+. ...+.....+.+|+.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000 0012334678999999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.01 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=196.5
Q ss_pred HHHHHcCcCCcccEEEEEE----cCCcEEEEEEccCCC----hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM----ADGVTVVVKRMKESS----AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (621)
.+.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 136 (355)
T 1vzo_A 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136 (355)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence 3557899999999999986 368999999987432 12345577899999999 69999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 137 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999743 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecccc-----ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 465 MINSA-----NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 465 ~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........... ..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~-~~- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILK-SE- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHH-CC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---hHHHHHHHHhc-cC-
Confidence 75432 23457889999999985 347899999999999999999999997432211 11121111111 11
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRRI 583 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~L 583 (621)
+ ..+......+.+|+.+||..||++|| ++.|++++.
T Consensus 283 -----~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----C-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 01123345688999999999999999 999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.65 Aligned_cols=256 Identities=19% Similarity=0.258 Sum_probs=194.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChh-----hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM-----ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.+.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 456899999999999995 45899999998743221 124678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 94 MET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 976 898888643 24588889999999999999999999 999999999999999999999999999987643
Q ss_pred c----ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc-
Q 045652 469 A----NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD- 542 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d- 542 (621)
. ....+|..|+|||++.+. .++.++|||||||++|||++|..||... ...+....+.............+
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTSSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHcCCCChhhhhhh
Confidence 2 234578889999999754 5899999999999999999999888642 12222222222211111000000
Q ss_pred ---cchh---c-CCC-----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 543 ---PEIA---S-STN-----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 543 ---~~~~---~-~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+... . ... .......+.+|+.+||+.||++|||+.|+++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000 0 000 022346799999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.10 Aligned_cols=244 Identities=23% Similarity=0.364 Sum_probs=201.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 356799999999999985 468999999986442 334678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 106 SALDLLEP------GPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999863 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ...... .+...... ..
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~----~~~~~~~~-----~~--- 239 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH----PMKVLF----LIPKNNPP-----TL--- 239 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHH----HHHHSCCC-----CC---
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC----HHHHHH----HhhcCCCC-----CC---
Confidence 23457888999999999999999999999999999999999986421 111111 11111111 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
.......+.+++.+||+.||++|||+.|++++..-.
T Consensus 240 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 240 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp --CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred --ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 112235689999999999999999999999886543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=328.95 Aligned_cols=240 Identities=23% Similarity=0.303 Sum_probs=198.9
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 467999999999999965 4889999998643 334567789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 100 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999998642 3589999999999999999999999 9999999999999999999999999999876432
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+.... +..... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~-~~~~~~------~~-- 234 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLR-IKKNEY------SI-- 234 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHH-HHTTCC------CC--
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHH-HhhccC------CC--
Confidence 23457888999999998889999999999999999999999986421 1111111 111110 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.......+.+++.+||+.||++|||+.|++++-
T Consensus 235 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 235 ---PKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 112235688999999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.63 Aligned_cols=244 Identities=19% Similarity=0.312 Sum_probs=193.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 3467999999999999965 589999999986655567889999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----c
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS----A 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~----~ 469 (621)
|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..... .
T Consensus 103 l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 103 VDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp HHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 99988642 23589999999999999999999999 999999999999999999999999998754322 2
Q ss_pred ccccccccccCcccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 NLAQALFAYKAPEAI-----QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~-----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....++..|+|||++ .+..++.++||||||+++|||++|+.||.... ........... .......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~~~-- 244 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKS-DPPTLLT-- 244 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHS-CCCCCSS--
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-------HHHHHHHHhcc-CCcccCC--
Confidence 334578899999998 46678999999999999999999999986421 11222221111 1111111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.||++|||+.|+++|
T Consensus 245 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 ------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 12234578999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=357.59 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=198.4
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+....++||||+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 103 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence 335678999999999999964 68999999985321 224567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC---CCCCcEEEeeecceec
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS---PENEPLISEFGFYTMI 466 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~ 466 (621)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 104 ~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 104 TGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999988643 3589999999999999999999999 999999999999995 4567999999999866
Q ss_pred ccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 467 NSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 467 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
... ....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++... +..+..... .+
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~----i~~~~~~~~-~~ 244 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKR----VETGKYAFD-LP 244 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH----HHHTCCCSC-SG
T ss_pred CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHH----HHhCCCCCC-Cc
Confidence 443 33457899999999875 59999999999999999999999996421 1122222 222221100 01
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
. .......+.+++.+||+.||++|||+.|+++|-
T Consensus 245 ~------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 245 Q------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp G------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred c------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 1 123346789999999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=333.55 Aligned_cols=254 Identities=21% Similarity=0.350 Sum_probs=180.7
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 46799999999999984 468999999986432 2345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 394 LLYLLHGD---RGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 394 L~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
|.+++... .......+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 99998631 111234689999999999999999999999 9999999999999999999999999998765322
Q ss_pred --------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 470 --------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 470 --------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ... ......... ...
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~---~~~~~~~~~-~~~ 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP----MKV---LMLTLQNDP-PSL 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGH---HHHHHTSSC-CCT
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch----hhH---HHHHhccCC-Ccc
Confidence 23357888999999865 5689999999999999999999999874321 111 111111111 000
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
................+.+++.+||+.||++|||+.|++++
T Consensus 248 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 -ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000001112233578999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=359.31 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=194.5
Q ss_pred HHHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 313 KAAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
|.+.+.||+|+||.||+|... ++..||+|+++... ......+.+|+.++++++||||+++++++.+....++|||||
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 345678999999999999964 68999999987542 233567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC---CCcEEEeeecceec
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE---NEPLISEFGFYTMI 466 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~ 466 (621)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.. +.+||+|||++...
T Consensus 119 ~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 119 KGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999988643 3589999999999999999999999 99999999999999764 45999999999876
Q ss_pred ccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 467 NSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 467 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
... ....+|+.|+|||++. ..++.++|||||||++|+|++|..||.... ..++.. .+..+... ...+
T Consensus 190 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~----~i~~~~~~-~~~~ 259 (494)
T 3lij_A 190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT----DQEILR----KVEKGKYT-FDSP 259 (494)
T ss_dssp BTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHHTCCC-CCSG
T ss_pred CCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHH----HHHhCCCC-CCch
Confidence 543 3345888999999986 579999999999999999999999997421 112222 22222111 1111
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. .......+.+++.+||+.||++|||+.|+++|
T Consensus 260 ~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 E------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp G------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred h------cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 11234578999999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=329.79 Aligned_cols=241 Identities=21% Similarity=0.328 Sum_probs=198.5
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 3467999999999999964 57899999986432 1234678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 98 RGELYKELQKH-----GRFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999743 3589999999999999999999998 9999999999999999999999999998765432
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ..+... .+..... ..
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~-~~~~~~~------~~--- 231 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-------HTETHR-RIVNVDL------KF--- 231 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHH-HHHTTCC------CC---
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-------HhHHHH-HHhcccc------CC---
Confidence 34457889999999999899999999999999999999999986421 111111 1111110 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+......+.+++.+||+.||++||++.|+++|-
T Consensus 232 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 232 --PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred --CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 112335688999999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.12 Aligned_cols=242 Identities=21% Similarity=0.353 Sum_probs=195.9
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--------hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEE
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--------AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 386 (621)
+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.+++++ +||||+++++++......++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 68999999999999975 69999999986432 12245688999999999 7999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+
T Consensus 180 e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 180 DLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999742 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred ccc---ccccccccccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 467 NSA---NLAQALFAYKAPEAIQS------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 467 ~~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...... .+..+..
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~----~i~~~~~ 322 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QILMLR----MIMEGQY 322 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHHTCC
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HHHHHH----HHHhCCC
Confidence 543 33467889999999853 358899999999999999999999986421 111111 1222111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. ...+.. ......+.+++.+||+.||++|||+.|++++
T Consensus 323 ~-~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 323 Q-FSSPEW------DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp C-CCHHHH------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-CCCccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 000110 1123568999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=326.20 Aligned_cols=239 Identities=20% Similarity=0.326 Sum_probs=190.5
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 467999999999999965 68999999986432 12356788999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 96 GELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 9999999743 3588999999999999999999999 9999999999999999999999999999876543
Q ss_pred -ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 -NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....++..|+|||.+.+..+ +.++||||||+++|||++|+.||.... ... +...+..+...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~-~~~~~~~~~~~--------- 229 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPT-LFKKIRGGVFY--------- 229 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHH-HHHHHHHCCCC---------
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHH-HHHHhhcCccc---------
Confidence 23456788999999987765 689999999999999999999986321 111 11122211100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+......+.+++.+||+.||++|||+.|++++
T Consensus 230 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011223568899999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.05 Aligned_cols=191 Identities=23% Similarity=0.299 Sum_probs=167.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcC------CCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRL------RHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.+ .|+||+++++++......++|||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 179 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence 4578999999999999854 5899999999754 33456778898888887 57799999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC--cEEEeeeccee
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE--PLISEFGFYTM 465 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~ 465 (621)
|+. ++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 180 ~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 180 LLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp CCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred ccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 995 69999987543 34589999999999999999999999 9999999999999999987 99999999977
Q ss_pred cccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 466 INSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
.... ....+|..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 6543 345678899999999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=337.47 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=194.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEe--CCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYR--TDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|.. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.+ ....++||||++
T Consensus 40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred EEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 457899999999999985 568999999997543 467889999999997 9999999999988 567899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceecccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSA 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~ 469 (621)
+++|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 117 ~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 117 NTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred chhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999885 388899999999999999999999 999999999999999777 8999999999876543
Q ss_pred ---ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc------
Q 045652 470 ---NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD------ 539 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 539 (621)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+....+..........+
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS---HHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc---hHHHHHHHHHhcCCchhhhHHHHhc
Confidence 33457788999999876 6789999999999999999999999863211 1111111111110000000
Q ss_pred -cccc---------------chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 -LLDP---------------EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 -~~d~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..++ ..............+.+|+.+||+.||++|||++|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000111112245779999999999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=345.67 Aligned_cols=249 Identities=14% Similarity=0.120 Sum_probs=178.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC--CCCCcccce-------EEEEeCC-
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL--RHSNVLAPL-------AYHYRTD- 380 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~~- 380 (621)
+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.+++.+ +||||++++ +++...+
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 3467999999999999954 68999999998643 23456677885444444 699977754 5554432
Q ss_pred ----------------eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhccCCCCCc
Q 045652 381 ----------------EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPAR------LKIVQGIARGIGYLHTELAHLDLP 438 (621)
Q Consensus 381 ----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~~iv 438 (621)
..++||||++ |+|.+++.... ..+.+..+ +.++.||+.||+|||++ +|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~iv 216 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSK----GLV 216 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CCc
Confidence 3799999998 89999997532 12344445 67789999999999999 999
Q ss_pred cCCCCCCCEEeCCCCCcEEEeeecceeccccc-cccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCcc
Q 045652 439 HGNLKSSNIFISPENEPLISEFGFYTMINSAN-LAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPSQYL 515 (621)
Q Consensus 439 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~ 515 (621)
||||||+|||++.++.+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999999876654 5566789999999987 67999999999999999999999999764
Q ss_pred cCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 516 TNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....... +.............. .......+..+.+|+.+||+.||++|||+.|+++|
T Consensus 297 ~~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 297 TPGIKGS---------WKRPSLRVPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CTTCTTC---------CCBCCTTSCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred Ccccccc---------hhhhhhhhccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 3211100 000000000000000 01112344678999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.47 Aligned_cols=189 Identities=22% Similarity=0.294 Sum_probs=161.4
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----CeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-----DEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 386 (621)
+.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++|++++||||+++++++... ...|+||
T Consensus 30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 457899999999999985 45889999999753 334567889999999999999999999998776 5689999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 110 EIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp ECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9996 599999974 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred ccc--------------------------ccccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 045652 467 NSA--------------------------NLAQALFAYKAPEAI-QSGKVTPKCDVYCLGIIILEILTGKFPSQ 513 (621)
Q Consensus 467 ~~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg~~P~~ 513 (621)
... ....+|..|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 432 234568889999986 55679999999999999999998665553
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=343.06 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=179.8
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv 385 (621)
+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++... ...++|
T Consensus 33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 457899999999999984 56899999998643 334566788999999999999999999998754 557999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 113 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 9999 7899998863 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---cccc
Q 045652 466 INSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---VTDL 540 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 540 (621)
.... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+........ +..+
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD----HIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHHHh
Confidence 6543 34567889999999876 679999999999999999999999996421 2222222222211100 0000
Q ss_pred ccc-------chhc-CC-C----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDP-------EIAS-ST-N----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~-------~~~~-~~-~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... .+.. .. . .+.....+.+|+.+||+.||++|||+.|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000 00 0 01223578999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=330.37 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=191.5
Q ss_pred HHHHcCcCCcccEEEEEEc--CCc--EEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA--DGV--TVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|.+. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.... .++|||
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 4578999999999999853 233 6899988743 2344678899999999999999999999987654 889999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 999999999997432 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred ccc-------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 468 SAN-------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 468 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
... ...++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.+..........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~- 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGERL- 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCCC-
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-------HHHHHHHHHccCCCC-
Confidence 332 2345667999999988889999999999999999999 999986421 112222221111100
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
......+..+.+++.+||+.||++|||+.+++++|+++...
T Consensus 245 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01123346789999999999999999999999999988654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=335.43 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=193.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--------CeeE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT--------DEKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~ 383 (621)
+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++... +..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 346799999999999996 568999999986432 22345678999999999999999999999873 4678
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+||||+++ +|.+.+.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 99999975 8887776432 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eecccc--------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 464 TMINSA--------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 464 ~~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+.+... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN----TEQHQLALISQLCGS 247 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCC
Confidence 876421 22346888999999876 45899999999999999999999998742 122222222222111
Q ss_pred Cc---cccccccchh-------c-CCCCHH------HHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GR---VTDLLDPEIA-------S-STNSPG------EMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~---~~~~~d~~~~-------~-~~~~~~------~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. .......... . ...... ..+.+.+|+.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 10 0000000000 0 000001 13458899999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.96 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=195.4
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh-------------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA-------------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD 380 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 380 (621)
+.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4578999999999999964 588999999864321 23567889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC---CcEE
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN---EPLI 457 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl 457 (621)
..++|||||++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999988643 3589999999999999999999999 999999999999999776 6999
Q ss_pred Eeeecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 458 SEFGFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 458 ~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+|||++...... ....+|+.|+|||++. ..++.++||||+||++|+|++|..||.... ..++.. .+..
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~----~i~~ 261 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN----DQDIIK----KVEK 261 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH----HHHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHH----HHHc
Confidence 999999877543 3456788999999987 569999999999999999999999997421 112222 2222
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+.... +... .......+.+|+.+||+.||++|||+.|+++|-
T Consensus 262 ~~~~~--~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 262 GKYYF--DFND-----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp CCCCC--CHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCC--Cccc-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 22110 0000 012235789999999999999999999999873
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=337.55 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=187.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv 385 (621)
+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence 346799999999999985 45899999998643 3344567889999999999999999999997654 67999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||++ ++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 109 MELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99997 488888852 388999999999999999999999 999999999999999999999999999987
Q ss_pred cccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHh----------
Q 045652 466 INSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAF---------- 532 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------- 532 (621)
.... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+....
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD----HIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHHH
Confidence 6543 33467889999999999899999999999999999999999997422 111111111100
Q ss_pred ---------hcCc-c-----ccccccchhcCCC---CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 533 ---------SEGR-V-----TDLLDPEIASSTN---SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 533 ---------~~~~-~-----~~~~d~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.... . .... +....... .......+.+|+.+||+.||++|||++|+++|-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLF-PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHS-CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhhHHHHHHhhCccccccchhhhc-ccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000 0 0000 00000000 112356799999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=352.37 Aligned_cols=254 Identities=15% Similarity=0.223 Sum_probs=199.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCC-CCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH-SNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.++| ++|..+..++...+..++||||+ ++
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 346799999999999995 5689999998764332 2357899999999987 45555666667778889999999 99
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe---CCCCCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI---SPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~ 469 (621)
+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 88 sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 88 SLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9999997432 4599999999999999999999999 99999999999999 58899999999999876543
Q ss_pred c-----------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 470 N-----------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 470 ~-----------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
. ...+|..|+|||++.+..++.++|||||||++|||++|+.||....... .......+........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~-- 236 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVATS-- 236 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-HHHHHHHHHHHHHHSC--
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-HHHHHHHHhhcccccc--
Confidence 2 4457889999999999999999999999999999999999997543211 1111111111111111
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
+. .+. ...+.++.+|+.+||+.||++||++.++++.|+++....
T Consensus 237 --~~-~l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 237 --IE-ALC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp --HH-HHH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HH-HHh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00 010 112357899999999999999999999999999886644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=329.37 Aligned_cols=243 Identities=22% Similarity=0.328 Sum_probs=195.0
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp EEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 3467999999999999965 58999999987543 34678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 111 L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 111 VSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp HHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence 99998632 24589999999999999999999999 9999999999999999999999999999876443
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ....+.. ...........
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~-~~~~~~~~~~~------- 247 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-------PMRAIFM-IPTNPPPTFRK------- 247 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHH-HHHSCCCCCSS-------
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHH-HhcCCCcccCC-------
Confidence 23457888999999998899999999999999999999999986421 1111111 11111111100
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.......+.+++.+||+.||++|||+.+++++-
T Consensus 248 -~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp -GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 122245789999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.55 Aligned_cols=261 Identities=20% Similarity=0.288 Sum_probs=182.0
Q ss_pred HHHcCcCCcccEEEEEEc---CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMMA---DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 390 (621)
.++||+|+||.||+|... +++.||||++..... ...+.+|+++|++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 357999999999999965 578999999975432 3467899999999999999999999965 567899999996
Q ss_pred CCChhHHhhcCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe----CCCCCcEEEeeec
Q 045652 391 GGSLLYLLHGDR----GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI----SPENEPLISEFGF 462 (621)
Q Consensus 391 ~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~ 462 (621)
++|.+++.... ......+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 58888775221 11223589999999999999999999999 99999999999999 6788999999999
Q ss_pred ceecccc-------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCC-----CCcchHHHHH
Q 045652 463 YTMINSA-------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGN-----GGIDVVEWVA 529 (621)
Q Consensus 463 a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-----~~~~~~~~~~ 529 (621)
++..... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...+....+.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9876432 234578899999999874 58999999999999999999999997532210 0112222222
Q ss_pred HHhhcCccccc--c-------------ccchhcCCC--------CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 530 SAFSEGRVTDL--L-------------DPEIASSTN--------SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 530 ~~~~~~~~~~~--~-------------d~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
..+.......+ + ......... .......+.+|+.+||+.||++|||++|+++|-
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 22111100000 0 000000000 001134688999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=340.98 Aligned_cols=260 Identities=19% Similarity=0.267 Sum_probs=197.8
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC--------CCCcccceEEEE----eCCe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR--------HSNVLAPLAYHY----RTDE 381 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~----~~~~ 381 (621)
+.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++. ....
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 457899999999999985 45899999999754 345677889999999995 788999999987 4457
Q ss_pred eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC--------
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-------- 453 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-------- 453 (621)
.++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred EEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhhhhh
Confidence 89999999 567766665432 245899999999999999999999842 799999999999999775
Q ss_pred -----------------------------------------CcEEEeeecceecccc-ccccccccccCcccccCCCCCc
Q 045652 454 -----------------------------------------EPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTP 491 (621)
Q Consensus 454 -----------------------------------------~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ 491 (621)
.+||+|||++...... ....+|..|+|||++.+..++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCc
Confidence 7999999999876543 3456789999999999999999
Q ss_pred chhhHHHHHHHHHHHhCCCCCCcccCCCCCc--chHHHHHHHhhc--------Ccc-cccccc-----------------
Q 045652 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGI--DVVEWVASAFSE--------GRV-TDLLDP----------------- 543 (621)
Q Consensus 492 ~~DvwSlGvvl~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~--------~~~-~~~~d~----------------- 543 (621)
++|||||||++|||+||+.||.......... +....+...... +.. ...+..
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 9999999999999999999997543322111 111111111110 000 000000
Q ss_pred -chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 -EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..............+.+|+.+||+.||++|||++|+++|
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000112245667889999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.19 Aligned_cols=253 Identities=17% Similarity=0.283 Sum_probs=198.4
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChh-----------------hHHHHHHHHHHHhcCCCCCcccceEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAM-----------------ARDAFDTEVRRLGRLRHSNVLAPLAYHY 377 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l~~~~~ 377 (621)
+.+.||+|+||.||+|.. +++.||||++...... ..+.+.+|++++++++||||+++++++.
T Consensus 35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 346799999999999999 8999999998643211 1178999999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhHH------hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeC
Q 045652 378 RTDEKLLVYEYIPGGSLLYL------LHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFIS 450 (621)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~ 450 (621)
+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.|||+ . +|+||||||+||+++
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNILMD 186 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGEEEC
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhEEEc
Confidence 99999999999999999998 5422 14568999999999999999999998 8 999999999999999
Q ss_pred CCCCcEEEeeecceecccc--ccccccccccCcccccCC-CCCc-chhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHH
Q 045652 451 PENEPLISEFGFYTMINSA--NLAQALFAYKAPEAIQSG-KVTP-KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 451 ~~~~~kl~DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 526 (621)
.++.+||+|||++...... ....++..|+|||++.+. .++. ++|||||||++|||++|+.||..... ..+...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~ 263 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELFN 263 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC---SHHHHH
T ss_pred CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHH
Confidence 9999999999999876443 345678899999999877 6666 99999999999999999999874221 112222
Q ss_pred HHHHHhhcCcccccc------ccchh--cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 527 WVASAFSEGRVTDLL------DPEIA--SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 527 ~~~~~~~~~~~~~~~------d~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+..+...... .+... ...........+.+++.+||+.||++|||+.|+++|
T Consensus 264 ----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 264 ----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22222111000 00000 000012334678999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=331.21 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=199.6
Q ss_pred HHHHcCcCCcccEEEEEE--cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCC------CcccceEEEEeCCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM--ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHS------NVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~~lv~ 386 (621)
+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+..++||
T Consensus 18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 96 (339)
T 1z57_A 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96 (339)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEE
Confidence 346799999999999986 35889999999754 34467788999999998765 4999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---------------
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP--------------- 451 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--------------- 451 (621)
||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 97 e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 97 ELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred cCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 999 889999997543 23588999999999999999999999 9999999999999987
Q ss_pred ----CCCcEEEeeecceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHH
Q 045652 452 ----ENEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 452 ----~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 526 (621)
++.+||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.... ..+...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD----SKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC----HHHHHH
T ss_pred ccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----hHHHHH
Confidence 668999999999876543 34567889999999999899999999999999999999999987422 112222
Q ss_pred HHHHHhhcC--------cccc---------------------ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHH
Q 045652 527 WVASAFSEG--------RVTD---------------------LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMR 577 (621)
Q Consensus 527 ~~~~~~~~~--------~~~~---------------------~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 577 (621)
.+....... .... ...+..............+.+|+.+||+.||++|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 221111100 0000 00000001112345567899999999999999999999
Q ss_pred HHHHH
Q 045652 578 EAVRR 582 (621)
Q Consensus 578 evl~~ 582 (621)
|+++|
T Consensus 325 ell~h 329 (339)
T 1z57_A 325 EALKH 329 (339)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=363.89 Aligned_cols=240 Identities=21% Similarity=0.269 Sum_probs=197.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..|+||||+
T Consensus 345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 3468999999999999954 58899999987431 22345678899999988 7999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc-
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS- 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 468 (621)
++|+|.++++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 425 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 425 NGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999743 3589999999999999999999999 999999999999999999999999999986422
Q ss_pred ---cccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ---ANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.... . .+.... +......
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~----~---~~~~~~-i~~~~~~------- 560 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----E---DELFQS-IMEHNVA------- 560 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----H---HHHHHH-HHSSCCC-------
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC----H---HHHHHH-HHhCCCC-------
Confidence 234568899999999999999999999999999999999999997421 1 122222 2222110
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcH-----HHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEM-----REAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 582 (621)
.+.....++.+|+.+||+.||++||++ +||++|
T Consensus 561 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 112334678999999999999999997 777765
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.03 Aligned_cols=243 Identities=20% Similarity=0.281 Sum_probs=196.6
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---------hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEE
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---------AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 384 (621)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+++++++. ||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 467999999999999964 58999999986432 123467889999999996 9999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999742 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecccc---ccccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 465 MINSA---NLAQALFAYKAPEAIQ------SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 465 ~~~~~---~~~~~~~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
..... ....++..|+|||++. ...++.++||||||+++|||++|+.||.... ..... ..+..+
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~----~~~~~~ 244 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLML----RMIMSG 244 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH----HHHHHT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----HHHHH----HHHhcC
Confidence 76543 2345788999999985 4568899999999999999999999986421 11111 111111
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... ...+ ........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~-~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 245 NYQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred Ccc-cCcc------cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111 0001 112344679999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=332.21 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=191.2
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh--------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA--------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.... .++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence 4578999999999999854 589999999864321 12345789999999999999999999986654 8999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC---cEEEeeec
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE---PLISEFGF 462 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~ 462 (621)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 93 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 93 LELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 999999999999863 34689999999999999999999999 9999999999999987664 99999999
Q ss_pred ceecccc---ccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
+...... ....++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+...+. .+.
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~----~~~ 236 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQIT----SGK 236 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC---SSCHHHHHH----HTC
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---HHHHHHHHH----hCc
Confidence 9877543 2345788999999974 56789999999999999999999999974321 112222221 111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ..+... ......+.+++.+||+.||++||++.|++++
T Consensus 237 ~~--~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YN--FIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CC--CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cc--cCchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11 011111 1223578999999999999999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.57 Aligned_cols=261 Identities=20% Similarity=0.315 Sum_probs=191.6
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe------eEEEEe
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE------KLLVYE 387 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e 387 (621)
.+.+.||+|+||.||+|....+..||+|++..... ...+|+++++.++||||+++++++...+. .++|||
T Consensus 43 ~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 34578999999999999987777799998864332 12379999999999999999999976443 789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC-CCCCcEEEeeecceec
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS-PENEPLISEFGFYTMI 466 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~ 466 (621)
|++++.+........ ....+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 119 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 119 YVPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp CCSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ccCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 998754433322111 134689999999999999999999999 999999999999999 7999999999999876
Q ss_pred ccc---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC-------
Q 045652 467 NSA---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG------- 535 (621)
Q Consensus 467 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------- 535 (621)
... ....+|..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES----GIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHHh
Confidence 433 334578889999998765 58999999999999999999999997422 122222222111100
Q ss_pred ---ccccccccchhc----CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhc
Q 045652 536 ---RVTDLLDPEIAS----STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQ 588 (621)
Q Consensus 536 ---~~~~~~d~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~ 588 (621)
...+..-+.... .........++.+|+.+||+.||++|||+.|+++| ++++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 000000000000 00011234679999999999999999999999987 455443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=328.93 Aligned_cols=242 Identities=20% Similarity=0.330 Sum_probs=192.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC----hhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS----AMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 387 (621)
+.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 346799999999999995 468999999987432 2345778999999999999999999999854 456899999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|++++ |.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99876 777776432 34689999999999999999999999 99999999999999999999999999998764
Q ss_pred cc------ccccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 468 SA------NLAQALFAYKAPEAIQSGK--VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 468 ~~------~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.. ....++..|+|||++.+.. ++.++||||||+++|||++|+.||.... ..+ +...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~-~~~~i~~~~~~- 231 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYK-LFENIGKGSYA- 231 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHH-HHHHHHHCCCC-
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHH-HHHHHhcCCCC-
Confidence 32 2345788999999987643 4789999999999999999999986421 111 11222222110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
. .......+.+++.+||+.||++|||+.|++++-
T Consensus 232 -----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 232 -----I-----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp -----C-----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred -----C-----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 0 112335688999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=337.19 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=195.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----CeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-----DEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 387 (621)
+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 31 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence 456899999999999985 46889999999743 334457789999999999999999999998765 35799999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 111 LME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 996 599999864 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred cc-------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc-
Q 045652 468 SA-------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT- 538 (621)
Q Consensus 468 ~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 538 (621)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....+..........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK----HYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS----SGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC----ChHHHHHHHHHHhCCCCHHH
Confidence 43 22357889999998754 45899999999999999999999998642 2223333332221111000
Q ss_pred --cccc-------cchhc--CC----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 --DLLD-------PEIAS--ST----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 --~~~d-------~~~~~--~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+ ..... .. ..+....++.+|+.+||+.||++|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000 00 001234678999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.71 Aligned_cols=247 Identities=18% Similarity=0.266 Sum_probs=182.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-h-hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-A-MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|.. .+++.||+|+++... . ...+.+..+...++.++||||+++++++.+.+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 89 (290)
T 3fme_A 11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD- 89 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-
Confidence 346799999999999995 568999999997542 2 223344555666888899999999999999999999999997
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.+++..... ....+++..++.++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 90 TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSK---LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH---SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhc---CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 588777753111 134689999999999999999999984 27999999999999999999999999999876443
Q ss_pred -ccccccccccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 -NLAQALFAYKAPEAI----QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....++..|+|||++ .+..++.++|||||||++|||++|+.||.... .....+.......... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~-~---- 234 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG------TPFQQLKQVVEEPSPQ-L---- 234 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS------CHHHHHHHHHHSCCCC-C----
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC------chHHHHHHHhccCCCC-c----
Confidence 234578899999996 45678999999999999999999999986321 1112222222221110 0
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.+++.+||+.||++|||+.|+++|
T Consensus 235 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 -----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 011234578999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=356.32 Aligned_cols=250 Identities=19% Similarity=0.341 Sum_probs=201.3
Q ss_pred HHHHHHHcCcCCcccEEEEEEcC----CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 312 MKAAAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 312 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.|.+.+.||+|+||.||+|.+.. +..||||.++.. .....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus 391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~lv~ 469 (656)
T 2j0j_A 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIM 469 (656)
T ss_dssp GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEEEE
Confidence 34456789999999999998632 568999998753 344567899999999999999999999998 456789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 470 E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 470 ELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp ECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999997532 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccc-----cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 467 NSAN-----LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 467 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
.... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.... ..+....+ ..+....
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~----~~~~~~~i----~~~~~~~- 612 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGRI----ENGERLP- 612 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHH----HHTCCCC-
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHH----HcCCCCC-
Confidence 5432 2335678999999988899999999999999999997 999986421 11222221 1111110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.+...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 613 ---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112334678999999999999999999999999998864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=330.58 Aligned_cols=249 Identities=21% Similarity=0.358 Sum_probs=191.9
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|...+ .||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 45789999999999998744 49999986432 223456778999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc----
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS---- 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~---- 468 (621)
+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||++.....
T Consensus 115 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 115 TLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp EHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999743 23588999999999999999999999 999999999999998 67999999999765421
Q ss_pred -----cccccccccccCcccccC---------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 469 -----ANLAQALFAYKAPEAIQS---------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 469 -----~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ... +...+..
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~-~~~~~~~ 257 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------AEA-IIWQMGT 257 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-------HHH-HHHHHHT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHH-HHHHhcc
Confidence 123347788999999864 357899999999999999999999986421 111 1111222
Q ss_pred CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 535 GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 535 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
+....... ......+.+++.+||..||++|||+.++++.|+++.....
T Consensus 258 ~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 258 GMKPNLSQ---------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp TCCCCCCC---------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CCCCCCCc---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 21111110 1122458899999999999999999999999998876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=329.54 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=190.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEe------CCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR------TDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~ 386 (621)
+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 346799999999999996 468999999987543 2356788999999999 79999999999987 45789999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 107 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp ECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999997542 24588999999999999999999999 9999999999999999999999999998776
Q ss_pred ccc----ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 467 NSA----NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 467 ~~~----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
... ....++..|+|||++. +..++.++|||||||++|||++|+.||.... .......... ...
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~ 251 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-------PMRALFLIPR-NPA 251 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHH-SCC
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHhhc-Ccc
Confidence 432 3345788999999986 5678999999999999999999999986421 1111111111 111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... .......+.+++.+||..||++||++.|++++
T Consensus 252 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 252 PRLK---------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCS---------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCC---------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1110 11223578999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.66 Aligned_cols=254 Identities=18% Similarity=0.269 Sum_probs=188.4
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCC-----------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESS-----------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT----- 379 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 379 (621)
.+.||+|+||.||+|...+|+.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 36799999999999998889999999985321 12247789999999999999999999998653
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
...++||||++ |+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEEEcCCCCEEEEe
Confidence 35799999997 6888888743 24689999999999999999999999 999999999999999999999999
Q ss_pred eecceecccc---ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 460 FGFYTMINSA---NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 460 fG~a~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
||++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----FYNQLNKIVEVVGTP 253 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHcCCC
Confidence 9999765432 33457788999999876 679999999999999999999999997421 112222222111111
Q ss_pred ccc-----------cccccchhcC------CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 RVT-----------DLLDPEIASS------TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~~~-----------~~~d~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... +.+....... ...+...+.+.+|+.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 0000000000 0011224568999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.99 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=187.7
Q ss_pred HHHcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEE--------------eCC
Q 045652 316 AEVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHY--------------RTD 380 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------------~~~ 380 (621)
.+.||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++. +..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 4679999999999999654 8999999998766667788999999999999999999999874 335
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC-CCCCcEEEe
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS-PENEPLISE 459 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 459 (621)
..++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+|
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 6799999997 699999863 3588999999999999999999999 999999999999997 567899999
Q ss_pred eecceecccc-------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHH
Q 045652 460 FGFYTMINSA-------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASA 531 (621)
Q Consensus 460 fG~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 531 (621)
||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~~~~~~~~ 240 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH----ELEQMQLILES 240 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHh
Confidence 9999876432 22345778999998865 678999999999999999999999987422 11111111111
Q ss_pred hhcC----------ccccccccchhcCCC-----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 532 FSEG----------RVTDLLDPEIASSTN-----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 532 ~~~~----------~~~~~~d~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... .....+......... .+....++.+++.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1000 000000000000000 01234678999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.33 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=191.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCee------EEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEK------LLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~lv 385 (621)
+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 356799999999999985 45899999999753 334467788999999999999999999999876654 999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+. ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 126 MPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred Ecccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99996 68988873 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcc---ccc
Q 045652 466 INSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV---TDL 540 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 540 (621)
.... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+......... ..+
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD----YLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCcHHHHHHh
Confidence 6543 33567889999999977 679999999999999999999999997421 11222222111110000 000
Q ss_pred cc-------cchhcC-C-----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LD-------PEIASS-T-----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d-------~~~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+ ...... . ..+.....+.+|+.+||+.||++|||+.|+++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000000 0 011234678999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=331.70 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=169.4
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe----CCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 391 (621)
+.||+|+||.||+|... +++.||||++.... . ........++.++||||+++++++.. ....++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 46999999999999965 68999999997532 1 12223334566799999999999876 3447899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeecceeccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTMINS 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~ 468 (621)
|+|.+++.... ...+++.+++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++.....
T Consensus 111 g~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 111 GELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred CCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 99999998543 24689999999999999999999999 9999999999999986 44599999999987654
Q ss_pred c--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 469 A--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 469 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
. ....+++.|+|||++.+..++.++|||||||++|||++|+.||....... ........+..... ...
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~-~~~----- 253 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA----ISPGMKRRIRLGQY-GFP----- 253 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CCC-----
T ss_pred cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh----hhhhHHHhhhcccc-ccC-----
Confidence 3 33456889999999988889999999999999999999999997532211 11111111111100 000
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
..........+.+|+.+||+.||++|||+.|++++-
T Consensus 254 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 254 -NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred -chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 011123346789999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.03 Aligned_cols=260 Identities=19% Similarity=0.312 Sum_probs=192.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC--------------
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-------------- 379 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------------- 379 (621)
+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 346799999999999985 5699999999865432 234799999999999999999998543
Q ss_pred ------------------------CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC
Q 045652 380 ------------------------DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435 (621)
Q Consensus 380 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 435 (621)
...++||||++ |+|.+.+..... ....+++..+..++.||+.||+|||+.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---- 160 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSL---- 160 (383)
T ss_dssp -----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----
Confidence 23789999997 588777653111 234689999999999999999999998
Q ss_pred CCccCCCCCCCEEeC-CCCCcEEEeeecceecccc---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCC
Q 045652 436 DLPHGNLKSSNIFIS-PENEPLISEFGFYTMINSA---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKF 510 (621)
Q Consensus 436 ~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~ 510 (621)
+|+||||||+|||++ .++.+||+|||+++..... ....++..|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999999998 6889999999999876443 334567889999998765 48999999999999999999999
Q ss_pred CCCcccCCCCCcchHHHHHHHhhcCc----------cccccccchhcC----CCCHHHHHHHHHHHhhcccCCCCCCCcH
Q 045652 511 PSQYLTNGNGGIDVVEWVASAFSEGR----------VTDLLDPEIASS----TNSPGEMEQLLEIGRACTQSDPEQRLEM 576 (621)
Q Consensus 511 P~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~d~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~ 576 (621)
||.... ..+....+........ ..+..-+..... ......+..+.+|+.+||+.||++|||+
T Consensus 241 pf~~~~----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 241 LFSGET----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp SSCCSS----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCC----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 997421 2222222222111100 000000000000 0011234668999999999999999999
Q ss_pred HHHHHH--HHHhhc
Q 045652 577 REAVRR--IVEIQQ 588 (621)
Q Consensus 577 ~evl~~--L~~i~~ 588 (621)
.|+++| ++++..
T Consensus 317 ~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 317 YEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHTSGGGHHHHH
T ss_pred HHHhcCHHHHHHHh
Confidence 999977 555544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.11 Aligned_cols=193 Identities=22% Similarity=0.275 Sum_probs=164.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CC-----CcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HS-----NVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.++ |+ +|+++++++...+..++|||
T Consensus 58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 3467999999999999854 5889999999753 334567788999998885 55 49999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC--CCCCcEEEeeeccee
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS--PENEPLISEFGFYTM 465 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~ 465 (621)
|++ ++|.+++.... ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 137 ~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 137 MLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp CCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred cCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 996 59999997543 24589999999999999999999952 12899999999999995 477899999999988
Q ss_pred cccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 466 INSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
.... ....+|..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7543 345678899999999999999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=344.22 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=191.1
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC----C--eeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT----D--EKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~lv~ 386 (621)
.+.+.||+|+||.||+|... +|+.||||++..... .+.+|+++|++++||||+++++++... + ..++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 34578999999999999964 589999999865322 234799999999999999999998652 2 256999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeeccee
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFYTM 465 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~ 465 (621)
||+++ +|.+.+..... ....+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 133 e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp ECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred hcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 99975 66665542110 235689999999999999999999998 99999999999999965 5689999999987
Q ss_pred cccc---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc-------
Q 045652 466 INSA---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE------- 534 (621)
Q Consensus 466 ~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------- 534 (621)
+... ....+|..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+....+...+..
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~----~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCSCCHHHHH
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHH
Confidence 6432 234578899999998764 79999999999999999999999997421 12222222211111
Q ss_pred ---CccccccccchhcCC----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhh
Q 045652 535 ---GRVTDLLDPEIASST----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQ 587 (621)
Q Consensus 535 ---~~~~~~~d~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 587 (621)
....+...+.+.... ..+....++.+|+.+||+.||++|||+.|+++| ++++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 011111111110000 011234679999999999999999999999987 44443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.84 Aligned_cols=256 Identities=19% Similarity=0.265 Sum_probs=193.7
Q ss_pred HHHHcCcCCcccEEEEEE--cCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCCcccceEEEE-----eCCee
Q 045652 315 AAEVLGNGGLGSSYKAMM--ADGVTVVVKRMKESS--AMARDAFDTEVRRLGRL---RHSNVLAPLAYHY-----RTDEK 382 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~~~ 382 (621)
+.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.+ +||||+++++++. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 346799999999999996 458899999986332 11223466777777766 8999999999987 44568
Q ss_pred EEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
++||||++ |+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 89999997 69999997543 23589999999999999999999999 999999999999999999999999999
Q ss_pred ceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR--- 536 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 536 (621)
+...... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCGGG
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHHcCCCCccc
Confidence 9876533 23456888999999998899999999999999999999999987421 1222222222211100
Q ss_pred ccc-ccccc--hh------cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 VTD-LLDPE--IA------SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ~~~-~~d~~--~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... ...+. .. ...........+.+|+.+||+.||++|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000 00 000112334678899999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=342.17 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=184.5
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..++|||||. |+|.
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 5799999999988777789999999986432 45678999999986 89999999999999999999999995 6999
Q ss_pred HHhhcCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-------------CCcEEEee
Q 045652 396 YLLHGDRGPSH--DELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-------------NEPLISEF 460 (621)
Q Consensus 396 ~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl~Df 460 (621)
+++........ ...++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99975432111 1113335678999999999999999 99999999999999754 47999999
Q ss_pred ecceeccccc--------cccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcch
Q 045652 461 GFYTMINSAN--------LAQALFAYKAPEAIQS-------GKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDV 524 (621)
Q Consensus 461 G~a~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 524 (621)
|+++...... ...+|+.|+|||++.+ ..++.++|||||||++|||+| |+.||..... ..
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~ 247 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-----RE 247 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-----HH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-----hH
Confidence 9998765432 2457889999999965 568999999999999999999 9999863211 11
Q ss_pred HHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
...+..... .. .. ..........++.+++.+||+.||++|||+.|+++|
T Consensus 248 ~~i~~~~~~---~~-----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 SNIIRGIFS---LD-----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHTCCC---CC-----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCC---cc-----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111111000 00 00 111234567889999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=319.72 Aligned_cols=243 Identities=21% Similarity=0.326 Sum_probs=195.2
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 4578999999999999965 68999999986432 23467789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC---CCcEEEeeecceeccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE---NEPLISEFGFYTMINS 468 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~ 468 (621)
++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 106 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999988642 3589999999999999999999999 99999999999999764 4699999999876644
Q ss_pred c---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 A---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
. ....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+.. ..+..+..... .+.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~----~~~~~~~~~~~-~~~- 245 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDIL----KRVETGKYAFD-LPQ- 245 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH----HHHHHCCCCCC-SGG-
T ss_pred CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC----HHHHH----HHHHcCCCCCC-chh-
Confidence 3 22346778999999875 58999999999999999999999986421 11111 22222221100 000
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......+.+++.+||+.||++|||+.|++++
T Consensus 246 -----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 -----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 01233578999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=328.58 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=196.7
Q ss_pred HHHHcCcCCcccEEEEEEc-CC-cEEEEEEccCCChhhHHHHHHHHHHHhcCCCCC------cccceEEEEeCCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DG-VTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN------VLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~ 386 (621)
+.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...+..++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T 2eu9_A 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101 (355)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence 4567999999999999864 34 78999999753 344677889999999997665 899999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEe-----------------
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFI----------------- 449 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll----------------- 449 (621)
||+ +++|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 102 e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 102 ELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred ecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecccccccccccccccc
Confidence 999 667777776432 24589999999999999999999999 99999999999999
Q ss_pred --CCCCCcEEEeeecceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHH
Q 045652 450 --SPENEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 450 --~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 526 (621)
+.++.+||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.... ..+...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE----NREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHH
T ss_pred cccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Confidence 56789999999999876543 34568889999999999999999999999999999999999997422 112222
Q ss_pred HHHHHhhcC--------cccc---------------------ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHH
Q 045652 527 WVASAFSEG--------RVTD---------------------LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMR 577 (621)
Q Consensus 527 ~~~~~~~~~--------~~~~---------------------~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 577 (621)
.+....... .... ...+..............+.+|+.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 222111100 0000 00000001112234566899999999999999999999
Q ss_pred HHHHH
Q 045652 578 EAVRR 582 (621)
Q Consensus 578 evl~~ 582 (621)
|+++|
T Consensus 330 e~l~h 334 (355)
T 2eu9_A 330 EALLH 334 (355)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.26 Aligned_cols=260 Identities=18% Similarity=0.284 Sum_probs=196.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-----------CCCcccceEEEEeCC--
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-----------HSNVLAPLAYHYRTD-- 380 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~~-- 380 (621)
+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ ||||+++++++...+
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 101 (373)
T 1q8y_A 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101 (373)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence 456799999999999995 56899999999743 344677889999999886 899999999988654
Q ss_pred --eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC------CC
Q 045652 381 --EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS------PE 452 (621)
Q Consensus 381 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~------~~ 452 (621)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++. +|+||||||+|||++ ..
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 102 GVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred CceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCCcCc
Confidence 678999999 889999997543 245899999999999999999999841 799999999999994 44
Q ss_pred CCcEEEeeecceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCC--cchHHHHH
Q 045652 453 NEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG--IDVVEWVA 529 (621)
Q Consensus 453 ~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~--~~~~~~~~ 529 (621)
+.+||+|||++...... ....+|..|+|||++.+..++.++|||||||++|||+||+.||......... .+....+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred ceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 47999999999876543 3456788999999999999999999999999999999999999753321111 11111111
Q ss_pred HHhhc--------Cc-----------ccccc--------ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 530 SAFSE--------GR-----------VTDLL--------DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 530 ~~~~~--------~~-----------~~~~~--------d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..... +. ..... +...............+.+|+.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 11110 00 00000 00000112335677889999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.11 Aligned_cols=252 Identities=18% Similarity=0.258 Sum_probs=192.7
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----CeeEEEEee
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-----DEKLLVYEY 388 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 388 (621)
.+.||+|+||.||+|... +|+.||||++... .......+.+|++++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 467999999999999964 5899999999743 334456788999999999999999999988764 568999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 96 MQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 96 699999874 3589999999999999999999999 999999999999999999999999999987643
Q ss_pred c--------------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 469 A--------------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 469 ~--------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
. ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD----YRHQLLLIFGIIG 240 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhC
Confidence 2 11346788999998764 678999999999999999999999987422 1111111111111
Q ss_pred cCcc----ccccccc-------hhc-CC-----CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 534 EGRV----TDLLDPE-------IAS-ST-----NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 534 ~~~~----~~~~d~~-------~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... .....+. +.. .. ..+.....+.+++.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1000 0000000 000 00 001234678999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.04 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=187.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEe-------------CC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR-------------TD 380 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------------~~ 380 (621)
+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++++++||||+++++++.+ ..
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (303)
T 1zy4_A 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88 (303)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred hhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence 346799999999999995 46899999998643 3446778999999999999999999999865 34
Q ss_pred eeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEee
Q 045652 381 EKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEF 460 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 460 (621)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 89 TLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp EEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEeeC
Confidence 5789999999999999997532 3578889999999999999999999 9999999999999999999999999
Q ss_pred ecceecccc------------------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCC
Q 045652 461 GFYTMINSA------------------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG 521 (621)
Q Consensus 461 G~a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 521 (621)
|++...... ....++..|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------ 231 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------ 231 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH------
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc------
Confidence 998765421 223467789999999764 68999999999999999998 54321
Q ss_pred cchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+..... ..+..... ...+ .........+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~-~~~~~~~~--~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERVNIL-KKLRSVSI--EFPP-----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHH-HHHHSTTC--CCCT-----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHHHHH-Hhcccccc--ccCc-----cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111 11211110 0011 1122334568999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.98 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=183.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe-------eEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE-------KLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~ 386 (621)
+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|++.+..++||||+++++++...+. .++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp EC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 347899999999999996 468999999886433 223456678888899999999999999976443 78999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hccCCCCCccCCCCCCCEEeCC-CCCcEEEeeecc
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH--TELAHLDLPHGNLKSSNIFISP-ENEPLISEFGFY 463 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a 463 (621)
||+++ +|...+.... .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||++
T Consensus 106 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp ECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred ecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 99976 5554443211 02346889999999999999999999 77 9999999999999996 899999999999
Q ss_pred eecccc---ccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---
Q 045652 464 TMINSA---NLAQALFAYKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR--- 536 (621)
Q Consensus 464 ~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 536 (621)
+..... ....+|..|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN----SAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC----hHHHHHHHHHHcCCCCHHH
Confidence 876543 2345788899999986554 8999999999999999999999997422 1222222222111100
Q ss_pred ---------ccccccc-----chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhh
Q 045652 537 ---------VTDLLDP-----EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQ 587 (621)
Q Consensus 537 ---------~~~~~d~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 587 (621)
.....+. .-............+.+|+.+||+.||++|||+.|+++| ++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0000000 000001112245789999999999999999999999987 44444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.54 Aligned_cols=242 Identities=19% Similarity=0.337 Sum_probs=191.4
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCC--CCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLR--HSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++||| +.
T Consensus 32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 110 (313)
T 3cek_A 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 110 (313)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence 34689999999999999888999999998643 3445678899999999997 5999999999999999999999 55
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+||+++ ++.+||+|||++......
T Consensus 111 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 111 NIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp SEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence 88999999743 3588999999999999999999999 999999999999997 488999999999876432
Q ss_pred -----ccccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh
Q 045652 470 -----NLAQALFAYKAPEAIQS-----------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS 533 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 533 (621)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... .....+.....
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~ 254 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIID 254 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH------HHHHHHHHHHh
Confidence 23357889999999865 468899999999999999999999986422 11122222221
Q ss_pred cCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 534 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
...... . .......+.+++.+||+.||++||++.|++++-
T Consensus 255 ~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 255 PNHEIE-----F-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp TTSCCC-----C-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cccccC-----C-----cccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 111000 0 011135688999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.63 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=191.2
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe------eEEEE
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE------KLLVY 386 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ 386 (621)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++..... .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46799999999999995 46899999998653 33345678899999999999999999999987654 49999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+. ++|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 109 e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 109 PFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp ECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred cccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 9997 58888764 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccc-ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc--------
Q 045652 467 NSA-NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR-------- 536 (621)
Q Consensus 467 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-------- 536 (621)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+........
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD----YLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC----HHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHHHHh
Confidence 443 33457889999999876 678999999999999999999999997421 1122222211111000
Q ss_pred ----------cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 ----------VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ----------~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.....+.. ....+.....+.+++.+||+.||++|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDF--TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCT--TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccH--HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 01112345679999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.80 Aligned_cols=251 Identities=18% Similarity=0.296 Sum_probs=175.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHH-HHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVR-RLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
..+.||+|+||.||+|.. .+|+.||||+++... ......+..|+. +++.++||||+++++++...+..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 457899999999999996 468999999997542 333445566666 77888999999999999999999999999975
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
+|.+++..........+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN---LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH---HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc---CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 888777531111235689999999999999999999984 27999999999999999999999999999876443
Q ss_pred -ccccccccccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 -NLAQALFAYKAPEAI----QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....++..|+|||++ .+..++.++|||||||++|||++|+.||...... .+.+.. ...+. .+.
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~-~~~~~-----~~~ 249 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQ-VVKGD-----PPQ 249 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CC-CCCSC-----CCC
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHH-HhcCC-----CCC
Confidence 223578889999998 4567899999999999999999999998742210 011100 00111 011
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.. .........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 250 LSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 110 0012234678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.61 Aligned_cols=240 Identities=21% Similarity=0.260 Sum_probs=182.4
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
..+.||+|+||.||.....+++.||||++..... ..+.+|+++|+++ +||||+++++++.+....++|||||. |+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 3467999999997766666899999999865332 2356899999999 79999999999999999999999996 59
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-----CCCcEEEeeecceeccc
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-----ENEPLISEFGFYTMINS 468 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~a~~~~~ 468 (621)
|.+++..... .+.+..++.++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++....
T Consensus 104 L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 104 LQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp HHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred HHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 9999975432 234445678999999999999999 9999999999999953 23578999999987643
Q ss_pred c-------ccccccccccCccccc---CCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcc
Q 045652 469 A-------NLAQALFAYKAPEAIQ---SGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537 (621)
Q Consensus 469 ~-------~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (621)
. ....+|+.|+|||++. ...++.++|||||||++|||+| |..||.... . ...........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-----~---~~~~~~~~~~~- 246 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-----Q---RQANILLGACS- 246 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-----T---HHHHHHTTCCC-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-----H---HHHHHHhccCC-
Confidence 2 2345789999999997 4567889999999999999999 888885311 1 11111111111
Q ss_pred ccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 538 ~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.... .........+.+|+.+||+.||++|||+.|+++|
T Consensus 247 ~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 LDCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111 1112445668899999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.91 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=201.4
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe------CCeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR------TDEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv 385 (621)
.+.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence 3557899999999999985 46899999998754 44556789999999999999999999998755 5667899
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCC---cEEEeeec
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENE---PLISEFGF 462 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~ 462 (621)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 97 mEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp EECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999998543 233588899999999999999999999 9999999999999997765 89999999
Q ss_pred ceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh------
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS------ 533 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------ 533 (621)
+...... ....++..|+|||++.+..++.++|||||||++|||++|..||.... ....|......
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~------~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW------QPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC------HHHHSSTTCC------C
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc------chhhhhhhhhcccchhh
Confidence 9876543 23467889999999999999999999999999999999999986421 11111000000
Q ss_pred --cCccccc--cccchh-cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHH-----HHHHHHHhhccC
Q 045652 534 --EGRVTDL--LDPEIA-SSTNSPGEMEQLLEIGRACTQSDPEQRLEMRE-----AVRRIVEIQQSD 590 (621)
Q Consensus 534 --~~~~~~~--~d~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-----vl~~L~~i~~~~ 590 (621)
....... +..... ...........+.+++.+||..||++|||+.| ..+.++.+....
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000 000000 11123456788999999999999999999988 456666666543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.66 Aligned_cols=244 Identities=19% Similarity=0.284 Sum_probs=176.3
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||.||+|... +|+.||||++..... ...+.+..+..+++.++||||+++++++.+.+..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 4568999999999999964 689999999975432 22334455566788889999999999999999999999999 5
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+.+..+.... ...+++..++.++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 108 TCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred CcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 5665555422 2458999999999999999999998 6 8999999999999999999999999998766433
Q ss_pred --ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 --NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....++..|+|||++. ...++.++|||||||++|||++|+.||.... ...+.+........ ..
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~-~~--- 249 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK------TDFEVLTKVLQEEP-PL--- 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHHSCC-CC---
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC------ccHHHHHHHhccCC-CC---
Confidence 2345788999999984 4568899999999999999999999986421 11122222222111 00
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... .......+.+++.+||+.||++||++.|++++
T Consensus 250 --~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 --LPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 11233568999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.50 Aligned_cols=234 Identities=21% Similarity=0.332 Sum_probs=191.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh------hhHHHHHHHHHHHhcCC--CCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA------MARDAFDTEVRRLGRLR--HSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 346799999999999984 5689999999864321 12245678999999996 59999999999999999999
Q ss_pred EeecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC-CCCCcEEEeeecc
Q 045652 386 YEYIPG-GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS-PENEPLISEFGFY 463 (621)
Q Consensus 386 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a 463 (621)
|||+.+ ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 127 ~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 127 LERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999976 8999999742 3589999999999999999999999 999999999999999 7889999999999
Q ss_pred eecccc--ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 464 TMINSA--NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 464 ~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
+..... ....++..|+|||++.+..+ +.++|||||||++|||++|+.||.... . ... +.. .
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~----~~~-~~~--~ 261 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------E----IIR-GQV--F 261 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H----HHH-CCC--C
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------h----hhc-ccc--c
Confidence 877543 33457889999999977665 688999999999999999999986311 0 111 110 0
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
. .......+.+++.+||+.||++|||+.|++++
T Consensus 262 ~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 F---------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11223568899999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.54 Aligned_cols=234 Identities=20% Similarity=0.325 Sum_probs=187.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChh------hHHHHHHHHHHHhcC----CCCCcccceEEEEeCCeeE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM------ARDAFDTEVRRLGRL----RHSNVLAPLAYHYRTDEKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~~~~~~~~ 383 (621)
+.+.||+|+||.||+|.. .+++.||||+++..... ....+.+|+.++.++ +||||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 457899999999999985 56899999999754321 233456799999998 8999999999999999999
Q ss_pred EEEee-cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC-CCCCcEEEeee
Q 045652 384 LVYEY-IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS-PENEPLISEFG 461 (621)
Q Consensus 384 lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG 461 (621)
+|||| +.+++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 115 ~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999 7899999999743 3589999999999999999999999 999999999999999 88999999999
Q ss_pred cceecccc--ccccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 462 FYTMINSA--NLAQALFAYKAPEAIQSGKVT-PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 462 ~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
++...... ....++..|+|||++.+..+. .++||||||+++|||++|+.||.... + + . ....
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~-~---~-~~~~- 250 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------E-I---L-EAEL- 250 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H-H---H-HTCC-
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------H-H---h-hhcc-
Confidence 99876543 334578889999998776664 58999999999999999999986311 1 1 1 1110
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.........+.+++.+||+.||++|||+.|++++
T Consensus 251 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011233568899999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=307.86 Aligned_cols=229 Identities=14% Similarity=0.125 Sum_probs=179.4
Q ss_pred HHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 467999999999999965 48999999997542 33457789999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL 471 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 471 (621)
++|.+++... ....++.+++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999521 35567889999999999999999 99999999999999999999998543
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
|++| ++.++|||||||++|||+||+.||.............. ... + ....+... .
T Consensus 175 ------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~----~~~-~---~~~~~~~~----~ 229 (286)
T 3uqc_A 175 ------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER----DTA-G---QPIEPADI----D 229 (286)
T ss_dssp ------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB----CTT-S---CBCCHHHH----C
T ss_pred ------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH----Hhc-c---CCCChhhc----c
Confidence 4443 68899999999999999999999975332111000000 000 0 00000000 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
...+..+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 1234568999999999999999 99999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=346.32 Aligned_cols=234 Identities=23% Similarity=0.315 Sum_probs=190.0
Q ss_pred HHHHcCcCCcccEEEEEEc--CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe-----eEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMA--DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE-----KLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~ 386 (621)
+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++...+. .|+||
T Consensus 84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 3467999999999999964 5899999998643 34456678999999999999999999999987665 69999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++.. .+++.+++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++..
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 99999999987642 589999999999999999999999 99999999999999975 8999999999988
Q ss_pred cccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 467 NSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 467 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
.......+|+.|+|||++.+. ++.++|||||||++|||++|..||....... +.
T Consensus 232 ~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~~-------- 285 (681)
T 2pzi_A 232 NSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LP-------- 285 (681)
T ss_dssp TCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------CC--------
T ss_pred ccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------------cc--------
Confidence 777777799999999998754 4899999999999999999988875321100 00
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCc-HHHHHHHHHHh
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLE-MREAVRRIVEI 586 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~L~~i 586 (621)
...........+.+++.+||+.||++||+ ++++...|..+
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001123357899999999999999995 55555556554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.67 Aligned_cols=226 Identities=20% Similarity=0.305 Sum_probs=175.0
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHH-hcCCCCCcccceEEEEe----CCeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRL-GRLRHSNVLAPLAYHYR----TDEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 390 (621)
+.||+|+||.||+|.. .+++.||+|+++.. ..+.+|++++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 5699999999999985 56899999998642 3467888888 55689999999999887 567899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeecceecc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTMIN 467 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 467 (621)
+|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 999999997543 24689999999999999999999999 9999999999999998 7889999999986543
Q ss_pred ccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 468 SANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 468 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
+..++.++|||||||++|||++|+.||............ ......+.. ....+.
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~----~~~~~~~~~-~~~~~~--- 225 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQY-EFPNPE--- 225 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----CCSSCTTCC-SSCHHH---
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----HHHHhhccc-cCCchh---
Confidence 245788999999999999999999999643211000000 000000000 000000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
.......+.+++.+||+.||++|||+.|+++|-
T Consensus 226 ---~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 226 ---WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp ---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---cccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 012346789999999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.10 Aligned_cols=242 Identities=11% Similarity=0.132 Sum_probs=184.7
Q ss_pred HHHHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCC--------hhhHHHHHHHHHHHhcCC---------CCCcccce
Q 045652 311 LMKAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESS--------AMARDAFDTEVRRLGRLR---------HSNVLAPL 373 (621)
Q Consensus 311 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l~ 373 (621)
-.|.+.+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|++++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4567788999999999999998 78999999987432 223477889999998886 77777777
Q ss_pred EEEE-----------------e-------------CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 045652 374 AYHY-----------------R-------------TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIAR 423 (621)
Q Consensus 374 ~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 423 (621)
+++. + .+..++||||+++|++.+.+.+ ..+++..++.++.||+.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHH
Confidence 6643 1 6778999999999987766642 35899999999999999
Q ss_pred HHHHHH-hccCCCCCccCCCCCCCEEeCCCC--------------------CcEEEeeecceeccccccccccccccCcc
Q 045652 424 GIGYLH-TELAHLDLPHGNLKSSNIFISPEN--------------------EPLISEFGFYTMINSANLAQALFAYKAPE 482 (621)
Q Consensus 424 ~L~~LH-~~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~y~aPE 482 (621)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...+|..|+|||
T Consensus 173 aL~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSG
T ss_pred HHHHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChh
Confidence 999999 88 999999999999999887 8999999999877543 447889999999
Q ss_pred cccCCCCCcchhhHHHHHH-HHHHHhCCCCCCcccCCCCCcchHHHHHHHhh-cCccccccccchhcCCCCHHHHHHHHH
Q 045652 483 AIQSGKVTPKCDVYCLGII-ILEILTGKFPSQYLTNGNGGIDVVEWVASAFS-EGRVTDLLDPEIASSTNSPGEMEQLLE 560 (621)
Q Consensus 483 ~~~~~~~~~~~DvwSlGvv-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~l~~ 560 (621)
++.+.. +.++||||++++ .+++++|..||... .........+. ......... ........+++.+
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~d 314 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMTFKTKCN-----TPAMKQIKRKIQE 314 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCCCSSCCC-----SHHHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhccCcccc-----hhhhhhcCHHHHH
Confidence 998666 899999998777 77888899987521 00011111111 111110000 0112456788999
Q ss_pred HHhhcccCCCCCCCcHHHHH-HH
Q 045652 561 IGRACTQSDPEQRLEMREAV-RR 582 (621)
Q Consensus 561 li~~cl~~dP~~Rps~~evl-~~ 582 (621)
|+.+||+.| |++|++ +|
T Consensus 315 li~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHhccC-----CHHHHHhcC
Confidence 999999977 999998 54
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=316.86 Aligned_cols=237 Identities=19% Similarity=0.184 Sum_probs=176.2
Q ss_pred HHcCcCCcccEEEEE-EcCCcEEEEEEccCCCh---hhHHHHHHHHHHHhcCCC-CCc---------ccceEE-------
Q 045652 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA---MARDAFDTEVRRLGRLRH-SNV---------LAPLAY------- 375 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------v~l~~~------- 375 (621)
+.||+|+||.||+|. ..+|+.||||+++.... ...+.+.+|+.+++.++| +|. +...+.
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 579999999999999 45699999999873322 235678999999999987 321 111111
Q ss_pred -----EEe-----CCeeEEEEeecCCCChhHHhhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCC
Q 045652 376 -----HYR-----TDEKLLVYEYIPGGSLLYLLHGDR--GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLK 443 (621)
Q Consensus 376 -----~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlk 443 (621)
+.. ....+++|+++ +++|.+++.... ......+++..++.++.||+.||+|||++ +|+|||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iiHrDiK 238 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYLR 238 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCCC
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcc
Confidence 111 12356777776 679999884110 01234578889999999999999999999 99999999
Q ss_pred CCCEEeCCCCCcEEEeeecceecccc-ccccccccccCcccc----------cCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 045652 444 SSNIFISPENEPLISEFGFYTMINSA-NLAQALFAYKAPEAI----------QSGKVTPKCDVYCLGIIILEILTGKFPS 512 (621)
Q Consensus 444 p~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~~~DvwSlGvvl~elltg~~P~ 512 (621)
|+|||++.++.+||+|||+++..... ....+ ..|+|||++ .+..++.++|||||||++|||+||+.||
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999876554 23345 899999999 5556889999999999999999999999
Q ss_pred CcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 513 QYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....... .. ...+... ...+..+.+|+.+||+.||++||++.|++++
T Consensus 318 ~~~~~~~----~~----------------~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 318 TDDAALG----GS----------------EWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CTTGGGS----CS----------------GGGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcchhh----hH----------------HHHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 7432110 00 0001000 1123568999999999999999998888655
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=283.77 Aligned_cols=180 Identities=15% Similarity=0.096 Sum_probs=128.5
Q ss_pred cCcCCcccEEEEE-EcCCcEEEEEEccCCC----------hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEE
Q 045652 319 LGNGGLGSSYKAM-MADGVTVVVKRMKESS----------AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 319 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.|+.|.+..++ ...|+.|++|++.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5666676666654 3458899999986431 23456799999999999 6999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||++|++|.++|.... .++.. +|+.||+.||+|+|++ |||||||||+|||++.++.+||+|||+|+..
T Consensus 322 Eyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp ECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred ecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999998533 35543 5899999999999999 9999999999999999999999999999876
Q ss_pred ccc----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 045652 467 NSA----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511 (621)
Q Consensus 467 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P 511 (621)
... ....||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 543 33468899999999875 567789999999998887766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-27 Score=256.16 Aligned_cols=178 Identities=18% Similarity=0.260 Sum_probs=144.9
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh--------hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA--------MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
..+.||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 578889988643211 12455899999999999999998777777888889999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++..
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 99999999999863 457999999999999999 9999999999999998 9999999999987
Q ss_pred ccc-----------ccccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 045652 467 NSA-----------NLAQALFAYKAPEAIQS--GKVTPKCDVYCLGIIILEILTGKFPS 512 (621)
Q Consensus 467 ~~~-----------~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~ 512 (621)
... ....+|+.|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 653 23467889999999976 56888899999999988888877665
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=213.30 Aligned_cols=159 Identities=30% Similarity=0.599 Sum_probs=142.4
Q ss_pred cHHHHHHHHHHcCCCCCCCCCCCCCCCCCCCCCCceeeEEeCC----CcEEEEEecCCCCee--eeCcccccccCCCCCC
Q 045652 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLK----GIVTGLYINSMGLSG--KIDVDALTELTGLRGL 75 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~~~l~~w~~~~~~c~~~~~~w~gv~c~~----~~v~~l~l~~~~l~g--~~~~~~~~~l~~l~~L 75 (621)
+|++||++||+++.++..+.+|..+++||.. .|.||+|.. ++|+.|+|++++++| .+|. .+..+++|
T Consensus 6 ~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~---~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~----~l~~l~~L 78 (313)
T 1ogq_A 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNR---TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS----SLANLPYL 78 (313)
T ss_dssp HHHHHHHHHHHHTTCCGGGTTCCTTSCTTTT---CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG----GGGGCTTC
T ss_pred HHHHHHHHHHHhcCCcccccCCCCCCCCCcC---CCcceEeCCCCCCceEEEEECCCCCccCCcccCh----hHhCCCCC
Confidence 4789999999999877778999877888853 499999974 799999999999999 7874 56778899
Q ss_pred CEEecCC-CcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcc
Q 045652 76 RAIYLDK-NQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLS 152 (621)
Q Consensus 76 ~~l~l~~-N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~ 152 (621)
++|+|++ |.++|.+|.. ++.+++|++|+|++|+++|.+|..+.++++|++|+|++|+++|.+|.. .+++|+.|+|+
T Consensus 79 ~~L~L~~~n~l~~~~p~~-l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPA-IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGG-GGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CeeeCCCCCcccccCChh-HhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 9999994 9999999987 899999999999999999999999999999999999999999999864 68999999999
Q ss_pred cCccccccCccccccc
Q 045652 153 SNKLEGEIPASLLRFN 168 (621)
Q Consensus 153 ~N~l~g~ip~~~~~~~ 168 (621)
+|+++|.+|..+.++.
T Consensus 158 ~N~l~~~~p~~l~~l~ 173 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFS 173 (313)
T ss_dssp SSCCEEECCGGGGCCC
T ss_pred CCcccCcCCHHHhhhh
Confidence 9999999998876654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-23 Score=208.15 Aligned_cols=139 Identities=19% Similarity=0.204 Sum_probs=114.4
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCCh------------------hhHHHHHHHHHHHhcCCCCCcccceEEEEe
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSA------------------MARDAFDTEVRRLGRLRHSNVLAPLAYHYR 378 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 378 (621)
+.||+|+||.||+|...+|+.||+|.++.... .....+.+|++++++++ | +++.+++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence 78999999999999997799999999864321 23567899999999999 5 677775543
Q ss_pred CCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEE
Q 045652 379 TDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLIS 458 (621)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 458 (621)
+..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++.+||+
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE-TTEEEEC
T ss_pred -cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE-CCcEEEE
Confidence 55699999999999988 421 12347999999999999999 999999999999999 9999999
Q ss_pred eeecceeccccccccccccccCccccc
Q 045652 459 EFGFYTMINSANLAQALFAYKAPEAIQ 485 (621)
Q Consensus 459 DfG~a~~~~~~~~~~~~~~y~aPE~~~ 485 (621)
|||+++.. ..|+|||++.
T Consensus 235 DFG~a~~~---------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV---------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET---------TSTTHHHHHH
T ss_pred ECCCCeEC---------CCCCHHHHHH
Confidence 99998643 3478888874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=215.54 Aligned_cols=131 Identities=24% Similarity=0.382 Sum_probs=109.6
Q ss_pred cHHHHHHHHHHcCCCCCCCCCCCCCCCCCCCCCCceeeEEeCCCcEEEEEecCCCCeee---eCcccc------------
Q 045652 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGK---IDVDAL------------ 66 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~~~l~~w~~~~~~c~~~~~~w~gv~c~~~~v~~l~l~~~~l~g~---~~~~~~------------ 66 (621)
+|++||++||+++.++..+.+|+.+++||. |.||+|+.++|+.|+|+++++.|. +++ .+
T Consensus 12 ~~~~all~~k~~~~~~~~l~~W~~~~~~C~-----w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~-~l~~L~~L~~l~~~ 85 (768)
T 3rgz_A 12 REIHQLISFKDVLPDKNLLPDWSSNKNPCT-----FDGVTCRDDKVTSIDLSSKPLNVGFSAVSS-SLLSLTGLESLFLS 85 (768)
T ss_dssp HHHHHHHHHHTTCSCTTSSTTCCTTSCGGG-----STTEEEETTEEEEEECTTSCCCEEHHHHHH-HTTTCTTCCEEECT
T ss_pred HHHHHHHHHHhhCCCcccccCCCCCCCCcC-----CcceEECCCcEEEEECCCCCcCCccCccCh-hHhccCcccccCCc
Confidence 489999999999987668899987788885 999999999999999999999998 553 11
Q ss_pred --------cccCCCCCCCEEecCCCcccccCCc--ccccCCCCCCEEeCccCcccccCCCCC-CCCCCcCeeeccCcccc
Q 045652 67 --------TELTGLRGLRAIYLDKNQFSGEIPP--GYFDEMGALRKLWFSNNKFRGRLPPSL-FKLPHLTELHLESNQFN 135 (621)
Q Consensus 67 --------~~l~~l~~L~~l~l~~N~l~g~ip~--~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~ 135 (621)
..+..|++|++|+|++|.|+|.+|. . ++++++|++|+|++|.++|.+|..+ .++++|++|+|++|+++
T Consensus 86 ~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 86 NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS-LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp TSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGG-GGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred CCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHH-HhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 3566778999999999999999987 6 8889999999999999998888775 66777777777777776
Q ss_pred ccCC
Q 045652 136 GTIP 139 (621)
Q Consensus 136 g~~p 139 (621)
+.+|
T Consensus 165 ~~~~ 168 (768)
T 3rgz_A 165 GANV 168 (768)
T ss_dssp EETH
T ss_pred CcCC
Confidence 6554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.4e-21 Score=216.61 Aligned_cols=154 Identities=23% Similarity=0.399 Sum_probs=134.0
Q ss_pred cHHHHHHHHHHcCCCCCCCCCCCCCC-----CCCCCCCCce------------eeEEeC-CCcEEEEEecCCCCeeeeCc
Q 045652 2 SESEALLKLKSSFTNAKALDSWMPST-----APCRGGEEEW------------SGVVCL-KGIVTGLYINSMGLSGKIDV 63 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~~~l~~w~~~~-----~~c~~~~~~w------------~gv~c~-~~~v~~l~l~~~~l~g~~~~ 63 (621)
+|++||++||+++.++ +|+.++ +|| .|.| .||+|+ .++|+.|+|++++|+|.||+
T Consensus 269 ~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~---~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 269 KDYKALKAIWEALDGK----NWRYYSGTINNTIH---SLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHTTGG----GCCCCCSSCSSCCC---CCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred HHHHHHHHHHHHcCCC----CCCcCCCcccccCC---ccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 4899999999999765 787544 562 1249 999997 58999999999999999994
Q ss_pred ccccccCCCCCCCEEec-CCCccccc------------------------------------------------------
Q 045652 64 DALTELTGLRGLRAIYL-DKNQFSGE------------------------------------------------------ 88 (621)
Q Consensus 64 ~~~~~l~~l~~L~~l~l-~~N~l~g~------------------------------------------------------ 88 (621)
.+..|++|+.|+| ++|.++|.
T Consensus 342 ----~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 342 ----AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp ----GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred ----HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 5778889999999 88877766
Q ss_pred ----------------------CCcccccCCCCCCEEeCccCcccc-----------------cCCCCCC--CCCCcCee
Q 045652 89 ----------------------IPPGYFDEMGALRKLWFSNNKFRG-----------------RLPPSLF--KLPHLTEL 127 (621)
Q Consensus 89 ----------------------ip~~~~~~l~~L~~l~l~~N~l~g-----------------~~p~~~~--~l~~L~~l 127 (621)
||.+ +++|++|+.|+|++|+|+| .+|..++ ++++|++|
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~-l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKA-IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred ccccccchhhceeccccCcccchhHH-HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 8876 8999999999999999999 4999998 99999999
Q ss_pred eccCccccccCCCC--CCCCccEEEcccCc-ccc-ccCcccccc
Q 045652 128 HLESNQFNGTIPSF--DQPTLVRLNLSSNK-LEG-EIPASLLRF 167 (621)
Q Consensus 128 ~l~~N~l~g~~p~~--~~~~L~~l~l~~N~-l~g-~ip~~~~~~ 167 (621)
+|++|++.|.+|.. .+++|+.|+|++|+ |+| .+|..+.++
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L 540 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540 (876)
T ss_dssp EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhh
Confidence 99999999999974 68999999999998 999 899876544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.2e-20 Score=206.14 Aligned_cols=155 Identities=20% Similarity=0.362 Sum_probs=135.8
Q ss_pred cHHHHHHHHHHcCCCCC---------CCCCCCCCCCCCCCCCCce---eeEEeC-CCcEEEEEecCCCCeeeeCcccccc
Q 045652 2 SESEALLKLKSSFTNAK---------ALDSWMPSTAPCRGGEEEW---SGVVCL-KGIVTGLYINSMGLSGKIDVDALTE 68 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~~---------~l~~w~~~~~~c~~~~~~w---~gv~c~-~~~v~~l~l~~~~l~g~~~~~~~~~ 68 (621)
.|+.||.+|++++..+. ...+|+.++++|. | .||+|+ .++|+.|+|++++++|.+|. .
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~-----w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~----~ 100 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDM-----WGAQPGVSLNSNGRVTGLSLEGFGASGRVPD----A 100 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGG-----TTCCTTEEECTTCCEEEEECTTSCCEEEECG----G
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCccc-----ccCCCCeEEcCCCCEEEEEecCcccCCcCCh----H
Confidence 48899999999987542 2347988888885 9 999995 47999999999999999994 5
Q ss_pred cCCCCCCCEEecCCC-----------------------------------------------------------------
Q 045652 69 LTGLRGLRAIYLDKN----------------------------------------------------------------- 83 (621)
Q Consensus 69 l~~l~~L~~l~l~~N----------------------------------------------------------------- 83 (621)
+..|++|++|+|++|
T Consensus 101 l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~ 180 (636)
T 4eco_A 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180 (636)
T ss_dssp GGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred HhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence 778889999999988
Q ss_pred -------------cccccCCcccccCCCCCCEEeCccCccccc-----------------CCCCCC--CCCCcCeeeccC
Q 045652 84 -------------QFSGEIPPGYFDEMGALRKLWFSNNKFRGR-----------------LPPSLF--KLPHLTELHLES 131 (621)
Q Consensus 84 -------------~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~-----------------~p~~~~--~l~~L~~l~l~~ 131 (621)
+|+| ||.+ ++++++|++|+|++|+|+|. +|..++ ++++|++|+|++
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~ 258 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKA-VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEEC
T ss_pred cchhhhhhccccCCCcc-CCHH-HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecC
Confidence 4556 8887 89999999999999999997 999999 999999999999
Q ss_pred ccccccCCCC--CCCCccEEEcccCc-ccc-ccCcccccc
Q 045652 132 NQFNGTIPSF--DQPTLVRLNLSSNK-LEG-EIPASLLRF 167 (621)
Q Consensus 132 N~l~g~~p~~--~~~~L~~l~l~~N~-l~g-~ip~~~~~~ 167 (621)
|++.|.+|.. .+++|+.|+|++|+ |+| .+|..+.++
T Consensus 259 n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L 298 (636)
T 4eco_A 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298 (636)
T ss_dssp CTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred CcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhh
Confidence 9999999975 68999999999999 999 999876543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=179.92 Aligned_cols=135 Identities=21% Similarity=0.267 Sum_probs=104.1
Q ss_pred HHcCcCCcccEEEEEE-cCCcE--EEEEEccCCCh------------------------hhHHHHHHHHHHHhcCCCCCc
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVT--VVVKRMKESSA------------------------MARDAFDTEVRRLGRLRHSNV 369 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~ni 369 (621)
+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+++|.++.|+++
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5799999999999997 78989 99998754311 112367899999999988865
Q ss_pred ccceEEEEeCCeeEEEEeecCC-C----ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hccCCCCCccCCCC
Q 045652 370 LAPLAYHYRTDEKLLVYEYIPG-G----SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH-TELAHLDLPHGNLK 443 (621)
Q Consensus 370 v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~~ivH~Dlk 443 (621)
....-+.. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|||||
T Consensus 133 ~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~----givHrDlk 198 (258)
T 1zth_A 133 SVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA----ELVHADLS 198 (258)
T ss_dssp CCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS----CEECSSCS
T ss_pred CCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC----CEEeCCCC
Confidence 33222222 356899999942 3 67666431 224456789999999999999 88 99999999
Q ss_pred CCCEEeCCCCCcEEEeeecceecc
Q 045652 444 SSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 444 p~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+|||++. .++|+|||++....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 89999999997653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=205.91 Aligned_cols=120 Identities=31% Similarity=0.494 Sum_probs=109.9
Q ss_pred cCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCc
Q 045652 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTL 146 (621)
Q Consensus 69 l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L 146 (621)
+..+.+|++|+|++|+|+|.||.+ ++++++|+.|+|++|+|+|.||.+++++++|++|||++|+|+|.+|.. .+++|
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L 706 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKE-IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGG-GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC
T ss_pred hhccccccEEECcCCcccccCCHH-HhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence 334678999999999999999987 999999999999999999999999999999999999999999999975 68999
Q ss_pred cEEEcccCccccccCcc--ccccccCCCCCCCCCCCCCCCCCcccc
Q 045652 147 VRLNLSSNKLEGEIPAS--LLRFNASSFSGNAGLCGKNLGVECRNA 190 (621)
Q Consensus 147 ~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~~c~~~~~~~c~~~ 190 (621)
++|||++|+|+|.||.. +..++..+|.||+++||.|+. .|...
T Consensus 707 ~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp SEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred CEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 99999999999999974 667888899999999999986 78543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.5e-18 Score=173.88 Aligned_cols=160 Identities=18% Similarity=0.258 Sum_probs=133.2
Q ss_pred cHHHHHHHHHHcCC-CC-CCCCCCC----CCCCCCCCCCCceeeEEeC----------CCcEEEEEecCCCCeeeeCccc
Q 045652 2 SESEALLKLKSSFT-NA-KALDSWM----PSTAPCRGGEEEWSGVVCL----------KGIVTGLYINSMGLSGKIDVDA 65 (621)
Q Consensus 2 ~~~~~l~~~k~~~~-~~-~~l~~w~----~~~~~c~~~~~~w~gv~c~----------~~~v~~l~l~~~~l~g~~~~~~ 65 (621)
+|.+||++||..+. ++ +.+.+|. .+.++|. |.|+.|. ..+|+.|+|++++++ .||.
T Consensus 27 ~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~-----~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~-- 98 (328)
T 4fcg_A 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET-----RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD-- 98 (328)
T ss_dssp CHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC-----SHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS--
T ss_pred hHHHHHHHHHHhccCCchhhhhhhcccccccccccc-----cCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh--
Confidence 58899999999884 33 3467883 3466675 9999994 378999999999998 6774
Q ss_pred ccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCC---
Q 045652 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFD--- 142 (621)
Q Consensus 66 ~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--- 142 (621)
.+..|++|++|+|++|.|+ .||.. ++.+++|++|+|++|+|+ .+|..++++++|++|+|++|++.|.+|...
T Consensus 99 --~l~~l~~L~~L~L~~n~l~-~lp~~-~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~ 173 (328)
T 4fcg_A 99 --QAFRLSHLQHMTIDAAGLM-ELPDT-MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173 (328)
T ss_dssp --CGGGGTTCSEEEEESSCCC-CCCSC-GGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE
T ss_pred --hhhhCCCCCEEECCCCCcc-chhHH-HhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc
Confidence 3556789999999999999 89987 899999999999999999 899999999999999999999999999752
Q ss_pred --------CCCccEEEcccCccccccCcccccccc---CCCCCC
Q 045652 143 --------QPTLVRLNLSSNKLEGEIPASLLRFNA---SSFSGN 175 (621)
Q Consensus 143 --------~~~L~~l~l~~N~l~g~ip~~~~~~~~---~~~~~n 175 (621)
+++|+.|+|++|+++ .+|..+..+.. ..+.+|
T Consensus 174 ~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N 216 (328)
T 4fcg_A 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216 (328)
T ss_dssp C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESS
T ss_pred cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCC
Confidence 789999999999999 89987765543 334455
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-16 Score=153.08 Aligned_cols=150 Identities=23% Similarity=0.332 Sum_probs=121.8
Q ss_pred CCCCCCCCCCCCCCCCceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccccc
Q 045652 20 LDSWMPSTAPCRGGEEEWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE 88 (621)
Q Consensus 20 l~~w~~~~~~c~~~~~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ 88 (621)
..-|+.++..|+ |.+|.|.. ..++.|+|++|.+++..+ ..+..+.+|++|+|++|+|+ .
T Consensus 9 ~~~~~~~~~~Cs-----~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~----~~~~~l~~L~~L~L~~N~l~-~ 78 (229)
T 3e6j_A 9 HSAACPSQCSCS-----GTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP----GVFDSLINLKELYLGSNQLG-A 78 (229)
T ss_dssp --CCCCTTCEEE-----TTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT----TTTTTCTTCCEEECCSSCCC-C
T ss_pred hhccCCCCCEEe-----CCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH----HHhhCccCCcEEECCCCCCC-C
Confidence 335555677786 99999952 358899999999998544 35677889999999999997 6
Q ss_pred CCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc-
Q 045652 89 IPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL- 165 (621)
Q Consensus 89 ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~- 165 (621)
+|+..|..+++|+.|+|++|+|++..|..+..+++|++|+|++|+|+ .+|.. .+++|+.|+|++|+|++..+..+.
T Consensus 79 i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 157 (229)
T 3e6j_A 79 LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157 (229)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred cChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhC
Confidence 88887899999999999999999877777899999999999999999 77764 679999999999999954444444
Q ss_pred --ccccCCCCCCCCCCC
Q 045652 166 --RFNASSFSGNAGLCG 180 (621)
Q Consensus 166 --~~~~~~~~~n~~~c~ 180 (621)
++....+.+|+..|.
T Consensus 158 l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 158 LSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CTTCCEEECTTSCBCTT
T ss_pred CCCCCEEEeeCCCccCC
Confidence 344556778877663
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-17 Score=168.71 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=100.2
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh--------------h--------hHHHHHHHHHHHhcCCCCCcccce
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA--------------M--------ARDAFDTEVRRLGRLRHSNVLAPL 373 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~--------~~~~~~~E~~~l~~l~h~niv~l~ 373 (621)
.+.||+|+||.||+|...+|+.||||+++.... . .+-...+|...|.++.+.++....
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 467999999999999988999999998753210 0 011124677788888655543332
Q ss_pred EEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC
Q 045652 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453 (621)
Q Consensus 374 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~ 453 (621)
-+... ..+|||||++|++|.++.. . .....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 180 p~~~~--~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 180 PIAQS--RHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKH----GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp EEEEE--TTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEEEEE
T ss_pred eeecc--CceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeCCC
Confidence 22222 3479999999988876532 1 12356889999999999998 999999999999999877
Q ss_pred C----------cEEEeeecceeccc
Q 045652 454 E----------PLISEFGFYTMINS 468 (621)
Q Consensus 454 ~----------~kl~DfG~a~~~~~ 468 (621)
. +.|+||+.+....+
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CcccccccccceEEEEeCCcccCCC
Confidence 3 78999998766544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=6e-16 Score=149.07 Aligned_cols=142 Identities=18% Similarity=0.229 Sum_probs=117.9
Q ss_pred CceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEE
Q 045652 35 EEWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKL 103 (621)
Q Consensus 35 ~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l 103 (621)
|.|..+.|.. ..++.|+|++|++++..+. ..+..+++|+.|+|++|+|++ +|+..|..+++|+.|
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~L~~N~i~~-i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEAT---GIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEI 86 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCC---CCGGGCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEE
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCch---hhhccCCCCCEEECCCCcCCE-ECHHHhCCCCCCCEE
Confidence 3588999952 2467899999999985553 235678899999999999995 666569999999999
Q ss_pred eCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccccc---cCCCCCCCCC
Q 045652 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGNAGL 178 (621)
Q Consensus 104 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~~ 178 (621)
+|++|+|++..|..+.++++|++|+|++|++++..|.. .+++|+.|+|++|+|++..|..+..+. ...+.+|+..
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 99999999888888999999999999999999887764 579999999999999988787766544 4567888776
Q ss_pred CC
Q 045652 179 CG 180 (621)
Q Consensus 179 c~ 180 (621)
|.
T Consensus 167 c~ 168 (220)
T 2v70_A 167 CN 168 (220)
T ss_dssp CS
T ss_pred CC
Confidence 64
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.9e-15 Score=144.31 Aligned_cols=141 Identities=23% Similarity=0.214 Sum_probs=114.9
Q ss_pred CceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEE
Q 045652 35 EEWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKL 103 (621)
Q Consensus 35 ~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l 103 (621)
|.|..|.|.. ..++.|+|++|++++ ++. ..+..+++|+.|+|++|++++..|. .|..+++|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~---~~~~~l~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L 85 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPP---GAFSPYKKLRRIDLSNNQISELAPD-AFQGLRSLNSL 85 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECT---TSSTTCTTCCEEECCSSCCCEECTT-TTTTCSSCCEE
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCH---hHhhCCCCCCEEECCCCcCCCcCHH-HhhCCcCCCEE
Confidence 4689999952 368999999999986 443 3567788999999999999965555 49999999999
Q ss_pred eCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc---cccCCCCCCCCC
Q 045652 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR---FNASSFSGNAGL 178 (621)
Q Consensus 104 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~n~~~ 178 (621)
+|++|.|+...+..+..+++|++|+|++|++++..|.. .+++|+.|+|++|+|++..|..+.. +....+.+|++.
T Consensus 86 ~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 86 VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 99999999655555789999999999999999877764 5799999999999999766655544 445567888877
Q ss_pred CC
Q 045652 179 CG 180 (621)
Q Consensus 179 c~ 180 (621)
|.
T Consensus 166 c~ 167 (220)
T 2v9t_B 166 CD 167 (220)
T ss_dssp CS
T ss_pred CC
Confidence 74
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.62 E-value=4.9e-16 Score=158.26 Aligned_cols=110 Identities=32% Similarity=0.467 Sum_probs=74.7
Q ss_pred CCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcc
Q 045652 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLS 152 (621)
Q Consensus 75 L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~ 152 (621)
|+.|+|++|++++.+|.. +..+++|+.|+|++|.+++.+|. +..+++|++|+|++|+++|.+|.. .+++|+.|+|+
T Consensus 199 L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 276 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVL-FGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276 (313)
T ss_dssp CSEEECCSSEEEECCGGG-CCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred ccEEECcCCcccCcCCHH-HhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECc
Confidence 555555555555444433 56666666666666666665554 666677777777777777777753 46778888888
Q ss_pred cCccccccCcc--ccccccCCCCCCCCCCCCCCCCCc
Q 045652 153 SNKLEGEIPAS--LLRFNASSFSGNAGLCGKNLGVEC 187 (621)
Q Consensus 153 ~N~l~g~ip~~--~~~~~~~~~~~n~~~c~~~~~~~c 187 (621)
+|+|+|.+|.. +.++....+.+|+++||.|+. .|
T Consensus 277 ~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 88888888864 345556678899999988765 45
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.58 E-value=7.8e-15 Score=138.04 Aligned_cols=143 Identities=25% Similarity=0.332 Sum_probs=106.6
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..+.|.. ..++.|+|++|.+++..+. ..+..+++|++|+|++|+|++.+|.. |..+++|+.|+
T Consensus 9 ~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~ 84 (192)
T 1w8a_A 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSD---GLFGRLPHLVKLELKRNQLTGIEPNA-FEGASHIQELQ 84 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCS---CSGGGCTTCCEEECCSSCCCCBCTTT-TTTCTTCCEEE
T ss_pred CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCc---cccccCCCCCEEECCCCCCCCcCHhH-cCCcccCCEEE
Confidence 588888852 2678888998888763332 12566788999999999999655554 88899999999
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc-c-cccCCCCCCCCCCC
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL-R-FNASSFSGNAGLCG 180 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~n~~~c~ 180 (621)
|++|+|++..|..+.++++|++|+|++|+|++.+|.. .+++|+.|+|++|.|++..+-.+. . +....+.++...|+
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 9999999888888889999999999999999887764 578899999999999887763221 1 22223445555566
Q ss_pred CC
Q 045652 181 KN 182 (621)
Q Consensus 181 ~~ 182 (621)
.|
T Consensus 165 ~P 166 (192)
T 1w8a_A 165 AP 166 (192)
T ss_dssp SS
T ss_pred CC
Confidence 54
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-14 Score=138.31 Aligned_cols=140 Identities=23% Similarity=0.293 Sum_probs=114.0
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|.+|.|.. ..++.|+|++|++++ ++. ..+..+++|++|+|++|+++ .+|+..|..+++|++|+
T Consensus 8 ~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~---~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 8 SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPN---GVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCT---TTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CCh---hhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEE
Confidence 599999952 358899999999985 443 24667889999999999999 58877789999999999
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc---ccccCCCCCCCCCC
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL---RFNASSFSGNAGLC 179 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~c 179 (621)
|++|+|++..+..+.++++|++|+|++|++++..+.. ..++|+.|+|++|++++..+..+. ++....+.+|+..|
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 9999999766667899999999999999999665543 579999999999999965554444 34455677887665
Q ss_pred C
Q 045652 180 G 180 (621)
Q Consensus 180 ~ 180 (621)
.
T Consensus 163 ~ 163 (208)
T 2o6s_A 163 T 163 (208)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.53 E-value=3.2e-14 Score=133.82 Aligned_cols=130 Identities=23% Similarity=0.343 Sum_probs=107.7
Q ss_pred EeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCC
Q 045652 41 VCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK 120 (621)
Q Consensus 41 ~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~ 120 (621)
.|.. +.++++++++. .||. .+. .+|+.|+|++|+|++..|...|+.+++|++|+|++|+|++..|..|.+
T Consensus 7 ~C~~---~~l~~s~~~l~-~ip~----~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 76 (192)
T 1w8a_A 7 HCEG---TTVDCTGRGLK-EIPR----DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76 (192)
T ss_dssp EEET---TEEECTTSCCS-SCCS----CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred EECC---CEEEcCCCCcC-cCcc----CCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCC
Confidence 6753 57899999994 5774 222 389999999999996444445899999999999999999999999999
Q ss_pred CCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccccc---cCCCCCCCCCCC
Q 045652 121 LPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGNAGLCG 180 (621)
Q Consensus 121 l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~~c~ 180 (621)
+++|++|+|++|+|++..|.. .+++|+.|+|++|+|++.+|..+..+. ...+.+|+..|.
T Consensus 77 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 999999999999999887763 679999999999999998898766544 456778877664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.3e-14 Score=131.02 Aligned_cols=121 Identities=25% Similarity=0.363 Sum_probs=86.9
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|.++.|.. ..++.|+|++|++++ ++. ..+..+++|++|+|++|+|+ .+|+..|..+++|+.|+
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~---~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~ 82 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQS-LPH---GVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILY 82 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCC-CCT---TTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccE-eCH---HHhcCcccccEEECCCCcce-EeChhHccCCCccCEEE
Confidence 599999952 356777888877774 332 23456677888888888887 46666577788888888
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccC
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
|++|+|++..|..+.++++|++|+|++|+|++..+.. .+++|+.|+|++|.+++..|
T Consensus 83 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 83 LHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8888888666666777888888888888887443332 36778888888888877665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-14 Score=166.95 Aligned_cols=135 Identities=19% Similarity=0.216 Sum_probs=107.1
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccc----cCCcccccCCCCCCEEeCccCcccccCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSG----EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK 120 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g----~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~ 120 (621)
..++.|+|++|++++..+. ..+..+.+|+.|+|++|.+++ .+++..|..+++|+.|+|++|+|++..|..+.+
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~---~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 502 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGD---QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502 (844)
T ss_dssp TTCCEEEEESCCCCCCCSS---SSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSS
T ss_pred CccceeeCCCCcccccccc---cccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccc
Confidence 3456666776666653221 123346778888888888862 222344888999999999999999988999999
Q ss_pred CCCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCccccccccCCCCCCCCCCCCC
Q 045652 121 LPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGNAGLCGKN 182 (621)
Q Consensus 121 l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n~~~c~~~ 182 (621)
+++|++|+|++|+|++..|....++|+.|+|++|+|+|.+|..+.++....+.+|++.|..+
T Consensus 503 l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 503 LTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred hhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 99999999999999976666556899999999999999999988888888899999999654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-13 Score=135.57 Aligned_cols=125 Identities=26% Similarity=0.333 Sum_probs=89.6
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+|++|++++..+ ..+..+++|++|+|++|+|++ +++..|..+++|++|+|++|+|++..|..+..+++|+
T Consensus 36 ~l~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 110 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSD----ATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLD 110 (251)
T ss_dssp TCCEEECTTSCCCCCCT----TTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred CCCEEEccCCCcCccCH----hHhcCcccCCEEECCCCcCCc-cCHhHhccCCcCCEEECCCCcccccChhHhcccCCCC
Confidence 57889999999887443 346677788888888888885 5555578888888888888888876667778888888
Q ss_pred eeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc---cccCCCCCC
Q 045652 126 ELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR---FNASSFSGN 175 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~n 175 (621)
+|+|++|+|++..|.. ..++|+.|+|++|+|++..|..+.. +....+.+|
T Consensus 111 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 111 KLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 8888888887544432 4678888888888888544444433 333344555
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.7e-13 Score=134.75 Aligned_cols=116 Identities=16% Similarity=0.181 Sum_probs=71.7
Q ss_pred eeeEEeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC
Q 045652 37 WSGVVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP 116 (621)
Q Consensus 37 w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~ 116 (621)
|.|+.|.. ..+.+++++++++. +|. .+. .+|+.|+|++|++++ +++..|..+++|++|+|++|+|++..|.
T Consensus 7 ~~gC~C~~-~~~~l~~~~~~l~~-~p~----~~~--~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 7 VTGCTCNE-GKKEVDCQGKSLDS-VPS----GIP--ADTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp HHSSEEEG-GGTEEECTTCCCSS-CCS----CCC--TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred CCceEcCC-CCeEEecCCCCccc-cCC----CCC--CCCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 66777732 23346666666653 443 111 366777777777774 4433466777777777777777766666
Q ss_pred CCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccC
Q 045652 117 SLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 117 ~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
.+.++++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..|
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 124 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPS 124 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred HhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcCh
Confidence 6677777777777777776444432 45677777777777774333
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.46 E-value=3.7e-13 Score=133.96 Aligned_cols=111 Identities=28% Similarity=0.350 Sum_probs=69.8
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++ + ..+..+++|++|+|++|.+++ +|+..++.+++|++|+|++|++++..|..+.++++|
T Consensus 63 ~~L~~L~l~~n~l~~-~-----~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 135 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-----SALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNL 135 (272)
T ss_dssp TTCCEEECTTSCCCC-C-----GGGTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred CCCcEEECCCCCCCC-c-----hhhcCCCCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCC
Confidence 456777777777665 2 235556667777777777763 454446666777777777777766555556666777
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCc
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~ 162 (621)
++|+|++|++++..|.. ..++|+.|+|++|++++..|.
T Consensus 136 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 175 (272)
T 3rfs_A 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEG 175 (272)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHH
Confidence 77777777666444432 456666777777766654443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=141.51 Aligned_cols=117 Identities=22% Similarity=0.318 Sum_probs=62.3
Q ss_pred CcEEEEEecCCCCeeeeCccccc------ccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALT------ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSL 118 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~------~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~ 118 (621)
..+..|+|++|++.+.+|.. +. .+.++++|++|+|++|+|+ .||.. ++.+++|+.|+|++|++++ +|..+
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~-~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~-l~~l~~L~~L~L~~N~l~~-l~~~l 225 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEP-LASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNSPLSA-LGPAI 225 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSC-SEEEC-CCCEEESTTCCEEEEEEECCC-CCCGG-GGGCTTCCEEEEESSCCCC-CCGGG
T ss_pred cCCCEEECCCCCCccccChh-HhhccchhhhccCCCCCEEECcCCCcC-cchHh-hcCCCCCCEEEccCCCCCc-Cchhh
Confidence 35666666666666666531 11 1223455555555555555 45544 5555555555555555553 44455
Q ss_pred CCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc
Q 045652 119 FKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 119 ~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
+++++|++|+|++|++.+.+|.. .+++|+.|+|++|++.+.+|..+.
T Consensus 226 ~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~ 274 (328)
T 4fcg_A 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274 (328)
T ss_dssp GGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGG
T ss_pred ccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhh
Confidence 55555555555555555555542 345555555555555555554443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.8e-13 Score=130.34 Aligned_cols=114 Identities=19% Similarity=0.272 Sum_probs=100.8
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++|.+++ ++. ..+.++.+|++|+|++|+|++ +|++.|..+++|++|+|++|+|++..|..+.++++
T Consensus 56 l~~L~~L~L~~N~i~~-i~~---~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 130 (220)
T 2v70_A 56 LPQLRKINFSNNKITD-IEE---GAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSS 130 (220)
T ss_dssp CTTCCEEECCSSCCCE-ECT---TTTTTCTTCCEEECCSSCCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTT
T ss_pred CCCCCEEECCCCcCCE-ECH---HHhCCCCCCCEEECCCCccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCcc
Confidence 4578999999999987 433 357788999999999999995 77767999999999999999999999999999999
Q ss_pred cCeeeccCccccccCCCC--CCCCccEEEcccCccccccCc
Q 045652 124 LTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~ 162 (621)
|++|+|++|+|++..|.. .+++|+.|+|++|.+++..+-
T Consensus 131 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred CCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 999999999999887764 578999999999999987663
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=135.75 Aligned_cols=106 Identities=26% Similarity=0.457 Sum_probs=50.5
Q ss_pred CCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCC-C--CCCCcc
Q 045652 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS-F--DQPTLV 147 (621)
Q Consensus 71 ~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~--~~~~L~ 147 (621)
.+++|++|+|++|+|+ .+|++.|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++ +|. . .+++|+
T Consensus 98 ~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~ 175 (290)
T 1p9a_G 98 TLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLD 175 (290)
T ss_dssp TCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCTTTTTTCTTCC
T ss_pred cCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc-cCHHHhcCcCCCC
Confidence 3445555555555555 3443335555555555555555554433444455555555555555542 222 1 244555
Q ss_pred EEEcccCccccccCcccccc---ccCCCCCCCCCC
Q 045652 148 RLNLSSNKLEGEIPASLLRF---NASSFSGNAGLC 179 (621)
Q Consensus 148 ~l~l~~N~l~g~ip~~~~~~---~~~~~~~n~~~c 179 (621)
.|+|++|+|+ .||..+... ....+.+|++.|
T Consensus 176 ~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp EEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred EEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 5555555555 445443322 223344555544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.1e-13 Score=126.28 Aligned_cols=123 Identities=21% Similarity=0.283 Sum_probs=92.8
Q ss_pred EEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeee
Q 045652 49 GLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128 (621)
Q Consensus 49 ~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~ 128 (621)
.+++++++++ .||.. + ..+|+.|+|++|+|+ .||.. |..+++|+.|+|++|.|++..|..|.++++|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~----~--~~~l~~L~L~~n~i~-~ip~~-~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ 84 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKG----I--PRDVTELYLDGNQFT-LVPKE-LSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI 84 (193)
T ss_dssp EEECTTSCCS-SCCSC----C--CTTCCEEECCSSCCC-SCCGG-GGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred EEEcCCCCCC-cCCCC----C--CCCCCEEECCCCcCc-hhHHH-hhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE
Confidence 3556666665 35531 2 247889999999998 78864 88899999999999999987778889999999999
Q ss_pred ccCccccccCCCC--CCCCccEEEcccCccccccCcccc---ccccCCCCCCCCCCC
Q 045652 129 LESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL---RFNASSFSGNAGLCG 180 (621)
Q Consensus 129 l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~c~ 180 (621)
|++|+|++..|.. .+++|+.|+|++|+|++..+..+. ++....+.+|++.|.
T Consensus 85 Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 85 LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9999998766643 578899999999999843333343 344556778887764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=3e-13 Score=145.01 Aligned_cols=137 Identities=20% Similarity=0.262 Sum_probs=114.4
Q ss_pred Cceee--EEeCC----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCE
Q 045652 35 EEWSG--VVCLK----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRK 102 (621)
Q Consensus 35 ~~w~g--v~c~~----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~ 102 (621)
|.|.+ |.|.. ..++.|+|++|.+++..+ ..+..+++|++|+|++|.+.+.||+..|..+++|++
T Consensus 8 c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~----~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~ 83 (455)
T 3v47_A 8 CSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE----TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83 (455)
T ss_dssp CEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT----TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCE
T ss_pred eEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh----hHhccCccccEEECcCCcccceECcccccccccCCE
Confidence 34666 88853 358999999999987544 357788999999999999999998888999999999
Q ss_pred EeCccCcccccCCCCCCCCCCcCeeeccCccccccCCC---C-CCCCccEEEcccCccccccCcc-cccc---ccCCCCC
Q 045652 103 LWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS---F-DQPTLVRLNLSSNKLEGEIPAS-LLRF---NASSFSG 174 (621)
Q Consensus 103 l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~---~-~~~~L~~l~l~~N~l~g~ip~~-~~~~---~~~~~~~ 174 (621)
|+|++|++++..|..++++++|++|+|++|++++.+|. + ..++|+.|+|++|++++..|.. +..+ ....+.+
T Consensus 84 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp EECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTT
T ss_pred EeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCC
Confidence 99999999999999999999999999999999986653 2 5789999999999999887865 4443 3444555
Q ss_pred C
Q 045652 175 N 175 (621)
Q Consensus 175 n 175 (621)
|
T Consensus 164 n 164 (455)
T 3v47_A 164 N 164 (455)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=6.7e-13 Score=124.81 Aligned_cols=119 Identities=27% Similarity=0.327 Sum_probs=101.5
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..+.|.. ..++.|+|++|+++ .+| ..+.++++|+.|+|++|+|++ +++..|..+++|+.|+
T Consensus 11 ~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip----~~~~~l~~L~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~ 84 (193)
T 2wfh_A 11 LDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVP----KELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLI 84 (193)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCC----GGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred CCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhH----HHhhcccCCCEEECCCCcCCE-eCHhHccCCCCCCEEE
Confidence 578888852 36889999999997 466 356778899999999999994 7766699999999999
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCC-C-CCCCccEEEcccCcccccc
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS-F-DQPTLVRLNLSSNKLEGEI 160 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g~i 160 (621)
|++|+|++..|..|.++++|++|+|++|+|++..+. + .+++|+.|+|++|.+...-
T Consensus 85 Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 85 LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 999999998888999999999999999999954443 3 5789999999999998643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.42 E-value=6.4e-13 Score=127.78 Aligned_cols=110 Identities=19% Similarity=0.270 Sum_probs=98.4
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+..|+|++|.+++-.+ ..+.+|++|++|+|++|+|+ .||++.|..+++|+.|+|++|+|++..|..|.++++|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~----~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 130 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAP----DAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNL 130 (220)
T ss_dssp TTCCEEECCSSCCCEECT----TTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCEEECCCCcCCCcCH----HHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCC
Confidence 578999999999987544 35778899999999999999 7998888999999999999999999989999999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccc
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ 159 (621)
++|+|++|+|++..+.. .+++|+.|+|++|.+...
T Consensus 131 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99999999999766653 578999999999999753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.41 E-value=6.4e-13 Score=132.05 Aligned_cols=108 Identities=30% Similarity=0.479 Sum_probs=75.2
Q ss_pred EEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCe
Q 045652 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTE 126 (621)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~ 126 (621)
++.|+|++|++++ ++. ..+..+++|++|+|++|+++ .+|+..|..+++|++|+|++|.+++..+..+.++++|++
T Consensus 39 l~~L~l~~n~l~~-~~~---~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 113 (270)
T 2o6q_A 39 TKKLDLQSNKLSS-LPS---KAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAE 113 (270)
T ss_dssp CSEEECCSSCCSC-CCT---TSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCE
T ss_pred CCEEECcCCCCCe-eCH---HHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCE
Confidence 4555555555553 222 24556677888888888887 577766677888888888888887655566677888888
Q ss_pred eeccCccccccCCCC--CCCCccEEEcccCccccc
Q 045652 127 LHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 127 l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ 159 (621)
|+|++|++++..|.. .+++|+.|+|++|++++.
T Consensus 114 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 114 LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred EECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence 888888887655542 467788888888887743
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.1e-13 Score=140.37 Aligned_cols=122 Identities=23% Similarity=0.194 Sum_probs=82.1
Q ss_pred CceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccC-CCCCCCEEecCCCcccccCCcccccCCCCCCE
Q 045652 35 EEWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELT-GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRK 102 (621)
Q Consensus 35 ~~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~-~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~ 102 (621)
|.|.-+.|.. ..++.|+|++|++++ ++. ..+. .+.+|+.|+|++|+|++ +|++.|..+++|+.
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~---~~~~~~l~~L~~L~L~~N~i~~-i~~~~~~~l~~L~~ 92 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRA---EWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRY 92 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECT---TSSSSCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCE
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cCh---hhhhhcccccCEEECCCCcCCc-cChhhccCCCCCCE
Confidence 3577888842 347789999999987 433 2233 56677777777777773 55545777777777
Q ss_pred EeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCc
Q 045652 103 LWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 103 l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~ 162 (621)
|+|++|+|++..|..|.++++|++|+|++|++++..|.. .+++|+.|+|++|+|++ +|.
T Consensus 93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~ 153 (361)
T 2xot_A 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPV 153 (361)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCG
T ss_pred EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCH
Confidence 777777777666666777777777777777777555542 45667777777777663 443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=7.5e-13 Score=147.86 Aligned_cols=127 Identities=16% Similarity=0.202 Sum_probs=104.7
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|++++ |++ ..+.+|++|++|+|++|+|+ .||++.|.+|++|++|+|++|+|++..|..|.++++|
T Consensus 52 ~~~~~LdLs~N~i~~-l~~---~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L 126 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRH-LGS---YSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 126 (635)
T ss_dssp TTCCEEECTTSCCCE-ECT---TTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTC
T ss_pred cCCCEEEeeCCCCCC-CCH---HHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCC
Confidence 368999999999986 654 35778899999999999999 5887779999999999999999998777789999999
Q ss_pred CeeeccCccccccCCC-C-CCCCccEEEcccCcccc-ccCccccccc---cCCCCCCC
Q 045652 125 TELHLESNQFNGTIPS-F-DQPTLVRLNLSSNKLEG-EIPASLLRFN---ASSFSGNA 176 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g-~ip~~~~~~~---~~~~~~n~ 176 (621)
++|+|++|+|++..|. + .+++|+.|+|++|++++ .+|..+..+. ...+.+|.
T Consensus 127 ~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 127 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp CEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence 9999999999965543 2 57899999999999976 4677655443 34455553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-13 Score=150.53 Aligned_cols=137 Identities=23% Similarity=0.338 Sum_probs=101.9
Q ss_pred CCCCCCCCCCCCCCCCceeeE-EeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCC
Q 045652 20 LDSWMPSTAPCRGGEEEWSGV-VCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMG 98 (621)
Q Consensus 20 l~~w~~~~~~c~~~~~~w~gv-~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~ 98 (621)
+.+|..+.++|......|.|+ .|..++++.|+|++|+|++ ||.. + +++|++|+|++|+|+ .|| . .++
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~----l--~~~L~~L~Ls~N~l~-~ip-~---~l~ 100 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDN----L--PPQITVLEITQNALI-SLP-E---LPA 100 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSC----C--CTTCSEEECCSSCCS-CCC-C---CCT
T ss_pred HHHHhccCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHh----H--cCCCCEEECcCCCCc-ccc-c---ccC
Confidence 557876778885322249999 7987889999999999987 7752 2 267888888888888 688 3 367
Q ss_pred CCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCccccccccCCCCCC
Q 045652 99 ALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGN 175 (621)
Q Consensus 99 ~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n 175 (621)
+|+.|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ ||..+.++....+++|
T Consensus 101 ~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 101 SLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQLTM-LPELPTSLEVLSVRNN 170 (571)
T ss_dssp TCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred CCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCccCc-CCCcCCCcCEEECCCC
Confidence 88888888888887 777 655 78888888888876 666 67778888888888875 7764444554555555
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=131.06 Aligned_cols=118 Identities=23% Similarity=0.372 Sum_probs=78.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|...+.+++ ..+..+++|++|+|++|++++ +++..+..+++|++|+|++|.+++..+..+..+++|
T Consensus 80 ~~L~~L~l~~n~~l~~~~~---~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 155 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDP---ATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155 (285)
T ss_dssp TTCCEEECCSCTTCCCCCT---TTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred cCCCEEeCCCCCCccccCH---HHhcCCcCCCEEECCCCcCCE-ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCc
Confidence 4677888888863333433 345566777777777777774 444447777777777777777776555567777777
Q ss_pred CeeeccCccccccCCC-C-CCCCccEEEcccCccccccCccccc
Q 045652 125 TELHLESNQFNGTIPS-F-DQPTLVRLNLSSNKLEGEIPASLLR 166 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g~ip~~~~~ 166 (621)
++|+|++|++++..+. + ..++|+.|+|++|++++..|..+..
T Consensus 156 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 199 (285)
T 1ozn_A 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199 (285)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred cEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccC
Confidence 7777777777754443 2 4567777777777777666665543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.2e-12 Score=126.94 Aligned_cols=112 Identities=24% Similarity=0.377 Sum_probs=73.8
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.++. ++. ..+..+++|++|+|++|+++ .+|+..|..+++|+.|+|++|++++..|..+.++++|
T Consensus 61 ~~L~~L~l~~n~l~~-i~~---~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 135 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQT-LPA---GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKL 135 (270)
T ss_dssp TTCCEEECCSSCCSC-CCT---TTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCEEECCCCccCe-eCh---hhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCC
Confidence 457778888887763 443 22455667777777777777 4665556777777777777777776666666777777
Q ss_pred CeeeccCccccccCCC-C-CCCCccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIPS-F-DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g~ip 161 (621)
++|+|++|++++..+. + ..++|+.|+|++|++++..|
T Consensus 136 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 136 TYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 7777777777643333 1 45677777777777764333
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=1.9e-12 Score=119.04 Aligned_cols=106 Identities=25% Similarity=0.350 Sum_probs=87.9
Q ss_pred EEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCee
Q 045652 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127 (621)
Q Consensus 48 ~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l 127 (621)
+.+++++++|+. ||. .+ ..+|++|+|++|+|++ +++..|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 12 ~~l~~s~n~l~~-ip~----~~--~~~l~~L~L~~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L 83 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPT----GI--PTTTQVLYLYDNQITK-LEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQL 83 (170)
T ss_dssp TEEECTTSCCSS-CCS----CC--CTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CEEEeCCCCcCc-cCc----cC--CCCCcEEEcCCCcCCc-cChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEE
Confidence 456777788775 664 22 2789999999999996 555559999999999999999997766778999999999
Q ss_pred eccCccccccCCC-C-CCCCccEEEcccCccccccC
Q 045652 128 HLESNQFNGTIPS-F-DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 128 ~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g~ip 161 (621)
+|++|+|++..|. + .+++|+.|+|++|.+++..+
T Consensus 84 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 84 SLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999999976664 3 57999999999999997654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=146.25 Aligned_cols=131 Identities=20% Similarity=0.154 Sum_probs=84.3
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccccc-CCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE-IPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~-ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
.++.|+|++|.+.+.+| ..+..+++|+.|+|++|++++. +|. .+..+++|+.|+|++|++++.+|..+.++++|
T Consensus 425 ~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 499 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFD----GIFLGLTSLNTLKMAGNSFKDNTLSN-VFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499 (606)
T ss_dssp TCCEEECTTSCCEECCT----TTTTTCTTCCEEECTTCEEGGGEECS-CCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred cCCEEECcCCCCCccch----hhhcCCCCCCEEECCCCcCCCcchHH-hhccCCCCCEEECCCCcCCccChhhhcccccC
Confidence 44555555555555433 2345566777777777777764 343 36777777777777777777777777777777
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccccc----cCCCCCCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFN----ASSFSGNAGLCGKN 182 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~----~~~~~~n~~~c~~~ 182 (621)
++|+|++|++++.+|.. .+++|+.|+|++|+|+ .+|..+..++ ...+.+|+..|..+
T Consensus 500 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 77777777777666643 4567777777777777 5666554433 34566777776543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.1e-12 Score=118.42 Aligned_cols=128 Identities=24% Similarity=0.297 Sum_probs=100.9
Q ss_pred EeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCC
Q 045652 41 VCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK 120 (621)
Q Consensus 41 ~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~ 120 (621)
.|. .+.++++++++.. +|.. ...+|+.|+|++|+++ .+|+..+..+++|++|+|++|+|++..|..+.+
T Consensus 6 ~C~---~~~l~~~~~~l~~-~p~~------~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 74 (177)
T 2o6r_A 6 SCS---GTEIRCNSKGLTS-VPTG------IPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK 74 (177)
T ss_dssp EEE---TTEEECCSSCCSS-CCTT------CCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred EeC---CCEEEecCCCCcc-CCCC------CCCCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccC
Confidence 674 3678899988874 5531 2368999999999999 577776899999999999999999766677899
Q ss_pred CCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc---ccccCCCCCCCCCC
Q 045652 121 LPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL---RFNASSFSGNAGLC 179 (621)
Q Consensus 121 l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~c 179 (621)
+++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..+..+. ++....+.+|+..|
T Consensus 75 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 75 LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 999999999999999766653 579999999999999954333333 34455677886655
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=132.32 Aligned_cols=116 Identities=21% Similarity=0.218 Sum_probs=72.7
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccc-cCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG-RLPPSLFKLP 122 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~l~ 122 (621)
...+..|+|++|.+++..+. ..+..+++|++|+|++|.+++.+|. .+..+++|+.|+|++|.+++ .+|..+..++
T Consensus 100 l~~L~~L~l~~n~l~~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 175 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEF---SVFLSLRNLIYLDISHTHTRVAFNG-IFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175 (306)
T ss_dssp CTTCCEEECTTSEEESSTTT---TTTTTCTTCCEEECTTSCCEECSTT-TTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred CCCCCEEECCCCcccccccc---hhhhhccCCCEEECCCCcCCccchh-hcccCcCCCEEECCCCccccccchhHHhhCc
Confidence 34677777777777653221 2355566677777777777654443 36667777777777777765 4666667777
Q ss_pred CcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcc
Q 045652 123 HLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPAS 163 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~ 163 (621)
+|++|+|++|++++..|.. ..++|+.|+|++|++++..+..
T Consensus 176 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 218 (306)
T 2z66_A 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218 (306)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGG
T ss_pred CCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhh
Confidence 7777777777776655543 4566677777777666543333
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-12 Score=133.26 Aligned_cols=106 Identities=26% Similarity=0.322 Sum_probs=50.0
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+|++|++++ ++. ..+.+|++|++|+|++|+|+ .+|+..|..+++|+.|+|++|+|++..|..|.++++|+
T Consensus 65 ~L~~L~L~~N~i~~-i~~---~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 139 (361)
T 2xot_A 65 NLHSLLLSHNHLNF-ISS---EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139 (361)
T ss_dssp TCCEEECCSSCCCE-ECT---TTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred ccCEEECCCCcCCc-cCh---hhccCCCCCCEEECCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCC
Confidence 34455555555543 221 12334445555555555554 23333345555555555555555544445555555555
Q ss_pred eeeccCccccccCCCC------CCCCccEEEcccCccc
Q 045652 126 ELHLESNQFNGTIPSF------DQPTLVRLNLSSNKLE 157 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~------~~~~L~~l~l~~N~l~ 157 (621)
+|+|++|+|++ +|.. .+++|+.|+|++|+|+
T Consensus 140 ~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 140 KLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp EEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCC
T ss_pred EEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCC
Confidence 55555555542 3321 2345555555555555
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.36 E-value=3.4e-13 Score=121.09 Aligned_cols=110 Identities=21% Similarity=0.244 Sum_probs=93.5
Q ss_pred CcEEEEEecCCCCe-eeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLS-GKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 45 ~~v~~l~l~~~~l~-g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
..++.|++++++++ |.+|. .+..+++|++|+|++|.+++ + . .++.+++|++|+|++|.+++.+|..+.++++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~----~~~~l~~L~~L~l~~n~l~~-~-~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 89 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG----LTDEFEELEFLSTINVGLTS-I-A-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS----CCTTCTTCCEEECTTSCCCC-C-T-TCCCCTTCCEEECCSSCCCSCTHHHHHHCTT
T ss_pred ccCeEEEccCCcCChhHHHH----HHhhcCCCcEEECcCCCCCC-c-h-hhhcCCCCCEEECCCCcccchHHHHhhhCCC
Confidence 46889999999998 77873 45678899999999999996 4 3 4889999999999999999888888888999
Q ss_pred cCeeeccCcccccc-CCC-C-CCCCccEEEcccCccccccC
Q 045652 124 LTELHLESNQFNGT-IPS-F-DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 124 L~~l~l~~N~l~g~-~p~-~-~~~~L~~l~l~~N~l~g~ip 161 (621)
|++|+|++|++++. .|. + ..++|+.|+|++|++++..+
T Consensus 90 L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 99999999999873 223 2 67899999999999996544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.9e-12 Score=121.92 Aligned_cols=112 Identities=24% Similarity=0.352 Sum_probs=95.9
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++ ++. ..+..+++|++|+|++|+|+ .+|+..+..+++|++|+|++|+|++..|..+.++++|
T Consensus 52 ~~L~~L~l~~n~l~~-~~~---~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 126 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQS-LPN---GVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQL 126 (208)
T ss_dssp TTCSEEECCSSCCCC-CCT---TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred ccCcEEECCCCccCc-cCh---hhcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcC
Confidence 578999999999985 543 24567889999999999999 5777768999999999999999998777778999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
++|+|++|++++..+.. ..++|+.|+|++|.+++..|
T Consensus 127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 127 KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99999999999655542 57899999999999988776
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.9e-12 Score=138.78 Aligned_cols=132 Identities=17% Similarity=0.119 Sum_probs=101.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.++|++|.+++.++ ..+..+++|+.|+|++|++++..|. .|..+++|+.|+|++|.+++..|..+.++++|
T Consensus 275 ~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLK----SVFSHFTDLEQLTLAQNEINKIDDN-AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp SCCCEEECCSSCCCEECT----TTTTTCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred cCceEEEecCccccccch----hhcccCCCCCEEECCCCcccccChh-HhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 357788888888887655 2466778899999999999865454 48889999999999999988888888899999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc---ccccCCCCCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL---RFNASSFSGNAGLCGK 181 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~c~~ 181 (621)
++|+|++|++++..|.. .+++|+.|+|++|++++..+..+. ++....+.+|+..|..
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 99999999998777753 578899999999999864333333 3445567788766643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.36 E-value=4.9e-13 Score=144.52 Aligned_cols=111 Identities=20% Similarity=0.091 Sum_probs=69.9
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCC-CCCCc
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHL 124 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~L 124 (621)
.++.|+|++|.+++..+ ..+++|+.|+|++|.|++..|.. ++.+++|+.|+|++|.|++.+|..+. ++++|
T Consensus 100 ~L~~L~L~~N~l~~~~~-------~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L 171 (487)
T 3oja_A 100 SIETLHAANNNISRVSC-------SRGQGKKNIYLANNKITMLRDLD-EGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171 (487)
T ss_dssp TCCEEECCSSCCCCEEE-------CCCSSCEEEECCSSCCCSGGGBC-GGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC
T ss_pred CcCEEECcCCcCCCCCc-------cccCCCCEEECCCCCCCCCCchh-hcCCCCCCEEECCCCCCCCcChHHHhhhCCcc
Confidence 34455555555554222 12456777777777777644444 66677777777777777776666665 57777
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCccccccCcccc
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
++|+|++|.|++..+...+++|+.|+|++|+|++ +|..+.
T Consensus 172 ~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~ 211 (487)
T 3oja_A 172 EHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQ 211 (487)
T ss_dssp CEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGG
T ss_pred cEEecCCCccccccccccCCCCCEEECCCCCCCC-CCHhHc
Confidence 7777777777765444456777777777777775 343343
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=145.55 Aligned_cols=131 Identities=21% Similarity=0.211 Sum_probs=107.9
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.+..++++.|.+.+..+ ..+..+..|+.|+|++|++.+.++++.|..+++|+.|+|++|+|++.+|..|.++++|+
T Consensus 446 ~l~~l~ls~n~l~~~~~----~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~ 521 (635)
T 4g8a_A 446 NLIYLDISHTHTRVAFN----GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 521 (635)
T ss_dssp TCCEEECTTSCCEECCT----TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ccccccccccccccccc----cccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCC
Confidence 45666777777766444 34566789999999999876555555699999999999999999999999999999999
Q ss_pred eeeccCccccccCCCC--CCCCccEEEcccCccccccCcccccc----ccCCCCCCCCCCC
Q 045652 126 ELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRF----NASSFSGNAGLCG 180 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~----~~~~~~~n~~~c~ 180 (621)
+|+|++|+|++..|.. .+++|+.|+|++|+|++..|..+..+ ....+.+|++.|.
T Consensus 522 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 522 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9999999999776653 57999999999999999888877554 3456789998884
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.35 E-value=4.9e-13 Score=151.30 Aligned_cols=156 Identities=15% Similarity=0.197 Sum_probs=70.6
Q ss_pred cHHHHHHHHHHcCCCC--CCCCCCCCCCCCCCCCCCceeeEEeCCCcEEEEEecCCCCeeeeCccc--------------
Q 045652 2 SESEALLKLKSSFTNA--KALDSWMPSTAPCRGGEEEWSGVVCLKGIVTGLYINSMGLSGKIDVDA-------------- 65 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~--~~l~~w~~~~~~c~~~~~~w~gv~c~~~~v~~l~l~~~~l~g~~~~~~-------------- 65 (621)
.+.++|+++..++... ..-..|.....++. .|.++.+..++++.|+|.++++... +...
T Consensus 132 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 132 CTKQALMEMADTLTDSKTAKKQQPTGDSTPSG----TATNSAVSTPLTPKIELFANGKDEA-NQALLQHKKLSQYSIDED 206 (727)
T ss_dssp CCCHHHHHHHHHHHHHHTTC------------------------------------------------------------
T ss_pred cchhhhhhhhhhcccccCcccCCCcCCCCccc----cCCCceecCCccceEEeeCCCCCcc-hhhHhhcCccCcccccCc
Confidence 3567888888776432 22345644333333 4888887777777777665554321 1000
Q ss_pred ----------ccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCcccc
Q 045652 66 ----------LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFN 135 (621)
Q Consensus 66 ----------~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 135 (621)
...+..+..|+.|+|++|.++ .||.. +..+++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+
T Consensus 207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred cccccceecChhhhccCCCCcEEECCCCCCC-CCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 012344556667777777766 56665 345666777777777666 66666666667777777777666
Q ss_pred ccCCCC--CCCCccEEEcccCccccccCcccccc
Q 045652 136 GTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRF 167 (621)
Q Consensus 136 g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~ 167 (621)
.||.. .+++|+.|+|++|.|+ .||..+..+
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l 315 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNL 315 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSC
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcC
Confidence 55653 4566666666666665 666555443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.8e-12 Score=124.09 Aligned_cols=111 Identities=28% Similarity=0.403 Sum_probs=96.7
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|++++ ++. ..+..+++|++|+|++|+|+ .+|+..|..+++|+.|+|++|+|+ .+|..+..+++|
T Consensus 64 ~~L~~L~L~~N~l~~-i~~---~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L 137 (229)
T 3e6j_A 64 INLKELYLGSNQLGA-LPV---GVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL 137 (229)
T ss_dssp TTCCEEECCSSCCCC-CCT---TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTC
T ss_pred cCCcEEECCCCCCCC-cCh---hhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCC
Confidence 578999999999954 554 34677899999999999999 577777899999999999999999 899999999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
++|+|++|+|++..+.. .+++|+.|+|++|.+++..+
T Consensus 138 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 138 THLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999999999655442 57899999999999998765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.4e-12 Score=140.83 Aligned_cols=143 Identities=19% Similarity=0.206 Sum_probs=96.9
Q ss_pred CCCCCCCCCCCCCCCCCceeeEEeCC------------------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEec
Q 045652 19 ALDSWMPSTAPCRGGEEEWSGVVCLK------------------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYL 80 (621)
Q Consensus 19 ~l~~w~~~~~~c~~~~~~w~gv~c~~------------------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l 80 (621)
.+.+|..+.+||. ....|.++.|.. ..+..++++++.+.. +|.. .+..+++|++|+|
T Consensus 8 ~l~~~~~~~~C~~-~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~-lp~~---~~~~l~~L~~L~L 82 (597)
T 3oja_B 8 NVKPRQPEYKCID-SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAA---LLDSFRQVELLNL 82 (597)
T ss_dssp ---CCCSEECCCC-C--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESE-ECTH---HHHHCCCCSEEEC
T ss_pred cccCCCCCCcCcc-cCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCC-cCHH---HHccCCCCcEEEC
Confidence 4678876666553 333477766631 234556676666553 5542 2445677888888
Q ss_pred CCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCcccc
Q 045652 81 DKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 81 ~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g 158 (621)
++|.+++ +|+..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..|.. .+++|+.|+|++|+|++
T Consensus 83 ~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~ 161 (597)
T 3oja_B 83 NDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161 (597)
T ss_dssp TTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC
Confidence 8888885 44434888888888888888888877777888888888888888888444432 56788888888888887
Q ss_pred ccCcccccc
Q 045652 159 EIPASLLRF 167 (621)
Q Consensus 159 ~ip~~~~~~ 167 (621)
..|..+..+
T Consensus 162 ~~~~~~~~l 170 (597)
T 3oja_B 162 IEDDTFQAT 170 (597)
T ss_dssp CCTTTTTTC
T ss_pred CChhhhhcC
Confidence 777655543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.3e-13 Score=136.16 Aligned_cols=113 Identities=19% Similarity=0.155 Sum_probs=61.9
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccccc--CC-cccccCCCCCCEEeCccCcccccCCC---C-
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE--IP-PGYFDEMGALRKLWFSNNKFRGRLPP---S- 117 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~--ip-~~~~~~l~~L~~l~l~~N~l~g~~p~---~- 117 (621)
..++.|+|++|.+.+..+ ..+..+++|++|+|++|++.|. ++ ...++.+++|++|+|++|+++. +|. .
T Consensus 145 ~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 219 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSC----EQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAAL 219 (310)
T ss_dssp SCCCEEEEECCSSCCCCT----TSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhH----HHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHH
Confidence 467788888888765333 2455666777777777776542 22 1223455556666666665541 221 1
Q ss_pred CCCCCCcCeeeccCccccccCCCC--C---CCCccEEEcccCccccccCcc
Q 045652 118 LFKLPHLTELHLESNQFNGTIPSF--D---QPTLVRLNLSSNKLEGEIPAS 163 (621)
Q Consensus 118 ~~~l~~L~~l~l~~N~l~g~~p~~--~---~~~L~~l~l~~N~l~g~ip~~ 163 (621)
+.++++|++|+|++|++++.+|.. . .++|+.|+|++|+|+ .+|..
T Consensus 220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~ 269 (310)
T 4glp_A 220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKG 269 (310)
T ss_dssp HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSC
T ss_pred HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhh
Confidence 244555555555555555554421 1 145555555555555 45543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=6e-12 Score=125.37 Aligned_cols=118 Identities=15% Similarity=0.213 Sum_probs=97.0
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+|++|++++ ++. ..+..+++|++|+|++|++++ +++..|..+++|++|+|++|.+++..|..+.++++|+
T Consensus 29 ~l~~L~ls~n~l~~-~~~---~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (276)
T 2z62_A 29 STKNLDLSFNPLRH-LGS---YSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103 (276)
T ss_dssp TCCEEECTTCCCCE-ECT---TTTTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CccEEECCCCcccc-cCH---hHhccccCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCcccc
Confidence 58899999999987 433 256778899999999999994 6665588999999999999999988888899999999
Q ss_pred eeeccCccccccCCC-C-CCCCccEEEcccCcccc-ccCccccccc
Q 045652 126 ELHLESNQFNGTIPS-F-DQPTLVRLNLSSNKLEG-EIPASLLRFN 168 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g-~ip~~~~~~~ 168 (621)
+|+|++|++++..+. + ..++|+.|+|++|++++ .+|..+..+.
T Consensus 104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~ 149 (276)
T 2z62_A 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149 (276)
T ss_dssp EEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred EEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCC
Confidence 999999999865553 2 57899999999999986 4687766543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.3e-12 Score=117.07 Aligned_cols=104 Identities=25% Similarity=0.430 Sum_probs=86.2
Q ss_pred EEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCee
Q 045652 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127 (621)
Q Consensus 48 ~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l 127 (621)
+.+++++++|+ .||. .+ ..+|+.|+|++|+|++ +|+..|..+++|+.|+|++|+|++..|..|.++++|++|
T Consensus 15 ~~l~~~~n~l~-~iP~----~~--~~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L 86 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA----GI--PTDKQRLWLNNNQITK-LEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQL 86 (174)
T ss_dssp SEEECCSSCCS-SCCS----CC--CTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cEEEeCCCCCC-ccCC----Cc--CCCCcEEEeCCCCccc-cCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEE
Confidence 56888888885 5774 22 2789999999999996 555559999999999999999998555567899999999
Q ss_pred eccCccccccCCC-C-CCCCccEEEcccCccccc
Q 045652 128 HLESNQFNGTIPS-F-DQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 128 ~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~g~ 159 (621)
+|++|+|++..+. + .+++|+.|+|++|.|+..
T Consensus 87 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 87 DLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ECCCCccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 9999999965554 3 578999999999999853
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.34 E-value=4.6e-12 Score=126.02 Aligned_cols=132 Identities=24% Similarity=0.277 Sum_probs=109.6
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++ ++. ..+..+++|++|+|++|++++ +|+..++.+++|++|+|++|+|++..|..+.++++|
T Consensus 85 ~~L~~L~L~~n~l~~-~~~---~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 159 (272)
T 3rfs_A 85 TNLTYLILTGNQLQS-LPN---GVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNL 159 (272)
T ss_dssp TTCCEEECTTSCCCC-CCT---TTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCEEECCCCccCc-cCh---hHhcCCcCCCEEECCCCcCCc-cCHHHhccCCCCCEEECCCCccCccCHHHhccCccC
Confidence 578999999999986 433 346778899999999999994 676668999999999999999998777778999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc---cccCCCCCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR---FNASSFSGNAGLCGK 181 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~n~~~c~~ 181 (621)
++|+|++|++++..|.. .+++|+.|+|++|++++..|..+.. +....+.+|+..|..
T Consensus 160 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 160 TELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 99999999999766643 5799999999999999877755544 445567888877654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-12 Score=142.34 Aligned_cols=121 Identities=21% Similarity=0.272 Sum_probs=95.1
Q ss_pred ceeeEEeCC-------------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCE
Q 045652 36 EWSGVVCLK-------------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRK 102 (621)
Q Consensus 36 ~w~gv~c~~-------------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~ 102 (621)
.|.|+ |+. ..++.|+|++|++++..+ ..+.++++|++|+|++|++++ +|++.|+.+++|++
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~ 78 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH----GDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEH 78 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECS----STTSSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCE
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccCh----hhhhcCCcccEEECCCCCcCc-cChhhccccccCCE
Confidence 48888 742 368999999999987554 356778889999999999986 44444888999999
Q ss_pred EeCccCcccccCCCCCCCCCCcCeeeccCccccc-cCCC-C-CCCCccEEEcccCccccccCc
Q 045652 103 LWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNG-TIPS-F-DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 103 l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~-~-~~~~L~~l~l~~N~l~g~ip~ 162 (621)
|+|++|++++..|..++++++|++|+|++|++++ .+|. + .+++|+.|+|++|++.+.+|.
T Consensus 79 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~ 141 (549)
T 2z81_A 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141 (549)
T ss_dssp EECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred EECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCH
Confidence 9999999988777778889999999999998885 3443 2 567888888888886667763
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.3e-12 Score=123.53 Aligned_cols=125 Identities=14% Similarity=0.175 Sum_probs=99.9
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCc-ccccCCcccccCCCCCCEEeCcc-CcccccCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQ-FSGEIPPGYFDEMGALRKLWFSN-NKFRGRLPPSLFKLP 122 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~-l~g~ip~~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~ 122 (621)
..++.|+|++|++++ ++. ..+.++++|++|+|++|. ++ .||+..|..+++|++|+|++ |++++..|..+.+++
T Consensus 31 ~~l~~L~l~~n~l~~-i~~---~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~ 105 (239)
T 2xwt_C 31 PSTQTLKLIETHLRT-IPS---HAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105 (239)
T ss_dssp TTCCEEEEESCCCSE-ECT---TTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCT
T ss_pred CcccEEEEeCCcceE-ECH---HHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCC
Confidence 578999999999986 543 356778899999999997 87 68876699999999999998 999987778899999
Q ss_pred CcCeeeccCccccccCCCC-CCCCcc---EEEcccC-ccccccCccccccc----cCCCCCC
Q 045652 123 HLTELHLESNQFNGTIPSF-DQPTLV---RLNLSSN-KLEGEIPASLLRFN----ASSFSGN 175 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~-~~~~L~---~l~l~~N-~l~g~ip~~~~~~~----~~~~~~n 175 (621)
+|++|+|++|++++ +|.+ ..++|+ .|+|++| ++++..+..+..+. ...+.+|
T Consensus 106 ~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n 166 (239)
T 2xwt_C 106 LLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166 (239)
T ss_dssp TCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred CCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence 99999999999996 7765 566676 9999999 88854444444333 3444455
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2e-12 Score=141.96 Aligned_cols=106 Identities=27% Similarity=0.324 Sum_probs=90.2
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+|++|+|++ || .+..|++|+.|+|++|+|+ .||.. ++.|++|+.|+|++|+|++ +| .++++++|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp-----~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~ 511 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LC-----HLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQ 511 (567)
T ss_dssp TCSEEECTTSCCSS-CC-----CGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCC
T ss_pred CceEEEecCCCCCC-Cc-----CccccccCcEeecCccccc-ccchh-hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCc
Confidence 46779999999886 55 2666788999999999999 89986 8899999999999999997 77 899999999
Q ss_pred eeeccCccccccC-CCC--CCCCccEEEcccCccccccC
Q 045652 126 ELHLESNQFNGTI-PSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 126 ~l~l~~N~l~g~~-p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
+|+|++|+|++.+ |.. .+++|+.|+|++|+|++..|
T Consensus 512 ~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp EEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred EEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 9999999999876 653 67899999999999997655
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1e-11 Score=138.15 Aligned_cols=126 Identities=17% Similarity=0.171 Sum_probs=105.4
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++-.+ ..+.++++|++|+|++|++++ +++..|.++++|++|+|++|.+++..|..|+++++|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~Ls~n~l~~-i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 106 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKS----YSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106 (606)
T ss_dssp TTCCEEECTTSCCCEECT----TTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTC
T ss_pred CCcCEEECCCCCcCEeCh----hhccCCccCcEEeCCCCcccc-cCHHHhhchhhcCEeECCCCcccccChhhcCCcccC
Confidence 478999999999987444 357788999999999999996 544458999999999999999999889999999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCcccc-ccCcccccccc---CCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEG-EIPASLLRFNA---SSFSGN 175 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g-~ip~~~~~~~~---~~~~~n 175 (621)
++|+|++|++++..|.. ..++|+.|+|++|++++ .+|..+.++.. ..+.+|
T Consensus 107 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp CEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred CEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999998665443 67899999999999986 78987766543 345555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.3e-12 Score=119.81 Aligned_cols=110 Identities=23% Similarity=0.262 Sum_probs=91.7
Q ss_pred CcEEEEEecCCCCe-eeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLS-GKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 45 ~~v~~l~l~~~~l~-g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
..++.|+|++|+++ |.+|. .+..+++|+.|+|++|.+++ + . .+..+++|++|+|++|.+++.+|..+.++++
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~----~~~~l~~L~~L~l~~n~l~~-~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 96 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG----LTAEFVNLEFLSLINVGLIS-V-S-NLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS----CCGGGGGCCEEEEESSCCCC-C-S-SCCCCSSCCEEEEESCCCCSCCCHHHHHCTT
T ss_pred ccCCEEECCCCCCChhhHHH----HHHhCCCCCEEeCcCCCCCC-h-h-hhccCCCCCEEECcCCcCchHHHHHHhhCCC
Confidence 56899999999998 77874 25667899999999999995 4 3 4889999999999999999888888888999
Q ss_pred cCeeeccCccccccC--CCC-CCCCccEEEcccCccccccC
Q 045652 124 LTELHLESNQFNGTI--PSF-DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 124 L~~l~l~~N~l~g~~--p~~-~~~~L~~l~l~~N~l~g~ip 161 (621)
|++|+|++|++++.. +.+ .+++|+.|+|++|.+++..+
T Consensus 97 L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp CCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred CCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 999999999998632 233 67899999999999995444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-12 Score=146.10 Aligned_cols=128 Identities=20% Similarity=0.183 Sum_probs=100.3
Q ss_pred ceeeEEeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCC
Q 045652 36 EWSGVVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLP 115 (621)
Q Consensus 36 ~w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p 115 (621)
.|..|.+....++.|+|++|.+++..+ ..+.+|++|++|+|++|.+.+.|+++.|.++++|++|+|++|.+++..|
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~----~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTA----SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECS----SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccCh----hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 477777755789999999999987544 3567778888888888877778876668888888888888888888888
Q ss_pred CCCCCCCCcCeeeccCccccccCCC---C-CCCCccEEEcccCccccccC-cccccc
Q 045652 116 PSLFKLPHLTELHLESNQFNGTIPS---F-DQPTLVRLNLSSNKLEGEIP-ASLLRF 167 (621)
Q Consensus 116 ~~~~~l~~L~~l~l~~N~l~g~~p~---~-~~~~L~~l~l~~N~l~g~ip-~~~~~~ 167 (621)
..|.++++|++|+|++|.+++.+|. + .+++|+.|+|++|++++..| ..+.++
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L 147 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTC
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhC
Confidence 8888888888888888888886664 2 56788888888888887654 344433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.4e-12 Score=147.50 Aligned_cols=114 Identities=23% Similarity=0.303 Sum_probs=101.4
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++|.+. .||. .+..|.+|++|+|++|.|+ .||.. |+.|++|++|+|++|.|+ .+|..|++|++
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~----~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~ 294 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISA----NIFKYDFLTRLYLNGNSLT-ELPAE-IKNLSNLRVLDLSHNRLT-SLPAELGSCFQ 294 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCG----GGGGCCSCSCCBCTTSCCS-CCCGG-GGGGTTCCEEECTTSCCS-SCCSSGGGGTT
T ss_pred CCCCcEEECCCCCCC-CCCh----hhcCCCCCCEEEeeCCcCc-ccChh-hhCCCCCCEEeCcCCcCC-ccChhhcCCCC
Confidence 357889999999988 5774 3447889999999999999 89987 899999999999999999 89999999999
Q ss_pred cCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc
Q 045652 124 LTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR 166 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~ 166 (621)
|++|+|++|.|+ .||.. .+++|+.|+|++|.|+|.+|..+..
T Consensus 295 L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 295 LKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp CSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred CCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 999999999997 78864 6789999999999999999987643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=9.3e-12 Score=132.82 Aligned_cols=111 Identities=24% Similarity=0.276 Sum_probs=90.7
Q ss_pred ccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCC
Q 045652 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPT 145 (621)
Q Consensus 68 ~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~ 145 (621)
.+.++++|++|+|++|+++ .+|. +..+++|+.|+|++|+|++..|..|.++++|++|+|++|++++..|.. .+++
T Consensus 180 ~~~~l~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 256 (440)
T 3zyj_A 180 AFEGLSNLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS 256 (440)
T ss_dssp TTTTCSSCCEEECTTSCCS-SCCC--CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTT
T ss_pred hhhcccccCeecCCCCcCc-cccc--cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCC
Confidence 3556778999999999998 6874 788999999999999999988999999999999999999999776653 5789
Q ss_pred ccEEEcccCccccccCcccc---ccccCCCCCCCCCCCC
Q 045652 146 LVRLNLSSNKLEGEIPASLL---RFNASSFSGNAGLCGK 181 (621)
Q Consensus 146 L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~c~~ 181 (621)
|+.|+|++|+|++..+..+. ++....+.+|++.|..
T Consensus 257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp CCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred CCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 99999999999955444443 4445678899988864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.28 E-value=8e-13 Score=147.79 Aligned_cols=125 Identities=16% Similarity=0.228 Sum_probs=104.4
Q ss_pred CCcEEEEEecCCCCeee-----------------eCcccccccC--CCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 44 KGIVTGLYINSMGLSGK-----------------IDVDALTELT--GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~-----------------~~~~~~~~l~--~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
-..++.|+|++|.++|. +|. .+. .|++|++|+|++|+++|.+|.. ++++++|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~----~l~~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~ 279 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE----DLKWDNLKDLTDVEVYNCPNLTKLPTF-LKALPEMQLIN 279 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS----CCCGGGCTTCCEEEEECCTTCSSCCTT-TTTCSSCCEEE
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCch----hhhhcccCCCCEEEecCCcCCccChHH-HhcCCCCCEEE
Confidence 35789999999999995 663 566 7889999999999999999987 89999999999
Q ss_pred CccCc-ccc-cCCCCCCCC------CCcCeeeccCccccccCCC--C--CCCCccEEEcccCccccccCcccccc---cc
Q 045652 105 FSNNK-FRG-RLPPSLFKL------PHLTELHLESNQFNGTIPS--F--DQPTLVRLNLSSNKLEGEIPASLLRF---NA 169 (621)
Q Consensus 105 l~~N~-l~g-~~p~~~~~l------~~L~~l~l~~N~l~g~~p~--~--~~~~L~~l~l~~N~l~g~ip~~~~~~---~~ 169 (621)
|++|+ |+| .+|..++++ ++|++|+|++|+++ .+|. . .+++|+.|+|++|+++|.+| .+..+ ..
T Consensus 280 Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~ 357 (636)
T 4eco_A 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLAS 357 (636)
T ss_dssp CTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESE
T ss_pred CcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCE
Confidence 99998 999 899888876 89999999999998 8887 3 67899999999999999999 55433 33
Q ss_pred CCCCCC
Q 045652 170 SSFSGN 175 (621)
Q Consensus 170 ~~~~~n 175 (621)
..+.+|
T Consensus 358 L~L~~N 363 (636)
T 4eco_A 358 LNLAYN 363 (636)
T ss_dssp EECCSS
T ss_pred EECCCC
Confidence 344444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=8.7e-12 Score=128.60 Aligned_cols=107 Identities=23% Similarity=0.332 Sum_probs=88.0
Q ss_pred ceeeEEeCCCcEEEEEecCC-CCeeeeCcccccccCCCCCCCEEecCC-CcccccCCcccccCCCCCCEEeCccCccccc
Q 045652 36 EWSGVVCLKGIVTGLYINSM-GLSGKIDVDALTELTGLRGLRAIYLDK-NQFSGEIPPGYFDEMGALRKLWFSNNKFRGR 113 (621)
Q Consensus 36 ~w~gv~c~~~~v~~l~l~~~-~l~g~~~~~~~~~l~~l~~L~~l~l~~-N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~ 113 (621)
.|..|.|. ++ +|++ ||. |..+.+|+.|+|++ |+|++ ||+..|+.|++|+.|+|++|+|+|.
T Consensus 9 ~~~~v~~~----------~~n~l~~-ip~-----l~~~~~L~~L~l~~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~ 71 (347)
T 2ifg_A 9 GSSGLRCT----------RDGALDS-LHH-----LPGAENLTELYIENQQHLQH-LELRDLRGLGELRNLTIVKSGLRFV 71 (347)
T ss_dssp SSSCEECC----------SSCCCTT-TTT-----SCSCSCCSEEECCSCSSCCE-ECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred cCCEEEcC----------CCCCCCc-cCC-----CCCCCCeeEEEccCCCCCCC-cChhHhccccCCCEEECCCCcccee
Confidence 47777775 33 5554 552 67788999999996 99995 7766699999999999999999999
Q ss_pred CCCCCCCCCCcCeeeccCccccccCCCC-CCCCccEEEcccCccccc
Q 045652 114 LPPSLFKLPHLTELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 114 ~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ 159 (621)
.|..|.+|++|++|+|++|+|++..|.. ....|+.|+|++|.|...
T Consensus 72 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 9999999999999999999999654443 334499999999999853
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-11 Score=132.53 Aligned_cols=111 Identities=23% Similarity=0.270 Sum_probs=89.8
Q ss_pred cCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCc
Q 045652 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTL 146 (621)
Q Consensus 69 l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L 146 (621)
+.++.+|++|+|++|+++ .+|. +..+++|+.|+|++|+|++..|..|.++++|++|+|++|++++..|.. .+++|
T Consensus 192 ~~~l~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 268 (452)
T 3zyi_A 192 FEGLFNLKYLNLGMCNIK-DMPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268 (452)
T ss_dssp TTTCTTCCEEECTTSCCS-SCCC--CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCCCCEEECCCCccc-cccc--ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCC
Confidence 556778899999999998 4663 788899999999999999988999999999999999999999877754 57899
Q ss_pred cEEEcccCccccccCcccc---ccccCCCCCCCCCCCCC
Q 045652 147 VRLNLSSNKLEGEIPASLL---RFNASSFSGNAGLCGKN 182 (621)
Q Consensus 147 ~~l~l~~N~l~g~ip~~~~---~~~~~~~~~n~~~c~~~ 182 (621)
+.|+|++|+|++..+..+. ++....+.+|++.|...
T Consensus 269 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 9999999999954444443 44456788998888643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.9e-12 Score=120.01 Aligned_cols=101 Identities=14% Similarity=0.240 Sum_probs=48.3
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|++++++++ .++ .+..+++|++|+|++|.++ .++ . +..+++|++|+|++|.+++..|..++.+++|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-----~l~~l~~L~~L~l~~n~~~-~~~-~-l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-----GIEYAHNIKDLTINNIHAT-NYN-P-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp TCCEEEEESSCCS-CCT-----TGGGCTTCSEEEEESCCCS-CCG-G-GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred CccEEeccCCCcc-ChH-----HHhcCCCCCEEEccCCCCC-cch-h-hhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 3455555555554 232 1333445555555555443 122 2 44455555555555555554455555555555
Q ss_pred eeeccCccccccCCCC--CCCCccEEEcccCc
Q 045652 126 ELHLESNQFNGTIPSF--DQPTLVRLNLSSNK 155 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~ 155 (621)
+|+|++|++++..|.. .+++|+.|+|++|+
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 5555555555433321 34455555555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=9.4e-12 Score=122.97 Aligned_cols=136 Identities=17% Similarity=0.083 Sum_probs=104.4
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCCCChhH
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLY 396 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 396 (621)
.++.|+.+.||++... +..+++|+...........+.+|+++++.+. +..+.++++++...+..|+||||++|.+|.+
T Consensus 21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 99 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence 4677788899999753 6899999986422122345889999999985 6778899999988889999999999999987
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc--------------------------------------------
Q 045652 397 LLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL-------------------------------------------- 432 (621)
Q Consensus 397 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------- 432 (621)
.+.. ......++.+++++|..||+..
T Consensus 100 ~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 100 EYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred ccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 6321 1123468899999999999810
Q ss_pred -----------CCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 433 -----------AHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 433 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
.+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358899999999999876556799998764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.4e-11 Score=135.87 Aligned_cols=116 Identities=20% Similarity=0.211 Sum_probs=64.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+.+-.+ .+..+++|+.|+|++|.+++..|...+..+++|++|+|++|.+++.+|..+.++++|
T Consensus 373 ~~L~~L~l~~n~l~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 447 (570)
T 2z63_A 373 TSLKYLDLSFNGVITMSS-----NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447 (570)
T ss_dssp SCCCEEECCSCSEEEEEE-----EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred CccCEEECCCCccccccc-----cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcC
Confidence 467777888777765322 134455555666666666544443345555555555555555555555555555555
Q ss_pred CeeeccCcccc-ccCCCC--CCCCccEEEcccCccccccCcccc
Q 045652 125 TELHLESNQFN-GTIPSF--DQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 125 ~~l~l~~N~l~-g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
++|+|++|+++ +.+|.. ..++|+.|+|++|++++..|..+.
T Consensus 448 ~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 491 (570)
T 2z63_A 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491 (570)
T ss_dssp CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh
Confidence 55555555554 345532 345555555555555554454443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.26 E-value=9.1e-12 Score=130.66 Aligned_cols=149 Identities=20% Similarity=0.235 Sum_probs=103.3
Q ss_pred CCCCCCCCCCCCCCCCceeeEEeCC------------------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecC
Q 045652 20 LDSWMPSTAPCRGGEEEWSGVVCLK------------------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLD 81 (621)
Q Consensus 20 l~~w~~~~~~c~~~~~~w~gv~c~~------------------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~ 81 (621)
+++|..+.+||.. ...|.++.|.. ..++.++++++.+.. +|.. .+..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~-~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~-l~~~---~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDS-NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAA---LLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC-------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESE-ECTH---HHHHCCCCSEEECT
T ss_pred cCCCCCccceehh-hhhhccceeeeeeecccccccccccccccCCceEEEecCCchhh-CChh---HhcccccCcEEECC
Confidence 5688876676652 12354544430 345667777776653 6642 24557789999999
Q ss_pred CCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCCccEEEcccCcccc
Q 045652 82 KNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 82 ~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g 158 (621)
+|.+++ +|+..|..+++|++|+|++|.+++..|..++++++|++|+|++|+++ .+|.. ..++|+.|+|++|++++
T Consensus 78 ~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~ 155 (390)
T 3o6n_A 78 DLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER 155 (390)
T ss_dssp TSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCc
Confidence 999985 66555899999999999999999888888999999999999999998 55542 57899999999999997
Q ss_pred ccCccccccc---cCCCCCC
Q 045652 159 EIPASLLRFN---ASSFSGN 175 (621)
Q Consensus 159 ~ip~~~~~~~---~~~~~~n 175 (621)
..|..+..+. ...+.+|
T Consensus 156 ~~~~~~~~l~~L~~L~l~~n 175 (390)
T 3o6n_A 156 IEDDTFQATTSLQNLQLSSN 175 (390)
T ss_dssp CCTTTTSSCTTCCEEECCSS
T ss_pred cChhhccCCCCCCEEECCCC
Confidence 6666554433 3344444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.7e-12 Score=128.64 Aligned_cols=126 Identities=19% Similarity=0.122 Sum_probs=85.6
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccC--Ccc-cccCCCCCCEEeCccCcccc--cCCCC-C
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEI--PPG-YFDEMGALRKLWFSNNKFRG--RLPPS-L 118 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~i--p~~-~~~~l~~L~~l~l~~N~l~g--~~p~~-~ 118 (621)
..++.|+|++|.+++..+ ..+..+++|++|+|++|+++|.+ |+. .+..+++|+.|+|++|+|++ .+|.. +
T Consensus 149 ~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 224 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFSC----EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224 (312)
T ss_dssp TTCCEEEEESCSCCCCCT----TTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHH
T ss_pred CCCcEEEeeCCCCccchH----HHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHH
Confidence 568888888888876443 34666778888888888887652 333 12677888888888888873 33322 3
Q ss_pred CCCCCcCeeeccCccccccCCC--C-CCCCccEEEcccCccccccCcccc-ccccCCCCCC
Q 045652 119 FKLPHLTELHLESNQFNGTIPS--F-DQPTLVRLNLSSNKLEGEIPASLL-RFNASSFSGN 175 (621)
Q Consensus 119 ~~l~~L~~l~l~~N~l~g~~p~--~-~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~n 175 (621)
.++++|++|+|++|++++.+|. . .+++|+.|+|++|+|+ .||..+. ++....+++|
T Consensus 225 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N 284 (312)
T 1wwl_A 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYN 284 (312)
T ss_dssp HTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSS
T ss_pred hcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCceEEECCCC
Confidence 4677888888888888876643 2 3577888888888887 7776554 3444445555
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=112.46 Aligned_cols=103 Identities=18% Similarity=0.260 Sum_probs=85.5
Q ss_pred CCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEc
Q 045652 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNL 151 (621)
Q Consensus 74 ~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l 151 (621)
..+.|++++|+|+ .||.. + .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|.. .+++|+.|+|
T Consensus 10 ~~~~l~~s~n~l~-~ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 85 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSL 85 (170)
T ss_dssp ETTEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEeCCCCcC-ccCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEEC
Confidence 3578999999999 69986 3 488999999999999988999999999999999999999655543 5799999999
Q ss_pred ccCccccccCccccc---cccCCCCCCCCCCC
Q 045652 152 SSNKLEGEIPASLLR---FNASSFSGNAGLCG 180 (621)
Q Consensus 152 ~~N~l~g~ip~~~~~---~~~~~~~~n~~~c~ 180 (621)
++|+|++..|..+.. +....+.+|+..|.
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999999655544544 44556788887664
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.9e-11 Score=131.86 Aligned_cols=127 Identities=19% Similarity=0.196 Sum_probs=100.8
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..|.|.. ..++.|+|++|++++-.+ ..+..+++|++|+|++|.+++..|.. |.++++|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~ 86 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ----DEFASFPHLEELELNENIVSAVEPGA-FNNLFNLRTLG 86 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT----TTTTTCTTCCEEECTTSCCCEECTTT-TTTCTTCCEEE
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH----hHccCCCCCCEEECCCCccCEeChhh-hhCCccCCEEE
Confidence 477899952 367889999999987443 35677889999999999999655554 88999999999
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccccc
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRF 167 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~ 167 (621)
|++|++++..+..|.++++|++|+|++|++++..|.. .+++|+.|+|++|++++..|..+..+
T Consensus 87 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 151 (477)
T 2id5_A 87 LRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGL 151 (477)
T ss_dssp CCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTC
T ss_pred CCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCC
Confidence 9999998655566888999999999999998777753 57889999999999887666655443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.25 E-value=3.1e-11 Score=121.10 Aligned_cols=106 Identities=26% Similarity=0.223 Sum_probs=54.3
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCC----------------------CCEEecCCCcccccCCcccccCCCCCCEE
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRG----------------------LRAIYLDKNQFSGEIPPGYFDEMGALRKL 103 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~----------------------L~~l~l~~N~l~g~ip~~~~~~l~~L~~l 103 (621)
.++.|+|++|.+++..+ ..+..+++ |++|+|++|+|+ .+|.. +..+++|+.|
T Consensus 32 ~l~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~-~~~l~~L~~L 105 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSL----ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLL-GQTLPALTVL 105 (290)
T ss_dssp TCCEEECTTSCCSEEEG----GGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCC-TTTCTTCCEE
T ss_pred CCCEEEcCCCcCCccCH----HHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchh-hccCCCCCEE
Confidence 46677777777765333 12334444 455555555554 44443 4455555555
Q ss_pred eCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccc
Q 045652 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLE 157 (621)
Q Consensus 104 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~ 157 (621)
+|++|+|++..|..|.++++|++|+|++|+|++..|.. ..++|+.|+|++|+|+
T Consensus 106 ~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 106 DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 55555555444444555555555555555555332221 3445555555555555
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=3.9e-11 Score=120.03 Aligned_cols=116 Identities=20% Similarity=0.297 Sum_probs=87.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCc-ccccCCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK-FRGRLPPSLFKLPH 123 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~-l~g~~p~~~~~l~~ 123 (621)
..++.|+|+++++++ ++. ..+..+++|++|+|++|.+++..|. .|..+++|++|+|++|. ++...|..+..+++
T Consensus 32 ~~l~~L~l~~n~i~~-~~~---~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~ 106 (285)
T 1ozn_A 32 AASQRIFLHGNRISH-VPA---ASFRACRNLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLRSVDPATFHGLGR 106 (285)
T ss_dssp TTCSEEECTTSCCCE-ECT---TTTTTCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTT
T ss_pred CCceEEEeeCCcCCc-cCH---HHcccCCCCCEEECCCCccceeCHh-hcCCccCCCEEeCCCCCCccccCHHHhcCCcC
Confidence 367888999988876 433 2456678888888888888854454 48888888888888887 66655778888888
Q ss_pred cCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc
Q 045652 124 LTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
|++|+|++|++++..|.. ..++|+.|+|++|++++..+..+.
T Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 150 (285)
T 1ozn_A 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150 (285)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhc
Confidence 888888888888766653 568888888888888854444343
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=135.45 Aligned_cols=115 Identities=19% Similarity=0.223 Sum_probs=78.6
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccc--cCCcccccCCCCCCEEeCccCcccccCCCC-CCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSG--EIPPGYFDEMGALRKLWFSNNKFRGRLPPS-LFKL 121 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g--~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l 121 (621)
..++.|+|++|.+++.+| ..+..+++|+.|+|++|++++ .+|.. +..+++|+.|+|++|++++.+|.. +..+
T Consensus 353 ~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~l 427 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVF----QGCSTLKRLQTLILQRNGLKNFFKVALM-TKNMSSLETLDVSLNSLNSHAYDRTCAWA 427 (562)
T ss_dssp CCCCEEECCSSCCCTTTT----TTCCSCSSCCEEECCSSCCCBTTHHHHT-TTTCTTCCEEECTTSCCBSCCSSCCCCCC
T ss_pred CCceEEECCCCccccchh----hhhcccCCCCEEECCCCCcCCcccchhh-hcCCCCCCEEECCCCcCCCccChhhhcCc
Confidence 567788888888877555 345667777777777777774 22333 677777777777777777766654 5667
Q ss_pred CCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCcccc
Q 045652 122 PHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 122 ~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
++|++|+|++|++++.+|....++|+.|+|++|+++ .||..+.
T Consensus 428 ~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~ 470 (562)
T 3a79_B 428 ESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVT 470 (562)
T ss_dssp TTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTT
T ss_pred ccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhc
Confidence 777777777777776666543366777777777776 5666544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=122.37 Aligned_cols=117 Identities=21% Similarity=0.280 Sum_probs=98.0
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++ ++. ..+..+++|++|+|++|.+++ +++..|..+++|+.|+|++|.+++..+..+.++++|
T Consensus 52 ~~L~~L~l~~n~l~~-~~~---~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 126 (276)
T 2z62_A 52 PELQVLDLSRCEIQT-IED---GAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126 (276)
T ss_dssp TTCSEEECTTCCCCE-ECT---TTTTTCTTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTC
T ss_pred cCCcEEECCCCcCCc-cCH---HHccCCcCCCEEECCCCccCc-cChhhhcCCccccEEECCCCCccccCchhcccCCCC
Confidence 578999999999986 443 346778899999999999995 555558999999999999999998777789999999
Q ss_pred CeeeccCccccc-cCCCC--CCCCccEEEcccCccccccCccccc
Q 045652 125 TELHLESNQFNG-TIPSF--DQPTLVRLNLSSNKLEGEIPASLLR 166 (621)
Q Consensus 125 ~~l~l~~N~l~g-~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~ 166 (621)
++|+|++|++++ .+|.. .+++|+.|+|++|++++..|..+..
T Consensus 127 ~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 171 (276)
T 2z62_A 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171 (276)
T ss_dssp CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred CEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh
Confidence 999999999986 36754 5799999999999999765555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.1e-12 Score=131.14 Aligned_cols=107 Identities=19% Similarity=0.201 Sum_probs=53.0
Q ss_pred EEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCC-----CCCCEEeCccCcccccCCCCCCCC
Q 045652 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEM-----GALRKLWFSNNKFRGRLPPSLFKL 121 (621)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l-----~~L~~l~l~~N~l~g~~p~~~~~l 121 (621)
++.|+|++|+++|.+|...+ +..+++|++|+|++|++++. |.. ++.+ ++|++|+|++|++++..|..++++
T Consensus 97 L~~L~L~~n~l~~~~~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~-~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 97 LQELTLENLEVTGTAPPPLL--EATGPDLNILNLRNVSWATR-DAW-LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp CCEEEEEEEBCBSCCCCCSS--SCCSCCCSEEEEESCBCSSS-SSH-HHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred ccEEEccCCcccchhHHHHH--HhcCCCccEEEccCCCCcch-hHH-HHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 44455555555554442100 14445555555555555543 432 4444 555555555555555544555555
Q ss_pred CCcCeeeccCccccccCC---C---CCCCCccEEEcccCccc
Q 045652 122 PHLTELHLESNQFNGTIP---S---FDQPTLVRLNLSSNKLE 157 (621)
Q Consensus 122 ~~L~~l~l~~N~l~g~~p---~---~~~~~L~~l~l~~N~l~ 157 (621)
++|++|+|++|++.|.++ . ..+++|+.|+|++|+|+
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 555555555555554321 1 23455555555555555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-11 Score=127.47 Aligned_cols=133 Identities=22% Similarity=0.283 Sum_probs=97.3
Q ss_pred CCCCCCCCCCCCCCceeeEEeC-------------CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccccc
Q 045652 22 SWMPSTAPCRGGEEEWSGVVCL-------------KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE 88 (621)
Q Consensus 22 ~w~~~~~~c~~~~~~w~gv~c~-------------~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ 88 (621)
.|.....+|. |.|+ |+ ...++.|+|++|++++ ++. ..+..+++|++|+|++|++++
T Consensus 22 ~~~~~~~~C~-----~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~---~~~~~l~~L~~L~L~~n~l~~- 90 (353)
T 2z80_A 22 SSNQASLSCD-----RNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISN---SDLQRCVNLQALVLTSNGINT- 90 (353)
T ss_dssp -----CCEEC-----TTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECT---TTTTTCTTCCEEECTTSCCCE-
T ss_pred CCCccCCCCC-----CCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCH---HHhccCCCCCEEECCCCccCc-
Confidence 3444455564 8887 63 1368899999999886 443 346778899999999999996
Q ss_pred CCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCC---C-CCCCccEEEcccCc-cccccCcc
Q 045652 89 IPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS---F-DQPTLVRLNLSSNK-LEGEIPAS 163 (621)
Q Consensus 89 ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~---~-~~~~L~~l~l~~N~-l~g~ip~~ 163 (621)
+++..|..+++|++|+|++|++++..+..+.++++|++|+|++|+++ .+|. + ..++|+.|+|++|+ +++..|..
T Consensus 91 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 91 IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHH
Confidence 54445889999999999999999644444889999999999999998 4554 2 57899999999995 55433444
Q ss_pred ccc
Q 045652 164 LLR 166 (621)
Q Consensus 164 ~~~ 166 (621)
+..
T Consensus 170 ~~~ 172 (353)
T 2z80_A 170 FAG 172 (353)
T ss_dssp TTT
T ss_pred ccC
Confidence 443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.2e-11 Score=110.43 Aligned_cols=101 Identities=19% Similarity=0.312 Sum_probs=82.9
Q ss_pred CEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEccc
Q 045652 76 RAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSS 153 (621)
Q Consensus 76 ~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~ 153 (621)
+.+++++|+|+ .||.. + .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+.. .+++|+.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~-~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAG-I--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCC-c--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 68999999997 89987 4 389999999999999988999999999999999999999754442 579999999999
Q ss_pred CccccccCccccc---cccCCCCCCCCCCC
Q 045652 154 NKLEGEIPASLLR---FNASSFSGNAGLCG 180 (621)
Q Consensus 154 N~l~g~ip~~~~~---~~~~~~~~n~~~c~ 180 (621)
|+|++..|..+.. +....+.+|+..|.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 9999544443544 44556778876653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.3e-11 Score=116.40 Aligned_cols=122 Identities=16% Similarity=0.237 Sum_probs=99.6
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|++++|.++. +..+..+++|++|+|++|++++..|.. ++.+++|++|+|++|++++..|..++.+++|
T Consensus 66 ~~L~~L~l~~n~~~~------~~~l~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L 138 (197)
T 4ezg_A 66 HNIKDLTINNIHATN------YNPISGLSNLERLRIMGKDVTSDKIPN-LSGLTSLTLLDISHSAHDDSILTKINTLPKV 138 (197)
T ss_dssp TTCSEEEEESCCCSC------CGGGTTCTTCCEEEEECTTCBGGGSCC-CTTCTTCCEEECCSSBCBGGGHHHHTTCSSC
T ss_pred CCCCEEEccCCCCCc------chhhhcCCCCCEEEeECCccCcccChh-hcCCCCCCEEEecCCccCcHhHHHHhhCCCC
Confidence 468899999985542 246778899999999999999877776 8999999999999999999889999999999
Q ss_pred CeeeccCccccccCCCC-CCCCccEEEcccCccccccCccccc---cccCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIPASLLR---FNASSFSGN 175 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~n 175 (621)
++|+|++|++-+.+|.+ .+++|+.|+|++|++++ +| .+.. +....+.+|
T Consensus 139 ~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 139 NSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp CEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred CEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 99999999854567754 67899999999999986 44 3333 333445555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=136.28 Aligned_cols=118 Identities=20% Similarity=0.166 Sum_probs=65.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCccccc---CCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR---LPPSLFKL 121 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~---~p~~~~~l 121 (621)
..++.|+|++|.+.+..+. ..+..+++|+.|+|++|.+++..|. .+..+++|+.|+|++|.+++. .+..+..+
T Consensus 400 ~~L~~L~l~~n~l~~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 475 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQ---SPFQNLHLLKVLNLSHSLLDISSEQ-LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475 (606)
T ss_dssp TTCSEEECTTCCEECCTTC---CTTTTCTTCCEEECTTCCCBTTCTT-TTTTCTTCCEEECTTCBCGGGEECSSCGGGGC
T ss_pred ccCCeEECCCCcCCCcccc---hhhhCcccCCEEECCCCccCCcCHH-HHhCCCCCCEEECCCCCCCccccccchhhccC
Confidence 4577777777777765543 1244455666666666666643333 255566666666666665541 22345555
Q ss_pred CCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc
Q 045652 122 PHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR 166 (621)
Q Consensus 122 ~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~ 166 (621)
++|++|+|++|++++..|.. .+++|+.|+|++|++++.+|..+..
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 522 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTT
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCc
Confidence 55556666555555554432 3455555555555555555544433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.4e-11 Score=134.39 Aligned_cols=125 Identities=22% Similarity=0.231 Sum_probs=100.0
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccc--cCCcccccCCCCCCEEeCccCcccccCCCC-CCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSG--EIPPGYFDEMGALRKLWFSNNKFRGRLPPS-LFKL 121 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g--~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l 121 (621)
..++.|+|++|.+++.+| ..+..+++|++|+|++|++++ .+|.. +..+++|+.|+|++|.+++.+|.. +..+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l 398 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVF----ENCGHLTELETLILQMNQLKELSKIAEM-TTQMKSLQQLDISQNSVSYDEKKGDCSWT 398 (520)
T ss_dssp CCCCEEECCSSCCCTTTT----TTCCCCSSCCEEECCSSCCCBHHHHHHH-HTTCTTCCEEECCSSCCBCCGGGCSCCCC
T ss_pred CcccEEEeECCccChhhh----hhhccCCCCCEEEccCCccCccccchHH-HhhCCCCCEEECCCCcCCcccccchhccC
Confidence 568899999999988666 356778899999999999986 56654 888999999999999999877765 7788
Q ss_pred CCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCccccccc---cCCCCCC
Q 045652 122 PHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGN 175 (621)
Q Consensus 122 ~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n 175 (621)
++|++|+|++|++++.+|....++|+.|+|++|+++ .||..+..+. ...+.+|
T Consensus 399 ~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N 454 (520)
T 2z7x_B 399 KSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454 (520)
T ss_dssp TTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred ccCCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCC
Confidence 999999999999988887665578899999999988 7887665443 3345555
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.21 E-value=4.8e-11 Score=127.72 Aligned_cols=122 Identities=23% Similarity=0.261 Sum_probs=97.9
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..|.|.. ..++.|+|++|++++..+ ..+.+|++|+.|+|++|++++ +++..|..+++|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~----~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~ 129 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA----DTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLE 129 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT----TTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEE
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH----HHcCCCCCCCEEECCCCccCC-cChhhccCcccCCEEE
Confidence 367899952 368899999999987444 356778899999999999995 5555589999999999
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCc
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~ 162 (621)
|++|+|++..+..+.++++|++|+|++|++++..+.. ..++|+.|+|++|+..+.+|.
T Consensus 130 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 189 (452)
T 3zyi_A 130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189 (452)
T ss_dssp CCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred CCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh
Confidence 9999999766677899999999999999998444322 578899999988666666765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-11 Score=113.57 Aligned_cols=111 Identities=23% Similarity=0.220 Sum_probs=94.0
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCccccc-CCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR-LPPSLFKLP 122 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~-~p~~~~~l~ 122 (621)
...++.|+|++|.+++. ..+..+++|++|+|++|++++.+|.. +..+++|++|+|++|.+++. .+..+..++
T Consensus 48 l~~L~~L~l~~n~l~~~------~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~ 120 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV------SNLPKLPKLKKLELSENRIFGGLDML-AEKLPNLTHLNLSGNKLKDISTLEPLKKLE 120 (168)
T ss_dssp GGGCCEEEEESSCCCCC------SSCCCCSSCCEEEEESCCCCSCCCHH-HHHCTTCCEEECBSSSCCSSGGGGGGSSCS
T ss_pred CCCCCEEeCcCCCCCCh------hhhccCCCCCEEECcCCcCchHHHHH-HhhCCCCCEEeccCCccCcchhHHHHhcCC
Confidence 45789999999998863 35778899999999999999767654 77899999999999999973 237899999
Q ss_pred CcCeeeccCccccccCC----CC-CCCCccEEEcccCccccccCc
Q 045652 123 HLTELHLESNQFNGTIP----SF-DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p----~~-~~~~L~~l~l~~N~l~g~ip~ 162 (621)
+|++|+|++|++++..+ .+ .+++|+.|++++|.+. .+|.
T Consensus 121 ~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 121 CLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred CCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999999999996655 22 6899999999999987 6664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.7e-11 Score=132.77 Aligned_cols=126 Identities=19% Similarity=0.143 Sum_probs=100.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++-.+ ..+.++++|++|+|++|++++..|.. |..+++|++|+|++|.+++..|..++++++|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~----~~~~~l~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 107 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQN----TTFSRLINLTFLDLTRCQIYWIHEDT-FQSQHRLDTLVLTANPLIFMAETALSGPKAL 107 (606)
T ss_dssp TTCCEEECTTCCCSEECT----TTSTTCTTCSEEECTTCCCCEECTTT-TTTCTTCCEEECTTCCCSEECTTTTSSCTTC
T ss_pred CcCcEEEccCCccCcCCh----hHhccCccceEEECCCCccceeChhh-ccCccccCeeeCCCCcccccChhhhcccccc
Confidence 468999999999987444 35778889999999999999655554 8999999999999999999999999999999
Q ss_pred CeeeccCccccccCC--CCCCCCccEEEcccCcccc-ccCccc--cccccCCCCCC
Q 045652 125 TELHLESNQFNGTIP--SFDQPTLVRLNLSSNKLEG-EIPASL--LRFNASSFSGN 175 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p--~~~~~~L~~l~l~~N~l~g-~ip~~~--~~~~~~~~~~n 175 (621)
++|+|++|++++..| -...++|+.|+|++|++++ .+|... .++....+.+|
T Consensus 108 ~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 163 (606)
T 3t6q_A 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163 (606)
T ss_dssp CEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSS
T ss_pred cEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccC
Confidence 999999999987433 3367889999999999986 345432 23334445555
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.9e-11 Score=120.58 Aligned_cols=127 Identities=20% Similarity=0.249 Sum_probs=105.0
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCc-ccccCCCCCCEEeCccCcccccCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPP-GYFDEMGALRKLWFSNNKFRGRLPPSLFKLP 122 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~ 122 (621)
...++.|+|++|.+.+ ++. .+..+++|++|+|++|++++ +|. ..+..+++|++|+|++|.+++..|..+.+++
T Consensus 77 ~~~L~~L~Ls~n~i~~-l~~----~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 150 (306)
T 2z66_A 77 TTSLKYLDLSFNGVIT-MSS----NFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150 (306)
T ss_dssp CSCCCEEECCSCSEEE-EEE----EEETCTTCCEEECTTSEEES-STTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT
T ss_pred ccccCEEECCCCcccc-Chh----hcCCCCCCCEEECCCCcccc-cccchhhhhccCCCEEECCCCcCCccchhhcccCc
Confidence 3578899999999885 553 46678899999999999995 553 5589999999999999999999999999999
Q ss_pred CcCeeeccCccccc-cCCCC--CCCCccEEEcccCccccccCccccccc---cCCCCCCC
Q 045652 123 HLTELHLESNQFNG-TIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGNA 176 (621)
Q Consensus 123 ~L~~l~l~~N~l~g-~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~ 176 (621)
+|++|+|++|.+++ .+|.. ..++|+.|+|++|++++..|..+..++ ...+.+|.
T Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 210 (306)
T 2z66_A 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210 (306)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCc
Confidence 99999999999987 46654 578999999999999987787665443 34455653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-11 Score=132.22 Aligned_cols=135 Identities=21% Similarity=0.220 Sum_probs=112.7
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCccc-ccCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFR-GRLPPSLFKLP 122 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~-g~~p~~~~~l~ 122 (621)
...++.|++++|.+.+..+. ..+..+++|++|+|++|.+++.+|.. +..+++|+.|+|++|.++ +.+|..+..++
T Consensus 395 l~~L~~L~l~~n~l~~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~ 470 (570)
T 2z63_A 395 LEQLEHLDFQHSNLKQMSEF---SVFLSLRNLIYLDISHTHTRVAFNGI-FNGLSSLEVLKMAGNSFQENFLPDIFTELR 470 (570)
T ss_dssp CTTCCEEECTTSEEESCTTS---CTTTTCTTCCEEECTTSCCEECCTTT-TTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred cCCCCEEEccCCccccccch---hhhhcCCCCCEEeCcCCcccccchhh-hhcCCcCcEEECcCCcCccccchhhhhccc
Confidence 45788999999998875553 34667889999999999999766654 899999999999999998 68999999999
Q ss_pred CcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccccc---ccCCCCCCCCCCCCC
Q 045652 123 HLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRF---NASSFSGNAGLCGKN 182 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~---~~~~~~~n~~~c~~~ 182 (621)
+|++|+|++|++++..|.. ..++|+.|+|++|++++..|..+..+ ....+.+|+..|..+
T Consensus 471 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 9999999999999887864 57899999999999998777665544 455678898877654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.19 E-value=7.4e-12 Score=143.23 Aligned_cols=124 Identities=22% Similarity=0.344 Sum_probs=101.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCc-ccc-cCCcccccCCC-------CCCEEeCccCcccccCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQ-FSG-EIPPGYFDEMG-------ALRKLWFSNNKFRGRLP 115 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~-l~g-~ip~~~~~~l~-------~L~~l~l~~N~l~g~~p 115 (621)
..++.|+|++|++.|.+|. .+..|++|+.|+|++|+ |+| .||.+ ++.++ +|+.|+|++|+|+ .+|
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~----~l~~L~~L~~L~Ls~N~~lsg~~iP~~-i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip 564 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPD----FLYDLPELQSLNIACNRGISAAQLKAD-WTRLADDEDTGPKIQIFYMGYNNLE-EFP 564 (876)
T ss_dssp TTCCEEEEESCTTCCSCCG----GGGGCSSCCEEECTTCTTSCHHHHHHH-HHHHHHCTTTTTTCCEEECCSSCCC-BCC
T ss_pred CCCCEEECcCCCCCccChH----HHhCCCCCCEEECcCCCCcccccchHH-HHhhhhcccccCCccEEEeeCCcCC-ccC
Confidence 4688899999999998883 56678899999999998 998 88876 55444 8999999999999 899
Q ss_pred C--CCCCCCCcCeeeccCccccccCCCC-CCCCccEEEcccCccccccCcccccccc----CCCCCCC
Q 045652 116 P--SLFKLPHLTELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIPASLLRFNA----SSFSGNA 176 (621)
Q Consensus 116 ~--~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip~~~~~~~~----~~~~~n~ 176 (621)
. .++++++|++|+|++|+++ .+|.+ .+++|+.|+|++|+++ .+|..+..+.. ..+.+|.
T Consensus 565 ~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 565 ASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp CHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred ChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCC
Confidence 8 8999999999999999998 88855 5788999999999998 88877655443 4455554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.5e-11 Score=132.44 Aligned_cols=125 Identities=14% Similarity=0.179 Sum_probs=103.9
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccc--cCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG--RLPPSLFKLP 122 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g--~~p~~~~~l~ 122 (621)
..+..|+++++++.+.. ....+++|++|+|++|++++.+|.. ++.+++|+.|+|++|++++ .+|..+.+++
T Consensus 302 ~~L~~L~l~~n~l~~~~------~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~ 374 (520)
T 2z7x_B 302 MNIKNFTVSGTRMVHML------CPSKISPFLHLDFSNNLLTDTVFEN-CGHLTELETLILQMNQLKELSKIAEMTTQMK 374 (520)
T ss_dssp CCCSEEEEESSCCCCCC------CCSSCCCCCEEECCSSCCCTTTTTT-CCCCSSCCEEECCSSCCCBHHHHHHHHTTCT
T ss_pred CceeEEEcCCCcccccc------chhhCCcccEEEeECCccChhhhhh-hccCCCCCEEEccCCccCccccchHHHhhCC
Confidence 35889999999876421 1256789999999999999888876 8999999999999999997 6788899999
Q ss_pred CcCeeeccCccccccCCCC---CCCCccEEEcccCccccccCcccc-ccccCCCCCCC
Q 045652 123 HLTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASLL-RFNASSFSGNA 176 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~n~ 176 (621)
+|++|+|++|++++.+|.. ..++|+.|+|++|++++.+|..+. ++....+++|.
T Consensus 375 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432 (520)
T ss_dssp TCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSC
T ss_pred CCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCc
Confidence 9999999999999878753 568999999999999998887763 55555666663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=5.9e-11 Score=133.88 Aligned_cols=132 Identities=22% Similarity=0.242 Sum_probs=92.5
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccccc----C---CcccccCCCCCCEEeCccCcccccCCC-C
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE----I---PPGYFDEMGALRKLWFSNNKFRGRLPP-S 117 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~----i---p~~~~~~l~~L~~l~l~~N~l~g~~p~-~ 117 (621)
.++.|+|++|++++ ++. ..+.++++|++|+|++|++++. + |...+..+++|+.|+|++|+|+ .+|. .
T Consensus 481 ~L~~L~Ls~N~l~~-i~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~ 555 (680)
T 1ziw_A 481 NLTILDLSNNNIAN-IND---DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEV 555 (680)
T ss_dssp TCCEEECCSSCCCC-CCT---TTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred CCCEEECCCCCCCc-CCh---hhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHH
Confidence 46667777777664 332 2355677788888888888742 1 2223677888888888888888 4554 5
Q ss_pred CCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcc----ccccccCCCCCCCCCCCCC
Q 045652 118 LFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPAS----LLRFNASSFSGNAGLCGKN 182 (621)
Q Consensus 118 ~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~----~~~~~~~~~~~n~~~c~~~ 182 (621)
|.++++|++|+|++|+|++..|.. ..++|+.|+|++|+|++..|.. +.++....+.+|++.|..+
T Consensus 556 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 788888999999888888443332 4688999999999998766553 3455566788999988643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=8.5e-11 Score=125.34 Aligned_cols=122 Identities=23% Similarity=0.291 Sum_probs=97.8
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..|.|.. ..++.|+|++|++++..+ ..+.++++|++|+|++|++++ +++..|..+++|+.|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~----~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~ 118 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKV----NSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLE 118 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECT----TTTSSCSSCCEEECCSSCCCE-ECGGGGTTCSSCCEEE
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCH----HHhhCCCCCCEEECCCCcCCc-cChhhccCCccCCEEE
Confidence 377899952 357889999999987433 357778899999999999994 6666699999999999
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCc
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~ 162 (621)
|++|+|++..+..+..+++|++|+|++|++++..+.. ..++|+.|+|++|+..+.+|.
T Consensus 119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 178 (440)
T 3zyj_A 119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE 178 (440)
T ss_dssp CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc
Confidence 9999999766667999999999999999998544432 568889999988666666665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.5e-11 Score=130.44 Aligned_cols=112 Identities=19% Similarity=0.210 Sum_probs=82.9
Q ss_pred EEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCee
Q 045652 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTEL 127 (621)
Q Consensus 48 ~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l 127 (621)
..++++++++++ ||. .+. ++|+.|+|++|++++ +|++.|..+++|++|+|++|++++..|..|.++++|++|
T Consensus 34 ~~l~ls~~~L~~-ip~----~~~--~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 105 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPK----DLP--PRTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYL 105 (562)
T ss_dssp CEEECTTSCCCS-CCT----TSC--TTCCEEECCSSCCCC-CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred cEEEcCCCCCcc-CCC----CCC--CCcCEEECCCCCccc-cChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEE
Confidence 677788888875 664 121 578888888888884 555457888888888888888887777888888888888
Q ss_pred eccCccccccCCCCCCCCccEEEcccCcccc-ccCccccccc
Q 045652 128 HLESNQFNGTIPSFDQPTLVRLNLSSNKLEG-EIPASLLRFN 168 (621)
Q Consensus 128 ~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g-~ip~~~~~~~ 168 (621)
+|++|+++ .+|...+++|+.|+|++|++++ .+|..+.++.
T Consensus 106 ~Ls~N~l~-~lp~~~l~~L~~L~Ls~N~l~~l~~p~~~~~l~ 146 (562)
T 3a79_B 106 DVSHNRLQ-NISCCPMASLRHLDLSFNDFDVLPVCKEFGNLT 146 (562)
T ss_dssp ECTTSCCC-EECSCCCTTCSEEECCSSCCSBCCCCGGGGGCT
T ss_pred ECCCCcCC-ccCccccccCCEEECCCCCccccCchHhhcccC
Confidence 88888887 6666677788888888888876 4566655443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-11 Score=132.10 Aligned_cols=29 Identities=14% Similarity=0.025 Sum_probs=25.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceEEEEeC
Q 045652 351 RDAFDTEVRRLGRLRHSNVLAPLAYHYRT 379 (621)
Q Consensus 351 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 379 (621)
.++|..|++++.+++|+|+|+++|||...
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 56799999999999999999999998654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=5.7e-11 Score=128.07 Aligned_cols=117 Identities=24% Similarity=0.199 Sum_probs=100.1
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++..| ..+.+|++|++|+|++|+++ .+|+..|..+++|+.|+|++|++++..|..+.++++|
T Consensus 56 ~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 130 (477)
T 2id5_A 56 PHLEELELNENIVSAVEP----GAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130 (477)
T ss_dssp TTCCEEECTTSCCCEECT----TTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCEEECCCCccCEeCh----hhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccC
Confidence 578999999999987545 35778899999999999999 6888778999999999999999999999999999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR 166 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~ 166 (621)
++|+|++|++++..|.. .+++|+.|+|++|++++..+..+..
T Consensus 131 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 174 (477)
T 2id5_A 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH 174 (477)
T ss_dssp CEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTT
T ss_pred CEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcc
Confidence 99999999999777653 5789999999999998543333433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=4.2e-11 Score=131.50 Aligned_cols=120 Identities=17% Similarity=0.227 Sum_probs=103.5
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccc-cCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRG-RLPPSLFKLP 122 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~l~ 122 (621)
-..++.|+|++|.+++..+ ..+..|++|++|+|++|++++ +|+..|+.+++|++|+|++|.+++ .+|..+++++
T Consensus 49 l~~L~~L~Ls~n~i~~~~~----~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~ 123 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEG----DAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123 (549)
T ss_dssp CTTCCEEECTTSCCCEECT----TTTTTCTTCCEEECTTSCCCS-CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCT
T ss_pred CCcccEEECCCCCcCccCh----hhccccccCCEEECCCCccCc-cCHHHhccCCCCcEEECCCCcccccchhhhhhccC
Confidence 3579999999999997444 357788999999999999995 666669999999999999999997 5788999999
Q ss_pred CcCeeeccCccccccCCCC---CCCCccEEEcccCccccccCccccccc
Q 045652 123 HLTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEGEIPASLLRFN 168 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g~ip~~~~~~~ 168 (621)
+|++|+|++|++.+.+|.. .+++|+.|+|++|++++.+|..+..+.
T Consensus 124 ~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 172 (549)
T 2z81_A 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIR 172 (549)
T ss_dssp TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCS
T ss_pred CccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccc
Confidence 9999999999977788742 578999999999999999998766543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=7.9e-11 Score=132.84 Aligned_cols=117 Identities=22% Similarity=0.230 Sum_probs=86.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
.+++.|+|++|++++ ++. ..+.++++|++|+|++|.+++..| +.|+++++|++|+|++|.+++..+..|+++++|
T Consensus 25 ~~l~~L~Ls~n~l~~-~~~---~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 99 (680)
T 1ziw_A 25 TNITVLNLTHNQLRR-LPA---ANFTRYSQLTSLDVGFNTISKLEP-ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99 (680)
T ss_dssp TTCSEEECCSSCCCC-CCG---GGGGGGTTCSEEECCSSCCCCCCT-THHHHCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCcEEECCCCCCCC-cCH---HHHhCCCcCcEEECCCCccCccCH-HHHhcccCcCEEECCCCccCccChhhhccCCCC
Confidence 478899999999887 443 235566788888888888885444 447888888888888888885444468888888
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR 166 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~ 166 (621)
++|+|++|++++..|.. .+++|+.|+|++|++++..|..+.+
T Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 143 (680)
T 1ziw_A 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143 (680)
T ss_dssp SEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSC
T ss_pred CEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcc
Confidence 88888888887555442 5678888888888888776665443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.4e-10 Score=121.53 Aligned_cols=125 Identities=23% Similarity=0.318 Sum_probs=99.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCC-CCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPS-LFKLPH 123 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~l~~ 123 (621)
..++.|+|+++.+.+ ++. ..+..+++|++|+|++|.+++ +|+..++.+++|++|+|++|.++. +|.. +.++++
T Consensus 69 ~~L~~L~L~~n~i~~-~~~---~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~ 142 (390)
T 3o6n_A 69 RQVELLNLNDLQIEE-IDT---YAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPK 142 (390)
T ss_dssp CCCSEEECTTSCCCE-ECT---TTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTT
T ss_pred ccCcEEECCCCcccc-cCh---hhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCCEEECCCCccCc-CCHHHhcCCCC
Confidence 468899999999986 433 357788999999999999995 666668999999999999999995 5655 689999
Q ss_pred cCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccccccCCCCCC
Q 045652 124 LTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGN 175 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n 175 (621)
|++|+|++|++++..|.. .+++|+.|+|++|++++.-...+.++....+.+|
T Consensus 143 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 999999999999776653 5789999999999999642233444444444444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.13 E-value=4.4e-11 Score=121.70 Aligned_cols=102 Identities=22% Similarity=0.113 Sum_probs=76.8
Q ss_pred CCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCC-CCCCcCeeeccCccccccCCCCCCCCccEEE
Q 045652 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF-KLPHLTELHLESNQFNGTIPSFDQPTLVRLN 150 (621)
Q Consensus 72 l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~ 150 (621)
+++|+.|+|++|++++ +++..++.+++|+.|+|++|.+++..|..+. .+++|++|+|++|++++..+....++|+.|+
T Consensus 119 ~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~ 197 (317)
T 3o53_A 119 GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD 197 (317)
T ss_dssp CSSCEEEECCSSCCCS-GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEE
T ss_pred cCCCCEEECCCCCCCC-ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEE
Confidence 5678899999999985 5544578888999999999999887777764 7888999999999988653334678899999
Q ss_pred cccCccccccCccccccc---cCCCCCC
Q 045652 151 LSSNKLEGEIPASLLRFN---ASSFSGN 175 (621)
Q Consensus 151 l~~N~l~g~ip~~~~~~~---~~~~~~n 175 (621)
|++|++++ +|..+..+. ...+.+|
T Consensus 198 Ls~N~l~~-l~~~~~~l~~L~~L~L~~N 224 (317)
T 3o53_A 198 LSSNKLAF-MGPEFQSAAGVTWISLRNN 224 (317)
T ss_dssp CCSSCCCE-ECGGGGGGTTCSEEECTTS
T ss_pred CCCCcCCc-chhhhcccCcccEEECcCC
Confidence 99999884 555454433 3345555
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=7.3e-11 Score=116.18 Aligned_cols=130 Identities=20% Similarity=0.187 Sum_probs=97.0
Q ss_pred CcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCC--cccceEEEEeCCeeEEEEeecCCCChhHH
Q 045652 320 GNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN--VLAPLAYHYRTDEKLLVYEYIPGGSLLYL 397 (621)
Q Consensus 320 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 397 (621)
+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998777888999997653 2245778999999986544 556888887777889999999998884
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc---------------------------------------------
Q 045652 398 LHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL--------------------------------------------- 432 (621)
Q Consensus 398 l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------- 432 (621)
... .. ...++.+++..|..||+..
T Consensus 104 ~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 210 11 1356778888888888641
Q ss_pred ---------CCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 433 ---------AHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 433 ---------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
.+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 012389999999999998776667999998643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=9.6e-11 Score=121.08 Aligned_cols=118 Identities=19% Similarity=0.265 Sum_probs=98.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC--CCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP--SLFKLP 122 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~ 122 (621)
..++.|+|++|.+++..+ ..+.++++|++|+|++|+++ .+|+..++.+++|++|+|++|++++ +|. .+.+++
T Consensus 76 ~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~ 149 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEE----DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLT 149 (353)
T ss_dssp TTCCEEECTTSCCCEECT----TTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCT
T ss_pred CCCCEEECCCCccCccCH----hhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCC
Confidence 578999999999987443 34777899999999999999 5888778999999999999999995 665 789999
Q ss_pred CcCeeeccCcc-ccccCCCC--CCCCccEEEcccCccccccCccccccc
Q 045652 123 HLTELHLESNQ-FNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFN 168 (621)
Q Consensus 123 ~L~~l~l~~N~-l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~ 168 (621)
+|++|+|++|+ +++..|.. ..++|+.|+|++|++++..|..+..+.
T Consensus 150 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 198 (353)
T 2z80_A 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198 (353)
T ss_dssp TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCS
T ss_pred CCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccc
Confidence 99999999995 55444432 578999999999999988887765443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.12 E-value=6.7e-11 Score=105.92 Aligned_cols=101 Identities=25% Similarity=0.319 Sum_probs=85.0
Q ss_pred CCCCCEEecCCCccc-ccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccE
Q 045652 72 LRGLRAIYLDKNQFS-GEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVR 148 (621)
Q Consensus 72 l~~L~~l~l~~N~l~-g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~ 148 (621)
..+|+.|+|++|.++ |.+|.. +..+++|+.|+|++|.+++. ..+.++++|++|+|++|++++.+|.. ..++|+.
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGL-TDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSC-CTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CccCeEEEccCCcCChhHHHHH-HhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 468999999999999 889985 89999999999999999976 78999999999999999999878865 4899999
Q ss_pred EEcccCccccc-cCccccccc---cCCCCCC
Q 045652 149 LNLSSNKLEGE-IPASLLRFN---ASSFSGN 175 (621)
Q Consensus 149 l~l~~N~l~g~-ip~~~~~~~---~~~~~~n 175 (621)
|+|++|++++. .|..+..++ ...+.+|
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N 123 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCC
Confidence 99999999973 345555443 3345555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.12 E-value=6.3e-11 Score=109.42 Aligned_cols=108 Identities=20% Similarity=0.184 Sum_probs=85.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCC-CCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLR-GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~-~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
..++.|+|++|+++. ++ .+..+. +|++|+|++|.|++ + + .+..+++|+.|+|++|.|++..|..+..+++
T Consensus 19 ~~L~~L~l~~n~l~~-i~-----~~~~~~~~L~~L~Ls~N~l~~-~-~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IE-----NLGATLDQFDAIDFSDNEIRK-L-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp TSCEEEECTTSCCCS-CC-----CGGGGTTCCSEEECCSSCCCE-E-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred CCceEEEeeCCCCch-hH-----HhhhcCCCCCEEECCCCCCCc-c-c-ccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 468899999998874 43 233344 89999999999995 5 3 3889999999999999999643344488999
Q ss_pred cCeeeccCccccccCCC---C-CCCCccEEEcccCccccccCcc
Q 045652 124 LTELHLESNQFNGTIPS---F-DQPTLVRLNLSSNKLEGEIPAS 163 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~---~-~~~~L~~l~l~~N~l~g~ip~~ 163 (621)
|++|+|++|+++ .+|. + ..++|+.|+|++|.++ .+|..
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHY 131 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhH
Confidence 999999999995 5664 2 5789999999999998 56764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.3e-10 Score=129.03 Aligned_cols=126 Identities=20% Similarity=0.225 Sum_probs=102.4
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++..+ ..+..+++|++|+|++|.|++ +|+..|+.+++|++|+|++|.|++..|..|+++++|
T Consensus 75 ~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 149 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDT----YAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149 (597)
T ss_dssp CCCSEEECTTSCCCEECT----TTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCcEEECCCCCCCCCCh----HHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCC
Confidence 468899999999987444 357788999999999999996 666668999999999999999996555557999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccccccCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFNASSFSGN 175 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~n 175 (621)
++|+|++|.+++..|.. .+++|+.|+|++|+|++.-+..+.++....+.+|
T Consensus 150 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 150 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp CEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred CEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 99999999999887753 5799999999999999753344445544445555
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.11 E-value=5.8e-11 Score=115.50 Aligned_cols=125 Identities=19% Similarity=0.153 Sum_probs=96.4
Q ss_pred CCcEEEEEecC-CCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCC---EEeCccC-cccccCCCCC
Q 045652 44 KGIVTGLYINS-MGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALR---KLWFSNN-KFRGRLPPSL 118 (621)
Q Consensus 44 ~~~v~~l~l~~-~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~---~l~l~~N-~l~g~~p~~~ 118 (621)
-..++.|+|++ |.+++ ++. ..+.++++|++|+|++|++++ +|. +..+++|+ .|+|++| ++++..+..+
T Consensus 79 l~~L~~L~l~~~n~l~~-i~~---~~f~~l~~L~~L~l~~n~l~~-lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~~~ 151 (239)
T 2xwt_C 79 LSKVTHIEIRNTRNLTY-IDP---DALKELPLLKFLGIFNTGLKM-FPD--LTKVYSTDIFFILEITDNPYMTSIPVNAF 151 (239)
T ss_dssp CTTCCEEEEEEETTCCE-ECT---TSEECCTTCCEEEEEEECCCS-CCC--CTTCCBCCSEEEEEEESCTTCCEECTTTT
T ss_pred CcCCcEEECCCCCCeeE-cCH---HHhCCCCCCCEEeCCCCCCcc-ccc--cccccccccccEEECCCCcchhhcCcccc
Confidence 35788999998 88885 554 245667899999999999995 885 78888888 9999999 9987766778
Q ss_pred CCCCCcC-eeeccCccccccCCCC--CCCCccEEEcccCc-cccccCcccccc----ccCCCCCCC
Q 045652 119 FKLPHLT-ELHLESNQFNGTIPSF--DQPTLVRLNLSSNK-LEGEIPASLLRF----NASSFSGNA 176 (621)
Q Consensus 119 ~~l~~L~-~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~-l~g~ip~~~~~~----~~~~~~~n~ 176 (621)
.++++|+ +|+|++|+++ .+|.. ..++|+.|+|++|+ +++..|..+..+ ....+.+|.
T Consensus 152 ~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~ 216 (239)
T 2xwt_C 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216 (239)
T ss_dssp TTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCC
T ss_pred cchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCc
Confidence 9999999 9999999998 77753 44789999999995 884334444433 334455553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.5e-10 Score=115.75 Aligned_cols=122 Identities=25% Similarity=0.351 Sum_probs=84.2
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..+.|.. ..++.|+|++|++.+-.+ ..+..+++|++|+|++|++++..|. .|..+++|++|+
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~ 108 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRK----DDFKGLQHLYALVLVNNKISKIHEK-AFSPLRKLQKLY 108 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECT----TTTTTCTTCCEEECCSSCCCEECGG-GSTTCTTCCEEE
T ss_pred cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCH----hHhhCCCCCcEEECCCCccCccCHh-HhhCcCCCCEEE
Confidence 488888842 256778888888775332 2466677888888888888854444 477888888888
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCC-C-CCCCccEEEcccCccc--cccCcccc
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS-F-DQPTLVRLNLSSNKLE--GEIPASLL 165 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~-~~~~L~~l~l~~N~l~--g~ip~~~~ 165 (621)
|++|+++ .+|..+. ++|++|+|++|++++..+. + .+++|+.|+|++|.++ |..|..+.
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 170 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSC
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCccccc
Confidence 8888887 5776665 6788888888888744333 2 5677888888888875 34454443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=2.3e-10 Score=116.95 Aligned_cols=113 Identities=25% Similarity=0.346 Sum_probs=62.0
Q ss_pred CcEEEEEecCCCCee-eeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSG-KIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g-~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
..++.|++++|.+.. .+.. ..+..+++|++|+|++|+++ .+|... .++|+.|+|++|++++..|..+.++++
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~---~~~~~l~~L~~L~l~~n~l~-~l~~~~---~~~L~~L~l~~n~l~~~~~~~~~~l~~ 217 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIEN---GAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNN 217 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCT---TGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTT
T ss_pred ccccEEECCCCcCCccCcCh---hhccCCCCcCEEECCCCccc-cCCccc---cccCCEEECCCCcCCccCHHHhcCCCC
Confidence 467778888887753 1221 23444555666666666665 355442 145555566665555555555555555
Q ss_pred cCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcccc
Q 045652 124 LTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
|++|+|++|++++..|.. ..++|+.|+|++|+++ .+|..+.
T Consensus 218 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp CCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred CCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 556666555555444422 3455555555555555 4554443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=4.2e-11 Score=121.41 Aligned_cols=108 Identities=16% Similarity=0.113 Sum_probs=78.9
Q ss_pred cEEEEEecCCCCeeeeCccccccc--CCCCCCCEEecCCCcccccCCc---ccccCCCCCCEEeCccCcccccCCCCCCC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTEL--TGLRGLRAIYLDKNQFSGEIPP---GYFDEMGALRKLWFSNNKFRGRLPPSLFK 120 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l--~~l~~L~~l~l~~N~l~g~ip~---~~~~~l~~L~~l~l~~N~l~g~~p~~~~~ 120 (621)
.++.|+|++|.+++.+|. .+ ..+.+|++|+|++|++++.+|. ..+..+++|++|+|++|.+++..|..+++
T Consensus 92 ~L~~L~l~~n~l~~~~~~----~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~ 167 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPP----LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRA 167 (310)
T ss_dssp CCCEEEEESCCCBSCCCC----CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCC
T ss_pred ceeEEEeeCCEeccchhh----hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhcc
Confidence 478888888888887764 23 5677888888888888876551 12346788888888888888777778888
Q ss_pred CCCcCeeeccCcccccc--CC-C---CCCCCccEEEcccCccc
Q 045652 121 LPHLTELHLESNQFNGT--IP-S---FDQPTLVRLNLSSNKLE 157 (621)
Q Consensus 121 l~~L~~l~l~~N~l~g~--~p-~---~~~~~L~~l~l~~N~l~ 157 (621)
+++|++|+|++|++.+. ++ . ..+++|+.|+|++|+++
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 210 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME 210 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC
Confidence 88888888888887652 22 1 14567777777777776
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.3e-10 Score=125.09 Aligned_cols=98 Identities=23% Similarity=0.279 Sum_probs=72.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.++ .|| ..+++|++|+|++|+|++ ||. +.. +|+.|+|++|+|++ +|. .+++|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip-------~~l~~L~~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~---~l~~L 142 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP-------ELPASLEYLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE---LPALL 142 (571)
T ss_dssp TTCSEEECCSSCCS-CCC-------CCCTTCCEEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC---CCTTC
T ss_pred CCCCEEECcCCCCc-ccc-------cccCCCCEEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC---cCccc
Confidence 45888888888887 465 235678888888888885 776 333 78888888888876 666 57778
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCccccccCc
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~ 162 (621)
++|+|++|+|++ +|. ..++|+.|+|++|+|++ ||.
T Consensus 143 ~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-lp~ 177 (571)
T 3cvr_A 143 EYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-LPE 177 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC
T ss_pred cEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-cch
Confidence 888888888875 666 56777788888887775 666
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.08 E-value=5.6e-11 Score=109.78 Aligned_cols=104 Identities=20% Similarity=0.299 Sum_probs=91.0
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC--CCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP--SLFKLP 122 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~ 122 (621)
..++.|+|++|.+++ + ..+..+++|++|+|++|+|+ .+|+..+..+++|++|+|++|.|+ .+|. .+..++
T Consensus 42 ~~L~~L~Ls~N~l~~-~-----~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~ 113 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRK-L-----DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLK 113 (176)
T ss_dssp TCCSEEECCSSCCCE-E-----CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCT
T ss_pred CCCCEEECCCCCCCc-c-----cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCC
Confidence 378999999999987 3 35778899999999999999 578776799999999999999996 5776 889999
Q ss_pred CcCeeeccCccccccCCCC------CCCCccEEEcccCccc
Q 045652 123 HLTELHLESNQFNGTIPSF------DQPTLVRLNLSSNKLE 157 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~------~~~~L~~l~l~~N~l~ 157 (621)
+|++|+|++|.++ .+|.. .+++|+.||+++|.+.
T Consensus 114 ~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 114 SLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999999998 56652 5799999999999886
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.5e-10 Score=119.20 Aligned_cols=103 Identities=21% Similarity=0.246 Sum_probs=85.2
Q ss_pred CEEecCCC-cccccCCcccccCCCCCCEEeCcc-CcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEc
Q 045652 76 RAIYLDKN-QFSGEIPPGYFDEMGALRKLWFSN-NKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNL 151 (621)
Q Consensus 76 ~~l~l~~N-~l~g~ip~~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l 151 (621)
..+++++| +|+ .||. +..+++|+.|+|++ |+|++..|..|++|++|++|+|++|+|+|..|.. .+++|+.|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 35689988 999 5997 88999999999996 9999888889999999999999999999988864 6899999999
Q ss_pred ccCccccccCccccc--cccCCCCCCCCCCCC
Q 045652 152 SSNKLEGEIPASLLR--FNASSFSGNAGLCGK 181 (621)
Q Consensus 152 ~~N~l~g~ip~~~~~--~~~~~~~~n~~~c~~ 181 (621)
++|+|++..|..+.. +..+.+.+|+..|..
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCCC
Confidence 999999543333332 445567788877753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-10 Score=127.17 Aligned_cols=100 Identities=21% Similarity=0.276 Sum_probs=88.9
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccC-CCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRL-PPSLFKLP 122 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~-p~~~~~l~ 122 (621)
...++.|+|++|.|+ .||. .+..|++|+.|+|++|+|++ || . ++.|++|+.|+|++|+|++.+ |..+++++
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~----~~~~l~~L~~L~Ls~N~l~~-lp-~-l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~ 533 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPP----ALAALRCLEVLQASDNALEN-VD-G-VANLPRLQELLLCNNRLQQSAAIQPLVSCP 533 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCG----GGGGCTTCCEEECCSSCCCC-CG-G-GTTCSSCCEEECCSSCCCSSSTTGGGGGCT
T ss_pred cccCcEeecCccccc-ccch----hhhcCCCCCEEECCCCCCCC-Cc-c-cCCCCCCcEEECCCCCCCCCCCcHHHhcCC
Confidence 457999999999999 6873 56778899999999999996 88 5 899999999999999999987 99999999
Q ss_pred CcCeeeccCccccccCCCC-----CCCCccEEEc
Q 045652 123 HLTELHLESNQFNGTIPSF-----DQPTLVRLNL 151 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~-----~~~~L~~l~l 151 (621)
+|++|+|++|+|++.+|.. .+++|+.||+
T Consensus 534 ~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 534 RLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp TCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999999999999887753 2689999875
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=5.2e-10 Score=114.35 Aligned_cols=114 Identities=22% Similarity=0.339 Sum_probs=55.1
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..+.|.. ..++.|+|++|++++ ++. ..+..+++|++|+|++|++++..|.. |..+++|++|+
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~---~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~ 106 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKD---GDFKNLKNLHTLILINNKISKISPGA-FAPLVKLERLY 106 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCT---TTTTTCTTCCEEECCSSCCCCBCTTT-TTTCTTCCEEE
T ss_pred CCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eCh---hhhccCCCCCEEECCCCcCCeeCHHH-hcCCCCCCEEE
Confidence 466666642 134445555555544 221 12344455555555555555322332 55555555555
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCC--CCCCCccEEEcccCccc
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKLE 157 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~ 157 (621)
|++|+++ .+|..+. ++|++|+|++|++++..+. ..+++|+.|+|++|+++
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 158 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCC
Confidence 5555555 3444433 4555555555555433322 13445555555555553
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.04 E-value=2.9e-10 Score=121.60 Aligned_cols=102 Identities=18% Similarity=0.143 Sum_probs=65.9
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|++++|++++ +| +..+++|+.|+|++|++++ ++ ++.+++|+.|+|++|+|++ +| ++.+++|
T Consensus 170 ~~L~~L~ls~n~l~~-l~------l~~l~~L~~L~l~~N~l~~-~~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L 235 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD------VSQNKLLNRLNCDTNNITK-LD---LNQNIQLTFLDCSSNKLTE-ID--VTPLTQL 235 (457)
T ss_dssp TTCCEEECCSSCCCC-CC------CTTCTTCCEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred CcCCEEECCCCccce-ec------cccCCCCCEEECcCCcCCe-ec---cccCCCCCEEECcCCcccc-cC--ccccCCC
Confidence 467888888888876 43 4456677777777777774 33 5667777777777777776 55 6677777
Q ss_pred CeeeccCccccccCCCCCCC----------CccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIPSFDQP----------TLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~----------~L~~l~l~~N~l~g~ip 161 (621)
++|+|++|+|++..+ ...+ +|+.|++++|.+.|.+|
T Consensus 236 ~~L~l~~N~l~~~~~-~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 236 TYFDCSVNPLTELDV-STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp SEEECCSSCCSCCCC-TTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred CEEEeeCCcCCCcCH-HHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 777777777765332 2222 34455555555555555
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=3.3e-10 Score=117.33 Aligned_cols=142 Identities=18% Similarity=0.243 Sum_probs=105.1
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEcc--CCC-hhhHHHHHHHHHHHhcCC--CCCcccceEEEEeC---CeeEEEEee
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMK--ESS-AMARDAFDTEVRRLGRLR--HSNVLAPLAYHYRT---DEKLLVYEY 388 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 388 (621)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 357899999999998754 678888775 322 122456789999999997 45678888888765 347999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc------------------------------------
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL------------------------------------ 432 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 432 (621)
++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9998774321 234778888899999999999999731
Q ss_pred ------------------CCCCCccCCCCCCCEEeCCCCC--cEEEeeecceec
Q 045652 433 ------------------AHLDLPHGNLKSSNIFISPENE--PLISEFGFYTMI 466 (621)
Q Consensus 433 ------------------~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~ 466 (621)
....++|+|++|.||+++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 0246899999999999997753 589999987653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.02 E-value=7.2e-10 Score=109.41 Aligned_cols=100 Identities=21% Similarity=0.342 Sum_probs=52.8
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|++++++++. ++ .+..+++|+.|+|++|++++ +|+ +..+++|+.|+|++|++++ +|.... ++|+
T Consensus 42 ~L~~L~l~~n~i~~-l~-----~l~~l~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~ 109 (263)
T 1xeu_A 42 GVQNFNGDNSNIQS-LA-----GMQFFTNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLS 109 (263)
T ss_dssp TCSEEECTTSCCCC-CT-----TGGGCTTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCC
T ss_pred cCcEEECcCCCccc-ch-----HHhhCCCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCcccc--Cccc
Confidence 45555666555542 22 24445556666666666653 443 5556666666666666654 333222 5566
Q ss_pred eeeccCccccccCCCC-CCCCccEEEcccCcccc
Q 045652 126 ELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g 158 (621)
+|+|++|++++ +|.+ .+++|+.|+|++|++++
T Consensus 110 ~L~L~~N~l~~-~~~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 110 RLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp EEECCSSCCSB-SGGGTTCTTCCEEECTTSCCCB
T ss_pred EEEccCCccCC-ChhhcCcccccEEECCCCcCCC
Confidence 66666666554 2332 45556666666666553
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.8e-10 Score=114.72 Aligned_cols=101 Identities=16% Similarity=0.080 Sum_probs=65.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++ ++ .+++|++|+|++|++++ ++.. .+++|+.|+|++|++++..|..++.+++|
T Consensus 80 ~~L~~L~Ls~n~l~~-l~--------~~~~L~~L~l~~n~l~~-~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L 146 (317)
T 3o53_A 80 STLRTLDLNNNYVQE-LL--------VGPSIETLHAANNNISR-VSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRV 146 (317)
T ss_dssp TTCCEEECCSSEEEE-EE--------ECTTCCEEECCSSCCSE-EEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSE
T ss_pred CCCCEEECcCCcccc-cc--------CCCCcCEEECCCCccCC-cCcc---ccCCCCEEECCCCCCCCccchhhhccCCC
Confidence 467777777777664 22 12567777777777774 3332 25667777777777776666667777777
Q ss_pred CeeeccCccccccCCCC---CCCCccEEEcccCcccc
Q 045652 125 TELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~g 158 (621)
++|+|++|++++..|.. .+++|+.|+|++|++++
T Consensus 147 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence 77777777776654432 34677777777777764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.01 E-value=3.1e-10 Score=114.84 Aligned_cols=120 Identities=23% Similarity=0.365 Sum_probs=88.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++ ++ .+..+++|+.|+|++|++++ +|+ +..+++|+.|+|++|.+++..| +..+++|
T Consensus 85 ~~L~~L~L~~n~l~~-~~-----~~~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L 153 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS-----AIAGLQSIKTLDLTSTQITD-VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNL 153 (308)
T ss_dssp CSCCEEECCSCCCSC-CG-----GGTTCTTCCEEECTTSCCCC-CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTC
T ss_pred CCCCEEEccCCcCCC-ch-----hhcCCCCCCEEECCCCCCCC-chh--hcCCCCCCEEECCCCccCcCcc--ccCCCCc
Confidence 578899999998876 32 46778889999999999985 664 7888999999999999886433 8888889
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCccccccC-ccccccccCCCCCC
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIP-ASLLRFNASSFSGN 175 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip-~~~~~~~~~~~~~n 175 (621)
++|+|++|++++..+-..+++|+.|+|++|++++..| ..+.++....+.+|
T Consensus 154 ~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N 205 (308)
T 1h6u_A 154 QYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205 (308)
T ss_dssp CEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTS
T ss_pred cEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCC
Confidence 9999999988864443367888888998888885333 11223333445555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.01 E-value=6.7e-10 Score=112.39 Aligned_cols=119 Identities=17% Similarity=0.295 Sum_probs=96.2
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++|.+++ ++ .+..+++|++|+|++|++++ +| . +..+++|+.|+|++|.+++ +|. +..+++
T Consensus 62 l~~L~~L~L~~n~i~~-~~-----~~~~l~~L~~L~L~~n~l~~-~~-~-~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~ 130 (308)
T 1h6u_A 62 LNNLIGLELKDNQITD-LA-----PLKNLTKITELELSGNPLKN-VS-A-IAGLQSIKTLDLTSTQITD-VTP-LAGLSN 130 (308)
T ss_dssp CTTCCEEECCSSCCCC-CG-----GGTTCCSCCEEECCSCCCSC-CG-G-GTTCTTCCEEECTTSCCCC-CGG-GTTCTT
T ss_pred cCCCCEEEccCCcCCC-Ch-----hHccCCCCCEEEccCCcCCC-ch-h-hcCCCCCCEEECCCCCCCC-chh-hcCCCC
Confidence 4579999999999876 33 27788999999999999995 65 3 8899999999999999997 554 899999
Q ss_pred cCeeeccCccccccCCCCCCCCccEEEcccCccccccCccccc---cccCCCCCC
Q 045652 124 LTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLR---FNASSFSGN 175 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~n 175 (621)
|++|+|++|++++..+-..+++|+.|+|++|++++ +|. +.. +....+.+|
T Consensus 131 L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDN 183 (308)
T ss_dssp CCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred CCEEECCCCccCcCccccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCC
Confidence 99999999999865553467999999999999996 443 433 333445555
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.00 E-value=7.9e-10 Score=110.87 Aligned_cols=106 Identities=25% Similarity=0.449 Sum_probs=78.9
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++|.+++ ++ .+..+++|++|+|++|.+++ +|. +..+++|+.|+|++|++++ + +.+..+++
T Consensus 67 l~~L~~L~L~~n~l~~-~~-----~l~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~ 135 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTD-IK-----PLANLKNLGWLFLDENKVKD-LSS--LKDLKKLKSLSLEHNGISD-I-NGLVHLPQ 135 (291)
T ss_dssp CTTCCEEECCSSCCCC-CG-----GGTTCTTCCEEECCSSCCCC-GGG--GTTCTTCCEEECTTSCCCC-C-GGGGGCTT
T ss_pred CCCCCEEEccCCccCC-Cc-----ccccCCCCCEEECCCCcCCC-Chh--hccCCCCCEEECCCCcCCC-C-hhhcCCCC
Confidence 3578889999998876 32 16677788888888888874 553 7788888888888888876 3 45777888
Q ss_pred cCeeeccCccccccCCCC-CCCCccEEEcccCccccccC
Q 045652 124 LTELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip 161 (621)
|++|+|++|++++. +.+ .+++|+.|+|++|++++..|
T Consensus 136 L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 136 LESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 88888888888754 443 56788888888888876443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.00 E-value=5.1e-10 Score=112.27 Aligned_cols=102 Identities=25% Similarity=0.436 Sum_probs=71.1
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+++++++.. ++ .+..+++|+.|+|++|++++ +++ +..+++|+.|+|++|.+++ +| .+..+++|+
T Consensus 47 ~L~~L~l~~~~i~~-~~-----~~~~l~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 47 SIDQIIANNSDIKS-VQ-----GIQYLPNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp TCCEEECTTSCCCC-CT-----TGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred cccEEEccCCCccc-Ch-----hHhcCCCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 46777777777653 22 35556777788888888874 554 6777788888888888775 33 377777888
Q ss_pred eeeccCccccccCCCC-CCCCccEEEcccCccccc
Q 045652 126 ELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ 159 (621)
+|+|++|++++ ++.. .+++|+.|+|++|++++.
T Consensus 116 ~L~L~~n~i~~-~~~l~~l~~L~~L~l~~n~l~~~ 149 (291)
T 1h6t_A 116 SLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI 149 (291)
T ss_dssp EEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCCC
T ss_pred EEECCCCcCCC-ChhhcCCCCCCEEEccCCcCCcc
Confidence 88888887775 3443 567788888888877753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.00 E-value=8.5e-10 Score=112.85 Aligned_cols=120 Identities=19% Similarity=0.269 Sum_probs=97.1
Q ss_pred EEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCe
Q 045652 47 VTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTE 126 (621)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~ 126 (621)
++.++++++++. .+|.. + .++|+.|+|++|.+++ +|+..|..+++|++|+|++|++++..|..+.++++|++
T Consensus 35 l~~l~~~~~~l~-~ip~~----~--~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 106 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKE----I--SPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQK 106 (332)
T ss_dssp TTEEECCSSCCS-SCCSC----C--CTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCE
T ss_pred CCEEECCCCCcc-ccCCC----C--CCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCE
Confidence 567899998887 46642 2 2589999999999995 65555999999999999999999988999999999999
Q ss_pred eeccCccccccCCCCCCCCccEEEcccCccccccCccccccc---cCCCCCC
Q 045652 127 LHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGN 175 (621)
Q Consensus 127 l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n 175 (621)
|+|++|+++ .+|....++|+.|+|++|++++..+..+..+. ...+.+|
T Consensus 107 L~L~~n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n 157 (332)
T 2ft3_A 107 LYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157 (332)
T ss_dssp EECCSSCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSC
T ss_pred EECCCCcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCC
Confidence 999999998 78876569999999999999954444444433 3344555
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.98 E-value=6.3e-10 Score=122.80 Aligned_cols=105 Identities=26% Similarity=0.441 Sum_probs=57.0
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|+|++|.+++-.+ +..|++|+.|+|++|.|++ +| . +..|++|+.|+|++|.|++ + +.+..|++|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~------l~~l~~L~~L~Ls~N~l~~-l~-~-l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L 133 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP------LTNLKNLGWLFLDENKIKD-LS-S-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQL 133 (605)
T ss_dssp TTCCEEECTTSCCCCCGG------GGGCTTCCEEECCSSCCCC-CT-T-STTCTTCCEEECTTSCCCC-C-GGGGGCTTC
T ss_pred CCCCEEEeeCCCCCCChh------hccCCCCCEEECcCCCCCC-Ch-h-hccCCCCCEEEecCCCCCC-C-ccccCCCcc
Confidence 467777777777765222 4445555666666666653 43 2 5555555555555555554 2 235555555
Q ss_pred CeeeccCccccccCCCC-CCCCccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip 161 (621)
+.|+|++|+|++. +.+ .+++|+.|+|++|+|++..|
T Consensus 134 ~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 134 ESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh
Confidence 5555555555543 322 34555555555555554433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-09 Score=116.86 Aligned_cols=97 Identities=22% Similarity=0.342 Sum_probs=50.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|++++|.+++ +|. . +.+|+.|+|++|++++ +|.. .++|++|+|++|++++ +| +++++++|
T Consensus 91 ~~L~~L~l~~n~l~~-lp~-~------~~~L~~L~l~~n~l~~-l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPE-L------PQSLKSLLVDNNNLKA-LSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp TTCSEEECCSSCCSS-CCC-C------CTTCCEEECCSSCCSC-CCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred CCCCEEEccCCcCCc-ccc-c------cCCCcEEECCCCccCc-ccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 356666676666665 542 1 2345555555555552 3321 1455555555555554 55 35555555
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCcccc
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 158 (621)
++|+|++|++++ +|.. .++|+.|+|++|++++
T Consensus 156 ~~L~l~~N~l~~-lp~~-~~~L~~L~L~~n~l~~ 187 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDL-PPSLEFIAAGNNQLEE 187 (454)
T ss_dssp CEEECCSSCCSC-CCCC-CTTCCEEECCSSCCSS
T ss_pred CEEECCCCcCcc-cCCC-cccccEEECcCCcCCc
Confidence 555555555553 4432 2355555555555554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-09 Score=115.27 Aligned_cols=101 Identities=27% Similarity=0.388 Sum_probs=62.9
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+|++|.+++ +| .+..+++|++|+|++|++++ +|.. +.+|++|+|++|++++ +| .++++++|+
T Consensus 132 ~L~~L~L~~n~l~~-lp-----~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~ 198 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-----ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLT 198 (454)
T ss_dssp TCCEEECCSSCCSS-CC-----CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCC
T ss_pred CCCEEECcCCCCCC-Cc-----ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCC
Confidence 44455555555543 33 25556667777777777764 6643 2466777777777765 55 467777777
Q ss_pred eeeccCccccccCCCCCCCCccEEEcccCccccccCc
Q 045652 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~ 162 (621)
+|+|++|++++ +|.. .++|+.|++++|+++ .+|.
T Consensus 199 ~L~l~~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp~ 232 (454)
T 1jl5_A 199 AIYADNNSLKK-LPDL-PLSLESIVAGNNILE-ELPE 232 (454)
T ss_dssp EEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-SCCC
T ss_pred EEECCCCcCCc-CCCC-cCcccEEECcCCcCC-cccc
Confidence 77777777765 4433 246777777777776 6663
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-09 Score=115.41 Aligned_cols=100 Identities=23% Similarity=0.157 Sum_probs=55.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|++++|.+++ ++ +..+++|++|+|++|++.|.++ ++.+++|+.|+|++|++++ +| ++.+++|
T Consensus 127 ~~L~~L~l~~N~l~~-l~------l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L 193 (457)
T 3bz5_A 127 PLLTYLNCARNTLTE-ID------VSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLL 193 (457)
T ss_dssp TTCCEEECTTSCCSC-CC------CTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTC
T ss_pred CcCCEEECCCCccce-ec------cccCCcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCC
Confidence 467788888888776 33 3344555555665555444552 4455555555555555554 33 4555555
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCcccc
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 158 (621)
+.|+|++|++++. +-...++|+.|+|++|+|++
T Consensus 194 ~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 194 NRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp CEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC
T ss_pred CEEECcCCcCCee-ccccCCCCCEEECcCCcccc
Confidence 5555555555532 32244555555555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.3e-09 Score=107.49 Aligned_cols=103 Identities=20% Similarity=0.315 Sum_probs=86.9
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++|.+++ ++. +..+++|++|+|++|++++ +|.. .. ++|+.|+|++|++++ +| .+..+++
T Consensus 62 l~~L~~L~L~~N~i~~-~~~-----l~~l~~L~~L~L~~N~l~~-l~~~--~~-~~L~~L~L~~N~l~~-~~-~l~~l~~ 129 (263)
T 1xeu_A 62 FTNLKELHLSHNQISD-LSP-----LKDLTKLEELSVNRNRLKN-LNGI--PS-ACLSRLFLDNNELRD-TD-SLIHLKN 129 (263)
T ss_dssp CTTCCEEECCSSCCCC-CGG-----GTTCSSCCEEECCSSCCSC-CTTC--CC-SSCCEEECCSSCCSB-SG-GGTTCTT
T ss_pred CCCCCEEECCCCccCC-Chh-----hccCCCCCEEECCCCccCC-cCcc--cc-CcccEEEccCCccCC-Ch-hhcCccc
Confidence 3579999999999986 332 6788999999999999995 7753 33 899999999999997 44 5899999
Q ss_pred cCeeeccCccccccCCCC-CCCCccEEEcccCccccc
Q 045652 124 LTELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ 159 (621)
|++|+|++|++++. |.. .+++|+.|+|++|++++.
T Consensus 130 L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 130 LEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred ccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch
Confidence 99999999999864 544 679999999999999965
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.5e-10 Score=126.30 Aligned_cols=132 Identities=24% Similarity=0.346 Sum_probs=83.6
Q ss_pred CCCCCCCCCCCCCCCCceeeEE--------eCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCc
Q 045652 20 LDSWMPSTAPCRGGEEEWSGVV--------CLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPP 91 (621)
Q Consensus 20 l~~w~~~~~~c~~~~~~w~gv~--------c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~ 91 (621)
...|..+.++|. |.|.. |....++.|++++++|+ .||.. +. ++|+.|+|++|+|+ .||.
T Consensus 12 w~~W~~~~~~~~-----~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~----l~--~~L~~L~L~~N~l~-~lp~ 78 (622)
T 3g06_A 12 WSAWRRAAPAEE-----SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDC----LP--AHITTLVIPDNNLT-SLPA 78 (622)
T ss_dssp HHHHHHTCCGGG-----HHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSC----CC--TTCSEEEECSCCCS-CCCC
T ss_pred HHHHHhcCCcch-----hccccccCcccccccCCCCcEEEecCCCcC-ccChh----hC--CCCcEEEecCCCCC-CCCC
Confidence 346765566664 87642 33456888999999888 57642 21 57777788877777 5775
Q ss_pred ccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCccccccccCC
Q 045652 92 GYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFNASS 171 (621)
Q Consensus 92 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~ 171 (621)
.+++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. ..++|+.|+|++|+|++ +|..+.++....
T Consensus 79 ----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~-~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~ 147 (622)
T 3g06_A 79 ----LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA-LPSGLCKLWIFGNQLTS-LPVLPPGLQELS 147 (622)
T ss_dssp ----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC-CCTTCCEEECCSSCCSC-CCCCCTTCCEEE
T ss_pred ----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC-CCCCcCEEECCCCCCCc-CCCCCCCCCEEE
Confidence 3677777777777777 3665 56677777777777764 444 44566666666666663 555444444444
Q ss_pred CCCC
Q 045652 172 FSGN 175 (621)
Q Consensus 172 ~~~n 175 (621)
+++|
T Consensus 148 Ls~N 151 (622)
T 3g06_A 148 VSDN 151 (622)
T ss_dssp CCSS
T ss_pred CcCC
Confidence 4444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.96 E-value=8.3e-10 Score=121.85 Aligned_cols=104 Identities=27% Similarity=0.422 Sum_probs=81.4
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...+..|+|++|.+++ + ..+..|++|+.|+|++|+|++ +| . +..|++|+.|+|++|.|++. ..+..|++
T Consensus 86 l~~L~~L~Ls~N~l~~-l-----~~l~~l~~L~~L~Ls~N~l~~-l~-~-l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~ 154 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-L-----SSLKDLKKLKSLSLEHNGISD-IN-G-LVHLPQLESLYLGNNKITDI--TVLSRLTK 154 (605)
T ss_dssp CTTCCEEECCSSCCCC-C-----TTSTTCTTCCEEECTTSCCCC-CG-G-GGGCTTCSEEECCSSCCCCC--GGGGSCTT
T ss_pred CCCCCEEECcCCCCCC-C-----hhhccCCCCCEEEecCCCCCC-Cc-c-ccCCCccCEEECCCCccCCc--hhhcccCC
Confidence 3467888888888775 3 246777888888888888884 54 3 77888888888888888864 56788888
Q ss_pred cCeeeccCccccccCCCCCCCCccEEEcccCcccc
Q 045652 124 LTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 158 (621)
|+.|+|++|+|++..|-..+++|+.|+|++|+|++
T Consensus 155 L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 155 LDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred CCEEECcCCcCCCchhhccCCCCCEEECcCCCCCC
Confidence 88888888888877774467888888888888885
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.95 E-value=2.1e-12 Score=121.96 Aligned_cols=109 Identities=22% Similarity=0.284 Sum_probs=73.8
Q ss_pred CcEEEEEecCCCCeeeeCc-cccc-ccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDV-DALT-ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLP 122 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~-~~~~-~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~ 122 (621)
..++.++++.+.++|.+|. ..++ .+..+++|++|+|++|++++ +| . +..+++|+.|+|++|.++ .+|..+..++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~-~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-S-LSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-C-HHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-c-cccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 3556666666677776652 1111 34556677788888888875 77 3 677778888888888777 5777666677
Q ss_pred CcCeeeccCccccccCCCC-CCCCccEEEcccCcccc
Q 045652 123 HLTELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 123 ~L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g 158 (621)
+|++|+|++|++++ +|.+ .+++|+.|+|++|++++
T Consensus 94 ~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp HCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCC
T ss_pred cCCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCc
Confidence 78888888887775 4433 45677777887777773
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-09 Score=112.16 Aligned_cols=120 Identities=18% Similarity=0.233 Sum_probs=78.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+..+++++|.+.+..+ +..+++|+.|+|++|.+++ +|+ +..+++|+.|+|++|.+++ + +.+..+++|
T Consensus 199 ~~L~~L~l~~n~l~~~~~------~~~~~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L 267 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP------VANMTRLNSLKIGNNKITD-LSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKL 267 (347)
T ss_dssp TTCCEEECCSSCCCCCGG------GGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred CccceeecccCCCCCCch------hhcCCcCCEEEccCCccCC-Ccc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCc
Confidence 456677777777664221 4556677777777777773 554 5677777777777777775 3 356777777
Q ss_pred CeeeccCccccccCCCC-CCCCccEEEcccCccccccCccccccc---cCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGNA 176 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~ 176 (621)
++|+|++|++++ +|.+ ..++|+.|+|++|++++..|..+..++ ...+.+|+
T Consensus 268 ~~L~l~~n~l~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 268 KMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp CEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred CEEEccCCccCC-ChhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 777777777764 3433 467777777777777766665554433 33455554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.92 E-value=4e-09 Score=116.62 Aligned_cols=64 Identities=28% Similarity=0.518 Sum_probs=36.6
Q ss_pred CCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCccccccc
Q 045652 98 GALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFN 168 (621)
Q Consensus 98 ~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~ 168 (621)
++|+.|+|++|+|++ +| ..+++|++|+|++|+|+ .+|. ..++|+.|+|++|+|+ .||..+..++
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~-~lp~~l~~l~ 284 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT-RLPESLIHLS 284 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc-ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence 445555555555554 44 33455666666666665 4554 4556666666666666 6666554443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.92 E-value=1.7e-09 Score=111.52 Aligned_cols=114 Identities=17% Similarity=0.167 Sum_probs=75.9
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCE-E
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRK-L 103 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~-l 103 (621)
.|..|.|.. ..++.|+|++|+++. ||. ..+.+|++|++|+|++|++.+.||++.|.++++|.. +
T Consensus 10 ~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~-i~~---~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 10 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQK---GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSE-ECT---TSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCC-cCH---HHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 578889942 246677777777763 654 235667777788888887776777776777777654 5
Q ss_pred eCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEccc
Q 045652 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSS 153 (621)
Q Consensus 104 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~ 153 (621)
++++|+++...|..|..+++|++|++++|++++..+.. ....+..|++++
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~ 137 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc
Confidence 66677777766777777778888888888776443322 233445555543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.5e-09 Score=116.49 Aligned_cols=121 Identities=23% Similarity=0.333 Sum_probs=93.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|++++|.+++ ++ .+..+++|+.|+|++|++++ +|+ +..+++|+.|+|++|++++..| +..+++|
T Consensus 265 ~~L~~L~l~~n~l~~-~~-----~~~~l~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 333 (466)
T 1o6v_A 265 TKLTELKLGANQISN-IS-----PLAGLTALTNLELNENQLED-ISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL 333 (466)
T ss_dssp TTCSEEECCSSCCCC-CG-----GGTTCTTCSEEECCSSCCSC-CGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTC
T ss_pred CCCCEEECCCCccCc-cc-----cccCCCccCeEEcCCCcccC-chh--hcCCCCCCEEECcCCcCCCchh--hccCccC
Confidence 468899999999886 32 26678899999999999995 554 6789999999999999998766 7889999
Q ss_pred CeeeccCccccccCCCC-CCCCccEEEcccCccccccCc-cccccccCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIPA-SLLRFNASSFSGNAG 177 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip~-~~~~~~~~~~~~n~~ 177 (621)
++|+|++|++++. +.+ .+++|+.|++++|++++.+|- .+.++....+.+|+.
T Consensus 334 ~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 334 QRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387 (466)
T ss_dssp CEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEE
T ss_pred CEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcc
Confidence 9999999999875 443 678999999999999987771 122333344555543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=7.1e-10 Score=111.96 Aligned_cols=182 Identities=19% Similarity=0.148 Sum_probs=119.6
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCC--cccceEEEEeCC---eeEEEEeecCC
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSN--VLAPLAYHYRTD---EKLLVYEYIPG 391 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~ 391 (621)
.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++....... ..|+|||+++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 47888888998863 46888886532 34567889999998884 333 334444332222 24799999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc---------------------------------------
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL--------------------------------------- 432 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------- 432 (621)
.+|..... ..++..++..++.++++.|+.||+..
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88875432 23677778888889999998888610
Q ss_pred ---------------CCCCCccCCCCCCCEEeCC--CCCcEEEeeecceeccccccccccccc---cCcccccC-----C
Q 045652 433 ---------------AHLDLPHGNLKSSNIFISP--ENEPLISEFGFYTMINSANLAQALFAY---KAPEAIQS-----G 487 (621)
Q Consensus 433 ---------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~y---~aPE~~~~-----~ 487 (621)
....++|+|++|.||++++ ...+.|+||+.+..-...........+ ..|+.... +
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235789999999999998 456789999987654332111111111 12221100 0
Q ss_pred ---------CCCcchhhHHHHHHHHHHHhCCCCC
Q 045652 488 ---------KVTPKCDVYCLGIIILEILTGKFPS 512 (621)
Q Consensus 488 ---------~~~~~~DvwSlGvvl~elltg~~P~ 512 (621)
......+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1122368999999999999998765
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.88 E-value=9.9e-10 Score=112.99 Aligned_cols=122 Identities=24% Similarity=0.317 Sum_probs=98.7
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++|.+++ ++ .+..+++|+.|+|++|.+++ ++ .+..+++|+.|+|++|.+++. +.+..+++
T Consensus 220 ~~~L~~L~l~~n~l~~-~~-----~~~~l~~L~~L~l~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~ 288 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITD-LS-----PLANLSQLTWLEIGTNQISD-IN--AVKDLTKLKMLNVGSNQISDI--SVLNNLSQ 288 (347)
T ss_dssp CTTCCEEECCSSCCCC-CG-----GGTTCTTCCEEECCSSCCCC-CG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTT
T ss_pred CCcCCEEEccCCccCC-Cc-----chhcCCCCCEEECCCCccCC-Ch--hHhcCCCcCEEEccCCccCCC--hhhcCCCC
Confidence 3578999999999875 32 26788899999999999995 64 388999999999999999974 45889999
Q ss_pred cCeeeccCccccccCCCC--CCCCccEEEcccCccccccC-ccccccccCCCCCCC
Q 045652 124 LTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP-ASLLRFNASSFSGNA 176 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip-~~~~~~~~~~~~~n~ 176 (621)
|++|+|++|++++..|.. .+++|+.|+|++|++++..| ..+.++....+.+|+
T Consensus 289 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred CCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence 999999999999877753 68999999999999998766 233444455566663
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2.2e-09 Score=115.19 Aligned_cols=119 Identities=29% Similarity=0.326 Sum_probs=97.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.|++++|.+++..+ +..+++|+.|+|++|.+++ +|+ +..+++|+.|+|++|++++..| +..+++|
T Consensus 243 ~~L~~L~l~~n~l~~~~~------~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 311 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP------LSGLTKLTELKLGANQISN-ISP--LAGLTALTNLELNENQLEDISP--ISNLKNL 311 (466)
T ss_dssp TTCSEEECCSSCCCCCGG------GTTCTTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTC
T ss_pred CCCCEEECCCCccccchh------hhcCCCCCEEECCCCccCc-ccc--ccCCCccCeEEcCCCcccCchh--hcCCCCC
Confidence 578899999999987432 6778899999999999995 554 7889999999999999997554 8899999
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCccccccCcccccc---ccCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRF---NASSFSGNA 176 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~---~~~~~~~n~ 176 (621)
++|+|++|++++..|....++|+.|++++|++++. | .+..+ ....+.+|.
T Consensus 312 ~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 312 TYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-S-SLANLTNINWLSAGHNQ 364 (466)
T ss_dssp SEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred CEEECcCCcCCCchhhccCccCCEeECCCCccCCc-h-hhccCCCCCEEeCCCCc
Confidence 99999999999887755789999999999999974 3 34333 334455554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.82 E-value=1.5e-11 Score=115.94 Aligned_cols=109 Identities=23% Similarity=0.283 Sum_probs=92.6
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++|.+++ +| .+..+++|++|+|++|.++ .+|.. +..+++|+.|+|++|++++ +| .+..+++
T Consensus 47 l~~L~~L~ls~n~l~~-l~-----~~~~l~~L~~L~l~~n~l~-~l~~~-~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~ 116 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-----SLSGMENLRILSLGRNLIK-KIENL-DAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-----CHHHHTTCCEEEEEEEEEC-SCSSH-HHHHHHCSEEEEEEEECCC-HH-HHHHHHH
T ss_pred CCCCCEEECCCCCCcc-cc-----ccccCCCCCEEECCCCCcc-cccch-hhcCCcCCEEECcCCcCCc-CC-ccccCCC
Confidence 4578999999999887 54 4556789999999999999 79975 7778999999999999997 56 6889999
Q ss_pred cCeeeccCccccccCC--C-CCCCCccEEEcccCccccccCc
Q 045652 124 LTELHLESNQFNGTIP--S-FDQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p--~-~~~~~L~~l~l~~N~l~g~ip~ 162 (621)
|++|+|++|++++..+ . ..+++|+.|+|++|.+++.+|.
T Consensus 117 L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999999999985322 2 2678999999999999988775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.82 E-value=2.6e-10 Score=119.37 Aligned_cols=114 Identities=25% Similarity=0.356 Sum_probs=58.0
Q ss_pred CcEEEEEecCCCCeeeeCccccc-ccCCC---------CCCCEEecCCCccc-ccCCc--ccccCCCCCCEEeCccCccc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALT-ELTGL---------RGLRAIYLDKNQFS-GEIPP--GYFDEMGALRKLWFSNNKFR 111 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~-~l~~l---------~~L~~l~l~~N~l~-g~ip~--~~~~~l~~L~~l~l~~N~l~ 111 (621)
..++.|+|++|.+++..+. .+. .+..+ ++|++|+|++|+++ +.+|. ..+..+++|+.|+|++|.++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~-~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGA-KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp TTCCEEECCSSCCHHHHHH-HHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCEEECcCCCCCHHHHH-HHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 5677777777777532211 111 12222 45666666666665 33431 12445555666666666555
Q ss_pred --c---cCCCCCCCCCCcCeeeccCcccc----ccCCCC--CCCCccEEEcccCccccc
Q 045652 112 --G---RLPPSLFKLPHLTELHLESNQFN----GTIPSF--DQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 112 --g---~~p~~~~~l~~L~~l~l~~N~l~----g~~p~~--~~~~L~~l~l~~N~l~g~ 159 (621)
| .+|..+..+++|++|+|++|+++ +.+|.. ..++|+.|+|++|++++.
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 2 33445555555666666666554 334431 345555555555555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.78 E-value=4.4e-10 Score=115.02 Aligned_cols=87 Identities=16% Similarity=0.178 Sum_probs=48.1
Q ss_pred CCCCCCEEecCCCccccc-CCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCc-ccccc-CCCC--CCCC
Q 045652 71 GLRGLRAIYLDKNQFSGE-IPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESN-QFNGT-IPSF--DQPT 145 (621)
Q Consensus 71 ~l~~L~~l~l~~N~l~g~-ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N-~l~g~-~p~~--~~~~ 145 (621)
.+.+|+.|+|++|.+++. +|.. +..+++|+.|+|++|.+++.+|..++.+++|++|+|++| .+++. +|.. ..++
T Consensus 91 ~~~~L~~L~L~~~~l~~~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~ 169 (336)
T 2ast_B 91 SPFRVQHMDLSNSVIEVSTLHGI-LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 169 (336)
T ss_dssp CCBCCCEEECTTCEECHHHHHHH-HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred cCCCCCEEEccCCCcCHHHHHHH-HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCC
Confidence 445566666666665544 4443 555666666666666665555555555666666666666 45432 3331 3455
Q ss_pred ccEEEcccC-cccc
Q 045652 146 LVRLNLSSN-KLEG 158 (621)
Q Consensus 146 L~~l~l~~N-~l~g 158 (621)
|+.|+|++| ++++
T Consensus 170 L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 170 LDELNLSWCFDFTE 183 (336)
T ss_dssp CCEEECCCCTTCCH
T ss_pred CCEEcCCCCCCcCh
Confidence 666666665 5554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.71 E-value=8.9e-10 Score=115.24 Aligned_cols=130 Identities=19% Similarity=0.250 Sum_probs=102.5
Q ss_pred CcEEEEEecCCCCe-eeeCcccccccCCCCCCCEEecCCCccc--c---cCCcccccCCCCCCEEeCccCccc----ccC
Q 045652 45 GIVTGLYINSMGLS-GKIDVDALTELTGLRGLRAIYLDKNQFS--G---EIPPGYFDEMGALRKLWFSNNKFR----GRL 114 (621)
Q Consensus 45 ~~v~~l~l~~~~l~-g~~~~~~~~~l~~l~~L~~l~l~~N~l~--g---~ip~~~~~~l~~L~~l~l~~N~l~----g~~ 114 (621)
..++.|+|++|+++ +.++. ....+..+++|+.|+|++|+++ | .+|.. +..+++|+.|+|++|.|+ +.+
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~-l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~-l~~~~~L~~L~Ls~n~l~~~g~~~l 236 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKE-WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG-LAYCQELKVLDLQDNTFTHLGSSAL 236 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHH-HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTT-GGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHH-HHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHH-hhcCCCccEEECcCCCCCcHHHHHH
Confidence 68999999999987 44441 1123556779999999999998 3 23334 788999999999999997 778
Q ss_pred CCCCCCCCCcCeeeccCcccccc----CCC----CCCCCccEEEcccCcccc----ccCccc----cccccCCCCCCC
Q 045652 115 PPSLFKLPHLTELHLESNQFNGT----IPS----FDQPTLVRLNLSSNKLEG----EIPASL----LRFNASSFSGNA 176 (621)
Q Consensus 115 p~~~~~l~~L~~l~l~~N~l~g~----~p~----~~~~~L~~l~l~~N~l~g----~ip~~~----~~~~~~~~~~n~ 176 (621)
|..+..+++|++|+|++|++++. +|. ...++|+.|+|++|.+++ .+|..+ .++....+.+|.
T Consensus 237 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 99999999999999999999876 444 237899999999999998 588765 334445566664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.69 E-value=2.4e-08 Score=102.84 Aligned_cols=110 Identities=20% Similarity=0.236 Sum_probs=88.8
Q ss_pred EeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC-CCC
Q 045652 41 VCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP-SLF 119 (621)
Q Consensus 41 ~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~-~~~ 119 (621)
.|... .++-++++|+ .||. .+ .++|+.|+|++|+|+ .||++.|.++++|++|+|++|++.+.+|. .|.
T Consensus 8 ~C~~~---~v~C~~~~Lt-~iP~----~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~ 76 (350)
T 4ay9_X 8 HCSNR---VFLCQESKVT-EIPS----DL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 76 (350)
T ss_dssp EEETT---EEEEESTTCC-SCCT----TC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBC
T ss_pred EeeCC---EEEecCCCCC-ccCc----Cc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhh
Confidence 67643 4677888887 4764 22 258999999999999 79988899999999999999999888875 568
Q ss_pred CCCCcCe-eeccCccccccCCCC--CCCCccEEEcccCccccccC
Q 045652 120 KLPHLTE-LHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 120 ~l~~L~~-l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
++++|.+ +.+++|+++...|.. .+++|+.|++++|++++..+
T Consensus 77 ~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~ 121 (350)
T 4ay9_X 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 121 (350)
T ss_dssp SCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC
T ss_pred cchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCc
Confidence 8998775 677789999666654 57999999999999985433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.69 E-value=3.5e-09 Score=109.73 Aligned_cols=112 Identities=20% Similarity=0.201 Sum_probs=55.3
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCC-CCCEEecCCCcccccCCcccccCC-----CCCCEEeCccCcccccCCCCCC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLR-GLRAIYLDKNQFSGEIPPGYFDEM-----GALRKLWFSNNKFRGRLPPSLF 119 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~-~L~~l~l~~N~l~g~ip~~~~~~l-----~~L~~l~l~~N~l~g~~p~~~~ 119 (621)
.++.|+|++|.+++.-+......+..++ +|+.|+|++|.+++..+.. +..+ ++|+.|+|++|.+++..+..+.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE-LVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHH-HHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHH-HHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 3556666666555422111112233444 5666666666665433332 3332 5566666666666654444332
Q ss_pred ----CC-CCcCeeeccCccccccCCCC------C-CCCccEEEcccCcccc
Q 045652 120 ----KL-PHLTELHLESNQFNGTIPSF------D-QPTLVRLNLSSNKLEG 158 (621)
Q Consensus 120 ----~l-~~L~~l~l~~N~l~g~~p~~------~-~~~L~~l~l~~N~l~g 158 (621)
.+ ++|++|+|++|++++..+.. . .++|+.|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 22 55666666666665433311 1 2456666666666653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.69 E-value=2.9e-10 Score=111.29 Aligned_cols=126 Identities=19% Similarity=0.175 Sum_probs=85.2
Q ss_pred ceeeEEeCCC--cEEEEEecC---CCCeeeeCccc--------------------ccccCCCCCCCE--EecCCCccc--
Q 045652 36 EWSGVVCLKG--IVTGLYINS---MGLSGKIDVDA--------------------LTELTGLRGLRA--IYLDKNQFS-- 86 (621)
Q Consensus 36 ~w~gv~c~~~--~v~~l~l~~---~~l~g~~~~~~--------------------~~~l~~l~~L~~--l~l~~N~l~-- 86 (621)
.|.|+.|... +|+.+...+ ..+.|.+++.. +..|.....|.. ++++.|...
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~ 158 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCM 158 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHHHH
Confidence 4999999643 666555544 23334443211 122222334444 677888443
Q ss_pred -ccCCcccccCCCCCCEEeCccCcccc--cCCCCCCCCCCcCeeeccCcccccc--CCCCCCCCccEEEcccCccccccC
Q 045652 87 -GEIPPGYFDEMGALRKLWFSNNKFRG--RLPPSLFKLPHLTELHLESNQFNGT--IPSFDQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 87 -g~ip~~~~~~l~~L~~l~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~g~--~p~~~~~~L~~l~l~~N~l~g~ip 161 (621)
+.++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. +......+|+.|+|++|.+++.+|
T Consensus 159 ~~~l~i-~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 159 AATLRI-IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHHHHH-HHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred HHHHHH-HHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccC
Confidence 32222 13568999999999999998 6777788999999999999999964 222221289999999999999888
Q ss_pred c
Q 045652 162 A 162 (621)
Q Consensus 162 ~ 162 (621)
.
T Consensus 238 ~ 238 (267)
T 3rw6_A 238 D 238 (267)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.68 E-value=1.3e-09 Score=111.57 Aligned_cols=127 Identities=20% Similarity=0.216 Sum_probs=92.3
Q ss_pred CcEEEEEecCCCCeee-eCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccC-cccc-cCCCCCCCC
Q 045652 45 GIVTGLYINSMGLSGK-IDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNN-KFRG-RLPPSLFKL 121 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~-~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N-~l~g-~~p~~~~~l 121 (621)
.+++.|+|+++.+++. ++ ..+..+++|++|+|++|.+++.+|.. ++.+++|++|+|++| .+++ .+|..+.++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~----~~~~~~~~L~~L~L~~~~l~~~~~~~-l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~ 167 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLH----GILSQCSKLQNLSLEGLRLSDPIVNT-LAKNSNLVRLNLSGCSGFSEFALQTLLSSC 167 (336)
T ss_dssp BCCCEEECTTCEECHHHHH----HHHTTBCCCSEEECTTCBCCHHHHHH-HTTCTTCSEEECTTCBSCCHHHHHHHHHHC
T ss_pred CCCCEEEccCCCcCHHHHH----HHHhhCCCCCEEeCcCcccCHHHHHH-HhcCCCCCEEECCCCCCCCHHHHHHHHhcC
Confidence 5688899999887764 44 23566788999999999988877775 778899999999998 6876 377777888
Q ss_pred CCcCeeeccCc-ccccc-CCCC--CCC-CccEEEcccC--ccc-cccCccccc---cccCCCCCCC
Q 045652 122 PHLTELHLESN-QFNGT-IPSF--DQP-TLVRLNLSSN--KLE-GEIPASLLR---FNASSFSGNA 176 (621)
Q Consensus 122 ~~L~~l~l~~N-~l~g~-~p~~--~~~-~L~~l~l~~N--~l~-g~ip~~~~~---~~~~~~~~n~ 176 (621)
++|++|+|++| .+++. +|.. ..+ +|+.|+|++| .++ +.+|..+.. +....+.+|.
T Consensus 168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~ 233 (336)
T 2ast_B 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 233 (336)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence 88999999988 88754 4432 456 8888888888 455 456654433 3334455554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.67 E-value=1.3e-09 Score=112.93 Aligned_cols=106 Identities=17% Similarity=0.174 Sum_probs=58.7
Q ss_pred EEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCc----ccccCCC-CCCEEeCccCcccccCCCCCCCC---
Q 045652 50 LYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPP----GYFDEMG-ALRKLWFSNNKFRGRLPPSLFKL--- 121 (621)
Q Consensus 50 l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~----~~~~~l~-~L~~l~l~~N~l~g~~p~~~~~l--- 121 (621)
..|+.++++|.+|. .+....+|++|+|++|.+++ ++. +.+..++ +|+.|+|++|.+++..+..+..+
T Consensus 3 ~~ls~n~~~~~~~~----~~~~~~~L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 77 (362)
T 3goz_A 3 YKLTLHPGSNPVEE----FTSIPHGVTSLDLSLNNLYS-ISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77 (362)
T ss_dssp EECCCCTTCCHHHH----HHTSCTTCCEEECTTSCGGG-SCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHT
T ss_pred cccccccchHHHHH----HHhCCCCceEEEccCCCCCh-HHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhc
Confidence 34556666665542 12233446666666666663 443 3355555 66666666666666555555443
Q ss_pred --CCcCeeeccCccccccCCC-----C-CC-CCccEEEcccCcccccc
Q 045652 122 --PHLTELHLESNQFNGTIPS-----F-DQ-PTLVRLNLSSNKLEGEI 160 (621)
Q Consensus 122 --~~L~~l~l~~N~l~g~~p~-----~-~~-~~L~~l~l~~N~l~g~i 160 (621)
++|++|+|++|++++..+. + .. ++|+.|+|++|++++..
T Consensus 78 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 125 (362)
T 3goz_A 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS 125 (362)
T ss_dssp SCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred cCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence 6666666666666654443 1 12 56666666666665433
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.42 E-value=9.1e-08 Score=93.54 Aligned_cols=77 Identities=25% Similarity=0.372 Sum_probs=63.3
Q ss_pred CCCCCCEEecCCCcccc--cCCcccccCCCCCCEEeCccCcccccCCCCCCCCC--CcCeeeccCccccccCCCC-----
Q 045652 71 GLRGLRAIYLDKNQFSG--EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLP--HLTELHLESNQFNGTIPSF----- 141 (621)
Q Consensus 71 ~l~~L~~l~l~~N~l~g--~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l~g~~p~~----- 141 (621)
.+++|+.|+|++|+|++ .||.. +..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|..
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~-~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSI-VQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTH-HHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhH-HhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 46789999999999997 56654 77899999999999999975 3444444 9999999999999988841
Q ss_pred ----CCCCccEEE
Q 045652 142 ----DQPTLVRLN 150 (621)
Q Consensus 142 ----~~~~L~~l~ 150 (621)
.+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 468888775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.1e-06 Score=88.45 Aligned_cols=135 Identities=19% Similarity=0.116 Sum_probs=95.0
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCC---CcccceEEEE-eCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHS---NVLAPLAYHY-RTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gs 393 (621)
.++.|....||+. |..+++|+.. .......+.+|.++|+.+.+. .+.+.+.+.. ..+..++||||++|..
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 4677888889987 5678888753 233456789999999999753 3556666664 3455789999999988
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL----------------------------------------- 432 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 432 (621)
+..... ..++..+...++.++++.|..||+..
T Consensus 100 l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 876432 12455556666666666666666421
Q ss_pred ---------------CCCCCccCCCCCCCEEeCC---CCCc-EEEeeeccee
Q 045652 433 ---------------AHLDLPHGNLKSSNIFISP---ENEP-LISEFGFYTM 465 (621)
Q Consensus 433 ---------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~DfG~a~~ 465 (621)
.+..++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235689999999999997 4554 7999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.4e-06 Score=85.92 Aligned_cols=135 Identities=19% Similarity=0.192 Sum_probs=94.5
Q ss_pred cCcCCcc-cEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 319 LGNGGLG-SSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 319 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
+..|..+ .||+.... ++..+++|+-... ....+.+|.+.|+.+. +-.+.++++++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3445555 58988743 4678889986532 3456788999998884 334778889999999999999999998887
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc-------------------------------------------
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL------------------------------------------- 432 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------- 432 (621)
+..... ......+..+++..|.-||+..
T Consensus 109 ~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 655321 1122345566666666666420
Q ss_pred -----------CCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 433 -----------AHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 433 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
.+..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112378999999999999877667999987643
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.34 E-value=5.6e-08 Score=103.88 Aligned_cols=115 Identities=23% Similarity=0.218 Sum_probs=76.0
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCC----CCCEEeCccCcccc----cCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMG----ALRKLWFSNNKFRG----RLPP 116 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~----~L~~l~l~~N~l~g----~~p~ 116 (621)
..++.|+|+++++++.-.......+..+++|++|+|++|.+++..+..++..+. +|++|+|++|.++. .+|.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 356677777777654211000123455677888888888887654444344555 68888888888873 5677
Q ss_pred CCCCCCCcCeeeccCccccccCCC-------CCCCCccEEEcccCccccc
Q 045652 117 SLFKLPHLTELHLESNQFNGTIPS-------FDQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 117 ~~~~l~~L~~l~l~~N~l~g~~p~-------~~~~~L~~l~l~~N~l~g~ 159 (621)
.+..+++|++|+|++|++++..+. ...++|+.|+|++|++++.
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 157 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 157 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHH
Confidence 788888888888888887654332 1245788888888888763
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.27 E-value=4.1e-08 Score=104.97 Aligned_cols=128 Identities=20% Similarity=0.263 Sum_probs=92.2
Q ss_pred CcEEEEEecCCCCeee----eCcccccccCCCCCCCEEecCCCcccccCCcc----cccCCCCCCEEeCccCccccc---
Q 045652 45 GIVTGLYINSMGLSGK----IDVDALTELTGLRGLRAIYLDKNQFSGEIPPG----YFDEMGALRKLWFSNNKFRGR--- 113 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~----~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~----~~~~l~~L~~l~l~~N~l~g~--- 113 (621)
..++.|+|++|.+++. ++ ..+..+++|+.|+|++|.+++.-+.. .....++|+.|+|++|.+++.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~----~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 331 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLC----RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS 331 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHH----HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred CCceEEECcCCCCCHHHHHHHH----HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHH
Confidence 5788999999988763 33 23445778999999999997543322 112346899999999999875
Q ss_pred -CCCCCCCCCCcCeeeccCccccccCCCC-------CCCCccEEEcccCcccc----ccCcccccc---ccCCCCCCC
Q 045652 114 -LPPSLFKLPHLTELHLESNQFNGTIPSF-------DQPTLVRLNLSSNKLEG----EIPASLLRF---NASSFSGNA 176 (621)
Q Consensus 114 -~p~~~~~l~~L~~l~l~~N~l~g~~p~~-------~~~~L~~l~l~~N~l~g----~ip~~~~~~---~~~~~~~n~ 176 (621)
+|..+..+++|++|+|++|++++..+.. ..++|+.|+|++|++++ .+|..+..+ ....+.+|.
T Consensus 332 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 332 HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 5667778899999999999987654321 25789999999999986 677665433 334556663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=8e-07 Score=91.57 Aligned_cols=78 Identities=8% Similarity=0.016 Sum_probs=54.3
Q ss_pred Hc-CcCCcccEEEEEEc-------CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCC-C--CCcccceEEEEeC---C
Q 045652 318 VL-GNGGLGSSYKAMMA-------DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLR-H--SNVLAPLAYHYRT---D 380 (621)
Q Consensus 318 ~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---~ 380 (621)
.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.+. + -.+.+++.++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 46 78888999998754 26788899865422 111245778999988884 2 3567777776554 3
Q ss_pred eeEEEEeecCCCChh
Q 045652 381 EKLLVYEYIPGGSLL 395 (621)
Q Consensus 381 ~~~lv~e~~~~gsL~ 395 (621)
..++||||++|..+.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 468999999987664
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.3e-07 Score=97.88 Aligned_cols=110 Identities=19% Similarity=0.146 Sum_probs=73.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccc-----cCCCCCCEEeCccCcccc----cCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYF-----DEMGALRKLWFSNNKFRG----RLP 115 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~-----~~l~~L~~l~l~~N~l~g----~~p 115 (621)
..++.|+|++|.++..-.. .+ ...|.+|+.|+|++|.|+..-... + ...++|+.|+|++|.|+. .++
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~-~l--~~~L~~L~~L~Ls~n~l~~~~~~~-L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~ 176 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLR-TL--LPVFLRARKLGLQLNSLGPEACKD-LRDLLLHDQCQITTLRLSNNPLTAAGVAVLM 176 (372)
T ss_dssp SCEEEEECTTCCCCHHHHH-HT--HHHHHTEEEEECCSSCCCHHHHHH-HHHHHHSTTCCCCEEECCSSCCHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHH-HH--HHHHHhccHhhcCCCCCCHHHHHH-HHHHHHhcCCccceeeCCCCCCChHHHHHHH
Confidence 4789999999987642211 11 113457888889888887432211 2 245778888888888864 244
Q ss_pred CCCCCCCCcCeeeccCcccccc----CCC--CCCCCccEEEcccCcccc
Q 045652 116 PSLFKLPHLTELHLESNQFNGT----IPS--FDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 116 ~~~~~l~~L~~l~l~~N~l~g~----~p~--~~~~~L~~l~l~~N~l~g 158 (621)
..+..+++|++|+|++|+++.. ++. ...++|+.|+|++|+++.
T Consensus 177 ~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 177 EGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred HHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 5556778888888888888642 111 134678888888888874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=3e-05 Score=78.92 Aligned_cols=142 Identities=15% Similarity=0.227 Sum_probs=79.4
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-----CCCcccce-E--EEEeCCeeEEEEeec
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-----HSNVLAPL-A--YHYRTDEKLLVYEYI 389 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~~ 389 (621)
.|+.|..+.||+....+| .+++|+.... ...+..|.++++.|. .|.++... + +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 355677889999987555 5889988752 233445555555553 24443311 1 123466789999999
Q ss_pred CCCChh--------------HHhhcC--CC--CCC-----CCCCHHHHH-------------------------------
Q 045652 390 PGGSLL--------------YLLHGD--RG--PSH-----DELTWPARL------------------------------- 415 (621)
Q Consensus 390 ~~gsL~--------------~~l~~~--~~--~~~-----~~l~~~~~~------------------------------- 415 (621)
+|..+. ..+|.. .. ... ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 112211 00 000 011232210
Q ss_pred HHHHHHHHHHHHHHh--------c-cCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 416 KIVQGIARGIGYLHT--------E-LAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 416 ~i~~~i~~~L~~LH~--------~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
.+..++..++++|++ . ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111224446667763 1 023479999999999999888889999999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.92 E-value=7.3e-07 Score=82.62 Aligned_cols=113 Identities=12% Similarity=0.151 Sum_probs=75.2
Q ss_pred CCcEEEEEecCC-CCeeeeCcccccccCCCCCCCEEecCCCccccc----CCcccccCCCCCCEEeCccCccccc----C
Q 045652 44 KGIVTGLYINSM-GLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE----IPPGYFDEMGALRKLWFSNNKFRGR----L 114 (621)
Q Consensus 44 ~~~v~~l~l~~~-~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~----ip~~~~~~l~~L~~l~l~~N~l~g~----~ 114 (621)
...++.|+|++| .+...-.......|...++|++|+|++|.|+.. |... +...++|++|+|++|.|+.. +
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~-L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM-LKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHH-HHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHH-HHhCCCcCEEECcCCcCCHHHHHHH
Confidence 456888888888 775321110112345567888899999988632 2222 44557888999999988753 4
Q ss_pred CCCCCCCCCcCeeec--cCccccccCC----CC--CCCCccEEEcccCccc
Q 045652 115 PPSLFKLPHLTELHL--ESNQFNGTIP----SF--DQPTLVRLNLSSNKLE 157 (621)
Q Consensus 115 p~~~~~l~~L~~l~l--~~N~l~g~~p----~~--~~~~L~~l~l~~N~l~ 157 (621)
...+...++|++|+| ++|.++..-- .. ..++|+.|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 556777788899999 7788864211 11 3477888898888875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.90 E-value=3.8e-07 Score=94.48 Aligned_cols=113 Identities=16% Similarity=0.152 Sum_probs=81.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccc-cC-CCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCC----
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTE-LT-GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSL---- 118 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~-l~-~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~---- 118 (621)
..++.|+|++|.++..-. ..+.. |. ...+|+.|+|++|.++..-.......+++|+.|+|++|.|+..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~-~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKC-TVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp TTCCEEECTTSCCCHHHH-HHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHH-HHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 468899999999875322 12222 22 236899999999999754333334457789999999999986543333
Q ss_pred -CCCCCcCeeeccCcccccc----CCC--CCCCCccEEEcccCcccc
Q 045652 119 -FKLPHLTELHLESNQFNGT----IPS--FDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 119 -~~l~~L~~l~l~~N~l~g~----~p~--~~~~~L~~l~l~~N~l~g 158 (621)
...++|++|+|++|.|+.. ++. ...++|+.|+|++|+|+.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 3567899999999999741 222 146789999999999974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=3.6e-05 Score=80.37 Aligned_cols=74 Identities=15% Similarity=0.163 Sum_probs=48.4
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh-------hhHHHHHHHHHHHhcCCC--CCc-ccceEEEEeCCeeEEE
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA-------MARDAFDTEVRRLGRLRH--SNV-LAPLAYHYRTDEKLLV 385 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~ni-v~l~~~~~~~~~~~lv 385 (621)
+.||.|.++.||++... +++.|+||....... ...+.+..|.++++.+.. +.. .+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 35899999999999743 468899998653211 123456778889888742 333 344433 45567899
Q ss_pred EeecCCC
Q 045652 386 YEYIPGG 392 (621)
Q Consensus 386 ~e~~~~g 392 (621)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.82 E-value=1.2e-06 Score=96.82 Aligned_cols=109 Identities=11% Similarity=0.071 Sum_probs=53.4
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCC-CCCCCEEecC----CCccccc-----CCcccccCCCCCCEEeCcc--Ccccc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTG-LRGLRAIYLD----KNQFSGE-----IPPGYFDEMGALRKLWFSN--NKFRG 112 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~-l~~L~~l~l~----~N~l~g~-----ip~~~~~~l~~L~~l~l~~--N~l~g 112 (621)
..++.|++..+++++.... .+.. +++|+.|+|+ .|++++. ++.. +..+++|+.|+|++ |.+++
T Consensus 378 ~~L~~L~l~~~~l~~~~~~----~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~-~~~~~~L~~L~L~~~~~~l~~ 452 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLE----SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSL-LIGCKKLRRFAFYLRQGGLTD 452 (592)
T ss_dssp TTCSEEEEEESCCCHHHHH----HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHH-HHHCTTCCEEEEECCGGGCCH
T ss_pred ccCeEEEeecCCccHHHHH----HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHH-HHhCCCCCEEEEecCCCCccH
Confidence 3566677766666653321 2221 4456666663 5566541 2221 34455566666642 22444
Q ss_pred cCCCCCCC-CCCcCeeeccCccccc-cCCCC--CCCCccEEEcccCcccc
Q 045652 113 RLPPSLFK-LPHLTELHLESNQFNG-TIPSF--DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 113 ~~p~~~~~-l~~L~~l~l~~N~l~g-~~p~~--~~~~L~~l~l~~N~l~g 158 (621)
..+..++. +++|++|+|++|++++ .++.. ..++|+.|+|++|.|++
T Consensus 453 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp HHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred HHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 43333332 5556666666655554 22221 34555666666665543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=9.2e-05 Score=74.24 Aligned_cols=139 Identities=20% Similarity=0.178 Sum_probs=91.1
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC---CCCcccceEEEEeCCeeEEEEeecCCCCh
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR---HSNVLAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.|+.|.+..+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+++.+....+..++||||+++..+
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 478899999999876 4678889987532 3567889999998884 35688888888888889999999998765
Q ss_pred h-----------HHhhcCCC-C----C------------CCCCCHHHHH---HHHH----------------HHHHHH-H
Q 045652 395 L-----------YLLHGDRG-P----S------------HDELTWPARL---KIVQ----------------GIARGI-G 426 (621)
Q Consensus 395 ~-----------~~l~~~~~-~----~------------~~~l~~~~~~---~i~~----------------~i~~~L-~ 426 (621)
. ..||.... . . ...-+|.... ++.. +++..+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 12232211 0 0 0012454322 1111 111111 2
Q ss_pred HHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 427 YLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 427 ~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.|......+.++|+|+.+.|++++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 332222345799999999999999887 8888874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.78 E-value=4.8e-05 Score=77.18 Aligned_cols=86 Identities=16% Similarity=0.157 Sum_probs=71.3
Q ss_pred CCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC-eeeccCccccccCCCC---CCCCcc
Q 045652 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT-ELHLESNQFNGTIPSF---DQPTLV 147 (621)
Q Consensus 72 l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~-~l~l~~N~l~g~~p~~---~~~~L~ 147 (621)
+.+|+.|+|++|+++ .||...|.++++|+.|+|++| ++-.-+..|.+|++|+ .|+|.+ +++ .|+.. ..++|+
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCC
Confidence 678999999999999 799999999999999999998 7754456788999999 999988 665 56542 468999
Q ss_pred EEEcccCccccccCc
Q 045652 148 RLNLSSNKLEGEIPA 162 (621)
Q Consensus 148 ~l~l~~N~l~g~ip~ 162 (621)
.|++++|+++ .|+.
T Consensus 301 ~l~l~~n~i~-~I~~ 314 (329)
T 3sb4_A 301 YVLATGDKIT-TLGD 314 (329)
T ss_dssp EEEECSSCCC-EECT
T ss_pred EEEeCCCccC-ccch
Confidence 9999999988 4554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.75 E-value=5.8e-05 Score=76.53 Aligned_cols=58 Identities=21% Similarity=0.156 Sum_probs=32.8
Q ss_pred CCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCCcc-EEEcccCccc
Q 045652 97 MGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPTLV-RLNLSSNKLE 157 (621)
Q Consensus 97 l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~L~-~l~l~~N~l~ 157 (621)
+++|+.|+|++|+++..-+..|.+|.+|+.|+|.+| ++ .|+.. ..++|+ .|+|.+ +++
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~ 286 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT 286 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce
Confidence 566666666666666333334566666666666665 43 44432 345566 666665 444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=8.3e-05 Score=73.87 Aligned_cols=74 Identities=20% Similarity=0.284 Sum_probs=53.8
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCC---CcccceEEEEeCCeeEEEEeecCCCC
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHS---NVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+|.|..+.||+....+|+.|++|+...........|..|++.|+.|... .+.+++++ . ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 347889999999999999999999987654433345688999999888422 24444443 2 3478999998765
Q ss_pred h
Q 045652 394 L 394 (621)
Q Consensus 394 L 394 (621)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0002 Score=75.32 Aligned_cols=74 Identities=11% Similarity=0.099 Sum_probs=48.1
Q ss_pred CCCccCCCCCCCEEeCCCCCcEEEeeecceecccccccc-----ccccccCcccccCC---CCCcchhhHHHHHHHHHHH
Q 045652 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQ-----ALFAYKAPEAIQSG---KVTPKCDVYCLGIIILEIL 506 (621)
Q Consensus 435 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-----~~~~y~aPE~~~~~---~~~~~~DvwSlGvvl~ell 506 (621)
..++|+|++|.|||++.++ ++|+||+.+..-....... -...|.+|+..... .-....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999776 9999999876643321111 11346666654311 1122355667888888887
Q ss_pred hCC
Q 045652 507 TGK 509 (621)
Q Consensus 507 tg~ 509 (621)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00094 Score=67.37 Aligned_cols=143 Identities=16% Similarity=0.141 Sum_probs=81.1
Q ss_pred cCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCC--CcccceEE-----EEeCCeeEEEEeecCC
Q 045652 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHS--NVLAPLAY-----HYRTDEKLLVYEYIPG 391 (621)
Q Consensus 319 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~~ 391 (621)
++ |....||+....+|+.+++|...... ...+.+..|..+++.+... .+++++.. ....+..+++|||++|
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 45 67778998877677789999986331 1345667788888877421 23444432 2234566889999987
Q ss_pred CChh-----H------H---hhc----CCCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhcc--
Q 045652 392 GSLL-----Y------L---LHG----DRGPSHDELTWPAR----LKI---------------VQGIARGIGYLHTEL-- 432 (621)
Q Consensus 392 gsL~-----~------~---l~~----~~~~~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~~-- 432 (621)
..+. . . +|. ........+++... ..+ ...+...++.+.+..
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5432 0 0 111 00001112222211 001 111112233333221
Q ss_pred -CCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 433 -AHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 433 -~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
.+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 889999987643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.38 E-value=1.8e-05 Score=87.14 Aligned_cols=102 Identities=13% Similarity=0.167 Sum_probs=54.8
Q ss_pred cEEEEEecCCCCeeeeCcccccccC-CCCCCCEEecCCC-ccccc-CCcccccCCCCCCEEeCccCcccccCCCCC----
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELT-GLRGLRAIYLDKN-QFSGE-IPPGYFDEMGALRKLWFSNNKFRGRLPPSL---- 118 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~-~l~~L~~l~l~~N-~l~g~-ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~---- 118 (621)
.++.|+|+++.+++..+ ..+. .+++|+.|+|++| .++.. ++. .+.++++|++|+|++|.+++..+..+
T Consensus 106 ~L~~L~L~~~~~~~~~~----~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 180 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCL----ELIAKSFKNFKVLVLSSCEGFSTDGLAA-IAATCRNLKELDLRESDVDDVSGHWLSHFP 180 (594)
T ss_dssp TCCEEEEESCBCCHHHH----HHHHHHCTTCCEEEEESCEEEEHHHHHH-HHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred CCCeEEeeCcEEcHHHH----HHHHHhCCCCcEEeCCCcCCCCHHHHHH-HHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence 46666666665554322 1221 3456666777666 44432 222 24456667777777776665433332
Q ss_pred CCCCCcCeeeccCccccccCCCC-------CCCCccEEEcccC
Q 045652 119 FKLPHLTELHLESNQFNGTIPSF-------DQPTLVRLNLSSN 154 (621)
Q Consensus 119 ~~l~~L~~l~l~~N~l~g~~p~~-------~~~~L~~l~l~~N 154 (621)
..+++|++|+|++|. +.++.. ..++|+.|+|++|
T Consensus 181 ~~~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 181 DTYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp TTCCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred hcCCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 255567777776665 222210 2466777777666
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00081 Score=67.67 Aligned_cols=144 Identities=15% Similarity=0.210 Sum_probs=79.3
Q ss_pred HcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCC--cccceE------EEEeCCeeEEEEeec
Q 045652 318 VLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN--VLAPLA------YHYRTDEKLLVYEYI 389 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e~~ 389 (621)
.|+.|....+|+....+| .+++|..... ...+.+..|+++++.+.... +.+++. +....+..+++|+|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 467788889999987656 6788987652 11234566777777764212 233331 112345678999999
Q ss_pred CCCChhH--------------HhhcC-CCCCCC---CC---CHHHHHH------------HHHHHHHHHHHHHhcc---C
Q 045652 390 PGGSLLY--------------LLHGD-RGPSHD---EL---TWPARLK------------IVQGIARGIGYLHTEL---A 433 (621)
Q Consensus 390 ~~gsL~~--------------~l~~~-~~~~~~---~l---~~~~~~~------------i~~~i~~~L~~LH~~~---~ 433 (621)
+|..+.. .+|.. ...... .. .|..... +...+...++++++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865321 11211 000000 01 1222110 0112444566665432 2
Q ss_pred CCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 434 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
+..++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3478999999999999977656799998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.33 E-value=2.6e-05 Score=71.98 Aligned_cols=89 Identities=17% Similarity=0.203 Sum_probs=67.0
Q ss_pred cCCCCCCCEEecCCC-ccccc----CCcccccCCCCCCEEeCccCccccc----CCCCCCCCCCcCeeeccCcccccc--
Q 045652 69 LTGLRGLRAIYLDKN-QFSGE----IPPGYFDEMGALRKLWFSNNKFRGR----LPPSLFKLPHLTELHLESNQFNGT-- 137 (621)
Q Consensus 69 l~~l~~L~~l~l~~N-~l~g~----ip~~~~~~l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~-- 137 (621)
+...+.|+.|+|++| .++.. |... +...++|+.|+|++|.|... +...+...++|++|+|++|+++..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~-L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEA-LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHH-HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHH-HHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 556778999999999 88742 3332 56678999999999999742 344455668899999999999742
Q ss_pred --CCCC--CCCCccEEEc--ccCcccc
Q 045652 138 --IPSF--DQPTLVRLNL--SSNKLEG 158 (621)
Q Consensus 138 --~p~~--~~~~L~~l~l--~~N~l~g 158 (621)
+... ..++|+.|+| ++|.++.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 1111 4578999999 8899874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00012 Score=80.45 Aligned_cols=117 Identities=15% Similarity=0.058 Sum_probs=76.5
Q ss_pred CcEEEEEecCCCCeeeeCccccc-ccCCCCCCCEEecCCCccc----ccCCcccccCCCCCCEEeCccCcccccCCCCCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALT-ELTGLRGLRAIYLDKNQFS----GEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLF 119 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~-~l~~l~~L~~l~l~~N~l~----g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~ 119 (621)
..++.|+|+++.+++.-. ..+. -+..+++|+.|+|++|.++ +.++.. +.++++|+.|+|++|.+++ +|..+.
T Consensus 164 ~~L~~L~L~~~~~~~~~~-~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~-~~~~~~L~~L~L~~~~~~~-l~~~~~ 240 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDG-KWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI-ARNCRSLVSVKVGDFEILE-LVGFFK 240 (592)
T ss_dssp TTCSEEECTTCEEECCCS-HHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHH-HHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred CCCCEEECccccccCcch-hHHHHHHhcCCCccEEEeeccCCCccCHHHHHHH-HhhCCCCcEEeccCccHHH-HHHHHh
Confidence 568899999998765411 0011 1235678899999999997 344443 5678999999999999886 777778
Q ss_pred CCCCcCeeeccCcccc---ccCCC--CCCCCccEEEcccCccccccCcccc
Q 045652 120 KLPHLTELHLESNQFN---GTIPS--FDQPTLVRLNLSSNKLEGEIPASLL 165 (621)
Q Consensus 120 ~l~~L~~l~l~~N~l~---g~~p~--~~~~~L~~l~l~~N~l~g~ip~~~~ 165 (621)
++++|++|+++++... +..+. ...++|+.|+++++. .+.+|..+.
T Consensus 241 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~ 290 (592)
T 3ogk_B 241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFP 290 (592)
T ss_dssp HCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGG
T ss_pred hhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHh
Confidence 8888888888763322 11111 134677777777653 234555443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00079 Score=68.19 Aligned_cols=143 Identities=13% Similarity=0.095 Sum_probs=72.9
Q ss_pred cCcCCccc-EEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCC--CCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 319 LGNGGLGS-SYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH--SNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 319 lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
|+.|.... +|+....+|..+++|....... +.+..|+++++.+.. -.+.+++.+.... -+++||++.+..+.
T Consensus 26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp --------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred CCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 44444333 6677654467788886543221 234567777777642 2345566653222 37899999776665
Q ss_pred HHhhcC---------------------CCCCCCCCCHHHHH-------HH-------------HHHHHHHHHHHHhc--c
Q 045652 396 YLLHGD---------------------RGPSHDELTWPARL-------KI-------------VQGIARGIGYLHTE--L 432 (621)
Q Consensus 396 ~~l~~~---------------------~~~~~~~l~~~~~~-------~i-------------~~~i~~~L~~LH~~--~ 432 (621)
+++... .......+...... .+ ...+...++.+... .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 443211 00001112111100 00 01112223333211 1
Q ss_pred CCCCCccCCCCCCCEEeCCC----CCcEEEeeecceec
Q 045652 433 AHLDLPHGNLKSSNIFISPE----NEPLISEFGFYTMI 466 (621)
Q Consensus 433 ~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~~ 466 (621)
.+..++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23478999999999999875 67899999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0016 Score=66.97 Aligned_cols=143 Identities=15% Similarity=0.201 Sum_probs=82.8
Q ss_pred HcCcCCcccEEEEEEc--------CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCC-cccceEEEEeCCeeEEEEee
Q 045652 318 VLGNGGLGSSYKAMMA--------DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSN-VLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 388 (621)
.|..|-...+|++... +++.+++|+..... .....+.+|.++++.|...+ ..++++++. + .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 4566777888998864 24789999864321 23455668999998885323 345555543 3 299999
Q ss_pred cCCCChhH-----------------HhhcCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHHHh
Q 045652 389 IPGGSLLY-----------------LLHGDRGPSHDEL--TWPARLKIVQGIAR-------------------GIGYLHT 430 (621)
Q Consensus 389 ~~~gsL~~-----------------~l~~~~~~~~~~l--~~~~~~~i~~~i~~-------------------~L~~LH~ 430 (621)
++|.+|.. .+|.......... -|.++.++..++.. .+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99866531 1122211111122 24555555544422 2344432
Q ss_pred c----cCCCCCccCCCCCCCEEeCCC----CCcEEEeeeccee
Q 045652 431 E----LAHLDLPHGNLKSSNIFISPE----NEPLISEFGFYTM 465 (621)
Q Consensus 431 ~----~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~ 465 (621)
. ..+..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 233468899999999999876 6899999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00082 Score=67.01 Aligned_cols=141 Identities=13% Similarity=0.069 Sum_probs=75.4
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCc-ccceEEEEeCCeeEEEEeec-CCCCh
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV-LAPLAYHYRTDEKLLVYEYI-PGGSL 394 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL 394 (621)
+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+ .+++++ +.+.-++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 45788888999998 46788887643211 1123568888877753333 344443 444467899999 66544
Q ss_pred hH------------------HhhcCCCCCCCCCCH-HHHHHHHH--------------HHHHHHHHH----HhccCCCCC
Q 045652 395 LY------------------LLHGDRGPSHDELTW-PARLKIVQ--------------GIARGIGYL----HTELAHLDL 437 (621)
Q Consensus 395 ~~------------------~l~~~~~~~~~~l~~-~~~~~i~~--------------~i~~~L~~L----H~~~~~~~i 437 (621)
.. .+|............ .....+.. .+...+..+ .....+..+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 31 112211100111111 11111111 111111111 111223458
Q ss_pred ccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 438 PHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 438 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
+|+|+.+.||+ ..++.+.++||..+..-
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 89999999999 55677899999877543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.98 E-value=4e-05 Score=84.42 Aligned_cols=88 Identities=10% Similarity=0.067 Sum_probs=60.0
Q ss_pred CCCCCCEEecC--C----CcccccCCcc-----cccCCCCCCEEeCccCcccccCCCCCCC-CCCcCeeeccCccccccC
Q 045652 71 GLRGLRAIYLD--K----NQFSGEIPPG-----YFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQFNGTI 138 (621)
Q Consensus 71 ~l~~L~~l~l~--~----N~l~g~ip~~-----~~~~l~~L~~l~l~~N~l~g~~p~~~~~-l~~L~~l~l~~N~l~g~~ 138 (621)
.+++|+.|+|+ + |.++ .+|.+ .+..+++|+.|+|++ .+++..+..++. +++|++|+|++|.+++..
T Consensus 395 ~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~ 472 (594)
T 2p1m_B 395 NRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472 (594)
T ss_dssp HCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred hCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence 36788888888 4 5666 23321 255678888888876 666655555555 788888888888886543
Q ss_pred CCC---CCCCccEEEcccCcccccc
Q 045652 139 PSF---DQPTLVRLNLSSNKLEGEI 160 (621)
Q Consensus 139 p~~---~~~~L~~l~l~~N~l~g~i 160 (621)
+.. ..++|+.|+|++|.+++..
T Consensus 473 ~~~l~~~~~~L~~L~L~~n~~~~~~ 497 (594)
T 2p1m_B 473 MHHVLSGCDSLRKLEIRDCPFGDKA 497 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCSCCHHH
T ss_pred HHHHHhcCCCcCEEECcCCCCcHHH
Confidence 321 3678888888888886543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.97 E-value=7.9e-05 Score=76.46 Aligned_cols=106 Identities=16% Similarity=0.227 Sum_probs=69.7
Q ss_pred CcEEEEEecCCC-CeeeeCcccccccCCCCCCCEEecCCCcccccCCccccc--CCCCCCEEeCcc--Cccccc-----C
Q 045652 45 GIVTGLYINSMG-LSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFD--EMGALRKLWFSN--NKFRGR-----L 114 (621)
Q Consensus 45 ~~v~~l~l~~~~-l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~--~l~~L~~l~l~~--N~l~g~-----~ 114 (621)
..+..|+|+++. + .++ .+. +.+|+.|+|..+.++...-.. +. .+++|+.|+|+. |...|. +
T Consensus 172 P~L~~L~L~g~~~l--~l~-----~~~-~~~L~~L~L~~~~l~~~~l~~-l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIG-----KKP-RPNLKSLEIISGGLPDSVVED-ILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp TTCCEEEEECCBTC--BCC-----SCB-CTTCSEEEEECSBCCHHHHHH-HHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred CCCcEEEEeCCCCc--eec-----ccc-CCCCcEEEEecCCCChHHHHH-HHHccCCCCcEEEEeccccccccchhHHHH
Confidence 578889988762 2 222 232 678999999888776432222 22 688999998863 332221 1
Q ss_pred CCCC--CCCCCcCeeeccCccccccCCC-----CCCCCccEEEcccCccccc
Q 045652 115 PPSL--FKLPHLTELHLESNQFNGTIPS-----FDQPTLVRLNLSSNKLEGE 159 (621)
Q Consensus 115 p~~~--~~l~~L~~l~l~~N~l~g~~p~-----~~~~~L~~l~l~~N~l~g~ 159 (621)
-..+ ..+++|++|+|.+|.+.+..+. ..+++|+.|+|+.|.|++.
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 1122 3578999999999988754331 2468899999999999863
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0011 Score=56.99 Aligned_cols=36 Identities=28% Similarity=0.573 Sum_probs=17.6
Q ss_pred CCCEEecCCCcccccCCcccccCCCCCCEEeCccCcc
Q 045652 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKF 110 (621)
Q Consensus 74 ~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l 110 (621)
+|+.|+|++|+|+ .||++.|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 3455555555555 45544444444444444444443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0008 Score=69.26 Aligned_cols=72 Identities=10% Similarity=0.052 Sum_probs=43.2
Q ss_pred HcCcCCcccEEEEEEcC---------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCc-ccceEEEEeCCeeEEEEe
Q 045652 318 VLGNGGLGSSYKAMMAD---------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV-LAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 387 (621)
.|+.|....+|+....+ +..+++|+....... ......|.++++.+...++ .++++.. . -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 36677788899988644 268889987543221 1123578888888853343 4555443 2 368999
Q ss_pred ecCCCCh
Q 045652 388 YIPGGSL 394 (621)
Q Consensus 388 ~~~~gsL 394 (621)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0048 Score=62.58 Aligned_cols=68 Identities=13% Similarity=0.177 Sum_probs=43.6
Q ss_pred CcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC---CCCcccceEE------EEeCCeeEEEEeecC
Q 045652 320 GNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR---HSNVLAPLAY------HYRTDEKLLVYEYIP 390 (621)
Q Consensus 320 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~ 390 (621)
|.|....||+....+| .+++|+...... ..|+.+++.|. -|++.+.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444678999987677 899998765431 35566665552 1224444422 233567789999999
Q ss_pred CCCh
Q 045652 391 GGSL 394 (621)
Q Consensus 391 ~gsL 394 (621)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.005 Score=64.63 Aligned_cols=71 Identities=13% Similarity=0.119 Sum_probs=47.3
Q ss_pred HcCcCCcccEEEEEEcC--------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCc-ccceEEEEeCCeeEEEEee
Q 045652 318 VLGNGGLGSSYKAMMAD--------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV-LAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 388 (621)
.|+.|-...||++...+ +..+++|+..... ..+.+.+|..+++.+...++ .++++.+. + .+||||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 46778888999998653 5789999885321 12445579999988853344 45565442 2 389999
Q ss_pred cCCCCh
Q 045652 389 IPGGSL 394 (621)
Q Consensus 389 ~~~gsL 394 (621)
++|.++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0018 Score=55.61 Aligned_cols=56 Identities=21% Similarity=0.343 Sum_probs=44.5
Q ss_pred EEecCCCccc-ccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCcccc
Q 045652 77 AIYLDKNQFS-GEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFN 135 (621)
Q Consensus 77 ~l~l~~N~l~-g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 135 (621)
.++.++++|+ ..||.. + -.+|+.|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777888886 357765 2 346999999999999655556788999999999999885
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0072 Score=63.82 Aligned_cols=72 Identities=13% Similarity=0.096 Sum_probs=45.9
Q ss_pred HcCcCCcccEEEEEEcC-CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCc-ccceEEEEeCCeeEEEEeecCCCCh
Q 045652 318 VLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV-LAPLAYHYRTDEKLLVYEYIPGGSL 394 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 394 (621)
.|+.|-...+|++...+ +..+++|+........ -...+|..+++.|...++ .++++++ .+ .+||||++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 47778888999998755 4788899875322111 112588999998865555 4566655 22 359999987554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.45 E-value=0.012 Score=54.58 Aligned_cols=103 Identities=12% Similarity=-0.025 Sum_probs=65.7
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccccc
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL 471 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 471 (621)
-+|.+.|... ..++++.+++.++.|.+.+|.-+-.+. .-..+=+.|..|++..+|.+.+.+ ..+
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s-------- 96 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AAD-------- 96 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-ccc--------
Confidence 4788988753 357999999999999999987762110 001223457899999999887653 111
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 045652 472 AQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFP 511 (621)
Q Consensus 472 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P 511 (621)
......+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 97 ~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 97 DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 01223467888763 4556788999999999998864333
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.00053 Score=70.25 Aligned_cols=110 Identities=17% Similarity=0.222 Sum_probs=74.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccC--CCCCCCEEecCC--Cccccc-----CCccc-ccCCCCCCEEeCccCcccccC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELT--GLRGLRAIYLDK--NQFSGE-----IPPGY-FDEMGALRKLWFSNNKFRGRL 114 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~--~l~~L~~l~l~~--N~l~g~-----ip~~~-~~~l~~L~~l~l~~N~l~g~~ 114 (621)
..++.|+|..++++. ..+..+. .+++|+.|+|+. |...|. |-+.. ...+++|++|+|++|.+++..
T Consensus 193 ~~L~~L~L~~~~l~~----~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~ 268 (362)
T 2ra8_A 193 PNLKSLEIISGGLPD----SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV 268 (362)
T ss_dssp TTCSEEEEECSBCCH----HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHH
T ss_pred CCCcEEEEecCCCCh----HHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHH
Confidence 467788887766543 2222332 578899999853 332222 11111 135899999999999998654
Q ss_pred CCCC---CCCCCcCeeeccCcccccc----CCCC--CCCCccEEEcccCcccc
Q 045652 115 PPSL---FKLPHLTELHLESNQFNGT----IPSF--DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 115 p~~~---~~l~~L~~l~l~~N~l~g~----~p~~--~~~~L~~l~l~~N~l~g 158 (621)
+..+ ..+++|++|+|+.|+|++. ++.. .+++|+.|+|++|.++.
T Consensus 269 ~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 269 VEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 4333 3578999999999999863 3332 45899999999998874
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.012 Score=61.10 Aligned_cols=99 Identities=16% Similarity=0.215 Sum_probs=55.6
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCccc-----ccCCCCCCC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFR-----GRLPPSLFK 120 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~-----g~~p~~~~~ 120 (621)
.++.++|+.+ ++ .|+.. .+.+ .+|+.+.| .|+++ .|+...|.++++|+.|+|.+|.+. -.-+..|.+
T Consensus 227 ~L~~l~l~~~-l~-~I~~~---aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~ 298 (401)
T 4fdw_A 227 QLKTIEIPEN-VS-TIGQE---AFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEG 298 (401)
T ss_dssp TCCCEECCTT-CC-EECTT---TTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTT
T ss_pred CCCEEecCCC-cc-Ccccc---cccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhC
Confidence 4556666543 22 23332 2223 46677777 34455 566666777777777777776654 122345666
Q ss_pred CCCcCeeeccCccccccCCCC---CCCCccEEEcccC
Q 045652 121 LPHLTELHLESNQFNGTIPSF---DQPTLVRLNLSSN 154 (621)
Q Consensus 121 l~~L~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N 154 (621)
|++|+.++|.+ .++ .|+.. ..++|+.|+|.+|
T Consensus 299 c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 299 CPKLARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp CTTCCEECCCT-TCC-EECTTTTTTCCSCCEEEECTT
T ss_pred CccCCeEEeCC-ceE-EEhhhhhcCCCCccEEEECcc
Confidence 77777777763 344 44432 2466777766444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.16 E-value=0.014 Score=60.50 Aligned_cols=104 Identities=14% Similarity=0.145 Sum_probs=77.2
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccc----ccCCcccccCCCCCCEEeCccCcccccCCCCCCCC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFS----GEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKL 121 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~----g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l 121 (621)
.++.+.|+. ++. .|+. ..+.++.+|+.++|.+|.+. ..|+...|..+++|+.|+|. |.++-.-...|.+|
T Consensus 249 ~L~~i~lp~-~i~-~I~~---~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c 322 (401)
T 4fdw_A 249 GITTVKLPN-GVT-NIAS---RAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGN 322 (401)
T ss_dssp CCSEEEEET-TCC-EECT---TTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTC
T ss_pred CccEEEeCC-Ccc-EECh---hHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCC
Confidence 466777743 333 3443 45677889999999988875 24888889999999999999 55774445678889
Q ss_pred CCcCeeeccCccccccCCC--CCCCCccEEEcccCccc
Q 045652 122 PHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKLE 157 (621)
Q Consensus 122 ~~L~~l~l~~N~l~g~~p~--~~~~~L~~l~l~~N~l~ 157 (621)
.+|+.|+|.+| ++ .|+. +...+|+.|++++|.+.
T Consensus 323 ~~L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 323 RKVTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTTPP 358 (401)
T ss_dssp CSCCEEEECTT-CC-EECTTSSSSSCCCEEEECCSSCC
T ss_pred CCccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCCCc
Confidence 99999999665 54 5554 32238999999999776
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.88 E-value=0.0019 Score=58.34 Aligned_cols=82 Identities=11% Similarity=0.090 Sum_probs=46.6
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCc-ccccCCcccccCC----CCCCEEeCccCc-ccccCCCCCC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQ-FSGEIPPGYFDEM----GALRKLWFSNNK-FRGRLPPSLF 119 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~-l~g~ip~~~~~~l----~~L~~l~l~~N~-l~g~~p~~~~ 119 (621)
.++.|||++..+ ....+..+.++++|+.|+|+++. ++..==. .+..+ ++|+.|+|+++. +|..==..+.
T Consensus 62 ~L~~LDLs~~~I----td~GL~~L~~~~~L~~L~L~~C~~ItD~gL~-~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~ 136 (176)
T 3e4g_A 62 KIQAIDATDSCI----MSIGFDHMEGLQYVEKIRLCKCHYIEDGCLE-RLSQLENLQKSMLEMEIISCGNVTDKGIIALH 136 (176)
T ss_dssp CEEEEEEESCCC----CGGGGGGGTTCSCCCEEEEESCTTCCHHHHH-HHHTCHHHHHHCCEEEEESCTTCCHHHHHHGG
T ss_pred eEeEEeCcCCCc----cHHHHHHhcCCCCCCEEEeCCCCccCHHHHH-HHHhcccccCCCCEEEcCCCCcCCHHHHHHHh
Confidence 577777777653 23345566677777777777764 5432101 13333 257777777653 5532112345
Q ss_pred CCCCcCeeeccCc
Q 045652 120 KLPHLTELHLESN 132 (621)
Q Consensus 120 ~l~~L~~l~l~~N 132 (621)
++++|++|+|++.
T Consensus 137 ~~~~L~~L~L~~c 149 (176)
T 3e4g_A 137 HFRNLKYLFLSDL 149 (176)
T ss_dssp GCTTCCEEEEESC
T ss_pred cCCCCCEEECCCC
Confidence 6667777777665
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.96 E-value=0.027 Score=58.73 Aligned_cols=142 Identities=13% Similarity=0.168 Sum_probs=82.7
Q ss_pred HcCcCCcccEEEEEEcC--------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCc-ccceEEEEeCCeeEEEEee
Q 045652 318 VLGNGGLGSSYKAMMAD--------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV-LAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 388 (621)
.+..|-...+|+....+ +..+++|+....... .-...+|.++++.+...++ .++++.+ . -++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 45667778899988653 578999986543221 1123578888888853333 4445432 2 3789999
Q ss_pred cCCCChhH-----------------HhhcCCC-----C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 045652 389 IPGGSLLY-----------------LLHGDRG-----P---SHDELTWPARLKIVQGI-------------------ARG 424 (621)
Q Consensus 389 ~~~gsL~~-----------------~l~~~~~-----~---~~~~l~~~~~~~i~~~i-------------------~~~ 424 (621)
++|.+|.. .+|.... . ......|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99866421 0111000 0 11112344444444332 223
Q ss_pred HHHHHhcc--------------------CCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 425 IGYLHTEL--------------------AHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 425 L~~LH~~~--------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+.+|.+.. .+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 34443221 2335789999999999 7788899999987754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=94.88 E-value=0.0028 Score=57.23 Aligned_cols=81 Identities=15% Similarity=0.074 Sum_probs=53.4
Q ss_pred CCCEEecCCCcccccCCcccccCCCCCCEEeCccCc-ccccCCCCCCCC----CCcCeeeccCcc-cccc-CC-CCCCCC
Q 045652 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNK-FRGRLPPSLFKL----PHLTELHLESNQ-FNGT-IP-SFDQPT 145 (621)
Q Consensus 74 ~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~g~-~p-~~~~~~ 145 (621)
.|+.|||+++.++.. --..+..+++|+.|+|+++. ++..-=..++.+ ++|++|+|+++. ++.. +- -...++
T Consensus 62 ~L~~LDLs~~~Itd~-GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSI-GFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGG-GGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred eEeEEeCcCCCccHH-HHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 688999998887632 11235778899999999885 664322234443 468999998874 5421 11 124688
Q ss_pred ccEEEcccCc
Q 045652 146 LVRLNLSSNK 155 (621)
Q Consensus 146 L~~l~l~~N~ 155 (621)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.83 E-value=0.003 Score=58.17 Aligned_cols=83 Identities=14% Similarity=0.177 Sum_probs=51.8
Q ss_pred CCCCCCEEecCCC-ccccc----CCcccccCCCCCCEEeCccCcccccCC----CCCCCCCCcCeeeccCccccccCC--
Q 045652 71 GLRGLRAIYLDKN-QFSGE----IPPGYFDEMGALRKLWFSNNKFRGRLP----PSLFKLPHLTELHLESNQFNGTIP-- 139 (621)
Q Consensus 71 ~l~~L~~l~l~~N-~l~g~----ip~~~~~~l~~L~~l~l~~N~l~g~~p----~~~~~l~~L~~l~l~~N~l~g~~p-- 139 (621)
.-..|+.|+|++| ++... |-. .+..-+.|+.|+|++|.|...-- ..+..-+.|++|+|++|+++..=-
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 3457888888875 66421 222 24455678888888888874322 223345678888888888863210
Q ss_pred --C--CCCCCccEEEcccC
Q 045652 140 --S--FDQPTLVRLNLSSN 154 (621)
Q Consensus 140 --~--~~~~~L~~l~l~~N 154 (621)
. ...+.|+.|+|++|
T Consensus 118 la~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHTTTTCCCSEEECCCC
T ss_pred HHHHHhhCCceeEEECCCC
Confidence 0 13467888888865
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=92.91 E-value=0.023 Score=52.23 Aligned_cols=88 Identities=15% Similarity=0.148 Sum_probs=44.2
Q ss_pred CCcEEEEEecCC-CCeeeeCcccccccCCCCCCCEEecCCCccccc----CCcccccCCCCCCEEeCccCccccc----C
Q 045652 44 KGIVTGLYINSM-GLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE----IPPGYFDEMGALRKLWFSNNKFRGR----L 114 (621)
Q Consensus 44 ~~~v~~l~l~~~-~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~----ip~~~~~~l~~L~~l~l~~N~l~g~----~ 114 (621)
...++.|+|+++ ++...=-......|..-..|+.|+|++|+|... |-. .+..-+.|+.|+|++|+|+.. |
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~-aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIE-LIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHH-HHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHH-HHhcCCccCeEecCCCcCCHHHHHHH
Confidence 345677777664 442110000001233345677777777777521 111 122345677777777777632 2
Q ss_pred CCCCCCCCCcCeeeccCc
Q 045652 115 PPSLFKLPHLTELHLESN 132 (621)
Q Consensus 115 p~~~~~l~~L~~l~l~~N 132 (621)
-..+..-..|++|+|++|
T Consensus 119 a~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHTTTTCCCSEEECCCC
T ss_pred HHHHhhCCceeEEECCCC
Confidence 223444455777777654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.48 E-value=0.46 Score=48.41 Aligned_cols=80 Identities=20% Similarity=0.239 Sum_probs=39.8
Q ss_pred cCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCC
Q 045652 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPT 145 (621)
Q Consensus 69 l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~ 145 (621)
+.+...|+.+.+..+ ++ .|....|.++.+|+.+.+..+ ++-.-...|.+|.+|+.+.+.+|.++ .|+.. ...+
T Consensus 236 f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~ 311 (379)
T 4h09_A 236 FYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVK 311 (379)
T ss_dssp TTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTT
T ss_pred ccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCC
Confidence 334455666666544 43 355555555666666655433 33222234455666666666555554 34432 2345
Q ss_pred ccEEEcc
Q 045652 146 LVRLNLS 152 (621)
Q Consensus 146 L~~l~l~ 152 (621)
|+.++|.
T Consensus 312 L~~i~lp 318 (379)
T 4h09_A 312 LSSVTLP 318 (379)
T ss_dssp CCEEECC
T ss_pred CCEEEcC
Confidence 5555553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.40 E-value=0.46 Score=48.79 Aligned_cols=79 Identities=16% Similarity=0.184 Sum_probs=37.3
Q ss_pred cCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCC
Q 045652 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPT 145 (621)
Q Consensus 69 l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~ 145 (621)
+.++..|+.+.+..+..+ |....|.++++|+.+.+. +.++-.-...|.+|.+|+.++|..| ++ .|... ...+
T Consensus 261 F~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~ 335 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQ 335 (394)
T ss_dssp TTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred eeecccccEEecccccce--ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCC
Confidence 344455566665544332 454555555566666554 2333222233455556666655433 22 33321 2345
Q ss_pred ccEEEcc
Q 045652 146 LVRLNLS 152 (621)
Q Consensus 146 L~~l~l~ 152 (621)
|+.+.|.
T Consensus 336 L~~i~ip 342 (394)
T 4gt6_A 336 LERIAIP 342 (394)
T ss_dssp CCEEEEC
T ss_pred CCEEEEC
Confidence 5555553
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.00 E-value=0.28 Score=50.43 Aligned_cols=78 Identities=14% Similarity=0.106 Sum_probs=41.6
Q ss_pred CCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCCcc
Q 045652 71 GLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPTLV 147 (621)
Q Consensus 71 ~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~L~ 147 (621)
++.+|+.+.+..| ++ .|+...|.++++|+.++|..+ ++-.-...|.+|.+|+.++|..| ++ .|+.. ..++|+
T Consensus 295 ~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 295 GCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLK 369 (394)
T ss_dssp TCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCC
T ss_pred ccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCC
Confidence 3445666665543 44 455555666666666666533 44222344566666666666554 43 44432 235666
Q ss_pred EEEccc
Q 045652 148 RLNLSS 153 (621)
Q Consensus 148 ~l~l~~ 153 (621)
.++|..
T Consensus 370 ~i~lp~ 375 (394)
T 4fs7_A 370 KVELPK 375 (394)
T ss_dssp EEEEEG
T ss_pred EEEECC
Confidence 666543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.41 E-value=0.33 Score=50.11 Aligned_cols=30 Identities=17% Similarity=0.418 Sum_probs=24.7
Q ss_pred CCccCCCCCCCEEe------CCCCCcEEEeeeccee
Q 045652 436 DLPHGNLKSSNIFI------SPENEPLISEFGFYTM 465 (621)
Q Consensus 436 ~ivH~Dlkp~NIll------~~~~~~kl~DfG~a~~ 465 (621)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4566799999987654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=89.82 E-value=0.31 Score=50.04 Aligned_cols=85 Identities=15% Similarity=0.267 Sum_probs=64.7
Q ss_pred ccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCC
Q 045652 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQP 144 (621)
Q Consensus 68 ~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~ 144 (621)
.+.++.+|+.+.+. +.++ .|+...|.++.+|+.++|..| ++-.-...|.+|.+|+.+.|..+ ++ .|+.. ..+
T Consensus 283 aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~ 357 (394)
T 4gt6_A 283 AFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCT 357 (394)
T ss_dssp TTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCT
T ss_pred ccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCC
Confidence 35567789999996 5566 699889999999999999865 55333456889999999999655 54 56642 458
Q ss_pred CccEEEcccCccc
Q 045652 145 TLVRLNLSSNKLE 157 (621)
Q Consensus 145 ~L~~l~l~~N~l~ 157 (621)
+|+.+++.+|...
T Consensus 358 ~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 358 ALNNIEYSGSRSQ 370 (394)
T ss_dssp TCCEEEESSCHHH
T ss_pred CCCEEEECCceee
Confidence 8999999887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.42 E-value=0.97 Score=41.74 Aligned_cols=117 Identities=11% Similarity=0.062 Sum_probs=77.3
Q ss_pred CCCCcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCC
Q 045652 365 RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKS 444 (621)
Q Consensus 365 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp 444 (621)
.||+++.. .+-.+.+...+.++.-+ +...+-. -..++...+++++..|+....+++.+ +|--|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~------ik~~~~~eKlr~l~ni~~l~~~~~~r------~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN------IKSFTKNEKLRYLLNIKNLEEVNRTR------YTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG------GGGSCHHHHHHHHHHGGGGGGGGGSS------EECCCSG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH------HHhcCHHHHHHHHHHHHHHHHHhcCc------eEEEEec
Confidence 68888865 45555665555555433 2222211 23478889999999999888666643 3778999
Q ss_pred CCEEeCCCCCcEEEeeecceeccccccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 045652 445 SNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQY 514 (621)
Q Consensus 445 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 514 (621)
+||+++.++.+++.-.|+-.. ++|. ..+...=.-.+=+++..+++++..|..
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~-------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV-------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT-------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred ceEEEcCCCCEEEEEccCccC-------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999987775221 2332 112222234577888899999988764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=89.12 E-value=0.63 Score=47.73 Aligned_cols=62 Identities=18% Similarity=0.144 Sum_probs=50.8
Q ss_pred ccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCc
Q 045652 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESN 132 (621)
Q Consensus 68 ~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 132 (621)
.+.++.+|+.++|.++ ++ .|+...|.++++|+.++|..| ++-.-...|.+|.+|+.++|..|
T Consensus 315 aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 315 AFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred hhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 4566789999999755 77 798888999999999999877 66333457889999999999765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=87.01 E-value=0.7 Score=46.99 Aligned_cols=93 Identities=17% Similarity=0.311 Sum_probs=66.8
Q ss_pred cCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCC
Q 045652 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPT 145 (621)
Q Consensus 69 l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~ 145 (621)
+.+..+|+.+.+..+ +. .|+...|..+++|+.++|.+|.++-.-...|.+|.+|+.+.|..| ++ .|+.. ...+
T Consensus 259 F~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~ 334 (379)
T 4h09_A 259 LQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKA 334 (379)
T ss_dssp TTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred cceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCC
Confidence 455678899998655 55 688888999999999999999888444567889999999999755 54 56543 3467
Q ss_pred ccEEEcccCccccccCccccccccCCCCC
Q 045652 146 LVRLNLSSNKLEGEIPASLLRFNASSFSG 174 (621)
Q Consensus 146 L~~l~l~~N~l~g~ip~~~~~~~~~~~~~ 174 (621)
|+.+.+ |..+.......|.|
T Consensus 335 L~~i~i---------p~~v~~I~~~aF~~ 354 (379)
T 4h09_A 335 LSTISY---------PKSITLIESGAFEG 354 (379)
T ss_dssp CCCCCC---------CTTCCEECTTTTTT
T ss_pred CCEEEE---------CCccCEEchhHhhC
Confidence 777654 44444444455554
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.48 E-value=2.8 Score=38.77 Aligned_cols=114 Identities=11% Similarity=0.077 Sum_probs=76.4
Q ss_pred CCCCcccceEEEEeCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhccCCCCCccCCCC
Q 045652 365 RHSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIG-YLHTELAHLDLPHGNLK 443 (621)
Q Consensus 365 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~~ivH~Dlk 443 (621)
.||++ -...-.+++...+.++.-+++.=...++ .++..++++++..|+.... +++++ +|--|.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~r------~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSARR------LIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSSS------EECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhCc------eeEEEe
Confidence 57877 3444455666666666543433333443 3778899999999888776 56543 477899
Q ss_pred CCCEEeCCCCCcEEEeeecceeccccccccccccccCcccccCCCCCcchhh-HHHHHHHHHHHhCCCCCC
Q 045652 444 SSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQSGKVTPKCDV-YCLGIIILEILTGKFPSQ 513 (621)
Q Consensus 444 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wSlGvvl~elltg~~P~~ 513 (621)
|+||+++.++.+++.-.|+- .-++|..+ + ..|. -.+=|++..++.++..|.
T Consensus 112 P~NL~f~~~~~p~i~hRGi~-------------~~lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVK-------------ESLPPDEW-----D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGGEEECTTCCEEESCCEET-------------TTBSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CceEEEeCCCcEEEEEcCCc-------------ccCCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999877752 22344322 1 2333 357778888898887765
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.66 E-value=0.89 Score=30.15 Aligned_cols=26 Identities=27% Similarity=0.511 Sum_probs=11.2
Q ss_pred hhhHHHHHHH-HHHHHHHHHhhhhhhh
Q 045652 219 IAAGVALSVM-LVSIAIVVIIRIRRKR 244 (621)
Q Consensus 219 i~~~v~~~v~-ll~l~~~~~~~~rrrr 244 (621)
++++++++++ ++.+++.+++++|||+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 4555554333 3333344444444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.49 E-value=0.92 Score=29.97 Aligned_cols=26 Identities=27% Similarity=0.433 Sum_probs=10.4
Q ss_pred hhhHHHHHHHHHHHHHHHHhhhhhhh
Q 045652 219 IAAGVALSVMLVSIAIVVIIRIRRKR 244 (621)
Q Consensus 219 i~~~v~~~v~ll~l~~~~~~~~rrrr 244 (621)
+++++++.++++.+++.++++.|||+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhh
Confidence 44444443333333333344444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.89 E-value=1.1 Score=29.60 Aligned_cols=27 Identities=33% Similarity=0.570 Sum_probs=11.7
Q ss_pred chhhHHHHHHHH-HHHHHHHHhhhhhhh
Q 045652 218 VIAAGVALSVML-VSIAIVVIIRIRRKR 244 (621)
Q Consensus 218 ~i~~~v~~~v~l-l~l~~~~~~~~rrrr 244 (621)
.+++++++++++ +.+++.+++++|||+
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 355555543333 333344444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 621 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-48
Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 31/282 (10%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G+G G+ YK V V + + + AF EV L + RH N+L + Y
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ +V ++ G SL + LH + I + A+G+ YLH
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH----AKS 124
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL------FAYKAPEAIQ---SG 487
+ H +LKS+NIF+ + I +FG T+ + + + + APE I+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 488 KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547
+ + DVY GI++ E++TG+ P I+ + + G ++ L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYS-------NINNRDQIIFMVGRGYLSPDLSKV--- 234
Query: 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+ + + C + ++R + + I + +S
Sbjct: 235 ---RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 60/300 (20%), Positives = 106/300 (35%), Gaps = 33/300 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
E +G G G ++ G V VK S + E+ + LRH N+L +A
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 377 YRTDEKL----LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE- 431
+ + LV +Y GSL L+ +T +K+ A G+ +LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEI 120
Query: 432 ---LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--------FAYKA 480
+ H +LKS NI + I++ G +SA + Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 481 PEAIQS------GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNG---GIDVVEWVASA 531
PE + + + D+Y +G++ EI + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 532 FSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591
+ L P I + S + + +I R C ++ RL + + ++ Q +G
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 8e-46
Identities = 52/278 (18%), Positives = 104/278 (37%), Gaps = 31/278 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G+G G + + V +K ++E AM+ + F E + +L H ++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
LV+E++ G L L L + + G+ YL
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE----EAC 121
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-----AYKAPEAIQSGKVTP 491
+ H +L + N + +S+FG + + + +PE + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
K DV+ G+++ E+ + + + +VVE +++ F L P +AS
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTGF------RLYKPRLAS---- 228
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+ +I C + PE R +R++ EI +S
Sbjct: 229 ----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-45
Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 31/275 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
E LG G G + V VK +K+ S M+ DAF E + +L+H ++ A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ ++ EY+ GSL+ L G +LT L + IA G+ ++ +
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIE----ERN 129
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAIQSGKVTP 491
H +L+++NI +S I++FG +I A+ + APEAI G T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
K DV+ GI++ EI+T G +V++ + + ++ P+
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPY---PGMTNPEVIQNLERGY------RMVRPDNCP---- 236
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
E+L ++ R C + PE R + +
Sbjct: 237 ----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-44
Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 33/276 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ LG G G V +K +KE S M+ D F E + + L H ++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ ++ EY+ G LL L R L++ + + + YL
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLE----SKQ 120
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-----FAYKAPEAIQSGKVTP 491
H +L + N ++ + +S+FG + ++ + PE + K +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 492 KCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
K D++ G+++ EI + GK P + TN + E +A L P +AS
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHIAQGL------RLYRPHLAS--- 227
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586
E++ I +C ++R + + I+++
Sbjct: 228 -----EKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 5e-44
Identities = 61/274 (22%), Positives = 103/274 (37%), Gaps = 29/274 (10%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
+ +G G G G V VK +K + AF E + +LRHSN++ L
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 377 YRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
L +V EY+ GSL+ L L LK + + YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLE----GN 122
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCD 494
+ H +L + N+ +S +N +S+FG +S + + + APEA++ K + K D
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 495 VYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGE 554
V+ GI++ EI + DVV V + + P+
Sbjct: 183 VWSFGILLWEIYSFGRVPYP---RIPLKDVVPRVEKGY------KMDAPDGCP------- 226
Query: 555 MEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
+ E+ + C D R + ++ I+
Sbjct: 227 -PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-42
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 31/278 (11%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYH 376
LG G G + V +K +K + M+ +AF E + + +LRH ++ A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV- 80
Query: 377 YRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD 436
+ +V EY+ GSLL L G+ G P + + IA G+ Y+ ++
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIASGMAYVE----RMN 133
Query: 437 LPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAIQSGKVTP 491
H +L+++NI + +++FG +I A+ + APEA G+ T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
K DV+ GI++ E+ T G +V++ V +
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYP---GMVNREVLDQVERGY---------RMPC-----P 236
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
P E L ++ C + +PE+R + + S
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-41
Identities = 48/294 (16%), Positives = 104/294 (35%), Gaps = 37/294 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
LG G G +K G+ + K + E R+ E++ L ++
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
Y E + E++ GGSL +L + K+ + +G+ YL +
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREKH-- 124
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--FAYKAPEAIQSGKVTPK 492
+ H ++K SNI ++ E + +FG + + + +Y +PE +Q + +
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 493 CDVYCLGIIILEILTGKFP-------------------------SQYLTNGNGGIDVVEW 527
D++ +G+ ++E+ G++P + T G
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 528 VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
+ + D + E S + + C +P +R ++++ +
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (373), Expect = 1e-40
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 31/284 (10%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
LG G G Y+ + +TV VK +KE + M + F E + ++H N++ L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
R ++ E++ G+LL L E++ L + I+ + YL
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE----KK 134
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANL-----AQALFAYKAPEAIQSGKVT 490
+ H +L + N + + +++FG ++ A+ + APE++ K +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
K DV+ G+++ EI T +V +LL+ +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDY-RMER 237
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMD 594
G E++ E+ RAC Q +P R E + + Q D
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 59/287 (20%), Positives = 102/287 (35%), Gaps = 39/287 (13%)
Query: 317 EVLGNGGLGSSYKAMMAD----GVTVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNVLA 371
EV+G G G Y + D + VK + + + F TE + H NVL+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 372 PLAYHYRTDEK-LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L R++ L+V Y+ G L + + T + +A+G+ +L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA- 147
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--------FAYKAPE 482
H +L + N + + +++FG + + A E
Sbjct: 148 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542
++Q+ K T K DV+ G+++ E++T P ++ + R LL
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTFDITVYLLQGRR---LLQ 255
Query: 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
PE + L E+ C E R E V RI I +
Sbjct: 256 PEYCP--------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 2e-40
Identities = 59/304 (19%), Positives = 103/304 (33%), Gaps = 53/304 (17%)
Query: 317 EVLGNGGLGSSYKAM------MADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNV 369
+G G G ++A V VK +K E+SA + F E + + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRG-------------------PSHDELT 410
+ L L++EY+ G L L P L+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 411 WPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470
+L I + +A G+ YL H +L + N + I++FG I SA+
Sbjct: 139 CAEQLCIARQVAAGMAYLS----ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 471 LAQAL------FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV 524
+A + PE+I + T + DV+ G+++ EI + Y G +V
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY---GMAHEEV 251
Query: 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584
+ +V +G + +L + R C P R R +
Sbjct: 252 IYYVR----DGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 585 EIQQ 588
+ +
Sbjct: 298 RMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-40
Identities = 55/275 (20%), Positives = 99/275 (36%), Gaps = 29/275 (10%)
Query: 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM--ARDAFDTEVRRLGRLRHSNVLAPL 373
+G G G K +DG +V K + S + +EV L L+H N++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 374 -AYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
RT+ L +V EY GG L ++ L L+++ + + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 432 -LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS----ANLAQALFAYKAPEAIQS 486
+ H +LK +N+F+ + + +FG ++N A Y +PE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
K D++ LG ++ E+ P + + +A EG+ + P
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKFRRI--PYRY 238
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
S ++L EI R + E +
Sbjct: 239 S--------DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (367), Expect = 7e-40
Identities = 63/294 (21%), Positives = 121/294 (41%), Gaps = 41/294 (13%)
Query: 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLA 371
+V+G G G + + V +K +K + R F +E +G+ H NV+
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
++ +++ E++ GSL L + G T + +++GIA G+ YL
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLA-- 145
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA---------YKAPE 482
++ H +L + NI ++ +S+FG + + + APE
Sbjct: 146 --DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 483 AIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541
AIQ K T DV+ GI++ E+++ G+ P +TN DV+ +
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----DVINAIEQ----------- 248
Query: 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGNMDA 595
D + + P + QL+ C Q D R + + V + ++ ++ ++ A
Sbjct: 249 DYRLPPPMDCPSALHQLM---LDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKA 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-39
Identities = 50/283 (17%), Positives = 103/283 (36%), Gaps = 39/283 (13%)
Query: 319 LGNGGLGSSYKAMMA---DGVTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
LG G GS + + + V +K +K + + E + + +L + ++ +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ + +LV E GG L L G R + +++ ++ G+ YL
Sbjct: 77 V-CQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLE----E 127
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-------FAYKAPEAIQSG 487
+ H +L + N+ + + IS+FG + + + + APE I
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 488 KVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
K + + DV+ G+ + E L+ G+ P + + +V+ ++ E
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQG---------KRMEC- 233
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
P +L + C E R + +R+ S
Sbjct: 234 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 5e-39
Identities = 60/272 (22%), Positives = 102/272 (37%), Gaps = 33/272 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAP 372
+G+G G+ Y A + + V +K+M S EVR L +LRH N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ R LV EY G + L + L + G +G+ YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLH--- 132
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFAYKAPEAIQS---GKV 489
++ H ++K+ NI +S + +FG +++ AN + APE I + G+
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 490 TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549
K DV+ LGI +E+ K P + + + + + A G +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS----------- 240
Query: 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
E +C Q P+ R ++
Sbjct: 241 ------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 6e-39
Identities = 53/275 (19%), Positives = 98/275 (35%), Gaps = 34/275 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
LG+G G YKA V K + S + + E+ L H N++ L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
Y + ++ E+ GG++ ++ P LT + + + YLH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLH----DN 129
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQS----- 486
+ H +LK+ NI + + + +++FG + F + APE +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
K DV+ LGI ++E+ + P L V ++ L P
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPPTLAQPSRW 241
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
SS + L + C + + + R + ++
Sbjct: 242 SS-----NFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (363), Expect = 1e-38
Identities = 48/269 (17%), Positives = 106/269 (39%), Gaps = 29/269 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E LG G G ++ A G K + ++ E++ + LRH ++
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+E +++YE++ GG L + + ++ ++ ++ + +G+ ++H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMH----EN 143
Query: 436 DLPHGNLKSSNIFISPE--NEPLISEFGFYTMINSANLAQALF---AYKAPEAIQSGKVT 490
+ H +LK NI + + NE + +FG ++ + + APE + V
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
D++ +G++ +L+G P G + + V S + + D I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSC--DWNMDDSAFSGI----- 252
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREA 579
+ + + R +DP R+ + +A
Sbjct: 253 -SEDGKDFI---RKLLLADPNTRMTIHQA 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 34/275 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPL 373
+G G + YK + V V +++ + R F E L L+H N++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 374 AYHYRTDEK----LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
T + +LV E + G+L L + + I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 430 TELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMINSANLAQAL--FAYKAPEAIQS 486
T + H +LK NIFI+ I + G T+ ++ + + APE +
Sbjct: 130 TR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
K DVY G+ +LE+ T ++P + + RVT + P
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYR------RVTSGVKPASF 234
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
P ++ EI C + + ++R +++ +
Sbjct: 235 DKVAIP----EVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 63/291 (21%), Positives = 109/291 (37%), Gaps = 41/291 (14%)
Query: 317 EVLGNGGLGSSYKAM------MADGVTVVVKRMKESSAM-ARDAFDTEVRRLGRLRHSNV 369
LG G G Y+ + V +K + E+++M R F E + +V
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRG-----PSHDELTWPARLKIVQGIARG 424
+ L + L++ E + G L L R P + +++ IA G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL------FAY 478
+ YL+ H +L + N ++ + I +FG I + + +
Sbjct: 146 MAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 479 KAPEAIQSGKVTPKCDVYCLGIIILEILTG-KFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
+PE+++ G T DV+ G+++ EI T + P Q L+N E V EG +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEGGL 253
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
D D + L E+ R C Q +P+ R E + I E +
Sbjct: 254 LDKPD----------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 64/286 (22%), Positives = 106/286 (37%), Gaps = 41/286 (14%)
Query: 317 EVLGNGGLGSSYKAMM----ADGVTVVVKRMKE---SSAMARDAFDTEVRRLGRLRHSNV 369
E LG+G G + V+V VK +K S A D F EV + L H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ L T +V E P GSLL L +G + +A G+GYL
Sbjct: 74 I-RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 128
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-------FAYKAPE 482
H +L + N+ ++ + I +FG + + + FA+ APE
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 483 AIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541
++++ + D + G+ + E+ T G+ P G++ + + EG L
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGE--RLP 235
Query: 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587
PE + + + C PE R ++E Q
Sbjct: 236 RPEDCP--------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 56/286 (19%), Positives = 114/286 (39%), Gaps = 38/286 (13%)
Query: 317 EVLGNGGLGSSYKAMMADG-----VTVVVKRMK-ESSAMARDAFDTEVRRLGRLRHSNVL 370
+V+G G G YK M+ V V +K +K + R F E +G+ H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ +++ EY+ G+L L G + + +++GIA G+ YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLA- 127
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-------AYKAPEA 483
+++ H +L + NI ++ +S+FG ++ A + APEA
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 484 IQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543
I K T DV+ GI++ E++T + + + +V++ + F
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDGFRL--------- 232
Query: 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
+ ++ C Q + +R + + V + ++ ++
Sbjct: 233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 58/291 (19%), Positives = 102/291 (35%), Gaps = 40/291 (13%)
Query: 317 EVLGNGGLGSSYKAMMADG---VTVVVKRMKE-SSAMARDAFDTEVRRLGRL-RHSNVLA 371
+V+G G G KA + + +KRMKE +S F E+ L +L H N++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE-----------LTWPARLKIVQG 420
L L EY P G+LL L R D L+ L
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 421 IARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL---FA 477
+ARG+ YL H +L + NI + I++FG
Sbjct: 136 VARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 191
Query: 478 YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRV 537
+ A E++ T DV+ G+++ EI++ ++ E + +
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQGY----- 243
Query: 538 TDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
L P +++ ++ R C + P +R + + + + +
Sbjct: 244 -RLEKPLNCD--------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-37
Identities = 55/270 (20%), Positives = 108/270 (40%), Gaps = 31/270 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E +G G G+ Y AM +A G V +++M ++ E+ + ++ N++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+ DE +V EY+ GGSL ++ + + + + +LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCRECLQALEFLH----SN 135
Query: 436 DLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGKVTP 491
+ H ++KS NI + + +++FGF I ++ + APE + P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
K D++ LGI+ +E++ G+ P + + + + G PE+ +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYL-------NENPLRALYLIATNGT------PELQNPEKL 242
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
L C D E+R +E ++
Sbjct: 243 SAIFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 54/271 (19%), Positives = 96/271 (35%), Gaps = 34/271 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAP 372
LG G G+ Y A + +K + ++ A EV LRH N+L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
Y + L+ EY P G++ L + +A + Y H
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCH--- 123
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL--FAYKAPEAIQSGKVT 490
+ H ++K N+ + E I++FG+ S+ Y PE I+
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
K D++ LG++ E L GK P + N + + ++ + P+ +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRV-------EFTFPDFVT--- 228
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
E ++ + +P QR +RE +
Sbjct: 229 -----EGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-37
Identities = 50/279 (17%), Positives = 98/279 (35%), Gaps = 41/279 (14%)
Query: 318 VLGNGGLGSSYKAMMAD---GVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAP 372
LG+G G+ K TV VK +K + +D E + +L + ++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ + +LV E G L L + + +++V ++ G+ YL
Sbjct: 74 IGI-CEAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-------FAYKAPEAIQ 485
+ H +L + N+ + ++ IS+FG + + + APE I
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 486 SGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544
K + K DV+ G+++ E + G+ P + + V + +G P
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGC--PA 233
Query: 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
++ ++ C D E R R+
Sbjct: 234 GCP--------REMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-37
Identities = 67/301 (22%), Positives = 114/301 (37%), Gaps = 48/301 (15%)
Query: 317 EVLGNGGLGSSYKAMMA------DGVTVVVKRMKESSAMA-RDAFDTEVRRLGRL-RHSN 368
+ LG G G +A +TV VK +K S+ + R+A +E++ L L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE-------------LTWPARL 415
++ L L++ EY G LL L R L L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL 475
+A+G+ +L + H +L + NI ++ I +FG I + +
Sbjct: 149 SFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 476 ------FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVA 529
+ APE+I + T + DV+ GI + E+ + G+ V
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP------GMPVDSKFY 258
Query: 530 SAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVE-IQQ 588
EG +L PE A ++ +I + C +DP +R ++ V+ I + I +
Sbjct: 259 KMIKEGF--RMLSPEHAP--------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
Query: 589 S 589
S
Sbjct: 309 S 309
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-36
Identities = 54/274 (19%), Positives = 98/274 (35%), Gaps = 34/274 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+ LG G G A+ V VK + + + + E+ L H NV+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ + + L EY GG L + D G + P + + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH----G 121
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF------AYKAPEAIQSGK 488
+ + H ++K N+ + + IS+FG T+ N + L Y APE ++ +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 489 V-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547
DV+ GI++ +L G+ P ++ S + E + +I
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------SCQEYSDWKEKKTYLNPWKKI-- 232
Query: 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
LL +P R+ + + +
Sbjct: 233 ----DSAPLALL---HKILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 54/300 (18%)
Query: 317 EVLGNGGLGSSYKAMM------ADGVTVVVKRM-KESSAMARDAFDTEVRRLGRL-RHSN 368
+VLG+G G A + V VK + +++ + R+A +E++ + +L H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 369 VLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDE------------------LT 410
++ L + L++EY G LL L R ++ LT
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 411 WPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470
+ L +A+G+ +L H +L + N+ ++ I +FG I S +
Sbjct: 163 FEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 471 LAQAL------FAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGID 523
+ APE++ G T K DV+ GI++ EI + G P GI
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP-------GIP 271
Query: 524 VVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583
V G D P A+ E++ I ++C D +R +
Sbjct: 272 VDANFYKLIQNGFKMDQ--PFYAT--------EEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 134 bits (337), Expect = 3e-35
Identities = 52/271 (19%), Positives = 109/271 (40%), Gaps = 29/271 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E LG+G G ++ + A G V K + + + E+ + +L H ++
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
E +L+ E++ GG L + + ++ + ++ G+ ++H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMH----EH 146
Query: 436 DLPHGNLKSSNIFISPENEPLI--SEFGFYTMINSANLAQALFA---YKAPEAIQSGKVT 490
+ H ++K NI + + +FG T +N + + A + APE + V
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
D++ +G++ +L+G P G ++ ++ V D E A S+
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFA----GEDDLETLQNVKRC-------DWEFDEDAFSSV 255
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
SP E + + + Q +P +RL + +A+
Sbjct: 256 SP-EAKDFI---KNLLQKEPRKRLTVHDALE 282
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 56/285 (19%), Positives = 105/285 (36%), Gaps = 40/285 (14%)
Query: 317 EVLGNGGLGSSYKAMMAD-----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVL 370
+VLG+G G+ YK + + V +K ++E+ S A E + + + +V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L T L+ + +P G LL + + L IA+G+ YL
Sbjct: 75 -RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYLE- 128
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL------FAYKAPEAI 484
L H +L + N+ + I++FG ++ + + A E+I
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 485 QSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543
T + DV+ G+ + E++T G P + ++S +G L P
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGER--LPQP 235
Query: 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
I + + I C D + R + RE + ++ +
Sbjct: 236 PICT--------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 61/299 (20%), Positives = 105/299 (35%), Gaps = 46/299 (15%)
Query: 317 EVLGNGGLGSSYKAMM------ADGVTVVVKRMKESSAMA-RDAFDTEVRRLGRLRHSNV 369
+ LG G G +A A TV VK +KE + + A +E++ L + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 370 LAPLAYHYRTDEK--LLVYEYIPGGSLLYLLHGDRGP-----------SHDELTWPARLK 416
+ L +++ E+ G+L L R D LT +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 417 IVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL- 475
+A+G+ +L H +L + NI +S +N I +FG I
Sbjct: 139 YSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 476 -----FAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVAS 530
+ APE I T + DV+ G+++ EI + G+ + E
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFCR 248
Query: 531 AFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589
EG T + P+ + ++ + C +P QR E V + + Q+
Sbjct: 249 RLKEG--TRMRAPDYTT--------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-34
Identities = 60/300 (20%), Positives = 108/300 (36%), Gaps = 50/300 (16%)
Query: 317 EVLGNGGLGSSYKAMM--------ADGVTVVVKRMK-ESSAMARDAFDTEVRRLGRL-RH 366
+ LG G G A V VK +K +++ +E+ + + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 367 SNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHD-----------ELTWPARL 415
N++ L + ++ EY G+L L R P + +L+ +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 416 KIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL 475
+ARG+ YL H +L + N+ ++ +N I++FG I+ + +
Sbjct: 139 SCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 476 ------FAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWV 528
+ APEA+ T + DV+ G+++ EI T G P + VE +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEEL 246
Query: 529 ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588
EG D +L + R C + P QR ++ V + I
Sbjct: 247 FKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-33
Identities = 47/284 (16%), Positives = 98/284 (34%), Gaps = 36/284 (12%)
Query: 317 EVLGNGGLGSSYKAMMAD----GVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLA 371
+G G G ++ + + V +K K +S R+ F E + + H +++
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
+ + ++ E G L L + L + + ++ + YL
Sbjct: 73 LIGV-ITENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLE-- 125
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL-----FAYKAPEAIQS 486
H ++ + N+ +S + + +FG + + +A + APE+I
Sbjct: 126 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
+ T DV+ G+ + EIL N DV+ + + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIEN-----------GERLP 229
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590
N P + L+ C DP +R E ++ I + +
Sbjct: 230 MPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-33
Identities = 52/271 (19%), Positives = 100/271 (36%), Gaps = 30/271 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
E LG G G ++ + + T + K +K + E+ L RH N+L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES 69
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+E ++++E+I G + ++ L + V + + +LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQFLH----SH 121
Query: 436 DLPHGNLKSSNIFISPENEPL--ISEFGFYTMINSANLAQALF---AYKAPEAIQSGKVT 490
++ H +++ NI I EFG + + + LF Y APE Q V+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 491 PKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550
D++ LG ++ +L+G P ++E + +A E + EI
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFL----AETNQQIIENIMNA--EYTFDEEAFKEI----- 230
Query: 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
E + + + R+ EA++
Sbjct: 231 -SIEAMDFV---DRLLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 125 bits (314), Expect = 8e-33
Identities = 60/286 (20%), Positives = 103/286 (36%), Gaps = 43/286 (15%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAP 372
E+LG GG+ + A + V VK ++ A F E + L H ++A
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 373 LAYHYRTDEKL----LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+V EY+ G +L ++H + +T ++++ + + +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFS 127
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-------AYKAP 481
H + H ++K +NI IS N + +FG I + + Y +P
Sbjct: 128 H----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541
E + V + DVY LG ++ E+LTG+ P G V E +
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-------GDSPVSVAYQHVREDPIPPSA 236
Query: 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL----EMREAVRRI 583
E S L + +PE R EMR + R+
Sbjct: 237 RHEGLS--------ADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 9e-32
Identities = 52/273 (19%), Positives = 100/273 (36%), Gaps = 32/273 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+VLG G A V +K + K++ + + E+ L +++H N++A
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ L+ + + GG L + T +++ + + YLH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLH----D 125
Query: 435 LDLPHGNLKSSNIFISPENE---PLISEFGFYTMINSANLAQAL---FAYKAPEAIQSGK 488
L + H +LK N+ +E +IS+FG M + ++ Y APE +
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 489 VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548
+ D + +G+I +L G P + E + A E +I
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLFEQILKA--EYEFDSPYWDDI--- 236
Query: 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
+ + R + DPE+R +A++
Sbjct: 237 ---SDSAKDFI---RHLMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 44/274 (16%), Positives = 85/274 (31%), Gaps = 40/274 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDA---FDTEVRRLGRLRHSNVLAP 372
++LG G + A +A +K +++ + + E + RL H +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
++ Y G LL + I + YLH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL------FAYKAPEAIQS 486
+ H +LK NI ++ + I++FG +++ + Y +PE +
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
D++ LG II +++ G P F G + I
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP--------------------FRAGNEYLIFQKIIK 224
Query: 547 SSTNSPGEM-EQLLEIGRACTQSDPEQRLEMREA 579
+ P + + ++ D +RL E
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 119 bits (299), Expect = 9e-31
Identities = 51/283 (18%), Positives = 99/283 (34%), Gaps = 44/283 (15%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK---------ESSAMARDAFDTEVRRLGRLRH 366
E+LG G + + VK + E R+A EV L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 367 SNVLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
+ L Y T+ LV++ + G L L L+ KI++ + I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVI 123
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL---FAYKAPE 482
LH L++ H +LK NI + + +++FGF ++ + + +Y APE
Sbjct: 124 CALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 483 AIQSG------KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536
I+ + D++ G+I+ +L G P + ++ +
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW----HRKQMLMLRMI-------- 227
Query: 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
++ + ++ L+ P++R EA
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTAEEA 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 57/277 (20%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLA 374
+VLG G G + +K +++ R EV R + +++ +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 72
Query: 375 YHYRTDEK----LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ L+V E + GG L + DRG T +I++ I I YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQA--FTEREASEIMKSIGEAIQYLH- 128
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPL---ISEFGFYTMINSANLAQALF---AYKAPEAI 484
+++ H ++K N+ + + +++FGF S N Y APE +
Sbjct: 129 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544
K CD++ LG+I+ +L G P N G+ + + + G+ +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY----SNHGLAISPGMKTRIRMGQ----YEFP 237
Query: 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
+ E++ L+ R +++P QR+ + E +
Sbjct: 238 NPEWSEVSEEVKMLI---RNLLKTEPTQRMTITEFMN 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (294), Expect = 7e-30
Identities = 40/290 (13%), Positives = 81/290 (27%), Gaps = 36/290 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+G+G G Y +A G V +K + E + ++ + + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+ ++ + G SL L + + L + + I Y+H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIH----SK 122
Query: 436 DLPHGNLKSSNIFISPE---NEPLISEFGFYTMINSANLAQALF-----------AYKAP 481
+ H ++K N + N I +FG A Q + Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541
+ + + D+ LG +++ G P Q L + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--------ATKRQKYERISEKKMS 234
Query: 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591
P P E L C + + + + + G
Sbjct: 235 TPIEVLCKGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 8e-30
Identities = 53/285 (18%), Positives = 100/285 (35%), Gaps = 29/285 (10%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK-----ESSAMARDAFDTEVRRLGRLRHSNVL 370
+ LG G + YKA V +K++K E+ E++ L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 371 APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
L LV++++ + + LT + +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQGLEYLH- 117
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQS 486
+ H +LK +N+ + +++FG S N A Y+APE +
Sbjct: 118 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 487 GKV-TPKCDVYCLGIIILEILTGKFPSQY---------LTNGNGGIDVVEWVASAFSEGR 536
++ D++ +G I+ E+L + G +W
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
VT P I + LL++ + +P R+ +A++
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 55/275 (20%), Positives = 97/275 (35%), Gaps = 37/275 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFD---TEVRRLGR-LRHSNVLA 371
++LG G G + A +K +K+ + D + E R L H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 372 PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTE 431
+ V EY+ GG L+Y + S + I G+ +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLH-- 120
Query: 432 LAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSG 487
+ + +LK NI + + I++FG + F Y APE +
Sbjct: 121 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 488 KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547
K D + G+++ E+L G+ P G ++ + R+ + P
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEELFHSI-------RMDNPFYPRWLE 227
Query: 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582
E + LL +PE+RL +R +R+
Sbjct: 228 K-----EAKDLL---VKLFVREPEKRLGVRGDIRQ 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-29
Identities = 53/286 (18%), Positives = 106/286 (37%), Gaps = 34/286 (11%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+V+GNG G Y+A + D G V +K++ + + E++ + +L H N++ +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYF 81
Query: 376 HYRTDEK------LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
Y + EK LV +Y+P H R L + + R + Y+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALF---AYKAP-EAI 484
+ H ++K N+ + P+ L + +FG + + Y+AP
Sbjct: 140 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTN-----------GNGGIDVVEWVASAFS 533
+ T DV+ G ++ E+L G+ + G + + + ++
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 534 EGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
E + + + P + + + + P RL EA
Sbjct: 256 EFKFPQIKAHPW-TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 9e-29
Identities = 59/279 (21%), Positives = 116/279 (41%), Gaps = 38/279 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK------ESSAMARDAFDTEVRRLGRLRHSNV 369
E LG+G K + G+ K +K ++R+ + EV L ++H NV
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ + + +L+ E + GG L D + LT + ++ I G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPL----ISEFGFYTMINSANLAQALF---AYKAPE 482
L + H +LK NI + N P I +FG I+ N + +F + APE
Sbjct: 131 ----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 483 AIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542
+ + + D++ +G+I +L+G P G+ + + V++ +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFL----GDTKQETLANVSAV--------NYE 234
Query: 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
E +N+ + + R DP++R+ ++++++
Sbjct: 235 FEDEYFSNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (282), Expect = 2e-28
Identities = 37/292 (12%), Positives = 78/292 (26%), Gaps = 38/292 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
+G G G ++ + + V +K S + E R L + + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYY 68
Query: 376 HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHL 435
+ ++ + G SL LL + + + + +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIH----EK 120
Query: 436 DLPHGNLKSSNIFISPENEPL-----ISEFGFYTMINSANLAQALF-----------AYK 479
L + ++K N I N + +FG Q + Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 480 APEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539
+ + + + D+ LG + + L G P Q L E + + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYERIGEKKQSTPLRE 239
Query: 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591
L P E + + + + ++ +
Sbjct: 240 LCA-------GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (277), Expect = 1e-27
Identities = 55/282 (19%), Positives = 104/282 (36%), Gaps = 26/282 (9%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMK--ESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
E +G G G YKA G T +K+++ + E+ L L+HSN++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 375 YHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAH 434
+ +LV+E++ L + G L + + GI Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCH----D 118
Query: 435 LDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF----AYKAPEAIQ-SGKV 489
+ H +LK N+ I+ E E I++FG Y+AP+ + S K
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 490 TPKCDVYCLGIIILEILTGKFPSQYLTN---------GNGGIDVVEWV-ASAFSEGRVTD 539
+ D++ +G I E++ G ++ G + W + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
+ + + G E +++ + DP QR+ ++A+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 52/291 (17%), Positives = 107/291 (36%), Gaps = 36/291 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRM-KESSAMARDAFDTEVRRLGRLRHSNVLAPLA 374
+G G G A + V V +K++ E++ L R RH N++
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 375 Y----HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT 430
+ + + ++ G L LL L+ + I RG+ Y+H+
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHS 127
Query: 431 ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-------AYKAPEA 483
++ H +LK SN+ ++ + I +FG + + + Y+APE
Sbjct: 128 A----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 484 IQSGKV-TPKCDVYCLGIIILEILTGKFP---------SQYLTNGNGGIDVVEWVASAFS 533
+ + K T D++ +G I+ E+L+ + ++ G +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 534 EGRVTDLLDPE---IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
+ R L P + + P + L++ +P +R+E+ +A+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 3e-27
Identities = 51/268 (19%), Positives = 90/268 (33%), Gaps = 33/268 (12%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAP 372
LG G G + +G +K +K+ + + + E L + H ++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ ++ +YI GG L LL P + + YLH
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLH--- 121
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-AYKAPEAIQSGKVTP 491
D+ + +LK NI + I++FGF + Y APE + +
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
D + GI+I E+L G P + + E + +A +L P +
Sbjct: 181 SIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNA-------ELRFPPFFN---- 225
Query: 552 PGEMEQLLEIGRACTQSDPEQRLEMREA 579
E + ++ D QRL +
Sbjct: 226 ----EDVKDLLSRLITRDLSQRLGNLQN 249
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 50/286 (17%), Positives = 104/286 (36%), Gaps = 31/286 (10%)
Query: 317 EVLGNGGLGSSYKA--MMADGVTVVVKRMKESSAMARDAFDT-----EVRRLGRLRHSNV 369
+G G G +KA + G V +KR++ + T +R L H NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 370 LAPLAYHYRTDEK-----LLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARG 424
+ + LV+E++ YL + ++ + RG
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMFQLLRG 128
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL---FAYKAP 481
+ +LH + H +LK NI ++ + +++FG + + ++ Y+AP
Sbjct: 129 LDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 482 EAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541
E + D++ +G I E+ K + ++ + +++ + E D+
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 542 DPEIASSTNSPGEMEQL--------LEIGRACTQSDPEQRLEMREA 579
P A + S +E+ ++ C +P +R+ A
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (272), Expect = 2e-26
Identities = 48/268 (17%), Positives = 89/268 (33%), Gaps = 35/268 (13%)
Query: 317 EVLGNGGLGSSYKAMMAD-GVTVVVKRMKESSAMARDAFDT------EVRRLGRLRHSNV 369
++G GG G Y AD G +K + + + + + +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 370 LAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLH 429
+ + D+ + + + GG L Y L H + I G+ ++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 430 TELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF--AYKAPEAIQSG 487
+ + + +LK +NI + IS+ G + ++ Y APE +Q G
Sbjct: 125 ----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 488 K-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546
D + LG ++ ++L G P + + D E L +
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFR----QHKTKDKHEIDRMT---------LTMAVE 227
Query: 547 SSTNSPGEMEQLLEIGRACTQSDPEQRL 574
+ E+ LL Q D +RL
Sbjct: 228 LPDSFSPELRSLL---EGLLQRDVNRRL 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 52/281 (18%), Positives = 96/281 (34%), Gaps = 26/281 (9%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM--ARDAFDTEVRRLGRLRHSNVLAPL 373
E +G G G YKA G V +K+++ + E+ L L H N++ L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
+ ++ LV+E++ ++ + P + + +G+ + H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLLQGLAFCH---- 119
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAI-QSGK 488
+ H +LK N+ I+ E +++FG Y+APE +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 489 VTPKCDVYCLGIIILEILTGKFP-------SQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541
+ D++ LG I E++T + Q E V +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 542 DPEIAS---STNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
P+ A S P E + DP +R+ + A
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-26
Identities = 50/278 (17%), Positives = 95/278 (34%), Gaps = 46/278 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDA------FDTEVRRLGRLR--HS 367
+LG+GG GS Y + ++D + V +K +++ EV L ++ S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 368 NVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
V+ L + R D +L+ E L+ +RG L + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRH 125
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQAL--FAYKAPEAI 484
H + + H ++K NI I L + +FG ++ Y PE I
Sbjct: 126 CH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 485 QSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543
+ + V+ LGI++ +++ G P ++ ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------IIRG 219
Query: 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVR 581
++ E + L+ R C P R E
Sbjct: 220 QVFFRQRVSSECQHLI---RWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 6e-26
Identities = 45/284 (15%), Positives = 95/284 (33%), Gaps = 28/284 (9%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMK--ESSAMARDAFDTEVRRLGRLRHSNVLAPL 373
E +G G G+ +KA V +KR++ + + E+ L L+H N++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
+ + LV+E+ Y + + + +G+G+ H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCH---- 118
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN-----LAQALFAYKAPEAIQSGK 488
++ H +LK N+ I+ E ++ FG L+ +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 489 VTPKCDVYCLGIIILEILTGKFPS----------QYLTNGNGGIDVVEWVASAFSEGRVT 538
+ D++ G I E+ P + + G +W +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 539 DLLDPEIASSTNSPGEM-EQLLEIGRACTQSDPEQRLEMREAVR 581
+ P S N ++ ++ + + +P QR+ EA++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 59/271 (21%), Positives = 97/271 (35%), Gaps = 36/271 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDA---FDTEVRRLGRLRHSNVLAP 372
++LG G G A G +K +++ +A+D TE R L RH + A
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
D V EY GG L + L +R + + + I + YLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-----YGAEIVSALEYLH--- 122
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALFA----YKAPEAIQSGK 488
D+ + ++K N+ + + I++FG S F Y APE ++
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 489 VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548
D + LG+++ E++ G+ P D +L EI
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP-------FYNQDHERLFEL---------ILMEEIRFP 225
Query: 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
E + LL + DP+QRL +
Sbjct: 226 RTLSPEAKSLL---AGLLKKDPKQRLGGGPS 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (256), Expect = 2e-24
Identities = 49/264 (18%), Positives = 82/264 (31%), Gaps = 35/264 (13%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAM---ARDAFDTEVRRLGRLRHSNVLAP 372
+ LG G G G +K + + + + E R L + ++
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 373 LAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+V EY+ GG + L + P I YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 433 AHLDLPHGNLKSSNIFISPENEPLISEFGFYT-MINSANLAQALFAYKAPEAIQSGKVTP 491
LDL + +LK N+ I + +++FGF + APE I S
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 492 KCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551
D + LG++I E+ G P F + + + ++
Sbjct: 218 AVDWWALGVLIYEMAAGYPP--------------------FFADQPIQIYEKIVSGKVRF 257
Query: 552 PGEM-EQLLEIGRACTQSDPEQRL 574
P L ++ R Q D +R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-24
Identities = 55/280 (19%), Positives = 103/280 (36%), Gaps = 22/280 (7%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPL 373
+ +G+G G+ A+ G V +K++ S + E+R L +RH NV+ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 374 AYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELA 433
+ ++ + G H++L +V + +G+ Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIH---- 138
Query: 434 HLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS-ANLAQALFAYKAPEAI-QSGKVTP 491
+ H +LK N+ ++ + E I +FG +S Y+APE I + T
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 492 KCDVYCLGIIILEILTGKFP---------SQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542
D++ +G I+ E++TGK + + G E +
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 543 PEIAS---STNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
PE+ ++ + + D EQR+ EA
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 5e-24
Identities = 58/274 (21%), Positives = 106/274 (38%), Gaps = 40/274 (14%)
Query: 317 EVLGNGGLGSSYKAMMA----DGVTVVVKRMKESS----AMARDAFDTEVRRLGRLRHSN 368
+VLG G G + G +K +K+++ A + TE + L +R S
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 369 VLAPLAYHYRTDEKL-LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
L L Y ++T+ KL L+ +YI GG L L + E+ I + +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEH 144
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF-----AYKAPE 482
LH L + + ++K NI + ++++FG + +A Y AP+
Sbjct: 145 LH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 483 AIQSGK--VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540
++ G D + LG+++ E+LTG P +G + ++ +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT----VDGEKNSQAEISRR--------I 248
Query: 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL 574
L E + L+ + DP++RL
Sbjct: 249 LKSEPPYPQEMSALAKDLI---QRLLMKDPKKRL 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 52/291 (17%), Positives = 99/291 (34%), Gaps = 43/291 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLA 374
LG G ++A+ + + VVVK +K + E++ L LR N++
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 375 YHYRTDEKL--LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL 432
+ LV+E++ L LT + I + + Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCH--- 146
Query: 433 AHLDLPHGNLKSSNIFISPENEPL-ISEFGFYTMINSANLAQALF---AYKAPEAIQSGK 488
+ + H ++K N+ I E+ L + ++G + +K PE + +
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 489 -VTPKCDVYCLGIIILEILTGKFP----------SQYLTNGNGGIDVVEWVASAFSE--- 534
D++ LG ++ ++ K P + G D+ +++ E
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 535 ------GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
GR + S N + L+ + D + RL REA
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 2e-22
Identities = 51/296 (17%), Positives = 104/296 (35%), Gaps = 42/296 (14%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVL--- 370
+G G G +KA G V +K++ + E++ L L+H NV+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 371 -----APLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGI 425
Y+ LV+++ L + + E+ ++Q + G+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-----VMQMLLNGL 130
Query: 426 GYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQALF--------A 477
Y+H + H ++K++N+ I+ + +++FG + A +Q
Sbjct: 131 YYIH----RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 478 YKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTN---------GNGGIDVVEW 527
Y+ PE + + P D++ G I+ E+ T Q T G I W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 528 V----ASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
+ + + ++ + L++ DP QR++ +A
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 6e-21
Identities = 52/285 (18%), Positives = 107/285 (37%), Gaps = 32/285 (11%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDA--FDTEVRRLGRLRHSNVLAPL 373
+G+G GS A G+ V VK++ A E+R L ++H NV+ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 374 AY-----HYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYL 428
+ + ++ G L ++ + LT ++ I RG+ Y+
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYI 137
Query: 429 HTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN--LAQALFAYKAPEAIQS 486
H D+ H +LK SN+ ++ + E I +FG + + +
Sbjct: 138 H----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 487 GKVTPKCDVYCLGIIILEILTGKFPSQYLTN-----------GNGGIDVVEWVASAFSEG 535
D++ +G I+ E+LTG+ + G G ++++ ++S +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 536 RVTDLLD-PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREA 579
+ L P++ + G +++ D ++R+ +A
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.6 bits (226), Expect = 1e-20
Identities = 45/311 (14%), Positives = 102/311 (32%), Gaps = 52/311 (16%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAY 375
LG G + + A M + V +K ++ + +A + E++ L R+ ++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 376 HYRTDEKLLVYEYIPGGSLLYL-----------LHGDRGPSHDELTWPARLKIVQGIARG 424
KLL + G + +++ L + H + +I + + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 425 IGYLHTELAHLDLPHGNLKSSNIFISPENEP-LISEFGFYTMINSANLAQALF------A 477
+ Y+H + H ++K N+ + + P + + + N+ +
Sbjct: 138 LDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 478 YKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEW---------- 527
Y++PE + D++ +I E++TG F + + D
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254
Query: 528 -------------------VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQS 568
+ S+ + L D S E +++ + Q
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314
Query: 569 DPEQRLEMREA 579
DP +R +
Sbjct: 315 DPRKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 4e-18
Identities = 47/300 (15%), Positives = 97/300 (32%), Gaps = 47/300 (15%)
Query: 317 EVLGNGGLGSSYKAM-MADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLA-- 371
+ +G+G G A V +K++ + E+ + + H N+++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 372 ----PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGY 427
P + LV E + + ++ + GI +
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134
Query: 428 LHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSANLAQAL---FAYKAPEAI 484
LH+ H +LK SNI + + I +FG ++ + Y+APE I
Sbjct: 135 LHSAGII----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 485 QSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE---------- 534
D++ +G I+ E++ K + V+E + + E
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 535 ------GRVTDLLDPEIASSTNSPGEMEQLLEIG-------RACTQSDPEQRLEMREAVR 581
+ L P++ + P + E DP +R+ + +A++
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.9 bits (190), Expect = 2e-16
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 11/168 (6%)
Query: 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLK----GIVTGLYINSMGL 57
+ +ALL++K N L SW+P+T C W GV+C V L ++ + L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRT---WLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 58 SGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPS 117
+ + L L L +Y+ P ++ L L+ ++ G +P
Sbjct: 63 PKPYPIPS--SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 118 LFKLPHLTELHLESNQFNGTIPS--FDQPTLVRLNLSSNKLEGEIPAS 163
L ++ L L N +GT+P P LV + N++ G IP S
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 3e-13
Identities = 22/80 (27%), Positives = 30/80 (37%), Gaps = 20/80 (25%)
Query: 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPAS 163
NN+ G LP L +L L L++ N G IP
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-------------------- 289
Query: 164 LLRFNASSFSGNAGLCGKNL 183
L RF+ S+++ N LCG L
Sbjct: 290 LQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 14/61 (22%), Positives = 21/61 (34%), Gaps = 2/61 (3%)
Query: 79 YLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTI 138
L N+ G +P G ++ L L S N G + P L +N+
Sbjct: 250 DLRNNRIYGTLPQG-LTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGS 307
Query: 139 P 139
P
Sbjct: 308 P 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 6/65 (9%)
Query: 51 YINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKF 110
+ + + G + LT L+ L ++ + N GEIP + ++NNK
Sbjct: 250 DLRNNRIYGTLP----QGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKC 303
Query: 111 RGRLP 115
P
Sbjct: 304 LCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 4e-14
Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 5/83 (6%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLES 131
L+ L + L N S P + L++L+F+NNK SL L ++ L
Sbjct: 306 LKNLTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 132 NQFNGTIPSFDQPTLVRLNLSSN 154
NQ + P + + +L L+
Sbjct: 361 NQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 4e-11
Identities = 25/142 (17%), Positives = 46/142 (32%), Gaps = 18/142 (12%)
Query: 50 LYINSMGLSGKIDVDALTELTGLR-------------GLRAIYLDKNQFSGEIPPGYFDE 96
L + + +S + LT+LT L+ GL A+ + +
Sbjct: 246 LDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 97 MGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNK 155
+ L L N + L L L +N+ + + S + L+ N+
Sbjct: 306 LKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQ 362
Query: 156 LEGEIP-ASLLRFNASSFSGNA 176
+ P A+L R + A
Sbjct: 363 ISDLTPLANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 2e-08
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLES 131
L L ++ NQ S P G + L +L + N+ + +L L +LT+L L +
Sbjct: 196 LTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 132 NQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
NQ + P L L L +N++ P
Sbjct: 251 NQISNLAPLSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 5/83 (6%)
Query: 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHL 129
T L L K + + ++ + L + + L +LT+++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 73
Query: 130 ESNQFNGTIPSFDQPTLVRLNLS 152
+NQ P + LV + ++
Sbjct: 74 SNNQLTDITPLKNLTKLVDILMN 96
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 2/94 (2%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLES 131
L L + + ++ L L +NN+ P + +L EL L
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNG 228
Query: 132 NQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLL 165
NQ L L+L++N++ P S L
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAPLSGL 262
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 12/66 (18%), Positives = 22/66 (33%), Gaps = 4/66 (6%)
Query: 102 KLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSSNKLEGEI 160
K + + L +T L + +I + L ++N S+N+L
Sbjct: 26 KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDIT 82
Query: 161 PASLLR 166
P L
Sbjct: 83 PLKNLT 88
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 1e-09
Identities = 25/89 (28%), Positives = 34/89 (38%), Gaps = 10/89 (11%)
Query: 85 FSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQP 144
S D +L +L SNNK LP P L L N +P
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPEL-PQ 324
Query: 145 TLVRLNLSSNKLEG--EIPASL--LRFNA 169
L +L++ N L +IP S+ LR N+
Sbjct: 325 NLKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 1e-06
Identities = 17/82 (20%), Positives = 30/82 (36%), Gaps = 11/82 (13%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLES 131
L + + N+ E+P L +L S N +P +L +LH+E
Sbjct: 283 PPSLEELNVSNNKLI-ELP----ALPPRLERLIASFNHL-AEVPELP---QNLKQLHVEY 333
Query: 132 NQFNGTIPSFDQPTLVRLNLSS 153
N P ++ L ++S
Sbjct: 334 NPLR-EFPDI-PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 7e-05
Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPAS 163
+ N + P L EL++ +N+ +P+ P L RL S N L E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL-PPRLERLIASFNHLA-EVPEL 322
Query: 164 L 164
Sbjct: 323 P 323
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 14/59 (23%), Positives = 21/59 (35%), Gaps = 6/59 (10%)
Query: 100 LRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158
+L +N LP PHL L N +P +L L + +N L+
Sbjct: 40 AHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPEL-PQSLKSLLVDNNNLKA 92
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.2 bits (132), Expect = 2e-09
Identities = 22/168 (13%), Positives = 46/168 (27%), Gaps = 31/168 (18%)
Query: 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDA----------FDTEVRRLGRLRH 366
+++G G + + VVK K + F R R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 367 SNVLA----PLAYHYRTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIA 422
+ + Y + ++ E I + +++ I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK------------ELYRVRVENPDEVLDMIL 113
Query: 423 RGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470
+ + H + HG+L N+ +S E +I +F +
Sbjct: 114 EEVAKFY----HRGIVHGDLSQYNVLVSEEGIWII-DFPQSVEVGEEG 156
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 23/94 (24%), Positives = 34/94 (36%), Gaps = 2/94 (2%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQF 134
+ L N+ + I G F + L L NNK P + L L L+L NQ
Sbjct: 33 TALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 135 NGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFN 168
+P TL L + N++ + N
Sbjct: 92 K-ELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 27/120 (22%), Positives = 39/120 (32%), Gaps = 25/120 (20%)
Query: 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRK-----------------------LW 104
L L +YL KNQ E+P + LR L
Sbjct: 74 AFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132
Query: 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASL 164
+ K G + + L+ + + TIP P+L L+L NK+ ASL
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASL 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 21/127 (16%), Positives = 39/127 (30%), Gaps = 33/127 (25%)
Query: 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRL----------------- 114
L ++LD N+ + + + L KL S N
Sbjct: 170 PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 115 ------PPSLFKLPHLTELHLESNQ--------FNGTIPSFDQPTLVRLNLSSNKLE-GE 159
P L ++ ++L +N F + + + ++L SN ++ E
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 160 IPASLLR 166
I S R
Sbjct: 289 IQPSTFR 295
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (126), Expect = 3e-08
Identities = 25/112 (22%), Positives = 42/112 (37%), Gaps = 7/112 (6%)
Query: 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128
GL L + L +N+ + + P F ++G L L+ N +L L L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 129 LESNQFNGTIPSFDQPT-LVRLNLSSNKLEGEIPASL-----LRFNASSFSG 174
L N + + L + SS+++ +P L R A+ G
Sbjct: 232 LNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 24/127 (18%), Positives = 36/127 (28%), Gaps = 27/127 (21%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQF 134
L+ +YL N +P F ++G L L+ N+ + L L L L N+
Sbjct: 131 LQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 135 NGTIPSF--------------------------DQPTLVRLNLSSNKLEGEIPASLLRFN 168
P L L L+ N + A L
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249
Query: 169 ASSFSGN 175
F G+
Sbjct: 250 LQKFRGS 256
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 5e-07
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 93 YFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLS 152
+ L L +NK L LP+L E+HL++NQ + P + L + L+
Sbjct: 168 PLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 13/58 (22%), Positives = 24/58 (41%)
Query: 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIP 161
+ S + L L LT L + N+ + P P L+ ++L +N++ P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 5e-07
Identities = 21/88 (23%), Positives = 28/88 (31%), Gaps = 11/88 (12%)
Query: 88 EIPPGYFDEMGALRKLWFSNNKFRGR----LPPSLFKLPHLTELHLESNQFNGTIP---- 139
E+ G LR LW ++ L +L L EL L +N
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 140 -SFDQPT--LVRLNLSSNKLEGEIPASL 164
S QP L +L L E+ L
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 8e-07
Identities = 11/91 (12%), Positives = 29/91 (31%), Gaps = 11/91 (12%)
Query: 75 LRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR----LPPSLFKLPHLTELHLE 130
++++ + + S + + + + + +L P L EL+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 131 SNQFNGTIPSF-------DQPTLVRLNLSSN 154
SN+ + +L+L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 1e-05
Identities = 15/74 (20%), Positives = 24/74 (32%), Gaps = 7/74 (9%)
Query: 100 LRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQFNG----TIPSFDQ--PTLVRLNLS 152
++ L + L L + L+ I S + P L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 153 SNKLEGEIPASLLR 166
SN+L +L+
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 11/48 (22%), Positives = 16/48 (33%), Gaps = 1/48 (2%)
Query: 88 EIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFN 135
E+P G + + L L N +P F L L N +
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 21/70 (30%), Positives = 25/70 (35%), Gaps = 3/70 (4%)
Query: 89 IPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPS--FDQPTL 146
+PPG L KL +NN L L +L L L+ N TIP F L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 147 VRLNLSSNKL 156
L N
Sbjct: 198 PFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 14/73 (19%), Positives = 23/73 (31%), Gaps = 4/73 (5%)
Query: 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQ 133
+ DK + +PP + L S N +L LT+L+L+ +
Sbjct: 11 SHLEVNCDKRNLT-ALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 134 FNGTIPSFDQPTL 146
P L
Sbjct: 67 LTKLQVDGTLPVL 79
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 1e-05
Identities = 26/98 (26%), Positives = 33/98 (33%), Gaps = 9/98 (9%)
Query: 66 LTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRL-PPSLFKLPHL 124
L L L + + L N+ + ALR L + LP L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRA-----LPPALAALRCLEVLQASDNALENVDGVANLPRL 67
Query: 125 TELHLESNQFNG--TIPSFDQ-PTLVRLNLSSNKLEGE 159
EL L +N+ I P LV LNL N L E
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 8e-04
Identities = 8/53 (15%), Positives = 15/53 (28%), Gaps = 3/53 (5%)
Query: 78 IYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR--LPPSLFK-LPHLTEL 127
+ L N+ L L N + L + LP ++ +
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.002
Identities = 9/41 (21%), Positives = 15/41 (36%), Gaps = 2/41 (4%)
Query: 101 RKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF 141
R L ++ L +L +T L L N+ P+
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPAL 39
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 4e-05
Identities = 11/61 (18%), Positives = 19/61 (31%), Gaps = 5/61 (8%)
Query: 83 NQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFK-LPHLTELHLESNQFNGTIPSF 141
N E+P F L S + LP + L L + + +P+
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLK---KLPTL 241
Query: 142 D 142
+
Sbjct: 242 E 242
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 3e-04
Identities = 15/76 (19%), Positives = 24/76 (31%), Gaps = 10/76 (13%)
Query: 78 IYLDKNQFSGEIPPGYFDEMG-----ALRKLWFSNNKFRGR----LPPSLF-KLPHLTEL 127
+ L+ S D L+ L N+ L + K+P L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 128 HLESNQFNGTIPSFDQ 143
L N+F+ D+
Sbjct: 308 ELNGNRFSEEDDVVDE 323
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 26/151 (17%), Positives = 39/151 (25%), Gaps = 33/151 (21%)
Query: 48 TGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRK----- 102
+GL G D+L L G L +Y++ Q + +G LR
Sbjct: 11 SGLRCTRDGAL-----DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 103 -------------------LWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQ 143
L S N L + L EL L N + +
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 144 PTLVRLN---LSSNKLEGEIPASLLRFNASS 171
+ KL+ L +S
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 10/40 (25%), Positives = 14/40 (35%), Gaps = 2/40 (5%)
Query: 115 PPSLFKLPHLTELHLESNQFNGTIPSFDQ-PTLVRLNLSS 153
L L L L+L N + + + L L L S
Sbjct: 171 IVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 621 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.55 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.54 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.38 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.31 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.24 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.18 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.15 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.09 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.07 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.02 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.02 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.01 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.0 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.85 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.81 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.72 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.7 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.67 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.62 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.6 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.49 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.47 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.41 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.36 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.32 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.87 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.67 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.44 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.28 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.17 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.04 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.16 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.4 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 81.4 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=411.55 Aligned_cols=248 Identities=20% Similarity=0.343 Sum_probs=198.0
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|++++++++|||||+++|+|.+.+..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 36799999999999999889999999997543 34678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-----c
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-----N 470 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-----~ 470 (621)
+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 89 ~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 89 DYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 998753 24589999999999999999999999 9999999999999999999999999999876443 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTN 550 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 550 (621)
...+|..|+|||++.+..|+.++|||||||++|||+|+..|+... ....++.+.+ ..+.. ...|
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i----~~~~~--~~~p------- 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDI----STGFR--LYKP------- 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHH----HHTCC--CCCC-------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC---CCHHHHHHHH----HhcCC--CCCc-------
Confidence 245678899999999999999999999999999999965444321 1112222222 22211 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 551 SPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
...++++.+|+.+||+.||++||||+|++++|++|.++
T Consensus 225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 22335789999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=414.07 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=200.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|++. ..||||+++.. .....+.|.+|+++|++++|||||++++++. .+..++|||||++|
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGS 88 (276)
T ss_dssp CCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence 3468999999999999864 36999998643 3445678999999999999999999999874 45689999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.++++... ..+++..++.++.||++||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 89 SLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999997533 4589999999999999999999998 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 ---NLAQALFAYKAPEAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ...+......+... |
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~----p 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIFMVGRGYLS----P 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHHTSCC----C
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCC----C
Confidence 23467899999999864 3589999999999999999999999974321 11222222222211 1
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..... ....++.+.+|+.+||+.||++|||++|++++|+.+..+
T Consensus 230 ~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DLSKV--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CGGGS--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cchhc--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11110 123346789999999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=409.68 Aligned_cols=241 Identities=23% Similarity=0.336 Sum_probs=202.2
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..++|||||
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeec
Confidence 45678999999999999964 68999999986432 233567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 89 PLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred CCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999743 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+ +...+...... .
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~----~~~~i~~~~~~------~-- 223 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQE----TYKRISRVEFT------F-- 223 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHH----HHHHHHTTCCC------C--
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC----HHH----HHHHHHcCCCC------C--
Confidence 44568999999999999999999999999999999999999996421 111 12222222110 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+...++++.+|+.+||+.||++|||++|+++|
T Consensus 224 ---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 12234678999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=411.30 Aligned_cols=242 Identities=22% Similarity=0.362 Sum_probs=203.4
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+|||||++|+
T Consensus 24 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 346799999999999984 5699999999876555557789999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 104 LTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred HHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9998864 3489999999999999999999999 9999999999999999999999999999887433
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+.+......+.. .. .
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~~~~~~~~-~~--------~ 237 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNGTP-EL--------Q 237 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHCSC-CC--------S
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCCC-CC--------C
Confidence 34458899999999999999999999999999999999999996421 11222222222211 11 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+......+.+|+.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112334678999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-51 Score=412.72 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=205.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|.+. +++.||||+++... ...+.|.+|+++|++++|||||+++++|.+.+..++|||||++|+
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 4567999999999999965 58899999997543 346779999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc---
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN--- 470 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 470 (621)
|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 100 LLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp HHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred hHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999997543 35689999999999999999999999 99999999999999999999999999998765432
Q ss_pred --cccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 471 --LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 471 --~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
...+++.|+|||++.+..|+.++|||||||++|||++|..|+.... . . ..+...+..+.. +.
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~---~-~~~~~~i~~~~~-----~~---- 236 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---D---L-SQVYELLEKDYR-----ME---- 236 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---C---H-HHHHHHHHTTCC-----CC----
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---h---H-HHHHHHHhcCCC-----CC----
Confidence 2346778999999999999999999999999999999877765311 1 1 112222222211 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.+...++++.+|+.+||+.||++|||++|+++.|+.+..
T Consensus 237 -~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112334678999999999999999999999999988754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-51 Score=410.64 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=196.7
Q ss_pred HHHcCcCCcccEEEEEEcC-C---cEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMMAD-G---VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.||+|+||.||+|.... + ..||||.+... .....+.|.+|+++|++++|||||++++++.+.+..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 3679999999999998642 3 36899998654 44456789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccccc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSAN 470 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 470 (621)
+|+|.+++.... ..+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999887532 4589999999999999999999998 99999999999999999999999999998764321
Q ss_pred ---------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 471 ---------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 471 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
...+|+.|||||.+.+..++.++|||||||++|||+| |+.||.... ..++... +..+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~~~~~----i~~~~~~-- 252 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQDVINA----IEQDYRL-- 252 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHH----HHTTCCC--
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC----HHHHHHH----HHcCCCC--
Confidence 1235778999999999999999999999999999998 899987422 1222222 2222110
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
..+...+..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 253 --------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 --------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11223446789999999999999999999999999988653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=409.02 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=203.0
Q ss_pred HHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||++++++. .+..++||||+++|+
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCc
Confidence 3457899999999999999888999999997543 34678999999999999999999999875 456799999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++.... ...+++.++++|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 94 L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 94 LVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp HHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred HHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999876432 23589999999999999999999998 9999999999999999999999999999887543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+|+.|+|||++.+..++.++|||||||++|||+||..|+... ....++. ..+..+.. +.
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~---~~~~~~~----~~i~~~~~-----~~---- 230 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG---MTNPEVI----QNLERGYR-----MV---- 230 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHH----HHHHTTCC-----CC----
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC---CCHHHHH----HHHHhcCC-----CC----
Confidence 2345678899999999889999999999999999999976665421 1111222 22222211 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.+...++++.+|+.+||+.||++||||+|+++.|+++..
T Consensus 231 -~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 112334578999999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=403.17 Aligned_cols=243 Identities=20% Similarity=0.315 Sum_probs=196.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..|+|||||++|
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 346899999999999996 469999999986543 233567899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 89 ELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999963 34699999999999999999999999 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ---NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....||+.|||||++.+..+ +.++|||||||++|||+||+.||..... .... ... .......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~---~~~-~~~~~~~------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQE---YSD-WKEKKTY------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST---TSHH---HHH-HHTTCTT-------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh---HHHH---HHH-HhcCCCC-------
Confidence 33568999999999988776 5789999999999999999999974221 1111 111 1111100
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+++.+|+.+||+.||++|||++|+++|
T Consensus 226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00112334678899999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=411.00 Aligned_cols=245 Identities=19% Similarity=0.302 Sum_probs=203.0
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|+. .+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++|||||++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 3456899999999999995 468999999998666566678999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|.+++.+. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 ~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 95 AVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999997643 23589999999999999999999999 9999999999999999999999999999876432
Q ss_pred -ccccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 -NLAQALFAYKAPEAIQ-----SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....||+.|+|||++. +..|+.++|||||||++|||+||+.||.... ..+....+ .. +......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~----~~~~~~~i---~~-~~~~~~~-- 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN----PMRVLLKI---AK-SEPPTLA-- 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC----GGGHHHHH---HH-SCCCCCS--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHH---Hc-CCCCCCC--
Confidence 3466899999999984 4568999999999999999999999997422 22222221 11 1111111
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.+...++++.+|+.+||+.||++|||++|+++|
T Consensus 237 ------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 ------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112334678999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=396.42 Aligned_cols=244 Identities=20% Similarity=0.383 Sum_probs=204.9
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+.+..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 467999999999999998889999999986443 4578999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-----c
Q 045652 396 YLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-----N 470 (621)
Q Consensus 396 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-----~ 470 (621)
+++... ...+++..+++++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.+... .
T Consensus 88 ~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 88 NYLREM----RHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred Hhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 998643 34688999999999999999999998 9999999999999999999999999999876443 2
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 471 LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 471 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
...+|..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+ +...+..+.. ...|
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~----~~~----~~~~i~~~~~--~~~p------ 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT----NSE----TAEHIAQGLR--LYRP------ 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHH----HHHHHHTTCC--CCCC------
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC----HHH----HHHHHHhCCC--CCCc------
Confidence 2446788999999999999999999999999999998 899987432 112 2222222211 1111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
...++++.+|+.+||+.||++|||++|++++|.+|
T Consensus 224 --~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 --HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22335789999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=404.13 Aligned_cols=249 Identities=19% Similarity=0.290 Sum_probs=190.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--CCeeEEEEeec
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--TDEKLLVYEYI 389 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 389 (621)
+.+.||+|+||.||+|+. .+|+.||||.++.. .....+.+.+|++++++++|||||++++++.+ .+..|+|||||
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 346899999999999985 56899999998654 34456778999999999999999999999865 35578999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc-CCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL-AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
++|+|.+++..... ....+++..++.++.||+.||+|||++. ...+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999864221 1346999999999999999999999871 112499999999999999999999999999987654
Q ss_pred c----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 469 A----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 469 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
. ....+|+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+ +...+..+....+
T Consensus 167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~----~~~----~~~~i~~~~~~~~---- 234 (269)
T d2java1 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKE----LAGKIREGKFRRI---- 234 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHH----HHHHHHHTCCCCC----
T ss_pred CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC----HHH----HHHHHHcCCCCCC----
Confidence 3 33568899999999999999999999999999999999999996421 112 2222232322111
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+...++++.+|+.+||+.||++|||+.|+++|
T Consensus 235 ------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 ------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 12234578999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=396.52 Aligned_cols=240 Identities=22% Similarity=0.372 Sum_probs=194.2
Q ss_pred HHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe----CCeeEEEEeec
Q 045652 317 EVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR----TDEKLLVYEYI 389 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 389 (621)
+.||+|+||+||+|... +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....++|||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 46999999999999954 5889999998643 34456779999999999999999999999876 24478999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCC--CccCCCCCCCEEeC-CCCCcEEEeeecceec
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLD--LPHGNLKSSNIFIS-PENEPLISEFGFYTMI 466 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~ 466 (621)
++|+|.+++.+. ..+++..++.++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++..
T Consensus 95 ~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~----~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 95 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHC----CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999743 4589999999999999999999998 6 99999999999997 5789999999999865
Q ss_pred ccc--ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 467 NSA--NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 467 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
... ....||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+...+..+.... .
T Consensus 166 ~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~~~~----~ 233 (270)
T d1t4ha_ 166 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA----S 233 (270)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG----G
T ss_pred cCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHHcCCCCc----c
Confidence 443 34578999999999875 699999999999999999999999963211 112222222221111 1
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ....+++.+|+.+||+.||++|||++|+++|
T Consensus 234 ~~-----~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG-----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 1123468899999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=400.10 Aligned_cols=244 Identities=20% Similarity=0.372 Sum_probs=201.7
Q ss_pred HcCcCCcccEEEEEEc---CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 318 VLGNGGLGSSYKAMMA---DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.||+|+||.||+|.+. ++..||||+++.. .....+.|.+|+++|++++|||||++++++.. +..++|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 3999999999999753 3568999999754 34456789999999999999999999999864 56899999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 95 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 99998643 24699999999999999999999999 9999999999999999999999999999876543
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..++.. .+..+...+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~----~~~~~~----~i~~~~~~~------ 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEVMA----FIEQGKRME------ 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----THHHHH----HHHTTCCCC------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC----HHHHHH----HHHcCCCCC------
Confidence 22346788999999998999999999999999999998 899997432 222222 233322111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.++..++++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 233 ----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112344678999999999999999999999999987754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-50 Score=408.97 Aligned_cols=244 Identities=25% Similarity=0.319 Sum_probs=202.9
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
|...+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 34457899999999999985 568999999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
|++|+|..++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 97 CLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred cCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999877653 24589999999999999999999999 999999999999999999999999999998887
Q ss_pred cccccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccch
Q 045652 469 ANLAQALFAYKAPEAIQS---GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEI 545 (621)
Q Consensus 469 ~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 545 (621)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.... ..+.+........ ....
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-------~~~~~~~i~~~~~-~~~~---- 235 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNES-PALQ---- 235 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCC-CCCS----
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCC-CCCC----
Confidence 778889999999999864 468999999999999999999999986421 1222222222211 1111
Q ss_pred hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 546 ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....++.+.+|+.+||+.||++|||++|+++|
T Consensus 236 -----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 -----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11234578999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=401.57 Aligned_cols=243 Identities=21% Similarity=0.347 Sum_probs=197.8
Q ss_pred HHcCcCCcccEEEEEEcC---CcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 317 EVLGNGGLGSSYKAMMAD---GVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
++||+|+||.||+|.+.+ ++.||||+++.. +....+.|.+|+++|++++|||||+++++|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998543 568999999643 23346789999999999999999999999864 567899999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
|+|.++++.. ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999999743 4589999999999999999999999 9999999999999999999999999999876432
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP 543 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 543 (621)
....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+ +...+..+....
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~~~----~~~~i~~~~~~~---- 230 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSE----VTAMLEKGERMG---- 230 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHH----HHHHHHTTCCCC----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC----HHH----HHHHHHcCCCCC----
Confidence 22357789999999999999999999999999999998 899987422 112 222233322111
Q ss_pred chhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhh
Q 045652 544 EIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQ 587 (621)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 587 (621)
.+...+.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 231 ------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 ------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11233467899999999999999999999999887653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=416.31 Aligned_cols=260 Identities=19% Similarity=0.303 Sum_probs=201.0
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+.+..++|||||++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 456899999999999995 56899999998754 3344678899999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
+|.+++.+. ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 160 (322)
T d1s9ja_ 90 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160 (322)
T ss_dssp EHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHH----CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhC----CEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence 999999743 358999999999999999999996 5 7999999999999999999999999999876432
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh----------------
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS---------------- 533 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------------- 533 (621)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ............
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK---ELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT---HHHHHC----------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhcCCcccCCcccccccccc
Confidence 4457899999999999999999999999999999999999999753211 000000000000
Q ss_pred -----cCc----cccccccchh---cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHh
Q 045652 534 -----EGR----VTDLLDPEIA---SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEI 586 (621)
Q Consensus 534 -----~~~----~~~~~d~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i 586 (621)
... ..+..+.... ..........++.+|+.+||+.||++|||++|+++| +++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000 0000000000 000001123578999999999999999999999987 5443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=398.29 Aligned_cols=249 Identities=22% Similarity=0.381 Sum_probs=198.4
Q ss_pred HHHcCcCCcccEEEEEEcCC-----cEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 316 AEVLGNGGLGSSYKAMMADG-----VTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.++||+|+||.||+|.+.+. ..||||+++.. .......|.+|++++++++|||||+++|++.+.+..++|||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 36799999999999986542 47999998754 3444567999999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
.++++.+++.... ..+++.++++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999886532 4699999999999999999999999 9999999999999999999999999999876432
Q ss_pred -------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 -------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....+|+.|+|||++.+..++.++|||||||++|||++|..|+.... ...++ ...+..+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~----~~~i~~~~~----- 231 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEV----MKAINDGFR----- 231 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH----HHHHHTTCC-----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CHHHH----HHHHhccCC-----
Confidence 12346788999999999999999999999999999999766654311 11122 222222211
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
+ ..+...+..+.+|+.+||+.||++||||.||++.|+++...
T Consensus 232 ~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 L-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp C-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C-----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 11123446789999999999999999999999999988754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-50 Score=405.05 Aligned_cols=244 Identities=20% Similarity=0.301 Sum_probs=186.4
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..|+|||||+||
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 4578999999999999964 68999999987543 233456889999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC---CCCCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS---PENEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~~ 469 (621)
+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 93 ~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 93 ELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp BHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred cHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999974 34699999999999999999999999 999999999999995 5789999999999876543
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..++... +..+... . .
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~----i~~~~~~-~-~---- 229 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAKLFEQ----ILKAEYE-F-D---- 229 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHH----HHTTCCC-C-C----
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HHHHHHH----HhccCCC-C-C----
Confidence 34568999999999999999999999999999999999999996421 1122221 2211110 0 0
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
....+..++++.+|+.+||+.||++|||++|+++|
T Consensus 230 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 -SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01112344678999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-49 Score=409.14 Aligned_cols=246 Identities=20% Similarity=0.349 Sum_probs=204.8
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||++|
T Consensus 29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 108 (350)
T d1koaa2 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 108 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3457899999999999995 569999999998777677788999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC--CCCcEEEeeecceecccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP--ENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~- 469 (621)
+|.+++... ...+++.++..|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 109 ~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 109 ELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp BHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999643 24599999999999999999999999 9999999999999964 678999999999887554
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|+.|||||++.+..|+.++|||||||++|||+||+.||... ...+....+ . ..... . .+..
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i---~-~~~~~-~-~~~~-- 248 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLRNV---K-SCDWN-M-DDSA-- 248 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHH---H-HTCCC-S-CCGG--
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC----CHHHHHHHH---H-hCCCC-C-Cccc--
Confidence 3456899999999999999999999999999999999999999642 112222222 1 11110 0 0000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.....+++.+|+.+||+.||++|||++|+++|
T Consensus 249 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 ---FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12234678999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=399.44 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=201.0
Q ss_pred HHHHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 313 KAAAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g 96 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 96 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCC
Confidence 34567899999999999999888899999997543 34678999999999999999999999984 56689999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
+|..++.... ...++|.+++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 97 ~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 97 SLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp BHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred chhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999886432 23589999999999999999999999 9999999999999999999999999999876433
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|+.|+|||++.+..++.++|||||||++|||+||..|+.... ...++...+ ..+.. +
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~---~~~~~~~~i----~~~~~-----~---- 233 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV----ERGYR-----M---- 233 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHH----HTTCC-----C----
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---CHHHHHHHH----HhcCC-----C----
Confidence 22457788999999999999999999999999999999777765311 112222222 22111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
......++++.+++.+||+.||++|||+++|++.|+.....
T Consensus 234 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11123346789999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-49 Score=407.67 Aligned_cols=246 Identities=19% Similarity=0.325 Sum_probs=204.8
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..|+|||||++|
T Consensus 32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 111 (352)
T d1koba_ 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 111 (352)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3457899999999999995 569999999998766666778999999999999999999999999999999999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeC--CCCCcEEEeeecceecccc-
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFIS--PENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~~~~~- 469 (621)
+|.+++... ...+++.+++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 112 ~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 112 ELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp BHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred hHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999887643 24589999999999999999999999 999999999999998 6789999999999987654
Q ss_pred --ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhc
Q 045652 470 --NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIAS 547 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 547 (621)
....+|+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+....+ ..+... ..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~i----~~~~~~--~~----- 248 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQNV----KRCDWE--FD----- 248 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHH----HHCCCC--CC-----
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH----HhCCCC--CC-----
Confidence 33568889999999999999999999999999999999999996421 11222222 111110 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 548 STNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.......++++.+|+.+||+.||++|||+.|+++|
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112344678999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=403.16 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=199.5
Q ss_pred HHHHHcCcCCcccEEEEEEcC-C-----cEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD-G-----VTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (621)
.+.+.||+|+||+||+|+... + ..||+|.+... .......+.+|+.+|.++ +|||||++++++.+.+..++|
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 345789999999999998533 2 37999998643 333456789999999998 899999999999999999999
Q ss_pred EeecCCCChhHHhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCE
Q 045652 386 YEYIPGGSLLYLLHGDRGP------------------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNI 447 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NI 447 (621)
||||++|+|.++++..+.. ....+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDlKp~Ni 195 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNV 195 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCchhcc
Confidence 9999999999999754321 123589999999999999999999999 999999999999
Q ss_pred EeCCCCCcEEEeeecceeccccc------cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCC
Q 045652 448 FISPENEPLISEFGFYTMINSAN------LAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNG 520 (621)
Q Consensus 448 ll~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~ 520 (621)
|++.++.+||+|||+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~--- 272 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--- 272 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH---
Confidence 99999999999999998764432 3446889999999999999999999999999999998 8999874321
Q ss_pred CcchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHH
Q 045652 521 GIDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIV 584 (621)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 584 (621)
. +.+...+..+.. +. .+...++++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~----~~~~~~~~~~~~-----~~-----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D----ANFYKLIQNGFK-----MD-----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S----HHHHHHHHTTCC-----CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----HHHHHHHhcCCC-----CC-----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 112222222211 11 11233467999999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=397.66 Aligned_cols=241 Identities=17% Similarity=0.213 Sum_probs=199.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.+.+..|+|||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 457899999999999996 569999999986432 2335678999999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 92 gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 92 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999998743 4689999999999999999999999 9999999999999999999999999999876432
Q ss_pred -----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 470 -----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 470 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||... ...++. ..+..+.. .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~----~~i~~~~~------~ 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEYLIF----QKIIKLEY------D 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHH----HHHHTTCC------C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CHHHHH----HHHHcCCC------C
Confidence 2346899999999999999999999999999999999999999742 111222 22222211 0
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRI 583 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 583 (621)
+ +....+++.+|+.+||+.||++|||++|++.+-
T Consensus 229 ~-----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 229 F-----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp C-----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred C-----CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 1 112345789999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=390.30 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=196.0
Q ss_pred HHHHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-CeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-DEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|++++++++||||++++|++.+. +..++||||+++|+
T Consensus 11 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 346799999999999998 57899999997543 457799999999999999999999998654 56799999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-ccc
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-NLA 472 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~ 472 (621)
|.+++.... ...+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 88 L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 88 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 999996432 23589999999999999999999998 9999999999999999999999999999876443 345
Q ss_pred cccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCCCC
Q 045652 473 QALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASSTNS 551 (621)
Q Consensus 473 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 551 (621)
.++..|+|||++.+..+++++|||||||++|||+| |+.||... ...++...+ ..+.. +.. +
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~~i----~~~~~-----~~~-----~ 222 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRV----EKGYK-----MDA-----P 222 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHHH----TTTCC-----CCC-----C
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC----CHHHHHHHH----HcCCC-----CCC-----C
Confidence 56788999999998999999999999999999998 67776532 222333332 22211 111 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 552 PGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
...++++.+|+.+||+.||++|||+.|++++|++++.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2233678999999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=392.70 Aligned_cols=248 Identities=19% Similarity=0.349 Sum_probs=195.0
Q ss_pred HHHHHcCcCCcccEEEEEEcC----CcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 314 AAAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
.+.+.||+|+||.||+|.+.. +..||||.++.. .....+.|.+|++++++++|||||++++++. .+..++||||
T Consensus 10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~ 88 (273)
T d1mp8a_ 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 88 (273)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEe
Confidence 345789999999999998532 457999998743 3445678999999999999999999999985 5678999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+++|+|.+++.... ..+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 89 CTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp CTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999876433 4689999999999999999999999 999999999999999999999999999987643
Q ss_pred c-----ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 469 A-----NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 469 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
. ....+|+.|+|||++.+..++.++|||||||++|||+| |..||.... ..++...+ ..+....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~----~~~~~~~i----~~~~~~~--- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGRI----ENGERLP--- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHH----HTTCCCC---
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC----HHHHHHHH----HcCCCCC---
Confidence 2 23456788999999999999999999999999999998 888886422 22333322 2222111
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.++..++.+.+|+.+||+.||++|||+.|++++|+.+.+
T Consensus 230 -------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 230 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122344679999999999999999999999999998864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=393.35 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=200.7
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC------hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEE
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS------AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (621)
.+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (293)
T d1jksa_ 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 92 (293)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4457899999999999996 569999999986321 224678999999999999999999999999999999999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC----CcEEEeeec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN----EPLISEFGF 462 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~ 462 (621)
|||++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 93 E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 93 ELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999743 3589999999999999999999999 999999999999999877 499999999
Q ss_pred ceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 463 YTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 463 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.... +......
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~----i~~~~~~- 234 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLAN----VSAVNYE- 234 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH----HHTTCCC-
T ss_pred hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----HHHHHHH----HHhcCCC-
Confidence 9887543 33567889999999999999999999999999999999999997421 1122211 2221110
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+... +..+..+.+|+.+||+.||++|||++|+++|
T Consensus 235 -~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 -FEDEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -CCHHHH-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCchhc-----CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001110 1223568899999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=388.59 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=202.7
Q ss_pred HHcCcCCcccEEEEEEcC----CcEEEEEEccC-CChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-CeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMMAD----GVTVVVKRMKE-SSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-DEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~ 390 (621)
++||+|+||+||+|.+.+ ...||||+++. ......+.|.+|+++|++++||||++++|++.+. +..++|||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 569999999999998643 23689999974 3455568899999999999999999999998764 57899999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.++++.. ...+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 113 ~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 113 HGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred cCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998753 34578889999999999999999999 9999999999999999999999999999876432
Q ss_pred -------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccc
Q 045652 470 -------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLD 542 (621)
Q Consensus 470 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 542 (621)
....+|+.|+|||.+.+..++.++||||||+++|||+||..||.... ...++...+ ..+.. ...
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~---~~~~~~~~i----~~g~~--~~~ 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYL----LQGRR--LLQ 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH----HTTCC--CCC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC---CHHHHHHHH----HcCCC--CCC
Confidence 22346788999999999999999999999999999999888876422 112222222 22211 111
Q ss_pred cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 543 PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
| ...++.+.+|+.+||+.||++||+|.||+++|+++.....
T Consensus 256 p--------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 256 P--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred c--------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 1 2233578999999999999999999999999999987533
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-48 Score=395.37 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=201.5
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeec
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYI 389 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (621)
.+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..|+|||||
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 3457899999999999995 569999999986432 223567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc
Q 045652 390 PGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA 469 (621)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 469 (621)
+||+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 87 EGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred CCcccccccccc-----ccccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999998743 4578889999999999999999999 9999999999999999999999999999887544
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+..... ..+...
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i-~~~~~~---------- 219 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKI-LNAELR---------- 219 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHH-HHCCCC----------
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-------HHHHHHHH-HcCCCC----------
Confidence 45678999999999999999999999999999999999999997421 11222222 121110
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
.++..++++.+++.+||..||.+|+ |++|+++|
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0122335689999999999999996 89999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=391.15 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=204.1
Q ss_pred HHHHcCcCCcccEEEEEEc------CCcEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKESS-AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|++. +++.||||+++... ....+.|.+|+++|++++||||+++++++...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 4567999999999999853 35789999997543 3446779999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEE
Q 045652 388 YIPGGSLLYLLHGDRG-------------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIF 448 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIl 448 (621)
|+++|+|.++++.... .....+++..++.|+.|++.||+|||++ +||||||||+|||
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ivHrDlKp~NIL 172 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL 172 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----CeEeeEEcccceE
Confidence 9999999999964321 1223589999999999999999999999 9999999999999
Q ss_pred eCCCCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCcccCCCCC
Q 045652 449 ISPENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK-FPSQYLTNGNGG 521 (621)
Q Consensus 449 l~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~ 521 (621)
++.++.+||+|||+++..... ....+++.|+|||.+.+..|+.++|||||||++|||++|. .||... ..
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~----~~ 248 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM----AH 248 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC----CH
Confidence 999999999999999866432 2344677899999999999999999999999999999986 455532 11
Q ss_pred cchHHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 522 IDVVEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
.++. ..+..+.... .+...++++.+|+.+||+.||++||||.||++.|++|.+
T Consensus 249 ~e~~----~~v~~~~~~~----------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 EEVI----YYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHH----HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHH----HHHHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2222 2233332211 112334678999999999999999999999999998853
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=390.65 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=199.8
Q ss_pred HHcCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC----eeEEEEeecCCC
Q 045652 317 EVLGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD----EKLLVYEYIPGG 392 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g 392 (621)
+.||+|+||.||+|++ +|+.||||+++... .....++.|+..+.+++|||||++++++.+.+ ..++|||||++|
T Consensus 9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 5699999999999987 68999999987433 22233445566667789999999999998754 578999999999
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc----CCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTEL----AHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+|.+++++. .++|..+++++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999742 4899999999999999999999631 123899999999999999999999999999987643
Q ss_pred c--------ccccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCC-------cchHHH
Q 045652 469 A--------NLAQALFAYKAPEAIQSG------KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGG-------IDVVEW 527 (621)
Q Consensus 469 ~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~-------~~~~~~ 527 (621)
. ....+|+.|+|||++.+. .++.++|||||||++|||+||..||......... ....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 2 234578999999998754 2678999999999999999999887543221111 011222
Q ss_pred HHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccC
Q 045652 528 VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSD 590 (621)
Q Consensus 528 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 590 (621)
+........ .+|.+............+.+|+.+||+.||++|||+.||+++|+++.+..
T Consensus 241 ~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 241 MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 233332222 22222222223456677999999999999999999999999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=391.22 Aligned_cols=240 Identities=21% Similarity=0.265 Sum_probs=200.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..|+|||||+
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence 357899999999999995 569999999987432 2235678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 89 GGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp TCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999753 3588999999999999999999999 9999999999999999999999999999876432
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ...+ ...+..+.+. .
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~----~~~i~~~~~~------~- 224 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERL----FELILMEEIR------F- 224 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHH----HHHHHHCCCC------C-
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHHH----HHHHhcCCCC------C-
Confidence 34568999999999999999999999999999999999999997421 1112 2222222110 1
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
+....+++.+|+.+||++||++||+ ++|+++|
T Consensus 225 ----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1223457899999999999999994 8889876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-48 Score=385.63 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=199.5
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCe----eEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDE----KLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~ 386 (621)
+.+.||+|+||.||+|+. .+|+.||||+++.. +....+.+.+|++++++++||||+++++++...+. .|+||
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence 346799999999999995 56999999999743 23445678999999999999999999999887543 78999
Q ss_pred eecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceec
Q 045652 387 EYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMI 466 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 466 (621)
||++|++|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+...
T Consensus 91 E~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhhhhh
Confidence 999999999988743 4689999999999999999999999 9999999999999999999999999988765
Q ss_pred ccc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 467 NSA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 467 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
... ....||+.|+|||++.+..+++++|||||||++|||+||+.||... ...+............
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-------~~~~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPIP- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHCCCCC-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-------CHHHHHHHHHhcCCCC-
Confidence 322 2345789999999999999999999999999999999999999642 1222223333322211
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-cHHHHHHHHHHhhc
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-EMREAVRRIVEIQQ 588 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~~ 588 (621)
+.. ..+..++++.+++.+||+.||++|| |++++++.|.++++
T Consensus 234 ---~~~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 ---PSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ---GGG----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ---Cch----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 100 0122346789999999999999999 89999999988763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=392.70 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=193.9
Q ss_pred HHHHHcCcCCcccEEEEEEc------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCC-eeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTD-EKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~l 384 (621)
.+.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++++...+ ..++
T Consensus 16 ~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~i 95 (299)
T d1ywna1 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 95 (299)
T ss_dssp EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEE
Confidence 34578999999999999853 2468999999753 334456788888888877 6899999999887654 5789
Q ss_pred EEeecCCCChhHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC
Q 045652 385 VYEYIPGGSLLYLLHGDRG-----------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~ 453 (621)
|||||++|+|.++++.... .....+++.+++.++.||++||+|||++ +|+||||||+|||++.++
T Consensus 96 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 96 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGG
T ss_pred EEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcCCccceeECCCC
Confidence 9999999999999975431 1124589999999999999999999999 999999999999999999
Q ss_pred CcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCcccCCCCCcchHH
Q 045652 454 EPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK-FPSQYLTNGNGGIDVVE 526 (621)
Q Consensus 454 ~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~ 526 (621)
.+||+|||+|+..... ....||+.|+|||++.+..++.++|||||||++|||+||. .||.... ..+
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-------~~~ 244 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------IDE 244 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------CSH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-------HHH
Confidence 9999999999865432 2345788999999999999999999999999999999975 5665321 112
Q ss_pred HHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 527 WVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 527 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.+...+..+..... +...++++.+++.+||+.||++|||++|++++|+++.++
T Consensus 245 ~~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 EFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 22223333221111 122345789999999999999999999999999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=389.98 Aligned_cols=247 Identities=22% Similarity=0.373 Sum_probs=197.6
Q ss_pred HHHHcCcCCcccEEEEEEc-CCc----EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGV----TVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (621)
+.++||+|+||.||+|.+. +|+ .||+|+++.. .....+.|.+|++++++++|||||+++++|.+. ..+++|||
T Consensus 13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~ 91 (317)
T d1xkka_ 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 91 (317)
T ss_dssp EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEe
Confidence 4578999999999999853 343 6899988643 334567899999999999999999999999764 56788999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+.+|+|.+++... ...+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 92 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp CTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred ccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 9999999988753 34689999999999999999999999 999999999999999999999999999987643
Q ss_pred c------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccccc
Q 045652 469 A------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL 541 (621)
Q Consensus 469 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (621)
. ....+|+.|+|||++.+..|+.++|||||||++|||+| |..||.... ..++... +..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----~~~~~~~----i~~~~~~--- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSI----LEKGERL--- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----GGGHHHH----HHHTCCC---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC----HHHHHHH----HHcCCCC---
Confidence 2 22346889999999999999999999999999999999 788886422 2222222 2222110
Q ss_pred ccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 542 DPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 542 d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
..++..+..+.+|+.+||+.||++|||+.|++++|+.+..
T Consensus 233 -------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112344678999999999999999999999999988754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=386.09 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=201.8
Q ss_pred HHHcCcCCcccEEEEEEc-CCc--EEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMMA-DGV--TVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.||+|+||.||+|.+. +|. .||||+++.. .....+.|.+|+++|.++ +|||||++++++.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 467999999999999854 344 5788887643 334566799999999999 79999999999999999999999999
Q ss_pred CCChhHHhhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEe
Q 045652 391 GGSLLYLLHGDR-----------GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISE 459 (621)
Q Consensus 391 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 459 (621)
+|+|.++++... ......+++.++++++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCceEEcc
Confidence 999999997542 11245799999999999999999999999 999999999999999999999999
Q ss_pred eecceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCC-CCCcccCCCCCcchHHHHHHHhhcC
Q 045652 460 FGFYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKF-PSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 460 fG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~-P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
||+++..... ....+|..|+|||.+.+..++.++|||||||++|||++|.. ||... ...+ +...+..+
T Consensus 171 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-------~~~~-~~~~i~~~ 242 (309)
T d1fvra_ 171 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAE-LYEKLPQG 242 (309)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHH-HHHHGGGT
T ss_pred ccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-------CHHH-HHHHHHhc
Confidence 9999866443 23457889999999999999999999999999999999765 55421 1112 22222222
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCC
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDG 591 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 591 (621)
.. +. .+...++++.+|+.+||+.||++||||+||+++|+++.+...
T Consensus 243 ~~-----~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 243 YR-----LE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CC-----CC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CC-----CC-----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11 11 112344679999999999999999999999999999876543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=381.45 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=190.7
Q ss_pred HHHHcCcCCcccEEEEEEcC----CcEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMAD----GVTVVVKRMKES---SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|++.. ...||||+++.. .....+.|.+|+++|++++|||||+++|++.+ ...++|||
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeee
Confidence 34679999999999998532 247899998643 23345689999999999999999999999965 56789999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
|+++|++.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 91 LAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999888643 24599999999999999999999998 99999999999999999999999999998864
Q ss_pred cc-------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcchHHHHHHHhhcCcccc
Q 045652 468 SA-------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDVVEWVASAFSEGRVTD 539 (621)
Q Consensus 468 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (621)
.. ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+. +......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~----~~~~---~~~i~~~~~~~- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQI---LHKIDKEGERL- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH---HHHHHTSCCCC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC----HHHH---HHHHHhCCCCC-
Confidence 43 22346678999999999999999999999999999998 899986421 1222 22222222111
Q ss_pred ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHh
Q 045652 540 LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEI 586 (621)
Q Consensus 540 ~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 586 (621)
......+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 235 ---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11123346789999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=385.53 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=201.0
Q ss_pred HHHHHHcCcCCcccEEEEEEcC--------CcEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCee
Q 045652 313 KAAAEVLGNGGLGSSYKAMMAD--------GVTVVVKRMKESS-AMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEK 382 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (621)
|.+.+.||+|+||.||+|+... +..||||+++... ......+.+|...+.++ +|||||+++++|.+++..
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 3445789999999999998422 3479999997543 34457788999999888 799999999999999999
Q ss_pred EEEEeecCCCChhHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC
Q 045652 383 LLVYEYIPGGSLLYLLHGDRGP-----------SHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP 451 (621)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~ 451 (621)
++|||||++|+|.+++...... ....+++.+++.++.||+.||+|||++ +||||||||+|||++.
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTE 170 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecccceeecC
Confidence 9999999999999999754321 235689999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCcccCCCCCcch
Q 045652 452 ENEPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILT-GKFPSQYLTNGNGGIDV 524 (621)
Q Consensus 452 ~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 524 (621)
++.+||+|||+++..... ....+++.|+|||.+.++.|+.++|||||||++|||++ |..||.... .
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~----~--- 243 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----V--- 243 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----H---
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC----H---
Confidence 999999999999876443 22456788999999999999999999999999999998 677775321 1
Q ss_pred HHHHHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 525 VEWVASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 525 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
..+...+..+.... . +...++++.+|+.+||+.||++|||+.||++.|+++..
T Consensus 244 -~~~~~~i~~~~~~~-----~-----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -EELFKLLKEGHRMD-----K-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHHTTCCCC-----C-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCC-----C-----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 12223333322111 1 12234578999999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=385.93 Aligned_cols=253 Identities=19% Similarity=0.232 Sum_probs=194.0
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChh-----hHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAM-----ARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+.+..|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999995 56999999998643321 12468899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
++++..+... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 8877766542 34588889999999999999999999 9999999999999999999999999999876543
Q ss_pred ---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccccc--
Q 045652 470 ---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDP-- 543 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 543 (621)
....+|+.|+|||++.+. .|+.++|||||||++|||+||+.||... ...+....+.............+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~----~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC----CHHHHHHHHHHhcCCCChhhccchhc
Confidence 234578899999998654 5799999999999999999999998642 223333333332211110000000
Q ss_pred -----chhcC-CC-----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 544 -----EIASS-TN-----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 544 -----~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..... .. .....+++.+|+.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000 00 01224678999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-47 Score=376.80 Aligned_cols=243 Identities=20% Similarity=0.270 Sum_probs=198.9
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---------hhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEE
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---------AMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLL 384 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 384 (621)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++ ||||+++++++.+.+..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 46799999999999995 568999999986432 122456889999999997 9999999999999999999
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|||||++|+|.++++.. ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 vmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999743 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecccc---ccccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 465 MINSA---NLAQALFAYKAPEAIQ------SGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 465 ~~~~~---~~~~~~~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
.+... ....||..|+|||.+. ...++.++||||+||++|||+||+.||.... ..+ +...+..+
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~----~~~----~~~~i~~~ 230 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QML----MLRMIMSG 230 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH----HHHHHHHT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC----HHH----HHHHHHhC
Confidence 87643 3456788999999985 2357899999999999999999999997421 111 12222222
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... .. .......++++.+|+.+||+.||++|||++|+++|
T Consensus 231 ~~~-~~------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQ-FG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCC-CC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCC-CC------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 211 00 01112345679999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=389.62 Aligned_cols=243 Identities=20% Similarity=0.308 Sum_probs=192.7
Q ss_pred HHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCCcccceEEEEe----CCeeEEEEeecC
Q 045652 317 EVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYR----TDEKLLVYEYIP 390 (621)
Q Consensus 317 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~ 390 (621)
+.||+|+||.||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....|+|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 4699999999999985 56899999999643 3567899987655 89999999999876 355799999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeecceecc
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTMIN 467 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 467 (621)
||+|.+++.... ...+++.++..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccceeeecc
Confidence 999999997532 34699999999999999999999999 9999999999999985 4579999999998765
Q ss_pred cc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 468 SA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 468 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.. ....||+.|+|||++.+..|+.++|||||||++|||+||+.||..... ......+...+..+.. ....
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~----~~~~~~~~~~i~~~~~-~~~~-- 238 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIRMGQY-EFPN-- 238 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC----C--------CCCSCSS-SCCT--
T ss_pred CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH----HHHHHHHHHHHhcCCC-CCCC--
Confidence 43 345689999999999999999999999999999999999999975322 1111212111111110 0000
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......++++.+|+.+||+.||++|||+.|+++|
T Consensus 239 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 ----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0012345679999999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-47 Score=389.50 Aligned_cols=240 Identities=20% Similarity=0.235 Sum_probs=200.9
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+....++||||+.
T Consensus 45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 356899999999999996 469999999986422 2235678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|..++... ..+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 125 ~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 125 GGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp TCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 99999999743 3589999999999999999999999 9999999999999999999999999999987643
Q ss_pred ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcCC
Q 045652 470 NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASST 549 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 549 (621)
....||+.|||||++.+..|+.++|||||||++|||+||+.||... . ....... +..+...
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~---~~~~~~~-i~~~~~~----------- 256 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----Q---PIQIYEK-IVSGKVR----------- 256 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----S---HHHHHHH-HHHCCCC-----------
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----C---HHHHHHH-HhcCCCC-----------
Confidence 4567899999999999999999999999999999999999999642 1 1121222 2222110
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 550 NSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
.+....+++.+++.+||+.||.+|+ |++|+++|
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0122346789999999999999994 89999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=386.91 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=199.9
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
+.+.||+|+||.||+|... +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..|+|||||+||+
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 4568999999999999964 68999999997654 345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC--CCcEEEeeecceecccc--
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE--NEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~~-- 469 (621)
|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 88 L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 88 IFERINTSA----FELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 999997432 3589999999999999999999999 99999999999999854 47999999999877543
Q ss_pred -ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchhcC
Q 045652 470 -NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIASS 548 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 548 (621)
....+++.|+|||.+.+..|+.++||||+||++|||++|+.||.... ..++... +..+... ++....
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----~~~~~~~----i~~~~~~--~~~~~~-- 227 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIEN----IMNAEYT--FDEEAF-- 227 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHH----HHHTCCC--CCHHHH--
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC----HHHHHHH----HHhCCCC--CChhhc--
Confidence 33457889999999999999999999999999999999999997421 1122222 1111110 011000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 549 TNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+....++.+|+.+||..||++|||+.|+++|
T Consensus 228 ---~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 ---KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223568999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-46 Score=387.70 Aligned_cols=243 Identities=18% Similarity=0.223 Sum_probs=194.6
Q ss_pred HHHHcCcCCcccEEEEEEc-CCcEEEEEEccCCCh---hhHHHHH---HHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKESSA---MARDAFD---TEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|+.. +|+.||||++..... .....+. +|+++++.++|||||++++++.+.+..|+|||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEE
Confidence 3468999999999999954 699999999863221 1122333 45777888899999999999999999999999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecc
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMIN 467 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 467 (621)
||++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 88 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 88 LMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp CCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred ecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999743 3578999999999999999999999 99999999999999999999999999998775
Q ss_pred cc--ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccc
Q 045652 468 SA--NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPE 544 (621)
Q Consensus 468 ~~--~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 544 (621)
.. ....||+.|+|||++.. ..|+.++|||||||++|||+||+.||..... .+... +........ +
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~-~~~~~~~~~------~- 226 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHE-IDRMTLTMA------V- 226 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHH-HHHHSSSCC------C-
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHH-HHHhcccCC------C-
Confidence 43 44568999999999964 5689999999999999999999999975321 12221 111111111 0
Q ss_pred hhcCCCCHHHHHHHHHHHhhcccCCCCCCCc-----HHHHHHH
Q 045652 545 IASSTNSPGEMEQLLEIGRACTQSDPEQRLE-----MREAVRR 582 (621)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 582 (621)
..+...++++.+|+.+||+.||++||| ++|+++|
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011223467899999999999999999 6888876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=380.03 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=203.7
Q ss_pred HHHHcCcCCcccEEEEEE------cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCCcccceEEEEeCCeeEEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM------ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRL-RHSNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 386 (621)
+.++||+|+||.||+|++ .+++.||||+++.. .......|.+|+.+++++ +|||||++++++.+.+..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 457899999999999984 24678999999754 344566789999999999 6999999999999999999999
Q ss_pred eecCCCChhHHhhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC
Q 045652 387 EYIPGGSLLYLLHGDRG-------------PSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN 453 (621)
Q Consensus 387 e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~ 453 (621)
|||++|+|.++++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGR 182 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTT
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccccccccccccC
Confidence 99999999999975431 1223589999999999999999999999 999999999999999999
Q ss_pred CcEEEeeecceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHH
Q 045652 454 EPLISEFGFYTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEW 527 (621)
Q Consensus 454 ~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 527 (621)
.+|++|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+|+..|+.... ...+ .
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~---~~~~---~ 256 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM---PVDS---K 256 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CSSH---H
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC---CHHH---H
Confidence 9999999999876532 23456889999999999999999999999999999999555543211 1111 1
Q ss_pred HHHHhhcCccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 528 VASAFSEGRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 528 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
+...+..+... . .+...+..+.+|+.+||+.||++||||.|+++.|+++...
T Consensus 257 ~~~~i~~~~~~-----~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 FYKMIKEGFRM-----L-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHTCCC-----C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC-----C-----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22222222111 0 1122346789999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=383.21 Aligned_cols=239 Identities=19% Similarity=0.288 Sum_probs=195.5
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCC---hhhHHHHHHHHHHHh-cCCCCCcccceEEEEeCCeeEEEEeecC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESS---AMARDAFDTEVRRLG-RLRHSNVLAPLAYHYRTDEKLLVYEYIP 390 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (621)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|..++. .++|||||++++++.+.+..|+|||||+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 46899999999999995 469999999996432 223455667777765 6899999999999999999999999999
Q ss_pred CCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc-
Q 045652 391 GGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA- 469 (621)
Q Consensus 391 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~- 469 (621)
+|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 87 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999743 3588999999999999999999999 9999999999999999999999999999865432
Q ss_pred ---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccccccchh
Q 045652 470 ---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLLDPEIA 546 (621)
Q Consensus 470 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 546 (621)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ... +...+..+.. ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~----~~~~i~~~~~------~~- 222 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEE----LFHSIRMDNP------FY- 222 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH----HHHHHHHCCC------CC-
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHH----HHHHHHcCCC------CC-
Confidence 33568899999999999999999999999999999999999997421 111 2222222211 11
Q ss_pred cCCCCHHHHHHHHHHHhhcccCCCCCCCcHH-HHHHH
Q 045652 547 SSTNSPGEMEQLLEIGRACTQSDPEQRLEMR-EAVRR 582 (621)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 582 (621)
+...++++.+|+.+||+.||++||++. |+++|
T Consensus 223 ----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 223 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 122346689999999999999999995 77654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=377.29 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=203.9
Q ss_pred HHHHcCcCCcccEEEEEEc------CCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMMA------DGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (621)
+.+.||+|+||.||+|.+. +++.||||+++.. .......|.+|++++++++|||||++++++...+..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999853 3578999999754 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhcCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeec
Q 045652 388 YIPGGSLLYLLHGDR-----GPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGF 462 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 462 (621)
||++|+|.+++.... ......+++..+.+++.|+++||.|||++ +|+||||||+|||++.++++||+|||+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999886421 11234579999999999999999999999 999999999999999999999999999
Q ss_pred ceecccc------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCcccCCCCCcchHHHHHHHhhcC
Q 045652 463 YTMINSA------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGK-FPSQYLTNGNGGIDVVEWVASAFSEG 535 (621)
Q Consensus 463 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~ 535 (621)
++..... ....+++.|+|||.+.+..++.++|||||||++|||+||. .||... ...+... .+..+
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~-~i~~~ 251 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLR-FVMEG 251 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHH-HHHTT
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-------CHHHHHH-HHHhC
Confidence 9876433 2234678899999999999999999999999999999985 565432 2222222 22222
Q ss_pred ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhc
Q 045652 536 RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQ 588 (621)
Q Consensus 536 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 588 (621)
..... +...+..+.+++.+||+.||++|||+.||+++|++..+
T Consensus 252 ~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 21111 12234679999999999999999999999999987654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=372.25 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=193.1
Q ss_pred HHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCC
Q 045652 316 AEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA--MARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 46799999999999995 5699999999964332 2356788999999999999999999999999999999999976
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc---
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA--- 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~--- 469 (621)
++..++.... ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 86 DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 4444443222 34599999999999999999999999 9999999999999999999999999999776433
Q ss_pred -ccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc---cccc----
Q 045652 470 -NLAQALFAYKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR---VTDL---- 540 (621)
Q Consensus 470 -~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 540 (621)
....+|+.|+|||.+.... ++.++|||||||++|||++|+.||.... ..+....+........ ....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC----HHHHHHHHHHhcCCCchhhcccccccc
Confidence 3346888999999887665 5789999999999999999999996421 1122221211111100 0000
Q ss_pred -cccchhcCC-C-----CHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 -LDPEIASST-N-----SPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 -~d~~~~~~~-~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
......... . .+....++.+|+.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000 0 01223678999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-45 Score=369.38 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=196.1
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCCCC
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESS--AMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPGGS 393 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (621)
.+.||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..+++|||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 46799999999999999899999999997543 2235788999999999999999999999999999999999998877
Q ss_pred hhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc----
Q 045652 394 LLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA---- 469 (621)
Q Consensus 394 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 469 (621)
+..+... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 87 ~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 7666542 34699999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCcccccc-------
Q 045652 470 NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDLL------- 541 (621)
Q Consensus 470 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 541 (621)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....+.............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 334577889999998754 57999999999999999999999996421 122222222211111000000
Q ss_pred -ccchh------cCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 542 -DPEIA------SSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 542 -d~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+.... .........+.+.+|+.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000112234678999999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=374.24 Aligned_cols=234 Identities=21% Similarity=0.323 Sum_probs=190.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCCh------hhHHHHHHHHHHHhcCC--CCCcccceEEEEeCCeeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSA------MARDAFDTEVRRLGRLR--HSNVLAPLAYHYRTDEKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 385 (621)
+.+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|+.+|++++ |||||++++++.+.+..++|
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 346799999999999995 5689999999864211 11234678999999996 89999999999999999999
Q ss_pred EeecCC-CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCC-CCcEEEeeecc
Q 045652 386 YEYIPG-GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPE-NEPLISEFGFY 463 (621)
Q Consensus 386 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a 463 (621)
|||+.+ +++.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 88 ~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccccc
Confidence 999976 578888764 24589999999999999999999999 99999999999999854 78999999999
Q ss_pred eecccc--ccccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccccc
Q 045652 464 TMINSA--NLAQALFAYKAPEAIQSGKV-TPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVTDL 540 (621)
Q Consensus 464 ~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (621)
+..... ....||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... .+ ..+.. .
T Consensus 159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i----~~~~~--~ 222 (273)
T d1xwsa_ 159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI----IRGQV--F 222 (273)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH----HHCCC--C
T ss_pred eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HH----hhccc--C
Confidence 876543 44568999999999987665 567999999999999999999996411 11 11111 0
Q ss_pred cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 541 LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 541 ~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+. ...++++.+|+.+||+.||++|||++|+++|
T Consensus 223 ~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 FR---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC---------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 1223578999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=370.46 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=191.9
Q ss_pred HHHHHcCcCCcccEEEEEE-cC-CcEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCCcccceEEEEe-----CCe
Q 045652 314 AAAEVLGNGGLGSSYKAMM-AD-GVTVVVKRMKESS--AMARDAFDTEVRRLGRL---RHSNVLAPLAYHYR-----TDE 381 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~ 381 (621)
.+.+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+|+.+ +||||+++++++.. ...
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 3456899999999999986 34 6789999986322 22233456788777766 79999999999864 235
Q ss_pred eEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeee
Q 045652 382 KLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFG 461 (621)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 461 (621)
.+++|||+.++++....... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred EEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecchh
Confidence 78999999887776555432 34689999999999999999999999 99999999999999999999999999
Q ss_pred cceecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 462 FYTMINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 462 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
+++..... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.... ..+....+..........
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCGG
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCchh
Confidence 98766433 45668999999999999999999999999999999999999997421 222222222221110000
Q ss_pred cc----cccc--h------hcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 DL----LDPE--I------ASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ~~----~d~~--~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ..+. . ..........+.+.+|+.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000 0 0000012234578899999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=370.24 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=192.7
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEEEEe
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLLVYE 387 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 387 (621)
..++||+|+||+||+|+. .+|+.||||+++.... .+.+|+++|++++||||+++++++... ...++|||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 346799999999999996 4699999999975432 234799999999999999999998653 24689999
Q ss_pred ecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceec
Q 045652 388 YIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMI 466 (621)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~ 466 (621)
||+++.+..+.+... ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 100 y~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 100 YVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp CCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred ccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 998764443332111 234699999999999999999999998 999999999999999775 8999999999876
Q ss_pred ccc---ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc--------
Q 045652 467 NSA---NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE-------- 534 (621)
Q Consensus 467 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 534 (621)
... ....++..|+|||.+.+ ..|+.++||||+||++|||++|+.||.... ..+....+......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~----~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS----GVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC----HHHHHHHHHHHhCCChHHhhhh
Confidence 543 33467889999998865 568999999999999999999999996422 11221111111100
Q ss_pred -------CccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhhcc
Q 045652 535 -------GRVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQQS 589 (621)
Q Consensus 535 -------~~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~ 589 (621)
............ ....+...+++.+|+.+||+.||++|||+.|+++| ++++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 000000000000 01112344678999999999999999999999987 6666553
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=361.79 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=192.2
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC------eeEEE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD------EKLLV 385 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv 385 (621)
+.+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ ..++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 456899999999999995 56999999999743 3344667889999999999999999999997654 46999
Q ss_pred EeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 386 YEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
|||+ +.+|..+++. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++.
T Consensus 102 ~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred Eecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccceec
Confidence 9999 6688887753 3599999999999999999999999 999999999999999999999999999988
Q ss_pred cccc-ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcC--------
Q 045652 466 INSA-NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEG-------- 535 (621)
Q Consensus 466 ~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-------- 535 (621)
.... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+.......
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD----HLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC----hHHHHHHHHhccCCCcHHHHhhh
Confidence 7654 445688899999998764 57899999999999999999999997421 111111111110000
Q ss_pred ----------ccccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH--HHHhh
Q 045652 536 ----------RVTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR--IVEIQ 587 (621)
Q Consensus 536 ----------~~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 587 (621)
...+........ ......+.+.+|+.+||..||++|||++|+++| ++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchHH--hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000000 012234568899999999999999999999987 55543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=362.80 Aligned_cols=255 Identities=18% Similarity=0.241 Sum_probs=190.1
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEe--------CCeeE
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYR--------TDEKL 383 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~~~ 383 (621)
+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++.. .+..+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 346799999999999995 57999999998643 23345678899999999999999999999865 34578
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
+||||+.++.+..+.. ....++...+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 94 iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 94 LVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp EEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeeccee
Confidence 9999998776665443 234688999999999999999999999 9999999999999999999999999999
Q ss_pred eecccc--------ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhc
Q 045652 464 TMINSA--------NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSE 534 (621)
Q Consensus 464 ~~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 534 (621)
+.+... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||... ........+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~----~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN----TEQHQLALISQLCGS 240 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC----CHHHHHHHHHHhcCC
Confidence 766432 234578899999998765 6899999999999999999999998642 122222222222211
Q ss_pred Cc---ccccccc----c---hhcCCCC-H------HHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GR---VTDLLDP----E---IASSTNS-P------GEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~---~~~~~d~----~---~~~~~~~-~------~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ....... . ....... . ...+.+.+|+.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 0000000 0 0000000 0 113467899999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=356.48 Aligned_cols=256 Identities=18% Similarity=0.263 Sum_probs=199.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCCeeEEEEeecCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTDEKLLVYEYIPG 391 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (621)
+.+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+....++|+|++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 346899999999999995 56899999998643 234567889999999999999999999999999999999999999
Q ss_pred CChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceecccc--
Q 045652 392 GSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINSA-- 469 (621)
Q Consensus 392 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 469 (621)
++|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 86 ~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 86 DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999888764 34688999999999999999999999 9999999999999999999999999999877543
Q ss_pred --ccccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc--------
Q 045652 470 --NLAQALFAYKAPEAIQSGK-VTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT-------- 538 (621)
Q Consensus 470 --~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 538 (621)
....++..|+|||.+.... ++.++||||+||++|||++|+.||... ....+....+..........
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC---CCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2334567799999987655 689999999999999999999997532 11222222222211111000
Q ss_pred -c-----ccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 -D-----LLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 -~-----~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
+ ................+.+.+|+.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000011122334678999999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-43 Score=360.92 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=193.2
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeC--CeeEEEEee
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRT--DEKLLVYEY 388 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~ 388 (621)
|.+.++||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|++++ ||||+++++++... ...++||||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 34567899999999999995 569999999997543 467889999999995 99999999999854 458999999
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCC-CcEEEeeecceecc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPEN-EPLISEFGFYTMIN 467 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~ 467 (621)
|.+++|..+. +.+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 114 ~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 114 VNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred cCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999997664 2489999999999999999999999 999999999999998665 58999999998775
Q ss_pred cc---ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhh---------c
Q 045652 468 SA---NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFS---------E 534 (621)
Q Consensus 468 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------~ 534 (621)
.. ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||..... ..+....+..... .
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~---~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS---HHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch---hHHHHHHHHHHHCCchhhhhhhh
Confidence 43 344578899999998765 479999999999999999999999874221 1111111111100 0
Q ss_pred Ccc------ccc-------cccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 535 GRV------TDL-------LDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 535 ~~~------~~~-------~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
... ... ...............+++.+|+.+||+.||++|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000 000011111122344678999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=361.74 Aligned_cols=246 Identities=19% Similarity=0.264 Sum_probs=196.7
Q ss_pred HHHHHHcCcCCcccEEEEEE----cCCcEEEEEEccCCC----hhhHHHHHHHHHHHhcCCC-CCcccceEEEEeCCeeE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM----ADGVTVVVKRMKESS----AMARDAFDTEVRRLGRLRH-SNVLAPLAYHYRTDEKL 383 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 383 (621)
|.+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 44567899999999999984 247899999986432 2234567899999999976 89999999999999999
Q ss_pred EEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecc
Q 045652 384 LVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFY 463 (621)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 463 (621)
++|||+.+|+|.+++... ..+....+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 106 ~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999753 3467888999999999999999999 9999999999999999999999999999
Q ss_pred eecccc-----ccccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 464 TMINSA-----NLAQALFAYKAPEAIQSG--KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 464 ~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
+.+... ....+++.|+|||.+.+. .++.++|||||||+||||+||+.||..... .+....+........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~----~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcccCC
Confidence 876432 334577889999999754 478899999999999999999999975332 222233322222111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCC-----cHHHHHHH
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRL-----EMREAVRR 582 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 582 (621)
. ..+.....++.+++.+||++||++|| |++|+++|
T Consensus 253 ~-----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 P-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp C-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred C-----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1 11123446799999999999999999 47888875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=356.95 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=189.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeCC----eeEEEEee
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES-SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRTD----EKLLVYEY 388 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 388 (621)
+.+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 457899999999999984 57999999999754 3444667899999999999999999999987643 23455566
Q ss_pred cCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecceeccc
Q 045652 389 IPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYTMINS 468 (621)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 468 (621)
+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 92 LMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 779999999964 3589999999999999999999999 999999999999999999999999999987643
Q ss_pred c-------ccccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc--
Q 045652 469 A-------NLAQALFAYKAPEAIQS-GKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT-- 538 (621)
Q Consensus 469 ~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 538 (621)
. ....+|+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+...............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH----YLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC----HHHHHHHHhhhccCCChhhh
Confidence 2 23457788999999854 567899999999999999999999996421 111111111111100000
Q ss_pred ---------cc--cccchhcCC---CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 539 ---------DL--LDPEIASST---NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 539 ---------~~--~d~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
.. ..+...... ..+....++.+|+.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000000 001223568999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-43 Score=356.33 Aligned_cols=253 Identities=15% Similarity=0.186 Sum_probs=192.3
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcccce-EEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVLAPL-AYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|++++++++|+|++..+ +++.+.+..++||||+ ++
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence 346799999999999985 5689999998865432 34578899999999877766555 4556677888999999 56
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC---CCCcEEEeeecceecccc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP---ENEPLISEFGFYTMINSA 469 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~~~ 469 (621)
++...+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.+...
T Consensus 88 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 88 SLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp BHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred chhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 776666532 34689999999999999999999999 9999999999999864 457999999999876432
Q ss_pred -----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCccc
Q 045652 470 -----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGRVT 538 (621)
Q Consensus 470 -----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (621)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...................... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~-- 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P-- 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-C--
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-C--
Confidence 23458899999999999999999999999999999999999997644322222221111111110 0
Q ss_pred cccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhcc
Q 045652 539 DLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQS 589 (621)
Q Consensus 539 ~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 589 (621)
.+.. ....++++.+++.+||+.||++||++.++.+.|+.+...
T Consensus 237 ---~~~~-----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 ---IEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---HHHH-----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---hhHh-----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0001 112336789999999999999999999998888877543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7e-43 Score=351.15 Aligned_cols=256 Identities=14% Similarity=0.173 Sum_probs=201.0
Q ss_pred HHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCC-CCcccceEEEEeCCeeEEEEeecCCC
Q 045652 315 AAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH-SNVLAPLAYHYRTDEKLLVYEYIPGG 392 (621)
Q Consensus 315 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g 392 (621)
+.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+++++.+.| +|++.+++++......++||||+ ++
T Consensus 9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 346799999999999995 4689999998864322 3456789999999975 89999999999999999999999 78
Q ss_pred ChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCC-----CCCcEEEeeecceecc
Q 045652 393 SLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISP-----ENEPLISEFGFYTMIN 467 (621)
Q Consensus 393 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~a~~~~ 467 (621)
+|.++++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 86 ~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 86 SLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999987533 3589999999999999999999999 9999999999999974 5679999999998764
Q ss_pred cc-----------ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc
Q 045652 468 SA-----------NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR 536 (621)
Q Consensus 468 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (621)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||....... .......+........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-HHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-HHHHHHHHHhccCCCC
Confidence 32 23458999999999999999999999999999999999999997533211 1111111111111111
Q ss_pred cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHHHHHhhccCCC
Q 045652 537 VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRRIVEIQQSDGN 592 (621)
Q Consensus 537 ~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 592 (621)
.. .+. ...++++.+++..|+..+|++||+++.+.+.|+++......
T Consensus 237 ~~-----~l~-----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 237 LR-----ELC-----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HH-----HHT-----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hH-----Hhc-----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 00 110 12235689999999999999999999999988887665443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=358.67 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=191.6
Q ss_pred HHHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC-----CeeEE
Q 045652 313 KAAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT-----DEKLL 384 (621)
Q Consensus 313 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 384 (621)
|.+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 34567899999999999995 56999999999754 233456788999999999999999999998643 33466
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
+|+|+.+|+|.++++. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 100 i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhc
Confidence 7788889999999953 3599999999999999999999999 99999999999999999999999999987
Q ss_pred ecccc-ccccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHHhhcCc------
Q 045652 465 MINSA-NLAQALFAYKAPEAIQSG-KVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASAFSEGR------ 536 (621)
Q Consensus 465 ~~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------ 536 (621)
..... ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||... ........+........
T Consensus 170 ~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~----~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCChHHhhh
Confidence 76543 445678889999987665 4689999999999999999999999642 11222222221111100
Q ss_pred ------------cccccccchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 537 ------------VTDLLDPEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 537 ------------~~~~~d~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
........+.. ......+++.+|+.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFAN--VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHH--HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhh--hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000 001234568999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=356.02 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=185.8
Q ss_pred HHHHHcCcCCcccEEEEEEc-CCcEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCCcccceEEEEeC------CeeEE
Q 045652 314 AAAEVLGNGGLGSSYKAMMA-DGVTVVVKRMKES--SAMARDAFDTEVRRLGRLRHSNVLAPLAYHYRT------DEKLL 384 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 384 (621)
.+.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++... ...|+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence 34578999999999999964 6999999999743 334456788999999999999999999998643 57899
Q ss_pred EEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 385 VYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
|||||.++ +.+.+. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+|++|||+++
T Consensus 100 v~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 100 VMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhh
Confidence 99999764 445543 2488999999999999999999999 99999999999999999999999999987
Q ss_pred ecccc---ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcchHHHHHHH----------
Q 045652 465 MINSA---NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDVVEWVASA---------- 531 (621)
Q Consensus 465 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---------- 531 (621)
..... ....+|..|+|||++.+..+++++||||+||++|||++|+.||.... .......+...
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~----~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD----YIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC----HHHHHHHHHHhccCCCHHHHH
Confidence 66443 34457889999999999999999999999999999999999986421 11111111110
Q ss_pred ---------hhcCc-cc-----cccccchhcCC--CCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 532 ---------FSEGR-VT-----DLLDPEIASST--NSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 532 ---------~~~~~-~~-----~~~d~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..... .. ........... .......++.+|+.+||..||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00 00000000000 012346789999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-38 Score=328.56 Aligned_cols=262 Identities=17% Similarity=0.220 Sum_probs=188.8
Q ss_pred HHHHHcCcCCcccEEEEEE-cCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-----------CCCcccceEEEEeC--
Q 045652 314 AAAEVLGNGGLGSSYKAMM-ADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-----------HSNVLAPLAYHYRT-- 379 (621)
Q Consensus 314 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~-- 379 (621)
.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 16 ~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 3457899999999999995 579999999997543 34567889999998875 57899999987653
Q ss_pred CeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCCCccCCCCCCCEEeCCCCC----
Q 045652 380 DEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHT-ELAHLDLPHGNLKSSNIFISPENE---- 454 (621)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~---- 454 (621)
...+++|+++..+.......... ....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~----~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC----GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT----CEECSCCSGGGEEEEEEETTTTE
T ss_pred cceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc----CcccccCChhHeeeeccCccccc
Confidence 45667777765554433322221 24568899999999999999999997 6 8999999999999986654
Q ss_pred --cEEEeeecceecccc-ccccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCcccCCCCCcch--HHHHH
Q 045652 455 --PLISEFGFYTMINSA-NLAQALFAYKAPEAIQSGKVTPKCDVYCLGIIILEILTGKFPSQYLTNGNGGIDV--VEWVA 529 (621)
Q Consensus 455 --~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~--~~~~~ 529 (621)
++++|||.+...... ....+|+.|+|||++.+..++.++||||+||+++||++|+.||............ .....
T Consensus 169 ~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred ceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 899999998876543 4456888999999999999999999999999999999999998753321111111 00000
Q ss_pred HHhhc------------------Cccccccc---------cchhcCCCCHHHHHHHHHHHhhcccCCCCCCCcHHHHHHH
Q 045652 530 SAFSE------------------GRVTDLLD---------PEIASSTNSPGEMEQLLEIGRACTQSDPEQRLEMREAVRR 582 (621)
Q Consensus 530 ~~~~~------------------~~~~~~~d---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 582 (621)
..+.. ........ .............+++.+|+.+||+.||++|||++|+++|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11100 00000000 0001122345677889999999999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.91 E-value=6.8e-25 Score=221.67 Aligned_cols=160 Identities=30% Similarity=0.600 Sum_probs=144.1
Q ss_pred cHHHHHHHHHHcCCCCCCCCCCCCCCCCCCCCCCceeeEEeCC----CcEEEEEecCCCCeee--eCcccccccCCCCCC
Q 045652 2 SESEALLKLKSSFTNAKALDSWMPSTAPCRGGEEEWSGVVCLK----GIVTGLYINSMGLSGK--IDVDALTELTGLRGL 75 (621)
Q Consensus 2 ~~~~~l~~~k~~~~~~~~l~~w~~~~~~c~~~~~~w~gv~c~~----~~v~~l~l~~~~l~g~--~~~~~~~~l~~l~~L 75 (621)
+|++||++||+++.++..+.+|..++|||.. .|.||+|+. .+|+.|+|++++++|. || ..+..|++|
T Consensus 6 ~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~---~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp----~~l~~L~~L 78 (313)
T d1ogqa_ 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNR---TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP----SSLANLPYL 78 (313)
T ss_dssp HHHHHHHHHHHHTTCCGGGTTCCTTSCTTTT---CSTTEEECCSSSCCCEEEEEEECCCCSSCEECC----GGGGGCTTC
T ss_pred HHHHHHHHHHHHCCCCCcCCCCCCCCCCCCC---cCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCC----hHHhcCccc
Confidence 5899999999999988889999988999953 499999963 3799999999999984 45 467788999
Q ss_pred CEEecCC-CcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcc
Q 045652 76 RAIYLDK-NQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLS 152 (621)
Q Consensus 76 ~~l~l~~-N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~ 152 (621)
++|+|++ |+|+|+||++ |++|++|++|+|++|+|+|..|..+..+..|+++++++|++.+.+|.. ..+.|+.++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~-i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPA-IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGG-GGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred cccccccccccccccccc-cccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 9999986 9999999998 899999999999999999999999999999999999999999999965 67999999999
Q ss_pred cCccccccCcccccccc
Q 045652 153 SNKLEGEIPASLLRFNA 169 (621)
Q Consensus 153 ~N~l~g~ip~~~~~~~~ 169 (621)
+|.++|.+|..+..+..
T Consensus 158 ~n~l~~~ip~~~~~l~~ 174 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSK 174 (313)
T ss_dssp SSCCEEECCGGGGCCCT
T ss_pred ccccccccccccccccc
Confidence 99999999988766543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.6e-23 Score=195.44 Aligned_cols=160 Identities=17% Similarity=0.163 Sum_probs=119.3
Q ss_pred HHHcCcCCcccEEEEEEcCCcEEEEEEccCCCh------------------hhHHHHHHHHHHHhcCCCCCcccceEEEE
Q 045652 316 AEVLGNGGLGSSYKAMMADGVTVVVKRMKESSA------------------MARDAFDTEVRRLGRLRHSNVLAPLAYHY 377 (621)
Q Consensus 316 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 377 (621)
.++||+|+||.||+|...+|+.||||+++.... .......+|...+.++.|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 467999999999999988999999998753210 1123456789999999999999877653
Q ss_pred eCCeeEEEEeecCCCChhHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCCCccCCCCCCCEEeCCCCCcEE
Q 045652 378 RTDEKLLVYEYIPGGSLLYLLHGDRGPSHDELTWPARLKIVQGIARGIGYLHTELAHLDLPHGNLKSSNIFISPENEPLI 457 (621)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl 457 (621)
..+++|||+++..+.+ ++......++.|++.+|+|||++ +|+||||||+|||+++++ ++|
T Consensus 84 ---~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp ---TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETTE-EEE
T ss_pred ---CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCCC-EEE
Confidence 2479999998765543 23334567999999999999999 999999999999999654 899
Q ss_pred EeeecceeccccccccccccccC------cccccCCCCCcchhhHHHHHH
Q 045652 458 SEFGFYTMINSANLAQALFAYKA------PEAIQSGKVTPKCDVYCLGII 501 (621)
Q Consensus 458 ~DfG~a~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~DvwSlGvv 501 (621)
+|||.|.....+... .|.. .+. ....|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 999999876543221 1111 111 13568889999997543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.55 E-value=4.3e-15 Score=148.76 Aligned_cols=139 Identities=29% Similarity=0.423 Sum_probs=105.1
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCC---------------------CCCCEEecCCCcccccCCcccccCCCCCCEE
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGL---------------------RGLRAIYLDKNQFSGEIPPGYFDEMGALRKL 103 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l---------------------~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l 103 (621)
..+..+++++|.+.|.+|. .+..+..+ ..+..+++++|.+.|.+|.. +..+++|+.|
T Consensus 149 ~~L~~l~l~~n~l~~~ip~-~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~-~~~~~~l~~l 226 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPD-SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL-FGSDKNTQKI 226 (313)
T ss_dssp TTCCEEECCSSCCEEECCG-GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGG-CCTTSCCSEE
T ss_pred cccceeecccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 3566677777777777663 22222111 02334555555555555554 6778899999
Q ss_pred eCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCcc--ccccccCCCCCCCCCC
Q 045652 104 WFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPAS--LLRFNASSFSGNAGLC 179 (621)
Q Consensus 104 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~--~~~~~~~~~~~n~~~c 179 (621)
++++|.++|.+| .++.+++|++|+|++|+|+|.+|.. .+++|++|+|++|+|+|.||.. +.++....+.+|+.+|
T Consensus 227 ~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~ 305 (313)
T d1ogqa_ 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEE
T ss_pred cccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCcccc
Confidence 999999998766 6889999999999999999999975 6799999999999999999974 5567778899999999
Q ss_pred CCCCCCCc
Q 045652 180 GKNLGVEC 187 (621)
Q Consensus 180 ~~~~~~~c 187 (621)
|.|++ .|
T Consensus 306 g~plp-~c 312 (313)
T d1ogqa_ 306 GSPLP-AC 312 (313)
T ss_dssp STTSS-CC
T ss_pred CCCCC-CC
Confidence 98875 55
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.54 E-value=1.8e-14 Score=133.25 Aligned_cols=122 Identities=26% Similarity=0.318 Sum_probs=86.1
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.|..|.|.. ..++.|+|++|.+++.++. ..+.++++|+.|+|++|.+++ ++++.|..+++|+.|+
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~---~~f~~l~~L~~L~L~~N~i~~-~~~~~~~~~~~L~~L~ 84 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSD---GLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQ 84 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCS---CSGGGCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEE
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccc---cccCCCceEeeeecccccccc-ccccccccccccceee
Confidence 477788842 2567788888877765654 234556777788888888874 4555577788888888
Q ss_pred CccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccC
Q 045652 105 FSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 105 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
|++|+|++..|..|.++++|++|+|++|+|++..|.. .+++|+.|+|++|.+.+..+
T Consensus 85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 8888888766667777888888888888887555543 46778888888887775443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.47 E-value=9.3e-14 Score=128.38 Aligned_cols=133 Identities=22% Similarity=0.321 Sum_probs=108.2
Q ss_pred eeEEeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCC
Q 045652 38 SGVVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPS 117 (621)
Q Consensus 38 ~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~ 117 (621)
.|-+|.. +.++.++++|+ +||. .+. .++++|+|++|+|++.++...|..+++|+.|+|++|++++..+..
T Consensus 4 ~~C~C~~---~~v~Cs~~~L~-~iP~----~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~ 73 (192)
T d1w8aa_ 4 AMCHCEG---TTVDCTGRGLK-EIPR----DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73 (192)
T ss_dssp TTSEEET---TEEECTTSCCS-SCCS----CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTT
T ss_pred CCCEEcC---CEEEEeCCCcC-ccCC----CCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccc
Confidence 3447854 46889999998 5774 232 589999999999998888888999999999999999999999999
Q ss_pred CCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc---cccCCCCCCCCCCC
Q 045652 118 LFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR---FNASSFSGNAGLCG 180 (621)
Q Consensus 118 ~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~n~~~c~ 180 (621)
+..+++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..|..+.. +....+.+|+..|.
T Consensus 74 ~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 999999999999999999665653 5799999999999999655554443 44456778876653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.38 E-value=4.8e-13 Score=113.77 Aligned_cols=99 Identities=27% Similarity=0.380 Sum_probs=84.0
Q ss_pred EEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeee
Q 045652 49 GLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELH 128 (621)
Q Consensus 49 ~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~ 128 (621)
.|+|++|+++ .++ .+..|.+|++|+|++|+|+ .||++ ++.+++|+.|+|++|+|++ +| .+.++++|++|+
T Consensus 2 ~L~Ls~n~l~-~l~-----~l~~l~~L~~L~ls~N~l~-~lp~~-~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~ 71 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-----HLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELL 71 (124)
T ss_dssp EEECTTSCCS-SCC-----CGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEE
T ss_pred EEEcCCCCCC-CCc-----ccccCCCCCEEECCCCccC-cchhh-hhhhhcccccccccccccc-cC-ccccccccCeEE
Confidence 4789999987 243 4677889999999999999 79986 8899999999999999995 55 589999999999
Q ss_pred ccCccccccCCC---C-CCCCccEEEcccCcccc
Q 045652 129 LESNQFNGTIPS---F-DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 129 l~~N~l~g~~p~---~-~~~~L~~l~l~~N~l~g 158 (621)
+++|+++. +|. . ..++|+.|++++|.++.
T Consensus 72 l~~N~i~~-~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 72 LCNNRLQQ-SAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSCCCS-SSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCccCC-CCCchhhcCCCCCCEEECCCCcCCc
Confidence 99999984 443 2 56899999999999984
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=5.6e-12 Score=122.53 Aligned_cols=129 Identities=26% Similarity=0.381 Sum_probs=84.8
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccc----------------------cCCcccccCCCCCCE
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSG----------------------EIPPGYFDEMGALRK 102 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g----------------------~ip~~~~~~l~~L~~ 102 (621)
.++..|+|++|+++. |+. +..+++|++|+|++|++++ .++...+..+.+|+.
T Consensus 55 ~~L~~L~L~~N~l~~-l~~-----~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~ 128 (266)
T d1p9ag_ 55 TRLTQLNLDRAELTK-LQV-----DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128 (266)
T ss_dssp TTCCEEECTTSCCCE-EEC-----CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE
T ss_pred ccccccccccccccc-ccc-----ccccccccccccccccccccccccccccccccccccccccceeecccccccccccc
Confidence 457777777777763 432 2345555555665555552 233333444555555
Q ss_pred EeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccccc---cCCCCCCCC
Q 045652 103 LWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGNAG 177 (621)
Q Consensus 103 l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~~ 177 (621)
|++++|.+++..|..+..++.|+.|++++|+|++..|.. .+++|+.|+|++|+|+ .||..+..+. ...+.|||+
T Consensus 129 L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 566666666544555667888888888888888655543 4788999999999998 8988765443 456788988
Q ss_pred CCC
Q 045652 178 LCG 180 (621)
Q Consensus 178 ~c~ 180 (621)
.|.
T Consensus 208 ~Cd 210 (266)
T d1p9ag_ 208 LCN 210 (266)
T ss_dssp CCS
T ss_pred CCC
Confidence 875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.1e-11 Score=121.57 Aligned_cols=131 Identities=24% Similarity=0.383 Sum_probs=101.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+..|+|+++++.. ++. ..+..+.+|+.+++++|+|+ .||++.|..+++|+.|+|++|+|++..|..+.++++|
T Consensus 105 ~~L~~L~l~~n~~~~-~~~---~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L 179 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQE-LGP---GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179 (284)
T ss_dssp TTCCEEECTTSCCCC-CCT---TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred ccCCEEecCCccccc-ccc---cccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhhhcccccc
Confidence 457777888777654 222 23455678899999999998 5777778889999999999999998778888899999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCccccc---cccCCCCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASLLR---FNASSFSGNAGLCG 180 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~n~~~c~ 180 (621)
++|+|++|++++..|.. .+++|+.|++++|++++..|..+.. +....+++|++.|.
T Consensus 180 ~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred chhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 99999999999877764 5688999999999998766655544 34456778887663
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.18 E-value=1.6e-11 Score=104.10 Aligned_cols=95 Identities=24% Similarity=0.404 Sum_probs=78.7
Q ss_pred CEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC-CCCCccEEEcccC
Q 045652 76 RAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF-DQPTLVRLNLSSN 154 (621)
Q Consensus 76 ~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N 154 (621)
|+|+|++|+++ .+|. ++.+++|++|+|++|.|+ .+|+.++.+++|++|+|++|++++ +|.+ .+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCccccccccCeEECCCC
Confidence 68999999999 7773 789999999999999998 689899999999999999999984 5654 6899999999999
Q ss_pred ccccccC--cccccc---ccCCCCCCC
Q 045652 155 KLEGEIP--ASLLRF---NASSFSGNA 176 (621)
Q Consensus 155 ~l~g~ip--~~~~~~---~~~~~~~n~ 176 (621)
+++. +| ..+..+ ....+.+|+
T Consensus 76 ~i~~-~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 76 RLQQ-SAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CCCS-SSTTGGGGGCTTCCEEECTTSG
T ss_pred ccCC-CCCchhhcCCCCCCEEECCCCc
Confidence 9984 44 334433 344566774
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=4.6e-11 Score=105.66 Aligned_cols=89 Identities=24% Similarity=0.374 Sum_probs=77.6
Q ss_pred cccCCCCCCCEEecCCC-cccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CC
Q 045652 67 TELTGLRGLRAIYLDKN-QFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQ 143 (621)
Q Consensus 67 ~~l~~l~~L~~l~l~~N-~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~ 143 (621)
..+.++++|+.|+|++| .++ .|++..|.++++|+.|+|++|+|+..-|..|..+++|++|+|++|+|+ .+|.. ..
T Consensus 25 ~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~ 102 (156)
T d2ifga3 25 HHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQG 102 (156)
T ss_dssp TTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCS
T ss_pred ccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcc
Confidence 45677889999999766 588 799888999999999999999999877888999999999999999998 66653 45
Q ss_pred CCccEEEcccCccc
Q 045652 144 PTLVRLNLSSNKLE 157 (621)
Q Consensus 144 ~~L~~l~l~~N~l~ 157 (621)
..|+.|+|++|.|.
T Consensus 103 ~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 103 LSLQELVLSGNPLH 116 (156)
T ss_dssp CCCCEEECCSSCCC
T ss_pred ccccccccCCCccc
Confidence 67999999999885
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=4.7e-11 Score=106.35 Aligned_cols=103 Identities=21% Similarity=0.208 Sum_probs=52.3
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.+..|+|++|+++. |+. -...+++|+.|+|++|+++ .|+. +..+++|+.|+|++|+++...|..+..+++|+
T Consensus 19 ~lr~L~L~~n~I~~-i~~----~~~~l~~L~~L~Ls~N~i~-~l~~--~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 19 RDRELDLRGYKIPV-IEN----LGATLDQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp SCEEEECTTSCCCS-CCC----GGGGTTCCSEEECCSSCCC-EECC--CCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCcEEECCCCCCCc-cCc----cccccccCCEEECCCCCCC-ccCC--cccCcchhhhhcccccccCCCccccccccccc
Confidence 34555666655543 321 1233455566666666665 4532 45555666666666666532222234455666
Q ss_pred eeeccCccccccCCC---C-CCCCccEEEcccCccc
Q 045652 126 ELHLESNQFNGTIPS---F-DQPTLVRLNLSSNKLE 157 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~---~-~~~~L~~l~l~~N~l~ 157 (621)
+|+|++|+++. ++. . .+++|+.|++++|.++
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccc
Confidence 66666665542 221 1 3455666666666554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=8.4e-11 Score=115.17 Aligned_cols=112 Identities=21% Similarity=0.291 Sum_probs=97.5
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+..+++++|.+++ |+. ..+..+.+|+.|+|++|+|+ .||+.+|..+++|+.|+|++|++++..|..|.++++|
T Consensus 129 ~~L~~l~l~~N~l~~-i~~---~~f~~~~~L~~L~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L 203 (284)
T d1ozna_ 129 AALQYLYLQDNALQA-LPD---DTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203 (284)
T ss_dssp TTCCEEECCSSCCCC-CCT---TTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred cccchhhhccccccc-cCh---hHhccccchhhcccccCccc-ccchhhhccccccchhhhhhccccccChhHhhhhhhc
Confidence 467889999999986 554 24566788999999999999 5777779999999999999999999999999999999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip 161 (621)
++|++++|++++..|.. ..++|++|+|++|.+.+.-+
T Consensus 204 ~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999999999766642 67899999999999997654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=5.1e-10 Score=108.34 Aligned_cols=87 Identities=30% Similarity=0.371 Sum_probs=78.2
Q ss_pred CCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCCcc
Q 045652 70 TGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPTLV 147 (621)
Q Consensus 70 ~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~L~ 147 (621)
..+.+|+.|++++|.++ .+|+..+..+++|+.|++++|+|++..|..+..+++|++|+|++|+|+ .+|.. ..++|+
T Consensus 121 ~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~ 198 (266)
T d1p9ag_ 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198 (266)
T ss_dssp TTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS
T ss_pred ccccccccccccccccc-eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCC
Confidence 44568999999999999 688888899999999999999999888888999999999999999999 88864 678999
Q ss_pred EEEcccCcccc
Q 045652 148 RLNLSSNKLEG 158 (621)
Q Consensus 148 ~l~l~~N~l~g 158 (621)
.|+|++|.+.-
T Consensus 199 ~L~L~~Np~~C 209 (266)
T d1p9ag_ 199 FAFLHGNPWLC 209 (266)
T ss_dssp EEECCSCCBCC
T ss_pred EEEecCCCCCC
Confidence 99999998864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=5.3e-10 Score=98.65 Aligned_cols=94 Identities=28% Similarity=0.382 Sum_probs=78.4
Q ss_pred ceeeEEeCC-------------CcEEEEEecCCC-CeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCC
Q 045652 36 EWSGVVCLK-------------GIVTGLYINSMG-LSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALR 101 (621)
Q Consensus 36 ~w~gv~c~~-------------~~v~~l~l~~~~-l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~ 101 (621)
.+++++|.. .+++.|+|.+++ ++ .|+. ..|.+|++|+.|+|++|+|+ .|++..|..+++|+
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~---~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLEL---RDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECG---GGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCC
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCc---hhhccccccCcceeeccccC-Cccccccccccccc
Confidence 378899941 368899998776 55 4765 45778899999999999999 68878899999999
Q ss_pred EEeCccCcccccCCCCCCCCCCcCeeeccCcccc
Q 045652 102 KLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFN 135 (621)
Q Consensus 102 ~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 135 (621)
.|+|++|+|+ .+|..+.....|+.|+|++|.|.
T Consensus 84 ~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 9999999999 67777666668999999999985
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=1.9e-10 Score=102.24 Aligned_cols=89 Identities=22% Similarity=0.259 Sum_probs=74.7
Q ss_pred ccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC--CCCC
Q 045652 68 ELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF--DQPT 145 (621)
Q Consensus 68 ~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~ 145 (621)
.+.+...|++|+|++|+++ .||. .+..+++|+.|||++|+++ .++ .+..+++|++|+|++|+++...+.. ..++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hccCcCcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 3456678999999999999 6875 4788999999999999999 464 5899999999999999998544432 5799
Q ss_pred ccEEEcccCccccccC
Q 045652 146 LVRLNLSSNKLEGEIP 161 (621)
Q Consensus 146 L~~l~l~~N~l~g~ip 161 (621)
|+.|+|++|+++ .++
T Consensus 89 L~~L~L~~N~i~-~~~ 103 (162)
T d1a9na_ 89 LTELILTNNSLV-ELG 103 (162)
T ss_dssp CCEEECCSCCCC-CGG
T ss_pred cccceecccccc-ccc
Confidence 999999999998 344
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.00 E-value=7.7e-10 Score=109.28 Aligned_cols=125 Identities=22% Similarity=0.248 Sum_probs=94.6
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..++.++++.++++. ++. ..+++|+.|+|++|.+++.++.. |..++.++.|++++|.+++..|..+.++++|
T Consensus 150 ~~L~~l~l~~n~l~~-l~~------~~~~~L~~L~l~~n~~~~~~~~~-~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 150 KKLSYIRIADTNITT-IPQ------GLPPSLTELHLDGNKITKVDAAS-LKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp TTCCEEECCSSCCCS-CCS------SCCTTCSEEECTTSCCCEECTGG-GTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred cccCccccccCCccc-cCc------ccCCccCEEECCCCcCCCCChhH-hhccccccccccccccccccccccccccccc
Confidence 357778888887753 442 12568899999999999776665 8889999999999999998888888899999
Q ss_pred CeeeccCccccccCCCC--CCCCccEEEcccCccccccCccc----------cccccCCCCCCCCCC
Q 045652 125 TELHLESNQFNGTIPSF--DQPTLVRLNLSSNKLEGEIPASL----------LRFNASSFSGNAGLC 179 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~--~~~~L~~l~l~~N~l~g~ip~~~----------~~~~~~~~~~n~~~c 179 (621)
++|+|++|+|+ .+|.. ..++|+.|+|++|+|+ .|+... ..+....+.+|+.-+
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred eeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 99999999998 66653 5789999999999998 565421 122334566777544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.85 E-value=3.1e-09 Score=97.87 Aligned_cols=101 Identities=31% Similarity=0.439 Sum_probs=63.7
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|++++++++. + ..+..|++|++|+|++|++++ +++ ++.+++|+.|++++|.+.. +| .+.+++.|+
T Consensus 41 ~l~~L~l~~~~i~~-l-----~~l~~l~nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~ 109 (199)
T d2omxa2 41 QVTTLQADRLGIKS-I-----DGVEYLNNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLT 109 (199)
T ss_dssp TCCEEECTTSCCCC-C-----TTGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred CCCEEECCCCCCCC-c-----cccccCCCcCcCccccccccC-ccc--ccCCccccccccccccccc-cc-ccccccccc
Confidence 46667777666542 2 234556677777777777774 443 5667777777777777663 33 366677777
Q ss_pred eeeccCccccccCCCCCCCCccEEEcccCccc
Q 045652 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLE 157 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~ 157 (621)
.|++++|.+....+-..+++|+.|++++|++.
T Consensus 110 ~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 110 GLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp EEECCSSCCCCCGGGTTCTTCSEEECCSSCCC
T ss_pred cccccccccccccccchhhhhHHhhhhhhhhc
Confidence 77777776664333335666777777777665
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.81 E-value=3.9e-09 Score=104.04 Aligned_cols=107 Identities=27% Similarity=0.397 Sum_probs=90.0
Q ss_pred ceeeEEeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCC
Q 045652 36 EWSGVVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLP 115 (621)
Q Consensus 36 ~w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p 115 (621)
.|.+|.|.. ++|+ +||. .+. ++|++|+|++|+++ .||+..|.++++|+.|++++|.++...|
T Consensus 11 ~~~~~~C~~----------~~L~-~lP~----~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~ 72 (305)
T d1xkua_ 11 HLRVVQCSD----------LGLE-KVPK----DLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISP 72 (305)
T ss_dssp ETTEEECTT----------SCCC-SCCC----SCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred cCCEEEecC----------CCCC-ccCC----CCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccch
Confidence 588888864 3343 3553 222 57999999999999 7998779999999999999999998888
Q ss_pred CCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCc
Q 045652 116 PSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 116 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~ 162 (621)
..|.+++.|++|+|++|+++ .+|......|..|++++|.+.+ ++.
T Consensus 73 ~~f~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~-l~~ 117 (305)
T d1xkua_ 73 GAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK-VRK 117 (305)
T ss_dssp TTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCB-BCH
T ss_pred hhhhCCCccCEecccCCccC-cCccchhhhhhhhhccccchhh-hhh
Confidence 89999999999999999998 6887777899999999999985 443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.74 E-value=9.2e-09 Score=95.43 Aligned_cols=102 Identities=25% Similarity=0.434 Sum_probs=53.7
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.|+|++|.+++ ++ .+..|++|++|+|++|+++ .||. +..+++|+.|++++|.+.. + ..+..++.|+
T Consensus 69 ~L~~L~L~~n~i~~-l~-----~~~~l~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~ 137 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IK-----PLANLKNLGWLFLDENKVK-DLSS--LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE 137 (210)
T ss_dssp TCCEEECCSSCCCC-CG-----GGTTCTTCCEEECCSSCCC-CGGG--GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCC
T ss_pred CCCEEeCCCccccC-cc-----ccccCcccccccccccccc-cccc--ccccccccccccccccccc-c-cccccccccc
Confidence 45556666655553 22 2344555666666666665 3442 4555566666666655542 2 2345555555
Q ss_pred eeeccCccccccCCCCCCCCccEEEcccCcccc
Q 045652 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g 158 (621)
.+++++|.+++..+....++|+.+++++|++++
T Consensus 138 ~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp EEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC
T ss_pred ccccccccccccccccccccccccccccccccc
Confidence 555555555432222244566666666666663
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.72 E-value=1.5e-08 Score=94.04 Aligned_cols=110 Identities=26% Similarity=0.417 Sum_probs=89.8
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
.++..|++++|.+++ + ..+.++++|+.|++++|.+. .++. +..+++|+.+++++|.+++ +..+.++++|
T Consensus 90 ~~L~~L~l~~n~i~~-l-----~~l~~l~~L~~L~l~~~~~~-~~~~--l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L 158 (210)
T d1h6ta2 90 KNLGWLFLDENKVKD-L-----SSLKDLKKLKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKITD--ITVLSRLTKL 158 (210)
T ss_dssp TTCCEEECCSSCCCC-G-----GGGTTCTTCCEEECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTC
T ss_pred ccccccccccccccc-c-----cccccccccccccccccccc-cccc--ccccccccccccccccccc--cccccccccc
Confidence 478899999998874 3 34778899999999999998 5653 7889999999999999985 3457789999
Q ss_pred CeeeccCccccccCCCCCCCCccEEEcccCccccccCcccccc
Q 045652 125 TELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRF 167 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~ 167 (621)
+++++++|++++..|-..+++|+.|+|++|+++ .||. +..+
T Consensus 159 ~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~~-l~~l 199 (210)
T d1h6ta2 159 DTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGL 199 (210)
T ss_dssp SEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCGG-GTTC
T ss_pred cccccccccccccccccCCCCCCEEECCCCCCC-CChh-hcCC
Confidence 999999999986434347899999999999998 4653 4433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.72 E-value=1.6e-08 Score=92.90 Aligned_cols=125 Identities=27% Similarity=0.388 Sum_probs=90.1
Q ss_pred eeeEEeCCCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC
Q 045652 37 WSGVVCLKGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP 116 (621)
Q Consensus 37 w~gv~c~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~ 116 (621)
++|+ +.-..++.|+|++|.+++ ++ .+.+|++|++|++++|.+. .+|+ +.++++|+.|++++|.+... .
T Consensus 55 l~~l-~~l~nL~~L~Ls~N~l~~-~~-----~l~~l~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~--~ 122 (199)
T d2omxa2 55 IDGV-EYLNNLTQINFSNNQLTD-IT-----PLKNLTKLVDILMNNNQIA-DITP--LANLTNLTGLTLFNNQITDI--D 122 (199)
T ss_dssp CTTG-GGCTTCCEEECCSSCCCC-CG-----GGTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--G
T ss_pred cccc-ccCCCcCcCccccccccC-cc-----cccCCcccccccccccccc-cccc--cccccccccccccccccccc--c
Confidence 4443 223578999999999876 32 3667888999999999988 5663 77889999999998888753 3
Q ss_pred CCCCCCCcCeeeccCccccccCCCC-CCCCccEEEcccCccccccCc--cccccccCCCCCC
Q 045652 117 SLFKLPHLTELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIPA--SLLRFNASSFSGN 175 (621)
Q Consensus 117 ~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip~--~~~~~~~~~~~~n 175 (621)
.+..+++|+.|++++|++. .+|.. ..++|+.|++++|++++ +|. .+.++....+.+|
T Consensus 123 ~~~~l~~L~~L~l~~n~l~-~~~~l~~~~~L~~L~l~~n~l~~-l~~l~~l~~L~~L~ls~N 182 (199)
T d2omxa2 123 PLKNLTNLNRLELSSNTIS-DISALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSN 182 (199)
T ss_dssp GGTTCTTCSEEECCSSCCC-CCGGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSS
T ss_pred ccchhhhhHHhhhhhhhhc-ccccccccccccccccccccccC-CccccCCCCCCEEECCCC
Confidence 4778888999999999887 34543 67888899999998885 332 1223333445555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.70 E-value=8.3e-09 Score=104.83 Aligned_cols=87 Identities=22% Similarity=0.340 Sum_probs=65.6
Q ss_pred cCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC-CCCCcc
Q 045652 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF-DQPTLV 147 (621)
Q Consensus 69 l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~L~ 147 (621)
+..+..++.++++.|++++ ++ . +..+++|+.|+|++|++++.. .+..+++|++|+|++|++++ +|.+ .+++|+
T Consensus 281 ~~~~~~l~~l~~~~n~l~~-~~-~-~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~ 354 (384)
T d2omza2 281 LAGLTALTNLELNENQLED-IS-P-ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNIN 354 (384)
T ss_dssp GTTCTTCSEEECCSSCCSC-CG-G-GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCC
T ss_pred ccccccccccccccccccc-cc-c-cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCC
Confidence 4556677888888888874 43 2 677888888888888888643 27788888888888888874 5544 578888
Q ss_pred EEEcccCccccccC
Q 045652 148 RLNLSSNKLEGEIP 161 (621)
Q Consensus 148 ~l~l~~N~l~g~ip 161 (621)
.|+|++|+|++..|
T Consensus 355 ~L~l~~N~l~~l~~ 368 (384)
T d2omza2 355 WLSAGHNQISDLTP 368 (384)
T ss_dssp EEECCSSCCCBCGG
T ss_pred EEECCCCcCCCChh
Confidence 88888888886544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.67 E-value=9.5e-09 Score=104.39 Aligned_cols=121 Identities=26% Similarity=0.323 Sum_probs=81.4
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCC---------
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLP--------- 115 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p--------- 115 (621)
..++.++++++.++. + +.+..+++|+.|++++|.+++ +++ ++.+++|+.|++++|.+++..|
T Consensus 219 ~~L~~L~l~~n~l~~-~-----~~l~~l~~L~~L~l~~n~l~~-~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~ 289 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I-----GTLASLTNLTDLDLANNQISN-LAP--LSGLTKLTELKLGANQISNISPLAGLTALTN 289 (384)
T ss_dssp TTCCEEECCSSCCCC-C-----GGGGGCTTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSE
T ss_pred CCCCEEECCCCCCCC-c-----chhhcccccchhccccCccCC-CCc--ccccccCCEeeccCcccCCCCcccccccccc
Confidence 456778888887664 2 234556667777777777764 332 4556666666666666654321
Q ss_pred -----------CCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcccCccccccCccccccc---cCCCCCCC
Q 045652 116 -----------PSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPASLLRFN---ASSFSGNA 176 (621)
Q Consensus 116 -----------~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~n~ 176 (621)
..+..+++|++|+|++|++++..|-..+++|+.|+|++|+|++ +| .+..++ ...+.+|.
T Consensus 290 l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQ 362 (384)
T ss_dssp EECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCc
Confidence 2356678999999999999975544478999999999999984 55 355443 34455663
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.62 E-value=1.3e-10 Score=107.07 Aligned_cols=84 Identities=24% Similarity=0.322 Sum_probs=56.8
Q ss_pred cCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCC-CCCCcc
Q 045652 69 LTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF-DQPTLV 147 (621)
Q Consensus 69 l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~L~ 147 (621)
+..|++|++|+|++|+++ .|+ . +..|++|+.|+|++|.|+ .+|.....+++|++|++++|+++. ++.. .+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~-~i~-~-l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIE-KIS-S-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEES-CCC-C-HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHSS
T ss_pred HhcccccceeECcccCCC-Ccc-c-ccCCccccChhhcccccc-cccccccccccccccccccccccc-ccccccccccc
Confidence 445667777777777777 565 2 667777777777777776 466544555667777777777763 3332 456777
Q ss_pred EEEcccCccc
Q 045652 148 RLNLSSNKLE 157 (621)
Q Consensus 148 ~l~l~~N~l~ 157 (621)
.|+|++|+++
T Consensus 119 ~L~L~~N~i~ 128 (198)
T d1m9la_ 119 VLYMSNNKIT 128 (198)
T ss_dssp EEEESEEECC
T ss_pred ccccccchhc
Confidence 7777777776
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.60 E-value=1.7e-10 Score=106.39 Aligned_cols=106 Identities=25% Similarity=0.327 Sum_probs=86.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+..|+|++|+++ .|+ .|.+|++|+.|+|++|+++ .||.. +..+++|+.|+|++|+++. ++ .+..+++|
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-----~l~~l~~L~~L~Ls~N~i~-~i~~~-~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L 117 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-----SLSGMENLRILSLGRNLIK-KIENL-DAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp TTCCEEECSEEEES-CCC-----CHHHHTTCCEEECCEEEEC-SCSSH-HHHHHHCCEEECSEEECCC-HH-HHHHHHHS
T ss_pred cccceeECcccCCC-Ccc-----cccCCccccChhhcccccc-ccccc-ccccccccccccccccccc-cc-cccccccc
Confidence 57889999999876 343 3667789999999999998 78864 5667789999999999985 43 47889999
Q ss_pred CeeeccCccccccCC---C-CCCCCccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIP---S-FDQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p---~-~~~~~L~~l~l~~N~l~g~ip 161 (621)
++|+|++|+++. ++ . ..+++|+.|+|++|.++...+
T Consensus 118 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 118 RVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccchhcc-ccccccccCCCccceeecCCCccccCcc
Confidence 999999999974 33 2 267999999999999985444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=1.5e-07 Score=88.98 Aligned_cols=83 Identities=23% Similarity=0.325 Sum_probs=40.9
Q ss_pred CCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCC-CCCCCCCcCeeeccC-ccccccCCCC--CCCCccEE
Q 045652 74 GLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPP-SLFKLPHLTELHLES-NQFNGTIPSF--DQPTLVRL 149 (621)
Q Consensus 74 ~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~-N~l~g~~p~~--~~~~L~~l 149 (621)
++++|+|++|+++ .||+..|.++++|++|+|++|.+...+|. .|.+++.+++|.+.. |++....|.. .+++|+.|
T Consensus 30 ~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 30 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp CCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 4555555555555 35544455555555555555555444332 344455555555432 3444333332 34555555
Q ss_pred EcccCccc
Q 045652 150 NLSSNKLE 157 (621)
Q Consensus 150 ~l~~N~l~ 157 (621)
++++|++.
T Consensus 109 ~l~~~~l~ 116 (242)
T d1xwdc1 109 LISNTGIK 116 (242)
T ss_dssp EEESCCCC
T ss_pred ccchhhhc
Confidence 55555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.47 E-value=9.1e-08 Score=89.61 Aligned_cols=104 Identities=26% Similarity=0.445 Sum_probs=74.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCc
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHL 124 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L 124 (621)
..+..++++.+...+. ..+.....+..+.++++.+....+ +..+++|+.|++++|.+++.. .++++++|
T Consensus 107 ~~L~~l~l~~~~~~~~------~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L 175 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDV------TPLAGLSNLQVLYLDLNQITNISP---LAGLTNLQYLSIGNAQVSDLT--PLANLSKL 175 (227)
T ss_dssp TTCCEEECTTSCCCCC------GGGTTCTTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCG--GGTTCTTC
T ss_pred cccccccccccccccc------chhccccchhhhhchhhhhchhhh---hccccccccccccccccccch--hhcccccc
Confidence 3566677777665542 234556778888888888874332 566788888888888887533 37788888
Q ss_pred CeeeccCccccccCCCC-CCCCccEEEcccCccccccC
Q 045652 125 TELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIP 161 (621)
Q Consensus 125 ~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip 161 (621)
++|+|++|++++ +|.+ .+++|+.|+|++|++++ +|
T Consensus 176 ~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~-i~ 211 (227)
T d1h6ua2 176 TTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD-VS 211 (227)
T ss_dssp CEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCB-CG
T ss_pred eecccCCCccCC-ChhhcCCCCCCEEECcCCcCCC-Cc
Confidence 888888888875 4544 57888888888888884 44
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.41 E-value=2.6e-07 Score=91.96 Aligned_cols=100 Identities=24% Similarity=0.383 Sum_probs=80.1
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCC
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPH 123 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~ 123 (621)
...++.|+|++++|+. ||. .+++|++|+|++|+|+ +||.. +.+|+.|++++|+++ .++.- .+.
T Consensus 37 ~~~l~~LdLs~~~L~~-lp~-------~~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~ 99 (353)
T d1jl5a_ 37 DRQAHELELNNLGLSS-LPE-------LPPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPL 99 (353)
T ss_dssp HHTCSEEECTTSCCSC-CCS-------CCTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTT
T ss_pred HcCCCEEEeCCCCCCC-CCC-------CCCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---ccc
Confidence 3468899999999974 763 2468999999999999 89864 468999999999998 45532 246
Q ss_pred cCeeeccCccccccCCCC-CCCCccEEEcccCccccccCc
Q 045652 124 LTELHLESNQFNGTIPSF-DQPTLVRLNLSSNKLEGEIPA 162 (621)
Q Consensus 124 L~~l~l~~N~l~g~~p~~-~~~~L~~l~l~~N~l~g~ip~ 162 (621)
|++|+|++|+++ .+|.. ..+.|+.|++++|.+++ +|.
T Consensus 100 L~~L~L~~n~l~-~lp~~~~l~~L~~L~l~~~~~~~-~~~ 137 (353)
T d1jl5a_ 100 LEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLKK-LPD 137 (353)
T ss_dssp CCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSC-CCC
T ss_pred cccccccccccc-cccchhhhccceeeccccccccc-ccc
Confidence 999999999998 66765 67899999999999984 443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=3.3e-07 Score=86.44 Aligned_cols=118 Identities=14% Similarity=0.155 Sum_probs=94.3
Q ss_pred ceeeEEeCC-----------CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEe
Q 045652 36 EWSGVVCLK-----------GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLW 104 (621)
Q Consensus 36 ~w~gv~c~~-----------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~ 104 (621)
.+..|.|.. ..++.|+|++|.++. |+. ..+.++++|++|+|++|.+...+|+..|..++.++.|+
T Consensus 9 ~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-l~~---~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 9 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRV-IQK---GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCE-ECT---TTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCc-cCh---hHhhccchhhhhhhccccccceeecccccccccccccc
Confidence 367888841 358899999999874 664 34678899999999999998888888899999999998
Q ss_pred Cc-cCcccccCCCCCCCCCCcCeeeccCccccccCCCC---CCCCccEEEcccCccc
Q 045652 105 FS-NNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSF---DQPTLVRLNLSSNKLE 157 (621)
Q Consensus 105 l~-~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~L~~l~l~~N~l~ 157 (621)
+. .|++....|..+.++++|++|++++|++....+.. ..+.|..+..+++++.
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred ccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccc
Confidence 76 57888888888999999999999999997433322 2456666777777776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.32 E-value=4.2e-07 Score=84.94 Aligned_cols=118 Identities=21% Similarity=0.349 Sum_probs=85.2
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLT 125 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~ 125 (621)
.++.++++++.++ .+..+.++++|+.|++++|...+ ++. +...+.+..++++++.+.... .+.++++|+
T Consensus 86 ~l~~l~~~~n~~~------~i~~l~~l~~L~~l~l~~~~~~~-~~~--~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~ 154 (227)
T d1h6ua2 86 KITELELSGNPLK------NVSAIAGLQSIKTLDLTSTQITD-VTP--LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQ 154 (227)
T ss_dssp SCCEEECCSCCCS------CCGGGTTCTTCCEEECTTSCCCC-CGG--GTTCTTCCEEECCSSCCCCCG--GGGGCTTCC
T ss_pred ccccccccccccc------ccccccccccccccccccccccc-cch--hccccchhhhhchhhhhchhh--hhccccccc
Confidence 5666777776654 23456778899999999999885 332 567888999999999887543 367888999
Q ss_pred eeeccCccccccCCCCCCCCccEEEcccCccccccCc--cccccccCCCCCC
Q 045652 126 ELHLESNQFNGTIPSFDQPTLVRLNLSSNKLEGEIPA--SLLRFNASSFSGN 175 (621)
Q Consensus 126 ~l~l~~N~l~g~~p~~~~~~L~~l~l~~N~l~g~ip~--~~~~~~~~~~~~n 175 (621)
+|++++|.+++..+-..+++|+.|+|++|++++ +|. .+.++....+.+|
T Consensus 155 ~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNN 205 (227)
T ss_dssp EEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTS
T ss_pred cccccccccccchhhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCC
Confidence 999999998755444467899999999999985 553 2233333445555
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=7.3e-07 Score=85.10 Aligned_cols=132 Identities=17% Similarity=0.124 Sum_probs=89.3
Q ss_pred CcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCCcccceEEEEeCCeeEEEEeecCCCChhHHhhcC
Q 045652 323 GLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLR-HSNVLAPLAYHYRTDEKLLVYEYIPGGSLLYLLHGD 401 (621)
Q Consensus 323 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 401 (621)
+.+.||+... ++..+++|+...........+.+|...+..+. +-.+.+++.+..+.+..++||++++|.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3467998865 56677888876443333445678888888774 434677788888888899999999998886544211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcc-------------------------------------------------
Q 045652 402 RGPSHDELTWPARLKIVQGIARGIGYLHTEL------------------------------------------------- 432 (621)
Q Consensus 402 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------------- 432 (621)
.. ...++.++++.+..||+..
T Consensus 105 -------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 105 -------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp -------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred -------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 11 1234555555566666421
Q ss_pred ------CCCCCccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 433 ------AHLDLPHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 433 ------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
....++|+|+.|.|||+++++..-|+||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012378999999999999776667999987643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.12 E-value=2.7e-06 Score=84.30 Aligned_cols=78 Identities=27% Similarity=0.400 Sum_probs=65.5
Q ss_pred CCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCccccccCCCCCCCCccEEEcc
Q 045652 73 RGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESNQFNGTIPSFDQPTLVRLNLS 152 (621)
Q Consensus 73 ~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~L~~l~l~ 152 (621)
.+|+.|+|++|.++ +||+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l-p~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL-PPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC-CTTCCEEECC
T ss_pred cCCCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh-cccccccccc
Confidence 36899999999999 79953 578999999999999 788764 57899999999997 56543 3579999999
Q ss_pred cCccccccCc
Q 045652 153 SNKLEGEIPA 162 (621)
Q Consensus 153 ~N~l~g~ip~ 162 (621)
+|.++ .+|.
T Consensus 107 ~n~l~-~lp~ 115 (353)
T d1jl5a_ 107 NNQLE-KLPE 115 (353)
T ss_dssp SSCCS-SCCC
T ss_pred ccccc-cccc
Confidence 99998 6775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=3.6e-06 Score=79.63 Aligned_cols=73 Identities=19% Similarity=0.221 Sum_probs=52.7
Q ss_pred CcCCc-ccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCC--CCcccceEEEEeCCeeEEEEeecCCCChh
Q 045652 320 GNGGL-GSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRH--SNVLAPLAYHYRTDEKLLVYEYIPGGSLL 395 (621)
Q Consensus 320 g~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (621)
..|.. +.||+....++..+++|....... ..+..|.+.++.+.. -.+.+++.+..+.+..++||+|++|.++.
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 44443 578999887788889998764432 346678888877743 33566788878888889999999886653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=1.3e-06 Score=76.71 Aligned_cols=65 Identities=22% Similarity=0.296 Sum_probs=29.0
Q ss_pred CCCCCEEecCCCcccccCCc--ccccCCCCCCEEeCccCcccccCCC-CCCCCCCcCeeeccCccccccC
Q 045652 72 LRGLRAIYLDKNQFSGEIPP--GYFDEMGALRKLWFSNNKFRGRLPP-SLFKLPHLTELHLESNQFNGTI 138 (621)
Q Consensus 72 l~~L~~l~l~~N~l~g~ip~--~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~~ 138 (621)
++.|++|+|++|+++ .+++ ..+..+++|+.|+|++|.++. +++ .......|+.|+|++|.+....
T Consensus 64 ~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 64 IPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp CTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred CCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCc
Confidence 344555555555555 2321 113345555555555555552 221 1122234555555555554433
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.67 E-value=2.2e-06 Score=88.19 Aligned_cols=109 Identities=24% Similarity=0.239 Sum_probs=79.6
Q ss_pred cEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCcccc----cCCcccccCCCCCCEEeCccCccccc----CCCC
Q 045652 46 IVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSG----EIPPGYFDEMGALRKLWFSNNKFRGR----LPPS 117 (621)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g----~ip~~~~~~l~~L~~l~l~~N~l~g~----~p~~ 117 (621)
.+..||++++++++.--. .-+..+++|+.|+|++|+++- .|... +..+++|+.|||++|.|+.. +...
T Consensus 3 ~l~~ld~~~~~i~~~~~~---~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~-L~~~~~L~~LdLs~N~i~~~~~~~l~~~ 78 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWA---ELLPLLQQCQVVRLDDCGLTEARCKDISSA-LRVNPALAELNLRSNELGDVGVHCVLQG 78 (460)
T ss_dssp EEEEEEEESCCCCHHHHH---HHHHHHTTCSEEEEESSCCCHHHHHHHHHH-HHTCTTCCEEECTTCCCHHHHHHHHHHT
T ss_pred CCCEEEeeCCcCChHHHH---HHHHhCCCCCEEEeCCCCCCHHHHHHHHHH-HhcCCCCCEEECcCCcCChHHHHHHHHH
Confidence 578999999999863211 113346788999999999872 34433 67899999999999998631 3333
Q ss_pred CC-CCCCcCeeeccCcccccc----CCC--CCCCCccEEEcccCcccc
Q 045652 118 LF-KLPHLTELHLESNQFNGT----IPS--FDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 118 ~~-~l~~L~~l~l~~N~l~g~----~p~--~~~~~L~~l~l~~N~l~g 158 (621)
+. ...+|++|+|++|+++.. ++. ...++|+.|+|++|.++.
T Consensus 79 l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 79 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred HhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 33 345799999999999753 222 256899999999999874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.64 E-value=5.8e-07 Score=79.12 Aligned_cols=87 Identities=18% Similarity=0.169 Sum_probs=60.4
Q ss_pred CCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCccccc--CCCCCCCCCCcCeeeccCccccccCCCC---CCCCc
Q 045652 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGR--LPPSLFKLPHLTELHLESNQFNGTIPSF---DQPTL 146 (621)
Q Consensus 72 l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~--~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~L 146 (621)
+..+..|++.+|..+ .++. .+..+++|++|+|++|+++.. ++..+..+++|+.|+|++|+++ .++.. ....|
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~-~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L 117 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRI-IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKL 117 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHH-HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCC
T ss_pred ccchhhcchhhhHhh-hhHH-HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhcccc
Confidence 334444444444443 3433 356789999999999999853 3344667899999999999997 45542 45678
Q ss_pred cEEEcccCccccccC
Q 045652 147 VRLNLSSNKLEGEIP 161 (621)
Q Consensus 147 ~~l~l~~N~l~g~ip 161 (621)
+.|+|++|.++....
T Consensus 118 ~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 118 EELWLDGNSLSDTFR 132 (162)
T ss_dssp SSCCCTTSTTSSSSS
T ss_pred ceeecCCCCcCcCcc
Confidence 999999999886544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=9.6e-05 Score=74.40 Aligned_cols=75 Identities=17% Similarity=0.171 Sum_probs=47.5
Q ss_pred HcCcCCcccEEEEEEcC-CcEEEEEEccCC-------ChhhHHHHHHHHHHHhcCC-C--CCcccceEEEEeCCeeEEEE
Q 045652 318 VLGNGGLGSSYKAMMAD-GVTVVVKRMKES-------SAMARDAFDTEVRRLGRLR-H--SNVLAPLAYHYRTDEKLLVY 386 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~ 386 (621)
.||.|....||++...+ ++.|+||.-... .....+....|.+.|+.+. + ..+.+++. .+.+..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEEE
Confidence 47899999999998544 678999965321 1112334556888887662 3 23444444 3566678999
Q ss_pred eecCCCCh
Q 045652 387 EYIPGGSL 394 (621)
Q Consensus 387 e~~~~gsL 394 (621)
|++.+..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99976543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.44 E-value=9e-06 Score=80.68 Aligned_cols=112 Identities=23% Similarity=0.286 Sum_probs=50.7
Q ss_pred CcEEEEEecCCCCeeeeCc---ccc------cccCCCCCCCEEecCCCccccc----CCcccccCCCCCCEEeCccCccc
Q 045652 45 GIVTGLYINSMGLSGKIDV---DAL------TELTGLRGLRAIYLDKNQFSGE----IPPGYFDEMGALRKLWFSNNKFR 111 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~---~~~------~~l~~l~~L~~l~l~~N~l~g~----ip~~~~~~l~~L~~l~l~~N~l~ 111 (621)
..++.|+|+++.+...-.. ..+ ........|+.|++++|.++-. +.. .+...+.|+.|+|++|+++
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~-~l~~~~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK-TFQSHRLLHTVKMVQNGIR 199 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH-HHHHCTTCCEEECCSSCCC
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccc-hhhhhhhhccccccccccc
Confidence 5688888888876421000 000 0112234555555555555311 111 1233445555555555554
Q ss_pred cc-----CCCCCCCCCCcCeeeccCcccccc----CCC--CCCCCccEEEcccCccc
Q 045652 112 GR-----LPPSLFKLPHLTELHLESNQFNGT----IPS--FDQPTLVRLNLSSNKLE 157 (621)
Q Consensus 112 g~-----~p~~~~~l~~L~~l~l~~N~l~g~----~p~--~~~~~L~~l~l~~N~l~ 157 (621)
.. +...+..+++|+.|+|++|+++.. +.. ...++|+.|+|++|+++
T Consensus 200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 21 223344455555555555554321 110 02345555555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.43 E-value=4.5e-06 Score=85.76 Aligned_cols=113 Identities=20% Similarity=0.182 Sum_probs=56.2
Q ss_pred CcEEEEEecCCCCeeeeCcccccc-c-CCCCCCCEEecCCCcccccCCcc---cccCCCCCCEEeCccCccccc----CC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTE-L-TGLRGLRAIYLDKNQFSGEIPPG---YFDEMGALRKLWFSNNKFRGR----LP 115 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~-l-~~l~~L~~l~l~~N~l~g~ip~~---~~~~l~~L~~l~l~~N~l~g~----~p 115 (621)
..+..+++++|.++..-.. .+.. + .....|+.+++++|.++..-... .+....+|+.|+|++|++++. ++
T Consensus 283 ~~l~~l~l~~n~i~~~~~~-~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~ 361 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGAR-LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361 (460)
T ss_dssp TTCCEEECTTCCCHHHHHH-HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred ccccccccccccccccccc-hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhh
Confidence 4566677777766431110 1100 1 12235666666666665321111 123345666666666666532 33
Q ss_pred CCCC-CCCCcCeeeccCcccccc----CCCC--CCCCccEEEcccCcccc
Q 045652 116 PSLF-KLPHLTELHLESNQFNGT----IPSF--DQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 116 ~~~~-~l~~L~~l~l~~N~l~g~----~p~~--~~~~L~~l~l~~N~l~g 158 (621)
..+. ..+.|++|+|++|+|+.. ++.. ..++|+.|||++|+|+.
T Consensus 362 ~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 3332 345566666666666531 1111 23566666666666653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.28 E-value=1.6e-05 Score=76.47 Aligned_cols=83 Identities=18% Similarity=0.184 Sum_probs=51.4
Q ss_pred CCCCCEEecCCCcccccCCcccccCCCCCCEEeCccCcccccCCCCCCCCCCcCeeeccCc-ccccc-CCC--CCCCCcc
Q 045652 72 LRGLRAIYLDKNQFSGEIPPGYFDEMGALRKLWFSNNKFRGRLPPSLFKLPHLTELHLESN-QFNGT-IPS--FDQPTLV 147 (621)
Q Consensus 72 l~~L~~l~l~~N~l~g~ip~~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N-~l~g~-~p~--~~~~~L~ 147 (621)
..+|++|||+++.+++.-....+..+++|++|+|+++.+++..+..++.+++|++|+|+++ .++.. +.. ...++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 3467777777777665433334666777777777777777666666777777777777763 44321 111 1346677
Q ss_pred EEEcccC
Q 045652 148 RLNLSSN 154 (621)
Q Consensus 148 ~l~l~~N 154 (621)
.|+|+++
T Consensus 125 ~L~ls~c 131 (284)
T d2astb2 125 ELNLSWC 131 (284)
T ss_dssp EEECCCC
T ss_pred ccccccc
Confidence 7777763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.25 E-value=1.4e-05 Score=79.29 Aligned_cols=114 Identities=18% Similarity=0.151 Sum_probs=75.3
Q ss_pred CcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccccc----CCcccccCCCCCCEEeCccCccccc----CCC
Q 045652 45 GIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE----IPPGYFDEMGALRKLWFSNNKFRGR----LPP 116 (621)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~----ip~~~~~~l~~L~~l~l~~N~l~g~----~p~ 116 (621)
..+..+.++.+.++-.-.......+.....|+.|+|++|+++.. +-...+..+++|+.|+|++|.|+.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 45777888887664211000011234456888999999988632 1112356788899999999988643 445
Q ss_pred CCCCCCCcCeeeccCccccccC--------CCCCCCCccEEEcccCcccc
Q 045652 117 SLFKLPHLTELHLESNQFNGTI--------PSFDQPTLVRLNLSSNKLEG 158 (621)
Q Consensus 117 ~~~~l~~L~~l~l~~N~l~g~~--------p~~~~~~L~~l~l~~N~l~g 158 (621)
.+..+++|++|+|++|.+++.- .....+.|+.|+|++|+++.
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 5678888999999999886431 11234678999999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.17 E-value=0.001 Score=64.65 Aligned_cols=138 Identities=14% Similarity=0.126 Sum_probs=78.9
Q ss_pred ccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCc--ccce-----EEEEeCCeeEEEEeecCCCChh--
Q 045652 325 GSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV--LAPL-----AYHYRTDEKLLVYEYIPGGSLL-- 395 (621)
Q Consensus 325 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~-- 395 (621)
-.||++...+|..|++|+.+... ...+++..|.+.+..|....+ +..+ ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999899999999987542 235667788888887742222 1111 1234456678999999764331
Q ss_pred ---HH---------hh----cCCCCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHhc---cCCCCC
Q 045652 396 ---YL---------LH----GDRGPSHDELTWP-------------------ARLKIVQGIARGIGYLHTE---LAHLDL 437 (621)
Q Consensus 396 ---~~---------l~----~~~~~~~~~l~~~-------------------~~~~i~~~i~~~L~~LH~~---~~~~~i 437 (621)
.+ +| .........+++. ....+...+...++.+... ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 01 1111111122211 1111222223333344322 124578
Q ss_pred ccCCCCCCCEEeCCCCCcEEEeeeccee
Q 045652 438 PHGNLKSSNIFISPENEPLISEFGFYTM 465 (621)
Q Consensus 438 vH~Dlkp~NIll~~~~~~kl~DfG~a~~ 465 (621)
+|+|+.+.|||++++ ..++||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 46899987653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.85 E-value=0.00039 Score=66.45 Aligned_cols=82 Identities=16% Similarity=0.115 Sum_probs=61.4
Q ss_pred CCCCEEecCCC--cccccCCcccccCCCCCCEEeCccC-cccccCCCCCCCCCCcCeeeccCc-cccccCCC--CCCCCc
Q 045652 73 RGLRAIYLDKN--QFSGEIPPGYFDEMGALRKLWFSNN-KFRGRLPPSLFKLPHLTELHLESN-QFNGTIPS--FDQPTL 146 (621)
Q Consensus 73 ~~L~~l~l~~N--~l~g~ip~~~~~~l~~L~~l~l~~N-~l~g~~p~~~~~l~~L~~l~l~~N-~l~g~~p~--~~~~~L 146 (621)
+.|+.|+|++. .++..--...+.++++|+.|+|++| .+++..+..+.++++|++|+|+++ .+++.-.. ...++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 57999999864 4443211223467899999999985 588888888999999999999994 66644322 256899
Q ss_pred cEEEcccC
Q 045652 147 VRLNLSSN 154 (621)
Q Consensus 147 ~~l~l~~N 154 (621)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 99999887
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.37 E-value=0.00043 Score=60.35 Aligned_cols=37 Identities=19% Similarity=0.197 Sum_probs=16.1
Q ss_pred CCCCCEEeCccCccccc----CCCCCCCCCCcCeeeccCcc
Q 045652 97 MGALRKLWFSNNKFRGR----LPPSLFKLPHLTELHLESNQ 133 (621)
Q Consensus 97 l~~L~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~ 133 (621)
.+.|+.|+|++|.++.. +-..+...++|++|+|++|.
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~ 111 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR 111 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCc
Confidence 34455555555554421 11123334445555555443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.04 E-value=0.0041 Score=62.01 Aligned_cols=71 Identities=13% Similarity=0.109 Sum_probs=46.2
Q ss_pred HcCcCCcccEEEEEEcC--------CcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCcc-cceEEEEeCCeeEEEEee
Q 045652 318 VLGNGGLGSSYKAMMAD--------GVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNVL-APLAYHYRTDEKLLVYEY 388 (621)
Q Consensus 318 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 388 (621)
.|+.|-.-.+|++...+ .+.|++++.-... ......+|..+++.+.-.+++ ++++++. + .+||||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEE
Confidence 46777778899988644 3567777664322 223456899999888533444 5666552 2 689999
Q ss_pred cCCCCh
Q 045652 389 IPGGSL 394 (621)
Q Consensus 389 ~~~gsL 394 (621)
++|..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.80 E-value=0.00084 Score=58.38 Aligned_cols=85 Identities=14% Similarity=0.186 Sum_probs=59.9
Q ss_pred CCCCCEEecCCC-ccccc----CCcccccCCCCCCEEeCccCcccccCCC----CCCCCCCcCeeeccCccccccC-CC-
Q 045652 72 LRGLRAIYLDKN-QFSGE----IPPGYFDEMGALRKLWFSNNKFRGRLPP----SLFKLPHLTELHLESNQFNGTI-PS- 140 (621)
Q Consensus 72 l~~L~~l~l~~N-~l~g~----ip~~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~L~~l~l~~N~l~g~~-p~- 140 (621)
.+.|+.|+|+++ .++.. +-. .+...++|+.|+|++|.++..-.. .+...+.|++|+|++|.++..- ..
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~-~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHH-HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 468999999874 56532 111 255678899999999998743222 3445788999999999987421 11
Q ss_pred ----CCCCCccEEEcccCccc
Q 045652 141 ----FDQPTLVRLNLSSNKLE 157 (621)
Q Consensus 141 ----~~~~~L~~l~l~~N~l~ 157 (621)
...++|+.|+|++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 14578999999999765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.16 E-value=0.0087 Score=57.41 Aligned_cols=143 Identities=11% Similarity=0.111 Sum_probs=73.2
Q ss_pred cCcCCcccEEEEEEcCCcEEEEEEccCCChhhHHHHHHHHHHHhcCCCCCc--ccceE------EEEeCCeeEEEEeecC
Q 045652 319 LGNGGLGSSYKAMMADGVTVVVKRMKESSAMARDAFDTEVRRLGRLRHSNV--LAPLA------YHYRTDEKLLVYEYIP 390 (621)
Q Consensus 319 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~------~~~~~~~~~lv~e~~~ 390 (621)
|..|---+.|+....+|+ +++|+..... ..+.+..|++++..|...++ ...+. +.........++.++.
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 556666788998876664 7889876432 23445567777777642221 11110 1223445667777776
Q ss_pred CCChhH--------------Hhh----cCCCCCCCCCCH------------------HHHHHHHHHHHHHHHHHHhccCC
Q 045652 391 GGSLLY--------------LLH----GDRGPSHDELTW------------------PARLKIVQGIARGIGYLHTELAH 434 (621)
Q Consensus 391 ~gsL~~--------------~l~----~~~~~~~~~l~~------------------~~~~~i~~~i~~~L~~LH~~~~~ 434 (621)
+..... .++ ............ ......+..+...+.-.+...-+
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 543311 000 000000000000 01112222333333333332234
Q ss_pred CCCccCCCCCCCEEeCCCCCcEEEeeecce
Q 045652 435 LDLPHGNLKSSNIFISPENEPLISEFGFYT 464 (621)
Q Consensus 435 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 464 (621)
.++||+|+.++||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.40 E-value=0.0034 Score=54.19 Aligned_cols=112 Identities=13% Similarity=0.157 Sum_probs=53.1
Q ss_pred CcEEEEEecCC-CCeeeeCcccccccCCCCCCCEEecCCCcccccCCc---ccccCCCCCCEEeCccCccccc----CCC
Q 045652 45 GIVTGLYINSM-GLSGKIDVDALTELTGLRGLRAIYLDKNQFSGEIPP---GYFDEMGALRKLWFSNNKFRGR----LPP 116 (621)
Q Consensus 45 ~~v~~l~l~~~-~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~ip~---~~~~~l~~L~~l~l~~N~l~g~----~p~ 116 (621)
..++.|+|+++ .++...-......+.....|+.|+|++|.++..--. +.+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 45666666652 332211100112344456677777777766532111 1134456677777777766532 223
Q ss_pred CCCCCCCcCeeec--cCcccccc----CCCC--CCCCccEEEcccCcc
Q 045652 117 SLFKLPHLTELHL--ESNQFNGT----IPSF--DQPTLVRLNLSSNKL 156 (621)
Q Consensus 117 ~~~~l~~L~~l~l--~~N~l~g~----~p~~--~~~~L~~l~l~~N~l 156 (621)
.+...++|+.++| ++|.+... +-.. ..++|+.|+++.|+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 4455566665443 34444311 1000 245666666665544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=81.40 E-value=0.055 Score=46.08 Aligned_cols=91 Identities=14% Similarity=0.123 Sum_probs=61.3
Q ss_pred CCcEEEEEecCCCCeeeeCcccccccCCCCCCCEEecCCCccccc----CCcccccCCCCCCEEeC--ccCcccc----c
Q 045652 44 KGIVTGLYINSMGLSGKIDVDALTELTGLRGLRAIYLDKNQFSGE----IPPGYFDEMGALRKLWF--SNNKFRG----R 113 (621)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~~l~l~~N~l~g~----ip~~~~~~l~~L~~l~l--~~N~l~g----~ 113 (621)
...++.|+|+++.++..--......+.....|+.|++++|.++.. |-. .+...++|+.++| ++|.+.. .
T Consensus 45 n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~-~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 45 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE-ALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH-GGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred CCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH-HHHhCccccEEeeccCCCcCcHHHHHH
Confidence 467999999999886432111112234567899999999999743 112 2556788887555 6777754 2
Q ss_pred CCCCCCCCCCcCeeeccCcccc
Q 045652 114 LPPSLFKLPHLTELHLESNQFN 135 (621)
Q Consensus 114 ~p~~~~~l~~L~~l~l~~N~l~ 135 (621)
+-..+...+.|+.|+|+.|...
T Consensus 124 La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCcCEEeCcCCCCc
Confidence 4445667889999999887653
|